Citrus Sinensis ID: 015931

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------40
Protein Sequence
MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR
Secondary Structure (PSIPRED)
ccccccccccEEEEccccccccccccccHHHHHccccccccccccccccccHHHHHHHHccccccccccccccccEEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEEcccccEEEEEEEcccccHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHHHHccccccccccccccHHHHccHHHHHHcccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccHHHHHcccccccccccccccccccHHHHHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHHEEEEEcccccEEEEEEEEcccccHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccccEEEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccccHHHHccHHHccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHnfskgrvlgrGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAsslhhpnivplvgfcidpeQGLFLIYKYVsggslerhlhekkkgvrgnstlpwSVRYKVALGIAESVAYLHNgtercvvhrdikpsnillsskkipklcdfglatwtsapsvpflcktvkgtfgylapeyfqhgkvsdktdVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLdprlkctsrNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWkkhnfsgiidcypqlqqTKSEMKSHLALAMVGvsefeeddhlycr
Flexible Loop (DISEMBL)
mnigasasATVLMVNLENGLCDSRAQELKWRKIQslersispvaNSLIRLSYGEILAATHNFSKGRVLGRGALSfvfkgkvgllrtsvaikrldkedkesSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHlhekkkgvrgnstlpwSVRYKVALGIAESVAYLHNGTERCVVHRDikpsnillsskKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTgrkpiearrlqgeenlVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAAcisseesrrpgIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMvgvsefeeddhlycr
Low Complexity Region (SEG)
MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSaqiarviqaaaaCISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR
Disordered region (IsUnstruct)
*********TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL********KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISS****RPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQ*******HLALAMVGV************
Disordered Region (DISOPRED)
************************************************RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA**LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE*****************************************************
Disordered Region (DISEMBL)
MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR
Disordered Region (DISPRO)
MNIGASASATVLMVNLENGLCDSRAQ*******************SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE****************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	398	2.2.26 [Sep-21-2011]
Q9LK03	717	Proline-rich receptor-lik	no	no	0.716	0.397	0.403	5e-57
Q5XF57	579	Probable receptor-like se	no	no	0.773	0.531	0.369	8e-57
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.721	0.559	0.399	3e-56
Q8RXC8	460	Receptor-like cytosolic s	no	no	0.738	0.639	0.401	6e-56
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.788	0.442	0.392	1e-55
Q8RWW0	744	Receptor-like serine/thre	no	no	0.728	0.389	0.420	4e-55
Q9FE20	456	Serine/threonine-protein	no	no	0.721	0.629	0.392	7e-55
Q9SGY7	718	Putative proline-rich rec	no	no	0.746	0.413	0.396	2e-54
Q9LV48	652	Proline-rich receptor-lik	no	no	0.728	0.444	0.395	4e-54
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.753	0.440	0.393	2e-53

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  221 bits (564), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 121/300 (40%), Positives = 186/300 (62%), Gaps = 15/300 (5%)

Query: 50  LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRE 107
            +Y E+  AT+ FS+  +LG+G   +VFKG   +LR    VA+K+L +   +  + F  E
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKG---MLRNGKEVAVKQLKEGSSQGEREFQAE 398

Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
           + I S +HH ++V LVG+CI   Q L L+Y++V   +LE HLH K     G  T+ WS R
Sbjct: 399 VGIISRVHHRHLVALVGYCIADAQRL-LVYEFVPNNTLEFHLHGK-----GRPTMEWSSR 452

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
            K+A+G A+ ++YLH      ++HRDIK SNIL+  K   K+ DFGLA   S  +   + 
Sbjct: 453 LKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVS 511

Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 287
             V GTFGYLAPEY   GK+++K+DV++FGVVLLEL+TGR+PI+   +  + +LV WA+P
Sbjct: 512 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARP 571

Query: 288 ILHR--GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE 345
           +L++   +   E ++D +L     +  ++AR++  AAAC+ S   RRP ++++  +L G 
Sbjct: 572 LLNQVSELGNFEVVVDKKLN-NEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGN 630

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1

 Score =  221 bits (563), Expect = 8e-57,   Method: Compositional matrix adjust.
 Identities = 122/330 (36%), Positives = 192/330 (58%), Gaps = 22/330 (6%)

Query: 29  KWRKIQSLERSISPVANSLIR-LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTS 87
           KWR  ++  +   P    LI+  +Y EI  AT++F +G ++G G  S V++G +   R  
Sbjct: 236 KWRGSETKNK---PKPQPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGR-R 291

Query: 88  VAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           +A+KRL KE  D    K F  EL I S + HPN   L+G C+  E+GL+L++++   G+L
Sbjct: 292 IAVKRLAKESGDMNKEKEFLTELGIISHVSHPNTALLLGCCV--EKGLYLVFRFSENGTL 349

Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
              LHE + G     +L W VRYK+A+G+A  + YLH      ++HRDIK SN+LL    
Sbjct: 350 YSALHENENG-----SLDWPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDY 404

Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            P++ DFGLA W            V+GTFGYLAPE    G + +KTD+YAFG++LLE++T
Sbjct: 405 EPQITDFGLAKWLPNKWTHHAVIPVEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIIT 464

Query: 266 GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACI 325
           GR+P+       +++++LWAKP +  G  +  EL+DP+L+    +  Q+ +++  A+ C+
Sbjct: 465 GRRPVNPT----QKHILLWAKPAMETGNTS--ELVDPKLQ-DKYDDQQMNKLVLTASHCV 517

Query: 326 SSEESRRPGIEEIIAIL-RGEEELIYCTWK 354
                 RP + +++ +L  G E  I  +W+
Sbjct: 518 QQSPILRPTMTQVLELLTNGNEAEIAKSWR 547

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  219 bits (558), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 119/298 (39%), Positives = 184/298 (61%), Gaps = 11/298 (3%)

Query: 50  LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 109
            +YGE+  AT+ FS+  +LG G   FV+KG +      VA+K+L     +  K F  E+ 
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNN-GNEVAVKQLKVGSAQGEKEFQAEVN 229

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           I S +HH N+V LVG+CI   Q L L+Y++V   +LE HLH K     G  T+ WS+R K
Sbjct: 230 IISQIHHRNLVSLVGYCIAGAQRL-LVYEFVPNNTLEFHLHGK-----GRPTMEWSLRLK 283

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
           +A+  ++ ++YLH      ++HRDIK +NIL+  K   K+ DFGLA   +  +   +   
Sbjct: 284 IAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK-IALDTNTHVSTR 342

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL 289
           V GTFGYLAPEY   GK+++K+DVY+FGVVLLEL+TGR+P++A  +  +++LV WA+P+L
Sbjct: 343 VMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLL 402

Query: 290 HRGM--AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE 345
            + +  +  E L D +L     +  ++AR++  AAAC+     RRP +++++ +L G 
Sbjct: 403 VQALEESNFEGLADIKLN-NEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGN 459

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1

 Score =  218 bits (555), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 126/314 (40%), Positives = 179/314 (57%), Gaps = 20/314 (6%)

Query: 39  SISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDK- 95
            I    +SL   S  +I  AT NFS   ++GRG  + V++G +  G L   +A+KRL K 
Sbjct: 120 DIYDFQSSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKL---IAVKRLTKG 176

Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 155
              E +  F  EL I + + HPN    +G CI  E G+ L+++    GSL   LH   K 
Sbjct: 177 TPDEQTAEFLSELGIIAHVDHPNTAKFIGCCI--EGGMHLVFRLSPLGSLGSLLHGPSK- 233

Query: 156 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
                 L WS RY VALG A+ + YLH G +R ++HRDIK  NILL+    P++CDFGLA
Sbjct: 234 ----YKLTWSRRYNVALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLA 289

Query: 216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
            W             +GTFGY APEYF HG V +KTDV+AFGV+LLEL+TG   ++    
Sbjct: 290 KWLPKQLTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALD---- 345

Query: 276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI 335
           + +++LVLWAKP+L R   A++EL+DP L     N  ++ R+   A+ CI      RP +
Sbjct: 346 ESQQSLVLWAKPLLER--KAIKELVDPSLG-DEYNREELIRLTSTASLCIDQSSLLRPRM 402

Query: 336 EEIIAILRGEEELI 349
            +++ +L G E+++
Sbjct: 403 SQVVELLLGHEDVV 416

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  217 bits (553), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 130/331 (39%), Positives = 191/331 (57%), Gaps = 17/331 (5%)

Query: 50  LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 109
            +Y E+   T  FSK  +LG G    V+KGK+   +  VA+K+L     +  + F  E+ 
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKL-VAVKQLKVGSGQGDREFKAEVE 399

Query: 110 IASSLHHPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           I S +HH ++V LVG+CI D E+   LIY+YV   +LE HLH K     G   L W+ R 
Sbjct: 400 IISRVHHRHLVSLVGYCIADSER--LLIYEYVPNQTLEHHLHGK-----GRPVLEWARRV 452

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
           ++A+G A+ +AYLH      ++HRDIK +NILL  +   ++ DFGLA    +     +  
Sbjct: 453 RIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQT-HVST 511

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 288
            V GTFGYLAPEY Q GK++D++DV++FGVVLLEL+TGRKP++  +  GEE+LV WA+P+
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPL 571

Query: 289 LHRGMAAVE--ELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE 345
           LH+ +   +  EL+D RL K    N  ++ R+I+ AAAC+     +RP + +++  L  E
Sbjct: 572 LHKAIETGDFSELVDRRLEKHYVEN--EVFRMIETAAACVRHSGPKRPRMVQVVRALDSE 629

Query: 346 EELIYCTWKKHNFSGIIDCYPQLQQTKSEMK 376
            ++        N  G    Y   Q     MK
Sbjct: 630 GDM--GDISNGNKVGQSSAYDSGQYNNDTMK 658

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  215 bits (548), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 129/307 (42%), Positives = 179/307 (58%), Gaps = 17/307 (5%)

Query: 44  ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 103
           A S+   +  E+  AT  FS  RVLG G    V++G +    T VA+K L ++++   + 
Sbjct: 331 ALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMED-GTEVAVKLLTRDNQNRDRE 389

Query: 104 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 163
           F  E+ + S LHH N+V L+G CI+  +   LIY+ V  GS+E HLHE         TL 
Sbjct: 390 FIAEVEMLSRLHHRNLVKLIGICIE-GRTRCLIYELVHNGSVESHLHE--------GTLD 440

Query: 164 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
           W  R K+ALG A  +AYLH  +   V+HRD K SN+LL     PK+ DFGLA   +  S 
Sbjct: 441 WDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 500

Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
             +   V GTFGY+APEY   G +  K+DVY++GVVLLELLTGR+P++  +  GEENLV 
Sbjct: 501 -HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVT 559

Query: 284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
           WA+P+L      +E+L+DP L  T  N   +A+V   A+ C+  E S RP + E++  L+
Sbjct: 560 WARPLL-ANREGLEQLVDPALAGT-YNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALK 617

Query: 344 GEEELIY 350
               LIY
Sbjct: 618 ----LIY 620

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  214 bits (546), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 115/293 (39%), Positives = 173/293 (59%), Gaps = 6/293 (2%)

Query: 50  LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 109
            ++ E+ AAT NF     LG G    V+KG++      VA+K+LD+   + ++ F  E++
Sbjct: 74  FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           + S LHHPN+V L+G+C D +Q L L+Y+++  GSLE HLH+          L W++R K
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPD---KEALDWNMRMK 189

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
           +A G A+ + +LH+     V++RD K SNILL     PKL DFGLA          +   
Sbjct: 190 IAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTR 249

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL 289
           V GT+GY APEY   G+++ K+DVY+FGVV LEL+TGRK I++    GE+NLV WA+P+ 
Sbjct: 250 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLF 309

Query: 290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
           +     + +L DPRLK      A + + +  A+ CI  + + RP I +++  L
Sbjct: 310 NDRRKFI-KLADPRLKGRFPTRA-LYQALAVASMCIQEQAATRPLIADVVTAL 360

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  213 bits (543), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 122/308 (39%), Positives = 182/308 (59%), Gaps = 11/308 (3%)

Query: 43  VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK 102
           +  S I  +Y E+   T  F K  V+G G    V+KG +      VAIK+L     E  +
Sbjct: 351 IGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKG-ILFEGKPVAIKQLKSVSAEGYR 409

Query: 103 AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL 162
            F  E+ I S +HH ++V LVG+CI  EQ  FLIY++V   +L+ HLH K   V     L
Sbjct: 410 EFKAEVEIISRVHHRHLVSLVGYCIS-EQHRFLIYEFVPNNTLDYHLHGKNLPV-----L 463

Query: 163 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
            WS R ++A+G A+ +AYLH      ++HRDIK SNILL  +   ++ DFGLA      +
Sbjct: 464 EWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDT-A 522

Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 282
              +   V GTFGYLAPEY   GK++D++DV++FGVVLLEL+TGRKP++  +  GEE+LV
Sbjct: 523 QSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLV 582

Query: 283 LWAKPILHRGM--AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
            WA+P L   +    + E++DPRL+     S ++ ++I+ AA+C+     +RP + +++ 
Sbjct: 583 EWARPRLIEAIEKGDISEVVDPRLENDYVES-EVYKMIETAASCVRHSALKRPRMVQVVR 641

Query: 341 ILRGEEEL 348
            L   ++L
Sbjct: 642 ALDTRDDL 649

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  212 bits (539), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 119/301 (39%), Positives = 182/301 (60%), Gaps = 11/301 (3%)

Query: 50  LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 109
            +Y E+  AT+ FS+  +LG+G   +V KG +   +  VA+K+L     +  + F  E+ 
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGK-EVAVKQLKAGSGQGEREFQAEVE 326

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           I S +HH ++V L+G+C+   Q L L+Y++V   +LE HLH K     G  T+ WS R K
Sbjct: 327 IISRVHHRHLVSLIGYCMAGVQRL-LVYEFVPNNNLEFHLHGK-----GRPTMEWSTRLK 380

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
           +ALG A+ ++YLH      ++HRDIK SNIL+  K   K+ DFGLA   S  +   +   
Sbjct: 381 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTR 439

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL 289
           V GTFGYLAPEY   GK+++K+DV++FGVVLLEL+TGR+P++A  +  +++LV WA+P+L
Sbjct: 440 VMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL 499

Query: 290 HRGM--AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE 347
           +R       E L D ++     +  ++AR++  AAAC+     RRP + +I+  L G   
Sbjct: 500 NRASEEGDFEGLADSKMG-NEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVS 558

Query: 348 L 348
           L
Sbjct: 559 L 559

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  209 bits (533), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 124/315 (39%), Positives = 179/315 (56%), Gaps = 15/315 (4%)

Query: 43  VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK 102
           V+N     SY E+   T  FS+  +LG G    V+KG +   R  VA+K+L     +  +
Sbjct: 320 VSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGR-EVAVKQLKIGGSQGER 378

Query: 103 AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL 162
            F  E+ I S +HH ++V LVG+CI  EQ   L+Y YV   +L  HLH       G   +
Sbjct: 379 EFKAEVEIISRVHHRHLVTLVGYCIS-EQHRLLVYDYVPNNTLHYHLHAP-----GRPVM 432

Query: 163 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
            W  R +VA G A  +AYLH      ++HRDIK SNILL +     + DFGLA       
Sbjct: 433 TWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELD 492

Query: 223 VPFLCKT-VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
           +     T V GTFGY+APEY   GK+S+K DVY++GV+LLEL+TGRKP++  +  G+E+L
Sbjct: 493 LNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESL 552

Query: 282 VLWAKPILHRGMAAVE--ELLDPRLKCTSRN--SAQIARVIQAAAACISSEESRRPGIEE 337
           V WA+P+L + +   E  EL+DPRL    +N    ++ R+++AAAAC+    ++RP + +
Sbjct: 553 VEWARPLLGQAIENEEFDELVDPRL---GKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQ 609

Query: 338 IIAILRGEEELIYCT 352
           ++  L   EE    T
Sbjct: 610 VVRALDTLEEATDIT 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	398
224065170	523	predicted protein [Populus trichocarpa]	1.0	0.760	0.830	0.0
224079445	520	predicted protein [Populus trichocarpa]	0.997	0.763	0.822	0.0
363807838	508	uncharacterized protein LOC100808074 [Gl	0.992	0.777	0.765	0.0
356569560	511	PREDICTED: proline-rich receptor-like pr	0.992	0.772	0.768	0.0
359488192	519	PREDICTED: probable receptor-like serine	0.989	0.759	0.775	0.0
217074712	389	unknown [Medicago truncatula]	0.964	0.987	0.790	1e-180
449445086	519	PREDICTED: proline-rich receptor-like pr	0.997	0.764	0.752	1e-177
297805364	539	kinase family protein [Arabidopsis lyrat	0.987	0.729	0.744	1e-174
15240345	552	protein kinase family protein [Arabidops	0.989	0.713	0.736	1e-173
110738055	548	protein kinase like protein [Arabidopsis	0.989	0.718	0.736	1e-173

>gi|224065170|ref|XP_002301698.1| predicted protein [Populus trichocarpa] gi|222843424|gb|EEE80971.1| predicted protein [Populus trichocarpa]

 Score =  689 bits (1778), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/401 (83%), Positives = 368/401 (91%), Gaps = 3/401 (0%)

Query: 1   MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATH 60
           MN+ +SASATVLMVNL+NGL ++RA+ELKWR+IQSLERSISPVANSL+R SY EILAAT+
Sbjct: 123 MNMNSSASATVLMVNLDNGLNETRAKELKWRRIQSLERSISPVANSLVRFSYSEILAATN 182

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           NFSKGRVLGRGALSFVF+GKVG LRT+VAIKRLDKEDKE+SKAFCRELMIASSL+H NIV
Sbjct: 183 NFSKGRVLGRGALSFVFRGKVGFLRTAVAIKRLDKEDKEASKAFCRELMIASSLYHSNIV 242

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST---LPWSVRYKVALGIAES 177
           PLVGFCIDPE+GLFL+YKYVSGGSLERHLH+KKK   G      L WSVRYKVALGIA++
Sbjct: 243 PLVGFCIDPEEGLFLVYKYVSGGSLERHLHDKKKVKVGVKGSSGLSWSVRYKVALGIAQA 302

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           +AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL
Sbjct: 303 IAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 362

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           APEYFQHGK+SDKTDVYAFGVVLLEL+TGRKPIEARR  GEENLVLWAKP+L +G  A+E
Sbjct: 363 APEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRPPGEENLVLWAKPLLQKGKGAIE 422

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHN 357
           ELLDPRL+CT RN+ QI ++IQAA AC+S+EESRRPGI+EII +LRGEE+ IY   KK N
Sbjct: 423 ELLDPRLECTLRNTTQIIQMIQAATACVSNEESRRPGIDEIIGMLRGEEQPIYSNRKKSN 482

Query: 358 FSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
           FSGIIDCYPQLQQTKSEM SHLALAM+GVSEFE+DDHL CR
Sbjct: 483 FSGIIDCYPQLQQTKSEMNSHLALAMLGVSEFEDDDHLCCR 523

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224079445|ref|XP_002305868.1| predicted protein [Populus trichocarpa] gi|222848832|gb|EEE86379.1| predicted protein [Populus trichocarpa]

 Score =  680 bits (1755), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/400 (82%), Positives = 367/400 (91%), Gaps = 3/400 (0%)

Query: 2   NIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHN 61
           ++  ++SATVLMVNL+NGL ++RA+ELKWR+IQSLERSISPVANSL+R SY EILAAT+N
Sbjct: 121 SMNMNSSATVLMVNLDNGLNETRAKELKWRRIQSLERSISPVANSLVRFSYREILAATNN 180

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           FSKGRVLGRGALSFVF+GKVG LRT+VAIKRLDKEDKE+SKAFCRELMIASSL+H NIVP
Sbjct: 181 FSKGRVLGRGALSFVFRGKVGFLRTAVAIKRLDKEDKEASKAFCRELMIASSLYHSNIVP 240

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST---LPWSVRYKVALGIAESV 178
           LVGFCIDP++GLFL+Y+YVSGGSLERHLH+KKKG  G      LPWSVRYKVALGIA+++
Sbjct: 241 LVGFCIDPDEGLFLVYRYVSGGSLERHLHDKKKGKGGVKGSSGLPWSVRYKVALGIAQAI 300

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           AYLHNGTERCVVHRDIKPSNILLSSKK+PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA
Sbjct: 301 AYLHNGTERCVVHRDIKPSNILLSSKKVPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PEYFQHGK+SDKTDVYAFGVVLLEL++GRKPIEAR+   EENLVLWAKP+L +G  A+EE
Sbjct: 361 PEYFQHGKISDKTDVYAFGVVLLELISGRKPIEARKPLREENLVLWAKPLLQKGNEAIEE 420

Query: 299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNF 358
           LLDPRLKCT RN+ QI  +IQAA ACIS+EESRRPGI+EII ILRGEE+ IY   KK NF
Sbjct: 421 LLDPRLKCTLRNTTQITHMIQAATACISNEESRRPGIDEIIGILRGEEQPIYSNRKKSNF 480

Query: 359 SGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
           SGIIDCYPQLQQTKSEM SHLALAM+GVSEFE+DDHLYCR
Sbjct: 481 SGIIDCYPQLQQTKSEMNSHLALAMLGVSEFEDDDHLYCR 520

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363807838|ref|NP_001242440.1| uncharacterized protein LOC100808074 [Glycine max] gi|255635407|gb|ACU18056.1| unknown [Glycine max]

 Score =  645 bits (1664), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/401 (76%), Positives = 360/401 (89%), Gaps = 6/401 (1%)

Query: 1   MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATH 60
           +N+ +SA+ATVLMVNL+NG+ +SRA E+KWR+++SLE+SISPV ++LIR SYGEI++AT 
Sbjct: 111 LNMSSSAAATVLMVNLDNGVSESRANEMKWRRMESLEKSISPVVHTLIRFSYGEIMSATR 170

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           NFSKGRVLGRGALS VF+G+VG+LRT+VAIKRLDKEDKES+KAFCRELMIASSLH  N+V
Sbjct: 171 NFSKGRVLGRGALSCVFRGRVGILRTAVAIKRLDKEDKESAKAFCRELMIASSLHSSNVV 230

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           PL+GFCIDPE+GLFL+YKYVSGGSLERHLH +KKG   +S LPW VRYKVA+GIAE+VAY
Sbjct: 231 PLLGFCIDPEEGLFLVYKYVSGGSLERHLHGRKKG---SSPLPWPVRYKVAIGIAEAVAY 287

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+GTERCVVHRDIKPSNILLSS+K PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE
Sbjct: 288 LHSGTERCVVHRDIKPSNILLSSRKTPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 347

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
           YFQHGKVSDKTDVYAFGVVLLEL+TGRKPIEA R  G+ENLVLWAKP L +G  A+EELL
Sbjct: 348 YFQHGKVSDKTDVYAFGVVLLELITGRKPIEATRPSGDENLVLWAKPFLQKGKGAIEELL 407

Query: 301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSG 360
           DP+LKC+ + S Q+ R+I+AAAAC+++EESRRPGI EIIAIL+GEEE +    KK +F G
Sbjct: 408 DPQLKCSLKFSNQMGRMIEAAAACVTNEESRRPGIREIIAILKGEEEPLLSKRKKSSFLG 467

Query: 361 ---IIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
              +IDCY QLQQT +EMKSHLALAM+GV+EFE+DD+LY R
Sbjct: 468 NGCVIDCYSQLQQTNNEMKSHLALAMLGVAEFEDDDYLYGR 508

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356569560|ref|XP_003552967.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Glycine max]

 Score =  642 bits (1656), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 308/401 (76%), Positives = 361/401 (90%), Gaps = 6/401 (1%)

Query: 1   MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATH 60
           +N+ +S++ATVLMVNL+NG+ +SRA+E+KWR+++SLE+SISPVA+SLIR SYGEI++AT 
Sbjct: 114 LNMSSSSAATVLMVNLDNGMSESRAREMKWRRMESLEKSISPVAHSLIRFSYGEIMSATR 173

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           NFSKGRVLGRGALS VF+G+VG+LRT+VAIKRLDKE KES+KAFCRELMIASSLH  N+V
Sbjct: 174 NFSKGRVLGRGALSCVFRGRVGILRTAVAIKRLDKESKESAKAFCRELMIASSLHSSNVV 233

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           PL+GFCIDPE+GLFL+YKYVSGGSLERHLH +KKG   +S L W VRYKVA+GIAE+VAY
Sbjct: 234 PLLGFCIDPEEGLFLVYKYVSGGSLERHLHGRKKG---SSPLLWPVRYKVAIGIAEAVAY 290

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+GTERCVVHRDIKPSNILLSS+KIPKLCDFGLATWTSAPS+PFLCKTVKGTFGYLAPE
Sbjct: 291 LHSGTERCVVHRDIKPSNILLSSRKIPKLCDFGLATWTSAPSLPFLCKTVKGTFGYLAPE 350

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
           YFQHGKVSDKTDVYAFGVVLLEL+TGRKPIEARR  GEENLVLWAKP L +G  A+EELL
Sbjct: 351 YFQHGKVSDKTDVYAFGVVLLELITGRKPIEARRSSGEENLVLWAKPFLQKGKGAIEELL 410

Query: 301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSG 360
           DP+LKC+ + S Q+ R+I+AAAAC+++EESRRPGI EIIAIL+GEEE +    KK +F G
Sbjct: 411 DPQLKCSLKFSNQMGRMIEAAAACVTNEESRRPGIHEIIAILKGEEEPLLSKRKKSSFLG 470

Query: 361 ---IIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
              +IDCY QLQQT +EMKSHLALAM GV+EFE+DD+LY R
Sbjct: 471 NGCVIDCYSQLQQTNNEMKSHLALAMSGVAEFEDDDYLYGR 511

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488192|ref|XP_002274329.2| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Vitis vinifera] gi|296087159|emb|CBI33533.3| unnamed protein product [Vitis vinifera]

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/401 (77%), Positives = 356/401 (88%), Gaps = 7/401 (1%)

Query: 1   MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATH 60
           +N+ +S +ATVLMVNL+NGL  SR++ELKWR+I+SLERSISPVAN+LIR  Y EI++AT 
Sbjct: 123 LNMSSSTAATVLMVNLDNGLTQSRSKELKWRRIESLERSISPVANTLIRFGYAEIVSATR 182

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           NF+KGRVLGRGALS VF+G+VG LRT+VAIKRLDKEDKES+KAFCRELMIASSL +PNIV
Sbjct: 183 NFNKGRVLGRGALSCVFRGRVGFLRTAVAIKRLDKEDKESAKAFCRELMIASSLQNPNIV 242

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           PLVGFCIDPE+GLFL+YKYVSGGSLERHLHEKK+GV+G S+LPWSVRYKVA+G+AESVAY
Sbjct: 243 PLVGFCIDPEEGLFLVYKYVSGGSLERHLHEKKRGVKGYSSLPWSVRYKVAVGVAESVAY 302

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+GT+RCVVHRDIKPSNILLSSKKIPKLCDFGLATWT APSVPFLCKTVKGTFGYLAPE
Sbjct: 303 LHSGTDRCVVHRDIKPSNILLSSKKIPKLCDFGLATWTPAPSVPFLCKTVKGTFGYLAPE 362

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
           YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  GEENLVLWAKP+L +   ++E+LL
Sbjct: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRPPGEENLVLWAKPLLQQ--ESIEQLL 420

Query: 301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSG 360
           DP LK T +NS QI R++QAAAACI+SEESRRP I+E++ ILRG E     + KK  F G
Sbjct: 421 DPCLKLTPKNSNQIGRMVQAAAACINSEESRRPSIDEVVVILRGREPNC-SSRKKSGFPG 479

Query: 361 ---IIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
              + DCY QL QTKSEM+SHLALAM+GV +FE+D H YCR
Sbjct: 480 NGFVTDCYAQL-QTKSEMRSHLALAMLGVPDFEDDAHFYCR 519

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|217074712|gb|ACJ85716.1| unknown [Medicago truncatula]

 Score =  636 bits (1640), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 306/387 (79%), Positives = 348/387 (89%), Gaps = 3/387 (0%)

Query: 13  MVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGA 72
           MVNL+NG+ +S  +ELK R+I+SLE++ISPVA+SL+R SYGEI+ AT NFSKGRVLGRGA
Sbjct: 1   MVNLDNGVSESLVKELKLRRIESLEKTISPVAHSLVRFSYGEIVYATRNFSKGRVLGRGA 60

Query: 73  LSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG 132
           LS VF+G+VGLLRT+VAIK+LDKEDKES+KAFCRELMIASSLH PNIVPLVGFCIDPE+G
Sbjct: 61  LSCVFRGRVGLLRTAVAIKQLDKEDKESAKAFCRELMIASSLHSPNIVPLVGFCIDPEEG 120

Query: 133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 192
           LFL+YKYVSGGSLERHLH +KKG +G+STLPWSVRYKVA+GIAE++AYLHNGTERCVVHR
Sbjct: 121 LFLVYKYVSGGSLERHLHGRKKGGKGSSTLPWSVRYKVAVGIAEAMAYLHNGTERCVVHR 180

Query: 193 DIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTD 252
           DIKPSNILLSSKK PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTD
Sbjct: 181 DIKPSNILLSSKKAPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTD 240

Query: 253 VYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSA 312
           VYAFGVVLLEL+TGRKPIE +R  GEENLVLWAKP L +G  A+EELLDP+LKC  R S 
Sbjct: 241 VYAFGVVLLELITGRKPIETKRSPGEENLVLWAKPYLQKGKGAIEELLDPQLKCNLRFSN 300

Query: 313 QIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSG---IIDCYPQLQ 369
           QI R+I+AAAAC+++EESRRP I EIIAIL+GEEE +    KK +F G   +IDCY QLQ
Sbjct: 301 QIGRMIEAAAACLTNEESRRPSIHEIIAILKGEEEPVVSKRKKSSFLGNGCVIDCYSQLQ 360

Query: 370 QTKSEMKSHLALAMVGVSEFEEDDHLY 396
           Q  +EMKSHLALAM+GVSEFE+DD+LY
Sbjct: 361 QPNNEMKSHLALAMLGVSEFEDDDYLY 387

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449445086|ref|XP_004140304.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Cucumis sativus] gi|449479863|ref|XP_004155731.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Cucumis sativus]

 Score =  627 bits (1618), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 304/404 (75%), Positives = 357/404 (88%), Gaps = 7/404 (1%)

Query: 1   MNIGASASA-TVLMVNLENGL-CDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAA 58
           MNIG+S +A TVLMVNL+NG+  ++  +ELKWR+I+SLE+SISPVA++LIR  Y EIL+A
Sbjct: 117 MNIGSSTTAATVLMVNLDNGMMAEALTKELKWRRIESLEKSISPVAHTLIRFRYREILSA 176

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
           T NFSKGRVLGRGALS VF+G+VG LRT+VAIKRLDKEDKES+KAFCRELMIASSLH+PN
Sbjct: 177 TRNFSKGRVLGRGALSCVFRGRVGFLRTAVAIKRLDKEDKESAKAFCRELMIASSLHNPN 236

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IVPLVGFCIDPE+GLFL+YKYVSGGSLERHLHEKK+G++G  +LPWSVR+K+ALGIAE+V
Sbjct: 237 IVPLVGFCIDPEEGLFLVYKYVSGGSLERHLHEKKRGMKGRFSLPWSVRFKIALGIAEAV 296

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           AYLHNGTERCVVHRDIKPSNILL+SKK+PKLCDFGLATWT+APSVPFLCKTVKGTFGYLA
Sbjct: 297 AYLHNGTERCVVHRDIKPSNILLTSKKMPKLCDFGLATWTAAPSVPFLCKTVKGTFGYLA 356

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PEYFQHGKVSDKTDVYA GVVLLEL+TGRKP EA R  GEENLVLWAKP+L +G  A+ E
Sbjct: 357 PEYFQHGKVSDKTDVYAVGVVLLELITGRKPFEA-RAHGEENLVLWAKPLLQKGKGAITE 415

Query: 299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL-IYCTWKKHN 357
           LLDP++ CT++NS QI ++I+AAAACI+ EESRRPGI EIIAIL+GEE+  +    K+++
Sbjct: 416 LLDPQVTCTTKNSNQIVQMIEAAAACITGEESRRPGILEIIAILKGEEKAPLPSRSKRYS 475

Query: 358 FSG---IIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
           F G   + DCY Q Q T SEM  HLALAM G+ EFE+DD+L+CR
Sbjct: 476 FLGHGCVTDCYSQFQNTNSEMTGHLALAMSGLPEFEDDDYLFCR 519

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297805364|ref|XP_002870566.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297316402|gb|EFH46825.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  618 bits (1594), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 297/399 (74%), Positives = 351/399 (87%), Gaps = 6/399 (1%)

Query: 5   ASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSK 64
           +  S TVLMVNLENG+ ++   +L+W + +SLE+SISPVAN+L+R SYGEI+AAT NFSK
Sbjct: 142 SGGSTTVLMVNLENGVKET-TDDLRWTRARSLEKSISPVANTLVRFSYGEIVAATRNFSK 200

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           GRVLGRGA S+VF+GK+G+ RT++AIKRLDKEDKES K+FCRELMIASSLH  NIVPL+G
Sbjct: 201 GRVLGRGACSYVFRGKIGMWRTTLAIKRLDKEDKESPKSFCRELMIASSLHSFNIVPLLG 260

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVAYLH 182
           FCIDPE+GLFL+YKYVSGGSLE +LH+KKK  GV+    LPWS RYKVALGIA+++AYLH
Sbjct: 261 FCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVALGIADAIAYLH 320

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
           NGTE+CVVHRDIKPSNILLSSKKIPKLCDFGLATWT+APS+PFLCKTVKGTFGYLAPEYF
Sbjct: 321 NGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSIPFLCKTVKGTFGYLAPEYF 380

Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP 302
           QHGK+SDKTDVYAFGVVLLEL+TGRKPIEARR  G+ENLV+WAKP+LHRGM A+ ELLDP
Sbjct: 381 QHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWAKPLLHRGMEAIVELLDP 440

Query: 303 RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL---IYCTWKKHNFS 359
           RLKCT +NS Q+ R+I+AAAAC+ +EESRRPG+EEI++IL+ EE L    + + K  N S
Sbjct: 441 RLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKSEEGLEPKTHSSRKNTNIS 500

Query: 360 GIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
           G+ID Y QLQQTKSEMK HL LAM+GV+EFE+DDH+Y R
Sbjct: 501 GMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDDDHVYGR 539

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15240345|ref|NP_198595.1| protein kinase family protein [Arabidopsis thaliana] gi|21536612|gb|AAM60944.1| protein kinase-like protein [Arabidopsis thaliana] gi|332006850|gb|AED94233.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  615 bits (1586), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 296/402 (73%), Positives = 351/402 (87%), Gaps = 8/402 (1%)

Query: 5   ASASATVLMVNLENGLCDSRAQ---ELKWRKIQSLERSISPVANSLIRLSYGEILAATHN 61
           +  S TVLMVNLENG+ ++      +L+W + +SLE+SISPVAN+L+R SYGEI+AAT N
Sbjct: 151 SGGSTTVLMVNLENGVKETTGNATDDLRWTRARSLEKSISPVANTLVRFSYGEIVAATRN 210

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           FSKGRVLGRGA S+VF+GK+G+ RT++AIKRLDKEDKES K+FCRELMIASSLH  NIVP
Sbjct: 211 FSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSLHSSNIVP 270

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVA 179
           L+GFCIDPE+GLFL+YKYVSGGSLE +LH+KKK  GV+    LPWS RYKVALGIA+++A
Sbjct: 271 LLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVALGIADAIA 330

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YLHNGTE+CVVHRDIKPSNILLSSKKIPKLCDFGLATWT+APSVPFLCKTVKGTFGYLAP
Sbjct: 331 YLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKGTFGYLAP 390

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 299
           EYFQHGK+SDKTDVYAFGVVLLEL+TGRKPIEARR  G+ENLV+WAKP+L RG+ A+ EL
Sbjct: 391 EYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRGIEAIVEL 450

Query: 300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL---IYCTWKKH 356
           LDPRLKCT +NS Q+ R+I+AAAAC+ +EESRRPG+EEI++IL+GEE +    + + K  
Sbjct: 451 LDPRLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPETHSSRKTT 510

Query: 357 NFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
           N SG+ID Y QLQQTKSEMK HL LAM+GV+EFE+DDH+Y R
Sbjct: 511 NISGMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDDDHVYGR 552

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110738055|dbj|BAF00962.1| protein kinase like protein [Arabidopsis thaliana]

 Score =  615 bits (1586), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 296/402 (73%), Positives = 351/402 (87%), Gaps = 8/402 (1%)

Query: 5   ASASATVLMVNLENGLCDSRAQ---ELKWRKIQSLERSISPVANSLIRLSYGEILAATHN 61
           +  S TVLMVNLENG+ ++      +L+W + +SLE+SISPVAN+L+R SYGEI+AAT N
Sbjct: 147 SGGSTTVLMVNLENGVKETTGNATDDLRWTRARSLEKSISPVANTLVRFSYGEIVAATRN 206

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           FSKGRVLGRGA S+VF+GK+G+ RT++AIKRLDKEDKES K+FCRELMIASSLH  NIVP
Sbjct: 207 FSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSLHSSNIVP 266

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVA 179
           L+GFCIDPE+GLFL+YKYVSGGSLE +LH+KKK  GV+    LPWS RYKVALGIA+++A
Sbjct: 267 LLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVALGIADAIA 326

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YLHNGTE+CVVHRDIKPSNILLSSKKIPKLCDFGLATWT+APSVPFLCKTVKGTFGYLAP
Sbjct: 327 YLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKGTFGYLAP 386

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 299
           EYFQHGK+SDKTDVYAFGVVLLEL+TGRKPIEARR  G+ENLV+WAKP+L RG+ A+ EL
Sbjct: 387 EYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRGIEAIVEL 446

Query: 300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL---IYCTWKKH 356
           LDPRLKCT +NS Q+ R+I+AAAAC+ +EESRRPG+EEI++IL+GEE +    + + K  
Sbjct: 447 LDPRLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPETHSSRKTT 506

Query: 357 NFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
           N SG+ID Y QLQQTKSEMK HL LAM+GV+EFE+DDH+Y R
Sbjct: 507 NISGMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDDDHVYGR 548

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	398
TAIR|locus:2156050	552	AT5G37790 [Arabidopsis thalian	0.997	0.719	0.716	1e-155
TAIR|locus:2028967	467	AT1G66460 [Arabidopsis thalian	0.979	0.835	0.717	1.1e-149
TAIR|locus:2195975	794	AT1G77280 [Arabidopsis thalian	0.886	0.444	0.418	1.1e-66
TAIR|locus:2026957	756	AT1G21590 [Arabidopsis thalian	0.871	0.458	0.397	3e-62
TAIR|locus:2160801	705	AT5G63940 [Arabidopsis thalian	0.839	0.473	0.414	3.9e-60
TAIR|locus:2059919	617	AT2G16750 [Arabidopsis thalian	0.841	0.542	0.397	3.2e-58
TAIR|locus:2038992	744	ALE2 "Abnormal Leaf Shape 2" [	0.743	0.397	0.407	6.3e-53
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.791	0.833	0.376	6.3e-53
TAIR|locus:504954886	1113	AT5G56890 [Arabidopsis thalian	0.748	0.267	0.404	9.6e-53
TAIR|locus:2172555	579	AT5G57670 [Arabidopsis thalian	0.776	0.533	0.365	4.4e-52

TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)]

 Score = 1518 (539.4 bits), Expect = 1.0e-155, P = 1.0e-155
 Identities = 291/406 (71%), Positives = 343/406 (84%)

Query:     2 NIGASA-SATVLMVNLENGLCDSRAQ---ELKWRKIQSLERSISPVANSLIRLSYGEILA 57
             N+  S  S TVLMVNLENG+ ++      +L+W + +SLE+SISPVAN+L+R SYGEI+A
Sbjct:   147 NLSVSGGSTTVLMVNLENGVKETTGNATDDLRWTRARSLEKSISPVANTLVRFSYGEIVA 206

Query:    58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 117
             AT NFSKGRVLGRGA S+VF+GK+G+ RT++AIKRLDKEDKES K+FCRELMIASSLH  
Sbjct:   207 ATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSLHSS 266

Query:   118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIA 175
             NIVPL+GFCIDPE+GLFL+YKYVSGGSLE +LH+KKK  GV+    LPWS RYKVALGIA
Sbjct:   267 NIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVALGIA 326

Query:   176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
             +++AYLHNGTE+CVVHRDIKPSNILLSSKKIPKLCDFGLATWT+APSVPFLCKTVKGTFG
Sbjct:   327 DAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKGTFG 386

Query:   236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 295
             YLAPEYFQHGK+SDKTDVYAFGVVLLEL+TGRKPIEARR  G+ENLV+WAKP+L RG+ A
Sbjct:   387 YLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRGIEA 446

Query:   296 VEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAILRGEEEL---IYCT 352
             + ELLDPRLKCT +NS            C+ +EESRRPG+EEI++IL+GEE +    + +
Sbjct:   447 IVELLDPRLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPETHSS 506

Query:   353 WKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 398
              K  N SG+ID Y QLQQTKSEMK HL LAM+GV+EFE+DDH+Y R
Sbjct:   507 RKTTNISGMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDDDHVYGR 552

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028967 AT1G66460 [Arabidopsis thaliana (taxid:3702)]

 Score = 1461 (519.4 bits), Expect = 1.1e-149, P = 1.1e-149
 Identities = 284/396 (71%), Positives = 329/396 (83%)

Query:     5 ASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSK 64
             +  S TVL+VNLEN   +    E+ W +  SLE+SISPVA+SLIR SY E+L AT NFSK
Sbjct:    73 SEGSETVLLVNLENETGELTG-EMNWSRGLSLEKSISPVADSLIRFSYRELLTATRNFSK 131

Query:    65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
              RVLGRGA S+VFKG++G+ R +VAIKRLDK+DKES K+FCRELMIASSL+ PN+VPL+G
Sbjct:   132 RRVLGRGACSYVFKGRIGIWRKAVAIKRLDKKDKESPKSFCRELMIASSLNSPNVVPLLG 191

Query:   125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS--TLPWSVRYKVALGIAESVAYLH 182
             FCIDP+QGLFL+YKYVSGGSLER LH+KKK     +   LPWS RYKVALGIA+++AYLH
Sbjct:   192 FCIDPDQGLFLVYKYVSGGSLERFLHDKKKKKSRKTPLNLPWSTRYKVALGIADAIAYLH 251

Query:   183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
             NGTE+CVVHRDIKPSNILLSS KIPKLCDFGLATWT+APSVPFLCKTVKGTFGYLAPEYF
Sbjct:   252 NGTEQCVVHRDIKPSNILLSSNKIPKLCDFGLATWTAAPSVPFLCKTVKGTFGYLAPEYF 311

Query:   243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP 302
             QHGK+SDKTDVYAFGVVLLEL+TGRKPIEARR  GEENLV+WAKP+LHRG+ A EELLDP
Sbjct:   312 QHGKISDKTDVYAFGVVLLELITGRKPIEARRPSGEENLVVWAKPLLHRGIEATEELLDP 371

Query:   303 RLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAILRGEE--EL-IYCTWKKHNFS 359
             RLKCT +NS            C+ +EESRRPG++EI++IL+G E  EL    + KK N  
Sbjct:   372 RLKCTRKNSASMERMIRAAAACVINEESRRPGMKEILSILKGGEGIELRTLSSRKKSNLP 431

Query:   360 GIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHL 395
             GI+DCYPQLQ+TKSEMKSHL LAM+GV+EFE DD L
Sbjct:   432 GIMDCYPQLQRTKSEMKSHLTLAMLGVTEFEADDLL 467

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)]

 Score = 678 (243.7 bits), Expect = 1.1e-66, P = 1.1e-66
 Identities = 154/368 (41%), Positives = 220/368 (59%)

Query:    31 RKI-QSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVA 89
             RK+ + LE      +++     Y E+++ T NFS    +G+G  S VF+G +   R  VA
Sbjct:   413 RKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRV-VA 471

Query:    90 IKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL 149
             +K L K+ ++    F  E+ I ++LHH NI+ L+GFC + +  L L+Y Y+S GSLE +L
Sbjct:   472 VKIL-KQTEDVLNDFVAEIEIITTLHHKNIISLLGFCFE-DHNLLLVYNYLSRGSLEENL 529

Query:   150 HEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL 209
             H  KK         WS RYKVA+G+AE++ YLHN   + V+HRD+K SNILLS    P+L
Sbjct:   530 HGNKKDPLA---FCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQL 586

Query:   210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
              DFGLA W S  +   +C  V GTFGYLAPEYF +GKV+DK DVYAFGVVLLELL+GRKP
Sbjct:   587 SDFGLARWASISTTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKP 646

Query:   270 IEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXX-CISSE 328
             I +   +G+E+LV+WAKPIL  G  +  +LLDP L+  + N+             CI   
Sbjct:   647 ISSGCPKGQESLVMWAKPILDDGKYS--QLLDPSLRDNNNNNDDQMQRMALAATLCIRRS 704

Query:   329 ESRRPGIEEIIAILRGEEELIYCTWKKHNFSGI-IDCYPQLQQTKSEMKSHLALAMVGVS 387
                RP +  ++ +L+G+E+ +    ++ N S    +     Q  +S ++SHL LA++ V 
Sbjct:   705 PQARPKMSIVLKLLKGDEDTLEWAMQQVNSSSEESEMLKDEQCQRSNLQSHLNLALLDV- 763

Query:   388 EFEEDDHL 395
                EDD +
Sbjct:   764 ---EDDSI 768

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)]

 Score = 636 (228.9 bits), Expect = 3.0e-62, P = 3.0e-62
 Identities = 145/365 (39%), Positives = 213/365 (58%)

Query:    34 QSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL 93
             +++E   + ++ S    +Y E+++ T NF     +G+G  S VF+G +   R  VA+K L
Sbjct:   381 ENVEGLQARISTSCQFFTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGR-EVAVKIL 439

Query:    94 DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 153
              K  +   K F  E+ I ++LHH N++ L+G+C +    L L+Y Y+S GSLE +LH  K
Sbjct:   440 -KRTECVLKDFVAEIDIITTLHHKNVISLLGYCFE-NNNLLLVYNYLSRGSLEENLHGNK 497

Query:   154 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 213
             K +       W+ RYKVA+GIAE++ YLHN   + V+HRD+K SNILLS    P+L DFG
Sbjct:   498 KDL---VAFRWNERYKVAVGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFG 554

Query:   214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
             LA W S  +   +C  V GTFGYLAPEYF +GK+++K DVYA+GVVLLELL+GRKP+ + 
Sbjct:   555 LAKWASESTTQIICSDVAGTFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSE 614

Query:   274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRP 333
               + +++LV+WAKPIL        +LLD  L+    NS            CI      RP
Sbjct:   615 SPKAQDSLVMWAKPILDD--KEYSQLLDSSLQ-DDNNSDQMEKMALAATLCIRHNPQTRP 671

Query:   334 GIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTK---SEMKSHLALAMVGVSEFE 390
              +  ++ +L+G+ E++   W K   S  ++    L+  K   S ++SHL LA + +    
Sbjct:   672 TMGMVLELLKGDVEML--KWAKLQVSNPLEDSMLLKDEKLRRSNLQSHLNLAFLDM---- 725

Query:   391 EDDHL 395
             EDD L
Sbjct:   726 EDDSL 730

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)]

 Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
 Identities = 145/350 (41%), Positives = 203/350 (58%)

Query:    45 NSLIRL-SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 103
             +S  RL +Y E+L+ T NF+   ++G G  S+V++G +   R  +A+K L K   +  K 
Sbjct:   344 SSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPDGR-ELAVKIL-KPCLDVLKE 401

Query:   104 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 163
             F  E+ + +S+HH NIV L GFC +    L L+Y Y+  GSLE +LH  +K  +      
Sbjct:   402 FILEIEVITSVHHKNIVSLFGFCFE-NNNLMLVYDYLPRGSLEENLHGNRKDAK---KFG 457

Query:   164 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
             W  RYKVA+G+AE++ YLHN  +  V+HRD+K SN+LL+    P+L DFG A+  S+ S 
Sbjct:   458 WMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDFGFASLASSTSQ 517

Query:   224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
                   + GTFGYLAPEYF HGKV+DK DVYAFGVVLLEL++GRKPI   + +G+E+LVL
Sbjct:   518 HVAGGDIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISGRKPICVDQSKGQESLVL 577

Query:   284 WAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAILR 343
             WA PIL  G  A  +LLDP L+  + N             CI      RP I  ++ IL+
Sbjct:   578 WANPILDSGKFA--QLLDPSLENDNSNDLIEKLLLAATL-CIKRTPHDRPQIGLVLKILQ 634

Query:   344 GEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDD 393
             GEEE     W K       D    L    + ++SH+ LA++ + +    D
Sbjct:   635 GEEEAT--EWGKQQVRASEDVSAYL----TNIESHINLALLDLEDDAASD 678

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)]

 Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
 Identities = 141/355 (39%), Positives = 205/355 (57%)

Query:    37 ERSISPVANSLIR-LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK 95
             ++ +  +   + R  SY  +  AT +FS   ++G+G  + V+KG +   +  VA+K L  
Sbjct:   251 DKQLKDILKDINRWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGK-GVAVKILKP 309

Query:    96 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 155
               KE+ K F  E+ I SSL H NI PL+G C+     L  +Y   S GSLE  L      
Sbjct:   310 SVKEAVKEFVHEVSIVSSLSHSNISPLIGVCVHYND-LISVYNLSSKGSLEETL------ 362

Query:   156 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
              +G   L W  R K+A+G+ E++ YLHN     V+HRD+K SN+LLS +  P+L DFGL+
Sbjct:   363 -QGKHVLRWEERLKIAIGLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLS 421

Query:   216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
              W S      + + V GTFGYLAPEYF +GKVSDK DVYAFGVVLLEL++GR  I +   
Sbjct:   422 MWGSKSCRYTIQRDVVGTFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSP 481

Query:   276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGI 335
             +G+E+LV+WAKP++ +G A  +ELLDP +  T  +             C++   + RP I
Sbjct:   482 RGQESLVMWAKPMIEKGNA--KELLDPNIAGTF-DEDQFHKMVLAATHCLTRAATYRPNI 538

Query:   336 EEIIAILRGEEELI-YCTWKKHNFSGIID-CYPQLQQTKSEMKSHLALAMVGVSE 388
             +EI+ +LRGE+++  +   ++ +  G  D  YP      S  + HL+LAMV V +
Sbjct:   539 KEILKLLRGEDDVSKWVKIEEDDEDGFDDEVYPN-----SNTELHLSLAMVDVED 588

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 6.3e-53, P = 6.3e-53
 Identities = 126/309 (40%), Positives = 174/309 (56%)

Query:    35 SLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 94
             SL  S++  A S+   +  E+  AT  FS  RVLG G    V++G +    T VA+K L 
Sbjct:   322 SLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMED-GTEVAVKLLT 380

Query:    95 KEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 154
             ++++   + F  E+ + S LHH N+V L+G CI+      LIY+ V  GS+E HLHE   
Sbjct:   381 RDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC-LIYELVHNGSVESHLHE--- 436

Query:   155 GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 214
                   TL W  R K+ALG A  +AYLH  +   V+HRD K SN+LL     PK+ DFGL
Sbjct:   437 -----GTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 491

Query:   215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
             A   +  S   +   V GTFGY+APEY   G +  K+DVY++GVVLLELLTGR+P++  +
Sbjct:   492 AREATEGS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQ 550

Query:   275 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPG 334
               GEENLV WA+P+L      +E+L+DP L  T  N             C+  E S RP 
Sbjct:   551 PSGEENLVTWARPLL-ANREGLEQLVDPALAGTY-NFDDMAKVAAIASMCVHQEVSHRPF 608

Query:   335 IEEIIAILR 343
             + E++  L+
Sbjct:   609 MGEVVQALK 617

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010068 "protoderm histogenesis" evidence=IMP

GO:0042335 "cuticle development" evidence=IMP

GO:0048367 "shoot system development" evidence=IGI

GO:0048645 "organ formation" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 6.3e-53, P = 6.3e-53
 Identities = 122/324 (37%), Positives = 180/324 (55%)

Query:    21 CDSRAQELKWRKIQSLERSISPVANSLIR--LSYGEILAATHNFSKGRVLGRGALSFVFK 78
             C     E K R   SL  S S  ++ ++    ++ E+  AT NF K  ++G G    V+K
Sbjct:    31 CSVSTSE-KSRAKSSLSESKSKGSDHIVAQTFTFSELATATRNFRKECLIGEGGFGRVYK 89

Query:    79 GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK 138
             G +     + AIK+LD    + ++ F  E+++ S LHHPN+V L+G+C D +Q L L+Y+
Sbjct:    90 GYLASTSQTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYE 148

Query:   139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN 198
             Y+  GSLE HLH+   G      L W+ R K+A G A+ + YLH+ T   V++RD+K SN
Sbjct:   149 YMPLGSLEDHLHDISPG---KQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSN 205

Query:   199 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGV 258
             ILL     PKL DFGLA          +   V GT+GY APEY   G+++ K+DVY+FGV
Sbjct:   206 ILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 265

Query:   259 VLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXX 318
             VLLE++TGRK I++ R  GE+NLV WA+P L +      ++ DP L+             
Sbjct:   266 VLLEIITGRKAIDSSRSTGEQNLVAWARP-LFKDRRKFSQMADPMLQ-GQYPPRGLYQAL 323

Query:   319 XXXXXCISSEESRRPGIEEIIAIL 342
                  C+  + + RP I +++  L
Sbjct:   324 AVAAMCVQEQPNLRPLIADVVTAL 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)]

 Score = 556 (200.8 bits), Expect = 9.6e-53, P = 9.6e-53
 Identities = 127/314 (40%), Positives = 181/314 (57%)

Query:    35 SLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 94
             S E SI+P   S    +  EI+ AT+NF + RVLG G    V++G V    T VA+K L 
Sbjct:   696 SFESSIAPFTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEG-VFDDGTKVAVKVLK 754

Query:    95 KEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 154
             ++D++ S+ F  E+ + S LHH N+V L+G CI+ ++   L+Y+ +  GS+E HLH    
Sbjct:   755 RDDQQGSREFLAEVEMLSRLHHRNLVNLIGICIE-DRNRSLVYELIPNGSVESHLH---- 809

Query:   155 GV-RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 213
             G+ + +S L W  R K+ALG A  +AYLH  +   V+HRD K SNILL +   PK+ DFG
Sbjct:   810 GIDKASSPLDWDARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFG 869

Query:   214 LA-TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
             LA           +   V GTFGY+APEY   G +  K+DVY++GVVLLELLTGRKP++ 
Sbjct:   870 LARNALDDEDNRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 929

Query:   273 RRLQGEENLVLWAKPILH--RGMAAV-EELLDPRLKCTSRNSXXXXXXXXXXXXCISSEE 329
              +  G+ENLV W +P L    G+AA+ ++ L P +   S               C+  E 
Sbjct:   930 SQPPGQENLVSWTRPFLTSAEGLAAIIDQSLGPEISFDS-----IAKVAAIASMCVQPEV 984

Query:   330 SRRPGIEEIIAILR 343
             S RP + E++  L+
Sbjct:   985 SHRPFMGEVVQALK 998

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)]

 Score = 540 (195.1 bits), Expect = 4.4e-52, P = 4.4e-52
 Identities = 120/328 (36%), Positives = 183/328 (55%)

Query:    31 RKIQSLERSISPVANSLIR-LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVA 89
             RK +  E    P    LI+  +Y EI  AT++F +G ++G G  S V++G +   R  +A
Sbjct:   235 RKWRGSETKNKPKPQPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRR-IA 293

Query:    90 IKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
             +KRL KE  D    K F  EL I S + HPN   L+G C+  E+GL+L++++   G+L  
Sbjct:   294 VKRLAKESGDMNKEKEFLTELGIISHVSHPNTALLLGCCV--EKGLYLVFRFSENGTLYS 351

Query:   148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
              LHE + G     +L W VRYK+A+G+A  + YLH      ++HRDIK SN+LL     P
Sbjct:   352 ALHENENG-----SLDWPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEP 406

Query:   208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
             ++ DFGLA W            V+GTFGYLAPE    G + +KTD+YAFG++LLE++TGR
Sbjct:   407 QITDFGLAKWLPNKWTHHAVIPVEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGR 466

Query:   268 KPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISS 327
             +P+       +++++LWAKP +  G  +  EL+DP+L+    +             C+  
Sbjct:   467 RPVNPT----QKHILLWAKPAMETGNTS--ELVDPKLQ-DKYDDQQMNKLVLTASHCVQQ 519

Query:   328 EESRRPGIEEIIAIL-RGEEELIYCTWK 354
                 RP + +++ +L  G E  I  +W+
Sbjct:   520 SPILRPTMTQVLELLTNGNEAEIAKSWR 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	398
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-41
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-34
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-32
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-31
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-18
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-17
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-16
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-15
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-15
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-13
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (438), Expect = 7e-52
 Identities = 75/199 (37%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 126
           LG G    V+  +       VAIK + KED  S      RE+ I   L+HPNIV L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
            D    L+L+ +Y  GGSL+  L E +        L      ++ L I E + YLH    
Sbjct: 61  EDENH-LYLVMEYCEGGSLKDLLKENEGK------LSEDEILRILLQILEGLEYLH---S 110

Query: 187 RCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH- 244
             ++HRD+KP NILL S     KL DFGL+      S   L KT+ GT  Y+APE     
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLS--KLLTSDKSLLKTIVGTPAYMAPEVLLGK 168

Query: 245 GKVSDKTDVYAFGVVLLEL 263
           G  S+K+D+++ GV+L EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  167 bits (426), Expect = 1e-49
 Identities = 71/230 (30%), Positives = 102/230 (44%), Gaps = 20/230 (8%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 120
           +     LG G+   V+  +       VAIK + K+  K+  +   RE+ I   L HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L     D ++ L+L+ +Y  GG L   L ++ +       L           I  ++ Y
Sbjct: 61  RLYDVFEDEDK-LYLVMEYCEGGDLFDLLKKRGR-------LSEDEARFYLRQILSALEY 112

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH    + +VHRD+KP NILL      KL DFGLA             T  GT  Y+APE
Sbjct: 113 LH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPE 166

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 290
                      D+++ GV+L ELLTG+ P       G++ L+   K I  
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIGK 211

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  163 bits (415), Expect = 7e-48
 Identities = 86/281 (30%), Positives = 124/281 (44%), Gaps = 31/281 (11%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK--AFCRELMIASSLHHPNI 119
           +   R LG G+   V+K K       VA+K L K  ++S K     RE+ I   L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L+    D +  L+L+ +Y  GG L  +L            L      K+AL I   + 
Sbjct: 61  VRLIDAFEDKDH-LYLVMEYCEGGDLFDYLSRGGP-------LSEDEAKKIALQILRGLE 112

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YLH      ++HRD+KP NILL    + K+ DFGLA      S      T  GT  Y+AP
Sbjct: 113 YLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAP 167

Query: 240 EYFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           E    G     K DV++ GV+L ELLTG+ P              ++   +   +  +  
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPP--------------FSGENILDQLQLIRR 213

Query: 299 LLDPRLKCTSRNSAQIAR-VIQAAAACISSEESRRPGIEEI 338
           +L P L+      +  +         C++ + S+RP  EEI
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  156 bits (398), Expect = 2e-45
 Identities = 73/212 (34%), Positives = 107/212 (50%), Gaps = 13/212 (6%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
            +++G +LGRG+   V+          +A+K   L  + +E  +A  RE+ I SSL HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 119 IVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           IV   G   D E+    I+ +YVSGGSL   L +  K       LP  V  K    I E 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-------LPEPVIRKYTRQILEG 113

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           +AYLH      +VHRDIK +NIL+ S  + KL DFG A             +V+GT  ++
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           APE  +  +     D+++ G  ++E+ TG+ P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (397), Expect = 3e-45
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 18/214 (8%)

Query: 63  SKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHP 117
           + G+ LG GA   V+KG            VA+K L ++  ++  + F RE  I   L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NIV L+G C + E  L ++ +Y+ GG L  +L + +        L  S     AL IA  
Sbjct: 62  NIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNR-----PKELSLSDLLSFALQIARG 115

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGY 236
           + YL     +  +HRD+   N L+    + K+ DFGL+                K    +
Sbjct: 116 MEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG--KLPIRW 170

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           +APE  + GK + K+DV++FGV+L E+ T G +P
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  155 bits (394), Expect = 7e-45
 Identities = 71/215 (33%), Positives = 106/215 (49%), Gaps = 21/215 (9%)

Query: 63  SKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHH 116
           + G+ LG GA   V+KGK     G  +  VA+K L KED      + F RE  I   L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PN+V L+G C + E  L+++ +Y+ GG L  +L + +        L  S     AL IA 
Sbjct: 61  PNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIAR 113

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFG 235
            + YL     +  +HRD+   N L+    + K+ DFGL+                K    
Sbjct: 114 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG--KLPIR 168

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           ++APE  + GK + K+DV++FGV+L E+ T G +P
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  155 bits (394), Expect = 8e-45
 Identities = 83/288 (28%), Positives = 127/288 (44%), Gaps = 36/288 (12%)

Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIV 120
           + LG GA   V+KGK+       T VA+K L KED      K F +E  +   L HPN+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN--STLPWSVRYKVALGIAESV 178
            L+G C + E  L+L+ +Y+ GG L  +L + +        STL        A+ IA+ +
Sbjct: 60  RLLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF--GY 236
            YL     +  VHRD+   N L+    + K+ DFGL+         +  K   G     +
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY--DDDYYRKKTGGKLPIRW 173

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA 295
           +APE  + G  + K+DV++FGV+L E+ T G  P     L  EE         L +G   
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG--LSNEE-----VLEYLRKGY-- 224

Query: 296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
                  RL        ++  ++    +C   +   RP   E++  L 
Sbjct: 225 -------RLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (367), Expect = 8e-41
 Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 59/299 (19%)

Query: 62  FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH 116
              G+ LG GA   V+KG +        T VA+K L +   +E  + F  E  I   L H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PNIV L+G C    + L+++ +Y+ GG L   L +          L      ++AL IA+
Sbjct: 61  PNIVRLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRKHG------EKLTLKDLLQMALQIAK 113

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL     +  VHRD+   N L++   + K+ DFGL+            + +     Y
Sbjct: 114 GMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLS------------RDIYEDDYY 158

Query: 237 ------------LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
                       +APE  + GK + K+DV++FGV+L E+ T G +P              
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-------------- 204

Query: 284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
           +        +  +E+    RL        ++  ++     C + +   RP   E++  L
Sbjct: 205 YPGMSNEEVLELLED--GYRLPRPENCPDELYELML---QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  140 bits (353), Expect = 5e-38
 Identities = 91/292 (31%), Positives = 134/292 (45%), Gaps = 30/292 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSL-HH 116
           ++   R LG G+   V+  +    R  VA+K L K+ +  SK    F RE+ I +SL H 
Sbjct: 1   SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PNIV L  F  D    L+L+ +YV GGSLE  L +  +       L  S    +   I  
Sbjct: 58  PNIVKLYDFFQDEGS-LYLVMEYVDGGSLEDLLKKIGR----KGPLSESEALFILAQILS 112

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATW----TSAPSVPFLCKTVK 231
           ++ YLH    + ++HRDIKP NILL    ++ KL DFGLA       S  S+P L  T  
Sbjct: 113 ALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 232 GTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 288
           GT GY+APE          S  +D+++ G+ L ELLTG  P E  +     +  L  K I
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL--KII 227

Query: 289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
           L     ++   L P        S   + +++     ++ +   R      ++
Sbjct: 228 LELPTPSLASPLSPSNPEL--ISKAASDLLK---KLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  127 bits (323), Expect = 2e-34
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 36/281 (12%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFC-RELMIASSLHHPNIVPLV 123
           + +G+G+   V+  +         +K +D     E  +     E+ I   L+HPNI+   
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG---NSTLPWSVRYKVALGIAESVAY 180
               + +  L ++ +Y  GG L + + ++KK  +       L W V+      +  ++ Y
Sbjct: 66  ESFEE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH    R ++HRDIKP NI L+S  + KL DFG++   S+     L KTV GT  YL+PE
Sbjct: 119 LH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPE 173

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
             Q+   + K+D+++ G VL EL T + P E   L     L L    IL           
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---KILKGQYP------ 221

Query: 301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI 341
                  S+ S+++  ++    + +  +   RP I +I+  
Sbjct: 222 ----PIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 2e-32
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 23/223 (10%)

Query: 62  FSKGRVLGRGALSFVFKG-------KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASS 113
             K +VLG GA   V+KG       KV +    VAIK L ++   +++K    E  + +S
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKI---PVAIKVLREETSPKANKEILDEAYVMAS 65

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           + HP++V L+G C      + LI + +  G L  ++   K  +     L W V+      
Sbjct: 66  VDHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------ 117

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           IA+ ++YL    E+ +VHRD+   N+L+ + +  K+ DFGLA         +  +  K  
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRL 275
             ++A E   H   + K+DV+++GV + EL+T G KP E    
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (304), Expect = 8e-32
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 13/208 (6%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           F     +G+G    V+K +       VAIK +  E KE  +    E+ I     HPNIV 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             G     +  L+++ ++ SGGSL+  L    +      TL  S    V   + + + YL
Sbjct: 62  YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQ------TLTESQIAYVCKELLKGLEYL 114

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H+     ++HRDIK +NILL+S    KL DFGL+    + +      T+ GT  ++APE 
Sbjct: 115 HS--NG-IIHRDIKAANILLTSDGEVKLIDFGLSA-QLSDTKA--RNTMVGTPYWMAPEV 168

Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                   K D+++ G+  +EL  G+ P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  120 bits (304), Expect = 1e-31
 Identities = 80/222 (36%), Positives = 104/222 (46%), Gaps = 25/222 (11%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKR-LDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           LG GA   V K ++       A+K      + +  K   REL I  S   P IV   G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 127 IDPEQG-LFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGIAESV----AY 180
           +D     + +  +Y  GGSL+    + KK+G R           KV   IAESV    +Y
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE--------KVLGKIAESVLKGLSY 120

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH    R ++HRDIKPSNILL+ K   KLCDFG+    S   V  L  T  GT  Y+APE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTFTGTSFYMAPE 173

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 282
             Q    S  +DV++ G+ LLE+   R P      +GE  L 
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP---EGEPPLG 212

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 6e-31
 Identities = 74/214 (34%), Positives = 115/214 (53%), Gaps = 21/214 (9%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 118
           N+  G ++GRGA   V+KG        VAIK++  E  +    K+  +E+ +  +L HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA--- 175
           IV  +G  I+    L++I +Y   GSL + +  KK G       P S+   VA+ +    
Sbjct: 61  IVKYIGS-IETSDSLYIILEYAENGSLRQII--KKFG-----PFPESL---VAVYVYQVL 109

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +AYLH   E+ V+HRDIK +NIL +   + KL DFG+AT  +  S      +V GT  
Sbjct: 110 QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPY 164

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           ++APE  +    S  +D+++ G  ++ELLTG  P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (286), Expect = 4e-29
 Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 26/212 (12%)

Query: 66  RVLGRGALSFVFK------GKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPN 118
             LG G    V K      GK+      +A+K +  E ++   K   REL I    + P 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKI------MAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV   G   +    + +  +Y+ GGSL++ L E +  +      P  +  K+A+ + + +
Sbjct: 61  IVGFYGAFYN-NGDISICMEYMDGGSLDKILKEVQGRI------PERILGKIAVAVLKGL 113

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YLH   +  ++HRD+KPSNIL++S+   KLCDFG+    S   V  L KT  GT  Y+A
Sbjct: 114 TYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGV----SGQLVNSLAKTFVGTSSYMA 167

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  Q    S K+D+++ G+ L+EL TGR P 
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (275), Expect = 1e-27
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 25/221 (11%)

Query: 61  NFSKGRVLGRGALSFVFK------GKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASS 113
           +  + +VLG+G+   V+K      GK+       A+K++    D+E  K   REL    S
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKI------YALKKIHVDGDEEFRKQLLRELKTLRS 55

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
              P +V   G      + + ++ +Y+ GGSL   L +K   +      P  V   +A  
Sbjct: 56  CESPYVVKCYGAFYKEGE-ISIVLEYMDGGSLAD-LLKKVGKI------PEPVLAYIARQ 107

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           I + + YLH  T+R ++HRDIKPSN+L++SK   K+ DFG++           C T  GT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGT 163

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
             Y++PE  Q    S   D+++ G+ LLE   G+ P     
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  108 bits (271), Expect = 3e-27
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 19/226 (8%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHP 117
           +F   RV+G+GA   V   +    +   A+K ++K+    K S +    E  I   L+HP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 118 NIVPL-VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
            +V L   F    E+ ++L+   + GG L  HL +K K           V++ +   I  
Sbjct: 61  FLVNLWYSFQ--DEENMYLVVDLLLGGDLRYHLSQKVKFSEE------QVKFWIC-EIVL 111

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
           ++ YLH    + ++HRDIKP NILL  +    + DF +AT  +  +   L  +  GT GY
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 282
           +APE       S   D ++ GV   E L G++P         + + 
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  106 bits (268), Expect = 1e-26
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 27/236 (11%)

Query: 107 ELMIASSLHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           E+ I   L HPNIV      ID   Q L+++ +Y  GG L + +   +K  +    +   
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEE 105

Query: 166 VRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
             +++   +  ++   HN +     V+HRD+KP+NI L +    KL DFGLA        
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--KILGHD 163

Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
               KT  GT  Y++PE   H    +K+D+++ G ++ EL     P  AR       L L
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-----NQLQL 218

Query: 284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
            +K         ++E    R+    R S+++  VI+   + ++ +  +RP  EE++
Sbjct: 219 ASK---------IKEGKFRRIP--YRYSSELNEVIK---SMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  111 bits (279), Expect = 2e-26
 Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 36/282 (12%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           V+ RG     +KGK         +K ++  +   S            L HPNIV L+G C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLC 752

Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
              E+G +LI++Y+ G +L   L            L W  R K+A+GIA+++ +LH    
Sbjct: 753 -RSEKGAYLIHEYIEGKNLSEVL----------RNLSWERRRKIAIGIAKALRFLHCRCS 801

Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF--GYLAPEYFQH 244
             VV  ++ P  I++  K  P L         S P +  LC   K      Y+APE  + 
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-------LSLPGL--LCTDTKCFISSAYVAPETRET 852

Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK---PILHRGMAAVEELLD 301
             +++K+D+Y FG++L+ELLTG+ P +A       ++V WA+      H  M      +D
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYSDCHLDM-----WID 906

Query: 302 PRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
           P ++   S N  +I  V+  A  C +++ + RP   +++  L
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 3e-26
 Identities = 73/214 (34%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 68  LGRGALSFVFKGKVGLLR---TSV--AIKRLDKE---DKESSKAFCRELMIASSLHHPNI 119
           LG+G  SF   GKV L+R   T    A+K L K+    ++  +    E  I S ++HP I
Sbjct: 1   LGKG--SF---GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L  +    E+ L+L+ +Y  GG L  HL +      G  +   +  Y  A  I  ++ 
Sbjct: 56  VKLH-YAFQTEEKLYLVLEYAPGGELFSHLSK-----EGRFSEERARFY--AAEIVLALE 107

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YLH+     +++RD+KP NILL +    KL DFGLA      S      T  GT  YLAP
Sbjct: 108 YLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAP 162

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           E           D ++ GV+L E+LTG+ P  A 
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  106 bits (266), Expect = 3e-26
 Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 37/234 (15%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-----EDKESSKAFCRELMIASSL 114
            +F  G+++G G+ S V   K        AIK LDK     E K   K    E  + + L
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKIEKEVLTRL 58

Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
             HP I+ L     D E  L+ + +Y   G L +++ +      G+     +  Y  A  
Sbjct: 59  NGHPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFY--AAE 110

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-- 231
           I  ++ YLH+   + ++HRD+KP NILL      K+ DFG A      S P   K     
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 232 ----------------GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                           GT  Y++PE          +D++A G ++ ++LTG+ P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (251), Expect = 3e-24
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 18/188 (9%)

Query: 89  AIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 146
           A+K  R+   D ++ K    E+ +   L HPN+V   G  +  E+ +++  +Y SGG+LE
Sbjct: 29  AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK-VYIFMEYCSGGTLE 87

Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
             L   +        L   V     L + E +AYLH      +VHRDIKP+NI L    +
Sbjct: 88  ELLEHGR-------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGV 137

Query: 207 PKLCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHGKVSDK---TDVYAFGVVLL 261
            KL DFG A      +       +++ GT  Y+APE    GK        D+++ G V+L
Sbjct: 138 IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197

Query: 262 ELLTGRKP 269
           E+ TG++P
Sbjct: 198 EMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  100 bits (250), Expect = 3e-24
 Identities = 72/221 (32%), Positives = 112/221 (50%), Gaps = 26/221 (11%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTS--VAIKR--LDKEDKESSKAFCRELM----IASS 113
           ++KG VLG+GA   V+    GL      +A+K+  LD  +  +++    +L     +  S
Sbjct: 2   WTKGEVLGKGAYGTVY---CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L H NIV  +G C+D +  + +  ++V GGS+   L   + G      LP  V  K    
Sbjct: 59  LKHVNIVQYLGTCLD-DNTISIFMEFVPGGSISSIL--NRFG-----PLPEPVFCKYTKQ 110

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAP-SVPFLCKT 229
           I + VAYLHN    CVVHRDIK +N++L    I KL DFG A    W     +   + K+
Sbjct: 111 ILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           + GT  ++APE         K+D+++ G  + E+ TG+ P+
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 5e-24
 Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 26/211 (12%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
            G  +G+G    V  G        VA+K L K+D  +++AF  E  + ++L HPN+V L+
Sbjct: 10  LGATIGKGEFGDVMLGD--YRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLL 66

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G  +     L+++ +Y++ GSL  +L       RG + +  + +   AL + E + YL  
Sbjct: 67  GVVLQ-GNPLYIVTEYMAKGSLVDYLRS-----RGRAVITLAQQLGFALDVCEGMEYLE- 119

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS----APSVPFLCKTVKGTFGYLAP 239
             E+  VHRD+   N+L+S   + K+ DFGLA   S    +  +P     VK T    AP
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP-----VKWT----AP 168

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           E  +  K S K+DV++FG++L E+ + GR P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 99.4 bits (248), Expect = 9e-24
 Identities = 81/295 (27%), Positives = 128/295 (43%), Gaps = 42/295 (14%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 120
           + LG G    V   +   L  +    VA+K L+   +E  ++ F RE+ I  +L H NIV
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 121 PLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
              G C  P  + L LI +Y+  GSL  +L   +  +     L   + +  +  I + + 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI-NLKRL---LLF--SSQICKGMD 123

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT--FGYL 237
           YL +   +  +HRD+   NIL+ S+ + K+ DFGLA         +  K    +  F Y 
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLT-GRK----PIEARRLQGEENLVLWAKPILHRG 292
           APE  +  K S  +DV++FGV L EL T G      P E  R+ G             +G
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA-----------QG 228

Query: 293 MAAVEELLD-----PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
              V  LL+      RL        ++  +++    C  +E   RP   ++I I+
Sbjct: 229 QMIVTRLLELLKEGERLPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 73/212 (34%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
            R LG G    V+ G      T VA+K L K    S +AF +E  I   L H  +V L  
Sbjct: 11  ERKLGAGQFGEVWMG-TWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C + E  ++++ +Y+S GSL   L   K G      LP  V   +A  IAE +AYL   
Sbjct: 69  VCSEEEP-IYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLV--DMAAQIAEGMAYLE-- 120

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLA 238
             R  +HRD+   NIL+    + K+ DFGLA       +T+     F    +K T    A
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF---PIKWT----A 172

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           PE   +G+ + K+DV++FG++L E++T GR P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 25/220 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED---KESSKAFCRELMIAS 112
           ++   RVLG+GA      G+  L R +     V  K ++      KE   A   E++I S
Sbjct: 1   HYIPIRVLGKGAF-----GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILS 54

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
            L HPNI+      +D +  L +  +Y +GG+L   +  +K  +     + W        
Sbjct: 55  LLQHPNIIAYYNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLF 108

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            I  +V+Y+H   +  ++HRDIK  NI L+   + KL DFG++      S   + +TV G
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMAETVVG 163

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           T  Y++PE  Q  K + K+D++A G VL ELLT ++  +A
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 97.3 bits (242), Expect = 4e-23
 Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 36/281 (12%)

Query: 64  KGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPN 118
           K ++LG G    V KG    +   ++  VAIK + D+  +++ +     ++   SL H  
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L+G C  P   L L+ +    GSL  H+ + +  +     L W V+      IA+ +
Sbjct: 71  IVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGM 122

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    E  +VHR++   NILL S  I ++ DFG+A         +     K    ++A
Sbjct: 123 YYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
            E    G+ + ++DV+++GV + E+++ G +P    R     +L       L +G    E
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKG----E 228

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 338
            L  P++ CT         V      C   +E+ RP  +E+
Sbjct: 229 RLAQPQI-CT-------IDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 97.1 bits (242), Expect = 5e-23
 Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 38/238 (15%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 114
           + +  R LG GA   V++G             VA+K L +   E  ++ F  E +I S  
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           +H NIV L+G   +     F++ + ++GG L+  L E +      S+L        A  +
Sbjct: 67  NHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVK 231
           A+   YL    E   +HRDI   N LL+ K   ++ K+ DFG+A            + + 
Sbjct: 126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA------------RDIY 170

Query: 232 GTFGY------------LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
               Y            + PE F  G  + KTDV++FGV+L E+ + G  P   R  Q
Sbjct: 171 RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 6e-23
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNI 119
           + K   LG G    V+K +       VA+K  RLD E++       RE+ +   L HPNI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L+       + L+L+++Y     L+++L ++   +  N      ++  +   +   +A
Sbjct: 61  VKLLDVIHTERK-LYLVFEYCDM-DLKKYLDKRPGPLSPNL-----IKS-IMYQLLRGLA 112

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           Y H      ++HRD+KP NIL++   + KL DFGLA     P   +  + V  T  Y AP
Sbjct: 113 YCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAP 167

Query: 240 EYFQHGKVSDKT-DVYAFGVVLLELLTGR 267
           E     K      D+++ G +  E++TG+
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 96.2 bits (239), Expect = 8e-23
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 20/206 (9%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           G ++G G    V +G+    + +V   + D     +++AF  E  + + LHH N+V L+G
Sbjct: 11  GEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
             +    GL+++ + +S G+L   L       RG + +      + +L +AE + YL + 
Sbjct: 67  VIL--HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSLDVAEGMEYLES- 118

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
             + +VHRD+   NIL+S   + K+ DFGLA               K    + APE  +H
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLAR-----VGSMGVDNSKLPVKWTAPEALKH 171

Query: 245 GKVSDKTDVYAFGVVLLELLT-GRKP 269
            K S K+DV+++GV+L E+ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 96.8 bits (242), Expect = 1e-22
 Identities = 76/228 (33%), Positives = 103/228 (45%), Gaps = 51/228 (22%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCRELMIAS 112
           +F   + LG G  SF   G+V L+R        A+K L K      K       E  I  
Sbjct: 2   DFEFIKTLGTG--SF---GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KV 170
           S+ HP +V L G   D    L+L+ +YV GG L  HL  +K G       P +  Y  +V
Sbjct: 57  SIRHPFLVNLYGSFQDD-SNLYLVMEYVPGGELFSHL--RKSG---RFPEPVARFYAAQV 110

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVP 224
            L +     YLH+     +V+RD+KP N+LL S    K+ DFG A      T+T      
Sbjct: 111 VLALE----YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------ 157

Query: 225 FLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
            LC    GT  YLAPE      +GK     D +A G+++ E+L G  P
Sbjct: 158 -LC----GTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 36/284 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 118
            + K RV+GRGA   V   +    +  V IK++  E   K+   A   E  +   L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 119 IVPLV-GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           I+     F  D  + L ++ +Y  GG+L  ++ +     R NS L         + I  +
Sbjct: 61  IIEYYENFLED--KALMIVMEYAPGGTLAEYIQK-----RCNSLLDEDTILHFFVQILLA 113

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
           + ++H    + ++HRD+K  NILL   K + K+ DFG++   S+ S  +   TV GT  Y
Sbjct: 114 LHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY---TVVGTPCY 167

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 296
           ++PE  +    + K+D++A G VL EL + ++  EA       NL      I+    A +
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------ANLPALVLKIMSGTFAPI 221

Query: 297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
            +   P L+             Q   + ++ + S+RP + +I+A
Sbjct: 222 SDRYSPDLR-------------QLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 20/212 (9%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELMIASSLHHPN 118
           KG +LG G+   V++G         A+K +      +  +E+ K   +E+ + S L HPN
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV  +G   + E  L++  + V GGSL + L  KK G     + P  V       I   +
Sbjct: 64  IVQYLGTERE-EDNLYIFLELVPGGSLAKLL--KKYG-----SFPEPVIRLYTRQILLGL 115

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YLH+   R  VHRDIK +NIL+ +  + KL DFG+A      S     K+ KG+  ++A
Sbjct: 116 EYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMA 169

Query: 239 PEYF-QHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE   Q G      D+++ G  +LE+ TG+ P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 34/283 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHP 117
           +F   + LG+G+   V+K K        A+K +D      KE   A   E+ I +S++HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NI+      +D  + L ++ +Y   G L + + ++KK  +    +P    +++ + +   
Sbjct: 60  NIISYKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRK---LIPEQEIWRIFIQLLRG 115

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           +  LH   E+ ++HRD+K +NILL +  + K+ D G++          + KT  GT  Y+
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYM 168

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           APE ++    S K+D+++ G +L E+ T   P EAR +Q     V        RG     
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------RGKY--- 218

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
               P +      S  +   I+   + +  +   RP  ++I+A
Sbjct: 219 ----PPI--PPIYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 69/208 (33%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           V+G GA   V K +       VAIK+    ++D++  K   RE+ +   L H NIV L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 183
                +  L+L+++YV    LE  L     G+      P +VR      + +++AY H +
Sbjct: 68  AFRR-KGRLYLVFEYVERTLLE-LLEASPGGLP-----PDAVR-SYIWQLLQAIAYCHSH 119

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE--- 240
                ++HRDIKP NIL+S   + KLCDFG A    A     L   V  T  Y APE   
Sbjct: 120 N----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174

Query: 241 -YFQHGKVSDKTDVYAFGVVLLELLTGR 267
               +GK     DV+A G ++ ELL G 
Sbjct: 175 GDTNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 24/216 (11%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       +   V   +A  I+ ++ YL    ++
Sbjct: 73  R-EPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KK 123

Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 176

Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
             + K S K+DV+AFGV+L E+ T G  P     L 
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 20/201 (9%)

Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKES-SKAFCRELMIASSLHHPNIVPLVG-FCID 128
           G++S V     G   T +A K +    K S  K   REL I      P IV   G F  +
Sbjct: 19  GSVSKVKHIPTG---TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75

Query: 129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 188
               + +  +++  GSL+R    KK G      +P  +  K+A+ + E + YL+N     
Sbjct: 76  NN--ICMCMEFMDCGSLDRIY--KKGG-----PIPVEILGKIAVAVVEGLTYLYN--VHR 124

Query: 189 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 248
           ++HRDIKPSNIL++S+   KLCDFG+    S   +  +  T  GT  Y++PE  Q GK +
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIADTFVGTSTYMSPERIQGGKYT 180

Query: 249 DKTDVYAFGVVLLELLTGRKP 269
            K+DV++ G+ ++EL  G+ P
Sbjct: 181 VKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 93.5 bits (232), Expect = 6e-22
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 66  RVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + +G+G    V    +G  R   VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 12  QTIGKGEFGDVM---LGDYRGNKVAVKCI-KNDA-TAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
             ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEAN 121

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
                VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  + 
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE 173

Query: 245 GKVSDKTDVYAFGVVLLELLT-GRKP 269
            K S K+DV++FG++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 7e-22
 Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 45/286 (15%)

Query: 68  LGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 123
           LG G    V KG           VA+K L +E   + K  F RE  + + L HP IV L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C      L L+ +    G L ++L       +    +P S   ++A  +A  +AYL  
Sbjct: 63  GVCKGE--PLMLVMELAPLGPLLKYL-------KKRREIPVSDLKELAHQVAMGMAYLE- 112

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYF 242
              +  VHRD+   N+LL ++   K+ DFG++    A S  +   T  +    + APE  
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE--EL 299
            +GK S K+DV+++GV L E  + G KP                    +  M   E   +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP--------------------YGEMKGAEVIAM 210

Query: 300 LDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
           L+   RL        +I  ++    +C       RP   E+ +  R
Sbjct: 211 LESGERLPRPEECPQEIYSIML---SCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 93.3 bits (232), Expect = 9e-22
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 27/211 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
            + LG G    V  GK    +  VAIK + +E   S   F  E  +   L HPN+V L G
Sbjct: 9   LKELGSGQFGVVHLGK-WRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 125 FCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
            C   +Q  +F++ +Y++ G L  +L E+K  +     L       +   + E++ YL  
Sbjct: 67  VCT--KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL------DMCSDVCEAMEYLE- 117

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYL 237
                 +HRD+   N L+    + K+ DFGLA       +TS+    F  K       + 
Sbjct: 118 --SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK-------WA 168

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRK 268
            PE F + + S K+DV++FGV++ E+ +  K
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 48/236 (20%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 114
            + KG+ LG G  + V+K +       VAIK++   +++ +K      A  RE+ +   L
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQEL 59

Query: 115 HHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA-- 171
            HPNI+ L+  F       + L+++++    LE+ + +K            S+    A  
Sbjct: 60  KHPNIIGLLDVFGHK--SNINLVFEFMET-DLEKVIKDK------------SIVLTPADI 104

Query: 172 ----LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
               L     + YLH+     ++HRD+KP+N+L++S  + KL DFGLA    +P+     
Sbjct: 105 KSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161

Query: 228 KTVKGTFGYLAPEYF-----QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 278
           + V  T  Y APE           V    D+++ G +  ELL  R P     L G+
Sbjct: 162 QVV--TRWYRAPELLFGARHYGVGV----DMWSVGCIFAELLL-RVPF----LPGD 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 93.6 bits (232), Expect = 1e-21
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 17/213 (7%)

Query: 66  RVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 120
           +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ HP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA+ + Y
Sbjct: 73  RLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 124

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           L    ER +VHRD+   N+L+ S    K+ DFGLA         +     K    ++A E
Sbjct: 125 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
              + K + ++DV+++GV + EL+T G KP + 
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLH 115
            +   + +G G+   ++  K         IK +D       +KE+SK   +E+++ + + 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMK 57

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--RGNSTLPWSVRYKVALG 173
           HPNIV            LF++ +Y  GG L + +  +++GV    +  L W V  +++LG
Sbjct: 58  HPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFV--QISLG 113

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKG 232
           +     ++H   +R ++HRDIK  NI LS    + KL DFG+A   +      L  T  G
Sbjct: 114 LK----HIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVG 164

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
           T  YL+PE  Q+   ++KTD+++ G VL EL T + P E   L 
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 16/209 (7%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPLVG- 124
           V+G GA + V+          VAIKR+D E  ++S     +E+   S  +HPN+V     
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 183
           F +  E  L+L+  Y+SGGSL   L   K        L  ++   V   + + + YLH N
Sbjct: 68  FVVGDE--LWLVMPYLSGGSL---LDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN 121

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGTFGYLAPEY 241
           G     +HRDIK  NILL      K+ DFG++   +        + KT  GT  ++APE 
Sbjct: 122 GQ----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 242 F-QHGKVSDKTDVYAFGVVLLELLTGRKP 269
             Q      K D+++FG+  +EL TG  P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 28/219 (12%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G G    V+K +       VA+K  R++ E +       RE+ +   L HPNIV L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 126 CIDPEQG-LFLIYKYVS---GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
                +G ++++++Y+     G L+    +         T    ++      + E + YL
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--------FTES-QIKC-YMKQLLEGLQYL 116

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 240
           H+     ++HRDIK SNIL+++  + KL DFGLA  +T   S  +  + +  T  Y  PE
Sbjct: 117 HS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPE 171

Query: 241 YFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGE 278
                     + D+++ G +L EL  G KPI     QG 
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLG-KPI----FQGS 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.8 bits (228), Expect = 2e-21
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLVG 124
             +G+G    V+KG +    T VA+K          K  F +E  I     HPNIV L+G
Sbjct: 1   EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C+  +Q ++++ + V GGSL   L +KK  +     L      +++L  A  + YL + 
Sbjct: 60  VCVQ-KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL------QMSLDAAAGMEYLES- 111

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
             +  +HRD+   N L+    + K+ DFG++               +    + APE   +
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169

Query: 245 GKVSDKTDVYAFGVVLLELLTG 266
           G+ + ++DV+++G++L E  + 
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 68  LGRGALSFVFK------GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +G+G+   VFK       +V  ++  + + ++++ ++E +     E  + + L    I+ 
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMK-QIDLSKMNRREREEA---IDEARVLAKLDSSYIIR 63

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
                +D +  L ++ +Y   G L + L   ++G        W    ++ LG+A    +L
Sbjct: 64  YYESFLD-KGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILLGLA----HL 117

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H+   + ++HRDIK  N+ L +    K+ D G+A   S  +      T+ GT  YL+PE 
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPEL 172

Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
            +    ++K+DV+A GVVL E  TG+ P +A
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.7 bits (228), Expect = 3e-21
 Identities = 74/263 (28%), Positives = 110/263 (41%), Gaps = 40/263 (15%)

Query: 68  LGRGALSFVFKGK---VGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPL 122
           LG G+   V +G+    G     VA+K L K DK  +    F +E  I  SL H N++ L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            G  +     L ++ +    GSL   L +   G         S     A+ IA  + YL 
Sbjct: 62  YGVVLTHP--LMMVTELAPLGSLLDRLRKDALGH-----FLISTLCDYAVQIANGMRYLE 114

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--------WTSAPS--VPFLCKTVKG 232
             ++R + HRD+   NILL+S    K+ DFGL          +       VP        
Sbjct: 115 --SKRFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP-------- 163

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENL--VLWAKPIL 289
            F + APE  +    S  +DV+ FGV L E+ T G +P       G + L  +      L
Sbjct: 164 -FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--GSQILKKIDKEGERL 220

Query: 290 HRGMAAVEELLDPRLKCTSRNSA 312
            R  A  +++ +  L+C + N A
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPA 243

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.0 bits (226), Expect = 6e-21
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           VLG+G    V+  +    +  +AIK + + D    +    E+ + S L H NIV  +G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 127 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 184
              E G F I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH  
Sbjct: 75  S--ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLH-- 125

Query: 185 TERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
            +  +VHRDIK  N+L+++   + K+ DFG  T      +    +T  GT  Y+APE   
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFG--TSKRLAGINPCTETFTGTLQYMAPEVID 182

Query: 244 HGK--VSDKTDVYAFGVVLLELLTGRKP 269
            G        D+++ G  ++E+ TG+ P
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 6e-21
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 21/217 (9%)

Query: 61  NFSKGRVLGRGALSFVF------KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 114
           N+ +G++LG+GA   V+       G+  L    V       E K+   A   E+ +  +L
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGR-ELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            H  IV   G C+  ++ L +  +Y+ GGS++  L       +    L  +V  K    I
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-------KAYGALTETVTRKYTRQI 113

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKG 232
            E V YLH+     +VHRDIK +NIL  S    KL DFG +    T   S   + K+V G
Sbjct: 114 LEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM-KSVTG 169

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           T  +++PE         K DV++ G  ++E+LT + P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 70/219 (31%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
            F K   +G G    V++ +       VA+K  R+D E      +  RE+ +  +L HPN
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 119 IVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV-RYK-VAL 172
           IV L    VG  +D    +FL+ +Y      E+ L      +  N   P+S  + K + L
Sbjct: 68  IVELKEVVVGKHLD---SIFLVMEYC-----EQDL----ASLLDNMPTPFSESQVKCLML 115

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            +   + YLH   E  ++HRD+K SN+LL+ K   K+ DFGLA     P+ P   K V  
Sbjct: 116 QLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-- 170

Query: 233 TFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 270
           T  Y APE            D++A G +L ELL   KP+
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 35/218 (16%)

Query: 67  VLGRGALSFVFKGK-----VGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
            LGRG    VF  K          T V +K L K   E+ +  F REL +   L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 178
            L+G C + E   ++I +Y   G L++ L   K         P S + KVAL   IA  +
Sbjct: 72  RLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY-- 236
            +L N      VHRD+   N L+SS++  K+            S+  L K V  +  Y  
Sbjct: 131 DHLSNAR---FVHRDLAARNCLVSSQREVKV------------SLLSLSKDVYNSEYYKL 175

Query: 237 ---------LAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
                    LAPE  Q    S K+DV++FGV++ E+ T
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 66  RVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 121
           +V+G G    V +G++ L       VAIK L     +  +  F  E  I     HPNI+ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  +   + + +I +Y+  GSL++ L E       +          +  GIA  + YL
Sbjct: 70  LEG-VVTKSRPVMIITEYMENGSLDKFLREN------DGKFTVGQLVGMLRGIASGMKYL 122

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
              +E   VHRD+   NIL++S  + K+ DFGL+         +  K  K    + APE 
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE-- 298
             + K +  +DV++FG+V+ E+++ G +P               +       + AVE+  
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWD-----------MSN---QDVIKAVEDGY 225

Query: 299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
            L P + C S        + Q    C   + + RP   +I++ L
Sbjct: 226 RLPPPMDCPS-------ALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 26/213 (12%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           +G G    V+ G   L +  VAIK + +E   S + F  E  +   L HP +V L G C 
Sbjct: 12  IGSGQFGLVWLGY-WLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           +    + L+++++  G L  +L   ++G     TL       + L + E +AYL      
Sbjct: 70  E-RSPICLVFEFMEHGCLSDYL-RAQRGKFSQETL-----LGMCLDVCEGMAYLE---SS 119

Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
            V+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WSSPEV 172

Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
           F   K S K+DV++FGV++ E+ + G+ P E R
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 28/215 (13%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCR---ELMIASSLHHPNIVPLVG 124
           + +GA   VF  K        AIK + K D        +   E  I S    P +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 183
           +    ++ L+L+ +Y+ GG L   L     G      L   V       I  ++ YLH N
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE--NVGS-----LDEDVARIYIAEIVLALEYLHSN 112

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYL 237
           G    ++HRD+KP NIL+ S    KL DFGL+         +        K + GT  Y+
Sbjct: 113 G----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 238 APEY---FQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           APE      H K     D ++ G +L E L G  P
Sbjct: 169 APEVILGQGHSK---TVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.1 bits (221), Expect = 3e-20
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 21/223 (9%)

Query: 66  RVLGRGALSFVFKGK------VGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 118
             LG GA   V++G        G     VA+K L K   +  K  F +E  + S+ +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L+G C+  E   ++I + + GG L  +L + +    G   L       + L +A+  
Sbjct: 61  IVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
            YL    +   +HRD+   N L+S K     ++ K+ DFGLA         +  K  +G 
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA--RDIYKSDYYRKEGEGL 174

Query: 234 FG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
               ++APE    GK + ++DV++FGV++ E+LT G++P  A 
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 59/193 (30%), Positives = 103/193 (53%), Gaps = 24/193 (12%)

Query: 106 RELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
           REL +    + P IV   G F  D E  + +  +++ GGSL++ L E K+       +P 
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKR-------IPE 102

Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
            +  KV++ +   +AYL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   + 
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLID 156

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQGEENL 281
            +  +  GT  Y++PE  Q    S ++D+++ G+ L+EL  GR PI   +A+ L+     
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA---- 212

Query: 282 VLWAKPILHRGMA 294
            ++ +P++     
Sbjct: 213 -IFGRPVVDGEEG 224

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 88.3 bits (219), Expect = 7e-20
 Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 32/224 (14%)

Query: 68  LGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVP 121
           LG GA   V+KG++      L  TSVAIK L +  + +  + F +E  + S L HPNIV 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTLPWSVRY----KVAL 172
           L+G C   EQ   ++++Y++ G L   L     H       G+ T+  S+       +A+
Sbjct: 73  LLGVCTK-EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL------ATWTSAPSVPFL 226
            IA  + YL   +    VHRD+   N L+      K+ DFGL      A +    S   L
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                    ++ PE   +GK + ++D+++FGVVL E+ + G +P
Sbjct: 189 ------PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 88.2 bits (219), Expect = 8e-20
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 15/213 (7%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           +++K   +G G    V+KG+       VA+K  RL+ E++       RE+ +   L HPN
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L    +  E  L+LI++++S   L+++L    KG   ++ L  S  Y++  GI    
Sbjct: 61  IVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL--- 115

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            + H    R V+HRD+KP N+L+ +K + KL DFGLA     P   +  + V  T  Y A
Sbjct: 116 -FCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRA 169

Query: 239 PEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPI 270
           PE      + S   D+++ G +  E+ T +KP+
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPN 118
           + K   +G G    V+K +  L    VAIK++ K   ES    K   RE+ +   L+HPN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAES 177
           I+ L+      +  L+L+++++          +  K ++     LP S+       + + 
Sbjct: 60  IIKLLD-VFRHKGDLYLVFEFM--------DTDLYKLIKDRQRGLPESLIKSYLYQLLQG 110

Query: 178 VAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
           +A+ H +G    ++HRD+KP N+L++++ + KL DFGLA    +P  P+    V  T  Y
Sbjct: 111 LAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWY 164

Query: 237 LAPE-YFQHGKVSDKTDVYAFGVVLLELLTGR 267
            APE        S   D+++ G +  ELL+ R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           R LG G    V++G +    T VA+K L K      K F  E  I   L HP ++ L   
Sbjct: 12  RKLGAGQFGEVWEG-LWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
           C   E+ ++++ + +  GSL  +L            LP  +   +A  +A  +AYL    
Sbjct: 70  CTL-EEPIYIVTELMKYGSLLEYLQGGAGR---ALKLPQLI--DMAAQVASGMAYLE--- 120

Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAP 239
            +  +HRD+   N+L+    I K+ DFGLA       + +     F    +K T    AP
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF---PIKWT----AP 173

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           E   + + S K+DV++FG++L E++T GR P
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 19/208 (9%)

Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVP 121
           RV+G+G    V+ G +      +   A+K L++  D E  + F +E +I     HPN++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVA 179
           L+G C+  E    ++  Y+  G L R+       +R  +  P +V+  +  G  +A+ + 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL-RNF------IRSETHNP-TVKDLIGFGLQVAKGME 112

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYL 237
           YL     +  VHRD+   N +L      K+ DFGLA   +             K    ++
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLT 265
           A E  Q  K + K+DV++FGV+L EL+T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 13/213 (6%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           F+  R LG G    V++G     R  VAIK L  +D    + F +E+     L H +++ 
Sbjct: 8   FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L   C   E  +++I + +  GSL   L   +  V   ++L       +A  +AE +AYL
Sbjct: 67  LFAVCSVGEP-VYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYL 120

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
               E+  +HRD+   NIL+    + K+ DFGLA         +L    K  + + APE 
Sbjct: 121 E---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEA 175

Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
             HG  S K+DV++FG++L E+ T G+ P    
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 60/181 (33%), Positives = 90/181 (49%), Gaps = 13/181 (7%)

Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 146
           VA+K+L     E  + F RE+ I  SL H NIV   G C     + L L+ +Y+  GSL 
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95

Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
            +L + ++ +     L ++ +      I + + YL  G++R  VHRD+   NIL+ S+  
Sbjct: 96  DYLQKHRERLDHRKLLLYASQ------ICKGMEYL--GSKRY-VHRDLATRNILVESENR 146

Query: 207 PKLCDFGLATWTSAPSVPFLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
            K+ DFGL          +  +    +  F Y APE     K S  +DV++FGVVL EL 
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELF 205

Query: 265 T 265
           T
Sbjct: 206 T 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 18/221 (8%)

Query: 55  ILAATHNFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELM 109
           IL  T  F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           + +S+ +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+  
Sbjct: 62  VMASVDNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ-- 117

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
               IA+ + YL    ER +VHRD+   N+L+ + +  K+ DFGLA    A    +  + 
Sbjct: 118 ----IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            K    ++A E   H   + ++DV+++GV + EL+T G KP
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 34/213 (15%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
            LG G+   V+K         VAIK +    +E  +   +E+ I      P IV   G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYG-S 66

Query: 127 IDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
                 L+++ +Y   GS+        + L E++            + Y+   G+     
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---------ILYQTLKGLE---- 113

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGY 236
           YLH+      +HRDIK  NILL+ +   KL DFG++   T T A        TV GT  +
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-----NTVIGTPFW 165

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +APE  Q    ++K D+++ G+  +E+  G+ P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 30/225 (13%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 116
           +VLG+G  SF   GKV L          A+K L K+    D +       + ++A +  H
Sbjct: 1   KVLGKG--SF---GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +  L   C   +  LF + +YV+GG L  H+    +        P +  Y  A  I  
Sbjct: 56  PFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR-----FDEPRARFY--AAEIVL 107

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + +LH   ER +++RD+K  N+LL S+   K+ DFG+        V     T  GT  Y
Sbjct: 108 GLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDY 162

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
           +APE   +       D +A GV+L E+L G+ P E      E+ L
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG---DDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 86.0 bits (213), Expect = 7e-19
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 16/177 (9%)

Query: 106 RELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
           REL +    + P IV   G F  D E  + +  +++ GGSL++ L  KK G      +P 
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPE 98

Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
           ++  K+++ +   + YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   + 
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLID 152

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
            +  +  GT  Y++PE  Q    + ++D+++ G+ L+E+  GR PI     +  E +
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 8e-19
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 29/218 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHH--- 116
           + +  ++GRGA   V++GK       VA+K   LD  D + S    RE+ + S L     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-REVALLSQLRQSQP 61

Query: 117 PNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           PNI    G +   P   L++I +Y  GGS+ R L +           P + +Y +++ I 
Sbjct: 62  PNITKYYGSYLKGPR--LWIIMEYAEGGSV-RTLMKAG---------PIAEKY-ISVIIR 108

Query: 176 E---SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
           E   ++ Y+H      V+HRDIK +NIL+++    KLCDFG+A             T  G
Sbjct: 109 EVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVG 163

Query: 233 TFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 269
           T  ++APE    GK  D K D+++ G+ + E+ TG  P
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 88/303 (29%), Positives = 137/303 (45%), Gaps = 54/303 (17%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTS---------VAIKRLDKED-KESSKAFCRELMIASS 113
           K RVLG G       GKV L             VA+K L +E  ++++  + +E+ I  +
Sbjct: 8   KIRVLGEGHF-----GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT 62

Query: 114 LHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           L+H NIV   G C +   +GL LI +YV  GSL  +L + K  +        +     A 
Sbjct: 63  LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--------AQLLLFAQ 114

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            I E +AYLH+   +  +HRD+   N+LL + ++ K+ DFGLA   + P      +  + 
Sbjct: 115 QICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVRED 169

Query: 233 ----TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL------- 281
                F Y A E  +  K S  +DV++FGV L ELLT     ++   + EE +       
Sbjct: 170 GDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228

Query: 282 -VLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
            V+    +L RGM         RL C      ++  +++    C  +E   RP    +I 
Sbjct: 229 TVVRLIELLERGM---------RLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIP 276

Query: 341 ILR 343
           IL+
Sbjct: 277 ILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 16/209 (7%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           N  K   +G GA   V+K         VAIK++    +        E++I     HPNIV
Sbjct: 23  NLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIV 78

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
                 +  ++ L+++ +Y+ GGSL   + +          +       V   + + + Y
Sbjct: 79  DYYDSYLVGDE-LWVVMEYMDGGSLTDIITQNFV------RMNEPQIAYVCREVLQGLEY 131

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+   + V+HRDIK  NILLS     KL DFG A   +         +V GT  ++APE
Sbjct: 132 LHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPE 186

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +      K D+++ G++ +E+  G  P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 64/200 (32%), Positives = 108/200 (54%), Gaps = 25/200 (12%)

Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV-GFCIDPEQG-LFLIYKYVSGGSL 145
           + I ++  +++E S+   +E+ + S++ HPNIV     F    E G L+++  Y  GG L
Sbjct: 33  INISKMSPKEREESR---KEVAVLSNMKHPNIVQYQESF---EENGNLYIVMDYCEGGDL 86

Query: 146 ERHLHEKKKGV--RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS 203
            + ++  ++GV    +  L W V+  +AL       ++H   +R ++HRDIK  NI L+ 
Sbjct: 87  YKKIN-AQRGVLFPEDQILDWFVQICLAL------KHVH---DRKILHRDIKSQNIFLTK 136

Query: 204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
               KL DFG+A   +  S   L +T  GT  YL+PE  ++   ++K+D++A G VL E+
Sbjct: 137 DGTIKLGDFGIARVLN--STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194

Query: 264 LTGRKPIEARRLQGEENLVL 283
            T +   EA  ++   NLVL
Sbjct: 195 CTLKHAFEAGNMK---NLVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 61/189 (32%), Positives = 91/189 (48%), Gaps = 34/189 (17%)

Query: 105 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE-RHLHEKKKGVRGNSTLP 163
           CRE+ I   ++HPN+V       D    + ++ +++ GGSLE  H+              
Sbjct: 120 CREIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEGTHI-------------- 164

Query: 164 WSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
              ++   VA  I   +AYLH    R +VHRDIKPSN+L++S K  K+ DFG++   +  
Sbjct: 165 ADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221

Query: 222 SVPFLCKTVKGTFGYLAPEY----FQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQ 276
             P  C +  GT  Y++PE       HG       D+++ GV +LE   GR P    R Q
Sbjct: 222 MDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-Q 278

Query: 277 GEENLVLWA 285
           G+     WA
Sbjct: 279 GD-----WA 282

Length = 353

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 68/286 (23%), Positives = 135/286 (47%), Gaps = 28/286 (9%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHP 117
           NF   + +GRG  S V++    L    VA+K++   D  D ++     +E+ +   L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           N++      I+ +  L ++ +    G L R +   KK  R    +P    +K  + +  +
Sbjct: 63  NVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKR---LIPEKTVWKYFVQLCSA 118

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT  Y+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYM 173

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           +PE       + K+D+++ G +L E+   + P    ++    NL    K I        E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI--------E 221

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
           +   P L  +   S ++ +++     CI+ +  +RP I  +  + +
Sbjct: 222 QCDYPPLP-SDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 22/221 (9%)

Query: 65  GRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 120
           GR +G G    V++G        + +VA+K        S +  F +E  I     HP+IV
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G   +    ++++ +    G L  +L   K       +L  +     +  ++ ++AY
Sbjct: 71  KLIGVITENP--VWIVMELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAY 122

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           L   ++R V HRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 123 LE--SKRFV-HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPE 178

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN 280
                + +  +DV+ FGV + E+L  G KP      QG +N
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKP-----FQGVKN 214

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 83.0 bits (205), Expect = 5e-18
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 24/219 (10%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIKRL-------DKEDKESS--KAFCRELMIASSL 114
           KG ++G G+   V+ G        +A+K++         +D++ S   A  RE+ +   L
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            H NIV  +G  +D +  L +  +YV GGS+   L+              ++       I
Sbjct: 64  QHENIVQYLGSSLDADH-LNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQI 115

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT----V 230
            + + YLHN   R ++HRDIK +NIL+ +K   K+ DFG++    A S+          +
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +G+  ++APE  +    + K D+++ G +++E+LTG+ P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.0 bits (205), Expect = 5e-18
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 37/289 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL------DKEDKESSKAFCRELMIASSL 114
            + KG+ LG GA S  ++ +     T +A+K++        E +E  +A  +E+ + + L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 115 HHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           +HP+I+ ++G  C D    LF+  ++++GGS+   L   K G    +     + Y     
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLS--KYGAFKEAV---IINY--TEQ 111

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSA--PSVPFLCKTV 230
           +   ++YLH   E  ++HRD+K +N+L+ S+ +  ++ DFG A   +A           +
Sbjct: 112 LLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168

Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 290
            GT  ++APE  +  +     DV++ G V++E+ T + P  A +     +L L  K    
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASA 226

Query: 291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
               ++ E L P L+                  C+  +   RP   E++
Sbjct: 227 TTAPSIPEHLSPGLR-------------DVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 70/226 (30%), Positives = 93/226 (41%), Gaps = 54/226 (23%)

Query: 67  VLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED------KESSKAFCRELMIASSLH 115
           VLGRG       GKV L          AIK L K D       ES     R    A+S  
Sbjct: 6   VLGRGHF-----GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--VALG 173
           HP +V L   C   E  +  + +Y +GG L  H+H          + P +V Y   V LG
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV------FSEPRAVFYAACVVLG 113

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK----- 228
           +     YLH   E  +V+RD+K  N+LL ++   K+ DFG            LCK     
Sbjct: 114 LQ----YLH---ENKIVYRDLKLDNLLLDTEGFVKIADFG------------LCKEGMGF 154

Query: 229 -----TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                T  GT  +LAPE       +   D +  GV++ E+L G  P
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 86.0 bits (213), Expect = 5e-18
 Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 37/239 (15%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 122
           R++G+G +  V+     +    VA+K++ +   E+    K F RE  IA+ L HP IVP+
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--------I 174
              C D +  ++    Y+ G +L+  L    K V    +L   +  K ++G        I
Sbjct: 68  YSICSDGDP-VYYTMPYIEGYTLKSLL----KSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA------------PS 222
             ++ Y+H+   + V+HRD+KP NILL       + D+G A +                +
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 223 VPFLCKTVKG----TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
           + +   T+ G    T  Y+APE       S+ TD+YA GV+L ++LT   P   RR +G
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY--RRKKG 236

Length = 932

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 29/224 (12%)

Query: 61  NFSKGRVLGRGALSFVFKG------------KVGLLRTSVAIKRLDKEDKESSKAFCREL 108
            + KG ++G+G    V+              +V L  T     R D   K+  KA   E+
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATI--AGRHDSRQKDMVKALRSEI 59

Query: 109 MIASSLHHPNIVPLVGFCIDPEQ-GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
                L H NIV  +GF    E   +FL  +YV GGS+   L   +   R    L     
Sbjct: 60  ETLKDLDHLNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCL---RTYGRFEEQLVRFFT 114

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
            +V  G+A    YLH+   + ++HRD+K  N+L+ +  I K+ DFG++  +         
Sbjct: 115 EQVLEGLA----YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167

Query: 228 KTVKGTFGYLAPEYFQ--HGKVSDKTDVYAFGVVLLELLTGRKP 269
            +++G+  ++APE         S K D+++ G V+LE+  GR+P
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 83.3 bits (206), Expect = 6e-18
 Identities = 77/257 (29%), Positives = 123/257 (47%), Gaps = 38/257 (14%)

Query: 27  ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 81
           E++W+ I+S+  +    I P      +L Y        +N S G+ LG GA   V +   
Sbjct: 2   EVRWKVIESINGNEYVYIDP-----TQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATA 56

Query: 82  -GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCI--DPEQG 132
            GL ++   +K   K  K ++     +A   EL I S L +H NIV L+G C    P   
Sbjct: 57  YGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP--- 113

Query: 133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 192
           + +I +Y   G L   L  K++       L  S  Y+VA G+A    +L   ++ C+ HR
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMA----FL--ASKNCI-HR 165

Query: 193 DIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT----FGYLAPEYFQHGKVS 248
           D+   N+LL+  KI K+CDFGLA      S       VKG       ++APE   +   +
Sbjct: 166 DLAARNVLLTHGKIVKICDFGLARDIMNDS----NYVVKGNARLPVKWMAPESIFNCVYT 221

Query: 249 DKTDVYAFGVVLLELLT 265
            ++DV+++G++L E+ +
Sbjct: 222 FESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 31/209 (14%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVG 124
           +LG+G    VFKG +   +T VA+K   KED  +E    F  E  I     HPNIV L+G
Sbjct: 2   LLGKGNFGEVFKGTLKD-KTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C    Q ++++ + V GG     L +KK  ++    +      K AL  A  +AYL   
Sbjct: 60  VCTQ-RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLV------KFALDAAAGMAYLE-- 110

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSA--PSVPFLCKTVKGTFGY 236
           ++ C+ HRD+   N L+    + K+ DFG++       ++S+    +P     +K T   
Sbjct: 111 SKNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP-----IKWT--- 161

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            APE   +G+ S ++DV+++G++L E  +
Sbjct: 162 -APEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 58/219 (26%), Positives = 112/219 (51%), Gaps = 14/219 (6%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHP 117
           NF   + +GRG  S V++    L R  VA+K++   +  D ++ +   +E+ +   L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 118 NIVP-LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           N++  L  F  D E  L ++ +    G L + +   KK  R    +P    +K  + +  
Sbjct: 63  NVIKYLDSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKR---LIPERTVWKYFVQLCS 117

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
           +V ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT  Y
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYY 172

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
           ++PE       + K+D+++ G +L E+   + P    ++
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 28/212 (13%)

Query: 68  LGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           LG G    V  GK  G  +  VAIK + KE   S   F  E  +   L H  +V L G C
Sbjct: 12  LGTGQFGVVKYGKWRG--QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
              ++ ++++ +Y+S G L  +L E  K  + +  L      ++   + E +AYL +   
Sbjct: 69  -TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL------EMCKDVCEGMAYLES--- 118

Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
           +  +HRD+   N L+  +   K+ DFGL+       +TS+    F  +       +  PE
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPE 171

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
              + K S K+DV+AFGV++ E+ + G+ P E
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 66  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 116

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 117 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 170

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 276
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 38/221 (17%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELM---IA-SSLHHPN 118
           LGRGA   V K +     T +A+KR+      +E K       R LM   I+  S+  P 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-------RLLMDLDISMRSVDCPY 61

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLE---RHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            V   G      +G   I   V   SL+   + +++K        T+P  +  K+A+ I 
Sbjct: 62  TVTFYGALF--REGDVWICMEVMDTSLDKFYKKVYDKGL------TIPEDILGKIAVSIV 113

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTF 234
           +++ YLH  ++  V+HRD+KPSN+L++     KLCDFG+    S   V  + KT+  G  
Sbjct: 114 KALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI----SGYLVDSVAKTIDAGCK 167

Query: 235 GYLAPEYF---QHGKVSD-KTDVYAFGVVLLELLTGRKPIE 271
            Y+APE      + K  D K+DV++ G+ ++EL TGR P +
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 121
           RV+GRG+ + V   ++       A+K + KE    D++       + +   + +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+ ++ YL
Sbjct: 61  LHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEISLALNYL 112

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGTFGYLAP 239
           H   ER +++RD+K  N+LL S+   KL D+G+      P  +    C    GT  Y+AP
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GTPNYIAP 165

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
           E  +        D +A GV++ E++ GR P +
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 21/200 (10%)

Query: 88  VAIK--RLDKEDKESSKA-FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 144
           VAIK  R D  ++E  +A F RE  + + L+HPNIV L+     P   LF +++YV G +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 204
           L   L         +  LP     ++ L + +++A  HN   + +VHRD+KP NI++S  
Sbjct: 66  LREVL-------AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQT 115

Query: 205 KI---PKLCDFGLATW---TSAPSVPFLCKT--VKGTFGYLAPEYFQHGKVSDKTDVYAF 256
            +    K+ DFG+ T         V  L +T  V GT  Y APE  +   V+  +D+YA+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 257 GVVLLELLTGRKPIEARRLQ 276
           G++ LE LTG++ ++   + 
Sbjct: 176 GLIFLECLTGQRVVQGASVA 195

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 30/215 (13%)

Query: 66  RVLGRGALSFVFKGKVGLLRT--SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           + LG G    V  GK    R    VAIK +  E   S + F  E  +   L HP +V L 
Sbjct: 10  KELGSGQFGVVHLGK---WRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C   ++ L+++ +++  G L  +L +++  +  +  L       +   + E + YL  
Sbjct: 66  GVCTQ-QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQDVCEGMEYLER 118

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYL 237
            +    +HRD+   N L+SS  + K+ DFG+        +TS+    F  K       + 
Sbjct: 119 NS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK-------WS 168

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
            PE F   K S K+DV++FGV++ E+ T G+ P E
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 29/216 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNIV 120
           F+    +G+G+   V+K         VAIK +D E+ E       +E+   S    P I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
              G  +     L++I +Y  GGS         L E                  +   + 
Sbjct: 63  KYYGSFLK-GSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------------ILREVL 108

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGT 233
             + YLH   E   +HRDIK +NILLS +   KL DFG++   ++       K  T  GT
Sbjct: 109 LGLEYLHE--EG-KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----SKRNTFVGT 161

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             ++APE  +     +K D+++ G+  +EL  G  P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 25/191 (13%)

Query: 86  TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           T VAIK L K+   S +AF  E  +   L HP +V L  + +  ++ +++I +Y+  GSL
Sbjct: 31  TKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVVTQEPIYIITEYMENGSL 87

Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
              L   +        L  +    +A  IAE +A++     +  +HRD++ +NIL+S   
Sbjct: 88  VDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETL 139

Query: 206 IPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 259
             K+ DFGLA       +T+     F  K       + APE   +G  + K+DV++FG++
Sbjct: 140 CCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEAINYGTFTIKSDVWSFGIL 192

Query: 260 LLELLT-GRKP 269
           L E++T GR P
Sbjct: 193 LTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 72/216 (33%), Positives = 99/216 (45%), Gaps = 34/216 (15%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS---------VAIKRLDKEDKESSKA-FCRELMIASSLH 115
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 10  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 116 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H NIV   G C  D   G+ LI +++  GSL+ +L   K  +     L ++V+      I
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ------I 118

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG-- 232
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL   T A        TVK   
Sbjct: 119 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL---TKAIETDKEYYTVKDDL 172

Query: 233 ---TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
               F Y APE     K    +DV++FGV L ELLT
Sbjct: 173 DSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 70/212 (33%), Positives = 106/212 (50%), Gaps = 19/212 (8%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF +   LG G  + V+KG+       VA+K   LD E+   S A  RE+ +   L H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHEN 59

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG--NSTLPWSVRYKVALGIAE 176
           IV L    I  E  L L+++Y+    L++++     GVRG  +     S  Y++  GIA 
Sbjct: 60  IVRLHD-VIHTENKLMLVFEYMDK-DLKKYM--DTHGVRGALDPNTVKSFTYQLLKGIA- 114

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
              + H   E  V+HRD+KP N+L++ +   KL DFGLA     P   F  + V  T  Y
Sbjct: 115 ---FCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWY 166

Query: 237 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGR 267
            AP+     +  S   D+++ G ++ E++TGR
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 27/225 (12%)

Query: 69  GRGALSFVFK--GKVGLLRTSVAIKRLDKEDKES----SKAFCRELMIASSLHHPNIVPL 122
           GRG    V+K   K G      AIK+  K DKE     S++ CRE+ +   L H N+V L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 123 VGFCIDP-EQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           V   ++  ++ ++L++ Y      +    H + K V    ++  S+ +++  G+     Y
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV----HY 123

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFL-CKTVKGTFG 235
           LH      V+HRD+KP+NIL+  +       K+ D GLA   +AP  P      V  T  
Sbjct: 124 LH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 236 YLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEE 279
           Y APE     +   K  D++A G +  ELLT   PI     +G E
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PI----FKGRE 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 5e-17
 Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 70  RGALSFVFKGKVGLLRTSVAIKRLDKEDKESS------KAFCRELMIASSLHHPNIVPLV 123
           +GA   V+  K        AIK L K D  +       KA    +MI      P +  L 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAKLY 63

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYL 181
            +    +  L+L+ +Y++GG     +  K  G      LP  W+ +Y     IAE V  +
Sbjct: 64  -YSFQSKDYLYLVMEYLNGGDCASLI--KTLGG-----LPEDWAKQY-----IAEVVLGV 110

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
            +  +R ++HRDIKP N+L+      KL DFGL+            K   GT  YLAPE 
Sbjct: 111 EDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPET 164

Query: 242 FQHGKVSDK-TDVYAFGVVLLELLTGRKPIEA 272
              G   DK +D ++ G V+ E L G  P  A
Sbjct: 165 IL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 37/215 (17%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK----EDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG G    V   KV     + A+K + K    E  +    F  E  I    +HP IV L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
               D ++ ++++ +Y  GG L   L ++  G+    T     R+ +A  +  +  YLHN
Sbjct: 60  RTFKD-KKYIYMLMEYCLGGELWTILRDR--GLFDEYT----ARFYIA-CVVLAFEYLHN 111

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVKGTFG 235
              R +++RD+KP N+LL S    KL DFG A        TWT        C    GT  
Sbjct: 112 ---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-------FC----GTPE 157

Query: 236 YLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKP 269
           Y+APE     K  D + D ++ G++L ELLTGR P
Sbjct: 158 YVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.6 bits (196), Expect = 5e-17
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 18/217 (8%)

Query: 68  LGRGALSFVFKG--KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           LG G    V KG  K+   +  VAIK L ++ +K       RE  I   L +P IV ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C    + L L+ +  SGG L + L  KK  +  ++ +   + ++V++G+     YL   
Sbjct: 63  VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV--ELMHQVSMGMK----YLE-- 112

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQ 243
             +  VHRD+   N+LL ++   K+ DFGL+    A    +  ++  K    + APE   
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171

Query: 244 HGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
             K S ++DV+++G+ + E  + G+KP   ++++G E
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPY--KKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 28/210 (13%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K      +AF +E  I   L H  +VPL  + +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E+ ++++ +++  GSL   L   K+G      LP  V   +A  IA+ +AY+    ER
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLV--DMAAQIADGMAYI----ER 120

Query: 188 C-VVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              +HRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 173

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL+T GR P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 19/208 (9%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNIVPL 122
              +G GA   VFK K      +VA+K++     E        RE+    +  HP +V L
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 123 VGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           +   + P   G  L+ +Y+    L   L ++++       LP +        + + VAY+
Sbjct: 65  LD--VFPHGSGFVLVMEYM-PSDLSEVLRDEER------PLPEAQVKSYMRMLLKGVAYM 115

Query: 182 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           H NG    ++HRD+KP+N+L+S+  + K+ DFGLA   S          V  T  Y APE
Sbjct: 116 HANG----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170

Query: 241 -YFQHGKVSDKTDVYAFGVVLLELLTGR 267
             +   K     D++A G +  ELL G 
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           ++G G+   V K K       VAIK+    ++DK   K   RE+ +   L H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                ++ L+L++++V    L+    + +K   G   L  S   K    I   + + H+ 
Sbjct: 68  VF-RRKKRLYLVFEFVDHTVLD----DLEKYPNG---LDESRVRKYLFQILRGIEFCHSH 119

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF-- 242
               ++HRDIKP NIL+S   + KLCDFG A   +AP    +      T  Y APE    
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVG 174

Query: 243 --QHGKVSDKTDVYAFGVVLLELLTG 266
             ++G+     D++A G ++ E+LTG
Sbjct: 175 DTKYGR---AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 74/288 (25%), Positives = 131/288 (45%), Gaps = 41/288 (14%)

Query: 68  LGRGALSFVFK-GKVGLLRTSVAIKRLD-------KEDKESSKAF---CREL-MIASSLH 115
           LG GA   V+K  K    +  +A+K ++       K+ +E  K+      E+ +I   L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 174
           HPNIV      ++ ++ L+++   + G  L  H +  K+K  R      W++  ++ L  
Sbjct: 68  HPNIVRYYKTFLENDR-LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
             ++ YLH   E+ +VHRD+ P+NI+L       + DFGLA      S      +V GT 
Sbjct: 125 --ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTI 177

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            Y  PE  ++    +K DV+AFG +L ++ T + P              ++  +L     
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP-------------FYSTNMLSLATK 224

Query: 295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
            VE + +P  +     S  +  VI    +C++ +   RP I ++ A++
Sbjct: 225 IVEAVYEPLPEGMY--SEDVTDVIT---SCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 62/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLH 115
             NF   + +G+G  S V+K    L    VA+K++   +  D ++ +   +E+ +   L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++  +   I+  + L ++ +    G L R +   KK  R    +P    +K  + + 
Sbjct: 61  HPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKR---LIPERTIWKYFVQLC 116

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
            ++ ++H    + ++HRDIKP+N+ +++  + KL D GL  + S+ +         GT  
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPY 171

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 295
           Y++PE       + K+D+++ G +L E+   + P        + NL    K I       
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEKCDYPP 227

Query: 296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI 341
           +              S ++  ++   + CI+ +  +RP I  ++ +
Sbjct: 228 LP---------ADHYSEELRDLV---SRCINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 30/224 (13%)

Query: 66  RVLGRGALSFVFKGKVGLL-----RTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNI 119
           R LG GA   VF G+   L     +  VA+K L +    ++ K F RE  + ++  H NI
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNST--LPWSVRYKVAL 172
           V   G C + +    ++++Y+  G L + L              +    L  S   ++A+
Sbjct: 71  VKFYGVCTEGDP-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTV 230
            IA  + YL     +  VHRD+   N L+    + K+ DFG++   +T+          V
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD------YYRV 180

Query: 231 KGT----FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            G       ++ PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 28/210 (13%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K    S ++F  E  I   L H  +V L  + +
Sbjct: 14  LGNGQFGEVWMGTWNG-NTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAV 69

Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E+ ++++ +Y+S GSL   L   K G      LP  V   +A  +A  +AY+    ER
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLV--DMAAQVAAGMAYI----ER 120

Query: 188 C-VVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              +HRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 173

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL+T GR P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 15/210 (7%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVG 124
           LG+G    V   +V       A K+LDK+    ++  +    E  I   +    IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
           +  + +  L L+   ++GG L+ H++       G    P +     A  I   + +LH  
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYN-----VGEPGFPEARAIFYAAQIICGLEHLHQ- 113

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
             R +V+RD+KP N+LL      ++ D GLA            K   GT GY+APE  Q 
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQG 168

Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
                  D +A G  L E++ GR P   R+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL----HHPNIVP 121
           + LG G    V+  +       VAIK++ K  K  S   C  L    SL     HPNIV 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L     + ++ L+ +++Y     +E +L++  K  R       SV   +   I + +A++
Sbjct: 63  LKEVFRENDE-LYFVFEY-----MEGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHI 115

Query: 182 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGTFGYLAP 239
           H +G      HRD+KP N+L+S  ++ K+ DFGLA    S P  P+       T  Y AP
Sbjct: 116 HKHG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY--TDYVSTRWYRAP 167

Query: 240 EYF-QHGKVSDKTDVYAFGVVLLELLTGR 267
           E   +    S   D++A G ++ EL T R
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 27/221 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 115
           N+  G++LG+GA   V+          +A+K++  D E  E+SK   A   E+ +  +L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 116 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H  IV   G   DP E+ L +  +++ GGS++  L       +    L  +V  K    I
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-------KSYGALTENVTRKYTRQI 115

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC------K 228
            E V+YLH+     +VHRDIK +NIL  S    KL DFG     ++  +  +C      K
Sbjct: 116 LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-----ASKRLQTICLSGTGMK 167

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +V GT  +++PE         K D+++ G  ++E+LT + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 27/221 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 115
           N+  G++LGRGA   V+          +A+K++  D + +E+SK   A   E+ +  +L 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 116 HPNIVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H  IV   G   DPE+    I+ +Y+ GGS++  L       +    L  +V  +    I
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQI 115

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC------K 228
            + V+YLH+     +VHRDIK +NIL  S    KL DFG     ++  +  +C      K
Sbjct: 116 LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG-----ASKRIQTICMSGTGIK 167

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +V GT  +++PE         K DV++    ++E+LT + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 61/185 (32%), Positives = 92/185 (49%), Gaps = 11/185 (5%)

Query: 130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV 189
           +  L LI +Y SGG L + + ++ K       LP+   Y+V L   + V  L     R +
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLK-----EHLPFQ-EYEVGLLFYQIVLALDEVHSRKM 190

Query: 190 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 249
           +HRD+K +NI L    I KL DFG +   S      +  +  GT  YLAPE ++  + S 
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250

Query: 250 KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK--PILHRGMAAVEELLDPRLKCT 307
           K D+++ GV+L ELLT  +P +    +     VL+ K  P      + ++ LLDP L   
Sbjct: 251 KADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLL--- 307

Query: 308 SRNSA 312
           S+N A
Sbjct: 308 SKNPA 312

Length = 478

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 31/211 (14%)

Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF----CRELMIASSLHHPNIVPL---- 122
           G    V++ +       VA+K+L K +KE    F     RE+ I   L HPNIV +    
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKL-KMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVV 73

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV--RYKVALGIAESVAY 180
           VG  +D    ++++ +YV     E  L    K +      P+       + L +   VA+
Sbjct: 74  VGSNLDK---IYMVMEYV-----EHDL----KSLMETMKQPFLQSEVKCLMLQLLSGVAH 121

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH   +  ++HRD+K SN+LL+++ I K+CDFGLA    +P  P+    V  T  Y APE
Sbjct: 122 LH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPE 176

Query: 241 YFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 270
                K  S   D+++ G +  ELLT +KP+
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 43/290 (14%)

Query: 63  SKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 118
           +K +V+G G    VF+G +   G    +VAIK L     E  +  F  E  I     H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL--GIAE 176
           I+ L G  +   +   +I +Y+  G+L+++L +            +S    V +  GIA 
Sbjct: 68  IIRLEG-VVTKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAA 118

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFG 235
            + YL   ++   VHRD+   NIL++S    K+ DFGL+      P   +     K    
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA 294
           + APE   + K +  +DV++FG+V+ E+++ G +P              W     H  M 
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-------------YWDMSN-HEVMK 221

Query: 295 AVEE--LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
           A+ +   L   + C S        V Q    C   + +RRP   +I+ +L
Sbjct: 222 AINDGFRLPAPMDCPS-------AVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 32/229 (13%)

Query: 66  RVLGRGALSFVFKGKV-GLL----RTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 119
           R +G+GA   VF+ +  GLL     T VA+K L +E     +A F RE  + +   HPNI
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRY---------- 168
           V L+G C   +  + L+++Y++ G L   L H   +     S    S R           
Sbjct: 71  VKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 169 ----KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
                +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+    +    
Sbjct: 130 TEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-- 184

Query: 225 FLCKTVKGTF---GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              K  +       ++ PE   + + + ++DV+A+GVVL E+ + G +P
Sbjct: 185 -YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 14/211 (6%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIVPLV 123
           RV+G+G+   V   +         IK+L+  +      KA  +E  + S L HPNIV   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPWSVRYKVALGIAESVAYLH 182
                 +  L+++  +  GG L   L E+K K +  N  + W V+      IA ++ YLH
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLH 119

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
              E+ ++HRD+K  N+ L+   I K+ D G+A          +  T+ GT  Y++PE F
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELF 174

Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
            +   + K+DV+A G  + E+ T +    A+
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 49/239 (20%)

Query: 61  NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIAS 112
           N   G+ LG G       A +F  KG+ G   T+VA+K L +    S  +    E  +  
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGY--TTVAVKMLKENASSSELRDLLSEFNLLK 58

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNSTLP 163
            ++HP+++ L G C      L LI +Y   GSL   L E +K         G R +S L 
Sbjct: 59  QVNHPHVIKLYGACSQDG-PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 164 WSVRYKVALG--------IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
                 + +G        I+  + YL    E  +VHRD+   N+L++  +  K+ DFGL+
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 216 ---------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
                       S   +P     VK    ++A E       + ++DV++FGV+L E++T
Sbjct: 175 RDVYEEDSYVKRSKGRIP-----VK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           +G G    V+K +       VAIK +  E  +  +   +E+ +     HPNIV   G  +
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV---AYLHNG 184
             ++ L+++ +Y  GGSL+               L      ++A    E++   AYLH  
Sbjct: 71  RRDK-LWIVMEYCGGGSLQDIYQV------TRGPLS---ELQIAYVCRETLKGLAYLH-- 118

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYLAPEY 241
            E   +HRDIK +NILL+     KL DFG++   T T A       K+  GT  ++APE 
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR-----KSFIGTPYWMAPEV 172

Query: 242 FQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
                 G    K D++A G+  +EL   + P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 65/247 (26%), Positives = 97/247 (39%), Gaps = 57/247 (23%)

Query: 61  NFSKGRVLGRGALSFVF------KGKVGLLRTSVAIKRLDKED---KESSKAFC--RELM 109
           +F   +V+GRGA   V+       G+V       A+K L K D   +         R+++
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQV------YAMKVLRKSDMIKRNQIAHVRAERDIL 55

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
             +    P IV L  +    E+ L+L+ +Y+ GG L   L   +K V    T  +   Y 
Sbjct: 56  ADA--DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARF---Y- 106

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT------------- 216
               IAE V  L +  +   +HRDIKP NIL+ +    KL DFGL               
Sbjct: 107 ----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 217 --------------WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 262
                                     +  GT  Y+APE  +      + D ++ GV+L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 263 LLTGRKP 269
           +L G  P
Sbjct: 223 MLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 15/210 (7%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L+   I  E  L+L+++++    L++ +          S +P  +       + + +
Sbjct: 61  IVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASPL-----SGIPLPLIKSYLFQLLQGL 113

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           A+ H  + R V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  Y A
Sbjct: 114 AFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 168

Query: 239 PEYFQHGKV-SDKTDVYAFGVVLLELLTGR 267
           PE     K  S   D+++ G +  E++T R
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 24/191 (12%)

Query: 86  TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           T VA+K L K    S +AF  E  +  +L H  +V L    +  E+ +++I +Y++ GSL
Sbjct: 31  TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VVTKEEPIYIITEYMAKGSL 88

Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
              L   K    G   LP  + +     IAE +AY+     +  +HRD++ +N+L+S   
Sbjct: 89  LDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIE---RKNYIHRDLRAANVLVSESL 140

Query: 206 IPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 259
           + K+ DFGLA       +T+     F  K       + APE    G  + K+DV++FG++
Sbjct: 141 MCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGIL 193

Query: 260 LLELLT-GRKP 269
           L E++T G+ P
Sbjct: 194 LYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 29/205 (14%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLVGFC 126
           +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
              +Q ++++ + V GG     L  +   ++    +      ++    A  + YL +   
Sbjct: 63  TQ-KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELI------QMVENAAAGMEYLES--- 112

Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGL---------ATWTSAPSVPFLCKTVKGTFGYL 237
           +  +HRD+   N L++ K + K+ DFG+         A+      +P     VK T    
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP-----VKWT---- 163

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLE 262
           APE   +G+ S ++DV++FG++L E
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 54/295 (18%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 115
           N+ +G++LG+GA   V+          +A K++  D E  E+SK   A   E+ +  +L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 116 HPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H  IV   G   D  E+ L +  +Y+ GGS++  L       +    L  SV  K    I
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-------KAYGALTESVTRKYTRQI 115

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC------K 228
            E ++YLH+     +VHRDIK +NIL  S    KL DFG     ++  +  +C      +
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG-----ASKRLQTICMSGTGIR 167

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 288
           +V GT  +++PE         K DV++ G  ++E+LT + P              WA+  
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP--------------WAE-- 211

Query: 289 LHRGMAAVEEL----LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
            +  MAA+ ++     +P+L       + I+   +    CI  E   RP  EE++
Sbjct: 212 -YEAMAAIFKIATQPTNPQL------PSHISEHARDFLGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)

Query: 68  LGRGALSFVFKGKVGLLRT--SVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIVPLV 123
           LG G    V KG   + ++  +VA+K L  ++ + +      RE  +   L +P IV ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L + L + K     N T    + ++V++G+     YL  
Sbjct: 63  GIC--EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT---ELVHQVSMGMK----YLE- 112

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  KT  K    + APE  
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   + ++G E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--KGMKGNE 206

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 17/210 (8%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 121
           RV+GRG+ + V   ++   R   A+K + KE    D++       + +  ++ +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L   C   E  LF + ++VSGG L  H+  ++K       LP       +  I+ ++ +L
Sbjct: 61  LHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRK-------LPEEHARFYSAEISLALNFL 112

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H   ER +++RD+K  N+LL ++   KL D+G+      P       T  GT  Y+APE 
Sbjct: 113 H---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEI 167

Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
            +        D +A GV++ E++ GR P +
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 71/235 (30%), Positives = 103/235 (43%), Gaps = 40/235 (17%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED--KESSKAFC---RELM 109
            +F   +V+GRGA      G+V L+R        A+K L K +  K S  AF    R++M
Sbjct: 43  EDFDVIKVIGRGAF-----GEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 110 I-ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSV 166
             A+S     IV L  +    ++ L+++ +Y+ GG L   +         N  +P  W+ 
Sbjct: 98  AHANS---EWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM--------SNYDIPEKWAR 145

Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            Y      AE V  L        +HRD+KP N+LL      KL DFG      A  +   
Sbjct: 146 FY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VR 199

Query: 227 CKTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
           C T  GT  Y++PE  +     G    + D ++ GV L E+L G  P  A  L G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 52/168 (30%), Positives = 92/168 (54%), Gaps = 13/168 (7%)

Query: 106 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPW 164
           +E ++ + + HPNIV       + +  L+++ +Y  GG L + +  ++ K    ++ L W
Sbjct: 47  KEAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
            V  ++ LG    V ++H   E+ V+HRDIK  NI L+     KL DFG A   ++P   
Sbjct: 106 FV--QMCLG----VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GA 155

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           + C  V GT  Y+ PE +++   ++K+D+++ G +L EL T + P +A
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 72/211 (34%), Positives = 107/211 (50%), Gaps = 30/211 (14%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 128 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V    A  IA  +AY+    E
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR----LPQLVDM--AAQIASGMAYV----E 119

Query: 187 RC-VVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAP 239
           R   VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + AP
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAP 172

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           E   +G+ + K+DV++FG++L EL T GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   VFKG     +  VAIK +D E+ E   +   +E+ + S    P + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---S 177
              G  +   + L++I +Y+ GGS    L   + G       P+   +++A  + E    
Sbjct: 66  KYYGSYLKGTK-LWIIMEYLGGGSA---LDLLRAG-------PFD-EFQIATMLKEILKG 113

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH+  +   +HRDIK +N+LLS +   KL DFG+A   +   +     T  GT  ++
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWM 168

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           APE  Q      K D+++ G+  +EL  G  P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 22/205 (10%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVG- 124
           +LG G    V+K    L R  +A+K +  +   E  K    EL I      P I+   G 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
           F +  E  + +  +++ GGSL+ +             +P  V  ++A+ + + + YL + 
Sbjct: 68  FFV--ENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
               ++HRD+KPSN+L++++   KLCDFG++T      V  + KT  GT  Y+APE    
Sbjct: 115 K---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISG 167

Query: 245 GKVSDKTDVYAFGVVLLELLTGRKP 269
            +    +DV++ G+  +EL  GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 25/230 (10%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 121
           +VLG+G+   V   ++       AIK L K+    D +       + ++A +  HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L   C   +  LF + +YV+GG L   +   +K     S      R+  A  +  ++ +L
Sbjct: 61  LHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS------RFYAA-EVTLALMFL 112

Query: 182 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           H +G    V++RD+K  NILL ++   KL DFG+        V     T  GT  Y+APE
Sbjct: 113 HRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPE 166

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 290
             Q  +     D +A GV++ E++ G+ P EA     E++L    + ILH
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEA---DNEDDLF---ESILH 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 19/213 (8%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 121
           +V+G+G+   V   K        A+K L K+     KE         ++  ++ HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L  +       L+ +  YV+GG L  HL  ++         P       A  IA ++ YL
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGELFFHLQRERS-------FPEPRARFYAAEIASALGYL 112

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H      +++RD+KP NILL S+    L DFGL       S      T  GT  YLAPE 
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEV 167

Query: 242 FQHGKVSDKT-DVYAFGVVLLELLTGRKPIEAR 273
               +  D+T D +  G VL E+L G  P  +R
Sbjct: 168 L-RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 66  RVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           RV+GRG+ + V     K    +    V  K L  +D++       + +   +  +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L   C      LFL+ +YV+GG L  H+  ++K       LP       A  I  ++ +L
Sbjct: 61  LHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRK-------LPEEHARFYAAEICIALNFL 112

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H   ER +++RD+K  N+LL +    KL D+G+      P       T  GT  Y+APE 
Sbjct: 113 H---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEI 167

Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
            +  +     D +A GV++ E++ GR P +
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 70/221 (31%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGL--LRTS---VAIKRLDKEDKESSKA---FCRELMIA 111
            +F  G  LG G  SF   G+V +   + +    AIK L K +    K      +E  I 
Sbjct: 18  SDFEMGETLGTG--SF---GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSIL 72

Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
             L HP IV ++    D E  ++ + ++V GG L  HL       R     P  V     
Sbjct: 73  MELSHPFIVNMMCSFQD-ENRVYFLLEFVVGGELFTHL-------RKAGRFPNDVAKFYH 124

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             +  +  YLH+     +++RD+KP N+LL +K   K+ DFG A       VP    T+ 
Sbjct: 125 AELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC 176

Query: 232 GTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           GT  YLAPE  Q   HGK     D +  GV+L E + G  P
Sbjct: 177 GTPEYLAPEVIQSKGHGKA---VDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 17/219 (7%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           LG G  + VFKG+  L    VA+K  RL+ E+     A  RE+ +  +L H NIV L   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHANIVTLHDI 71

Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            I  E+ L L+++Y+    L+++L        GN     +V+      +   ++Y H   
Sbjct: 72  -IHTERCLTLVFEYLDS-DLKQYLDNC-----GNLMSMHNVKI-FMFQLLRGLSYCH--- 120

Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-YFQH 244
           +R ++HRD+KP N+L++ K   KL DFGLA   S P+  +  + V  T  Y  P+     
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178

Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
            + S   D++  G +L E+ TGR       ++ E +L+ 
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV-GFC 126
           LG GA   V+K +        A K +  E +E  + F  E+ I S   HPNIV L   + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
            + +  L+++ ++  GG+L+  + E ++G+    T P  +RY V   + E++ +LH+   
Sbjct: 73  YENK--LWILIEFCDGGALDSIMLELERGL----TEP-QIRY-VCRQMLEALNFLHS--- 121

Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQH 244
             V+HRD+K  NILL+     KL DFG+    SA +   L K  T  GT  ++APE    
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 245 GKVSD-----KTDVYAFGVVLLELLTGRKP 269
               D     K D+++ G+ L+EL     P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 21/222 (9%)

Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES--SKAFCRELM 109
           +G +   T+ +   + +G GA   V   +  L   +VAIK++ K       +K   REL 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           +   L H NI+ L    I P + ++ + + + G  L R L  +             ++Y 
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP-------LEKQFIQY- 112

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
               I   + Y+H+     VVHRD+KPSNIL++     K+CDFGLA        P +   
Sbjct: 113 FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR----IQDPQMTGY 165

Query: 230 VKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           V   + Y APE      K   + D+++ G +  E+L G KP+
Sbjct: 166 VSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 36/218 (16%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCREL-MIASSLHHPNIVPLVG- 124
           +GRGA   V K       T +A+KR+    D++  K    +L ++  S   P IV   G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 125 --------FCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
                    C++  +  L   YKYV         +E        S +P  +  K+A+   
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYV---------YEVL-----KSVIPEEILGKIAVATV 117

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTF 234
           +++ YL    E  ++HRD+KPSNILL      KLCDFG+    S   V  + KT   G  
Sbjct: 118 KALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGI----SGQLVDSIAKTRDAGCR 171

Query: 235 GYLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            Y+APE            ++DV++ G+ L E+ TG+ P
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 21/213 (9%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNI 119
           RVLG+G+   V   ++       A+K L K+      D E +    R L +A +  HP +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFL 58

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
             L   C      LF + ++V+GG L  H+ + ++     +          A  I  ++ 
Sbjct: 59  TQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEITSALM 110

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           +LH   ++ +++RD+K  N+LL  +   KL DFG+              T  GT  Y+AP
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAP 165

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           E  Q        D +A GV+L E+L G  P EA
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMIASSLHH 116
           +V+G+G+      GKV L R        A+K L K+     KE         ++  ++ H
Sbjct: 1   KVIGKGSF-----GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +V L  F       L+ +  Y++GG L  HL       R    L    R+  A  IA 
Sbjct: 56  PFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAA-EIAS 107

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
           ++ YLH+     +V+RD+KP NILL S+    L DFGL       +      T  GT  Y
Sbjct: 108 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEY 162

Query: 237 LAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEAR 273
           LAPE   H +  D+T D +  G VL E+L G  P  +R
Sbjct: 163 LAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 26/207 (12%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G G+   VFK +       VAIK+    ++D    K   RE+ +   L HPN+V L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE- 67

Query: 126 CIDPEQGLFLIYKYVSGGSLERH--LHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
               ++ L L+++Y        H  L+E +K  RG   +P  +  K+     ++V + H 
Sbjct: 68  VFRRKRKLHLVFEYCD------HTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCH- 117

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF- 242
               C+ HRD+KP NIL++ +   KLCDFG A   + P   +       T  Y APE   
Sbjct: 118 -KHNCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLV 173

Query: 243 ---QHGKVSDKTDVYAFGVVLLELLTG 266
              Q+G      DV+A G V  ELLTG
Sbjct: 174 GDTQYGP---PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 26/266 (9%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           R LG GA   VF  +   L  +     VA+K L      + K F RE  + ++L H +IV
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHE---------KKKGVRGNSTLPWSVRYKVA 171
              G C D +  L ++++Y+  G L + L             +  +    L  S    +A
Sbjct: 71  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             IA  + YL     +  VHRD+   N L+ +  + K+ DFG++    +     +     
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLV---LWAKP 287
               ++ PE   + K + ++DV++FGV+L E+ T G++P      Q     V   +    
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW----FQLSNTEVIECITQGR 242

Query: 288 ILHRGMAAVEELLDPRLKCTSRNSAQ 313
           +L R     +E+ D  L C  R   Q
Sbjct: 243 VLERPRVCPKEVYDIMLGCWQREPQQ 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 17/215 (7%)

Query: 64  KGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPN 118
           K +VLG GA   V+KG        ++  VAIK L +    +++K    E  + + +  P 
Sbjct: 11  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +  L+G C+     + L+ + +  G L  ++ E K  +     L W V+      IA+ +
Sbjct: 71  VCRLLGICL--TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGM 122

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           +YL    E  +VHRD+   N+L+ S    K+ DFGLA         +     K    ++A
Sbjct: 123 SYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
            E   H + + ++DV+++GV + EL+T G KP + 
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 54/287 (18%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKA----------F----CR 106
           RVLG GA   V   K        A+K +D E     DK  ++A          F    C 
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCH 97

Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E        +P  V ++   +D          Y + G L + +  + K  R         
Sbjct: 98  EDFAKKDPRNPENVLMIALVLD----------YANAGDLRQEIKSRAKTNRT------FR 141

Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            ++  L   + +  +H+   + ++HRDIK +NILL S  + KL DFG +   +A     +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201

Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
            +T  GT  Y+APE ++    S K D+++ GV+L ELLT ++P +   ++          
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---------- 251

Query: 287 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP 333
            ++H+ +A      DP     S    +I        A +SS+  RRP
Sbjct: 252 EVMHKTLAG---RYDPLPPSISPEMQEI------VTALLSSDPKRRP 289

Length = 496

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 61/173 (35%), Positives = 86/173 (49%), Gaps = 36/173 (20%)

Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           E  +   + HP I+ L  F  + +Q  L+++ +YV GG L  +L  +  G   NST    
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNST---G 103

Query: 166 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTS 219
           + Y  A  I  ++ YLH+   + +V+RD+KP NILL  +   KL DFG A      TWT 
Sbjct: 104 LFY--ASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT- 157

Query: 220 APSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
                 LC    GT  YLAPE  Q   H K     D +A G+++ E+L G  P
Sbjct: 158 ------LC----GTPEYLAPEVIQSKGHNKA---VDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 63/253 (24%), Positives = 125/253 (49%), Gaps = 33/253 (13%)

Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           VA+K++D   ++  +    E++I    HH N+V +    +  ++ L+++ +++ GG+L  
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-LWVVMEFLEGGALTD 108

Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
            +   +      +T        V L +  +++YLHN   + V+HRDIK  +ILL+S    
Sbjct: 109 IVTHTRMNEEQIAT--------VCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRI 157

Query: 208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
           KL DFG     S   VP   K++ GT  ++APE         + D+++ G++++E++ G 
Sbjct: 158 KLSDFGFCAQVSK-EVPKR-KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Query: 268 KPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQA-AAACIS 326
            P              + +P L + M  + + L PR+K    +S +++ V++      + 
Sbjct: 216 PP-------------YFNEPPL-QAMRRIRDNLPPRVK----DSHKVSSVLRGFLDLMLV 257

Query: 327 SEESRRPGIEEII 339
            E S+R   +E++
Sbjct: 258 REPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 118
           F+  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            +   G C   E   +L+ +Y  G +   LE H    KK ++            +  G  
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCLGSASDILEVH----KKPLQEVEIA------AICHGAL 125

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +AYLH+      +HRDIK  NILL+     KL DFG A+  S P+  F+     GT  
Sbjct: 126 QGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS-PANSFV-----GTPY 176

Query: 236 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           ++APE       G+   K DV++ G+  +E L  RKP
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 50/188 (26%), Positives = 96/188 (51%), Gaps = 26/188 (13%)

Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSL- 145
           VA+K++D   ++  +    E++I     HPNIV +   + +  E  L+++ +++ GG+L 
Sbjct: 47  VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE--LWVVMEFLEGGALT 104

Query: 146 ----ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL 201
                  ++E++                V L + +++++LH    + V+HRDIK  +ILL
Sbjct: 105 DIVTHTRMNEEQIAT-------------VCLAVLKALSFLHA---QGVIHRDIKSDSILL 148

Query: 202 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLL 261
           +S    KL DFG     S   VP   K++ GT  ++APE         + D+++ G++++
Sbjct: 149 TSDGRVKLSDFGFCAQVSK-EVPRR-KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206

Query: 262 ELLTGRKP 269
           E++ G  P
Sbjct: 207 EMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 17/212 (8%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 121
           +V+G+G+   V   K  L     A+K L K+     KE         ++  ++ HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L  +     + L+ +  +V+GG L  HL  ++       + P       A  IA ++ YL
Sbjct: 61  L-HYSFQTTEKLYFVLDFVNGGELFFHLQRER-------SFPEPRARFYAAEIASALGYL 112

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H+     +V+RD+KP NILL S+    L DFGL       +      T  GT  YLAPE 
Sbjct: 113 HSIN---IVYRDLKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEV 167

Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
            +     +  D +  G VL E+L G  P   R
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 16/222 (7%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSL 114
           HN    R LG GA   VF  +   L     +  VA+K L      + K F RE  + ++L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG----VRGN--STLPWSVRY 168
            H +IV   G C++ +  L ++++Y+  G L + L            GN  + L  S   
Sbjct: 65  QHEHIVKFYGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +A  IA  + YL     +  VHRD+   N L+    + K+ DFG++    +     +  
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                  ++ PE   + K + ++DV++ GVVL E+ T G++P
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 17/212 (8%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 121
           +V+G+G+   V   K     +  A+K L K+     KE +       ++  +L HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L  +     + L+ +  YV+GG L  HL  ++  +      P +  Y  A  +A ++ YL
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-----PRARFY--AAEVASAIGYL 112

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H+     +++RD+KP NILL S+    L DFGL      P       T  GT  YLAPE 
Sbjct: 113 HSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEV 167

Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
            +        D +  G VL E+L G  P  +R
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.5 bits (183), Expect = 8e-15
 Identities = 72/236 (30%), Positives = 114/236 (48%), Gaps = 38/236 (16%)

Query: 66  RVLGRGALSFVFKGKVGLLR--------TSVAIKRLDK-----EDKESSKAFCRELMIAS 112
           +VLG+G  SF   GKV L+R           A+K L K      D+  +K    E  I +
Sbjct: 2   KVLGQG--SF---GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILA 53

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
            ++HP IV L  +    E  L+LI  ++ GG L   L ++      +      V++ +A 
Sbjct: 54  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED------VKFYLA- 105

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK- 231
            +A ++ +LH+     +++RD+KP NILL  +   KL DFGL    S  S+    K    
Sbjct: 106 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSF 158

Query: 232 -GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
            GT  Y+APE       +   D ++FGV++ E+LTG  P + +  +    ++L AK
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 23/206 (11%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           LG G  + V+KG+  L    VA+K  RL+ E+     A  RE+ +   L H NIV L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72

Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESVAYLH 182
            I  E+ L L+++Y+    L+++L +      GNS    +V+   +++  G+     Y H
Sbjct: 73  -IHTEKSLTLVFEYLDK-DLKQYLDDC-----GNSINMHNVKLFLFQLLRGLN----YCH 121

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-Y 241
               R V+HRD+KP N+L++ +   KL DFGLA   S P+  +  + V  T  Y  P+  
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176

Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGR 267
                 S + D++  G +  E+ TGR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.1 bits (182), Expect = 9e-15
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 17/213 (7%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNI 119
           + K   +G G    V+K +  +   ++A+K  RL++ED+       RE+ +   + H NI
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L    +  E+ L+L+++Y+    L++H+       + N  L  +  Y++  GI    A
Sbjct: 64  VRLQD-VVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAK-NPRLIKTYLYQILRGI----A 116

Query: 180 YLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           Y H+     V+HRD+KP N+L+       KL DFGLA     P   F  + V  T  Y A
Sbjct: 117 YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRA 171

Query: 239 PEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 270
           PE     +  S   D+++ G +  E++  +KP+
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 20/210 (9%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPLVG-F 125
           LG+G    V+K        ++A+K +  E  ES       EL I      P IV   G F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            I  E  +++  +Y+  GSL++ L+       G   +P  V  ++   + + + +L    
Sbjct: 69  FI--EGAVYMCMEYMDAGSLDK-LYAGGVATEG---IPEDVLRRITYAVVKGLKFLKE-- 120

Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
           E  ++HRD+KP+N+L++     KLCDFG+    S   V  L KT  G   Y+APE  + G
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 246 KVSD------KTDVYAFGVVLLELLTGRKP 269
             +       ++DV++ G+ +LE+  GR P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 23/222 (10%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           LG G  + VFKG+  L    VA+K  RL+ E+     A  RE+ +   L H NIV L   
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72

Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESVAYLH 182
            +  ++ L L+++Y     L++ L +      GN     +V+   Y++  G+A    Y H
Sbjct: 73  -VHTDKSLTLVFEY-----LDKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLA----YCH 121

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-Y 241
               R V+HRD+KP N+L++ +   KL DFGLA   S P+  +  + V  T  Y  P+  
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176

Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
               + S + D++  G +  E+ +GR       ++ E +L+ 
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 27/192 (14%)

Query: 86  TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 31  TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 87

Query: 146 ERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 204
              L    K   G+   LP  + +     IAE +A++    +R  +HRD++ +NIL+S+ 
Sbjct: 88  LDFL----KSDEGSKQPLPKLIDFSAQ--IAEGMAFIE---QRNYIHRDLRAANILVSAS 138

Query: 205 KIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGV 258
            + K+ DFGLA       +T+     F  K       + APE    G  + K+DV++FG+
Sbjct: 139 LVCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGI 191

Query: 259 VLLELLT-GRKP 269
           +L+E++T GR P
Sbjct: 192 LLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 17/187 (9%)

Query: 88  VAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS-- 144
           VA+K L       + + F +E+ I S L  PNI  L+G C      L +I +Y+  G   
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-LCMIMEYMENGDLN 107

Query: 145 --LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 202
             L++H+ E       + +L +S    +A  IA  + YL        VHRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVG 164

Query: 203 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGT----FGYLAPEYFQHGKVSDKTDVYAFGV 258
                K+ DFG     +  S  +  + V+G       ++A E    GK + K+DV+AFGV
Sbjct: 165 KNYTIKIADFG--MSRNLYSSDY-YR-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220

Query: 259 VLLELLT 265
            L E+LT
Sbjct: 221 TLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   VF          VAIK+++ + +   +    E+++   L +PNIV 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 122 LV-GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            +  F +  E  LF++ +Y++GGSL   + E        + +  +    V     +++ +
Sbjct: 81  FLDSFLVGDE--LFVVMEYLAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEF 130

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH      V+HRDIK  N+LL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 131 LHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 183

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE         K D+++ G++ +E++ G  P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 15/209 (7%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   V+KG     +  VAIK +D E+ E   +   +E+ + S    P I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G  +   + L++I +Y+ GGS    L   K G    + +   +R      I + + Y
Sbjct: 66  RYYGSYLKGTK-LWIIMEYLGGGSA---LDLLKPGPLEETYIATILRE-----ILKGLDY 116

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH  +ER  +HRDIK +N+LLS +   KL DFG+A   +   +     T  GT  ++APE
Sbjct: 117 LH--SER-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE 171

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +      K D+++ G+  +EL  G  P
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHH-PNIVPLVG- 124
           +G G    V+K +       +A+K++ +   KE +K    +L +    H  P IV   G 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
           F  D +     I   +    L++ L   +  +      P  +  K+ + I +++ YL   
Sbjct: 83  FITDSD---VFICMELMSTCLDKLLKRIQGPI------PEDILGKMTVAIVKALHYLK-- 131

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF- 242
            +  V+HRD+KPSNILL +    KLCDFG+    S   V    KT   G   Y+APE   
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGI----SGRLVDSKAKTRSAGCAAYMAPERID 187

Query: 243 ---QHGKVSDKTDVYAFGVVLLELLTGRKP 269
               + K   + DV++ G+ L+EL TG+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 28/212 (13%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELMIASSL-HHPNIVP 121
           LG+GA   V+K      +  VA+K++     +  D  + + F RE+M    L  HPNIV 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD--AQRTF-REIMFLQELGDHPNIVK 71

Query: 122 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           L+     + ++ ++L+++Y     +E  LH     +R N       RY +   + +++ Y
Sbjct: 72  LLNVIKAENDKDIYLVFEY-----METDLHAV---IRANILEDVHKRY-IMYQLLKALKY 122

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----TWTSAPSVPFLCKTVKGTFGY 236
           +H+G    V+HRD+KPSNILL+S    KL DFGLA         P  P L   V  T  Y
Sbjct: 123 IHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV-ATRWY 178

Query: 237 LAPE-YFQHGKVSDKTDVYAFGVVLLELLTGR 267
            APE      + +   D+++ G +L E+L G+
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 77/299 (25%), Positives = 131/299 (43%), Gaps = 45/299 (15%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   VFKG     +  VAIK +D E+ E   +   +E+ + S    P + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 66  KYYGSYLK-DTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILRE-----ILKGLDY 116

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYL 237
           LH+  +   +HRDIK +N+LLS     KL DFG+A   T T      F+     GT  ++
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWM 168

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           APE  +      K D+++ G+  +EL  G  P                    H  +  ++
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPP--------------------HSELHPMK 208

Query: 298 EL-LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA---ILRGEEELIYCT 352
            L L P+    +        + +   AC++ E S RP  +E++    I+R  ++  Y T
Sbjct: 209 VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLT 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 39/285 (13%)

Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 121
           +V+G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  +   + + ++ +Y+  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 70  LEG-VVTKSKPVMIVTEYMENGSLDAFLRKHD----GQFTVIQLV--GMLRGIASGMKYL 122

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 240
              ++   VHRD+   NIL++S  + K+ DFGL+      P   +  +  K    + APE
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE- 298
              + K +  +DV+++G+V+ E+++ G +P      Q                + A+EE 
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--------------IKAIEEG 225

Query: 299 -LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
             L   + C        A + Q    C   + + RP  E+I++IL
Sbjct: 226 YRLPAPMDCP-------AALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           V+G GA   V K +    +  VAIK+    +E++E  +   REL +  +L   NIV L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                   L+L+++YV    LE  L E   GV      P  VR  +   + +++ + H  
Sbjct: 68  -AFRRRGKLYLVFEYVEKNMLEL-LEEMPNGV-----PPEKVRSYI-YQLIKAIHWCHKN 119

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
               +VHRDIKP N+L+S   + KLCDFG A   S  S     + V  T  Y +PE    
Sbjct: 120 D---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLG 175

Query: 245 GKVSDKTDVYAFGVVLLELLTGR 267
                  D+++ G +L EL  G+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 16/206 (7%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G G    V+K +  L    VA+K  RL+ ED+       RE+ +   L+HPNIV L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
               E  L+L+++++    L++++            +  S  Y++  GIA    Y H+  
Sbjct: 67  VHS-ENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIK-SYLYQLLQGIA----YCHS-- 117

Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
              V+HRD+KP N+L+  +   KL DFGLA     P   +  + V  T  Y APE     
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGS 174

Query: 246 K-VSDKTDVYAFGVVLLELLTGRKPI 270
           +  S   D+++ G +  E++  R+P+
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 22/218 (10%)

Query: 68  LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 122
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLER---------HLHEKKKGVR-GNSTLPWSVRYKVAL 172
            G C +    L ++++Y+  G L R          +    + V  G  TL   +   +A 
Sbjct: 73  YGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML--AIAS 129

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            IA  + YL        VHRD+   N L+    + K+ DFG++    +     +      
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              ++ PE   + K + ++D+++FGVVL E+ T G++P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 24/220 (10%)

Query: 68  LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 121
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ S L HPNIV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----------HEKKKGVRGNSTLPWSVRYKV 170
           L+G  +  EQ L +I+ Y S   L   L            +  K V+  STL  +    +
Sbjct: 73  LLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK--STLEPADFVHI 129

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              IA  + +L   +   VVH+D+   N+L+  K   K+ D GL     A     L    
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                +++PE   +GK S  +D++++GVVL E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 24/239 (10%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHH-PNIVP 121
           +G+G    V++ +    R   A+K L K++  + K        R +++ + L   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L  F    +  L+L+  Y+SGG L  HL ++ +              +    IAE V  L
Sbjct: 61  L-KFSFQTDSDLYLVTDYMSGGELFWHLQKEGR----------FSEDRAKFYIAELVLAL 109

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGTFGYLAP 239
            +  +  +V+RD+KP NILL +     LCDFGL  A  T   +    C    GT  YLAP
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC----GTTEYLAP 165

Query: 240 EYFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           E     K   K  D ++ GV++ E+  G  P  A   Q     + + K    + + + E
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDE 224

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 118
           F+  R +G G+   V+  +       VAIK++    K+S++ +    +E+     + HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            +   G C   E   +L+ +Y  G +   LE H    KK ++            +  G  
Sbjct: 87  SIEYKG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AITHGAL 135

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +AYLH+     ++HRDIK  NILL+     KL DFG A+  S P+  F+     GT  
Sbjct: 136 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-PANSFV-----GTPY 186

Query: 236 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           ++APE       G+   K DV++ G+  +EL   + P+
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 28/224 (12%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 121
           ++LG+G+   VF  ++       AIK L K+    D +       + +++ +  HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 122 LVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           L  +C    ++ LF + +Y++GG L  H+    K       LP +  Y  A  I   + +
Sbjct: 61  L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-----FDLPRATFY--AAEIICGLQF 111

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT---SAPSVPFLCKTVKGTFGYL 237
           LH+   + +V+RD+K  NILL +    K+ DFG+        A +  F C    GT  Y+
Sbjct: 112 LHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-C----GTPDYI 163

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
           APE     K +   D ++FGV+L E+L G+ P        EE L
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG---HDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 13/163 (7%)

Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E  + + ++ P IVPL  F     + L+L+  +++GG L  HL  + +            
Sbjct: 43  ERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGR----------FD 91

Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
             +     AE +  L N  +  V++RD+KP NILL  +    LCDFGL            
Sbjct: 92  LSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-- 149

Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             T  GT  YLAPE       +   D +  GV+L E+LTG  P
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 71/236 (30%), Positives = 107/236 (45%), Gaps = 64/236 (27%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDK-------EDKESSKAFCRELMI 110
           +VLG+G       GKV  +R           A+K L K       +D   +KA   E  I
Sbjct: 2   KVLGKGGY-----GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA---ERNI 53

Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             ++ HP IV L+ +       L+LI +Y+SGG L  HL  +++G+    T         
Sbjct: 54  LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTA------CF 104

Query: 171 ALG-IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK- 228
            L  I+ ++ +LH   ++ +++RD+KP NILL ++   KL DFG            LCK 
Sbjct: 105 YLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFG------------LCKE 149

Query: 229 ---------TVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
                    T  GT  Y+APE      HGK     D ++ G ++ ++LTG  P  A
Sbjct: 150 SIHEGTVTHTFCGTIEYMAPEILMRSGHGKA---VDWWSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 46/233 (19%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNI 119
           +VLG+G+   V   ++       AIK L K+      D E +    R L +A    HP +
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFL 58

Query: 120 VPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
             L  FC    ++ LF + +Y++GG L  H+    +     +          A  I   +
Sbjct: 59  THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-------YAAEIICGL 109

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK---------- 228
            +LH    + +++RD+K  N+LL      K+ DFG+            CK          
Sbjct: 110 QFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGM------------CKENMNGEGKAS 154

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
           T  GT  Y+APE  +  K ++  D ++FGV+L E+L G+ P      + E+ L
Sbjct: 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG---EDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAIK+++ + +   +    E+++     HPNIV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
            +   +  ++ L+++ +Y++GGSL   + E        + +       V     +++ +L
Sbjct: 81  YLDSYLVGDE-LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFL 131

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAP 239
           H+     V+HRDIK  NILL      KL DFG      A   P   K  T+ GT  ++AP
Sbjct: 132 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAP 184

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           E         K D+++ G++ +E++ G  P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 118
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 125

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+     GT  
Sbjct: 126 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV-----GTPY 176

Query: 236 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           ++APE       G+   K DV++ G+  +EL   + P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 41/216 (18%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
            LG G+ + V+KG+  L    VA+K  RL+ E+     A  RE  +   L H NIV L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLHD 70

Query: 125 FCIDPEQGLFLIYKYVS---GGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESV 178
             I  ++ L L+++Y+       ++           G      +VR   +++  G+A   
Sbjct: 71  I-IHTKKTLTLVFEYLDTDLKQYMDDC---------GGGLSMHNVRLFLFQLLRGLA--- 117

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            Y H   +R V+HRD+KP N+L+S +   KL DFGLA   S PS  +  + V  T  Y  
Sbjct: 118 -YCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRP 171

Query: 239 P-------EYFQHGKVSDKTDVYAFGVVLLELLTGR 267
           P       EY      S   D++  G +  E+ TGR
Sbjct: 172 PDVLLGSTEY------STSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPL 122
           V+G G    V +G++   G     VAIK L     E   + F  E  I     HPNI+ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            G  +   + + +I +++  G+L+  L +      G  T+   V   +  GIA  + YL 
Sbjct: 71  EGV-VTKSRPVMIITEFMENGALDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL- 122

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGTFG--YLAP 239
             +E   VHRD+   NIL++S  + K+ DFGL+ +     S P    ++ G     + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           E   + K +  +DV+++G+V+ E+++ G +P
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 23/219 (10%)

Query: 61  NFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           +F+   VLG+G+   V     KG   L    +  K +  +D +       + ++A S   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +  L   C      L+ + +YV+GG L   + +      G    P +V Y  A  IA 
Sbjct: 61  PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQV-----GRFKEPHAVFY--AAEIAI 112

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WTSAPSVPFLCKTVKGT 233
            + +LH+   + +++RD+K  N++L S+   K+ DFG+     W    +     KT  GT
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT-----KTFCGT 164

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
             Y+APE   +       D +AFGV+L E+L G+ P E 
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 31/222 (13%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLL--RTS---VAIKRLDK------EDKESSKAFCRELM 109
           +F+   VLG+G  SF   GKV L   + +    AIK L K      +D E +    R L 
Sbjct: 1   DFNFLMVLGKG--SF---GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA 55

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           +      P  +  +  C      L+ + +YV+GG L  H+ +      G    P +V Y 
Sbjct: 56  LPGK---PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPHAVFY- 106

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
            A  IA  + +LH+   + +++RD+K  N++L ++   K+ DFG+             +T
Sbjct: 107 -AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRT 160

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
             GT  Y+APE   +       D +AFGV+L E+L G+ P +
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 15/221 (6%)

Query: 64  KGRVLGRGALSFVFKG--KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +G  +GRG    V+K   K G      A+K++  E    S + CRE+ +   L HPN++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIA 62

Query: 122 LVG-FCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           L   F    ++ ++L++ Y           H   K  +    LP S+   +   I + + 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 180 YLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFL-CKTVKGTF 234
           YLH      V+HRD+KP+NIL+      +   K+ D G A   ++P  P      V  TF
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 235 GYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARR 274
            Y APE     +   K  D++A G +  ELLT       R+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           +G G+   V+          VA+K++    K+  E  +   +E+     L HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 125 FCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
            C   E   +L+ +Y  G +   LE H    KK ++            +  G  + +AYL
Sbjct: 89  -CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AITHGALQGLAYL 137

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H+     ++HRDIK  NILL+     KL DFG A+  S+P+  F+     GT  ++APE 
Sbjct: 138 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSAS-KSSPANSFV-----GTPYWMAPEV 188

Query: 242 ---FQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                 G+   K DV++ G+  +E L  RKP
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 56/238 (23%), Positives = 110/238 (46%), Gaps = 28/238 (11%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           +G G+   V    V      VA+K++D   ++  +    E++I     H N+V +    +
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ L+++ +++ GG+L   +   +      +         V L + ++++ LH    +
Sbjct: 88  VGDE-LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLKALSVLH---AQ 135

Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
            V+HRDIK  +ILL+     KL DFG     S   VP   K++ GT  ++APE       
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRR-KSLVGTPYWMAPELISRLPY 193

Query: 248 SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLK 305
             + D+++ G++++E++ G  P              + +P L + M  + + L P+LK
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KAMKMIRDNLPPKLK 237

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 37/211 (17%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 71

Query: 128 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
             E  L+++ ++ +GG+       LER L E +  V    TL             E++ Y
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------------EALNY 118

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYL 237
           LH   E  ++HRD+K  NIL +     KL DFG++   T T      F+     GT  ++
Sbjct: 119 LH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWM 170

Query: 238 APEYFQHGKVSD-----KTDVYAFGVVLLEL 263
           APE        D     K DV++ G+ L+E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.1 bits (169), Expect = 5e-13
 Identities = 85/340 (25%), Positives = 129/340 (37%), Gaps = 83/340 (24%)

Query: 65  GRVLGRGALSFVFKGK-VGLLRTS----VAIKRLDKEDKESS--KAFCRELMIASSL-HH 116
           G+ LGRGA   V +    G+ +++    VA+K L KE   +S  KA   EL I   + HH
Sbjct: 12  GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGHH 70

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--------- 167
            N+V L+G C  P   L +I +Y   G+L  +L  K++            R         
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130

Query: 168 -----------------------------------YKVALGIAESVAY---LHNGTE--- 186
                                              YK  L + + ++Y   +  G E   
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190

Query: 187 -RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
            R  +HRD+   NILLS   + K+CDFGLA               +    ++APE     
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 246 KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLK 305
             + ++DV++FGV+L E+ +                 L A P  + G+   EE    RLK
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS-----------------LGASP--YPGVQIDEEFCR-RLK 290

Query: 306 CTSRNSA---QIARVIQAAAACISSEESRRPGIEEIIAIL 342
             +R  A       +      C  +    RP   E++ IL
Sbjct: 291 EGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 66/256 (25%), Positives = 122/256 (47%), Gaps = 30/256 (11%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 120 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 136

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA         F+      T 
Sbjct: 137 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTR 186

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            Y APE        +  D+++ G ++ EL+ G     +   QG +++  W K I   G  
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG-----SVIFQGTDHIDQWNKVIEQLGTP 241

Query: 295 AVEELLDPRLKCTSRN 310
           + E +   RL+ T RN
Sbjct: 242 SAEFM--NRLQPTVRN 255

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 22/172 (12%)

Query: 104 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 163
             +E  +   L H NI+P++  CI+  +  F++Y Y++ G+L+  L + + G   N    
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ-A 113

Query: 164 WSVRYKVALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
            S +  V +   IA  ++YLH    R V+H+DI   N ++  +   K+ D  L    S  
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNAL----SRD 166

Query: 222 SVP--FLC------KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             P  + C      + VK    ++A E   + + S  +DV++FGV+L EL+T
Sbjct: 167 LFPMDYHCLGDNENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED---KESSKAFCRELMIASSLHHP 117
           +V+GRGA      G+V L+R        A+K L K +   +  S  F  E  I +  + P
Sbjct: 49  KVIGRGAF-----GEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 118 NIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGI 174
            +V L  FC    ++ L+++ +Y+ GG L          +  N  +P  W+  Y      
Sbjct: 104 WVVQL--FCAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDVPEKWAKFYT----- 148

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           AE V  L       ++HRD+KP N+LL      KL DFG         +   C T  GT 
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTP 207

Query: 235 GYLAPEYFQH----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
            Y++PE  +     G    + D ++ GV L E+L G  P  A  L G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)

Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG G     V    +G+ +       +VA+K L  D  DK+ S       M+     
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVR--------GNSTLPWSV 166
           H NI+ L+G C   +  L+++ +Y S G+L  +L  ++  G+             L +  
Sbjct: 77  HKNIINLLGACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
               A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDVHNIDYY 190

Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 70/256 (27%), Positives = 105/256 (41%), Gaps = 64/256 (25%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED---KESSKAFCRELMIA 111
            +F   +V+GRGA      G+V L++        A+K+L K +   KE       E  I 
Sbjct: 1   DDFESIKVIGRGAF-----GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL 55

Query: 112 SSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
           +   +P +V L  +     E  L+LI +Y+ GG +   L  KK       T  +      
Sbjct: 56  AEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFY------ 106

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-------------- 216
              IAE++  + +  +   +HRDIKP N+LL +K   KL DFGL T              
Sbjct: 107 ---IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163

Query: 217 -------WTSAPSVPFLCK----------------TVKGTFGYLAPEYFQHGKVSDKTDV 253
                  +    S P   K                TV GT  Y+APE F     + + D 
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV-GTPDYIAPEVFLQTGYNKECDW 222

Query: 254 YAFGVVLLELLTGRKP 269
           ++ GV++ E+L G  P
Sbjct: 223 WSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 73/235 (31%), Positives = 104/235 (44%), Gaps = 35/235 (14%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLR--------TSVAIKRLDK-----EDKESSKAFCRE 107
           NF   RVLG GA      GKV L+R           A+K L K     + K +       
Sbjct: 1   NFELLRVLGTGAY-----GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER 55

Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
            ++ +    P +V L  +    +  L LI  YV+GG L  HL++     R + T      
Sbjct: 56  QVLEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQ-----REHFTE----- 104

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
            +V + IAE V  L +  +  +++RDIK  NILL S+    L DFGL+    A       
Sbjct: 105 SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERA 163

Query: 228 KTVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN 280
            +  GT  Y+APE  + G        D ++ GV+  ELLTG  P     + GE+N
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT---VDGEQN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 68/221 (30%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
            +G G    V+K +       VA+K  RLD E +       RE+ I   L+H NIV L  
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 125 FCIDPEQGL---------FLIYKYVSG---GSLERHL-HEKKKGVRGNSTLPWSVRYKVA 171
              D +  L         +L+++Y+     G LE  L H  +  ++              
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-----------SFM 122

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTV 230
             + E + Y H    +  +HRDIK SNILL++K   KL DFGLA  + S  S P+  K +
Sbjct: 123 KQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 231 KGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             T  Y  PE      +     DV++ G +L EL T +KPI
Sbjct: 180 --TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)

Query: 67  VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 122
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALG 173
           +G C +    L+L  +Y   G+L   L + +               STL        A  
Sbjct: 74  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              VK T
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 181

Query: 234 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            G     ++A E   +   +  +DV+++GV+L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 7e-13
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 17/209 (8%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           ++ K   LG G+ + V+KGK  +    VA+K  RL +E+     A  RE  +   L H N
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHAN 64

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L+   I  ++ L L+++YV    L +++ +   G+      P +V+  +   +   +
Sbjct: 65  IV-LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLH-----PENVKLFL-FQLLRGL 116

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           +Y+H   +R ++HRD+KP N+L+S     KL DFGLA   S PS  +  + V  T  Y  
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRP 171

Query: 239 PE-YFQHGKVSDKTDVYAFGVVLLELLTG 266
           P+      + S   D++  G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 21/212 (9%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNIV 120
           VLG+G+   V   +        AIK L K+      D E +     E  + +    P  +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV---EKRVLALQDKPPFL 63

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
             +  C      L+ + +YV+GG L  H+ +      G    P +V Y  A  I+  + +
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPQAVFY--AAEISVGLFF 116

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH    R +++RD+K  N++L S+   K+ DFG+        V    +T  GT  Y+APE
Sbjct: 117 LH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPE 171

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              +       D +A+GV+L E+L G+ P + 
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)

Query: 65  GRVLGRGALSFVFKG-----KVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPN 118
            R LG+G+   V++G       G   T VAIK +++      +  F  E  +    +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLE---RHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           +V L+G      Q   ++ + ++ G L+   R    + +   G          ++A  IA
Sbjct: 71  VVRLLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +AYL     +  VHRD+   N +++     K+ DFG+          +  K  KG   
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMT--RDIYETDYYRKGGKGLLP 184

Query: 236 --YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             ++APE  + G  + K+DV++FGVVL E+ T
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)

Query: 64  KGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +G  +GRG    V+K K   G      A+K++  E    S + CRE+ +   L HPN++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVIS 62

Query: 122 LVG-FCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           L   F    ++ ++L++ Y           H   K  +    LP  +   +   I + + 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 180 YLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFL-CKTVKGTF 234
           YLH      V+HRD+KP+NIL+      +   K+ D G A   ++P  P      V  TF
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 235 GYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARR 274
            Y APE     +   K  D++A G +  ELLT       R+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 20/218 (9%)

Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPL 122
           LG  A   ++KG + L        VAIK L D  + +    F +E  + + LHHPNIV L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK----GVRGN------STLPWSVRYKVAL 172
           +G  +  EQ + ++++Y++ G L   L  +      G   +      S+L       +A+
Sbjct: 73  LG-VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            IA  + YL   +    VH+D+   NIL+  +   K+ D GL+    +     +      
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              ++ PE   +GK S  +D+++FGVVL E+ + G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 56/203 (27%), Positives = 83/203 (40%), Gaps = 20/203 (9%)

Query: 88  VAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 144
           VA+KR+ K         +    E  I ++     +V L+    D E  L+L  +YV GG 
Sbjct: 29  VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY-LYLAMEYVPGGD 87

Query: 145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 204
             R L      +  +       R+ +A    E+V  LH   E   +HRD+KP N L+ + 
Sbjct: 88  F-RTLLNNLGVLSEDHA-----RFYMAEMF-EAVDALH---ELGYIHRDLKPENFLIDAS 137

Query: 205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
              KL DFGL+             +V G+  Y+APE  +        D ++ G +L E L
Sbjct: 138 GHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL 192

Query: 265 TGRKPIEARRLQGE-ENLVLWAK 286
            G  P          ENL  W +
Sbjct: 193 CGFPPFSGSTPNETWENLKYWKE 215

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 64/232 (27%), Positives = 94/232 (40%), Gaps = 58/232 (25%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
           + +G GA   V           VAIK++    +D   +K   RE+ +   L H NI+ L+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 124 GFCIDPEQGLF----------------LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
                P    F                +I    S   L    H               ++
Sbjct: 66  DILRPPSPEDFNDVYIVTELMETDLHKVIK---SPQPLT-DDH---------------IQ 106

Query: 168 ---YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPS 222
              Y++  G+     YLH+     V+HRD+KPSNIL++S    K+CDFGLA         
Sbjct: 107 YFLYQILRGL----KYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Query: 223 VPFLCKTVKGTFGYLAPE----YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             FL + V  T  Y APE      ++ K     D+++ G +  ELLT RKP+
Sbjct: 160 KGFLTEYVV-TRWYRAPELLLSSSRYTK---AIDIWSVGCIFAELLT-RKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 16/213 (7%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPN 118
            + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L    +  ++ L L+++Y      ++ L  KK     N  +   +       + + +
Sbjct: 61  IVRLYD-VLHSDKKLTLVFEYC-----DQDL--KKYFDSCNGDIDPEIVKSFMFQLLKGL 112

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           A+ H      V+HRD+KP N+L++     KL DFGLA     P   +  + V  T  Y  
Sbjct: 113 AFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRP 167

Query: 239 PEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 270
           P+     K+   + D+++ G +  EL    +P+
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 19/218 (8%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 119
           F + RVLG+G    V   +V       A K+L+K+  +  K     L     L   N   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V  + +  + +  L L+   ++GG L+ H++       G +          A  I   + 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-----GEAGFEEGRAVFYAAEICCGLE 116

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG---TFGY 236
            LH   ER +V+RD+KP NILL      ++ D GLA       VP   +T+KG   T GY
Sbjct: 117 DLHQ--ER-IVYRDLKPENILLDDHGHIRISDLGLAV-----HVP-EGQTIKGRVGTVGY 167

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
           +APE  ++ + +   D +A G +L E++ G+ P + R+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 34/225 (15%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC----RELMIASSLH 115
             +     +G GA   V           VAIK++   + ++   FC    RE+ I     
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFK 61

Query: 116 HPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRY 168
           H NI+ ++     P       ++++ +      +E  L+   K ++   T   S   ++Y
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQEL-----METDLY---KLIK---TQHLSNDHIQY 110

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP--FL 226
            +   I   + Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL
Sbjct: 111 FL-YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 270
            + V  T  Y APE   + K   K  D+++ G +L E+L+ R P+
Sbjct: 167 TEYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 26/221 (11%)

Query: 65  GRVLGRGALSFVFKGK-VGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG G    V   + +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK------ 169
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++         P  V  +      
Sbjct: 83  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 170 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
               A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA       + + 
Sbjct: 142 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHHIDYY 196

Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 73  LSFVFKGKVGL-LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ 131
           L F F  + G  L  +V I R D  +K +   F +E+ I S L  PNI+ L+G C+D E 
Sbjct: 35  LQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-ED 92

Query: 132 GLFLIYKYVSGGSLE-----RHLHEKKK----GVRGNSTLP---WSVRYKVALGIAESVA 179
            L +I +Y+  G L       HL +K++     V     LP   +S    VAL IA  + 
Sbjct: 93  PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YL   +    VHRD+   N L+      K+ DFG++    A     +         ++A 
Sbjct: 153 YL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW 209

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELL 264
           E    GK +  +DV+AFGV L E+L
Sbjct: 210 ECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 64/235 (27%), Positives = 87/235 (37%), Gaps = 42/235 (17%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIKRLD----KEDKESSKAFC----------RELM 109
           KG  LG G    V K    L    VAIK++       D    +             REL 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 110 IASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           I + + H NI+ LV  +    E     +   +    L       KK V     L  S   
Sbjct: 73  IMNEIKHENIMGLVDVYV---EGDFINLVMDIMASDL-------KKVVDRKIRLTESQVK 122

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            + L I   +  LH       +HRD+ P+NI ++SK I K+ DFGLA     P       
Sbjct: 123 CILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 229 TVKG------------TFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             +             T  Y APE      K     D+++ G +  ELLTG KP+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233

Length = 335

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVG 124
           LG+G    V   +V       A K+LDK+    K   K    E  I   ++ P IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           +  + +  L L+   ++GG L+ H+ +  ++G+     + +S +      I   + +LH 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH- 112

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK---GTFGYLAPE 240
                +V+RD+KP N+LL  +   +L D GLA            KT+    GT GY+APE
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------KTITQRAGTNGYMAPE 164

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +    S   D +A G  + E++ GR P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 26/220 (11%)

Query: 65  GRVLGRGALSFVFKGK-VGLL----RTSVAIKRL--DKEDKESSKAFCRELMIASSLHHP 117
           G+ LG GA   V K + VGL      ++VA+K L  D  +K+ S       M+     H 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 118 NIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPWSVRYKV----- 170
           NI+ L+G C   ++G L+++ +Y + G+L   L  ++  G   +   P      +     
Sbjct: 77  NIINLLGVCT--QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 171 ---ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
              A  +A  + +L   +++C+ HRD+   N+L++   + K+ DFGLA       + +  
Sbjct: 135 VSFAYQVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLA--RDIHHIDYYR 189

Query: 228 KTVKGTFGY--LAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           KT  G      +APE       + ++DV++FGV+L E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 24/221 (10%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPL 122
           +V+GRGA   V   +    R   A+K L K +   +  S  F  E  I +  + P +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAY 180
             +    ++ L+++ +Y+ GG L          +  N  +P  W+  Y      AE V  
Sbjct: 109 F-YAFQDDRYLYMVMEYMPGGDL--------VNLMSNYDVPEKWARFYT-----AEVVLA 154

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           L        +HRD+KP N+LL      KL DFG     +   +   C T  GT  Y++PE
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPE 213

Query: 241 YFQH----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
             +     G    + D ++ GV L E+L G  P  A  L G
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +  L  +    +  L  + +YV+GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT------RFYGA-EIVSA 107

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGTFG 235
           + YLH+G    +V+RD+K  N++L      K+ DFGL     T A ++   C    GT  
Sbjct: 108 LDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC----GTPE 160

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           YLAPE  +        D +  GVV+ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 69/226 (30%), Positives = 102/226 (45%), Gaps = 34/226 (15%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSL-HHPN 118
           F    V+G G    V+K +       VAIK +D  ++++E  K    E  I     +HPN
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPN 64

Query: 119 IVPLVGFCIDP-----EQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKV 170
           I    G  I       +  L+L+ +   GGS   L + L +K K ++      W + Y +
Sbjct: 65  IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE----W-IAY-I 118

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK-- 228
                  +AYLH   E  V+HRDIK  NILL+     KL DFG+    SA     L +  
Sbjct: 119 LRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV----SAQLDSTLGRRN 171

Query: 229 TVKGTFGYLAPEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKP 269
           T  GT  ++APE     +  D +     DV++ G+  +EL  G+ P
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 13/215 (6%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 119
           F + RVLG+G    V   +V       A KRL+K+  +  K     L     L   N   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V  + +  + +  L L+   ++GG L+ H++       GN   P     +     AE + 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-----GN---PGFEEERALFYAAEILC 113

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
            L +      V+RD+KP NILL      ++ D GLA     P    +   V GT GY+AP
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV--KIPEGESIRGRV-GTVGYMAP 170

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
           E   + + +   D +  G ++ E++ G+ P   R+
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 72/242 (29%), Positives = 108/242 (44%), Gaps = 50/242 (20%)

Query: 61  NFSKGRVLGRGALSFVF---------KGKV---GLLRTSVAIKRLDKEDKESSKAFCREL 108
           NF   +VLG GA   VF          GK+    +L+ +  +++    +   ++    E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           +  S    P +V L  +    E  L LI  YVSGG +  HL+++             VR+
Sbjct: 61  VRQS----PFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED------EVRF 109

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
                I  ++ +LH   +  +V+RDIK  NILL S+    L DFGL       S  FL +
Sbjct: 110 YSG-EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGL-------SKEFLSE 158

Query: 229 TVK------GTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 278
             +      GT  Y+APE  +    HGK     D ++ G+++ ELLTG  P     L+GE
Sbjct: 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFT---LEGE 212

Query: 279 EN 280
            N
Sbjct: 213 RN 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 76/258 (29%), Positives = 110/258 (42%), Gaps = 45/258 (17%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS------VAIKRLDK----EDKESSKAFCRELMI 110
           +F+  R LG G+      G+V L          VAIKR +K    + K+    F  E  I
Sbjct: 31  DFNFIRTLGTGSF-----GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKI 84

Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
            + ++HP  V L G   D E  L+L+ ++V GG     L       R N   P  V    
Sbjct: 85  LNYINHPFCVNLYGSFKD-ESYLYLVLEFVIGGEFFTFL-------RRNKRFPNDVGCFY 136

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
           A  I     YL +     +V+RD+KP N+LL      K+ DFG A      +      T+
Sbjct: 137 AAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY-----TL 188

Query: 231 KGTFGYLAPEYF---QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 287
            GT  Y+APE      HGK +   D +  G+ + E+L G  P  A      E L+++ K 
Sbjct: 189 CGTPEYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPPFYA-----NEPLLIYQKI 240

Query: 288 ILHRGMAAVEELLDPRLK 305
           +   G+    + LD   K
Sbjct: 241 L--EGIIYFPKFLDNNCK 256

Length = 340

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--FCRELMIASSLHHPNIVPLVG 124
           V+G+G+   V           VAIK+++   +  S A    RE+ +   L HP+IV +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESVAYLHN 183
             + P +  F    YV    +E  LH+    ++ N  L     ++  L  +  ++ Y+H 
Sbjct: 67  IMLPPSRREFKDI-YVVFELMESDLHQV---IKANDDLT-PEHHQFFLYQLLRALKYIHT 121

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYLAPE- 240
                V HRD+KP NIL ++    K+CDFGLA   +   P+  F    V  T  Y APE 
Sbjct: 122 AN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV-ATRWYRAPEL 177

Query: 241 ---YFQHGKVSDKTDVYAFGVVLLELLTGR 267
              +F   K +   D+++ G +  E+LTG+
Sbjct: 178 CGSFF--SKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 47/182 (25%), Positives = 92/182 (50%), Gaps = 14/182 (7%)

Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           VA+K +D   ++  +    E++I     H N+V +    +  E+ L+++ +++ GG+L  
Sbjct: 49  VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE-LWVLMEFLQGGALTD 107

Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
            + + +      +T        V   + +++ YLH+   + V+HRDIK  +ILL+     
Sbjct: 108 IVSQTRLNEEQIAT--------VCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRV 156

Query: 208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
           KL DFG     S   VP   K++ GT  ++APE         + D+++ G++++E++ G 
Sbjct: 157 KLSDFGFCAQISK-DVPKR-KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Query: 268 KP 269
            P
Sbjct: 215 PP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 22/222 (9%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIA--SSLHHPNIV 120
           ++GRG    V+  +        A+K LDK+     +  + A    +M++  S+   P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            +      P++ L  I   ++GG L  H H  + GV     + +      A  I   + +
Sbjct: 61  CMTYAFHTPDK-LCFILDLMNGGDL--HYHLSQHGVFSEKEMRF-----YATEIILGLEH 112

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           +HN   R VV+RD+KP+NILL      ++ D GLA   S            GT GY+APE
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE 165

Query: 241 YFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 281
             Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 9/183 (4%)

Query: 88  VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 146
           VA+K L ++ +K +   F +E+ I S L  PNI+ L+  CI  +  L +I +Y+  G L 
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-LCMITEYMENGDLN 107

Query: 147 RHL--HE-KKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 202
           + L  HE ++   + +  T+ +S    +A  IA  + YL   +    VHRD+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 203 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 262
                K+ DFG++    +     +         +++ E    GK +  +DV+AFGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 263 LLT 265
           +LT
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 83/343 (24%), Positives = 131/343 (38%), Gaps = 88/343 (25%)

Query: 65  GRVLGRGALSFVFKGKV-GLLRTS----VAIKRLDKEDKESS--KAFCRELMIASSL-HH 116
           G+VLG GA   V +    G+ + S    VA+K L KE   +S  KA   EL I   + +H
Sbjct: 12  GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML-KEGATASEHKALMSELKILIHIGNH 70

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV-------------------- 156
            N+V L+G C  P   L +I ++   G+L   L  K++                      
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 157 ----------------------RGNSTLPWSVR---YKVALGIAESVAY---LHNGTE-- 186
                                    ST P       +K  L + + + Y   +  G E  
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 187 --RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
             R  +HRD+   NILLS   + K+CDFGLA             + +    ++APE    
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250

Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD--- 301
              + ++DV++FGV+L E+ +                 L A P  + G+   EE      
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS-----------------LGASP--YPGVQINEEFCQRLK 291

Query: 302 --PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
              R++     + +I R++    AC   +   RP    ++ IL
Sbjct: 292 DGTRMRAPENATPEIYRIM---LACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 39/281 (13%)

Query: 61  NFSKGRVLGRGALSFVFKGK------VGLLRTSVAIKRLDKEDKESSKAFCR-ELMIASS 113
           NF   +VLG GA   VF  +       G L     +K+     K  +    R E  +   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           +     +  + +    +  L LI  Y++GG L  HL ++++              +V + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----------FKEQEVQIY 110

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
             E V  L +  +  +++RDIK  NILL S     L DFGL+       V     +  GT
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGT 169

Query: 234 FGYLAPEYFQHGKVS-DKT-DVYAFGVVLLELLTGRKPIEARRLQGEEN-------LVLW 284
             Y+AP+  + G    DK  D ++ GV++ ELLTG  P     + GE+N        +L 
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT---VDGEKNSQAEISRRILK 226

Query: 285 AKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQIAR 316
           ++P   + M+A     ++ LL  DP  RL C   ++ +I +
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 66/256 (25%), Positives = 94/256 (36%), Gaps = 57/256 (22%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKEDKESSKAFCR---ELMIA 111
            +F K ++LG+G +     G+V L+R        A+K LDK++        R   E  I 
Sbjct: 1   KHFKKIKLLGKGDV-----GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL 55

Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
           ++L HP +  L       E  L L+  Y  GG L R L  +         L   V     
Sbjct: 56  ATLDHPFLPTLYA-SFQTETYLCLVMDYCPGGELFRLLQRQPGKC-----LSEEV---AR 106

Query: 172 LGIAESVA---YLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP--- 224
              AE +    YLH  G    +V+RD+KP NILL       L DF L+  +     P   
Sbjct: 107 FYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162

Query: 225 ------------------FLCKTVK------GTFGYLAPEYFQHGKVSDKTDVYAFGVVL 260
                             F  +         GT  Y+APE           D +  G++L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222

Query: 261 LELLTGRKPIEARRLQ 276
            E+L G  P +     
Sbjct: 223 YEMLYGTTPFKGSNRD 238

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 68/250 (27%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           LG G    V+K +       VA+K++   +++D     A  RE+ I   L HPN+VPL+ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKK-------------KGVRGNSTLPWSVRYKVA 171
             ++                 ++   ++               G+  N     SV+   +
Sbjct: 75  MAVERP---------------DKSKRKRGSVYMVTPYMDHDLSGLLENP----SVKLTES 115

Query: 172 ------LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
                 L + E + YLH   E  ++HRDIK +NIL+ ++ I K+ DFGLA  +   P  P
Sbjct: 116 QIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 225 FLCKTVKGTFG------------YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIE 271
                  G  G            Y  PE     +  +   D++  G V  E+ T R+PI 
Sbjct: 173 ----KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI- 226

Query: 272 ARRLQGEENL 281
              LQG+ ++
Sbjct: 227 ---LQGKSDI 233

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 67  VLGRGALSFVFKGKVGL--LRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HHPNIVPL 122
           V+G G    V +  +    L+ + AIK L +   E+  + F  EL +   L HHPNI+ L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKK---------KGVRGNSTLPWSVRYKVALG 173
           +G C +    L++  +Y   G+L   L + +         K     STL      + A  
Sbjct: 69  LGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           +A  + YL   +E+  +HRD+   N+L+      K+ DFGL+              VK T
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV--------YVKKT 176

Query: 234 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            G     ++A E   +   + K+DV++FGV+L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 21/203 (10%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++ +HP IV L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG-AF 78

Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             +  L+++ ++  GG+++  + E  +G+    T P  ++  +   + E++ YLH+    
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGL----TEP-QIQV-ICRQMLEALQYLHS---M 129

Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQHG 245
            ++HRD+K  N+LL+     KL DFG+    SA +V  L +  +  GT  ++APE     
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 246 KVSD-----KTDVYAFGVVLLEL 263
            + D     K D+++ G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 68  LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAFC--RELMIA---SSLHHPNI 119
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +     +  HPN+
Sbjct: 9   IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 120 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           V L   C     D E  L L++++V    L  +L +          +P      +   + 
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP-----EPGVPTETIKDMMFQLL 120

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
             + +LH+     VVHRD+KP NIL++S    KL DFGLA      S      +V  T  
Sbjct: 121 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVTLW 174

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           Y APE       +   D+++ G +  E+   RKP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 15/219 (6%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTS---VAIK--RLDKEDKESSKAFCRELMIASSLHH 116
              G++LG G    V +G++     S   VA+K  +LD       + F  E        H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 117 PNIVPLVGFCIDPE--QGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
           PN++ L+G C +    Q +    +I  ++  G L   L   + G      LP     K  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFM 119

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
           + IA  + YL N   R  +HRD+   N +L       + DFGL+    +       +  K
Sbjct: 120 VDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               ++A E       + K+DV+AFGV + E+ T G+ P
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.4 bits (156), Expect = 2e-11
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAIK+++ + +   +    E+++     +PNIV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 122 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 81  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDF 130

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+     V+HRDIK  NILL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 131 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 183

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE         K D+++ G++ +E++ G  P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 16/206 (7%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           +G G    V+K +        AIK +  E  E      +E+++     H NIV   G  +
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ L++  ++  GGSL+   H    G    S + +  R  +     + + YLH+  + 
Sbjct: 77  RRDK-LWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127

Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF---QH 244
             +HRDIK +NILL+     KL DFG++   +A       K+  GT  ++APE     + 
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERK 183

Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPI 270
           G  +   D++A G+  +EL   + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 19/218 (8%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHPN 118
           F   RVLG+G    V   +V       A K+L+K+  +  K       E  I   ++   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +V L  +  + +  L L+   ++GG L+ H++       GN           A  I   +
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYN-----MGNPGFDEERAVFYAAEITCGL 115

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF--LCKTVKGTFGY 236
             LH   ER +V+RD+KP NILL      ++ D GLA       +P     +   GT GY
Sbjct: 116 EDLH--RER-IVYRDLKPENILLDDYGHIRISDLGLAV-----EIPEGETIRGRVGTVGY 167

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
           +APE  ++ + +   D +  G ++ E++ G+ P   R+
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +GRGA   V   K       VAIK++    +++  +K   RE+ +   L H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71

Query: 126 CIDPEQ-----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS-VRYKVALGIAESVA 179
            + P        ++++Y+      ++  LH+    +R + TL     +Y +   +   + 
Sbjct: 72  IMPPPHREAFNDVYIVYEL-----MDTDLHQI---IRSSQTLSDDHCQYFL-YQLLRGLK 122

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           Y+H+     V+HRD+KPSN+LL++    K+CDFGLA  T++    F+ + V  T  Y AP
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVV-TRWYRAP 177

Query: 240 EYFQHGKVSDKT---DVYAFGVVLLELLTGRKPI 270
           E   +   S+ T   DV++ G +  ELL GRKP+
Sbjct: 178 ELLLN--CSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 54/220 (24%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSL-HHPNIVPLVGF 125
           +G G  S V K +        AIK + K  K   +    RE+     L  HPNI+ L+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 126 CIDPEQG-LFLI--------YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
             D + G L L+        Y+ + G   +R L EK+  V+       S  Y+    + +
Sbjct: 67  LFDRKTGRLALVFELMDMNLYELIKG--RKRPLPEKR--VK-------SYMYQ----LLK 111

Query: 177 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG--- 232
           S+ ++H NG    + HRDIKP NIL+    I KL DFG             C+ +     
Sbjct: 112 SLDHMHRNG----IFHRDIKPENILI-KDDILKLADFG------------SCRGIYSKPP 154

Query: 233 ------TFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLT 265
                 T  Y APE     G    K D++A G V  E+L+
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 30/214 (14%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIA--SSLHHPNIV 120
           ++GRG    V+  +        A+K LDK+     +  + A    +M++  S+   P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            +      P++ L  I   ++GG L  H H  + GV   + + +    ++ LG+     +
Sbjct: 61  CMSYAFHTPDK-LSFILDLMNGGDL--HYHLSQHGVFSEAEMRFYAA-EIILGLE----H 112

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA----PSVPFLCKTVKGTFGY 236
           +HN   R VV+RD+KP+NILL      ++ D GLA   S      SV        GT GY
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--------GTHGY 161

Query: 237 LAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKP 269
           +APE  Q G   D + D ++ G +L +LL G  P
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 34/225 (15%)

Query: 65  GRVLGRGALSFVFKGKV-GLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG G    V + +  G+ +       +VA+K L  +  DK+ +       ++     
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK-----------KGVRGNSTLP- 163
           H NI+ L+G C   E  L++I +Y + G+L   L  ++           K      +   
Sbjct: 77  HKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 164 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
             S  Y+VA G+     YL   + RC+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 136 LVSCAYQVARGME----YLE--SRRCI-HRDLAARNVLVTEDNVMKIADFGLA--RGVHD 186

Query: 223 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + +  KT  G     ++APE       + ++DV++FG+++ E+ T
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 33/220 (15%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G+G    VFK +    +  VA+K+  ++ E +       RE+ I   L H N+V L+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 126 CIDPEQG-------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           C              +L++++     L   L  K      N     S   KV   +   +
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK------NVKFTLSEIKKVMKMLLNGL 132

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP----FLCKTVKGTF 234
            Y+H      ++HRD+K +NIL++   I KL DFGLA   S         +  + V  T 
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV--TL 187

Query: 235 GYLAPEYF----QHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            Y  PE       +G      D++  G ++ E+ T R PI
Sbjct: 188 WYRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 18/188 (9%)

Query: 88  VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCI--DPEQGLFLIYKYVSGGS 144
           VA+K L  +  K +   F +E+ I S L +PNI+ L+G C+  DP   L +I +Y+  G 
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGD 103

Query: 145 LERHLHEKK---KGVRGNSTLPWSVRYK----VALGIAESVAYLHNGTERCVVHRDIKPS 197
           L + L +++        N+ +P SV       +A+ IA  + YL +      VHRD+   
Sbjct: 104 LNQFLSQREIESTFTHANN-IP-SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR 158

Query: 198 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFG 257
           N L+ +    K+ DFG++    +     +         ++A E    GK +  +DV+AFG
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218

Query: 258 VVLLELLT 265
           V L E+ T
Sbjct: 219 VTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 39/219 (17%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 121
           +VLG+G+   V   ++       A+K L K+    D +       + ++A +  +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 122 LVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           L  +C    ++ LF + ++++GG L  H+ +K     G   L     Y+     AE V  
Sbjct: 61  L--YCTFQTKEHLFFVMEFLNGGDLMFHIQDK-----GRFDL-----YRATFYAAEIVCG 108

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK----------TV 230
           L     + +++RD+K  N++L      K+ DFG+            CK          T 
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGM------------CKENVFGDNRASTF 156

Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            GT  Y+APE  Q  K +   D ++FGV+L E+L G+ P
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 16/209 (7%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 122 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+     V+HRDIK  NILL      KL DFG     + P        V GT  ++APE
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-GTPYWMAPE 186

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                    K D+++ G++ +E++ G  P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 19/218 (8%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 119
           F   RVLG+G    V   +V       A K+L+K+  +  K     L     L   N   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V  + +  + +  L L+   ++GG L+ H++       GN         +     AE   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-----MGNPGFD---EQRAIFYAAELCC 113

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG---TFGY 236
            L +     +V+RD+KP NILL  +   ++ D GLA       +P   +TV+G   T GY
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV-----QIP-EGETVRGRVGTVGY 167

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
           +APE   + K +   D +  G ++ E++ G+ P   R+
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 37/230 (16%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHH 116
           +F   +++  GA   V+  +    R   A+K+++K++     +  + F  E  I +   +
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAEN 60

Query: 117 PNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           P +V +  FC  + ++ L ++ +YV GG     L  K  G      LP  +     +  A
Sbjct: 61  PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL--KNIG-----ALPVDM---ARMYFA 108

Query: 176 ESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-------------WTS 219
           E+V    YLHN     +VHRD+KP N+L++S    KL DFGL+                 
Sbjct: 109 ETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165

Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +  FL K V GT  Y+APE           D +A G++L E L G  P
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 26/221 (11%)

Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG G     V    +G+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-------GVRGNSTLPWSVRY 168
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++         +        + + 
Sbjct: 80  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 169 KVALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            V+    +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 139 LVSCTYQVARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDVNNIDYY 193

Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 29/222 (13%)

Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           +   ++  G ++G G+   V++         VAIK++ ++ +  +    REL+I  +L+H
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN----RELLIMKNLNH 118

Query: 117 PNIVPLVGF----CIDP-EQGLFL--IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
            NI+ L  +    C    E+ +FL  + +++   ++ +++   K   R N  LP  +   
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYM---KHYARNNHALPLFLVKL 174

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT--WTSAPSVPFL 226
            +  +  ++AY+H+   + + HRD+KP N+L+       KLCDFG A        SV ++
Sbjct: 175 YSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231

Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKT--DVYAFGVVLLELLTG 266
           C        Y APE    G  +  T  D+++ G ++ E++ G
Sbjct: 232 CSRF-----YRAPE-LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 12/209 (5%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPNIVPLVG 124
           LG+G    V   ++       A K+L+K+  +  K +     E  I + +H   IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
           +    +  L L+   ++GG L  H++   +   G    P +  Y     I   + +LH  
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE-PRACFY--TAQIISGLEHLH-- 114

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
            +R +++RD+KP N+LL +    ++ D GLA            K   GT G++APE  Q 
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171

Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
            +     D +A GV L E++  R P  AR
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRAR 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 15/202 (7%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 126
           LG G+ + V+KG   +    VA+K +  + +E       RE  +   L H NIV L+   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHDI 71

Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
           I  ++ L  +++Y+    L +++ +   G+      P++VR      +   +AY+H    
Sbjct: 72  IHTKETLTFVFEYMHT-DLAQYMIQHPGGLH-----PYNVRL-FMFQLLRGLAYIHG--- 121

Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG- 245
           + ++HRD+KP N+L+S     KL DFGLA   S PS  +  + V  T  Y  P+      
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179

Query: 246 KVSDKTDVYAFGVVLLELLTGR 267
             S   D++  G + +E+L G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 85/343 (24%), Positives = 129/343 (37%), Gaps = 89/343 (25%)

Query: 65  GRVLGRGALSFVFKG------KVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HH 116
           G+ LGRGA   V +       K    RT VA+K L +    S  +A   EL I   + HH
Sbjct: 12  GKPLGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHH 70

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------------KGVRGNSTL 162
            N+V L+G C  P   L +I ++   G+L  +L  K+              +G  G   +
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDI 130

Query: 163 PWSVR------------------------------------YKVALGIAESVAY---LHN 183
              ++                                    YK  L + + + Y   +  
Sbjct: 131 SEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAK 190

Query: 184 GTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           G E    R  +HRD+   NILLS   + K+CDFGLA               +    ++AP
Sbjct: 191 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 250

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 299
           E       + ++DV++FGV+L E+ +                 L A P  + G+   EE 
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWEIFS-----------------LGASP--YPGVKIDEEF 291

Query: 300 LDPRLKCTSRNSA---QIARVIQAAAACISSEESRRPGIEEII 339
              RLK  +R  A       + Q    C   E S+RP   E++
Sbjct: 292 CR-RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +  L  +       L  + +Y +GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA------RFYGA-EIVSA 107

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGTFG 235
           + YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   C    GT  
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC----GTPE 160

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           YLAPE  +        D +  GVV+ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 17/211 (8%)

Query: 66  RVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +    +  ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIAE 176
           V L+G  +   Q   +I + ++ G L+ +L   +  +  N            ++A  IA+
Sbjct: 72  VRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG- 235
            +AYL+       VHRD+   N +++     K+ DFG+          +  K  KG    
Sbjct: 131 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 185

Query: 236 -YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 22/212 (10%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH---HPNIVPL 122
           +G GA   V+K +       VA+K +  +  E        RE+ +   L    HPNIV L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 123 VGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +  C     D E  + L++++V    L  +L +          LP      +       +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP-----PGLPAETIKDLMRQFLRGL 121

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH     C+VHRD+KP NIL++S    KL DFGLA      S       V  T  Y A
Sbjct: 122 DFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA---RIYSCQMALTPVVVTLWYRA 175

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE       +   D+++ G +  E+   RKP+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 16/214 (7%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
           H++   + +G G    V+K +        A+K +  E  +      +E+ +     H NI
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V   G  +  E+ L++  +Y  GGSL+   H    G      + +  R  +     + +A
Sbjct: 69  VAYFGSYLSREK-LWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETL-----QGLA 120

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YLH+   +  +HRDIK +NILL+     KL DFG+A   +A       K+  GT  ++AP
Sbjct: 121 YLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAP 175

Query: 240 EYF---QHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           E     ++G  +   D++A G+  +EL   + P+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 28/198 (14%)

Query: 84  LRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS 141
           LR   AIKR+ +   +   + F  EL +   L HHPNI+ L+G C +    L+L  +Y  
Sbjct: 21  LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLYLAIEYAP 79

Query: 142 GGSL------ERHLHEKKKGVRGN---STLPWSVRYKVALGIAESVAYLHNGTERCVVHR 192
            G+L       R L         N   STL        A  +A  + YL   +++  +HR
Sbjct: 80  HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 136

Query: 193 DIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG-----YLAPEYFQHGKV 247
           D+   NIL+    + K+ DFGL+              VK T G     ++A E   +   
Sbjct: 137 DLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVY 188

Query: 248 SDKTDVYAFGVVLLELLT 265
           +  +DV+++GV+L E+++
Sbjct: 189 TTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 31/173 (17%)

Query: 107 ELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGN 159
           E M+   +  +PN + L  + +   +G  LI  Y+  G L      E  L E +      
Sbjct: 58  EPMVHQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAE------ 110

Query: 160 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWT 218
                 V+ K+   + E++  LH      ++H DIK  N+L    K    LCD+GL    
Sbjct: 111 ------VK-KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160

Query: 219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
             PS         GT  Y +PE  +        D +A GV+  ELLTG+ P +
Sbjct: 161 GTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 61.7 bits (149), Expect = 3e-10
 Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 32/188 (17%)

Query: 107 ELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           E+ +   L H NIV  +  F     Q L+++ ++   G L R++   +K  +    +   
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEH 118

Query: 166 VRYKVALGIAESVAYLHN-----GTERCVVHRDIKPSNILLSS----------------- 203
               +   +  ++AY HN       ER V+HRD+KP NI LS+                 
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS--DKTDVYAFGVVLL 261
           + I K+ DFGL+      S+   C    GT  Y +PE   H   S  DK+D++A G ++ 
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSC---VGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 262 ELLTGRKP 269
           EL +G+ P
Sbjct: 235 ELCSGKTP 242

Length = 1021

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 68  LGRGALSFV--FKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPL 122
           LG+GA   V   +        +VAIK++      K  +K   REL +      H NI  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 123 VGFCI---DPEQGLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAESV 178
               I        L+L Y+ +    +E  LH+  + G         S  Y++  G+    
Sbjct: 68  YDMDIVFPGNFNELYL-YEEL----MEADLHQIIRSGQPLTDAHFQSFIYQILCGLK--- 119

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV---PFLCKTVKGTFG 235
            Y+H+     V+HRD+KP N+L+++    K+CDFGLA   S        F+ + V  T  
Sbjct: 120 -YIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRW 174

Query: 236 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           Y APE    FQ    +   DV++ G +L ELL GRKP+
Sbjct: 175 YRAPEIMLSFQ--SYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 42/222 (18%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIAS-----SLHHPNIV 120
           +G GA   V+K +       VA+K++     E     +  RE  IA      S  HPNIV
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPNIV 64

Query: 121 PLVGFC----IDPEQGLFLIYKYVSGGSLERHLH---EK--KKGVRGNSTLPWSVRYKVA 171
            L+  C     D E  L L++++V     ++ L     K  K G+      P +++  + 
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLP-----PETIK-DLM 113

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCK 228
             +   V +LH+     +VHRD+KP NIL++S    K+ DFGLA   ++  A     L  
Sbjct: 114 RQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-----LTS 165

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            V  T  Y APE       +   D+++ G +  EL   R+P+
Sbjct: 166 VVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 63/245 (25%), Positives = 96/245 (39%), Gaps = 47/245 (19%)

Query: 61  NFSKGRVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 117
           +F   +V+GRGA      V K   G +     +++ D  +KE       E  I       
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +V +  +    ++ L+LI +++ GG +   L +K        TL           IAE+
Sbjct: 62  WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLS---EEATQFYIAET 110

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-------------WTSAPSVP 224
           V  +    +   +HRDIKP N+LL +K   KL DFGL T              T  P   
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 225 F--------------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
           F                    L  +  GT  Y+APE F     +   D ++ GV++ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 265 TGRKP 269
            G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 25/212 (11%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           ++LG+G       GKV L++        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +  L  +       L  + +Y +GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA------RFYGA-EIVSA 107

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH  +E+ VV+RD+K  N++L      K+ DFGL             KT  GT  YL
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYL 163

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           APE  +        D +  GVV+ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 15/219 (6%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESS--KAFCRELMIASSLHH 116
           F+ GR+LG+G    V + ++     S   VA+K L  +   SS  + F RE        H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 117 PNIVPLVGFCID--PEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
           PN++ L+G  +    +  L    +I  ++  G L   L   + G     TLP     +  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFM 119

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
           + IA  + YL +   +  +HRD+   N +L+      + DFGL+    +          K
Sbjct: 120 IDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               +LA E       +  +DV+AFGV + E++T G+ P
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 23/194 (11%)

Query: 88  VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           VA+K++    ++  S K   REL +     H N++  +     P    F    YV    +
Sbjct: 28  VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE-EIYVVTELM 86

Query: 146 ERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 202
           +  LH  K  V         V+   Y++  G    + YLH+     ++HRDIKP N+L++
Sbjct: 87  QSDLH--KIIVSPQPLSSDHVKVFLYQILRG----LKYLHSAG---ILHRDIKPGNLLVN 137

Query: 203 SKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPEYF---QHGKVSDKTDVYAFGV 258
           S  + K+CDFGLA       S     + V  T  Y APE     +H   +   D+++ G 
Sbjct: 138 SNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRH--YTSAVDIWSVGC 193

Query: 259 VLLELLTGRKPIEA 272
           +  ELL  R   +A
Sbjct: 194 IFAELLGRRILFQA 207

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 71/295 (24%), Positives = 128/295 (43%), Gaps = 66/295 (22%)

Query: 68  LGRGALSFVFKGK---VG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           LG+G  + +FKG    VG    L +T V +K LDK  +  S++F     + S L H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G C+  ++ + ++ +YV  GSL+ +L + K  +     + W       L +A+ +A+
Sbjct: 63  LNYGVCVCGDESI-MVQEYVKFGSLDTYLKKNKNLI----NISWK------LEVAKQLAW 111

Query: 181 -LHNGTERCVVHRDIKPSNILL--------SSKKIPKLCDFGLATWTSAPSVPFLCKTV- 230
            LH   ++ + H ++   N+LL         +    KL D G+       S+  L K + 
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI-------SITVLPKEIL 164

Query: 231 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTG-RKPIEA----RRLQGEENLVLW 284
                ++ PE  ++ + +S   D ++FG  L E+ +G  KP+ A    ++LQ  E+    
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---- 220

Query: 285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
                             R +  +    ++A +I     C+  E   RP    II
Sbjct: 221 ------------------RHQLPAPKWTELANLIN---QCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 18/209 (8%)

Query: 68  LGRGALSFVFKGKV--GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           +G G    V  G+   G+ +  V +K L      +    F +E+     L+HPN++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            CI+      L+ ++   G L+ +L   +  V   +     V  ++A  +A  + +LH  
Sbjct: 63  QCIESIP-YLLVLEFCPLGDLKNYLRSNRGMVAQMAQK--DVLQRMACEVASGLLWLHQA 119

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT-FGYLAPE--- 240
                +H D+   N  L++    K+ D+GLA     P   ++ K        +LAPE   
Sbjct: 120 D---FIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 241 -YFQHGKVSDKT---DVYAFGVVLLELLT 265
              Q     D+T   ++++ GV + EL T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.0 bits (142), Expect = 8e-10
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 44/291 (15%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           F    ++G G    V+KG+        AIK +D    E  +      M+    HH NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 122 LVGFCI--DP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
             G  I  +P   +  L+L+ ++   GS+   +    K  +GN+     + Y +   I  
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAY-ICREILR 122

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---TSAPSVPFLCKTVKGT 233
            +++LH   +  V+HRDIK  N+LL+     KL DFG++     T      F+     GT
Sbjct: 123 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GT 174

Query: 234 FGYLAPEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 288
             ++APE     +  D     K+D+++ G+  +E+  G  P+                P+
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------------PM 222

Query: 289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
             R +  +     PRLK + + S +    I+   +C+    S+RP  E+++
Sbjct: 223 --RALFLIPRNPAPRLK-SKKWSKKFQSFIE---SCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +  L  +       L  + +Y +GG L  HL   ++ V          R+  A  I  +
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSED----RARFYGA-EIVSA 107

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH      VV+RD+K  N++L      K+ DFGL       S     KT  GT  YL
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 162

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           APE  +        D +  GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 38/261 (14%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 126 -----CIDPEQGLFLIYKYVSGG---SLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAE 176
                 ++  Q ++++ + +       ++  L HE+             + Y++  GI  
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLYQMLCGIK- 140

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
              +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYY 191

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 296
            APE        +  D+++ G ++ E++ G          G +++  W K I   G    
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGV-----LFPGTDHIDQWNKVIEQLGTPCP 246

Query: 297 EEL--LDPRLKCTSRNSAQIA 315
           E +  L P ++    N  + A
Sbjct: 247 EFMKKLQPTVRTYVENRPKYA 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 38/228 (16%)

Query: 62  FSKGRVLGRGALSFVFKG---KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
           F    V+G G    V+KG   K G L    AIK +D  + E  +      M+    HH N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQL---AAIKVMDVTEDEEEEIKLEINMLKKYSHHRN 74

Query: 119 IVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           I    G  I       +  L+L+ ++   GS+     +  K  +GN+     + Y +   
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT----DLVKNTKGNALKEDWIAY-ICRE 129

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-- 231
           I   +A+LH      V+HRDIK  N+LL+     KL DFG++          L +TV   
Sbjct: 130 ILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--------LDRTVGRR 178

Query: 232 ----GTFGYLAPEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKPI 270
               GT  ++APE     +  D T     D+++ G+  +E+  G  P+
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 66/256 (25%), Positives = 117/256 (45%), Gaps = 42/256 (16%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 126 -----CIDPEQGLFLIYKYVSGG---SLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAE 176
                 ++  Q ++L+ + +       ++  L HE+             + Y++  GI  
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQMLCGI-- 132

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTF 234
              +LH+     ++HRD+KPSNI++ S    K+ DFGLA    TS    P++      T 
Sbjct: 133 --KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-----TR 182

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            Y APE        +  D+++ G ++ E++  R  I      G + +  W K I   G  
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKI---LFPGRDYIDQWNKVIEQLGTP 237

Query: 295 AVEELLDPRLKCTSRN 310
             E +   +L+ T RN
Sbjct: 238 CPEFM--KKLQPTVRN 251

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 20/213 (9%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
             +G GA   V           VAIK++    +    +K   REL I     H NI+ + 
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS-VRYKVALG-IAESVAYL 181
              + P    F    YV    +E  LH     +  +  L    +RY   L  +   + Y+
Sbjct: 71  DI-LRPPGADF-KDVYVVMDLMESDLHHI---IHSDQPLTEEHIRY--FLYQLLRGLKYI 123

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP---FLCKTVKGTFGYLA 238
           H+     V+HRD+KPSN+L++     ++ DFG+A   S+       F+ + V  T  Y A
Sbjct: 124 HSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRWYRA 179

Query: 239 PE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE      + +   D+++ G +  E+L GR+ +
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 30/167 (17%)

Query: 107 ELMIASSLHHPNIVPLVG-------FCIDPEQGLFLIYKYVSGGSLERHLHEKKKG---V 156
           E  + S L HP IV           FCI        I +Y  G  L+  L E K     +
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCI--------ITEYCEGRDLDCKLEELKHTGKTL 103

Query: 157 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 216
             N    W +  ++ LG    V Y+H   +R ++HRD+K  NI L    + K+ DFG++ 
Sbjct: 104 SENQVCEWFI--QLLLG----VHYMH---QRRILHRDLKAKNIFLK-NNLLKIGDFGVSR 153

Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
                    L  T  GT  Y++PE  +H     K+D+++ G +L E+
Sbjct: 154 LLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 40/226 (17%)

Query: 65  GRVLGRG--ALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIV 120
             ++G+    L  V   K     T VA+K+  LD   KE  K   +E++ +  L HPNI+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P V      +  L+++   ++ GS    L+ H             LP      +   +  
Sbjct: 63  PYV-TSFIVDSELYVVSPLMAYGSCEDLLKTHF---------PEGLPELAIAFILKDVLN 112

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV--------PFLCK 228
           ++ Y+H+  +   +HR +K S+ILLS      L          + S+             
Sbjct: 113 ALDYIHS--KGF-IHRSVKASHILLSGDGKVVLSGL-----RYSVSMIKHGKRQRVVHDF 164

Query: 229 TVKGTF--GYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
                    +L+PE  Q    G  ++K+D+Y+ G+   EL  G  P
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 76/325 (23%), Positives = 126/325 (38%), Gaps = 97/325 (29%)

Query: 27  ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGK- 80
           E++W+ I++ E +    I P      +L Y E       N   G+ LG GA   V +   
Sbjct: 5   EIRWKIIEAAEGNNYTFIDPT-----QLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATA 59

Query: 81  VGLLR----TSVAIKRLD-KEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG-- 132
            GL +      VA+K L      +  +A   EL I S L  H NIV L+G C     G  
Sbjct: 60  FGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---HGGP 116

Query: 133 LFLIYKYVSGGSL---------------------------ERHLHEKKKGVRGNSTL--- 162
           + +I +Y   G L                            +++  +KK +R +S     
Sbjct: 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQ 176

Query: 163 ---------PWSVRYKVALG------------------------IAESVAYLHNGTERCV 189
                    P S     +                          +A+ + +L   ++ C+
Sbjct: 177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCI 234

Query: 190 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT----FGYLAPEYFQHG 245
            HRD+   N+LL+  ++ K+CDFGLA      S       VKG       ++APE     
Sbjct: 235 -HRDVAARNVLLTDGRVAKICDFGLARDIMNDS----NYVVKGNARLPVKWMAPESIFDC 289

Query: 246 KVSDKTDVYAFGVVLLELLT-GRKP 269
             + ++DV+++G++L E+ + G+ P
Sbjct: 290 VYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSL-HHPNIVPLVG 124
           +G+G    V+K       +  A+K LD   +  E  +A   E  I  SL +HPN+V   G
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA---EYNILQSLPNHPNVVKFYG 86

Query: 125 FCIDPEQ----GLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAESVA 179
                ++     L+L+ +  +GGS+   +      G R +  +   + Y   LG+     
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ---- 142

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           +LHN     ++HRD+K +NILL+++   KL DFG++   +  S      T  GT  ++AP
Sbjct: 143 HLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAP 197

Query: 240 EYF----QHGKVSD-KTDVYAFGVVLLELLTGRKPI 270
           E      Q+    D + DV++ G+  +EL  G  P+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 65/245 (26%), Positives = 98/245 (40%), Gaps = 47/245 (19%)

Query: 61  NFSKGRVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 117
           +F   +V+GRGA      V K   G +     +++ D  +KE       E  I       
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +V +  +    +  L+LI +++ GG +   L +K        TL      +    IAE+
Sbjct: 62  WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTL---TEEETQFYIAET 110

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--------------SAPS- 222
           V  + +  +   +HRDIKP N+LL SK   KL DFGL T                S PS 
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 223 VPF------------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
             F                  L  +  GT  Y+APE F     +   D ++ GV++ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 265 TGRKP 269
            G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 65/229 (28%), Positives = 94/229 (41%), Gaps = 31/229 (13%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 118
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       IAE V
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLS------KFEDRLPEDM---ARFYIAEMV 112

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL-------ATWTSAPSVPFLCKTVK 231
             +H+  +   VHRDIKP N+LL      +L DFG         T  S+ +V        
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-------- 164

Query: 232 GTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
           GT  Y++PE  Q      GK   + D ++ GV + E+L G  P  A  L
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 42/234 (17%)

Query: 68  LGRGALSFVFKG----------KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 117
           LG+G  + ++KG                 SV +K L   D   S AF     + S L H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           ++V L G C+  E    ++ +YV  G L+  LH +K  V    +L W  +  VA  +A +
Sbjct: 62  HLVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNV----SLHW--KLDVAKQLASA 113

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT------SAPSVPFLCKTVK 231
           + YL +     +VH ++   NIL        +  +GL          S P +P    + +
Sbjct: 114 LHYLEDKK---LVHGNVCGKNIL--------VARYGLNEGYVPFIKLSDPGIPITVLSRE 162

Query: 232 ---GTFGYLAPEYFQHGKVSDKT--DVYAFGVVLLELLT-GRKPIEARRLQGEE 279
                  ++APE  ++G+ S     D ++FG  LLE+ + G +P+       +E
Sbjct: 163 ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 25/210 (11%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
             +G GA   V           VAIK+L +  +    +K   REL +   + H N++ L+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 124 G-FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
             F         Q ++L+   + G  L   +  +K            +++ V   I   +
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDD-------HIQFLV-YQILRGL 131

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            Y+H+     ++HRD+KPSNI ++     K+ DFGLA  T      ++      T  Y A
Sbjct: 132 KYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRA 183

Query: 239 PE-YFQHGKVSDKTDVYAFGVVLLELLTGR 267
           PE        +   D+++ G ++ ELLTG+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 14/215 (6%)

Query: 65  GRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           G+ LG G    V +G++     +L+ +V   ++    +   + F  E +      HPN++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 121 PLVGFCIDPEQ-----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L+G C+   +        +I  ++  G L   L   + G      LP  +  K    IA
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIA 122

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
             + YL   + +  +HRD+   N +L+      + DFGL+            +  K    
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           ++A E       + K+DV++FGV + E+ T G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLD-----KEDKESSKAFCRELMIASSLHHPNIVPL 122
           +G+G    VFK       +  A+K LD      E+ E+     + L       HPN+V  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKF 80

Query: 123 VG--FCIDPEQG--LFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAES 177
            G  +  D + G  L+L+ +  +GGS+   +    K+G R    +   + ++  +G+   
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ-- 138

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
             +LH       +HRD+K +NILL+++   KL DFG++   +  S      T  GT  ++
Sbjct: 139 --HLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWM 191

Query: 238 APEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKPI 270
           APE     +  D T     DV++ G+  +EL  G  P+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
           + +G GA   V      +   +VAIK+L +  ++   +K   REL++   ++H NI+ L+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 124 GFCIDPE------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
                P+      Q ++L+ +      ++ +L +  +    +  + + + Y++  GI   
Sbjct: 82  N-VFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLL-YQMLCGIK-- 132

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFG 235
             +LH+     ++HRD+KPSNI++ S    K+ DFGLA    TS    P++      T  
Sbjct: 133 --HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-----TRY 182

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
           Y APE        +  D+++ G ++ E++ G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.5 bits (133), Expect = 1e-08
 Identities = 63/227 (27%), Positives = 94/227 (41%), Gaps = 27/227 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 118
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
            +  + +    E  L+L+  Y  GG L   L + +  +  +    +     +A+   +SV
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI---DSV 118

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG-----LATWTSAPSVPFLCKTVKGT 233
             LH       VHRDIKP NIL+      +L DFG     +   T   SV        GT
Sbjct: 119 HQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV------GT 166

Query: 234 FGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
             Y++PE  Q      GK   + D ++ GV + E+L G  P  A  L
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 30/220 (13%)

Query: 67  VLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           ++GRG       G+V ++R        A+K + K     +E+   F  E  I S  + P 
Sbjct: 8   LVGRGHF-----GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           I  L  +    +  L+L+ +Y  GG L   L+      R        +       +AE V
Sbjct: 63  IPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLN------RYEDQFDEDM---AQFYLAELV 112

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
             +H+  +   VHRDIKP N+L+      KL DFG A   +A  +    K   GT  Y+A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIA 171

Query: 239 PEYFQHGKVSDKT------DVYAFGVVLLELLTGRKPIEA 272
           PE         K       D ++ GV+  E++ GR P   
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 45/231 (19%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRE----LMIASS-----L 114
           +V+GRGA   V   K+       A+K L+K +  K +  A  RE    L+         L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H         +    E  L+L+  Y  GG L   L       +    LP  +       +
Sbjct: 67  H---------YAFQDENNLYLVMDYYVGGDLLTLLS------KFEDRLPEDM---ARFYL 108

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG-----LATWTSAPSVPFLCKT 229
           AE V  + +  +   VHRDIKP N+LL      +L DFG     LA  T   +V      
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV---- 164

Query: 230 VKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
             GT  Y++PE  Q      G+   + D ++ GV + E+L G  P  A  L
Sbjct: 165 --GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 3/115 (2%)

Query: 156 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
           V  +  LP      +   + E++AYLH    R ++HRD+K  NI L   +   L DFG A
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Query: 216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
               A      C    GT    +PE         KTD+++ G+VL E+      +
Sbjct: 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 54/213 (25%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 70

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVR--YKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N    P +++   ++A  I
Sbjct: 71  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+          +  K  KG  
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 183

Query: 235 --GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 63/261 (24%), Positives = 98/261 (37%), Gaps = 67/261 (25%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED--KESSKAFCR-ELMIASS 113
           F K + +G GA      G+V L+R        A+K L K D    +  A  + E  I + 
Sbjct: 3   FVKIKTIGIGAF-----GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE 57

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
             +  +V L  +    +  L+ +  Y+ GG +   L   + G+          R+ +A  
Sbjct: 58  ADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDL----ARFYIA-E 109

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WT------------ 218
           +  ++  +H       +HRDIKP NIL+      KL DFGL T   WT            
Sbjct: 110 LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 219 -----------SAPSVPFLCKTVK----------------GTFGYLAPEYFQHGKVSDKT 251
                      S        K ++                GT  Y+APE       +   
Sbjct: 167 RQDSMEPSEEWSEID-RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225

Query: 252 DVYAFGVVLLELLTGRKPIEA 272
           D ++ GV+L E+L G+ P  A
Sbjct: 226 DWWSVGVILYEMLVGQPPFLA 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 14/103 (13%)

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
                VP V    + +   +L+ +++ G +L+    E+K+               +A  +
Sbjct: 50  RKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKE--------------DIAEQL 95

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 217
           AE +A LH      + H D+ P NIL+   KI  + D+  A +
Sbjct: 96  AELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 25/219 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHH-P 117
            + K   +G G    V+K +       VA+K  RL+ +++       RE+ +   L    
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 118 NIVPLVGFCID------PEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYK 169
            IV L+   ++       +  L+L+++Y+    L++ +  + +  G    +    S  Y+
Sbjct: 62  YIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAPSVPFLCK 228
           +  G    VA+ H   +  V+HRD+KP N+L+   K + K+ D GL    S P   +  +
Sbjct: 119 LLKG----VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171

Query: 229 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTG 266
            V  T  Y APE        S   D+++ G +  E+   
Sbjct: 172 IV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 63/280 (22%), Positives = 111/280 (39%), Gaps = 56/280 (20%)

Query: 75  FVFKGKVGLLRTSVAIKRLDKEDKESSKA----FCRELMIASSLHHPNIVPLVGFCIDPE 130
            ++KG        V I+   K+  +  K        E+     +   NI+ + GF ID  
Sbjct: 35  SIYKGIFN--NKEVIIRTF-KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91

Query: 131 QGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             L    LI +Y + G L   L ++K        L +  +  +A+   + +  L+  T +
Sbjct: 92  DDLPRLSLILEYCTRGYLREVLDKEKD-------LSFKTKLDMAIDCCKGLYNLYKYTNK 144

Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
              ++++   + L++     K+   GL    S+P  PF  K V     ++   YF +  +
Sbjct: 145 --PYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PF--KNVN----FMV--YFSYKML 192

Query: 248 SD-------KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
           +D       K D+Y+ GVVL E+ TG+ P E    +   +L++                L
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII---------NKNNSLKL 243

Query: 301 DPRLKCTSRNSAQIARVIQAAA-ACISSEESRRPGIEEII 339
              L C           I+    AC S +  +RP I+EI+
Sbjct: 244 P--LDC--------PLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 24/159 (15%)

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PN+V L  + +  E  +FL+ ++  GG L  H+  K   +       W+    VAL    
Sbjct: 45  PNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRWAAEMVVALDA-- 100

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS-APSVPFLCKTVKGTFG 235
               LH      +V RD+ P+NILL  +   +L  F    W+    S    C        
Sbjct: 101 ----LH---REGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDS----CDGEAVENM 147

Query: 236 YLAPEYFQHGKVSDKT---DVYAFGVVLLELLTGRKPIE 271
           Y APE    G +S++T   D ++ G +L ELLTG+  +E
Sbjct: 148 YCAPEV---GGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 16/209 (7%)

Query: 66  RVLGRGALSFVFKGKVGL---LRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 121
           R+LG G    + +G + L       VAI  L      +  + F  E +      H NIV 
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  I     + ++ +Y+S G+L+  L       +    L       +  G+A  + YL
Sbjct: 71  LEG-VITRGNTMMIVTEYMSNGALDSFLR------KHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
              +E   VH+ +    +L++S  + K+  F       + ++ +   + K    + APE 
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEA 179

Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            Q+   S  +DV++FG+V+ E+++ G +P
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 8/106 (7%)

Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
           S  Y+VA G++    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA      S  
Sbjct: 218 SFSYQVAKGMS----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            +    +    ++APE   +   + ++DV+++G++L E+ + G  P
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 8/92 (8%)

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKG 232
           I E + YLH    + ++HRD+K  NI ++      + D G A +   AP+  FL   + G
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--FL--GLAG 218

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
           T    APE     K + K D+++ G+VL E+L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           I   + Y+H+     ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T
Sbjct: 129 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----AT 180

Query: 234 FGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGR 267
             Y APE   +    ++T D+++ G ++ ELLTGR
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 42/163 (25%)

Query: 70  RGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH------------- 116
           RGA   V+ G+        A+K + K D           MI  ++ H             
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKAD-----------MINKNMVHQVQAERDALALSK 62

Query: 117 -PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            P IV L  + +     ++L+ +Y+ GG ++  LH     + G      +V+Y     I+
Sbjct: 63  SPFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLH-----IYGYFDEEMAVKY-----IS 111

Query: 176 ESVA---YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
           E      YLH      ++HRD+KP N+L+S++   KL DFGL+
Sbjct: 112 EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 31/233 (13%)

Query: 43  VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK 102
           V + L   ++G+I       S      R  ++   +GK          + + K  K  S+
Sbjct: 152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGK------PKCERLIAKRVKAGSR 205

Query: 103 AFCR---ELMIASSLHHPNIVPLVGFCIDPEQGLFL-------IYKYVSGGSLERHLHEK 152
           A  +   E++    L+H NI+ +            +       +Y ++   + +      
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK---- 261

Query: 153 KKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF 212
                 +  L    R  +   +  +V Y+H+   + ++HRDIK  NI L+      L DF
Sbjct: 262 ------DRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDF 311

Query: 213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           G A         F    V GT    +PE        + TD+++ G++LL++L+
Sbjct: 312 GTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 38/108 (35%), Positives = 59/108 (54%), Gaps = 21/108 (19%)

Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-------TW 217
           S  Y+VA G+ E +A     ++ CV HRD+   N+LL+  KI K+CDFGLA        +
Sbjct: 241 SFTYQVARGM-EFLA-----SKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293

Query: 218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            S  S  FL   VK    ++APE       +  +DV+++G++L E+ +
Sbjct: 294 VSKGST-FL--PVK----WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 21/109 (19%)

Query: 168 YKVALGIAESVAYLHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA-------T 216
           Y   +G +  VA   NG E    +  VHRD+   N+L+   K+ K+CDFGLA        
Sbjct: 238 YMDLVGFSYQVA---NGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN 294

Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + S  S  FL         ++APE   +   +  +DV++FG++L E+ T
Sbjct: 295 YISKGST-FL------PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 32/207 (15%)

Query: 71  GALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLVGF-- 125
           G +      + G     VAIK+L +    +  + +A+ REL +   + H N++ L+    
Sbjct: 29  GTVCSALDRRTG---AKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLDVFT 84

Query: 126 ---CIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
               +D     +L+  ++ G  L + + HEK    R        +++ V   + + + Y+
Sbjct: 85  PDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDR--------IQFLV-YQMLKGLKYI 134

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H      ++HRD+KP N+ ++     K+ DFGLA  T +    ++      T  Y APE 
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV-----TRWYRAPEV 186

Query: 242 FQHGKVSDKT-DVYAFGVVLLELLTGR 267
             +     +T D+++ G ++ E+LTG+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 41/157 (26%), Positives = 61/157 (38%), Gaps = 46/157 (29%)

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WT------------ 218
           IAE    + +  +   +HRDIKP NIL+      KL DFGL T   WT            
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166

Query: 219 SAPSVPF------------------------------LCKTVKGTFGYLAPEYFQHGKVS 248
              S+ F                              L  ++ GT  Y+APE       +
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226

Query: 249 DKTDVYAFGVVLLELLTGRKPIEARR-LQGEENLVLW 284
              D ++ GV+L E+L G+ P  A+  L+ +  ++ W
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 18/140 (12%)

Query: 27  ELKWRKIQSLERSISPVANSLIRLSYGEI-LAATHNFSK-----GRVLGRGALSFVFKGK 80
           E++WR I+S    ISP  +  I +   ++   +   F +     GR+LG GA   V +G 
Sbjct: 2   EIRWRVIES----ISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGT 57

Query: 81  V-GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGL 133
             GL R+     VA+K L    + S K A   EL I + L  H NIV L+G C      +
Sbjct: 58  AYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-SGPI 116

Query: 134 FLIYKYVSGGSLERHLHEKK 153
           ++I +Y   G L  +LH+ +
Sbjct: 117 YIITEYCFYGDLVNYLHKNR 136

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 63/269 (23%), Positives = 99/269 (36%), Gaps = 83/269 (30%)

Query: 61  NFSKGRVLGRGA---LSFVFK---GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 114
           +F   +V+G+GA   +  V K   GK+  ++T +  +   K+     KA  R+++  S  
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAE-RDVLAESD- 59

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---- 170
             P +V L  +     Q L+LI +++ GG L   L                ++Y      
Sbjct: 60  -SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML----------------IKYDTFSED 101

Query: 171 --ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL-------------- 214
                +AE V  +    +   +HRDIKP NIL+      KL DFGL              
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161

Query: 215 ---------------------------------ATWTSAPSVPFLCKTVKGTFGYLAPEY 241
                                            ATW     +  +  +  GT  Y+APE 
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEI 219

Query: 242 F-QHGKVSDKTDVYAFGVVLLELLTGRKP 269
           F Q G    + D ++ G ++ E L G  P
Sbjct: 220 FLQQG-YGQECDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 26/188 (13%)

Query: 88  VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV-----GFCIDPEQGLFLIYKYV 140
           VAIK+L +  + +  +K   REL +   + H N++ L+         D  Q  +L+  Y 
Sbjct: 43  VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY- 101

Query: 141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL 200
                   +    + + G+      V+Y V   +   + Y+H+     ++HRD+KP N+ 
Sbjct: 102 --------MQTDLQKIMGHPLSEDKVQYLV-YQMLCGLKYIHSAG---IIHRDLKPGNLA 149

Query: 201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVV 259
           ++     K+ DFGLA    A    ++      T  Y APE   +    ++T D+++ G +
Sbjct: 150 VNEDCELKILDFGLARHADAEMTGYVV-----TRWYRAPEVILNWMHYNQTVDIWSVGCI 204

Query: 260 LLELLTGR 267
           + E+LTG+
Sbjct: 205 MAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 17/213 (7%)

Query: 68  LGRGALSFVFKGKV--GLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           +G G    V  G+V  G     V +K L      +    F  E     SL H N++  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C +    L L+ ++   G L+ +L   +K      T   +   ++A  IA  + +LH  
Sbjct: 63  QCTEVTPYL-LVMEFCPLGDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ- 243
                +H D+   N LL++    K+ D+GL+              +     ++APE    
Sbjct: 120 N---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 244 -HGK--VSDKT---DVYAFGVVLLELLT-GRKP 269
            HG   V D+T   +V++ GV + EL   G +P
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 15/203 (7%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGF 125
           +G GA   V       LR  VA+K+L +  +    ++   REL +   + H N++ L+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
                        Y+    +   L+   K  + +      + Y++  G+     Y+H+  
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK----YIHSAG 138

Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
              ++HRD+KPSN+ ++     ++ DFGLA         ++      T  Y APE   + 
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV-----ATRWYRAPEIMLNW 190

Query: 246 KVSDKT-DVYAFGVVLLELLTGR 267
              ++T D+++ G ++ ELL G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 36/128 (28%), Positives = 48/128 (37%), Gaps = 45/128 (35%)

Query: 190 VHRDIKPSNILLSSKKIPKLCDFGLAT---WTS----------------APSVPF----- 225
           +HRDIKP NIL+      KL DFGL T   WT                  PS  +     
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 226 ---------------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
                                L  ++ GT  Y+APE       +   D ++ GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 265 TGRKPIEA 272
            G+ P  A
Sbjct: 243 VGQPPFLA 250

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 33/117 (28%), Positives = 61/117 (52%), Gaps = 10/117 (8%)

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSA--PSVPFLCKTVKGTFGY 236
           Y+H+     V+HRD+KP+N+ ++++  + K+ DFGLA           +L + +   + Y
Sbjct: 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-Y 184

Query: 237 LAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAKPILHR 291
            +P          K  D++A G +  E+LTG KP+ A   + E+  L+L + P++  
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVRE 240

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 23/166 (13%)

Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E  I  +++HP+I+ L G     +    ++ +Y +   L  +L  K+        +    
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRN-------IAICD 183

Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
              +   +  ++ YLH      ++HRDIK  NI ++      L DFG A +      P  
Sbjct: 184 ILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF------PVD 234

Query: 227 CKTVK-----GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
               K     GT    APE           D+++ G+VL E+ T  
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 32/200 (16%)

Query: 88  VAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGS 144
           V ++R++ E    E       EL ++   +HPNIVP    F  D E  L+++  +++ GS
Sbjct: 28  VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGS 85

Query: 145 LE----RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL 200
            +     H  +      G S L  ++ Y +  G+ +++ Y+H+      VHR +K S+IL
Sbjct: 86  AKDLICTHFMD------GMSEL--AIAY-ILQGVLKALDYIHH---MGYVHRSVKASHIL 133

Query: 201 LSSKKIPKLCDFGLATWTS-------APSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKT 251
           +S     K+   GL +  S          V    K       +L+PE  Q        K+
Sbjct: 134 ISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 191

Query: 252 DVYAFGVVLLELLTGRKPIE 271
           D+Y+ G+   EL  G  P +
Sbjct: 192 DIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 14/158 (8%)

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L HPNI+  +G C++    L L+++Y   G L+ +L +++   R +  L      ++A  
Sbjct: 52  LQHPNILQCLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACE 107

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           IA  V ++H   +   +H D+   N  L+S    K+ D+G+                   
Sbjct: 108 IAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 234 FGYLAPEYFQ--HGKV--SDKT---DVYAFGVVLLELL 264
             +LAPE     HG +  +++T   +V+A GV L EL 
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 40/204 (19%)

Query: 87  SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL-----VGFCIDPEQGLFLIYKYVS 141
           +V I  L+   +E  KA   E++++    HPNI+        G        L++I  +++
Sbjct: 29  TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG------SWLWVISPFMA 82

Query: 142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-NGTERCVVHRDIKPSNIL 200
            GS    L +       +  L  ++ +    G    + YLH NG     +HR+IK S+IL
Sbjct: 83  YGS-ANSLLKTYFPEGMSEALIGNILF----GALRGLNYLHQNG----YIHRNIKASHIL 133

Query: 201 LSSKKIPKLCDFGLATWTS----------APSVPFLCKTVKGTFGYLAPEYFQ---HGKV 247
           +S   +  L   GL+   S              P    +V     +L+PE  +   +G  
Sbjct: 134 ISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYG-Y 187

Query: 248 SDKTDVYAFGVVLLELLTGRKPIE 271
           + K+D+Y+ G+   EL TGR P +
Sbjct: 188 NVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	398
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
smart00090	237	RIO RIO-like kinase.	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
KOG1243	690	consensus Protein kinase [General function predict	99.36
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.28
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.15
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.03
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.74
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.71
PRK09902	216	hypothetical protein; Provisional	98.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.66
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.44
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.42
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.35
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.34
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.26
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.25
PF01636	239	APH: Phosphotransferase enzyme family This family	98.22
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.14
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.13
PLN02876	822	acyl-CoA dehydrogenase	98.09
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.05
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.92
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.92
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.81
PRK10593	297	hypothetical protein; Provisional	97.77
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.64
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.6
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.51
PRK05231	319	homoserine kinase; Provisional	97.5
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.4
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.35
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.35
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.24
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.2
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.14
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.99
PLN02236	344	choline kinase	96.96
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.8
KOG2270	520	consensus Serine/threonine protein kinase involved	96.53
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.45
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.44
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.44
PLN02756	418	S-methyl-5-thioribose kinase	96.41
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.41
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.23
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.15
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.15
PRK12396	409	5-methylribose kinase; Reviewed	96.11
COG2334	331	Putative homoserine kinase type II (protein kinase	95.93
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.87
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.43
PRK11768	325	serine/threonine protein kinase; Provisional	95.33
PRK06148	1013	hypothetical protein; Provisional	95.17
PTZ00384	383	choline kinase; Provisional	94.42
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	94.36

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-62  Score=464.44  Aligned_cols=291  Identities=43%  Similarity=0.764  Sum_probs=256.0

Q ss_pred             cccccCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeE
Q 015931           46 SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF  125 (398)
Q Consensus        46 ~~~~~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  125 (398)
                      ....|++.||..||++|+..++||+|+||.||+|...+ +..||||++.........+|.+|++++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            56789999999999999999999999999999999986 58999998876544314569999999999999999999999


Q ss_pred             EEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       126 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      |.+.+...+||||||++|+|.++|+....     .+++|.+|++|+.++|+||+|||+.+.++|+||||||+|||||+++
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~-----~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~  214 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKG-----EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF  214 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCC-----CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence            99876447899999999999999988542     1799999999999999999999999988999999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeecc-ccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      ++||+|||+|+...... ... ... .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+...+.+...++.|
T Consensus       215 ~aKlsDFGLa~~~~~~~-~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  215 NAKLSDFGLAKLGPEGD-TSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             CEEccCccCcccCCccc-cce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            99999999997655411 111 122 899999999999999999999999999999999999999987766667779999


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCH-HHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNS-AQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      .++.+..+  .+.+++|+++....+.. .++.++..++.+|++.+|.+||+|.||+++|+.+.
T Consensus       293 ~~~~~~~~--~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  293 AKPLLEEG--KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHCc--chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            99998887  79999999987434443 78899999999999999999999999999996543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-51  Score=370.83  Aligned_cols=250  Identities=30%  Similarity=0.463  Sum_probs=209.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      +....+.||+|..|+||++.++.+++.+|+|.+... +....+++.+|++++++.+||+||.++|.|......+.|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            566678999999999999999999999999999544 4556788999999999999999999999988755358999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |.+|||++++...       +.+++...-+|+.++++||.|||+ .+   ||||||||+|||++..|.+||||||.++.+
T Consensus       160 MDgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             cCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            9999999999875       459999999999999999999996 55   999999999999999999999999999877


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ...    ...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.|+........ ...           +.+..
T Consensus       230 vnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-~~~-----------~Ll~~  293 (364)
T KOG0581|consen  230 VNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-DIF-----------ELLCA  293 (364)
T ss_pred             hhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-CHH-----------HHHHH
Confidence            654    34678899999999999999999999999999999999999999987522111 111           12344


Q ss_pred             hcC---cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLD---PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d---~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +++   |++... ..++   ++..++..||++||.+||++.|+++
T Consensus       294 Iv~~ppP~lP~~-~fS~---ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 IVDEPPPRLPEG-EFSP---EFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HhcCCCCCCCcc-cCCH---HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            444   223211 1334   4555566799999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-51  Score=385.58  Aligned_cols=259  Identities=37%  Similarity=0.591  Sum_probs=208.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcE-EEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTS-VAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ..+...+.||+|+||+||+|.++  |+. ||||++.....  ...+.|.+|+.+|.+++|||||+++|+|.++...+++|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            34455566999999999999998  555 99999976532  22568999999999999999999999998876458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DfGla  215 (398)
                      |||+++|+|.++++...     ...+++..+++++.|||+|+.|||+++.  ||||||||+|||++.++ ++||+|||++
T Consensus       119 tEy~~~GsL~~~l~~~~-----~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKR-----KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             EEeCCCCcHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccc
Confidence            99999999999998842     2679999999999999999999998764  99999999999999997 9999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhc--cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQ--HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +......  ...+...||..|||||++.  ...++.|+||||||+++|||+||+.||.......   .   +..      
T Consensus       192 r~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~---~~~------  257 (362)
T KOG0192|consen  192 REKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---V---ASA------  257 (362)
T ss_pred             eeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---H---HHH------
Confidence            8765432  1234478999999999999  5689999999999999999999999998765411   0   000      


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                       .+.....+.+  +..   ....+..++..||+.||..||++.+++..|+.+..
T Consensus       258 -v~~~~~Rp~~--p~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  258 -VVVGGLRPPI--PKE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -HHhcCCCCCC--Ccc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence             1111112222  111   33445666667999999999999999999987544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-50  Score=387.77  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=211.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ..|..++.||+|||+.||.++...+|+.||+|++.+.   .....+...+|+++.+.++|||||+++++|.+. +++|+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-NNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-CceEEE
Confidence            5699999999999999999999889999999999864   345567788999999999999999999987764 559999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      .|+|++++|..+++..       .++++.+++.++.||+.||.|||+++   |+|||||..|+||+++.++||+|||||.
T Consensus        97 LELC~~~sL~el~Krr-------k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRR-------KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             EEecCCccHHHHHHhc-------CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceee
Confidence            9999999999999854       57999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .+..+...  ..+.+||+.|+|||++.....+..+||||+||++|-|+.|++||+.++..+..                 
T Consensus       167 ~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-----------------  227 (592)
T KOG0575|consen  167 QLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-----------------  227 (592)
T ss_pred             eecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-----------------
Confidence            88755432  35789999999999999999999999999999999999999999987544321                 


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.......+...+.   ...+|+.++|+++|.+|||+++|+.
T Consensus       228 ~~Ik~~~Y~~P~~ls~---~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  228 NKIKLNEYSMPSHLSA---EAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHhcCcccccccCH---HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2222222222222233   3456667899999999999999996

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-50  Score=367.94  Aligned_cols=204  Identities=31%  Similarity=0.575  Sum_probs=185.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ..+|...+.||+|+||+||+|+++.++..||||.+.+.  .+...+.+..|+.+|+.++|||||.+++++..+ +.+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-DFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-CeEEEE
Confidence            46888888999999999999999999999999999876  566777889999999999999999999986664 569999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC------CCeeEe
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK------KIPKLC  210 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~------~~~kl~  210 (398)
                      ||||.||+|.++++..       ..+++.+++.++.|||.||++||+++   ||||||||+||||+..      -.+||+
T Consensus        88 MEyC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             EEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEec
Confidence            9999999999999986       46999999999999999999999999   9999999999999865      468999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccc
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  276 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~  276 (398)
                      |||+|+.+....   ...+.+|++-|||||++...+|+.|+|+||+|++||+|++|+.||...+..
T Consensus       158 DFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  158 DFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             ccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            999999987543   345789999999999999999999999999999999999999999976654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-51  Score=355.05  Aligned_cols=262  Identities=23%  Similarity=0.389  Sum_probs=210.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV  136 (398)
                      .+|.+.++||.|+||.||++....+|..||.|.+.-.  +....+.+..|+.+|++++|||||+++++.+..+ .-++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3577888999999999999999999999999998743  4556778999999999999999999999544434 448899


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CceeecccccCcEEeCCCCCeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE-RCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||+|.+|+|...++..++   +...+++..+|+++.|++.||..+|+.-. ..|+||||||.||+|+.+|.+||+|||++
T Consensus        99 mE~c~~GDLsqmIk~~K~---qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKK---QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHhhcccCHHHHHHHHHh---ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            999999999999987543   24679999999999999999999998432 23999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +.+.....  ...+.+|||.||+||.+...+|+.||||||+||++|||+.-+.||.+++.      .....         
T Consensus       176 r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~---------  238 (375)
T KOG0591|consen  176 RFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCK---------  238 (375)
T ss_pred             hHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHH---------
Confidence            98876542  34568899999999999999999999999999999999999999998632      22111         


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                        ++-...+. +....-....+.+++..|+..||..||+...++..++.
T Consensus       239 --KI~qgd~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  239 --KIEQGDYP-PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --HHHcCCCC-CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence              11111121 01112234456677778999999999996555555443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-49  Score=362.51  Aligned_cols=253  Identities=28%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      .+.|-..+.||+|+||.|-+|..+.+|+.||||++.+...       .......+|+++|++++|||||++.+++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3567778999999999999999999999999999976421       122335799999999999999999999877654


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC---CCee
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPK  208 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~---~~~k  208 (398)
                       .|+||||++||+|.+++...       ..+.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   ..+|
T Consensus       251 -~YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  251 -SYMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             -eEEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEE
Confidence             79999999999999999875       45778888899999999999999998   9999999999999766   7899


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccCCc---CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV---SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  285 (398)
                      |+|||+|+..+...   ...+.+||+.|.|||++.+..+   ..+.|+||+||+||-+++|.+||.......  .     
T Consensus       320 ItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s-----  389 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S-----  389 (475)
T ss_pred             ecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c-----
Confidence            99999999887433   3578999999999999986643   347899999999999999999998654321  0     


Q ss_pred             hHHHhhchhhhhhhcCcccCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          286 KPILHRGMAAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                               ....+...++... .....-.++.++++.++|..||++|||+.|+++.
T Consensus       390 ---------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  390 ---------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ---------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                     1122222333221 2233445667888889999999999999999873

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-48  Score=349.58  Aligned_cols=243  Identities=27%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ..++|...++||+|+||+||.++.+++++.+|+|++++..   ....+....|..+|.+++||.||+++-.+++. +.+|
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-~kLy  101 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-EKLY  101 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-CeEE
Confidence            3578999999999999999999999999999999998652   34566788999999999999999999776664 5599


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +|+||+.||.|..+|++.       ..+++..+.-++..|+.||.|||+.+   ||||||||+|||||++|+++|+|||+
T Consensus       102 lVld~~~GGeLf~hL~~e-------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQRE-------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             EEEeccCCccHHHHHHhc-------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecccc
Confidence            999999999999999875       46999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++..-....  .+.+.+||+.|||||++.+..++..+|+||+|+++|||++|.+||...+...                 
T Consensus       172 ~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-----------------  232 (357)
T KOG0598|consen  172 CKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-----------------  232 (357)
T ss_pred             chhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-----------------
Confidence            985443322  2356899999999999999999999999999999999999999998765432                 


Q ss_pred             hhhhhcCcccCC-CCCCHHHHHHHHHHHHhcccccCCCCC
Q 015931          295 AVEELLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRP  333 (398)
Q Consensus       295 ~~~~~~d~~l~~-~~~~~~~~~~l~~l~~~cl~~~p~~RP  333 (398)
                      ....+....+.. +...+.+   ..+++...|..+|++|-
T Consensus       233 ~~~~I~~~k~~~~p~~ls~~---ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  233 MYDKILKGKLPLPPGYLSEE---ARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHHhcCcCCCCCccCCHH---HHHHHHHHhccCHHHhc
Confidence            122233222221 2223334   44555678999999996

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=361.83  Aligned_cols=253  Identities=31%  Similarity=0.471  Sum_probs=206.4

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +...+.||+|-||.||.|.++. ...||+|.+.... ...+.|.+|+++|++++|+|||+++|+|...+ .+|||||||+
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m~  284 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYMP  284 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEecc
Confidence            3445789999999999999985 4589999998653 34577999999999999999999999998755 5999999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      .|+|.++|....     ...++..+.+.++.|||+|++||++++   +|||||.++||||+++..+||+|||+|+...++
T Consensus       285 ~GsLl~yLr~~~-----~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  285 KGSLLDYLRTRE-----GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             cCcHHHHhhhcC-----CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            999999998733     267899999999999999999999988   999999999999999999999999999954433


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                      .. .......-+..|.|||.+..++++.|||||||||+||||+| |+.|+......+...       .+.++        
T Consensus       357 ~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~-------~le~G--------  420 (468)
T KOG0197|consen  357 EY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-------LLERG--------  420 (468)
T ss_pred             ce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH-------HHhcc--------
Confidence            22 12223334667999999999999999999999999999999 999987654332111       11111        


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       301 d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       .++.++..+++++..   ++..||+.+|++|||+..+...|+..
T Consensus       421 -yRlp~P~~CP~~vY~---lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  421 -YRLPRPEGCPDEVYE---LMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             -CcCCCCCCCCHHHHH---HHHHHhhCCcccCCCHHHHHHHHHHh
Confidence             245556666666554   55679999999999999998888754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=355.30  Aligned_cols=254  Identities=25%  Similarity=0.381  Sum_probs=212.4

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCC
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  131 (398)
                      ....++|..++.||+|+|++|++|+...+++.||||++.+.   .....+-+..|-+.|.+| .||.|++|+-.|.+. .
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-~  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-E  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-c
Confidence            34558999999999999999999999999999999999764   222334566788888888 899999999887775 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+|+|+||+++|+|.++|.+.       +.+++...+.++.+|+.||+|||++|   ||||||||+|||||.|+++||+|
T Consensus       148 sLYFvLe~A~nGdll~~i~K~-------Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITD  217 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKY-------GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITD  217 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHh-------CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEee
Confidence            599999999999999999986       46999999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCCc---------ee--eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchh
Q 015931          212 FGLATWTSAPSVP---------FL--CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  280 (398)
Q Consensus       212 fGla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~  280 (398)
                      ||.|+.++.....         ..  ....+||..|.+||++..+..++.+|+|+|||+||+|+.|.+||.+.+.-    
T Consensus       218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----  293 (604)
T KOG0592|consen  218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----  293 (604)
T ss_pred             ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----
Confidence            9999987643211         11  14578999999999999999999999999999999999999999876531    


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .            ..+++++-.+..+...++..   .+|+.+.|..||.+|+|..+|-+
T Consensus       294 -l------------iFqkI~~l~y~fp~~fp~~a---~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  294 -L------------IFQKIQALDYEFPEGFPEDA---RDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             -H------------HHHHHHHhcccCCCCCCHHH---HHHHHHHHccCccccccHHHHhh
Confidence             1            24455555555555555444   45556789999999999988877

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.2e-46  Score=354.99  Aligned_cols=266  Identities=26%  Similarity=0.413  Sum_probs=205.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||.||+|.+.     .++..||+|++.... ......+.+|+.++..+ +||||++++++|...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467899999999999999999752     335679999997543 33456789999999999 89999999999887776


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCC-------------------------------------------------------
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGV-------------------------------------------------------  156 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------  156 (398)
                      .+++||||+++|+|.+++.......                                                       
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            7899999999999999997532100                                                       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCc
Q 015931          157 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY  236 (398)
Q Consensus       157 ~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  236 (398)
                      ....++++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence            00235889999999999999999999888   999999999999999999999999999865433221112234567889


Q ss_pred             ccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHH
Q 015931          237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIA  315 (398)
Q Consensus       237 ~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  315 (398)
                      +|||++.+..++.++|||||||++|||++ |..||........  ..   . .       +........  +.   ....
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~---~-~-------~~~~~~~~~--~~---~~~~  304 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC---Q-R-------LKDGTRMRA--PE---NATP  304 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH---H-H-------HhcCCCCCC--CC---CCCH
Confidence            99999998899999999999999999997 9999976432210  00   0 0       111001111  11   1223


Q ss_pred             HHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          316 RVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       316 ~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            567788899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-46  Score=343.71  Aligned_cols=258  Identities=31%  Similarity=0.454  Sum_probs=202.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-cEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~lV~  137 (398)
                      ..++..++.||+|+||+||++.+.++|...|||.+...+....+.+.+|+.+|++++|||||+++|.....++ .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3467788999999999999999998899999999977644446778999999999999999999996444343 578999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla~  216 (398)
                      ||+++|+|.+++....      ..++++.+..++.|+++||+|||+++   |+||||||+||||+. ++.+||+|||+++
T Consensus        96 Ey~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAK  166 (313)
T ss_pred             eccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccc
Confidence            9999999999998753      26999999999999999999999888   999999999999999 7999999999998


Q ss_pred             ccCC-CCCceeeeccccCCCcccchhhccCC-cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          217 WTSA-PSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       217 ~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      .... ...........||+.|||||++..+. ...++|||||||++.||+||+.||...  .+   ...+...+..    
T Consensus       167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~---~~~~~~~ig~----  237 (313)
T KOG0198|consen  167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FE---EAEALLLIGR----  237 (313)
T ss_pred             ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cc---hHHHHHHHhc----
Confidence            7764 11112234578999999999998643 345999999999999999999999763  00   1111111100    


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                         +-.-|.+  +...+.+.   .+++..|+..+|.+|||+.++++..
T Consensus       238 ---~~~~P~i--p~~ls~~a---~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  238 ---EDSLPEI--PDSLSDEA---KDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---cCCCCCC--CcccCHHH---HHHHHHHhhcCcccCcCHHHHhhCh
Confidence               0011222  22233444   4455679999999999999999843

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=351.03  Aligned_cols=252  Identities=30%  Similarity=0.437  Sum_probs=208.1

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC----Ch-hhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCC
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DK-ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE  130 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  130 (398)
                      ...++|..++.||+|+||+|+.|.+..++..||+|++...    .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457899999999999999999999989999999977654    11 23456678999999999 999999999977655


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeE
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKL  209 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl  209 (398)
                      . +++||||+.||+|.+++...       .++.+..+..++.|++.|++|||+.+   |+||||||+|||+|.+ +++||
T Consensus        94 ~-~~ivmEy~~gGdL~~~i~~~-------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl  162 (370)
T KOG0583|consen   94 K-IYIVMEYCSGGDLFDYIVNK-------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKL  162 (370)
T ss_pred             e-EEEEEEecCCccHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEE
Confidence            5 89999999999999999883       56899999999999999999999988   9999999999999999 99999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCC-cC-CccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VS-DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      +|||++......  .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...          
T Consensus       163 ~DFG~s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----------  230 (370)
T KOG0583|consen  163 SDFGLSAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----------  230 (370)
T ss_pred             eccccccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----------
Confidence            999999977411  12346788999999999999876 75 78999999999999999999998743221          


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             ....+....+..+....  ...+..++.+||..+|.+|+|+.+|++
T Consensus       231 -------l~~ki~~~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  231 -------LYRKIRKGEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -------HHHHHhcCCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                   11223333343333321  345667778899999999999999994

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.9e-46  Score=329.20  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=206.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      +.|....++|+|+||+||+++++++|+.||||++....  +...+-.++|+.+|++++|+|+|.++.+|.. ...++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence            45777889999999999999999999999999996543  3344557899999999999999999999766 45589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |||+..-|+ -|....      ..++.+.+.+++.|++.|+.|+|+++   ++||||||+||||+.++.+||||||+|+.
T Consensus        81 E~~dhTvL~-eLe~~p------~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~  150 (396)
T KOG0593|consen   81 EYCDHTVLH-ELERYP------NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFART  150 (396)
T ss_pred             eecchHHHH-HHHhcc------CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHh
Confidence            999775444 444432      45899999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-HHHhhchhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-PILHRGMAA  295 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~  295 (398)
                      +..+..  ..+..+.|.+|.|||.+.+ .+|+...||||+||++.||++|.+-|.+...-+...++.... .+.++    
T Consensus       151 L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr----  224 (396)
T KOG0593|consen  151 LSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR----  224 (396)
T ss_pred             hcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH----
Confidence            875433  2356789999999999987 689999999999999999999999998766544333322211 11111    


Q ss_pred             hhhhcCc-------ccCC-------CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDP-------RLKC-------TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~-------~l~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      -..++..       ++..       +...+....-+++++..||+.||.+|++-++++.
T Consensus       225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111111       0110       1112233446789999999999999999999885

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=323.53  Aligned_cols=237  Identities=27%  Similarity=0.394  Sum_probs=205.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||.|+||.|.+++.+.+|..+|+|++++..   ....+...+|..+|+.+.||+++++++.+.+.+ .+|+|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-NLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-eEEEE
Confidence            57899999999999999999999999999999998763   334556789999999999999999999887754 58999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||++||.|..++.+.       .++++..++-++.||+.||+|||+..   |++|||||+|||||.+|.+||+|||+|+
T Consensus       123 meyv~GGElFS~Lrk~-------~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKS-------GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             EeccCCccHHHHHHhc-------CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceE
Confidence            9999999999999886       46999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .....     +-+.+||+.|+|||++....+..++|.|||||++|||+.|.+||..+++..                 ..
T Consensus       193 ~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-----------------iY  250 (355)
T KOG0616|consen  193 RVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-----------------IY  250 (355)
T ss_pred             EecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-----------------HH
Confidence            87543     357899999999999999999999999999999999999999999876521                 34


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCC
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR  332 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~R  332 (398)
                      .+++...+..+.+....++.|   +...|+.|-.+|
T Consensus       251 ~KI~~~~v~fP~~fs~~~kdL---l~~LL~vD~t~R  283 (355)
T KOG0616|consen  251 EKILEGKVKFPSYFSSDAKDL---LKKLLQVDLTKR  283 (355)
T ss_pred             HHHHhCcccCCcccCHHHHHH---HHHHHhhhhHhh
Confidence            556666666665555554444   456778888777

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-45  Score=366.60  Aligned_cols=263  Identities=27%  Similarity=0.438  Sum_probs=212.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      ..+....+.||+|.||.||+|...     .....||||.++..... ..++|.+|++++..++|||||+++|+|.+++. 
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P-  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP-  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe-
Confidence            345566778999999999999863     23467999999876554 77899999999999999999999999998655 


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGV-------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~-------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      .++|+|||..|+|.+||.......       ....+|+..+.+.||.|||.|+.||-++.   .|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            799999999999999998642211       01345899999999999999999999888   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHH
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  284 (398)
                      .+||+|||+++.....+.........-.++|||||.+..+++|.+||||||||+|||+++ |+.|+.+-..++.      
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------  714 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------  714 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH------
Confidence            999999999997655443322223345778999999999999999999999999999998 9999987654432      


Q ss_pred             hhHHHhhchhhhhhhcCcc-cCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          285 AKPILHRGMAAVEELLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                                 +..+-+.+ |.++..++.+   +..|+..||+.+|++||+++||-..|+..
T Consensus       715 -----------Ie~i~~g~lL~~Pe~CP~~---vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  715 -----------IECIRAGQLLSCPENCPTE---VYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             -----------HHHHHcCCcccCCCCCCHH---HHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                       11122222 3445445555   55566789999999999999999999863

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-45  Score=341.13  Aligned_cols=269  Identities=21%  Similarity=0.316  Sum_probs=210.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~l  135 (398)
                      .+.|...++||+|.||.||+|++..+|+.||+|++..+.  .....-..+|+.+|++++||||++|.+...+. ...+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356777889999999999999999999999999997654  44555678999999999999999999988776 457999


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |+|||++ +|.-++....      ..+++.++..++.|++.||+|||+.+   |+|||||.+|||||++|.+||+|||||
T Consensus       196 VFeYMdh-DL~GLl~~p~------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPG------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             EEecccc-hhhhhhcCCC------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccce
Confidence            9999966 8988887642      56999999999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-----HHH
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PIL  289 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-----~~~  289 (398)
                      +++...... ..+..+-|.+|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+.+.-++...+....     ..|
T Consensus       266 r~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  266 RFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            987765432 24667789999999999875 79999999999999999999999999876544333322111     001


Q ss_pred             hhchhhhh--hhcCcccCCCCCCH----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVE--ELLDPRLKCTSRNS----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~--~~~d~~l~~~~~~~----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...  .+.  ..+.+.........    ......++|+..+|..||.+|.|+.++++
T Consensus       345 ~~~--kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  345 PVS--KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccc--cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            000  000  11111111000000    11234577888899999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-44  Score=334.10  Aligned_cols=258  Identities=21%  Similarity=0.301  Sum_probs=201.8

Q ss_pred             cccCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh---hHHHHHHHHHHHHhCCCCCeeceee
Q 015931           48 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---SSKAFCRELMIASSLHHPNIVPLVG  124 (398)
Q Consensus        48 ~~~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~  124 (398)
                      ..++..++     +......||+|++|.||+|.+.  |+.||||.+......   ..+.|.+|+.++.+++||||++++|
T Consensus        13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             eecCHHHc-----CCCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            34455554     3333468999999999999984  789999999765332   2567889999999999999999999


Q ss_pred             EEEc--C-CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEE
Q 015931          125 FCID--P-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNIL  200 (398)
Q Consensus       125 ~~~~--~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIl  200 (398)
                      ++.+  . ...+++||||+++|+|.+++...       ..++|.....++.|++.||.|||+. +   ++||||||+||+
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nil  155 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFL  155 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEE
Confidence            9876  2 23578999999999999999764       4589999999999999999999974 5   889999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc--CCcCCccchhhHHHHHHHHHcCCCCCcccccccc
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE  278 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~  278 (398)
                      +++++.+||+|||+++......     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...+..+ 
T Consensus       156 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-  229 (283)
T PHA02988        156 VTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-  229 (283)
T ss_pred             ECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-
Confidence            9999999999999998654332     23458899999999976  678999999999999999999999998643221 


Q ss_pred             hhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          279 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                        +..   ...       ..  ..+...+...   ...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       230 --~~~---~i~-------~~--~~~~~~~~~~---~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        230 --IYD---LII-------NK--NNSLKLPLDC---PLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             --HHH---HHH-------hc--CCCCCCCCcC---cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence              100   000       00  0111111112   23466777899999999999999999998754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=332.38  Aligned_cols=264  Identities=25%  Similarity=0.370  Sum_probs=207.8

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ....|.....||.|..++||+|.....++.||||++..+... ....+.+|+..++.++||||++++..|... ..+|+|
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-~~LWvV  102 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-SELWVV  102 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-ceeEEe
Confidence            346888999999999999999999888999999999865433 357899999999999999999999887764 459999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |.||.+||+.+.+.....     ..+++..+..|..++++||.|||.+|   .||||||+.||||+.+|.+||+|||.+-
T Consensus       103 mpfMa~GS~ldIik~~~~-----~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP-----DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc-----ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence            999999999999988653     45999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCCceee--eccccCCCcccchhhcc--CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          217 WTSAPSVPFLC--KTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       217 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      .+.........  .+.+||+.|||||++..  ..|+.|+||||||++..||.+|..||....+-..  +..    .++..
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~----tLqn~  248 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLL----TLQND  248 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHH----HhcCC
Confidence            65443322211  45689999999999653  3689999999999999999999999986543211  110    00000


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         .....-..+. ..........+.+++..||+.||.+|||+.++++
T Consensus       249 ---pp~~~t~~~~-~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  249 ---PPTLLTSGLD-KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ---CCCcccccCC-hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence               0000000000 0011122346778888899999999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=346.56  Aligned_cols=250  Identities=24%  Similarity=0.424  Sum_probs=211.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ..|.....||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+ .+|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-eLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-ELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-eeEEEEee
Confidence            46778889999999999999999899999999998876666677899999999999999999999877764 48999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      |+||+|.+.+..        ..+++.++..|+..+++||+|||.++   |+|||||.+|||++.++.+||+|||++..+.
T Consensus       352 m~ggsLTDvVt~--------~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  352 MEGGSLTDVVTK--------TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             cCCCchhhhhhc--------ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            999999999976        35999999999999999999999988   9999999999999999999999999998877


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ...+.+||+.|||||+.....|++|.||||||++++||+-|.+||-..++-...      +        .+...
T Consensus       421 ~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------y--------LIa~n  484 (550)
T KOG0578|consen  421 EEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------Y--------LIATN  484 (550)
T ss_pred             cccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------H--------HHhhc
Confidence            6543  235678999999999999999999999999999999999999999764432111      1        12222


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      -.|.++.+...+.++++|   +.+||..|+.+||++.|+|+
T Consensus       485 g~P~lk~~~klS~~~kdF---L~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  485 GTPKLKNPEKLSPELKDF---LDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCCCcCCccccCHHHHHH---HHHHhhcchhcCCCHHHHhc
Confidence            234444444444555554   55799999999999999997

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2e-44  Score=349.52  Aligned_cols=264  Identities=24%  Similarity=0.391  Sum_probs=202.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||.||+|....     ++..||+|++.... ......+.+|+++++.+ +|+||++++++|...+ 
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~-  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG-  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence            4579999999999999999998533     33579999997543 33456788999999999 8999999999987754 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccC--------------------------------------------------------
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKG--------------------------------------------------------  155 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  155 (398)
                      ..++||||+++|+|.+++......                                                        
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            589999999999999998653210                                                        


Q ss_pred             -------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeee
Q 015931          156 -------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK  228 (398)
Q Consensus       156 -------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  228 (398)
                             .....++++..+++++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                   001235889999999999999999999888   9999999999999999999999999998654433222222


Q ss_pred             ccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCC
Q 015931          229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCT  307 (398)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  307 (398)
                      ...++..|+|||++.+..++.++|||||||++|||++ |+.||........  ..    ..       +.....+.  .+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~-------~~~~~~~~--~~  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KM-------VKRGYQMS--RP  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HH-------HHcccCcc--CC
Confidence            3345678999999988899999999999999999997 9999976432210  00    00       00101111  11


Q ss_pred             CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          308 SRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       308 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...   ...+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus       338 ~~~---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         338 DFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111   2356777789999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.6e-45  Score=343.88  Aligned_cols=247  Identities=29%  Similarity=0.478  Sum_probs=209.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||.||||+.+.+.+.||+|.+.+..  ....+.+.+|+++++.++|||||.++++|.. ...+++|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence            57888889999999999999999999999999998753  3456778999999999999999999998755 55589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+.| +|..++...       ..++++.+..|+.+++.||.|||+++   |+|||+||.|||++.++.+|+||||+|+.
T Consensus        81 e~a~g-~L~~il~~d-------~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQD-------GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             hhhhh-hHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhh
Confidence            99966 999999875       56999999999999999999999988   99999999999999999999999999998


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      +....  ...+...||+-|||||...+..|+..+|.||+||++|||.+|++||......      .           .+.
T Consensus       150 m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~------~-----------Lv~  210 (808)
T KOG0597|consen  150 MSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT------Q-----------LVK  210 (808)
T ss_pred             cccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH------H-----------HHH
Confidence            76543  3557789999999999999999999999999999999999999999864321      1           122


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+.......   .+.....+..++...|.+||.+|.|..+++.
T Consensus       211 ~I~~d~v~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  211 SILKDPVKP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHhcCCCCC---cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            222222221   2234455677777899999999999999986

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-44  Score=340.03  Aligned_cols=248  Identities=26%  Similarity=0.348  Sum_probs=200.8

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ..++|...++||+|+||.||+|+-+++|..+|+|++++..   ......+..|-.+|...++|+||+|+-.|.+. .++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-EYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-CeeE
Confidence            4589999999999999999999999999999999998764   34456678999999999999999999877664 5699


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      |||||++||++..+|...       ..|++..+..++.+++.|+..+|+.|   +|||||||+|+|||..|++||+||||
T Consensus       218 LiMEylPGGD~mTLL~~~-------~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRK-------DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             EEEEecCCccHHHHHHhc-------CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccc
Confidence            999999999999999875       57999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCC----------------------CCCc-----ee------------------eeccccCCCcccchhhccCCcCC
Q 015931          215 ATWTSA----------------------PSVP-----FL------------------CKTVKGTFGYLAPEYFQHGKVSD  249 (398)
Q Consensus       215 a~~~~~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~s~  249 (398)
                      +.-+..                      .+..     ..                  ....+|||.|+|||++.+..|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            852211                      0000     00                  02346999999999999999999


Q ss_pred             ccchhhHHHHHHHHHcCCCCCcccccccchh-HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhccccc
Q 015931          250 KTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSE  328 (398)
Q Consensus       250 ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~  328 (398)
                      .+|+||||||+||||.|.+||...++.+... ++.|...                +..+. ......+..+|+++|+. |
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~----------------l~fP~-~~~~s~eA~DLI~rll~-d  429 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET----------------LKFPE-EVDLSDEAKDLITRLLC-D  429 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh----------------ccCCC-cCcccHHHHHHHHHHhc-C
Confidence            9999999999999999999999988764322 2222111                11111 11111445666777888 9


Q ss_pred             CCCCCC
Q 015931          329 ESRRPG  334 (398)
Q Consensus       329 p~~RPt  334 (398)
                      |.+|..
T Consensus       430 ~~~RLG  435 (550)
T KOG0605|consen  430 PENRLG  435 (550)
T ss_pred             HHHhcC
Confidence            999976

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.1e-43  Score=332.98  Aligned_cols=268  Identities=26%  Similarity=0.359  Sum_probs=202.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCC----------------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeece
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL----------------LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPL  122 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  122 (398)
                      ++|...+.||+|+||.||++.+..                .+..||+|.+.... ......|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                23479999987653 3445679999999999999999999


Q ss_pred             eeEEEcCCCcEEEEEecCCCCCHHHHHhhhccC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015931          123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVV  190 (398)
Q Consensus       123 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iv  190 (398)
                      ++++.+.+ ..++||||+++|+|.+++......            ......++|..++.++.|++.||.|||+.+   |+
T Consensus        85 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          85 LGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99987754 489999999999999998653211            011235789999999999999999999988   99


Q ss_pred             ecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc--CCC
Q 015931          191 HRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRK  268 (398)
Q Consensus       191 HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt--G~~  268 (398)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986644332222233456788999999988899999999999999999987  556


Q ss_pred             CCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          269 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       269 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ||.......   ............   ....   ....+   +.....+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus       241 p~~~~~~~~---~~~~~~~~~~~~---~~~~---~~~~~---~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQ---VIENAGEFFRDQ---GRQV---YLFRP---PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHH---HHHHHHHHhhhc---cccc---cccCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776533211   111111111110   0000   00001   112245778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-43  Score=344.28  Aligned_cols=264  Identities=24%  Similarity=0.406  Sum_probs=202.5

Q ss_pred             hcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  131 (398)
                      .++|+..+.||+|+||.||+|..     ..++..||||++.... ....+.+.+|+.++..+ +||||++++++|.+.+ 
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~-  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG-  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence            45789999999999999999974     3456689999997542 33456788999999999 8999999999987755 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCC-------------------------------------------------------
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGV-------------------------------------------------------  156 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------  156 (398)
                      ..++||||+++|+|.+++.......                                                       
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            4799999999999999997532100                                                       


Q ss_pred             -------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC
Q 015931          157 -------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  223 (398)
Q Consensus       157 -------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  223 (398)
                                   .....++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                         01235899999999999999999999888   99999999999999999999999999986644322


Q ss_pred             ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCc
Q 015931          224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  302 (398)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  302 (398)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ....    ....+       ..+
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~~-------~~~  336 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKEG-------YRM  336 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHhC-------ccC
Confidence            111222345678999999999899999999999999999998 888986543211  1111    01110       000


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          303 RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       303 ~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .  .+...   ...+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       337 ~--~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         337 L--SPECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             C--CCCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            0  01111   2356778889999999999999999999974

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-45  Score=346.35  Aligned_cols=267  Identities=29%  Similarity=0.447  Sum_probs=209.3

Q ss_pred             CHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc
Q 015931           51 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCID  128 (398)
Q Consensus        51 ~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  128 (398)
                      +.++.....+.+.....||+|.||+||+|.+-.   .||||++...  ..+..+.|.+|+..+++-+|.||+-+.|||..
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            334455555667788899999999999999863   5999999865  34567889999999999999999999999987


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCee
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  208 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  208 (398)
                      +.  ..||+.+|+|-+|..+++...      ..++..+.+.|+.|+|+|+.|||.++   |||||||+.||||.+++.+|
T Consensus       460 p~--~AIiTqwCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  460 PP--LAIITQWCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             Cc--eeeeehhccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEE
Confidence            65  489999999999999998764      56899999999999999999999988   99999999999999999999


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhcc---CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  285 (398)
                      |+|||++..-.............|...|||||++..   .+|++.+||||||+|+|||+||..||...+.+..    .|+
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----ifm  604 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----IFM  604 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----EEE
Confidence            999999864433222222334568889999999964   3789999999999999999999999984433221    111


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                           .+    +..+.+++..  ......+.+.+|+..||.+++++||.+.+|+..|+...
T Consensus       605 -----VG----rG~l~pd~s~--~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  605 -----VG----RGYLMPDLSK--IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             -----ec----ccccCccchh--hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence                 01    1111122210  11223334555666799999999999999999887653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.3e-44  Score=310.12  Aligned_cols=269  Identities=22%  Similarity=0.322  Sum_probs=209.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh--hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .+|...+.||+|.||.||+|++..+|+.||||++......  ......+|+..|+.++|+||+.+++++...++ +.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~-l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN-LSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc-eEEEE
Confidence            3577788999999999999999999999999999865332  23467899999999999999999998877554 88999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||| ..+|+..++...      ..++...+..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+|+.
T Consensus        81 Efm-~tdLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   81 EFM-PTDLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             Eec-cccHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhc
Confidence            999 559999998764      57899999999999999999999998   99999999999999999999999999999


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh--hHHHhhchh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA--KPILHRGMA  294 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~  294 (398)
                      +..+....  +..+-|.+|.|||.+.+. .|+...|+||.||++.||+-|.+-|.+.+.-++...+-.+  .+...++.+
T Consensus       151 f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  151 FGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             cCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence            88765433  334789999999998875 6899999999999999999988888776543332222111  011111110


Q ss_pred             --hhhhhcC----cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          295 --AVEELLD----PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       295 --~~~~~~d----~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                        .+.+...    |.-......+....+.++++..++..||.+|+|+.|++++
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence              0111111    1111111223445567899999999999999999999874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4e-43  Score=328.13  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=199.7

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .|...+.||+|+||.||+|....+++.||+|.+....   ......+.+|+.++..++|+||+++++++.+. +..++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-CeEEEEE
Confidence            3677889999999999999998889999999987542   22334678999999999999999999987665 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++|+|..++....     ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..
T Consensus        80 e~~~~g~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          80 TIMNGGDLKFHIYNMG-----NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             EecCCCcHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            9999999998886532     146899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......   .....||..|+|||++.+..++.++|||||||++|||++|+.||............             ..
T Consensus       152 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-------------~~  215 (285)
T cd05631         152 IPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV-------------DR  215 (285)
T ss_pred             cCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH-------------HH
Confidence            543221   23456899999999999999999999999999999999999999865432111000             00


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                      .+.........   .....+.+++.+||+.+|.+||+     +.++++
T Consensus       216 ~~~~~~~~~~~---~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         216 RVKEDQEEYSE---KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HhhcccccCCc---cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            01111111111   12235667778999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-45  Score=337.90  Aligned_cols=269  Identities=22%  Similarity=0.293  Sum_probs=213.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||.|.||.||+|+...++..||||+.+..-. .....=++|+..|++++ |||||++.+++.+.+..+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            3578888999999999999999999999999999875422 12223368999999999 999999999999887679999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||| ..+|.++++.+.      ..++++.++.|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+
T Consensus        89 fE~M-d~NLYqLmK~R~------r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             HHhh-hhhHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence            9999 669999998874      67999999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhc-cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh-----hHHHh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----KPILH  290 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~-----~~~~~  290 (398)
                      ......   ..+..+.|.+|.|||++. .+.|+.+.|+||+|||++|+.+-++-|.+.+..++...+.-+     +..+.
T Consensus       159 ev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  159 EVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             ccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            776543   235678999999999886 467899999999999999999999999876654433222211     11122


Q ss_pred             hchhhhhhhcCcccCCC------CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          291 RGMAAVEELLDPRLKCT------SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ++. .+...+.-++..-      .-.+....+.++++.+|+..||.+|||+.+.++.
T Consensus       236 eg~-~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  236 EGY-NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hHH-HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            211 1222222222110      0112245678889999999999999999999984

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-44  Score=365.14  Aligned_cols=265  Identities=28%  Similarity=0.438  Sum_probs=214.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCc-----EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRT-----SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .+....+.||+|.||.||.|...+...     .||||.+... +.+...+|.+|..+++.++|||||+++|+|.+. ...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-GPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-CCc
Confidence            455667899999999999999864333     3999999765 456778999999999999999999999999994 447


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      +|++|||++|+|..+|.+......+...+.....+.++.|||+|++||++++   .|||||..+|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            8999999999999999987544445677999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +|+.+...+.......-.-...|||||.+..+.+|.|+|||||||++||++| |..||...+..+....           
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-----------  916 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-----------  916 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-----------
Confidence            9995544332211111123467999999999999999999999999999999 9999987654332111           


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                           -.-..+|..+.++++.   +.+++.+||+.+|++||++..|++.+..+..
T Consensus       917 -----~~~ggRL~~P~~CP~~---ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  917 -----VLEGGRLDPPSYCPEK---LYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             -----HHhCCccCCCCCCChH---HHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                 1112255555555554   4577788999999999999999998776543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-43  Score=337.25  Aligned_cols=245  Identities=28%  Similarity=0.410  Sum_probs=200.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++.+++||||+++++++.+. +..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-CEEEEE
Confidence            57888899999999999999999889999999997532   23446688999999999999999999987765 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        97 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             EcCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCce
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ..
T Consensus       167 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----------------~~  224 (329)
T PTZ00263        167 KVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-----------------IY  224 (329)
T ss_pred             EcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-----------------HH
Confidence            664332     23569999999999998889999999999999999999999997543211                 01


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                      ..+....+..+...+   ..+.+++.+||+.||.+||+     +.++++
T Consensus       225 ~~i~~~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        225 EKILAGRLKFPNWFD---GRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHHhcCCcCCCCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            111122222222222   34567778999999999997     677775

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=331.66  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=200.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|....+++.||+|++....   ......+.+|+++++.++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-RFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-CeEEEE
Confidence            36888999999999999999999889999999996532   23455688999999999999999999987664 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~  149 (291)
T cd05612          80 MEYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK  149 (291)
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcch
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||........                 .
T Consensus       150 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-----------------~  207 (291)
T cd05612         150 KLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-----------------Y  207 (291)
T ss_pred             hccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------------H
Confidence            664322     235689999999999988899999999999999999999999976432210                 1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIAI  341 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~~  341 (398)
                      ..+.......+...   ...+.+++.+||+.||.+||+     +.++++.
T Consensus       208 ~~i~~~~~~~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         208 EKILAGKLEFPRHL---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHHHhCCcCCCccC---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            11111111111112   234567778999999999995     8877753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.5e-43  Score=334.39  Aligned_cols=242  Identities=26%  Similarity=0.349  Sum_probs=195.1

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      +.||+|+||.||++....+++.||+|++...   .......+.+|+.++.+++||||+++++++... ...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-DRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-CEEEEEEeCCCC
Confidence            4799999999999999888999999999753   223445678899999999999999999987664 458999999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          80 GELFFHLSRE-------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            9999998764       45899999999999999999999988   9999999999999999999999999987532221


Q ss_pred             CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCc
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  302 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  302 (398)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +              ...+...
T Consensus       150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~--------------~~~~~~~  210 (323)
T cd05571         150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L--------------FELILME  210 (323)
T ss_pred             C--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---H--------------HHHHHcC
Confidence            1  1234679999999999998899999999999999999999999997543211   0              0111111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          303 RLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       303 ~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ....+...+   ..+.+++.+||+.||++||     ++.++++
T Consensus       211 ~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 EIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCCC---HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            111122222   3456677889999999999     7998876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.3e-43  Score=332.11  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=203.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|.+.... ....+.+.+|+.+++.++||||++++|+|...  ..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cce
Confidence            578999999999999999998755454    48999987543 34567789999999999999999999998764  357


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +|+||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        85 ~v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccc
Confidence            9999999999999998643      45899999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ...    ..    
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~----  224 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----IL----  224 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HH----
Confidence            987654433222223345678999999999999999999999999999998 999997543211   000    00    


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                         ..  ...+..+.   .....+.+++.+||+.+|.+||++.+++..|...
T Consensus       225 ---~~--~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         225 ---EK--GERLPQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             ---hC--CCCCCCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               00  00111111   1223567788899999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-42  Score=332.36  Aligned_cols=202  Identities=30%  Similarity=0.447  Sum_probs=176.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||.||++.+..++..||+|.+... .......+.+|++++.+++||||+++++++.+. +..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEe
Confidence            36899999999999999999999988999999999765 334456799999999999999999999988764 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+  +|+||||||+||+++.++.+||+|||++..
T Consensus        83 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          83 EHMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            999999999999764       35899999999999999999999742  299999999999999999999999999876


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      .....    .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             ccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            54322    234568999999999998899999999999999999999999997543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.2e-43  Score=324.85  Aligned_cols=262  Identities=29%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCC-----cEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      ++|+..+.||+|+||.||+|.....+     ..||+|.+.... ......|.+|+.++..++||||+++++++.+. ...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-QPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-Cce
Confidence            46888899999999999999875444     679999987543 34456789999999999999999999987764 457


Q ss_pred             EEEEecCCCCCHHHHHhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      +++|||+++++|.+++.......         .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            99999999999999997642210         01146899999999999999999999988   9999999999999999


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHH
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL  283 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~  283 (398)
                      +.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+   ...
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999986543332222233456788999999988899999999999999999998 999997644321   110


Q ss_pred             HhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       284 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                                    .+......  .........+.+++.+||+.+|.+||++.+|++.|++
T Consensus       238 --------------~i~~~~~~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 --------------MIRSRQLL--PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --------------HHHcCCcC--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                          01011110  0111223456777889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-43  Score=336.60  Aligned_cols=253  Identities=24%  Similarity=0.281  Sum_probs=202.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+..+++.||+|++....   ......+..|++++..++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-EYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-CEEEEE
Confidence            36888999999999999999999889999999997542   23456688999999999999999999987764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~  149 (333)
T cd05600          80 MEYVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK  149 (333)
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.........       ..    
T Consensus       150 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~~----  213 (333)
T cd05600         150 GIVTY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK-------YW----  213 (333)
T ss_pred             ccccc-----cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH-------hc----
Confidence            65431     234569999999999998899999999999999999999999997654322111000       00    


Q ss_pred             hhhc-CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          297 EELL-DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       297 ~~~~-d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ...+ .+....+  .......+.+++.+||..+|.+||++.++++.
T Consensus       214 ~~~~~~~~~~~~--~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         214 KETLQRPVYDDP--RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccccCCCCCcc--ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0001 1111000  01123456677788999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.9e-43  Score=322.72  Aligned_cols=256  Identities=23%  Similarity=0.370  Sum_probs=200.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeC---CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|+..+.||+|+||.||+|.+.   ..+..||+|.+.... ......+.+|+..+.+++||||+++++++... ...+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCcE
Confidence            357888999999999999999864   345689999997653 33456789999999999999999999988764 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.
T Consensus        83 lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence            9999999999999997642      46899999999999999999999888   99999999999999999999999998


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||......+   ...          
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~----------  219 (266)
T cd05064         154 LQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK----------  219 (266)
T ss_pred             cccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----------
Confidence            765432211 11112335678999999998999999999999999999775 999997543221   100          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                       .+.+...  ...+   ......+.+++.+||+.+|.+||++.+|++.|..
T Consensus       220 -~~~~~~~--~~~~---~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         220 -AVEDGFR--LPAP---RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -HHHCCCC--CCCC---CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence             0111101  1111   1223456777889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.2e-43  Score=334.04  Aligned_cols=264  Identities=27%  Similarity=0.410  Sum_probs=205.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      ++|...++||+|+||.||+|....     +++.||+|++.... ....+.+..|++++.++ +|+||++++++|...+..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            578889999999999999997532     34789999987543 33456788899999999 899999999998877777


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCC------------------------------------------------------CC
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGV------------------------------------------------------RG  158 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~------------------------------------------------------~~  158 (398)
                      ++++|||+++++|.+++.......                                                      ..
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            899999999999999986532100                                                      00


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCccc
Q 015931          159 NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA  238 (398)
Q Consensus       159 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  238 (398)
                      ...++|..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++..+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            136899999999999999999999888   99999999999999999999999999987643322222223456778999


Q ss_pred             chhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHH
Q 015931          239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARV  317 (398)
Q Consensus       239 PE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l  317 (398)
                      ||++.+..++.++|||||||++|||++ |..||......+.  +    ...       +.....+..  +   ......+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~----~~~-------~~~~~~~~~--~---~~~~~~~  305 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F----CRR-------LKEGTRMRA--P---EYATPEI  305 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H----HHH-------HhccCCCCC--C---ccCCHHH
Confidence            999999999999999999999999998 9999975332210  0    000       111000000  1   1123457


Q ss_pred             HHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          318 IQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       318 ~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .+++.+||+.+|++||++.||++.|+.
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            788899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=331.20  Aligned_cols=240  Identities=25%  Similarity=0.372  Sum_probs=191.8

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ||+|+||.||+|....+++.||+|.+...   .......+..|+.++.+++||||+++++++.+. +..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCc
Confidence            69999999999999988999999999643   233456688999999999999999999987764 45899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        80 L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  148 (312)
T cd05585          80 LFHHLQRE-------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-  148 (312)
T ss_pred             HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-
Confidence            99999764       45899999999999999999999988   99999999999999999999999999875432221 


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCccc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  304 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  304 (398)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..           ...+.....
T Consensus       149 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~-----------~~~~~~~~~  210 (312)
T cd05585         149 -KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EM-----------YRKILQEPL  210 (312)
T ss_pred             -ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HH-----------HHHHHcCCC
Confidence             223467999999999999889999999999999999999999999754321      11           111111122


Q ss_pred             CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          305 KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       305 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+...+   ..+.+++.+||+.+|.+||+...+.+
T Consensus       211 ~~~~~~~---~~~~~li~~~L~~dp~~R~~~~~~~e  243 (312)
T cd05585         211 RFPDGFD---RDAKDLLIGLLSRDPTRRLGYNGAQE  243 (312)
T ss_pred             CCCCcCC---HHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence            2222222   34566778899999999986443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=339.03  Aligned_cols=260  Identities=32%  Similarity=0.493  Sum_probs=206.3

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCc---E-EEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRT---S-VAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  130 (398)
                      ..++....++||+|+||.||+|.+...+.   . ||||.....   ......+|.+|+++++.++|||||+++|++... 
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-  233 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-  233 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-
Confidence            34566667999999999999999864322   3 899998752   466778999999999999999999999998774 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ..+++|||+|+||+|.++|....      ..++..++..++.+.|.||+|||+.+   ++||||.++|+|++.++.+||+
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence            55899999999999999998864      35999999999999999999999998   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHH
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      |||+++.......  ......-...|+|||.+..+.++.++|||||||++||+++ |..||.+....+..      ..+.
T Consensus       305 DFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------~kI~  376 (474)
T KOG0194|consen  305 DFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------AKIV  376 (474)
T ss_pred             ccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH------HHHH
Confidence            9999875541110  0112235678999999999999999999999999999999 89999875433110      0000


Q ss_pred             hhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                             ..  ..+...+...+.++..+   +.+||..+|++||||.++.+.|+.+..
T Consensus       377 -------~~--~~r~~~~~~~p~~~~~~---~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  377 -------KN--GYRMPIPSKTPKELAKV---MKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             -------hc--CccCCCCCCCHHHHHHH---HHHhccCChhhccCHHHHHHHHHHHHh
Confidence                   11  12223334455555444   458999999999999999999986543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=328.66  Aligned_cols=257  Identities=26%  Similarity=0.343  Sum_probs=208.3

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------------hhHHHHHHHHHHHHhCCCCCeece
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------------ESSKAFCRELMIASSLHHPNIVPL  122 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l  122 (398)
                      +..++|...+.||+|.||.|-+|....+++.||||++.+...              ...+...+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345889999999999999999999999999999999976421              123578899999999999999999


Q ss_pred             eeEEEcCC-CcEEEEEecCCCCCHHHHHhhhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          123 VGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       123 ~~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                      +.+..++. ..+|||+|||..|.+...-..        .+ +++.++++++.+++.||+|||.++   ||||||||+|+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d--------~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLL  242 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD--------KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLL  242 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC--------cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheE
Confidence            99866554 458999999998887543222        33 899999999999999999999999   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCC---ceeeeccccCCCcccchhhccCC----cCCccchhhHHHHHHHHHcCCCCCccc
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSV---PFLCKTVKGTFGYLAPEYFQHGK----VSDKTDVYAFGVVLLELLTGRKPIEAR  273 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~Gvvl~elltG~~Pf~~~  273 (398)
                      |+++|++||+|||.+........   .......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.++
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            99999999999999986633211   11123467999999999987743    356899999999999999999999875


Q ss_pred             ccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      ...+                 ...+++...+..+. .++....+-+|+.++|.+||..|.++.+|....
T Consensus       323 ~~~~-----------------l~~KIvn~pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  323 FELE-----------------LFDKIVNDPLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             hHHH-----------------HHHHHhcCcccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            4321                 34556666776553 334556677788899999999999999998754

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-43  Score=335.56  Aligned_cols=253  Identities=26%  Similarity=0.375  Sum_probs=213.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+++|+|+||.++..+++.+++.|++|.+....  ....+....|+.++++++|||||.+.+.+.+.+..++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999999989999999997653  3334567899999999999999999999888776689999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      +||+||+|.+.+...+.     ..++++.+..++.|++.|+.|||++.   |+|||||+.|||++.+..+||+|||+|+.
T Consensus        84 ~Y~eGg~l~~~i~~~k~-----~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG-----VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eecCCCCHHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhh
Confidence            99999999999988753     56899999999999999999999877   99999999999999999999999999999


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      +.....  ...++.||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+...   +              +.
T Consensus       156 l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---L--------------i~  216 (426)
T KOG0589|consen  156 LNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---L--------------IL  216 (426)
T ss_pred             cCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---H--------------HH
Confidence            877642  3457889999999999999999999999999999999999999999866432   1              11


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ++.....  .+........+..++..|++.+|..||++.+++..
T Consensus       217 ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 KINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1211111  11222333445566678999999999999999985

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-42  Score=330.67  Aligned_cols=242  Identities=25%  Similarity=0.342  Sum_probs=194.4

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      +.||+|+||.||++....++..||+|++...   .......+.+|+.++..++||||+++++++... ...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCC
Confidence            4799999999999999888999999999753   223445678899999999999999999987664 458999999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |+|..++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          80 GELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            9999888754       45899999999999999999999988   9999999999999999999999999987532222


Q ss_pred             CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCc
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  302 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  302 (398)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....                 ...+...
T Consensus       150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----------------~~~~~~~  210 (323)
T cd05595         150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----------------FELILME  210 (323)
T ss_pred             C--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHhcC
Confidence            1  12345699999999999988999999999999999999999999975432210                 1111111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          303 RLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       303 ~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ....+...+   ..+.+++.+||+.+|.+||     ++.++++
T Consensus       211 ~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         211 EIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCCC---HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            111111222   3456677789999999998     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-43  Score=324.04  Aligned_cols=249  Identities=35%  Similarity=0.569  Sum_probs=192.0

Q ss_pred             CceecccCceEEEEeeeC----CCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           65 GRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+.||.|.||.||+|.+.    ..+..|+||.+... .......|.+|++.+++++||||++++|+|...+. .++|+||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-LFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-EEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-ccccccc
Confidence            468999999999999987    34578999999654 33457889999999999999999999999995444 8999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|.+++.....     ..+++..++.|+.|+++||.|||+.+   ++|+||+++||++++++.+||+|||++....
T Consensus        83 ~~~g~L~~~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNK-----EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             -TTEBHHHHHHHTCT-----TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccccc-----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            999999999998622     56999999999999999999999988   9999999999999999999999999998774


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ............+...|+|||.+....++.++||||||+++|||++ |+.||.......      ..           ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~-----------~~  217 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------II-----------EK  217 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HH-----------HH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cc-----------cc
Confidence            3332222334557788999999998889999999999999999999 788886542211      11           11


Q ss_pred             hcCcc-cCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          299 LLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       299 ~~d~~-l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      +.+.. ...+...   ...+.+++..||+.+|.+|||+.+|++.|
T Consensus       218 ~~~~~~~~~~~~~---~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  218 LKQGQRLPIPDNC---PKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHTTEETTSBTTS---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccccceeccch---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11111 1111112   23466778899999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.5e-43  Score=347.98  Aligned_cols=254  Identities=23%  Similarity=0.312  Sum_probs=203.3

Q ss_pred             CCCCCceecccCceEEEEeeeCCC-CcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLL-RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .|...+.||+|+||.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++... +..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEEC
Confidence            488889999999999999988766 778999988666555566788999999999999999999998765 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|.+++.....   ...++++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       147 ~~gg~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        147 GSGGDLNKQIKQRLK---EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             CCCCCHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999998865321   1256899999999999999999999888   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ............||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .           +..+
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~-----------~~~~  283 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------I-----------MQQV  283 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------H-----------HHHH
Confidence            4332222345679999999999998899999999999999999999999997543211      0           1111


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ......  .........+.+++..||+.+|++||++.+++.
T Consensus       284 ~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        284 LYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HhCCCC--CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            111110  001112234677788999999999999999875

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=304.46  Aligned_cols=250  Identities=28%  Similarity=0.433  Sum_probs=209.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|..++.||+|-||.||.|+.+.++-.||+|++.+..   .+...++.+|+++-+.++||||+++++|+.+. ..+||
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-KRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-ceeEE
Confidence            368999999999999999999999999999999997652   33456789999999999999999999998875 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ++||.++|+|...|.....     ..+++.....++.|+|.||.|+|..+   |+||||||+|+|++..+.+|++|||.+
T Consensus       100 ilEya~~gel~k~L~~~~~-----~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM-----KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             EEEecCCchHHHHHHhccc-----ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCce
Confidence            9999999999999986432     56888999999999999999999888   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ...+.+.    ..+.+||..|++||...+...+.+.|+|++|++.||++.|.+||......+                 .
T Consensus       172 V~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-----------------t  230 (281)
T KOG0580|consen  172 VHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-----------------T  230 (281)
T ss_pred             eecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-----------------H
Confidence            7654322    256789999999999999999999999999999999999999998755221                 1


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ..++..-++..+...+.   ...+++..|+..+|.+|.+..||+..
T Consensus       231 YkrI~k~~~~~p~~is~---~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  231 YKRIRKVDLKFPSTISG---GAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHHHccccCCcccCh---hHHHHHHHHhccCccccccHHHHhhh
Confidence            22233333333322333   35566788999999999999999874

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-42  Score=325.14  Aligned_cols=268  Identities=23%  Similarity=0.305  Sum_probs=200.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||.||+|.++.+++.||+|++....  ......+.+|+++++.++||||+++++++... +..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-GKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-CEEEEEE
Confidence            46888999999999999999999889999999987542  23456788999999999999999999987664 5589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||++++.+..+....       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848          80 EYVEKNMLELLEEMP-------NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             ecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            999887776554322       45899999999999999999999888   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh-hHH-------H
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-KPI-------L  289 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~-~~~-------~  289 (398)
                      ....... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+........ .+.       .
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         150 LSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             ccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence            6433211 123456899999999999888999999999999999999999999765432211111000 000       0


Q ss_pred             hhchhhhhhhcCcccCCCCC-----CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTSR-----NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .... .......+.......     .......+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         229 YSNP-RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hccc-hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000 000000010000000     0012245788889999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-42  Score=318.05  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=203.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCC---CcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|+..+.||+|+||+||+|.+...   ...||+|.+.... ......|.+|+.++..++||||+++++++.+. ...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-RPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-CceE
Confidence            35788999999999999999988543   4579999987543 34456789999999999999999999987664 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||+
T Consensus        82 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          82 IITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             EEEEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence            9999999999999997642      46899999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...          
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~----------  219 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIK----------  219 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHH----------
Confidence            987753322222223345678999999998889999999999999999998 999986432211   100          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                       .+....  ....+   ......+.+++.+||+.+|++||++.+|++.|+.
T Consensus       220 -~~~~~~--~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         220 -AVEDGY--RLPPP---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             -HHHcCC--CCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence             011000  00101   1123456788889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-42  Score=329.49  Aligned_cols=243  Identities=26%  Similarity=0.350  Sum_probs=195.0

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      ++||+|+||.||++....+++.||+|++...   .......+.+|+.+++.++||||+++++++... ...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-DRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CEEEEEEeCCCC
Confidence            4699999999999999888999999999754   233456788999999999999999999887664 458999999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          80 GELFFHLSRE-------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence            9999888653       45899999999999999999999988   9999999999999999999999999987543221


Q ss_pred             CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCc
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  302 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  302 (398)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........                 ...+...
T Consensus       150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-----------------~~~~~~~  210 (328)
T cd05593         150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----------------FELILME  210 (328)
T ss_pred             c--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-----------------HHHhccC
Confidence            1  12345799999999999988999999999999999999999999975432110                 0011111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 015931          303 RLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIAI  341 (398)
Q Consensus       303 ~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  341 (398)
                      ....+...+   ..+.+++.+||+.+|.+||     ++.++++.
T Consensus       211 ~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 DIKFPRTLS---ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CccCCCCCC---HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            111111122   3456777889999999997     89988863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-42  Score=348.14  Aligned_cols=263  Identities=26%  Similarity=0.352  Sum_probs=207.6

Q ss_pred             HHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           54 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        54 e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      +.....++|...+.||+|+||+||+|....+++.||||++...  .......+.+|+..+..++|+|++++...+...+.
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            3444568999999999999999999999888999999998754  34455678899999999999999999876543221


Q ss_pred             -------cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          132 -------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       132 -------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                             .+++||||+++|+|.+++.....   ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~---~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSN  179 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCC
Confidence                   26799999999999999976432   2356899999999999999999999888   9999999999999999


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...+...      .
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~  253 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------V  253 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------H
Confidence            9999999999987654322222345679999999999999899999999999999999999999997543211      1


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .....       ....++ +  +..   ....+.+++.+||+.+|.+||++.++++.
T Consensus       254 ~~~~~-------~~~~~~-~--~~~---~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 MHKTL-------AGRYDP-L--PPS---ISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHh-------cCCCCC-C--CCC---CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11111       000111 1  111   22346677789999999999999999863

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-42  Score=325.13  Aligned_cols=268  Identities=24%  Similarity=0.347  Sum_probs=199.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||.|+||.||+|....++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-RCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEEe
Confidence            57888999999999999999998889999999997543 22345678999999999999999999987664 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ ++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        84 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          84 YLD-SDLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             CCC-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            996 59999886542      35789999999999999999999988   999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-----HHHhhc
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PILHRG  292 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-----~~~~~~  292 (398)
                      .....  ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.........     ..+...
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         154 SVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             cCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence            43221  1234568999999999865 468999999999999999999999997654432211111000     000000


Q ss_pred             h--hhhhhhcCcccCCCC---CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 M--AAVEELLDPRLKCTS---RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~--~~~~~~~d~~l~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .  ........+......   ........+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0  000011111110000   00011234678888999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.6e-42  Score=316.30  Aligned_cols=249  Identities=25%  Similarity=0.432  Sum_probs=196.0

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      +.||+|+||.||+|.+..+++.||+|.+... .......+.+|+++++.++||||++++++|...+ ..++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-CeEEEEeeccCCc
Confidence            3699999999999999888999999988654 3345567999999999999999999999987754 5899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        80 L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          80 FLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             HHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            999986532      45899999999999999999999888   999999999999999999999999998765432111


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR  303 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  303 (398)
                      .......++..|+|||.+.++.++.++||||||+++|||++ |..||........       ..       .+.....  
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~-------~~~~~~~--  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------RE-------AIEQGVR--  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HH-------HHHcCCC--
Confidence            11111223567999999998899999999999999999998 8888865332110       00       0111001  


Q ss_pred             cCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          304 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       304 l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ...+.   .....+.+++.+||+.+|.+|||+.+|+++|+
T Consensus       215 ~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPE---LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            11111   12345777888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=330.59  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=208.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ..|+....||+|.||.||+|.+..+++.||+|++..+. ......+..|+.+|.+++++||.++++.+..+. .++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-KLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-cHHHHHH
Confidence            46777889999999999999999999999999998763 345678899999999999999999999888754 4899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      ||.||++.+.+...       ..+++..+.-|+.+++.||.|||.++   .+|||||+.|||+..+|.+||+|||++..+
T Consensus        92 y~~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             HhcCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeee
Confidence            99999999999874       34578888889999999999999988   999999999999999999999999999887


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ......  ..+.+||+.|||||++....|+.|+||||||++.+||++|.+|+....+-....              .+.+
T Consensus       162 ~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------lIpk  225 (467)
T KOG0201|consen  162 TNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------LIPK  225 (467)
T ss_pred             echhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------eccC
Confidence            765433  257889999999999998899999999999999999999999998765522111              1222


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      -.-|.+..  ..+.   .+.+++..||+.+|+.||++.++++
T Consensus       226 ~~PP~L~~--~~S~---~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  226 SAPPRLDG--DFSP---PFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCCcccc--ccCH---HHHHHHHHHhhcCcccCcCHHHHhh
Confidence            23344432  2223   3555566799999999999999996

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.8e-42  Score=320.86  Aligned_cols=263  Identities=27%  Similarity=0.403  Sum_probs=203.9

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      .+++|...+.||+|+||.||+|.+..     .+..||+|.+.... ......|..|+.+++.++|+||+++++++.+.+ 
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence            35678999999999999999999876     67889999887543 334567899999999999999999999887755 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC---Cee
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPK  208 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~k  208 (398)
                      ..++||||+++++|.+++............++|..++.++.|++.||+|||+.+   ++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence            468999999999999999875432222346899999999999999999999988   99999999999998654   599


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ...   .
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~---~  233 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME---F  233 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---H
Confidence            999999987643221111112234567999999998899999999999999999997 999997543321   110   0


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      .        ...  .....+..   ....+.+++.+|++.+|++||++.+|++.|+
T Consensus       234 ~--------~~~--~~~~~~~~---~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 V--------TGG--GRLDPPKG---CPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             H--------HcC--CcCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0        000  01111111   1245677888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-42  Score=331.19  Aligned_cols=269  Identities=20%  Similarity=0.347  Sum_probs=197.8

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----CcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~  134 (398)
                      +|...+.||+|+||.||+|....++..||+|++...  .......+.+|+.+++.++||||+++++++....    ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477789999999999999999888999999998643  2234457889999999999999999999876433    2379


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+ +++|.+++...       ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             EEEecC-CCCHHHHHHhc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcc
Confidence            999999 57899988653       45899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC-ceeeeccccCCCcccchhhcc--CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH-------
Q 015931          215 ATWTSAPSV-PFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW-------  284 (398)
Q Consensus       215 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~-------  284 (398)
                      ++....... ........||..|+|||++.+  ..++.++|||||||++|||++|+.||..............       
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            986533221 111234569999999999875  5789999999999999999999999976442211110000       


Q ss_pred             --hhHHHhhchhhhhhhcCcccCCC--CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          285 --AKPILHRGMAAVEELLDPRLKCT--SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       285 --~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        ...............+.......  ...+.....+.+++.+||+.+|++|||+.|+++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence              00000000000000000000000  000011234678888999999999999999996

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-43  Score=337.44  Aligned_cols=247  Identities=30%  Similarity=0.433  Sum_probs=206.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      +-|..++.||.|+-|.|-.|++..+|+.+|||++.+..   ......+.+|+.+|+-+.|||++++++++.+ +..+|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEE
Confidence            56788999999999999999999999999999997652   2234568899999999999999999998765 5568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      .||+++|.|.+++..+       +++++..+.+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|.
T Consensus        91 lEyv~gGELFdylv~k-------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAs  160 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK-------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMAS  160 (786)
T ss_pred             EEecCCchhHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceee
Confidence            9999999999999876       56999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .-.++.   ...+.+|++.|.|||++.+.+| +.++||||.|||||.|+||+.||++++...   +...           
T Consensus       161 Le~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---LLlK-----------  223 (786)
T KOG0588|consen  161 LEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---LLLK-----------  223 (786)
T ss_pred             cccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---HHHH-----------
Confidence            665543   2457889999999999999887 679999999999999999999999765431   2111           


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         +-...+.-+...+.+.+   +|+.+|+..||.+|.|+.||++
T Consensus       224 ---V~~G~f~MPs~Is~eaQ---dLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  224 ---VQRGVFEMPSNISSEAQ---DLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ---HHcCcccCCCcCCHHHH---HHHHHHhccCccccccHHHHhh
Confidence               11111222223334444   4556899999999999999998

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-42  Score=337.08  Aligned_cols=266  Identities=26%  Similarity=0.401  Sum_probs=204.3

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE  130 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  130 (398)
                      ..++|..+++||+|+||.||+|.+..     .+..||||++.... ....+.+.+|++++.++. ||||++++++|.+. 
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence            35788899999999999999998642     23469999997543 334567999999999996 99999999998765 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCC------------------------------------------------------
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGV------------------------------------------------------  156 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~------------------------------------------------------  156 (398)
                      ..+++||||+++|+|.+++.......                                                      
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            45899999999999999987532100                                                      


Q ss_pred             -----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          157 -----------------------------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       157 -----------------------------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                                                         .....+++..+..++.|++.||+|||+.+   |+||||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                               01135889999999999999999999888   9999999999999


Q ss_pred             CCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchh
Q 015931          202 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  280 (398)
Q Consensus       202 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  280 (398)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........  
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence            9999999999999986543322112223457788999999998889999999999999999997 9999875322110  


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ..    .       .+....  ....   .......+.+++.+||+.+|++||++.+|+++|+..
T Consensus       349 ~~----~-------~~~~~~--~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         349 FY----N-------KIKSGY--RMAK---PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HH----H-------HHhcCC--CCCC---CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            00    0       011101  1111   112234577888899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-42  Score=332.56  Aligned_cols=247  Identities=26%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCC-cEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|+||.||+|.+...+ ..||+|.+...   .......+.+|+.++..++||||+++++++.+. +..+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEE
Confidence            357888999999999999999876544 68999998643   223456688999999999999999999988765 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       108 lv~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCC
Confidence            999999999999999764       45899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++......     ....||+.|+|||++.+..++.++|||||||++|||++|..||...+...                 
T Consensus       178 a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----------------  235 (340)
T PTZ00426        178 AKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-----------------  235 (340)
T ss_pred             CeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-----------------
Confidence            98664321     34579999999999998889999999999999999999999997643211                 


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIAI  341 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  341 (398)
                      ....+.......+...+.   .+.+++.+|++.+|.+|+     ++.++++.
T Consensus       236 ~~~~i~~~~~~~p~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        236 IYQKILEGIIYFPKFLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHHhcCCCCCCCCCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            011111111111222222   355677889999999995     88888764

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.2e-42  Score=317.97  Aligned_cols=255  Identities=26%  Similarity=0.401  Sum_probs=203.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|...+.||+|+||.||+|.....++.||+|.+.... .....+.+|++++..++||||+++++++... ...++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC-CCcEEEEEe
Confidence            45778889999999999999998889999999987543 3456789999999999999999999987764 457999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++....     ...+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        84 ~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          84 MTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             CCCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            99999999997643     246899999999999999999999888   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......      ...        .+..
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~--------~~~~  220 (263)
T cd05052         156 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYE--------LLEK  220 (263)
T ss_pred             cceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH--------HHHC
Confidence            43211 1112234668999999998899999999999999999998 999987543221      000        0111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...+..  +...   ...+.+++.+||+.+|++|||+.++++.|+.
T Consensus       221 ~~~~~~--~~~~---~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         221 GYRMER--PEGC---PPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCC--CCCC---CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            111111  1112   2446677789999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.4e-42  Score=320.04  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=200.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++|...+.||+|+||.||+|.+..++.    .+++|.+.... .....++..|+..+++++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccE
Confidence            467888999999999999999866555    47778775432 2344678888889999999999999998753  3468


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +++||+++|+|.+++....      ..++|..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        85 ~i~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcc
Confidence            9999999999999997643      46899999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||........   .    .....+ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~----~~~~~~-  227 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---P----DLLEKG-  227 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHHCC-
Confidence            987654332222334557789999999998899999999999999999998 9999976432211   0    001111 


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                              .....+...   ...+.+++.+||..+|.+|||+.|+++.|...
T Consensus       228 --------~~~~~~~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         228 --------ERLAQPQIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             --------CcCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                    011111111   23456677899999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.4e-42  Score=321.42  Aligned_cols=265  Identities=26%  Similarity=0.408  Sum_probs=206.7

Q ss_pred             hcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .++|...+.||+|+||.||++..     ..++..+|+|.+..........+.+|++++.+++||||+++++++... ...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-Ccc
Confidence            35788899999999999999975     234567999999876666677899999999999999999999998765 458


Q ss_pred             EEEEecCCCCCHHHHHhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCe
Q 015931          134 FLIYKYVSGGSLERHLHEKKKG------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  207 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~  207 (398)
                      ++||||+++++|.+++......      ......+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence            9999999999999999753210      011235899999999999999999999888   9999999999999999999


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhh
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAK  286 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~  286 (398)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ..    
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~----  232 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI----  232 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----
Confidence            9999999986543322222223446778999999998889999999999999999998 999986543221   00    


Q ss_pred             HHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          287 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       287 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                                ..+......  .........+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       233 ----------~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         233 ----------ECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             ----------HHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence                      011110000  000112235788889999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.3e-42  Score=332.11  Aligned_cols=204  Identities=30%  Similarity=0.366  Sum_probs=175.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|+..+.||+|+||+||++....+++.||+|++....   ......+..|+.++.+++||||+++++.+.+. ..+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-LNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CeEEEE
Confidence            47888999999999999999998889999999997532   23345678899999999999999999987764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          80 MEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             EcCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCCc---------------------------------eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHH
Q 015931          217 WTSAPSVP---------------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL  263 (398)
Q Consensus       217 ~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~el  263 (398)
                      ........                                 .......||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el  229 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence            54321100                                 001235799999999999988999999999999999999


Q ss_pred             HcCCCCCcccc
Q 015931          264 LTGRKPIEARR  274 (398)
Q Consensus       264 ltG~~Pf~~~~  274 (398)
                      ++|+.||....
T Consensus       230 l~G~~Pf~~~~  240 (363)
T cd05628         230 LIGYPPFCSET  240 (363)
T ss_pred             HhCCCCCCCCC
Confidence            99999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.9e-42  Score=327.31  Aligned_cols=201  Identities=29%  Similarity=0.461  Sum_probs=176.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|+..+.||+|+||.||++.+..++..+|+|.+... .......+.+|+++++.++||||++++++|.+. +..++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEE
Confidence            46899999999999999999999988999999998764 333456789999999999999999999998775 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||++.
T Consensus        83 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          83 EHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcch
Confidence            999999999999764       3589999999999999999999974 5   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ......    .....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         153 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             hhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            653321    134568999999999998889999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.9e-42  Score=319.96  Aligned_cols=261  Identities=25%  Similarity=0.396  Sum_probs=204.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .+|...+.||+|+||.||+|....     ++..||+|.+...... ..+.+.+|++++..++||||+++++++... ...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CCe
Confidence            467888999999999999998743     3578999999765443 567899999999999999999999998775 458


Q ss_pred             EEEEecCCCCCHHHHHhhhccC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          134 FLIYKYVSGGSLERHLHEKKKG-------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~-------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      ++||||+++++|.+++......       ......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            9999999999999999764210       112356899999999999999999999888   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ...  
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~--  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE--  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--
Confidence            99999999976533222111223446788999999999999999999999999999998 999986543221   111  


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                                  .+......  .........+.+++.+||+.+|.+||++.||++.|+
T Consensus       236 ------------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 ------------CITQGRLL--QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ------------HHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                        11111111  001112345677888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-43  Score=338.27  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=202.7

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      ...++|...++||+|+||+|+++..+.+++.+|||++++..   .+..+....|..++... +||.+++++.. ++...+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-fQT~~~  443 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-FQTKEH  443 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-cccCCe
Confidence            34578999999999999999999999999999999998863   45567778888888776 49999999985 455677


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|+||||+.||++..+.+.        ..+++..+.-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+||
T Consensus       444 l~fvmey~~Ggdm~~~~~~--------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADF  512 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT--------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADF  512 (694)
T ss_pred             EEEEEEecCCCcEEEEEec--------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccc
Confidence            9999999999995444432        46999999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      |+++..-....  .+.+.+||+.|||||++.+..|+...|+|||||+||||+.|..||.+++..+               
T Consensus       513 GlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---------------  575 (694)
T KOG0694|consen  513 GLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---------------  575 (694)
T ss_pred             ccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---------------
Confidence            99986543222  3568899999999999999999999999999999999999999999876543               


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  335 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  335 (398)
                        ....++......+   .....+.+.++.+.|..+|++|..+
T Consensus       576 --~FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  576 --VFDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --HHHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCC
Confidence              1222332222222   2334556777788999999999877

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-44  Score=336.36  Aligned_cols=241  Identities=29%  Similarity=0.475  Sum_probs=197.2

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      +.++-||+|+.|.||+|++.  ++.||||+++.-.       ..+++.|++++||||+.+.|+|.... .+|||||||+.
T Consensus       127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfCa~  196 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc-eeEEeeecccc
Confidence            45678999999999999997  6899999875322       25789999999999999999998754 47899999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |.|...|+..       .++.-.....|..+||.|+.|||.+.   |||||||+-||||..+..+||+|||.++......
T Consensus       197 GqL~~VLka~-------~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S  266 (904)
T KOG4721|consen  197 GQLYEVLKAG-------RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS  266 (904)
T ss_pred             ccHHHHHhcc-------CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence            9999999875       45888889999999999999999998   9999999999999999999999999998766542


Q ss_pred             CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCc
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  302 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  302 (398)
                         ....++||..|||||++.+.+.++|.||||||||||||+||..||..-....    +.|     .-+        ..
T Consensus       267 ---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-----GVG--------sN  326 (904)
T KOG4721|consen  267 ---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-----GVG--------SN  326 (904)
T ss_pred             ---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-----ecc--------CC
Confidence               2346889999999999999999999999999999999999999997644321    111     111        11


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          303 RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       303 ~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .|..+ ....+..-|.-|+.+||+..|..||++++++..|.-
T Consensus       327 sL~Lp-vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  327 SLHLP-VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ccccc-CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            11111 122333445556667999999999999999998853

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.7e-42  Score=319.28  Aligned_cols=262  Identities=22%  Similarity=0.335  Sum_probs=201.7

Q ss_pred             hhcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      .+++|+..+.||+|+||.||+|.+.     ..+..||+|.+.... ......+.+|+.+++.++||||+++++++.+. .
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-Q   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C
Confidence            4678999999999999999999764     234679999986432 33456788999999999999999999987664 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCee
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVR---GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  208 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  208 (398)
                      ..++||||+++++|.+++........   ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            58999999999999999976322111   1234688999999999999999999887   99999999999999999999


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ...    
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~----  232 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLR----  232 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----
Confidence            999999876543322111122345778999999998889999999999999999999 788886543221   110    


Q ss_pred             HHhhchhhhhhhcCccc-CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          288 ILHRGMAAVEELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                                .+..... ..+..   ....+.+++.+||+.+|.+|||+.|+++.|+
T Consensus       233 ----------~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 ----------FVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ----------HHHcCCcCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                      0001110 00111   2235677888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=334.29  Aligned_cols=252  Identities=27%  Similarity=0.365  Sum_probs=202.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||+||+|....+++.||+|++....   ......+..|+.++..++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-EHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-CeEEEE
Confidence            46888999999999999999999889999999997532   23456788999999999999999999987764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          80 MEYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             EcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCC---------------------------CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCC
Q 015931          217 WTSAPS---------------------------VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP  269 (398)
Q Consensus       217 ~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~P  269 (398)
                      ......                           .........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence            665432                           00112345699999999999999999999999999999999999999


Q ss_pred             CcccccccchhHHHHhhHHHhhchhhhhhhcC--cccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-HHHHHHH
Q 015931          270 IEARRLQGEENLVLWAKPILHRGMAAVEELLD--PRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIAI  341 (398)
Q Consensus       270 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~~  341 (398)
                      |........                 ...+..  ..+..+... .....+.+++..|+. +|.+||+ +.++++.
T Consensus       230 f~~~~~~~~-----------------~~~i~~~~~~~~~p~~~-~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         230 FYSDTLQET-----------------YNKIINWKESLRFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCHHHH-----------------HHHHhccCCcccCCCCC-CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            986542210                 011111  111111111 022345666778997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.9e-42  Score=315.05  Aligned_cols=261  Identities=24%  Similarity=0.425  Sum_probs=207.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|....+++.||+|.+...   .......+.+|+++++.++||||+++++++.+.+ ..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-ELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-eEEEE
Confidence            5788999999999999999999888999999987642   3344567889999999999999999999887654 57999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      +||+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          81 LELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEecCCCcHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccce
Confidence            999999999998865321   1245899999999999999999999888   9999999999999999999999999988


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......  ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......    ..+...        +
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~--------~  220 (267)
T cd08228         155 FFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQK--------I  220 (267)
T ss_pred             eccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHH--------H
Confidence            6643321  1123468889999999988889999999999999999999999986543211    111110        1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .....+...    .......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       221 ~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         221 EQCDYPPLP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             hcCCCCCCC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111111111    112335577888899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.7e-42  Score=321.30  Aligned_cols=269  Identities=22%  Similarity=0.288  Sum_probs=194.8

Q ss_pred             cCCCCCceecccCceEEEEeeeC-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhC---CCCCeeceeeEEEc----C
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKED--KESSKAFCRELMIASSL---HHPNIVPLVGFCID----P  129 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----~  129 (398)
                      ++|...+.||+|+||.||+|... ..+..||+|.+....  ......+.+|+.+++.+   +||||++++++|..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999874 346789999986532  22234566777776665   69999999998852    2


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                      ...+++||||+. ++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEE
Confidence            345899999995 699999876432     45899999999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH-Hhh-H
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL-WAK-P  287 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~-~~~-~  287 (398)
                      +|||+++......   ......||..|+|||.+.+..++.++|||||||++|||++|+.||......+...... ... +
T Consensus       152 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~  228 (290)
T cd07862         152 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  228 (290)
T ss_pred             ccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            9999998664432   2234568999999999988889999999999999999999999998654322111100 000 0


Q ss_pred             HHhhchhh---hhhhcCcccCC--CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 ILHRGMAA---VEELLDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 ~~~~~~~~---~~~~~d~~l~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........   ....+.+.-..  ....+.....+.+++.+||+.+|++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000000   00000000000  0000011234568889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=315.23  Aligned_cols=259  Identities=23%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             CCCCceecccCceEEEEeeeCCC---CcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-----
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  131 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  131 (398)
                      |...+.||+|+||.||+|....+   +..||+|.+....  ......+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999987543   4789999987542  3345678999999999999999999998765443     


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++|+||+++|+|..++..... ......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRL-GGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhc-cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence            36899999999999999866432 112346899999999999999999999888   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......   ...       
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~-------  226 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYD-------  226 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-------
Confidence            999986654332211222345678999999988889999999999999999999 889986543211   111       


Q ss_pred             hchhhhhhhcCc-ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          291 RGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       291 ~~~~~~~~~~d~-~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                             .+.+. ....+   ......+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus       227 -------~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         227 -------YLRHGNRLKQP---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             -------HHHcCCCCCCC---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                   11111 11111   1223467788889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-43  Score=322.07  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=209.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|.+.+.||+|.||.|-+|.....|..||||.+.++.   .++.-.+.+|+++++.++||||+.++.+|... ..+.|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-dKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-DKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-ceEEE
Confidence            467888899999999999999998889999999998763   44455688999999999999999999987654 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||..+|.|.+++...       ..|++..++.++.||+.|+.|+|.++   ++|||||.+|||||.|+++||+|||++
T Consensus       131 vMEYaS~GeLYDYiSer-------~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  131 VMEYASGGELYDYISER-------GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             EEEecCCccHHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchh
Confidence            99999999999999886       45999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      -.+....   ...+++|++-|.+||++++.+| ++..|-|||||+||.|+.|..||++.+..   .              
T Consensus       201 Nly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~--------------  260 (668)
T KOG0611|consen  201 NLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---R--------------  260 (668)
T ss_pred             hhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---H--------------
Confidence            8776544   2467899999999999998887 67899999999999999999999976532   1              


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      .+..+-...+..+.    ...+..-|++|||..+|.+|.|+.+|....
T Consensus       261 lvrQIs~GaYrEP~----~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  261 LVRQISRGAYREPE----TPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HHHHhhcccccCCC----CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            23333333333222    222344567889999999999999998754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.8e-42  Score=314.91  Aligned_cols=251  Identities=26%  Similarity=0.463  Sum_probs=198.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|+..+.||+|+||.||++.++. +..+|+|.+.... .....+.+|++++++++||||+++++++.+. ...++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-KPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-CCEEEEEEc
Confidence            457778899999999999998864 5689999886443 2346788999999999999999999987664 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|.+++....      ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          81 MENGCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            99999999987532      35899999999999999999999888   9999999999999999999999999988654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...+...   ....   +.. +      
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~---i~~-~------  217 (256)
T cd05114         152 DDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEM---ISR-G------  217 (256)
T ss_pred             CCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---HHC-C------
Confidence            32211 1122345668999999988889999999999999999999 899997543211   1111   000 0      


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                         .....+..   ....+.+++.+||+.+|.+||++.++++.|
T Consensus       218 ---~~~~~~~~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 ---FRLYRPKL---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCCC---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               00000111   123567888899999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=317.23  Aligned_cols=272  Identities=24%  Similarity=0.323  Sum_probs=209.3

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEec--CCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc----CCC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPLVGFCID----PEQ  131 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  131 (398)
                      ....|...+.||+|+||.|+.+....+|+.||+|++.  -...-..++..+|+.+|+.++|+||+.+.+.+..    .-+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4456777889999999999999999999999999997  3455567788899999999999999999998654    234


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+|+|+|+| +.+|.+.++..       ..|+...+..+..|+++||+|+|+.+   |+||||||+|+|++.+..+||+|
T Consensus       100 DvYiV~elM-etDL~~iik~~-------~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQ-------QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcC-------ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence            589999999 77999999874       44999999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ||+|+...........+..+.|.+|.|||.+.. ..||...||||.||++.||++|++-|.+.+.-.+..+.........
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            999998764322223456778999999998865 4799999999999999999999999988765443333322111100


Q ss_pred             hc------hhhhhhhcC-----cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          291 RG------MAAVEELLD-----PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       291 ~~------~~~~~~~~d-----~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..      .......+.     ++.......+......++|+.+||..||.+|+|++|.++
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            00      000111111     011000001112234677888999999999999999987

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.1e-42  Score=321.68  Aligned_cols=267  Identities=21%  Similarity=0.298  Sum_probs=197.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++..... .....+.+|+.+++.++||||+++++++.+. ...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEE
Confidence            4689999999999999999999988899999999975432 2234677899999999999999999987765 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+ .++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..
T Consensus        83 e~~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          83 EYV-HTDLCQYMDKHP------GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             ECC-CcCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence            999 568888876542      45899999999999999999999988   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc----
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----  292 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----  292 (398)
                      ......  ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......  .............    
T Consensus       153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  228 (303)
T cd07869         153 KSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDT  228 (303)
T ss_pred             ccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhh
Confidence            433221  1234568999999999865 457889999999999999999999997542211  0011000000000    


Q ss_pred             -h--hhhhhhcCcccC--CCCCCHH------HHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 -M--AAVEELLDPRLK--CTSRNSA------QIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 -~--~~~~~~~d~~l~--~~~~~~~------~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .  ..........+.  .+.....      ....+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             0  000000000000  0000000      1134567888999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-41  Score=315.60  Aligned_cols=260  Identities=23%  Similarity=0.391  Sum_probs=200.0

Q ss_pred             CCCCceecccCceEEEEeeeCCCCc--EEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----Cc
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QG  132 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  132 (398)
                      |..++.||+|+||.||+|.+...+.  .||+|.++..  .....+.+..|+++++.++||||++++++|....     ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999999876554  6999988654  3445677899999999999999999999876432     23


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .+++|||+++|+|.+++...... .....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCC
Confidence            68999999999999988543211 11245899999999999999999999887   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhh
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      |+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.......   ...    ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----~~~~  229 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD----YLRQ  229 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHc
Confidence            99987654332111223346778999999998899999999999999999999 889986532211   100    0000


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      +         .......   .....+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus       230 ~---------~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         230 G---------NRLKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             C---------CCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            0         0011111   122346788889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.9e-42  Score=318.40  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=201.2

Q ss_pred             cCCCCCceecccCceEEEEeeeC----CCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .+|+..+.||+|+||.||+|...    ..+..||+|.+... .......+.+|+++++.++||||+++++++...+ ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ-PVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-ceE
Confidence            46777889999999999999852    34678999999753 3344567889999999999999999999877654 579


Q ss_pred             EEEecCCCCCHHHHHhhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          135 LIYKYVSGGSLERHLHEKKKGV----------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~----------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      +||||+++++|.+++.......          .....+++..++.++.|++.||.|||+.+   ++||||||+||+++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence            9999999999999986432100          01245889999999999999999999888   9999999999999999


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHH
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL  283 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~  283 (398)
                      +.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......   ...
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999986644332222233446778999999988889999999999999999998 999986543211   100


Q ss_pred             HhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       284 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                          .       +..  ...+..+...   ...+.+++.+||+.+|.+||++.+|++.|.+
T Consensus       238 ----~-------~~~--~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 ----M-------VRK--RQLLPCSEDC---PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----H-------HHc--CCcCCCCCCC---CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                0       000  0001111111   2346677789999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=300.57  Aligned_cols=270  Identities=25%  Similarity=0.364  Sum_probs=216.5

Q ss_pred             HHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc----CC
Q 015931           55 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID----PE  130 (398)
Q Consensus        55 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~  130 (398)
                      +....++|.+.+.||+|||+.||.++.-.++..||+|++.....+..+..++|++..++++|||++++++++..    +.
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            44556899999999999999999999888899999999998887888899999999999999999999987653    33


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...||+++|...|+|.+.+.....   .+..+++.+++.|+.++++||++||+.. +++.||||||.|||+.+.+.+++.
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~---kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKI---KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEE
Confidence            458999999999999999987543   2357999999999999999999999876 569999999999999999999999


Q ss_pred             ccccccccCCCCCcee-------eeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchh
Q 015931          211 DFGLATWTSAPSVPFL-------CKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  280 (398)
Q Consensus       211 DfGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~  280 (398)
                      |||.+....-.-....       ......|..|.|||.+.   +...++++|||||||+||+|+.|..||+.-..++. +
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-S  250 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-S  250 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-e
Confidence            9999875432111000       01234688999999886   34679999999999999999999999986443221 1


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                                    .--.+..+.+..+... ...+.+.+++.+|++.||.+||++.+++..+..
T Consensus       251 --------------laLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  251 --------------LALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             --------------EEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                          1112233333333222 245667888889999999999999999998764

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.3e-42  Score=317.15  Aligned_cols=255  Identities=28%  Similarity=0.454  Sum_probs=206.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ..+|+..+.||.|+||.||+|.... +..+|+|.+..........+..|+.+++.++||||+++++++.+.+ ..++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e   82 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-PVYIITE   82 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-CeEEEEe
Confidence            4578889999999999999999987 8899999998776656678999999999999999999999887654 4799999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....     ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++...
T Consensus        83 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          83 LMEKGSLLAFLRSPE-----GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             ecccCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence            999999999997643     246899999999999999999999888   999999999999999999999999999766


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      .....  ......++..|+|||.+....++.++||||||+++|+|++ |+.||.......   ....           +.
T Consensus       155 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~-----------~~  218 (261)
T cd05148         155 KEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQ-----------IT  218 (261)
T ss_pred             CCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH-----------HH
Confidence            43221  1123346778999999988889999999999999999998 899997543211   1110           00


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .-.  ....+   ......+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       219 ~~~--~~~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 AGY--RMPCP---AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             hCC--cCCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            000  11111   1223456788889999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.1e-42  Score=320.94  Aligned_cols=264  Identities=26%  Similarity=0.391  Sum_probs=207.1

Q ss_pred             cCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++|...+.||+|+||.||+|...     .++..+++|.+........+.+.+|++++++++||||+++++++...+ ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-PLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC-ceE
Confidence            46778889999999999999753     235569999988766666678999999999999999999999987654 589


Q ss_pred             EEEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          135 LIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      +||||+++++|.+++......         ......++|..++.++.|++.||+|||+.+   |+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            999999999999999764210         011245899999999999999999999888   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHH
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  284 (398)
                      .++|+|||++................++..|+|||++.+..++.++||||||+++|||+| |+.||.......   ... 
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~-  236 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE-  236 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-
Confidence            999999999976544332222234456788999999998899999999999999999998 999986543221   110 


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                                   .+......  .........+.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus       237 -------------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         237 -------------CITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             -------------HHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                         01111110  001112345778888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6e-42  Score=333.24  Aligned_cols=256  Identities=25%  Similarity=0.315  Sum_probs=195.7

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .|...+.||+|+||+||+|....+++.||+|++....   ......+.+|++++..++||||+++++++.+. ..+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-CEEEEEE
Confidence            5778899999999999999999899999999997532   23456788999999999999999999988775 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          81 DYIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             ecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999999764       45899999999999999999999988   99999999999999999999999999764


Q ss_pred             cCCCCC---------------------------------------------ceeeeccccCCCcccchhhccCCcCCccc
Q 015931          218 TSAPSV---------------------------------------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTD  252 (398)
Q Consensus       218 ~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksD  252 (398)
                      ......                                             ........||..|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            311000                                             00012356999999999999888999999


Q ss_pred             hhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCC
Q 015931          253 VYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR  332 (398)
Q Consensus       253 v~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~R  332 (398)
                      ||||||++|||++|+.||..........      .+.       ..............+.+..+++.- +.|+..+|..|
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~~~------~i~-------~~~~~~~~~~~~~~s~~~~dli~~-ll~~~~~~~~R  296 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTETQL------KVI-------NWENTLHIPPQVKLSPEAVDLITK-LCCSAEERLGR  296 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHHHH------HHH-------ccccccCCCCCCCCCHHHHHHHHH-HccCcccccCC
Confidence            9999999999999999997654321100      000       000000111111122333333322 12677788889


Q ss_pred             CCHHHHHHH
Q 015931          333 PGIEEIIAI  341 (398)
Q Consensus       333 Pt~~evl~~  341 (398)
                      |++.++++.
T Consensus       297 ~~~~~~l~h  305 (381)
T cd05626         297 NGADDIKAH  305 (381)
T ss_pred             CCHHHHhcC
Confidence            999999873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=345.59  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=215.3

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceee-EEEcC--CC-
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVG-FCIDP--EQ-  131 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~--~~-  131 (398)
                      +...++++.+.|.+|||+.||.|.....+..||+|++...+....+.+.+|+++++.|. |+|||.+++ .....  ++ 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            45577888899999999999999998877999999998888888999999999999997 999999999 32221  11 


Q ss_pred             --cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          132 --GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       132 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                        .++|.||||+||+|-+++..+-.     ..|++.++++|+.|+++|+.+||... ++|||||||-+||||+.+++.||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence              26799999999999999987643     45999999999999999999999986 77999999999999999999999


Q ss_pred             eccccccccCCCC-Cceee------eccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccch
Q 015931          210 CDFGLATWTSAPS-VPFLC------KTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  279 (398)
Q Consensus       210 ~DfGla~~~~~~~-~~~~~------~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~  279 (398)
                      ||||.|.-.-... .....      -...-|+.|.|||.+.   +..+++|+|||+|||+||-|+....||+...     
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-----  262 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-----  262 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----
Confidence            9999986432221 10000      0123688999999875   4578999999999999999999999998642     


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                                      -..|++..+..+.. +.....|..||..||+.+|.+||++-+|+..+..+..
T Consensus       263 ----------------~laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  263 ----------------KLAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ----------------ceeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                            23455666665543 4566677888889999999999999999998866443

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.7e-42  Score=327.61  Aligned_cols=243  Identities=25%  Similarity=0.330  Sum_probs=194.1

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      +.||+|+||.||++....++..||+|++...   .......+..|++++..++||||+++++++... ..+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCC
Confidence            4699999999999999888999999999753   223445678899999999999999999887664 458999999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      |+|..++...       ..+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          80 GELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            9999988654       458999999999999999999997 56   999999999999999999999999998754322


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........                 ...+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-----------------~~~i~~  210 (325)
T cd05594         150 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----------------FELILM  210 (325)
T ss_pred             Cc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-----------------HHHHhc
Confidence            21  12345699999999999988999999999999999999999999975432110                 011111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIAI  341 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  341 (398)
                      .....+...+   ..+.+++.+||+.||++||     ++.++++.
T Consensus       211 ~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         211 EEIRFPRTLS---PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCCCC---HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1111112222   3456677889999999996     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=333.46  Aligned_cols=253  Identities=28%  Similarity=0.336  Sum_probs=196.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|+..+.||+|+||+||+|....+++.||||++....   ......+.+|+.++..++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-NYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CeEEEE
Confidence            47888999999999999999999889999999997532   23445678899999999999999999987764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          80 MEYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             ECCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccce
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCCce------------------------------------eeeccccCCCcccchhhccCCcCCccchhhHHHHH
Q 015931          217 WTSAPSVPF------------------------------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVL  260 (398)
Q Consensus       217 ~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl  260 (398)
                      .+.......                                    ......||+.|+|||++....++.++|||||||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            543211000                                    01124699999999999988999999999999999


Q ss_pred             HHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC---HHH
Q 015931          261 LELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG---IEE  337 (398)
Q Consensus       261 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~e  337 (398)
                      |||++|..||.........      ..+. ..    .  ...........+.   .+.+++.+|+. +|.+|++   +.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~------~~i~-~~----~--~~~~~~~~~~~s~---~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETY------RKII-NW----K--ETLQFPDEVPLSP---EAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHH------HHHH-cC----C--CccCCCCCCCCCH---HHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            9999999999765432110      0000 00    0  0000110111223   34555667886 9999998   888


Q ss_pred             HHH
Q 015931          338 IIA  340 (398)
Q Consensus       338 vl~  340 (398)
                      +++
T Consensus       293 ll~  295 (364)
T cd05599         293 IKS  295 (364)
T ss_pred             Hhc
Confidence            876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.6e-42  Score=324.92  Aligned_cols=242  Identities=26%  Similarity=0.373  Sum_probs=193.3

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ++||+|+||.||+|....+++.||+|++...   .......+..|.+++..+ +||||+++++++... +..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCC
Confidence            4699999999999999888999999999753   223445677888888865 799999999987764 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|...+...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          80 GGDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            99999988764       45899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   .              +..+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~--------------~~~i~~  210 (321)
T cd05591         150 GV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---L--------------FESILH  210 (321)
T ss_pred             Cc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---H--------------HHHHHc
Confidence            21  1234569999999999998899999999999999999999999998654321   0              111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCC-------CHHHHHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRP-------GIEEIIA  340 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------t~~evl~  340 (398)
                      .....+...   ...+.+++..||+.+|.+||       ++.++++
T Consensus       211 ~~~~~p~~~---~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         211 DDVLYPVWL---SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            111111111   23466777899999999999       7787775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-41  Score=317.04  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=202.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCc----EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .++|...+.||+|+||+||+|.+..++.    .||+|.+... .......+.+|+.++..++||||+++++++...  ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--TV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--Cc
Confidence            3578888999999999999998765555    4899998754 344566788999999999999999999998753  36


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++++||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCC
Confidence            79999999999999997642      45899999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++...............++..|+|||...+..++.++|||||||++|||++ |..||.......   +..+        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~--------  223 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL--------  223 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH--------
Confidence            9987654332211222345678999999988889999999999999999998 999986533211   1110        


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                         +.....  ...   .......+.+++.+||+.+|.+||++.++++.|+..
T Consensus       224 ---~~~~~~--~~~---~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         224 ---LEKGER--LPQ---PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ---HHCCCc--CCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence               111000  000   111234567788899999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=310.42  Aligned_cols=269  Identities=22%  Similarity=0.307  Sum_probs=205.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh--hHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~l  135 (398)
                      .++|...+.|++|.||.||+|+++.+++.||+|+++.+...  ---.-.+|+++|.+++|||||.+..+....+ +.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            35788889999999999999999999999999999865321  2234579999999999999999998765432 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |||||+. +|..++....      .++...++..+..|+++|++|||.+.   |+||||||+|+|++..|.+||+|||+|
T Consensus       155 VMe~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLA  224 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLA  224 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchh
Confidence            9999966 9999998764      57899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-----HHH
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PIL  289 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-----~~~  289 (398)
                      +.++.+...  .+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|.+...-++.+.+....     .+|
T Consensus       225 R~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  225 REYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             hhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence            998876443  3556789999999999876 58999999999999999999999998866543322221100     011


Q ss_pred             hhchhhhhhhcCccc--------CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVEELLDPRL--------KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l--------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +.. ..+...-...+        ............-++++...|..||.+|-|+.|.++
T Consensus       303 pg~-~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  303 PGY-SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCc-cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            000 00000000000        000000002244567778899999999999999986

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-41  Score=318.34  Aligned_cols=262  Identities=24%  Similarity=0.343  Sum_probs=201.4

Q ss_pred             CCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      +|...+.||+|+||.||+|....     ....+++|.+.... ......+.+|+.+++.++||||+++++.|...+ ..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-PLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-CcE
Confidence            47778899999999999998642     23568999887543 334567899999999999999999999887654 478


Q ss_pred             EEEecCCCCCHHHHHhhhccC-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccC
Q 015931          135 LIYKYVSGGSLERHLHEKKKG-----------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  197 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~  197 (398)
                      +|+||+++++|.+++......                 ......+++..++.++.|++.||+|||+.+   ++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence            999999999999998753210                 011245899999999999999999999888   999999999


Q ss_pred             cEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccc
Q 015931          198 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ  276 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~  276 (398)
                      ||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....+.
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999986543322111223345678999999988889999999999999999998 99999754322


Q ss_pred             cchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          277 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .   +...           +........  +.   .....+.+++.+||+.+|.+||++.++++.|+..
T Consensus       237 ~---~~~~-----------~~~~~~~~~--~~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 R---LFNL-----------LKTGYRMER--PE---NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             H---HHHH-----------HhCCCCCCC--CC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            1   1110           111011111  11   1224577788899999999999999999999753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.5e-42  Score=324.68  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=192.2

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHH---HhCCCCCeeceeeEEEcCCCcEEE
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIA---SSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      |...+.||+|+||.||+|.+..+++.||||++....   ....+.+..|+.++   +.++||||+++++++... +..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-DHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-CEEEE
Confidence            566789999999999999998889999999997532   22334566666554   567899999999987765 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|...+..        ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        80 v~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          80 VMEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             EEcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCC
Confidence            9999999999988754        35899999999999999999999988   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +.......  ......|++.|+|||.+.+..++.++|||||||++|||++|+.||........                 
T Consensus       149 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-----------------  209 (324)
T cd05589         149 KEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-----------------  209 (324)
T ss_pred             ccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-----------------
Confidence            75332221  12346799999999999988999999999999999999999999976432210                 


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ...+.......+...   ...+.+++.+||+.+|.+||     ++.++++
T Consensus       210 ~~~i~~~~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         210 FDSIVNDEVRYPRFL---SREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHHhCCCCCCCCC---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            111111111111112   23456778899999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-41  Score=313.61  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=201.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|+..+.||+|+||.||+|.... +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+. ...++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   82 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE-EPIYIITEY   82 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEec
Confidence            578888999999999999998764 67899999865432 456789999999999999999999987664 457999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++.....     ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++....
T Consensus        83 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          83 MAKGSLLDFLKSDEG-----GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             CCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence            999999999976432     46899999999999999999999888   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......++..|+|||++....++.++|||||||++|+|++ |..||.......   ....           +..
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~-----------~~~  219 (261)
T cd05072         155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA-----------LQR  219 (261)
T ss_pred             CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH-----------HHc
Confidence            43211 1122346778999999988889999999999999999998 999997543221   1110           111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...  .....   .....+.+++.+|++.+|++||++.++++.|+.
T Consensus       220 ~~~--~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         220 GYR--MPRME---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCC--CCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111  01011   122456778889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-41  Score=322.56  Aligned_cols=241  Identities=24%  Similarity=0.384  Sum_probs=188.8

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHh-CCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASS-LHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|.+..+++.||+|.+....   ......+..|..++.. .+||||+++++++... ...++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-EHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            46999999999999999889999999997532   2234455667777765 4899999999987664 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        80 gg~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          80 GGDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            99999998764       45899999999999999999999988   999999999999999999999999999764332


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +              ...+..
T Consensus       150 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~--------------~~~i~~  210 (316)
T cd05592         150 E--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---L--------------FDSILN  210 (316)
T ss_pred             C--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---H--------------HHHHHc
Confidence            2  12234679999999999998889999999999999999999999997643211   0              011111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHH-HHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EII  339 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl  339 (398)
                      .....+...+   ..+.+++.+||+.+|.+||++. +++
T Consensus       211 ~~~~~~~~~~---~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         211 DRPHFPRWIS---KEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCCCCC---HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1111111122   3456677889999999999976 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.7e-42  Score=324.07  Aligned_cols=237  Identities=27%  Similarity=0.394  Sum_probs=189.5

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|....+++.||+|++...   .......+..|..++..+ +||||+++++++... +.+++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-DRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-CEEEEEEcCCC
Confidence            4799999999999999988999999999753   223445677888888876 699999999987664 55899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          80 GGDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             CchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            99999988764       45899999999999999999999888   999999999999999999999999998754322


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +              ...+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~--------------~~~i~~  210 (320)
T cd05590         150 GK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---L--------------FEAILN  210 (320)
T ss_pred             CC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---H--------------HHHHhc
Confidence            11  1234579999999999998899999999999999999999999997654321   0              111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  335 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  335 (398)
                      .....+...   ...+.+++.+||+.||.+||++
T Consensus       211 ~~~~~~~~~---~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         211 DEVVYPTWL---SQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCCCC---CHHHHHHHHHHcccCHHHCCCC
Confidence            111111112   2345677789999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=312.78  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|+..+.||+|++|.||+|.... ++.||+|.+.... ...+.+.+|+.++++++||||+++++++... +..++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   81 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-EPIYIVTE   81 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC-CCeeeeee
Confidence            4578889999999999999999764 5789999987543 2356788999999999999999999987664 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....     ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        82 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          82 LMKYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             cccCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            999999999997642     246899999999999999999999888   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ...... .......+..|+|||++.+..++.++||||||+++|||++ |+.||.......   +..    .       +.
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~-------~~  218 (261)
T cd05068         154 KEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----Q-------VD  218 (261)
T ss_pred             cCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----H-------HH
Confidence            532211 1111223457999999988889999999999999999999 999997543211   000    0       00


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...  .+..   .......+.+++.+|++.+|.+||++.++++.|+.
T Consensus       219 ~~~--~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         219 QGY--RMPC---PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             cCC--CCCC---CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            000  0111   11223457788889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-41  Score=310.07  Aligned_cols=251  Identities=24%  Similarity=0.400  Sum_probs=203.8

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..+.||+|++|.||+|....+++.|++|.+...  .......+.+|+++++.++||||+++++++.+. +..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEE
Confidence            477788999999999999999888999999998643  344567789999999999999999999988765 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++..
T Consensus        80 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          80 YAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             eCCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceec
Confidence            9999999999986422     46899999999999999999999887   999999999999999999999999998866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......   ..              ..
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~--------------~~  212 (256)
T cd08529         152 SDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LI--------------LK  212 (256)
T ss_pred             cCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH--------------HH
Confidence            54322  1234568899999999998889999999999999999999999997544211   10              11


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      +.....  +.........+.+++.+||+.+|++||++.++++.
T Consensus       213 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         213 IIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHcCCC--CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            111111  01111233457788889999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.6e-41  Score=310.34  Aligned_cols=261  Identities=23%  Similarity=0.436  Sum_probs=207.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|+..+.||+|+||.||+|....+++.||+|.+...   .......+.+|++++++++|+|++++++++.+. +..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEE
Confidence            5788999999999999999999888999999988642   233456789999999999999999999998775 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          81 LELADAGDLSRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EecCCCCCHHHHHHHhcc---cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceee
Confidence            999999999999875321   1256899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||......    .......        +
T Consensus       155 ~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~--------~  220 (267)
T cd08224         155 FFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK--------I  220 (267)
T ss_pred             eccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh--------h
Confidence            65443211  23356888999999998888999999999999999999999999654321    1111100        0


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .....+..    ........+.+++.+||+.+|.+|||+.+|+++|+.+
T Consensus       221 ~~~~~~~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         221 EKCDYPPL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             hcCCCCCC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            00000111    1112334567888899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1e-41  Score=317.36  Aligned_cols=266  Identities=22%  Similarity=0.352  Sum_probs=208.9

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCC----CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      ..++|...++||+|+||.||+|.+..    .+..|++|.+... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45688889999999999999999865    2578999988754 334566788999999999999999999998876667


Q ss_pred             EEEEEecCCCCCHHHHHhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+++++|+++++|.+++...... ......+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999999764221 111246899999999999999999999888   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||...+...   +..+      
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~------  231 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY------  231 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH------
Confidence            999986644332222223456778999999988889999999999999999999 999997543221   1111      


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                           +....  .+....   .....+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       232 -----~~~~~--~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         232 -----LKDGY--RLAQPI---NCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             -----HHcCC--CCCCCC---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 01100  111111   1123567788899999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-41  Score=316.71  Aligned_cols=274  Identities=26%  Similarity=0.324  Sum_probs=203.3

Q ss_pred             cCCCCCceecccCceEEEEeee----CCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  134 (398)
                      .+|...+.||+|+||.||++..    ..++..||+|.+........+.+.+|+++++.++||||+++++++...+ ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4678889999999999999974    3457899999998776666778999999999999999999999876433 4578


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcc
Confidence            9999999999999997542      45899999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCcee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +........... .....++..|+|||++.+..++.++|||||||++|||++|..|+......-. ......... ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~  232 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQG-QMIV  232 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhccccccc-ccch
Confidence            987654322111 1112234569999999888899999999999999999999877643221100 000000000 0000


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ..+.+.+......+ ........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00111111111100 0111224577888899999999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.1e-42  Score=332.91  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=199.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ..++|...+.||+|+||.||++....+++.||+|.+...   .......+..|+.+++.++||||+++++++.+ +..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEE
Confidence            457899999999999999999999988999999999643   22334557889999999999999999988766 45589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++..        ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       120 lv~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999999999865        24788889999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccC----CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......             
T Consensus       189 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------------  254 (370)
T cd05596         189 CMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------------  254 (370)
T ss_pred             eeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------------
Confidence            986643321 112345799999999998653    47899999999999999999999998654321             


Q ss_pred             hchhhhhhhcCc--ccCCCCCCHHHHHHHHHHHHhcccccCCC--CCCHHHHHHH
Q 015931          291 RGMAAVEELLDP--RLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIAI  341 (398)
Q Consensus       291 ~~~~~~~~~~d~--~l~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~  341 (398)
                          ....+.+.  .+..+. .......+.+++.+||+.+|.+  ||++.++++.
T Consensus       255 ----~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         255 ----TYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----HHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                01111111  111111 1112234566778899999988  9999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.4e-42  Score=330.20  Aligned_cols=249  Identities=25%  Similarity=0.394  Sum_probs=192.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .+|...+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+++++.++|+||+++++++.+. +.+++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-GEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-CeEEEEEe
Confidence            45677889999999999999998889999999996543 33456789999999999999999999987664 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++|+|...           ...++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus       153 ~~~~~~L~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        153 FMDGGSLEGT-----------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             cCCCCccccc-----------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            9999998542           23567788899999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhcc-----CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      .....  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+..   .      
T Consensus       219 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~------  287 (353)
T PLN00034        219 AQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A------  287 (353)
T ss_pred             ccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H------
Confidence            43321  1234579999999998743     234568999999999999999999997433221111100   0      


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                        +.  .......   .......+.+++.+||+.+|++|||+.|+++.
T Consensus       288 --~~--~~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        288 --IC--MSQPPEA---PATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --Hh--ccCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00  0000000   11222456777889999999999999999873

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-41  Score=322.88  Aligned_cols=242  Identities=26%  Similarity=0.377  Sum_probs=193.1

Q ss_pred             ceecccCceEEEEeeeC---CCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           66 RVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +.||+|+||.||++...   .+++.||+|++....    ......+..|+++++.++||||+++++++... +..|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-GKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-CeEEEEEe
Confidence            57999999999999863   467899999997531    22345678899999999999999999987764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          81 YLSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999998764       45888999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 .+..
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----------------~~~~  211 (323)
T cd05584         151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----------------TIDK  211 (323)
T ss_pred             ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----------------HHHH
Confidence            32221  1234579999999999998889999999999999999999999997643211                 1112


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      +.......+...+   ..+.+++.+||+.+|.+||     ++.++++
T Consensus       212 ~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         212 ILKGKLNLPPYLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHcCCCCCCCCCC---HHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            2222222222222   3456777889999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=320.87  Aligned_cols=259  Identities=26%  Similarity=0.426  Sum_probs=202.6

Q ss_pred             hcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||.||+|..     ..++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++... +
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-G  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-C
Confidence            46799999999999999999975     2345679999987543 33456789999999999 799999999988765 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||+++|+|.+++.....     ..+++.++..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE-----SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECC
Confidence            58999999999999999976431     34899999999999999999999888   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ||+++...............++..|+|||.+....++.++|||||||++|||++ |..||........  ..    ..  
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~----~~--  256 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FY----KL--  256 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HH----HH--
Confidence            999986644322111223346778999999998889999999999999999998 9999875432110  00    00  


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                           +.....+.  .+.   .....+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       257 -----~~~~~~~~--~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         257 -----IKEGYRMA--QPE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             -----HHcCCcCC--CCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                 00000000  011   112357778889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.3e-42  Score=319.78  Aligned_cols=266  Identities=23%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCC-----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcC
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  129 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  129 (398)
                      ...++|+..+.||+|+||.||++.....     ...+|+|.+... .......+.+|++++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            4456788899999999999999987533     368999998754 234456788999999999 799999999988765


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhcc---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                      + ..+++|||+++|+|..++.....         .......+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus        89 ~-~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          89 G-PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             C-CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            4 58999999999999999975310         0012356899999999999999999999888   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccch
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  279 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  279 (398)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ 
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-  243 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-  243 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-
Confidence            99999999999999987654332111222345678999999988889999999999999999998 9999875432110 


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                        .    ...       ...  .....   .......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       244 --~----~~~-------~~~--~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 --F----KLL-------KEG--YRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             --H----HHH-------HcC--CcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence              0    000       000  00111   112234577888999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=323.19  Aligned_cols=242  Identities=23%  Similarity=0.351  Sum_probs=192.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCC-CeeceeeEEEcCCCcEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP-NIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~lV  136 (398)
                      +|...+.||+|+||.||+|....+++.||+|++...   .....+.+..|..++..++|+ +|+++++++.+ .+.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence            477889999999999999999988999999999753   223456678899999999765 57777777655 4568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          80 MEYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            9999999999998764       45899999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .              .
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~--------------~  210 (324)
T cd05587         150 ENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L--------------F  210 (324)
T ss_pred             ecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H--------------H
Confidence            5322221  1234679999999999998889999999999999999999999997543211   1              1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  335 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  335 (398)
                      ..+.......+...   ...+.+++.+||+.+|.+||+.
T Consensus       211 ~~i~~~~~~~~~~~---~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         211 QSIMEHNVSYPKSL---SKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHHcCCCCCCCCC---CHHHHHHHHHHhhcCHHHcCCC
Confidence            11111111111112   2346677789999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.9e-42  Score=329.07  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=199.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||+||++....+++.||+|++....   ......+..|+.++..++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-DNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CeEEEE
Confidence            46888999999999999999999889999999997542   23456688999999999999999999987664 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          80 MEYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             ECCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCe
Confidence            99999999999997642      46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhc------cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ........ ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........      ...+. 
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~-  222 (330)
T cd05601         151 RLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIM-  222 (330)
T ss_pred             ECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHH-
Confidence            76543321 223457999999999986      45678999999999999999999999976432210      00000 


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             .. ...+..+. .......+.+++..|++ +|.+|||+.++++
T Consensus       223 -------~~-~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         223 -------NF-QRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -------cC-CCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                   00 00011110 11122345566677997 9999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=317.50  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=198.8

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      +|...++||+|+||.||++....+++.||+|.+....   ......+.+|+.+++.++||||+++++++... ..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEE
Confidence            4777889999999999999998889999999997532   22334577899999999999999999987664 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++|+|.+++....     ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++..
T Consensus        80 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          80 TLMNGGDLKFHIYNMG-----NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             eccCCCcHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            9999999998886532     146899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......   .....|+..|+|||++.+..++.++|||||||++|||++|+.||..........  ..           ..
T Consensus       152 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~~-----------~~  215 (285)
T cd05605         152 IPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--EV-----------ER  215 (285)
T ss_pred             cCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--HH-----------HH
Confidence            543221   123568999999999998889999999999999999999999997643321100  00           00


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      .+......   ........+.+++..||+.||.+||     ++.++++
T Consensus       216 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         216 RVKEDQEE---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             Hhhhcccc---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            00010111   1111233466778899999999999     7878765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-42  Score=332.55  Aligned_cols=204  Identities=27%  Similarity=0.356  Sum_probs=174.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||++....+++.||||++...   .......+.+|++++..++||||+++++++.+. ..+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-QYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CeeEEE
Confidence            4788899999999999999999989999999998653   223446688999999999999999999988765 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          80 MEFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999999999754       45899999999999999999999988   9999999999999999999999999986


Q ss_pred             ccCCCCCc---------------------------------------------eeeeccccCCCcccchhhccCCcCCcc
Q 015931          217 WTSAPSVP---------------------------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKT  251 (398)
Q Consensus       217 ~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ks  251 (398)
                      ........                                             .......||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            33210000                                             000124699999999999988999999


Q ss_pred             chhhHHHHHHHHHcCCCCCcccc
Q 015931          252 DVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       252 Dv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      |||||||++|||++|+.||....
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~  252 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCC
Confidence            99999999999999999997644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=315.00  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=203.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCC-----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .++|...+.||+|+||.||+|.....     +..||+|.+.... ......+.+|+.++..++||||+++++++... ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CC
Confidence            35788889999999999999987543     3789999987543 34456788999999999999999999987765 45


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGV---RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                      .++||||+++|+|.+++.......   .....++|..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            799999999999999997643211   11245789999999999999999999888   999999999999999999999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.......   ....    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~----  233 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF----  233 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH----
Confidence            99999876544322112233456788999999988889999999999999999998 999986543221   1110    


Q ss_pred             HhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                             +..  ......+...   ...+.+++.+||+.+|++|||+.++++.|+
T Consensus       234 -------~~~--~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 -------VID--GGHLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -------Hhc--CCCCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                   000  0011111112   345778888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.5e-41  Score=325.34  Aligned_cols=200  Identities=25%  Similarity=0.385  Sum_probs=171.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----C
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  131 (398)
                      .++|...+.||+|+||.||++....++..||+|.+...  .......+.+|+.+++.++||||+++++++...+     .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            47899999999999999999999888999999999653  2344567889999999999999999999876433     2


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..|+||||+. ++|...+..         .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       100 ~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIHM---------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHhc---------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEec
Confidence            4789999995 467666642         3788999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ||+++......   ......||..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus       167 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         167 FGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             CCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99997543322   1234568999999999998899999999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.9e-41  Score=310.28  Aligned_cols=249  Identities=28%  Similarity=0.467  Sum_probs=199.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|...+.||+|+||.||++...  +..||+|.+....  ..+.+.+|+.++++++|+|++++++++...+...++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            47888899999999999999875  7789999986543  3467889999999999999999999877666678999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++.....     ..+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++....
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          82 MAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence            999999999976432     45899999999999999999999888   9999999999999999999999999987554


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ...     ....++..|+|||++.+..++.++||||||+++|||++ |+.||.......   +...           +..
T Consensus       154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-----------~~~  214 (256)
T cd05082         154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-----------VEK  214 (256)
T ss_pred             ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------Hhc
Confidence            322     22345678999999988889999999999999999997 999986532211   1100           111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...+..  ...   ....+.+++.+||+.+|++|||+.++++.|+.
T Consensus       215 ~~~~~~--~~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         215 GYKMDA--PDG---CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCC--CCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            011111  111   22356677889999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-41  Score=329.99  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=197.4

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      ...++|...+.||+|+||.||++....+++.||+|.+.+.   .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~  118 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-KYL  118 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEE
Confidence            3457899999999999999999999988999999998642   223345678899999999999999999987664 558


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++|+|.+++..        ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN--------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence            999999999999999864        34789999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccC----CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      ++........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+....           
T Consensus       188 ~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-----------  255 (370)
T cd05621         188 TCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-----------  255 (370)
T ss_pred             cceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-----------
Confidence            9987643321 122356799999999998753    378899999999999999999999976542210           


Q ss_pred             hhchhhhhhhcCc--ccCCCCCCHHHHHHHHHHHHhcccccCCC--CCCHHHHHHH
Q 015931          290 HRGMAAVEELLDP--RLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIAI  341 (398)
Q Consensus       290 ~~~~~~~~~~~d~--~l~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~  341 (398)
                            ...+.+.  .+..+. .......+.+++..|+..++.+  ||++.|+++.
T Consensus       256 ------~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         256 ------YSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ------HHHHHhCCcccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                  1111111  111111 1111233455566788755543  8999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-41  Score=317.11  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|...+.||+|+||.||+|....++..||+|.+..........+.+|+.+++.++||||+++++.+... ...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEeecc
Confidence            5788889999999999999998888999999999876655667789999999999999999999988764 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++....
T Consensus        99 ~~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          99 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             cCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999864        34889999999999999999999888   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      .....  .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||........  ....    .        ..
T Consensus       168 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~----~--------~~  231 (296)
T cd06654         168 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLI----A--------TN  231 (296)
T ss_pred             ccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHH----h--------cC
Confidence            32211  1234688999999999888899999999999999999999999976543211  0000    0        00


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.+..   .......+.+++.+||..+|.+|||+.+|++
T Consensus       232 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         232 GTPELQN---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCCCCC---ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            0111111   1122345677888999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.4e-41  Score=321.52  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=194.2

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ++||+|+||.||++.+..+++.||+|++...   .......+..|..++..+ +||||+++++++.+. ..+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCC
Confidence            4799999999999999988999999999753   223445678899999888 799999999987664 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          80 GGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence            99999888654       45999999999999999999999988   999999999999999999999999998743222


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc--chhHHHHhhHHHhhchhhhhhh
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG--EENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ..  ......||..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+..          ..+
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~----------~~~  217 (329)
T cd05588         150 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF----------QVI  217 (329)
T ss_pred             CC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH----------HHH
Confidence            11  1234679999999999999899999999999999999999999997432211  111111111          111


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC------HHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG------IEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt------~~evl~  340 (398)
                      .......+...   ...+.+++.+||+.+|.+||+      +.++++
T Consensus       218 ~~~~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         218 LEKQIRIPRSL---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HcCCCCCCCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            12222212222   234667778999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-41  Score=312.06  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=202.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCc---EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|+..+.||+|+||.||+|....++.   .+|+|.+... .....+.+..|++++..++|||++++.+++.+.+ ..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-PAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-CcE
Confidence            4578888999999999999999865443   7999998755 2344567899999999999999999999877654 579


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++++|.+++....      ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+
T Consensus        83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          83 IITEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence            9999999999999997542      46899999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCcee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          215 ATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       215 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +........... ......+..|+|||++....++.++|||||||++|||++ |+.||.......      ....     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~-----  222 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKA-----  222 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHH-----
Confidence            986643321111 111223457999999988889999999999999999997 999996543211      1000     


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                         +....  ...   ........+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       223 ---i~~~~--~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         223 ---INDGF--RLP---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---HhcCC--CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               10000  011   1112234577888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-41  Score=311.82  Aligned_cols=260  Identities=24%  Similarity=0.436  Sum_probs=206.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|+..+.||+|+||.||+|....++..+|||.+...   .......+.+|+.+++.++||||+++++++.+.+ ..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-eEEEE
Confidence            4678889999999999999998888999999988643   2334567889999999999999999999887754 58999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          81 LELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            999999999999875321   1356899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......  ......|+..|+|||++.+..++.++||||||+++|+|++|..||......    ......        .+
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~--------~~  220 (267)
T cd08229         155 FFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK--------KI  220 (267)
T ss_pred             ccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh--------hh
Confidence            6644321  123456889999999998888999999999999999999999999653321    111100        11


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .....+...    .......+.+++.+||+.+|.+|||+.+|+++++.
T Consensus       221 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         221 EQCDYPPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             hcCCCCCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            111111111    11223456677789999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.5e-41  Score=321.66  Aligned_cols=242  Identities=24%  Similarity=0.348  Sum_probs=192.4

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      +|...+.||+|+||.||+|....+++.||+|.+.+..   ......+..|..++..+ +|++|+++++++.+. +.+++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-DRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-CEEEEE
Confidence            4778899999999999999999889999999997542   22334567788888777 588899998876654 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        80 ~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          80 MEYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCce
Confidence            9999999999998764       45899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              .
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~--------------~  210 (323)
T cd05616         150 ENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L--------------F  210 (323)
T ss_pred             ecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H--------------H
Confidence            5432221  1234679999999999999999999999999999999999999997643221   1              1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  335 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  335 (398)
                      ..+.......+...   ...+.+++.+|++.+|.+|++.
T Consensus       211 ~~i~~~~~~~p~~~---s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         211 QSIMEHNVAYPKSM---SKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHHhCCCCCCCcC---CHHHHHHHHHHcccCHHhcCCC
Confidence            11111122212112   2346677889999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.2e-41  Score=312.91  Aligned_cols=255  Identities=25%  Similarity=0.339  Sum_probs=201.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++..........+.+|+.++..++||||+++++++... ...++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEe
Confidence            35799999999999999999999888999999999765555556788999999999999999999988765 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++...
T Consensus        87 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          87 YCGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             CCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceee
Confidence            99999999998653       45899999999999999999999887   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ......  .....|+..|+|||.+.   ...++.++|||||||++|||++|+.||..........  ...          
T Consensus       157 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~----------  222 (267)
T cd06646         157 TATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMS----------  222 (267)
T ss_pred             cccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eee----------
Confidence            432211  12346889999999884   3457889999999999999999999986443221100  000          


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ......+....   .......+.+++.+||+.+|.+|||+.++++.
T Consensus       223 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         223 KSNFQPPKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             cCCCCCCCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            00001111110   11122456778889999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-41  Score=324.43  Aligned_cols=265  Identities=26%  Similarity=0.426  Sum_probs=202.5

Q ss_pred             cCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      ++|...+.||+|+||.||+|.+     ..+++.||||.+.... ......+.+|+.++.++ +||||++++++|...+..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5789999999999999999974     2356789999997543 33456788999999999 689999999998877777


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCC--------------------------------------------------------
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGV--------------------------------------------------------  156 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  156 (398)
                      .++||||+++|+|.+++.......                                                        
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            899999999999999987532100                                                        


Q ss_pred             ----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeecccc
Q 015931          157 ----RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG  232 (398)
Q Consensus       157 ----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  232 (398)
                          .....+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                00134788999999999999999999888   99999999999999999999999999986543221111122345


Q ss_pred             CCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCH
Q 015931          233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNS  311 (398)
Q Consensus       233 t~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  311 (398)
                      +..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...   .        .+.....  ...+... 
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~---~--------~~~~~~~--~~~~~~~-  307 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC---R--------RLKEGTR--MRAPDYT-  307 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH---H--------HHhccCC--CCCCCCC-
Confidence            678999999988889999999999999999997 999986532211  000   0        0000000  1111111 


Q ss_pred             HHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          312 AQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       312 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                        ...+.+++..||+.+|.+|||+.+|++.|+..
T Consensus       308 --~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         308 --TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             --CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              13467888899999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-41  Score=314.73  Aligned_cols=269  Identities=29%  Similarity=0.380  Sum_probs=201.1

Q ss_pred             CCCCceecccCceEEEEeee----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEE
Q 015931           62 FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFL  135 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~l  135 (398)
                      |...+.||+|+||+||++..    ..++..||+|.+.... ......+.+|+++++.++||||+++++++...+ ..+++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            47789999999999987653    3457889999997643 234567889999999999999999999876543 45789


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++
T Consensus        86 v~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          86 IMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             EecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence            9999999999999965        34899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      +......... ......++..|+|||.+....++.++||||||+++|||++|..||......-. ..........  ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~--~~~  231 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM--TVV  231 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc--chh
Confidence            8665432111 11223456679999999888899999999999999999999999865432110 0110000000  000


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .+.+.++.....+ ........+.+++.+||+.+|++|||+.+|+++|+..
T Consensus       232 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         232 RLIELLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111111111100 1111234577788899999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-41  Score=311.88  Aligned_cols=263  Identities=24%  Similarity=0.327  Sum_probs=216.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      +.|...+.||.|.-|+||++..+.++..+|+|++.+..   .....+...|-+||+.++||.+..|+..+ +.++..|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-et~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-ETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-eccceeEEE
Confidence            45677789999999999999999999999999998753   34456678899999999999999999985 456778999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||+||+|..++++...     ..+++..++-++..++-||+|||-.|   ||+|||||+||||-++|++-|+||.|+.
T Consensus       156 meyCpGGdL~~LrqkQp~-----~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPG-----KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EecCCCccHHHHHhhCCC-----CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccc
Confidence            999999999999987653     67999999999999999999999988   9999999999999999999999999974


Q ss_pred             ccCC---------------------------------CCC---------------------ceeeeccccCCCcccchhh
Q 015931          217 WTSA---------------------------------PSV---------------------PFLCKTVKGTFGYLAPEYF  242 (398)
Q Consensus       217 ~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~  242 (398)
                      ....                                 ...                     ...+...+||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3210                                 000                     0112345799999999999


Q ss_pred             ccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHH
Q 015931          243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAA  322 (398)
Q Consensus       243 ~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~  322 (398)
                      .+...+.+.|+|+|||++|||+.|..||.+.+..+                 .+..++-..+..+. .+.....+.+||.
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-----------------Tl~NIv~~~l~Fp~-~~~vs~~akDLIr  369 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----------------TLRNIVGQPLKFPE-EPEVSSAAKDLIR  369 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-----------------hHHHHhcCCCcCCC-CCcchhHHHHHHH
Confidence            99999999999999999999999999999876543                 34555555555443 2244556778888


Q ss_pred             hcccccCCCCCC----HHHHHH--HHhcCccch
Q 015931          323 ACISSEESRRPG----IEEIIA--ILRGEEELI  349 (398)
Q Consensus       323 ~cl~~~p~~RPt----~~evl~--~L~~~~~~~  349 (398)
                      +.|.+||.+|..    +.||-+  .+++.+..+
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL  402 (459)
T ss_pred             HHhccChhhhhccccchHHhhcCccccCCChhh
Confidence            999999999998    888776  556655543

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.8e-41  Score=321.16  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=192.7

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ++||+|+||.||+|....+++.||+|++.+.   .......+..|+.++.++ +||||+++++++... ...++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCC
Confidence            4799999999999999988999999999754   233445677888888776 799999999987664 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          80 GGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence            99999888654       45899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccc--hhHHHHhhHHHhhchhhhhhh
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE--ENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ..  ......||..|+|||++.+..++.++|||||||++|||++|+.||........  .....+..          ..+
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~----------~~i  217 (329)
T cd05618         150 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF----------QVI  217 (329)
T ss_pred             CC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH----------HHH
Confidence            21  12345799999999999998999999999999999999999999963221110  01111111          111


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC------HHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG------IEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt------~~evl~  340 (398)
                      .......+...   ...+.+++.+||+.||.+||+      +.++++
T Consensus       218 ~~~~~~~p~~~---~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         218 LEKQIRIPRSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             hcCCCCCCCCC---CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            11122212222   234567778999999999998      466654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.8e-41  Score=320.65  Aligned_cols=242  Identities=24%  Similarity=0.373  Sum_probs=193.2

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||+||+|.+..+++.||+|++....   ......+..|..++..+ +||||+++++++... +.+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            46999999999999998889999999997532   23445677888888877 699999999987664 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          80 GGDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence            99999988764       35899999999999999999999888   999999999999999999999999998753222


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||..|+|||++.+..++.++|||||||++|+|++|+.||.......   .              ...+..
T Consensus       150 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~--------------~~~i~~  210 (318)
T cd05570         150 GV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---L--------------FQSILE  210 (318)
T ss_pred             CC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---H--------------HHHHHc
Confidence            11  1234568999999999999999999999999999999999999997543211   0              011111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH-----HHHHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGI-----EEIIA  340 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evl~  340 (398)
                      .....+...   ...+.+++.+||+.+|.+||++     .++++
T Consensus       211 ~~~~~~~~~---~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         211 DEVRYPRWL---SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCCCCCcC---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            111111112   2346677889999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-41  Score=319.84  Aligned_cols=242  Identities=26%  Similarity=0.369  Sum_probs=190.5

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHh-CCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASS-LHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|.+..+++.||+|.+....   ......+..|..++.. ++||||+++++++.+. ..+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCC
Confidence            47999999999999999889999999997542   2234556677888876 4899999999987765 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          80 GGDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence            99999999764       35899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||..|+|||++.+..++.++|||||||++|||++|+.||.......   +...           +. ...
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~-----------i~-~~~  212 (316)
T cd05619         150 DA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQS-----------IR-MDN  212 (316)
T ss_pred             CC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHH-----------HH-hCC
Confidence            21  1234569999999999998889999999999999999999999997643221   1000           00 001


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHH-HHHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EIIA  340 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl~  340 (398)
                      +.+  +..   ....+.+++.+||+.+|.+||++. ++.+
T Consensus       213 ~~~--~~~---~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         213 PCY--PRW---LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCC--Ccc---CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111  111   123456777899999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-41  Score=316.14  Aligned_cols=261  Identities=28%  Similarity=0.355  Sum_probs=200.8

Q ss_pred             CCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      +|...+.||+|+||.||+|....     .+..||+|++..... .....+..|+.++..++||||+++++++.+.+ ..+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-PLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-ceE
Confidence            46667889999999999998743     257899999975543 33466889999999999999999999987654 479


Q ss_pred             EEEecCCCCCHHHHHhhhcc---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          135 LIYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~---------~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      +++||+++++|.+++.....         .......+++..++.++.|++.||.|||+.+   |+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            99999999999999864211         0011245889999999999999999999888   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHH
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  284 (398)
                      .+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||......+   .   
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~---  235 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V---  235 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---
Confidence            999999999886644332222233456788999999988889999999999999999998 888887543211   1   


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                                 ...+.+....  .........+.+++..||+.+|.+||++++|++.|+.
T Consensus       236 -----------~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 -----------IEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----------HHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                       1111111111  0011223446778889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=309.32  Aligned_cols=253  Identities=28%  Similarity=0.383  Sum_probs=200.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++|...+.||+|++|.||+|....++..||+|.+....     ......+.+|++++++++||||+++++++.+.+ ..+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEE
Confidence            57899999999999999999998889999999986532     123456889999999999999999999887654 689


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        81 ~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999999999998764       45889999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCcee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++.......... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......     .. ...     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~-~~~-----  219 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----AI-FKI-----  219 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----HH-HHH-----
Confidence            976543221111 123457889999999998889999999999999999999999996532211     00 000     


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                        ......+.+  +   ......+.+++.+||..+|.+|||+.++++.
T Consensus       220 --~~~~~~~~~--~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 --ATQPTNPQL--P---SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --hccCCCCCC--C---ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              000001111  1   1122346677789999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.8e-41  Score=315.30  Aligned_cols=269  Identities=26%  Similarity=0.363  Sum_probs=204.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCC----------------cEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeec
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLR----------------TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVP  121 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  121 (398)
                      ..+|...+.||+|+||.||+|.....+                ..||+|.+.... ......+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357889999999999999998875432                458999987653 345678899999999999999999


Q ss_pred             eeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccC
Q 015931          122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG----VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  197 (398)
Q Consensus       122 l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~  197 (398)
                      +++++... ...++||||+++++|.+++......    ......+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus        84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          84 LLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            99988765 4579999999999999999764310    011236899999999999999999999888   999999999


Q ss_pred             cEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc--CCCCCccccc
Q 015931          198 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRKPIEARRL  275 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt--G~~Pf~~~~~  275 (398)
                      ||++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99999999999999999986544332222234456788999999988889999999999999999998  6777754322


Q ss_pred             ccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ..   ...........        .+.... ..........+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       240 ~~---~~~~~~~~~~~--------~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQ---VIENAGHFFRD--------DGRQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HH---HHHHHHhcccc--------cccccc-CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            11   11111000000        000000 0011112246788889999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.7e-41  Score=312.72  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=193.8

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ||+|+||+||++....+++.||+|.+.....   ...+.+..|+.+++.++||||+++.+++... ...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-TDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-CeEEEEEeCCCCCC
Confidence            6999999999999988899999999875422   2335678899999999999999999876654 55899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |..++.....   ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........ 
T Consensus        80 L~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          80 LRYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             HHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            9988854321   1356899999999999999999999988   99999999999999999999999999976644322 


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCccc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  304 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  304 (398)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........  .           ....+.....
T Consensus       153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~-----------~~~~~~~~~~  218 (280)
T cd05608         153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-----------LKQRILNDSV  218 (280)
T ss_pred             -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H-----------HHHhhcccCC
Confidence             1234568999999999999999999999999999999999999997543221100  0           0111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          305 KCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       305 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ..+.   .....+.+++.+||+.+|.+||     ++.++++
T Consensus       219 ~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 TYPD---KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCcc---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            1111   2234466777899999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.2e-41  Score=313.51  Aligned_cols=260  Identities=24%  Similarity=0.377  Sum_probs=202.6

Q ss_pred             cCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .+|...+.||+|+||.||++...     .++..+|+|.+..........+.+|+++++.++|+||+++++++.+.. ..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-PLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-ceE
Confidence            56778899999999999999642     346689999988776666778999999999999999999999887654 479


Q ss_pred             EEEecCCCCCHHHHHhhhccC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          135 LIYKYVSGGSLERHLHEKKKG--------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      +||||+++++|.+++......        ......+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            999999999999999764210        011135899999999999999999999888   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||........   .   
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---  234 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I---  234 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H---
Confidence            99999999876543322111223345778999999998899999999999999999998 9999865332211   0   


Q ss_pred             hHHHhhchhhhhhhcCc-ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          286 KPILHRGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                                 ..+... ....+...+   ..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       235 -----------~~~~~~~~~~~~~~~~---~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 -----------ECITQGRELERPRTCP---PEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -----------HHHHcCccCCCCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                       001010 011111122   34567778999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-41  Score=313.14  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=200.4

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC-----
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE-----  130 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  130 (398)
                      .+++.|+..+.||+|+||.||+|....+++.||+|.+.... .....+..|+.++.++ +||||+++++++...+     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888999999999999999998889999999997543 3345788899999998 7999999999887532     


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...++||||+++++|.+++.....     ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEc
Confidence            347899999999999999976432     46899999999999999999999888   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  285 (398)
                      |||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|+.||..........     
T Consensus       154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----  226 (272)
T cd06637         154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----  226 (272)
T ss_pred             cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----
Confidence            9999986543221  123456899999999986     3357889999999999999999999996533211000     


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                               .......+... ..   .....+.+++.+||..+|.+|||+.++++
T Consensus       227 ---------~~~~~~~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         227 ---------LIPRNPAPRLK-SK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ---------HHhcCCCCCCC-CC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                     00000111111 11   11234677888999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-41  Score=327.49  Aligned_cols=194  Identities=24%  Similarity=0.293  Sum_probs=168.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|...+.||+|+||.||++....+++.||+|....      ..+.+|++++++++||||+++++++... ...++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN-KFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC-CeeEEEEec
Confidence            679999999999999999999999999999997532      3467899999999999999999987664 457899999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      + +++|..++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       165 ~-~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        165 Y-KTDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             C-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            9 57898888654       35899999999999999999999988   9999999999999999999999999997543


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       234 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        234 DINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            2211 112345799999999999988999999999999999999999988754

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4e-41  Score=319.27  Aligned_cols=241  Identities=23%  Similarity=0.346  Sum_probs=189.6

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHh-CCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASS-LHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ++||+|+||.||+|.+..+++.||+|.+....   ......+..|..++.. .+||||+++++++.+. +.+++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-EHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-CEEEEEECCCC
Confidence            47999999999999999889999999997532   2234556678777775 4899999999987764 46899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          80 GGDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence            99999998764       45899999999999999999999988   999999999999999999999999998743222


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||..|+|||++.+..++.++|||||||++|||++|+.||.......   +..   .        +. ...
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~---~--------~~-~~~  212 (316)
T cd05620         150 DN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFE---S--------IR-VDT  212 (316)
T ss_pred             CC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---H--------HH-hCC
Confidence            11  1245679999999999998899999999999999999999999997543211   100   0        00 001


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHH-HHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EII  339 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl  339 (398)
                      +.+  +...+   ..+.+++.+||+.||.+||++. +++
T Consensus       213 ~~~--~~~~~---~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 PHY--PRWIT---KESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCC--CCCCC---HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111  11122   3456677889999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.1e-41  Score=312.59  Aligned_cols=248  Identities=25%  Similarity=0.295  Sum_probs=193.4

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ||+|+||.||++....+++.||+|.+....   ......+..|++++.+++||||+++++++.+. ...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-THLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-CeEEEEEecCCCCC
Confidence            699999999999998889999999996432   12234556799999999999999999987664 45899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |..++.....     ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......  
T Consensus        80 L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--  149 (277)
T cd05607          80 LKYHIYNVGE-----RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--  149 (277)
T ss_pred             HHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence            9988865432     45899999999999999999999888   9999999999999999999999999988665432  


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCccc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  304 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  304 (398)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  ....           ....+....
T Consensus       150 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~-----------~~~~~~~~~  215 (277)
T cd05607         150 -TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEEL-----------KRRTLEDEV  215 (277)
T ss_pred             -eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHH-----------HHHhhcccc
Confidence             12345689999999999988899999999999999999999999975432111  0010           011111111


Q ss_pred             CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          305 KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       305 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      ...  .......+.+++..||+.+|.+||++.|+++.+
T Consensus       216 ~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         216 KFE--HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccc--cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            100  011223467778889999999999998876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-41  Score=330.49  Aligned_cols=203  Identities=28%  Similarity=0.375  Sum_probs=173.4

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .|...+.||+|+||.||+|....+++.||+|++....   ......+.+|+.+++.++||||+++++.+.+. ..+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEEE
Confidence            5788899999999999999998889999999997532   23456788999999999999999999988765 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        81 E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          81 DYIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999998764       35889999999999999999999988   99999999999999999999999999753


Q ss_pred             cCCCC---------------------------------------------CceeeeccccCCCcccchhhccCCcCCccc
Q 015931          218 TSAPS---------------------------------------------VPFLCKTVKGTFGYLAPEYFQHGKVSDKTD  252 (398)
Q Consensus       218 ~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksD  252 (398)
                      +....                                             .........||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            21000                                             000012346999999999999889999999


Q ss_pred             hhhHHHHHHHHHcCCCCCcccc
Q 015931          253 VYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       253 v~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ||||||++|||++|+.||...+
T Consensus       231 iwSlGvil~elltG~~Pf~~~~  252 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQT  252 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCC
Confidence            9999999999999999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.2e-41  Score=320.93  Aligned_cols=238  Identities=28%  Similarity=0.399  Sum_probs=187.7

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHH-HHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||+||+|....+++.||+|++....   ......+..|.. +++.++||||+++++++.+. ...++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCC
Confidence            47999999999999999889999999997532   222344555554 45779999999999987664 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          80 GGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            99999998764       45899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...      .           ...+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~-----------~~~i~~  210 (323)
T cd05575         150 SK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------M-----------YDNILN  210 (323)
T ss_pred             CC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------H-----------HHHHHc
Confidence            21  1234569999999999998899999999999999999999999997643211      0           111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE  336 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  336 (398)
                      .........   ...+.+++.+||+.+|.+||++.
T Consensus       211 ~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         211 KPLRLKPNI---SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCCC---CHHHHHHHHHHhhcCHHhCCCCC
Confidence            111111112   23466777899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.8e-41  Score=309.74  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=198.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|...+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++.+++||||+++++++.+.+ ..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-PIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-CcEEEEEc
Confidence            457778899999999999998764 45699999875432 3467899999999999999999999886654 57999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        81 ~~~~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          81 MSNGCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            99999999997642      35899999999999999999999888   9999999999999999999999999988654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...   .        +..
T Consensus       152 ~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~--------~~~  216 (256)
T cd05113         152 DDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE---K--------VSQ  216 (256)
T ss_pred             CCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---H--------Hhc
Confidence            3321 11122345678999999988889999999999999999998 999986543211   000   0        000


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ...  .....   .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       217 ~~~--~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         217 GLR--LYRPH---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCC--CCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            000  00011   12346777888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=315.42  Aligned_cols=268  Identities=24%  Similarity=0.366  Sum_probs=200.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCC--------------CcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceee
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLL--------------RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVG  124 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~  124 (398)
                      ++|...+.||+|+||.||++.....              ...||+|.+... .......|.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788899999999999999876432              235899998764 3344567999999999999999999999


Q ss_pred             EEEcCCCcEEEEEecCCCCCHHHHHhhhcc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcE
Q 015931          125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  199 (398)
Q Consensus       125 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NI  199 (398)
                      ++... ...++||||+++++|.+++.....     .......+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          85 VCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            98764 458999999999999999965321     0011134789999999999999999999888   99999999999


Q ss_pred             EeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc--CCCCCccccccc
Q 015931          200 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRKPIEARRLQG  277 (398)
Q Consensus       200 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt--G~~Pf~~~~~~~  277 (398)
                      ++++++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976543322222223345778999999998899999999999999999998  566776533211


Q ss_pred             chhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                         ............   .....   ..   ........+.+++.+||+.+|.+||++.+|++.|+
T Consensus       241 ---~~~~~~~~~~~~---~~~~~---~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 ---VIENTGEFFRNQ---GRQIY---LS---QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHHhhhhc---ccccc---CC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               111111100000   00000   00   01112246888889999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7e-41  Score=307.96  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=193.6

Q ss_pred             eecccCceEEEEeee--CCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           67 VLGRGALSFVFKGKV--GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      .||+|+||.||+|.+  ..++..+|+|++....  ....+.+..|+.+++.++||||+++++++..  ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence            589999999999965  3457889999986543  3345678999999999999999999998743  346899999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |+|.+++...       ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          80 GPLNKFLQKN-------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            9999999753       35899999999999999999999888   9999999999999999999999999998765433


Q ss_pred             Cceee-eccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          223 VPFLC-KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       223 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                      ..... ....++..|+|||.+....++.++|||||||++|||++ |+.||.......   ...   .        +....
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~--------i~~~~  215 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQ---M--------IESGE  215 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H--------HHCCC
Confidence            21111 12234578999999988889999999999999999998 999997543221   111   0        11100


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       301 d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .+..  +...+   ..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       216 ~~~~--~~~~~---~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         216 RMEC--PQRCP---PEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCC--CCCCC---HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            1111  11122   346677889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.5e-41  Score=324.56  Aligned_cols=269  Identities=20%  Similarity=0.300  Sum_probs=199.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----CcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~  134 (398)
                      +|+..+.||+|+||.||++....+++.||+|.+...  .....+.+.+|+++++.++||||+++++++...+    ...|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999888999999998653  2334567889999999999999999999887654    2579


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +|+||+. ++|.+.+...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 lv~e~~~-~~l~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccc
Confidence            9999995 6888877543       45899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-----HH
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PI  288 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-----~~  288 (398)
                      ++........ ......+|..|+|||.+.+. .++.++|||||||++|||++|+.||...+............     ..
T Consensus       150 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9865433221 12334678999999998764 47899999999999999999999998655432111111000     00


Q ss_pred             Hhhchhhhhhhc-CcccCCC------CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          289 LHRGMAAVEELL-DPRLKCT------SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       289 ~~~~~~~~~~~~-d~~l~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      +..........+ ......+      .........+.+++.+||+.||.+|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000000000000 0000000      0001113456788889999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.3e-41  Score=311.75  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=197.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...++||+|+||.||+|.+..+++.||+|.+... .......+.+|++++.+++||||+++++++... +..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEe
Confidence            3677888999999999999999888999999998754 334456789999999999999999999988775 45789999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|..+.           .+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          80 FMDGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             cCCCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            99999996542           3788899999999999999999888   999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchh-HHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  297 (398)
                      ....    .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... ......        .+.
T Consensus       146 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~  213 (279)
T cd06619         146 VNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ--------CIV  213 (279)
T ss_pred             cccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH--------HHh
Confidence            4332    234568999999999998889999999999999999999999997533221110 000000        001


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ....+.+...    .....+.+++.+|++.+|.+||++.++++.
T Consensus       214 ~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         214 DEDPPVLPVG----QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ccCCCCCCCC----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1111111111    122346777889999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.4e-41  Score=312.98  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      +.|...+.||.|+||.||+|....++..|++|.+..........+..|+.+++.++||||+++++.+... ...++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-GKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-CeEEEEEec
Confidence            5788899999999999999999888999999999877777778899999999999999999999987764 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|..++....      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        91 ~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          91 CPGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999998886542      45899999999999999999999887   9999999999999999999999999987543


Q ss_pred             CCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ....  ......++..|+|||++.     ...++.++|||||||++|||++|..||...+...  ..    .        
T Consensus       162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~----~--------  225 (292)
T cd06644         162 KTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VL----L--------  225 (292)
T ss_pred             cccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HH----H--------
Confidence            3211  123456888999999884     3456889999999999999999999997543211  00    0        


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+.....+....   .......+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         226 KIAKSEPPTLSQ---PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHhcCCCccCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            011111111111   1122235677888999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.5e-41  Score=313.88  Aligned_cols=261  Identities=26%  Similarity=0.413  Sum_probs=202.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .++|...+.||+|+||.||+|...     .++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+ .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-P   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-c
Confidence            467889999999999999999874     256789999987543 344567999999999999999999999887654 4


Q ss_pred             EEEEEecCCCCCHHHHHhhhccC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccC
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKG---------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  197 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~  197 (398)
                      .++||||+++|+|.+++......               ......+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            79999999999999999753210               011235889999999999999999999888   999999999


Q ss_pred             cEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccc
Q 015931          198 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ  276 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~  276 (398)
                      ||++++++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999875543221111122345677999999988899999999999999999997 88888653321


Q ss_pred             cchhHHHHhhHHHhhchhhhhhhcCccc-CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          277 GEENLVLWAKPILHRGMAAVEELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      +   ..              ..+.+... ..+.   .....+.+++.+||+.+|.+|||+.|+++.|+
T Consensus       240 ~---~~--------------~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 E---VI--------------YYVRDGNVLSCPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H---HH--------------HHHhcCCCCCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1   11              11111111 1111   12345777888999999999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.9e-41  Score=323.07  Aligned_cols=267  Identities=21%  Similarity=0.324  Sum_probs=199.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----C
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  131 (398)
                      .++|...+.||+|+||.||++....+++.||||++...  .......+.+|+.+++.++||||+++++++...+     .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            47899999999999999999999888999999999753  2334567889999999999999999999765432     3


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+|+||||++ ++|.+.+..         .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh---------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEe
Confidence            4799999995 577777743         3789999999999999999999888   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh-----h
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----K  286 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~-----~  286 (398)
                      ||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...+.......+...     .
T Consensus       170 fG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (364)
T cd07875         170 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  246 (364)
T ss_pred             CCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99998654322   123456899999999999989999999999999999999999999765432211110000     0


Q ss_pred             HHHhhchhhhhhhcCcc--------------cCCC---CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          287 PILHRGMAAVEELLDPR--------------LKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       287 ~~~~~~~~~~~~~~d~~--------------l~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .........+......+              ...+   .........+.+++.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000000000000              0000   0000112356788899999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.3e-41  Score=312.52  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=199.0

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      |+..+.||+|+||.||+|....++..+++|.+..........+.+|+++++.++|||++++++++... ...++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEecC
Confidence            45667899999999999999888999999999876666677899999999999999999999988775 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +++|..++....      ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          86 GGAVDAVMLELE------RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            999999886532      46899999999999999999999988   999999999999999999999999998765332


Q ss_pred             CCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ..  ......++..|+|||++.     +..++.++|||||||++|||++|+.||.......  ....            .
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~------------~  220 (282)
T cd06643         157 IQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLK------------I  220 (282)
T ss_pred             cc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHH------------H
Confidence            11  123456899999999984     3457889999999999999999999997543211  0000            0


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .....+.+..+...   ...+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         221 AKSEPPTLAQPSRW---SSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             hhcCCCCCCCcccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00011111111111   2346677789999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-41  Score=330.94  Aligned_cols=205  Identities=26%  Similarity=0.339  Sum_probs=174.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||++....+++.||+|++....   ......+.+|+.++.+++||||+++++.+.+. +.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CEEEEE
Confidence            36888999999999999999999889999999986532   22345688999999999999999999987764 568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          80 MDYIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            9999999999999764       45889999999999999999999988   9999999999999999999999999975


Q ss_pred             ccCCCC-----------------------------------------CceeeeccccCCCcccchhhccCCcCCccchhh
Q 015931          217 WTSAPS-----------------------------------------VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYA  255 (398)
Q Consensus       217 ~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S  255 (398)
                      .+....                                         .........||+.|+|||++.+..++.++||||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  229 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  229 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence            321000                                         000012346999999999999889999999999


Q ss_pred             HHHHHHHHHcCCCCCccccc
Q 015931          256 FGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       256 ~Gvvl~elltG~~Pf~~~~~  275 (398)
                      |||++|||++|+.||.....
T Consensus       230 lGvilyell~G~~Pf~~~~~  249 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTP  249 (376)
T ss_pred             ccceeeehhhCCCCCCCCCH
Confidence            99999999999999986543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.2e-41  Score=318.31  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=191.0

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ++||+|+||.||+|....+++.||+|++....   ......+..|+.++.++ +||||+++++++.+. ..+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-SRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-CEEEEEEeCCC
Confidence            47999999999999999889999999997642   23445678899998888 699999999987654 55899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          80 GGDLMFHMQRQ-------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence            99999988754       45999999999999999999999988   999999999999999999999999998753322


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+....          +..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~----------~~~  217 (327)
T cd05617         150 GD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----------ILE  217 (327)
T ss_pred             CC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH----------HHh
Confidence            21  123467999999999999889999999999999999999999999754322211111111111          111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  335 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  335 (398)
                      .....+...+   ..+.+++.+||+.||.+||++
T Consensus       218 ~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         218 KPIRIPRFLS---VKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCCCCC---HHHHHHHHHHhccCHHHcCCC
Confidence            1111122222   345677788999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.2e-41  Score=308.00  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=198.7

Q ss_pred             ceecccCceEEEEeeeCC-CC--cEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGL-LR--TSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|++|.||+|.+.. .+  ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+  ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999998754 23  3699999987655 567789999999999999999999999877  56899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +++|.+++.....     ..++|..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.....
T Consensus        79 ~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          79 LGSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             CCcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence            9999999986431     35899999999999999999999888   999999999999999999999999999876543


Q ss_pred             CCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          222 SVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       222 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      .... ......++..|+|||++.+..++.++||||||+++|||++ |..||...+...   ...   .        +.. 
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~--------~~~-  215 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---K--------IDK-  215 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H--------HHh-
Confidence            2211 1123457789999999998899999999999999999998 999996433221   100   0        000 


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ....+..+   ......+.+++.+||+.+|++||++.+|++.|.
T Consensus       216 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         216 EGERLERP---EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCcCCCC---ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00111111   112345777888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-41  Score=321.91  Aligned_cols=239  Identities=26%  Similarity=0.330  Sum_probs=190.2

Q ss_pred             ceecccCceEEEEeee---CCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           66 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      +.||+|+||.||++..   ..+++.||+|++....  ......+..|++++++++||||+++++++.+. +..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-GKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CEEEEEEcCC
Confidence            5799999999999875   3468899999997542  22344577899999999999999999987764 4589999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        81 ~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          81 RGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            999999998653       45899999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                      ...  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......                 .+..+.
T Consensus       151 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----------------~~~~i~  211 (318)
T cd05582         151 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----------------TMTMIL  211 (318)
T ss_pred             CCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----------------HHHHHH
Confidence            321  1234679999999999998889999999999999999999999997643211                 011111


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHH
Q 015931          301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEE  337 (398)
Q Consensus       301 d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e  337 (398)
                      ......+...+   ..+.+++.+||+.+|.+||++.+
T Consensus       212 ~~~~~~p~~~~---~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         212 KAKLGMPQFLS---PEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             cCCCCCCCCCC---HHHHHHHHHHhhcCHhHcCCCCC
Confidence            11121122222   34566778899999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.5e-41  Score=307.84  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=199.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|+..+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++++++|+|++++++++.+  ...++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEe
Confidence            478888999999999999998764 67799999876433 34678999999999999999999998643  347899999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++....     ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++....
T Consensus        82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          82 MSKGSLLDFLKDGE-----GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             cCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            99999999997642     145899999999999999999999988   9999999999999999999999999998664


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+   ....           +..
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~-----------~~~  218 (260)
T cd05070         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ-----------VER  218 (260)
T ss_pred             Ccccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH-----------HHc
Confidence            43211 1112335678999999988889999999999999999999 899996543211   1100           000


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...  ...+   ......+.+++.+|++.+|.+|||+.++++.|+.
T Consensus       219 ~~~--~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 GYR--MPCP---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCC--CCCC---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            000  1111   1223457788889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.1e-41  Score=328.06  Aligned_cols=266  Identities=25%  Similarity=0.409  Sum_probs=202.7

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcC
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDP  129 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  129 (398)
                      ...++|...+.||+|+||.||+|.+.     ..+..||+|++.... ....+.+.+|+.++.++. ||||++++++|...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34457888899999999999999864     234689999997643 233457889999999997 99999999998775


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccC------------------------------------------------------
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKG------------------------------------------------------  155 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------  155 (398)
                      + ..++||||+++|+|.+++......                                                      
T Consensus       114 ~-~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         114 G-PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             C-CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            4 589999999999999999753210                                                      


Q ss_pred             -------------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCc
Q 015931          156 -------------------------------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  198 (398)
Q Consensus       156 -------------------------------------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~N  198 (398)
                                                           ......+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence                                                 011235788899999999999999999877   9999999999


Q ss_pred             EEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCccccccc
Q 015931          199 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQG  277 (398)
Q Consensus       199 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~  277 (398)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986543221111223457788999999998889999999999999999998 899986533211


Q ss_pred             chhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .  .    ...       +..-.  +...+...   ...+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       350 ~--~----~~~-------~~~~~--~~~~p~~~---~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         350 Q--F----YNA-------IKRGY--RMAKPAHA---SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             H--H----HHH-------HHcCC--CCCCCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            0  0    000       00000  11111112   2456777789999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.5e-41  Score=308.82  Aligned_cols=254  Identities=28%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+..+ ..||+|.+..... ....+.+|+++++.++||||+++++++.+  ...++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e   80 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE   80 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEE
Confidence            35688899999999999999988754 5699999975432 34578999999999999999999997643  34789999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++|+|.+++....     ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||.+...
T Consensus        81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          81 YMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             cCCCCcHHHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeec
Confidence            999999999997632     145899999999999999999999888   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ...... ......++..|+|||+..+..++.++||||||+++|||++ |..||.......   ..   ..        +.
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~---~~--------~~  217 (262)
T cd05071         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL---DQ--------VE  217 (262)
T ss_pred             cccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH---HH--------Hh
Confidence            543221 1123446778999999988889999999999999999999 888887543221   00   00        00


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...  ...   ........+.+++.+|++.+|.+||++.++++.|+.
T Consensus       218 ~~~--~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         218 RGY--RMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             cCC--CCC---CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            000  011   112234567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.7e-41  Score=322.86  Aligned_cols=268  Identities=21%  Similarity=0.329  Sum_probs=199.7

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  130 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  130 (398)
                      ..++|...+.||+|+||.||++....+++.||+|.+...  .......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            357899999999999999999999888999999999753  2334567889999999999999999999875432     


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...++||||++ ++|.+.+..         .+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEe
Confidence            24689999995 467776643         3889999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh-----
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----  285 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~-----  285 (398)
                      |||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...............     
T Consensus       162 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (355)
T cd07874         162 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_pred             eCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999998654322   123456899999999999888999999999999999999999999765432111100000     


Q ss_pred             hHHHhhchhhhhhhcCcc----------------cCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          286 KPILHRGMAAVEELLDPR----------------LKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~----------------l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ..........+...++..                .... .........+.+++.+||+.||.+|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000000011111000                0000 0001122456788899999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-40  Score=306.80  Aligned_cols=248  Identities=27%  Similarity=0.435  Sum_probs=193.0

Q ss_pred             eecccCceEEEEeeeC--CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCC
Q 015931           67 VLGRGALSFVFKGKVG--LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      .||+|+||.||+|.+.  ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++..  ...++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence            3899999999999764  345679999987653 3345678999999999999999999998743  3478999999999


Q ss_pred             CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC
Q 015931          144 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  223 (398)
Q Consensus       144 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  223 (398)
                      +|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        80 ~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          80 PLNKFLSGKK------DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            9999987532      46899999999999999999999888   99999999999999999999999999986544322


Q ss_pred             cee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          224 PFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       224 ~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ... .....++..|+|||.+....++.++|||||||++||+++ |..||......+.   .    ..       +.....
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~----~~-------~~~~~~  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---M----SF-------IEQGKR  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---H----HH-------HHCCCC
Confidence            111 111223578999999988889999999999999999996 9999975432210   0    00       111011


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      +  ..+...   ...+.+++.+||..+|++||++.+|.+.|+.
T Consensus       217 ~--~~~~~~---~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         217 L--DCPAEC---PPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             C--CCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            1  111122   2456677889999999999999999998874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-41  Score=337.16  Aligned_cols=270  Identities=15%  Similarity=0.202  Sum_probs=197.6

Q ss_pred             HHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCC------CCeeceeeEEE
Q 015931           54 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH------PNIVPLVGFCI  127 (398)
Q Consensus        54 e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~  127 (398)
                      ++...+++|...+.||+|+||+||+|.+..+++.||||++.... .....+..|++++..++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999998889999999996532 223445667777776654      45889999887


Q ss_pred             cCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCC-
Q 015931          128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKK-  205 (398)
Q Consensus       128 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~-  205 (398)
                      ......++||+++ +++|.+++...       ..+++..+..|+.|++.||.|||+ .+   |+||||||+|||++.++ 
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDT  270 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCc
Confidence            7666789999998 88999988754       459999999999999999999997 47   99999999999998765 


Q ss_pred             ---------------CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCC
Q 015931          206 ---------------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI  270 (398)
Q Consensus       206 ---------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf  270 (398)
                                     .+||+|||++......     .....||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                           4999999987643222     23467999999999999999999999999999999999999999


Q ss_pred             cccccccchhHHHHhhH----HHhhc--hhhhhhhcC------cccC--------C--CCCCHHHHHHHHHHHHhccccc
Q 015931          271 EARRLQGEENLVLWAKP----ILHRG--MAAVEELLD------PRLK--------C--TSRNSAQIARVIQAAAACISSE  328 (398)
Q Consensus       271 ~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~d------~~l~--------~--~~~~~~~~~~l~~l~~~cl~~~  328 (398)
                      ......+..........    .+...  .....++.+      +...        .  ..........+.+++.+||+.|
T Consensus       346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            76543221111111000    00000  000000100      0000        0  0000011245678999999999


Q ss_pred             CCCCCCHHHHHH
Q 015931          329 ESRRPGIEEIIA  340 (398)
Q Consensus       329 p~~RPt~~evl~  340 (398)
                      |.+|||+.|+++
T Consensus       426 P~~R~ta~e~L~  437 (467)
T PTZ00284        426 RQKRLNARQMTT  437 (467)
T ss_pred             hhhCCCHHHHhc
Confidence            999999999997

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.5e-41  Score=313.12  Aligned_cols=265  Identities=21%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      ..++|+..+.||+|+||.||+|...+     .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+ 
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            45789999999999999999997542     24579999886543 233456889999999999999999999877654 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCee
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGV---RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  208 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  208 (398)
                      ..++||||+++|+|.+++.......   .....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            5799999999999999997642211   11245678889999999999999999888   99999999999999999999


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......+   ..     
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~-----  231 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL-----  231 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-----
Confidence            999999886543322111122345678999999998899999999999999999998 788886532211   00     


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                               ..+.+....  .........+.+++.+||+.+|++|||+.++++.|+..
T Consensus       232 ---------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 ---------KFVMDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ---------HHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                     111111110  00111124677888899999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.3e-41  Score=310.28  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=199.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCc---EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .+|...+.||+|+||.||+|....++.   .||+|.+... .......|..|+.+++.++||||+++++++.+. ...++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-RPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-CceEE
Confidence            357778999999999999999876554   5999998764 344567899999999999999999999987654 45799


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          83 ITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             EEecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccc
Confidence            999999999999987642      45899999999999999999999888   999999999999999999999999998


Q ss_pred             cccCCCCCceeee-ccc--cCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhh
Q 015931          216 TWTSAPSVPFLCK-TVK--GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       216 ~~~~~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ............. ...  .+..|+|||++....++.++|||||||++|||++ |..||.......   ...+       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~-------  223 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINA-------  223 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHH-------
Confidence            7654322111111 111  2457999999998899999999999999999886 999997543221   1111       


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                          +..  +.....+.   .....+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       224 ----i~~--~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         224 ----IEQ--DYRLPPPM---DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ----HHc--CCcCCCcc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                100  00111111   122346678889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-41  Score=316.19  Aligned_cols=266  Identities=21%  Similarity=0.374  Sum_probs=204.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-------CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  129 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  129 (398)
                      .++|...+.||+|+||.||+|...       ..+..||+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888999999999999999752       234579999987542 34456789999999999 899999999987765


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                       ...++||||+++|+|.+++.......         .....+++..+..++.|++.||.|||+.+   ++||||||+||+
T Consensus        94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          94 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence             45899999999999999997642110         01245889999999999999999999988   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccch
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  279 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  279 (398)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......+  
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--  247 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  247 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence            99999999999999987654332222223346678999999988889999999999999999998 788886533211  


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                          ..... ...         .....+.   .....+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       248 ----~~~~~-~~~---------~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         248 ----LFKLL-KEG---------HRMDKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ----HHHHH-HcC---------CcCCCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                11100 000         0011111   123456677889999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.1e-41  Score=320.46  Aligned_cols=242  Identities=26%  Similarity=0.389  Sum_probs=188.3

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHH-HHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCREL-MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||+||+|.+..+++.||+|++....   ......+..|. .+++.++||||+++++++.+. +..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCC
Confidence            46999999999999999889999999997532   12233444444 356788999999999987665 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          80 GGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             CCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            99999999764       45788899999999999999999988   999999999999999999999999998754322


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   .              ...+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~--------------~~~i~~  210 (325)
T cd05602         150 NG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---M--------------YDNILN  210 (325)
T ss_pred             CC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---H--------------HHHHHh
Confidence            21  1234679999999999999899999999999999999999999997643221   0              111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+......+   ..+.+++.+||+.+|.+||++.+.+.
T Consensus       211 ~~~~~~~~~~---~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         211 KPLQLKPNIT---NSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCcCCCCCCC---HHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            1111111122   34566777899999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=306.27  Aligned_cols=255  Identities=29%  Similarity=0.467  Sum_probs=202.5

Q ss_pred             ceecccCceEEEEeeeCCC---CcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|.....   +..|++|.+...... ....+.+|++.+..++|+|++++++++.. +...++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            4699999999999998765   889999999865433 36788999999999999999999998877 455899999999


Q ss_pred             CCCHHHHHhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          142 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       142 ~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|.+++......  ......+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999875210  000256899999999999999999999988   9999999999999999999999999998776


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ............++..|+|||.+....++.++||||||+++|||++ |..||.......   ...           .+..
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-----------~~~~  222 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE-----------YLRK  222 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-----------HHHc
Confidence            5432222334567889999999988889999999999999999999 699997653211   110           0111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                        ......+.   .....+.+++.+||+.+|.+|||+.++++.|+
T Consensus       223 --~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --GYRLPKPE---YCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCCCc---cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              11111111   12345778888999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-41  Score=321.79  Aligned_cols=242  Identities=29%  Similarity=0.408  Sum_probs=189.5

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHH-HHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|....+++.||+|++...   .......+..|.. +++.++||||+++++++... +..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-CEEEEEEcCCC
Confidence            4699999999999999888999999999653   2223345556654 46779999999999987664 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          80 GGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            99999888653       45899999999999999999999988   999999999999999999999999998753222


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||..|+|||++.+..++.++|||||||++|||++|+.||...+...   +              ...+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~--------------~~~~~~  210 (325)
T cd05604         150 SD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---M--------------YDNILH  210 (325)
T ss_pred             CC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---H--------------HHHHHc
Confidence            11  1234579999999999999899999999999999999999999997643221   0              111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+......   ...+.+++.+|++.+|.+||++.+.++
T Consensus       211 ~~~~~~~~~---~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         211 KPLVLRPGA---SLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             CCccCCCCC---CHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            111111112   234567778999999999999864443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=306.28  Aligned_cols=250  Identities=28%  Similarity=0.500  Sum_probs=202.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||.|+||.||+|...  ++.||+|.+..... ..+++.+|+.++..++|+||+++++++.+ ....++|||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   80 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTE   80 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEE
Confidence            457888999999999999999875  78899999976544 56789999999999999999999999876 455899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.++..
T Consensus        81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          81 YMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             ecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccc
Confidence            9999999999976532     36899999999999999999999888   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ....     ....++..|+|||++..+.++.++||||||+++|||++ |+.||.......   +..           .+.
T Consensus       153 ~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-----------~~~  213 (256)
T cd05039         153 SQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP-----------HVE  213 (256)
T ss_pred             cccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-----------HHh
Confidence            4322     12335678999999988889999999999999999997 999986543221   110           001


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...  ....+.   .....+.+++.+||..+|.+||++.+++++|+.
T Consensus       214 ~~~--~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         214 KGY--RMEAPE---GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             cCC--CCCCcc---CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            100  111111   122456778889999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-41  Score=307.82  Aligned_cols=251  Identities=26%  Similarity=0.435  Sum_probs=197.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|+..+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+++++.++||||+++++++... ...++||||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEec
Confidence            357788999999999999998864 66899999865432 345688899999999999999999987654 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++....      ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        81 ~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          81 MANGCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence            99999999997642      35899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ...           .+..
T Consensus       152 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-----------~~~~  216 (256)
T cd05059         152 DDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE-----------SVSA  216 (256)
T ss_pred             ccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH-----------HHHc
Confidence            32211 1112234557999999998899999999999999999999 899997543221   000           1111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      ......  +..   ....+.+++.+||+.+|++|||+.++++.|
T Consensus       217 ~~~~~~--~~~---~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 GYRLYR--PKL---APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCcCCC--CCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            111111  111   234577888899999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-40  Score=307.89  Aligned_cols=257  Identities=23%  Similarity=0.393  Sum_probs=201.9

Q ss_pred             HHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           55 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        55 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      +..+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++..+ +..+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~   81 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFK   81 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEE
Confidence            345667777788999999999999998888899999999877666777899999999999999999999988765 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeEec
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTL--PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCD  211 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~D  211 (398)
                      +|+||+++++|.+++....      ..+  ++..+..++.|++.||.|||+.+   |+||||||+||+++. ++.++|+|
T Consensus        82 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEec
Confidence            9999999999999997642      234  78889999999999999999888   999999999999986 67999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCC--cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      ||++........  ......|+..|+|||++....  ++.++||||||+++|+|++|+.||.......   ...+.....
T Consensus       153 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~  227 (268)
T cd06624         153 FGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMF  227 (268)
T ss_pred             chhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhh
Confidence            999876543221  122345889999999986643  7889999999999999999999996432211   111100000


Q ss_pred             hhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                              . ..+.+     .......+.+++.+||+.+|.+|||+.++++
T Consensus       228 --------~-~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 --------K-IHPEI-----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --------c-cCCCC-----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                    0 01111     1112244667788999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=306.50  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=195.9

Q ss_pred             ceecccCceEEEEeeeCCCC---cEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|.+...+   ..+|+|.+..... ...+.+..|+.+++.++||||+++++++..  ...++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence            46999999999999875444   7899999876543 345678999999999999999999998653  34799999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|.+++...       ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.....
T Consensus        79 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          79 LGPLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999999764       35899999999999999999999888   999999999999999999999999999866543


Q ss_pred             CCcee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          222 SVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       222 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ..... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......   ....+.    ...       
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~----~~~-------  214 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML----ESG-------  214 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HcC-------
Confidence            32211 111223567999999998899999999999999999998 99999754321   111110    000       


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       . ....+..   ....+.+++.+||..+|.+||++.+|++.|+++
T Consensus       215 -~-~~~~~~~---~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         215 -E-RLPRPEE---CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -C-cCCCCCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             0 0111111   224567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-40  Score=305.66  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=203.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|+..+.||+|+||.||+|....++..+++|.+.....  .+.+.+|+++++.++||||+++++++.+. ...++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEec
Confidence            678889999999999999999988889999999975432  67899999999999999999999988775 558999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        80 ~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          80 CGAGSVSDIMKITN------KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            99999999997542      46899999999999999999999888   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.........  .            .+...
T Consensus       151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~------------~~~~~  214 (256)
T cd06612         151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F------------MIPNK  214 (256)
T ss_pred             cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h------------hhccC
Confidence            4321  123455888999999998888999999999999999999999999754322110  0            00000


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.+..   .......+.+++.+||+.+|.+|||+.+|++
T Consensus       215 ~~~~~~~---~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 PPPTLSD---PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCCc---hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1111111   1112245677888999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-40  Score=314.72  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=201.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||+|+||.||++.+..++..+|+|.+... ......++.+|++++.+++||||+++++++.+. +..++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-GEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CEEEEEee
Confidence            3688899999999999999999888999999998754 233456688999999999999999999988774 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |+++++|.+++...       ..+++..+..++.|+++||.|||+ .+   ++|+||||+||++++++.+||+|||++..
T Consensus        80 y~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (308)
T cd06615          80 HMDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  149 (308)
T ss_pred             ccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccc
Confidence            99999999999764       458999999999999999999997 46   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh------
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR------  291 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------  291 (398)
                      .....    .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....................      
T Consensus       150 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         150 LIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP  225 (308)
T ss_pred             ccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccc
Confidence            53321    23456899999999998888999999999999999999999999754322111100000000000      


Q ss_pred             -------------chhhhhhhc---CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          292 -------------GMAAVEELL---DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       292 -------------~~~~~~~~~---d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                                   .......+.   .+.+...    .....+.+++.+||+.+|++|||+.+|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG----AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCCccCcCc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         000000000   0111100    122347788889999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5e-42  Score=311.45  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC----cEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~lV  136 (398)
                      .|...+++|.|+||.||+|....+++.||||+.-.+...    -.+|+++|+.++|||||+++-++....+    ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            567788999999999999999998999999998655432    2368999999999999999987764332    24589


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DfGla  215 (398)
                      |||||. +|.+.+....   ..+..++.-.+.-+..||++||.|||+.+   |+||||||+|+|+|.+ |.+||||||.|
T Consensus       101 leymP~-tL~~~~r~~~---~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYT---RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHhchH-HHHHHHHHHh---hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence            999966 8999988632   12356888888899999999999999988   9999999999999966 99999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      +.+..+...   .+...|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+++..+  +++...+-+=....+
T Consensus       174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTRE  248 (364)
T ss_pred             eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHH
Confidence            988765432   345568889999999876 68999999999999999999999999865543  233222211000111


Q ss_pred             hhhh-------hcCcccCCCC----CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEE-------LLDPRLKCTS----RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~-------~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+..       ...+.+....    .......+.++++.++|+++|.+|.+..|++.
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1111       1112222111    12233456788889999999999999999986

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.9e-41  Score=331.53  Aligned_cols=264  Identities=22%  Similarity=0.351  Sum_probs=193.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-------CC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------EQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~  131 (398)
                      ..+|...+.||+|+||.||+|....+++.||||++....    ....+|+.+++.++||||+++++++...       ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999998889999999886432    2234799999999999999998876432       12


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEe
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLC  210 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~  210 (398)
                      .+++||||++ ++|.+++.....   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++ .+||+
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYAR---NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence            3668999996 578777754321   2356999999999999999999999988   99999999999999665 79999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      |||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|..||........  +.... ...
T Consensus       214 DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~-~~~  287 (440)
T PTZ00036        214 DFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRII-QVL  287 (440)
T ss_pred             ccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-HHh
Confidence            9999986654322   2345689999999998754 689999999999999999999999986543221  11100 000


Q ss_pred             hhc-hhhhhhhcCccc---CCCCCC---------HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRG-MAAVEELLDPRL---KCTSRN---------SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~-~~~~~~~~d~~l---~~~~~~---------~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ... ...+. ...+.+   ..+...         ......+.+++.+||+.+|.+|||+.|+++
T Consensus       288 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        288 GTPTEDQLK-EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCCCHHHHH-HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000 00000 000100   000000         011245778888999999999999999985

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.9e-41  Score=326.06  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=198.5

Q ss_pred             HHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC
Q 015931           54 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        54 e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  130 (398)
                      ++....++|...+.||+|+||.||++.+..+++.||+|++...   .......+.+|+.++..++||||+++++.+.+ +
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~  115 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-D  115 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-C
Confidence            3444568999999999999999999999999999999998642   22334557889999999999999999998766 4


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...++||||+++|+|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~  184 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA  184 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEE
Confidence            558999999999999999865        24788899999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccC----CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  286 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  286 (398)
                      |||+++....... .......||+.|+|||++...    .++.++|||||||++|||++|+.||...+....        
T Consensus       185 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--------  255 (371)
T cd05622         185 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--------  255 (371)
T ss_pred             eCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH--------
Confidence            9999987653321 122356799999999998753    378999999999999999999999986543210        


Q ss_pred             HHHhhchhhhhhhcC--cccCCCCCCHHHHHHHHHHHHhcccccCCC--CCCHHHHHHH
Q 015931          287 PILHRGMAAVEELLD--PRLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIAI  341 (398)
Q Consensus       287 ~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~  341 (398)
                               ...+..  ..+..+. .......+.+++.+|+..++.+  ||++.++++.
T Consensus       256 ---------~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         256 ---------YSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ---------HHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                     111111  0111111 1112234556667788744433  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.7e-41  Score=309.43  Aligned_cols=255  Identities=30%  Similarity=0.468  Sum_probs=196.7

Q ss_pred             ceecccCceEEEEeeeCCCC------cEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           66 RVLGRGALSFVFKGKVGLLR------TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +.||+|+||.||+|......      ..+|+|.+.... ......+.+|+++++.++||||+++++++...+ ..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-CeEEEEe
Confidence            36999999999999875433      679999886543 244567899999999999999999999987654 5899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-----CeeEeccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-----IPKLCDFG  213 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-----~~kl~DfG  213 (398)
                      |+++++|.+++............+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999764321112345899999999999999999999887   99999999999999877     89999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      ++................++..|+|||++.++.++.++|||||||++|||++ |..||.......   ....        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~--------  225 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH--------  225 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH--------
Confidence            9976543322111223345788999999999999999999999999999998 999986543211   1100        


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                         +..  ......+.   .....+.+++.+||..+|.+||++.+|++.|+
T Consensus       226 ---~~~--~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 ---VTA--GGRLQKPE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---Hhc--CCccCCcc---cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               000  00111111   12345677888999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-40  Score=305.22  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=202.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|...+.||+|++|.||++....+++.||+|.+....  ....+.+.+|++++++++|+|++++++.+...+..+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999998888999999986542  34456788999999999999999999876655556789999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++.....     ..+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++...
T Consensus        81 ~~~~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-----KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             ccCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            9999999999976422     46899999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+...      ......         
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~---------  215 (257)
T cd08223         153 ENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRII---------  215 (257)
T ss_pred             cccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHH---------
Confidence            43321  1234568899999999998889999999999999999999999997543211      111110         


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        ...+.  .........+.+++.+|++.+|.+||++.++++
T Consensus       216 --~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         216 --EGKLP--PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --hcCCC--CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              00110  011123345778888999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.3e-41  Score=318.08  Aligned_cols=242  Identities=23%  Similarity=0.357  Sum_probs=191.5

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV  136 (398)
                      +|...+.||+|+||.||+|....+++.||+|++....   ......+..|..++..+. |++|+++.+++.+ .+.+|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence            4677889999999999999998889999999997532   233456778888888886 5677778876655 4568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615          80 MEYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccc
Confidence            9999999999998764       45899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......  ......||..|+|||++.+..++.++|||||||++|||++|+.||.......   .              +
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~--------------~  210 (323)
T cd05615         150 EHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---L--------------F  210 (323)
T ss_pred             ccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---H--------------H
Confidence            5432221  1234569999999999998889999999999999999999999997643211   1              1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  335 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  335 (398)
                      ..+.......+...   ...+.+++.+||+.+|.+|++.
T Consensus       211 ~~i~~~~~~~p~~~---~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         211 QSIMEHNVSYPKSL---SKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHhCCCCCCccC---CHHHHHHHHHHcccCHhhCCCC
Confidence            11111112111112   2346677889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-40  Score=318.51  Aligned_cols=252  Identities=27%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             CCCCCceecccCceEEEEeeeC---CCCcEEEEEEecCC----ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           61 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE----DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      +|...+.||+|+||.||++...   .++..||+|++.+.    .....+.+..|+.++..+ +||||+++++++.. ++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence            4778899999999999998763   46789999998643    223345678899999999 59999999987665 455


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeC
Confidence            89999999999999999764       45899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      |+++........ ......||..|+|||++.+. .++.++|||||||++|||++|+.||..........  .....    
T Consensus       150 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~----  222 (332)
T cd05614         150 GLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRR----  222 (332)
T ss_pred             cCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHH----
Confidence            999865433221 12345799999999999765 47889999999999999999999997543221111  00000    


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                          +. ..++.+  +...+   ..+.+++.+||+.+|++||     ++.++++
T Consensus       223 ----~~-~~~~~~--~~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ----IL-KCDPPF--PSFIG---PEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----Hh-cCCCCC--CCCCC---HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                00 011111  11122   3456677899999999999     6777775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-40  Score=313.64  Aligned_cols=250  Identities=23%  Similarity=0.372  Sum_probs=202.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|+..+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEeecc
Confidence            6888999999999999999998888999999999866555567788999999999999999999988764 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          98 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             cCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999999864        34899999999999999999999888   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ......+++.|+|||.+.+..++.++|||||||++|+|++|..||...........              ....
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------------~~~~  230 (297)
T cd06656         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------------IATN  230 (297)
T ss_pred             CCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------------eccC
Confidence            3321  12334688899999999988899999999999999999999999976443211000              0000


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      -.+.+..   .......+.+++.+||+.+|.+||++.+|++
T Consensus       231 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         231 GTPELQN---PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0111111   1112234567778999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=309.62  Aligned_cols=256  Identities=27%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .+|...+.||+|+||.||+|.+..++.    .+|+|.+.... ......+.+|+.++.+++||||++++++|..  ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence            567888999999999999999865554    58999887654 3445678899999999999999999999876  4578


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        85 ~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcc
Confidence            9999999999999997643      45899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++...............++..|+|||.+....++.++||||||+++||+++ |+.||......+   +..   .      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~------  223 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPD---L------  223 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH---H------
Confidence            987654332222222334568999999988889999999999999999998 999997643321   110   0      


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                        +..  ......+..   ....+.+++.+||..+|.+||++.++++.|...
T Consensus       224 --~~~--~~~~~~~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         224 --LEK--GERLPQPPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             --HhC--CCCCCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              000  001111111   223567778899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-40  Score=313.66  Aligned_cols=260  Identities=23%  Similarity=0.336  Sum_probs=198.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCc--EEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|+..++||+|+||.||+|....++.  .+++|.+... .....+.+..|++++.++ +||||+++++++.+. ...++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-CcceE
Confidence            478889999999999999999876554  4788888743 334556789999999999 799999999987664 45799


Q ss_pred             EEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          136 IYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      |+||+++++|.+++......         ......+++..++.++.|++.||+|||+.+   |+||||||+||++++++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence            99999999999999753210         001235899999999999999999999887   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||++........   ......+..|+|||++....++.++|||||||++|||++ |..||.......   ...  
T Consensus       158 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~--  229 (297)
T cd05089         158 SKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE--  229 (297)
T ss_pred             EEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--
Confidence            99999999864322110   111223557999999988889999999999999999997 999997543221   100  


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       .        +.....+..  +.   .....+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       230 -~--------~~~~~~~~~--~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         230 -K--------LPQGYRMEK--PR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             -H--------HhcCCCCCC--CC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             0        111011111  11   1223467788899999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.2e-41  Score=318.63  Aligned_cols=238  Identities=28%  Similarity=0.403  Sum_probs=187.1

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHH-HHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ++||+|+||.||+|....+++.||+|++....   ......+..|.. +++.++||||+++++++.+. +..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            47999999999999999889999999997532   222344555554 57889999999999987664 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|...+...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          80 GGELFFHLQRE-------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            99999888653       45889999999999999999999888   999999999999999999999999998753222


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      ..  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...      .           ...+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~-----------~~~i~~  210 (321)
T cd05603         150 EE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------M-----------YDNILH  210 (321)
T ss_pred             CC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------H-----------HHHHhc
Confidence            21  1234568999999999998889999999999999999999999997643211      0           111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHH
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE  336 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  336 (398)
                      ..+..+...   ...+.+++.+||+.+|.+||+..
T Consensus       211 ~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 KPLQLPGGK---TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCCC---CHHHHHHHHHHccCCHhhcCCCC
Confidence            122222222   23466778899999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.2e-41  Score=316.17  Aligned_cols=264  Identities=24%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCC-------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  130 (398)
                      ++|...+.||+|+||.||++....       ....+|+|.+.... ......+..|++++..+ +||||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            578999999999999999997632       23569999997642 34456788999999999 7999999999987654


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                       ..++||||+++|+|.+++......         ......++|..++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        98 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          98 -PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             -ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence             589999999999999999764210         001235899999999999999999999888   9999999999999


Q ss_pred             CCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchh
Q 015931          202 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  280 (398)
Q Consensus       202 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  280 (398)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            9999999999999876543221111112234568999999988889999999999999999998 888886543211   


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                         .... ....         .....+.   .....+.+++.+||+.+|.+|||+.+|++.|..+.
T Consensus       251 ---~~~~-~~~~---------~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         251 ---LFKL-LKEG---------HRMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             ---HHHH-HHcC---------CCCCCCC---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence               0000 0000         0111111   12345667788999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.5e-41  Score=314.50  Aligned_cols=250  Identities=23%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|+..+.||.|+||.||+|....+++.|++|.+..........+.+|+.+++.++|||++++++++.+. ...++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-DELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-ceEEEEEEe
Confidence            4688889999999999999998888999999999766555567788999999999999999999988765 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|..++..        ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          98 LAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             cCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            999999998864        34899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........  ..            +...
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~~------------~~~~  230 (296)
T cd06655         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL------------IATN  230 (296)
T ss_pred             cccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH------------HHhc
Confidence            3321  112346888999999998888999999999999999999999999765432110  00            0000


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.+..+..   ....+.+++.+||..+|.+||++.+|++
T Consensus       231 ~~~~~~~~~~---~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         231 GTPELQNPEK---LSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcccCCccc---CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            0111111111   1234666778999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-40  Score=311.85  Aligned_cols=268  Identities=24%  Similarity=0.350  Sum_probs=200.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCC----------------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeece
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL----------------LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPL  122 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  122 (398)
                      ++|+..+.||+|+||.||++....                ++..||+|.+... .......+.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468899999999999999985432                3456999999754 33445689999999999999999999


Q ss_pred             eeEEEcCCCcEEEEEecCCCCCHHHHHhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCc
Q 015931          123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG----VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  198 (398)
Q Consensus       123 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~N  198 (398)
                      ++++...+ ..++||||+++++|.+++......    ......+++..++.++.|++.||+|||+.+   ++|+||||+|
T Consensus        85 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          85 LAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEecCC-ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99887654 479999999999999999764321    011235889999999999999999999988   9999999999


Q ss_pred             EEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc--CCCCCcccccc
Q 015931          199 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRKPIEARRLQ  276 (398)
Q Consensus       199 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt--G~~Pf~~~~~~  276 (398)
                      |++++++.++|+|||+++...............++..|+|||....+.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999986544322111222344678999999888889999999999999999998  77888653322


Q ss_pred             cchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          277 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      .   ............   .....   ...+.   .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       241 ~---~~~~~~~~~~~~---~~~~~---~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 Q---VIENTGEFFRDQ---GRQVY---LPKPA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHHHhhc---ccccc---CCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1   111111100000   00000   11111   12245778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.8e-41  Score=315.77  Aligned_cols=258  Identities=28%  Similarity=0.449  Sum_probs=201.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCc----EEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .++|...+.||+|+||.||+|.+..++.    .||+|.+.... ......+.+|+.+++.++||||++++++|....  .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT--I   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC--c
Confidence            3577888999999999999999866565    57889887543 233457889999999999999999999986543  5


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++++||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccc
Confidence            79999999999999987642      35899999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......   ...+    ...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~  227 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL----LEKG  227 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHCC
Confidence            9987654332212223445778999999988889999999999999999997 999986543211   1110    1000


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                               .....+.   .....+.+++..||..+|++||++.++++.|+...
T Consensus       228 ---------~~~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         228 ---------ERLPQPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             ---------CCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     0111111   12235677888999999999999999999998653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=339.70  Aligned_cols=267  Identities=26%  Similarity=0.410  Sum_probs=216.3

Q ss_pred             cccCHHHHHHhhc---------CCCCCceecccCceEEEEeeeCCCC---cEEEEEEecCCC-hhhHHHHHHHHHHHHhC
Q 015931           48 IRLSYGEILAATH---------NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKED-KESSKAFCRELMIASSL  114 (398)
Q Consensus        48 ~~~~~~e~~~~~~---------~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l  114 (398)
                      -.++|++-..|.+         ...+.++||.|.||.||+|.++..+   ..||||.++... .....+|+.|+.|+.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            3456665444433         3456789999999999999997555   469999998764 45567899999999999


Q ss_pred             CCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccc
Q 015931          115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  194 (398)
Q Consensus       115 ~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDl  194 (398)
                      +||||++|.|+... ...+.||.|||++|+|+.||....      +.+.+.+..-++++||.|++||-+.+   +|||||
T Consensus       688 dHPNIIrLEGVVTk-s~PvMIiTEyMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDL  757 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTK-SKPVMIITEYMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDL  757 (996)
T ss_pred             CCCcEEEEEEEEec-CceeEEEhhhhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHhhcC---chhhhh
Confidence            99999999998654 556899999999999999998864      45999999999999999999999988   999999


Q ss_pred             ccCcEEeCCCCCeeEeccccccccCCCCCceeeecccc--CCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCc
Q 015931          195 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG--TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE  271 (398)
Q Consensus       195 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~  271 (398)
                      .++|||++.|...|++|||+++.+.++.. ...++..|  ...|.|||.+...++|.+|||||||+++||.++ |.+|+.
T Consensus       758 AARNILVNsnLvCKVsDFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW  836 (996)
T KOG0196|consen  758 AARNILVNSNLVCKVSDFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  836 (996)
T ss_pred             hhhheeeccceEEEeccccceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence            99999999999999999999998765431 12223333  568999999999999999999999999999987 999998


Q ss_pred             ccccccchhHHHHhhHHHhhchhhhhhhc-CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          272 ARRLQGEENLVLWAKPILHRGMAAVEELL-DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ....++.                 +..+- +-+|..   ..++...|-+|++.||++|-.+||++.+|+..|.+.
T Consensus       837 dmSNQdV-----------------IkaIe~gyRLPp---PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  837 DMSNQDV-----------------IKAIEQGYRLPP---PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             ccchHHH-----------------HHHHHhccCCCC---CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            7655432                 11111 123332   334556678888999999999999999999998764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6e-41  Score=316.99  Aligned_cols=268  Identities=24%  Similarity=0.354  Sum_probs=198.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||+|+||.||+|....++..||+|.+..... .....+.+|++++++++||||+++++++... +..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEe
Confidence            578889999999999999999988899999999875432 2334677899999999999999999988764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ ++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        85 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          85 YLD-KDLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             CCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceec
Confidence            996 48888876542      45899999999999999999999988   999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH-----HHhhc
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP-----ILHRG  292 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~-----~~~~~  292 (398)
                      .....  ......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||...+..+..........     .+...
T Consensus       155 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07872         155 SVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI  232 (309)
T ss_pred             CCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence            43321  1123467899999998865 4688999999999999999999999976554322221111000     00000


Q ss_pred             h--hhhhhhcCcccCCC---CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 M--AAVEELLDPRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~--~~~~~~~d~~l~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .  ......-.+.....   .........+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0  00000000000000   000111234677888999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-41  Score=311.03  Aligned_cols=253  Identities=26%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||.|+||.||+|....++..||+|.+........+.+..|++++++++||||+++++++... ...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-NKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-CeEEEEee
Confidence            35688889999999999999999888999999999877666677899999999999999999999988764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          83 FCDGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             ccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999999987643      45899999999999999999999988   999999999999999999999999998755


Q ss_pred             CCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      .....  ......|+..|+|||.+.     ...++.++||||||+++|||++|+.||.......  ...           
T Consensus       154 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~-----------  218 (280)
T cd06611         154 KSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLL-----------  218 (280)
T ss_pred             ccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHH-----------
Confidence            43221  123456899999999875     3346789999999999999999999997543211  000           


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .+.....+.+..+...   ...+.+++..||+.+|.+||++.+|++
T Consensus       219 -~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         219 -KILKSEPPTLDQPSKW---SSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             -HHhcCCCCCcCCcccC---CHHHHHHHHHHhccChhhCcCHHHHhc
Confidence             0111111122111112   234567778899999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-40  Score=306.34  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=193.2

Q ss_pred             ceecccCceEEEEeeeCC---CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|.+..   ....||+|.+... .......+..|+.+++.++||||+++++++...++..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643   3457999998643 344567888999999999999999999988766666789999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|.+++....      ..+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.....
T Consensus        81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          81 HGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            999999997642      34678888999999999999999887   999999999999999999999999999755432


Q ss_pred             CCc--eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcC-CCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          222 SVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG-RKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       222 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ...  .......++..|+|||++.+..++.++||||||+++|||++| ..||......   .+...   ..        .
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~---~~--------~  217 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVY---LL--------Q  217 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---Hh--------c
Confidence            111  011233467789999999888899999999999999999995 5556533211   11110   00        0


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ..  ....+..   ....+.+++..||+.+|++||++.+|++.|+..
T Consensus       218 ~~--~~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         218 GR--RLLQPEY---CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CC--CCCCCCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            00  0110111   123577888899999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-40  Score=307.14  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=200.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCC---cEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+.||+|+||.||+|.+..++   ..+|+|.+.... ......+.+|+.++.+++||||+++++++... +..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEE
Confidence            57888999999999999999875333   479999987543 33456789999999999999999999987664 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcc
Confidence            999999999999997642      45899999999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCcee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          216 TWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       216 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ........... .....++..|+|||++.+..++.++||||||+++||+++ |..||......+   ....         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~---------  221 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKA---------  221 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHH---------
Confidence            87654321111 111223567999999998889999999999999999886 999997543221   1110         


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                        +.+..  .....   ......+.+++.+|++.+|.+||++.++++.|..
T Consensus       222 --~~~~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         222 --IEEGY--RLPAP---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --HhCCC--cCCCC---CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence              11100  01111   1122356678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-40  Score=313.94  Aligned_cols=261  Identities=25%  Similarity=0.382  Sum_probs=199.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCc--EEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|+..+.||+|+||.||+|.+..++.  .+|+|.+... .......+.+|++++.++ +||||+++++++.+. +..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-CCce
Confidence            3578888999999999999999876665  4577777543 334556788999999999 899999999987664 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          135 LIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      +||||+++++|.+++......         ......+++..++.++.|++.||+|||+.+   ++||||||+|||+++++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCC
Confidence            999999999999999764311         011246899999999999999999999888   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHH
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  284 (398)
                      .+||+|||++.......   ......++..|+|||++....++.++|||||||++|||+| |..||......+   ..  
T Consensus       162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~--  233 (303)
T cd05088         162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY--  233 (303)
T ss_pred             cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH--
Confidence            99999999986432111   0112234667999999988889999999999999999998 999997543221   10  


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       ..        +....  ....+..   ....+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       234 -~~--------~~~~~--~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 -EK--------LPQGY--RLEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             -HH--------HhcCC--cCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             00        10000  1111111   123467788899999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.9e-40  Score=305.51  Aligned_cols=254  Identities=27%  Similarity=0.411  Sum_probs=201.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...++||+|+||.||+|.... ++.||+|.+..... ....+.+|+.++++++|+||+++++++.+  ...++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e   80 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIITE   80 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEEEEE
Confidence            3578889999999999999998764 78899999875443 34678899999999999999999997643  34799999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....     ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++...
T Consensus        81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          81 YMENGSLVDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             cCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence            999999999987643     246899999999999999999999888   999999999999999999999999999766


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ...... ......++..|+|||++....++.++||||||+++|||++ |+.||.......   ....           +.
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~-----------~~  217 (260)
T cd05067         153 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQN-----------LE  217 (260)
T ss_pred             CCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHH-----------HH
Confidence            532211 1123346778999999998889999999999999999999 999997543211   1110           11


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...  ....+..   ....+.+++.+|+..+|++||+++++++.|+.
T Consensus       218 ~~~--~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         218 RGY--RMPRPDN---CPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             cCC--CCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            111  1111111   12357778889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-40  Score=309.10  Aligned_cols=271  Identities=25%  Similarity=0.333  Sum_probs=202.4

Q ss_pred             cCCCCCceecccCceEEEEeee----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~  133 (398)
                      ..|...+.||+|+||.||.+..    ..++..||+|.+.... ......+.+|+++++.++|||++++.+++.+. ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4567889999999999999974    3467889999987543 34456799999999999999999999988765 3457


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++++|.+++....      ..++|..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCc
Confidence            89999999999999986542      35899999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH-HHhhHHHhh
Q 015931          214 LATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWAKPILHR  291 (398)
Q Consensus       214 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~  291 (398)
                      +++......... ......++..|+|||++.+..++.++||||||+++|||++++.|............- .........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            998765432211 112345677899999998888999999999999999999988765432110000000 000000000


Q ss_pred             chhhhhhhcCc-ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          292 GMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       292 ~~~~~~~~~d~-~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                         .+..+.+. ....+   ......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       235 ---~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 ---LVRVLEEGKRLPRP---PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ---HHHHHHcCccCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence               00000000 11111   11234677888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.7e-41  Score=308.55  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=200.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||.||+|....+++.||+|.+..........+.+|+.+++.++||||+++++++... +..++||||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEEec
Confidence            5777788999999999999999888999999999876555556788999999999999999999987765 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        88 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          88 CGGGSLQDIYHVT-------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            9999999998754       45899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ....  ......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+....  ...    .      .
T Consensus       158 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~~----~------~  223 (267)
T cd06645         158 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLM----T------K  223 (267)
T ss_pred             Cccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hhh----h------c
Confidence            3221  123456899999999874   456889999999999999999999998654322110  000    0      0


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....+.+....   .....+.+++.+||+.+|++||++.+|++
T Consensus       224 ~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         224 SNFQPPKLKDKM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCCCCcccccC---CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000111111000   11234667888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2e-40  Score=309.90  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=198.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .|+..+.||+|+||.||++....+++.||+|.+....   ......+..|+.++..++|+|++++++.+.+. ...++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEE
Confidence            3667789999999999999999899999999986542   22335577899999999999999999987765 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++..
T Consensus        80 e~~~g~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          80 TLMNGGDLKFHIYHMGE-----AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             EecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            99999999999865431     45899999999999999999999888   99999999999999999999999999876


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......   .....|+..|+|||++.+..++.++||||||+++|+|++|+.||............   ....       .
T Consensus       152 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~-------~  218 (285)
T cd05630         152 VPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLV-------K  218 (285)
T ss_pred             cCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhh-------h
Confidence            543221   12346899999999999889999999999999999999999999764322110000   0000       0


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                      .. ....  ....   ...+.+++..||+.+|.+|||     +.|+++
T Consensus       219 ~~-~~~~--~~~~---~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         219 EV-QEEY--SEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hh-hhhc--CccC---CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            00 0011  1111   234567778899999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-40  Score=310.25  Aligned_cols=266  Identities=21%  Similarity=0.328  Sum_probs=205.6

Q ss_pred             cCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEc
Q 015931           50 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  128 (398)
Q Consensus        50 ~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  128 (398)
                      +.+..+..+.++|...+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.++..+ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            345566677899999999999999999999998889999999886532 2335678899999999 69999999998753


Q ss_pred             ----CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          129 ----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       129 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                          .+...++||||+++++|.+++.....   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~  160 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK---RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTE  160 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhc---cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCC
Confidence                23457999999999999998864321   1256899999999999999999999888   9999999999999999


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc-----CCcCCccchhhHHHHHHHHHcCCCCCcccccccch
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  279 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~  279 (398)
                      +.++|+|||+++.......  ......|+..|+|||++..     ..++.++|||||||++|||++|+.||........ 
T Consensus       161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-  237 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-  237 (286)
T ss_pred             CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-
Confidence            9999999999886643221  1234568999999998853     3478899999999999999999999975432110 


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                       +..            ......+.+..+..   ....+.+++.+||+.+|.+|||+.||++.
T Consensus       238 -~~~------------~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 -LFK------------IPRNPPPTLHQPEL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -Hhh------------ccccCCCcccCCCC---cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             000            00001111111111   12346778889999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.6e-40  Score=305.00  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      +|...+.||+|+||.||++....++..+|+|.+... .....+.+..|+.+++.++|+||+++++.+.+. ..+++||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-GHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEee
Confidence            477789999999999999999888999999998643 334556788999999999999999999987654 568999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++....     ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++++|||++....
T Consensus        80 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          80 CDGGDLMQKIKLQR-----GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             CCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            99999999886532     245889999999999999999999888   9999999999999999999999999987664


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+...   .   .....          
T Consensus       152 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~---~~~~~----------  213 (255)
T cd08219         152 SPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---L---ILKVC----------  213 (255)
T ss_pred             cccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---H---HHHHh----------
Confidence            4321  1234568899999999988889999999999999999999999997543211   0   00000          


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                       .....  .........+.+++.+||+.+|.+|||+.+|+..
T Consensus       214 -~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         214 -QGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -cCCCC--CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             00000  0011122346677889999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.8e-40  Score=303.94  Aligned_cols=252  Identities=29%  Similarity=0.405  Sum_probs=195.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~  133 (398)
                      .+|...+.||+|+||.||+|....++..||+|.+....     ......+.+|+.+++.++||||+++++++.+. ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999998889999999986432     23345688999999999999999999987653 3557


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++++||+++++|.+++...       ..+++...+.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCC
Confidence            8999999999999999764       35899999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++........ .......++..|+|||++.+..++.++|||||||++|||++|+.||.......     .. ..     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~-~~-----  220 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AI-FK-----  220 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HH-HH-----
Confidence            98765432111 11123458899999999998889999999999999999999999997532211     00 00     


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        .......+.+.  ......   +..+ .+||..+|++||+++||++
T Consensus       221 --~~~~~~~~~~~--~~~~~~---~~~l-i~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 --IATQPTNPQLP--SHISEH---ARDF-LGCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --HhcCCCCCCCc--hhcCHH---HHHH-HHHhcCChhhCcCHHHHhc
Confidence              00000111111  111122   2333 3688899999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.7e-40  Score=306.12  Aligned_cols=257  Identities=23%  Similarity=0.330  Sum_probs=189.7

Q ss_pred             ceecccCceEEEEeeeCC--CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           66 RVLGRGALSFVFKGKVGL--LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      +.||+|+||.||+|....  ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+.. ..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-PYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-CcEEEEECCCC
Confidence            368999999999998642  45679999987653 234457889999999999999999999887654 47899999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |+|.+++......  .....++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        80 g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          80 GDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CcHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9999999764321  1235678888899999999999999888   9999999999999999999999999987544332


Q ss_pred             CceeeeccccCCCcccchhhccC-------CcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHG-------KVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      .........++..|+|||++...       .++.++||||||+++|||++ |+.||........   ...  ... .   
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~--~~~-~---  225 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY--TVR-E---  225 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH--Hhh-c---
Confidence            21112234578889999998642       35789999999999999996 9999965432211   110  000 0   


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ......++.+.  ...++.   +.+++..|+ .+|.+|||+.+|++.|+
T Consensus       226 ~~~~~~~~~~~--~~~~~~---~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQLKLPKPRLK--LPLSDR---WYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCCCCccC--CCCChH---HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            01111122221  112233   455666798 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-40  Score=302.29  Aligned_cols=248  Identities=25%  Similarity=0.437  Sum_probs=196.5

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ++||+|+||.||++.... ++.||+|.+...... ....+.+|++++++++|+||+++++++.+.. ..++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-PIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-CeEEEEEcCCCCc
Confidence            469999999999999887 899999998765433 5568999999999999999999999887654 5799999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |.+++....      ..+++..+..++.+++.||.|||+++   ++||||||+||+++.++.++|+|||++.........
T Consensus        79 l~~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          79 LLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            999997642      35889999999999999999999988   999999999999999999999999999865432211


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR  303 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  303 (398)
                      .......++..|+|||.+.++.++.++||||||+++|||+| |..||..........              .+...  ..
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~--------------~~~~~--~~  213 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE--------------RIESG--YR  213 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH--------------HHhcC--CC
Confidence            11112334667999999988889999999999999999999 888886543221000              00000  01


Q ss_pred             cCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          304 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       304 l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ...+.   .....+.+++.+||..+|.+|||+.||++.|.
T Consensus       214 ~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQ---LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCc---cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            11111   12345777888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.1e-41  Score=307.67  Aligned_cols=253  Identities=32%  Similarity=0.502  Sum_probs=199.5

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHH--HHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK--AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      |...+.||+|+||+||++....+++.||+|.+.........  ....|+..+.+++||||+++++++.+ +...++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence            44568999999999999999998999999999877544332  34569999999999999999999877 4558899999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++...       ..+++..++.++.|+++||.+||+.+   ++|+||||+||++++++.++|+|||.+....
T Consensus        80 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   80 CPGGSLQDYLQKN-------KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             ETTEBHHHHHHHH-------SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             ccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999843       45899999999999999999999988   9999999999999999999999999997642


Q ss_pred             CCCCceeeeccccCCCcccchhhc-cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ...  .......++..|+|||.+. +...+.++||||+|+++|+|++|..||.............   ...       ..
T Consensus       150 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~-------~~  217 (260)
T PF00069_consen  150 ENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KIL-------KR  217 (260)
T ss_dssp             STT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHH-------HT
T ss_pred             ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcc-------cc
Confidence            211  1234567899999999998 7889999999999999999999999998652111111111   000       00


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..........   .....+.+++..||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 PLPSSSQQSR---EKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHTTSHT---TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccccccc---hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000   01156778888999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-40  Score=310.59  Aligned_cols=265  Identities=23%  Similarity=0.334  Sum_probs=205.8

Q ss_pred             cCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEc
Q 015931           50 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  128 (398)
Q Consensus        50 ~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  128 (398)
                      ++..++..++++|...+.||+|+||.||++....+++.+|+|.+.... .....+..|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            444566667899999999999999999999998889999999986543 2345677899999998 79999999998875


Q ss_pred             CC----CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          129 PE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       129 ~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      .+    ...++||||+++++|.+++.....   ....+++..++.++.|++.||+|||+.+   ++||||||+||+++++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~  164 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI---CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTE  164 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC
Confidence            43    347999999999999998865321   1246899999999999999999999887   9999999999999999


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCcccchhhccC-----CcCCccchhhHHHHHHHHHcCCCCCcccccccch
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  279 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~  279 (398)
                      +.+||+|||++........  ......|+..|+|||.+...     .++.++|||||||++|||++|+.||.......  
T Consensus       165 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--  240 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--  240 (291)
T ss_pred             CCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--
Confidence            9999999999886543221  12235688999999998643     36889999999999999999999997543211  


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+..            +.....+.+..   .......+.+++.+||+.+|.+||++.++++
T Consensus       241 ~~~~------------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         241 TLFK------------IPRNPPPTLLH---PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHH------------HhcCCCCCCCc---ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0100            00000111111   1122345778889999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=307.56  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=202.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||.|+||.||+|....+++.||+|.+.... ......+.+|+.+++.++|+|++++++++.+. ...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEE
Confidence            36788889999999999999998889999999987543 34456788999999999999999999987765 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++..        ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++..
T Consensus        80 ~~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          80 YCGGGSCLDLLKP--------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             eeCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceee
Confidence            9999999999875        25899999999999999999999888   999999999999999999999999999877


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......++..|+|||++.+..++.++||||||+++|+|+||+.||.......   ..   .        .+..
T Consensus       149 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~---~--------~~~~  212 (274)
T cd06609         149 TSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL---F--------LIPK  212 (274)
T ss_pred             ccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH---H--------Hhhh
Confidence            54321  1234568889999999998889999999999999999999999997543211   00   0        0111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.+....    ....+.+++.+||..+|.+|||+.++++
T Consensus       213 ~~~~~~~~~~----~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         213 NNPPSLEGNK----FSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cCCCCCcccc----cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1111111110    2234667788999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.6e-40  Score=301.67  Aligned_cols=247  Identities=28%  Similarity=0.457  Sum_probs=194.9

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ++||+|+||.||+|... ++..+|+|.+.... ......+.+|++++..++||||+++++++...+ ..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCCc
Confidence            36999999999999876 47889999987653 333457889999999999999999999987654 5799999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        79 L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          79 FLSFLRKKK------DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            999986542      45899999999999999999999888   999999999999999999999999998754332211


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR  303 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  303 (398)
                       ......++..|+|||++.++.++.++||||||+++|++++ |..||.......   ...           .+....  .
T Consensus       150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~-----------~~~~~~--~  212 (250)
T cd05085         150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE-----------QVEKGY--R  212 (250)
T ss_pred             -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH-----------HHHcCC--C
Confidence             1112344677999999998899999999999999999998 999997543221   000           011111  1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          304 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       304 l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ...+.   .....+.+++.+|++.+|.+||++.++++.|.
T Consensus       213 ~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQ---KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11111   12345777888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=303.97  Aligned_cols=254  Identities=25%  Similarity=0.363  Sum_probs=204.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||.|+||.||+|....+++.+++|.+........+.+.+|+++++.++||||+++++++.+. ..++++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-DKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-CEEEEEEeC
Confidence            5788889999999999999999888899999999876666678899999999999999999999987764 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        82 ~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          82 CGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             CCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence            99999999987642      45899999999999999999999888   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccC---CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHG---KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ....  ......++..|+|||.+.+.   .++.++||||||+++|||++|+.||........  ....    .      .
T Consensus       153 ~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~----~------~  218 (262)
T cd06613         153 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLI----S------K  218 (262)
T ss_pred             hhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----H------h
Confidence            3221  11335688899999998776   789999999999999999999999975432211  0000    0      0


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....+.+.   ........+.+++.+||..+|.+|||+.+|+.
T Consensus       219 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         219 SNFPPPKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccCCCcccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000111111   12223345778888999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.1e-40  Score=303.18  Aligned_cols=251  Identities=26%  Similarity=0.401  Sum_probs=204.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..+.||.|+||.||.+....++..+++|.+...  .......+.+|++++++++|+||+++++++.+. ...++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEE
Confidence            478889999999999999999888999999998754  344566788999999999999999999998774 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....     ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        80 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          80 YANGGTLYDKIVRQK-----GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             ecCCCcHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            999999999997643     246899999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......|+..|+|||.+.+..++.++||||||+++|||++|..||.......      .           +..
T Consensus       152 ~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~-----------~~~  212 (256)
T cd08221         152 GSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------L-----------VVK  212 (256)
T ss_pred             ccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------H-----------HHH
Confidence            44331  2234568999999999988888999999999999999999999997543221      0           111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      +....+.  .........+.+++.+||+.+|.+||++.++++.
T Consensus       213 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         213 IVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHcCCCC--CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1111111  1111223456777889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-40  Score=313.18  Aligned_cols=265  Identities=22%  Similarity=0.385  Sum_probs=201.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-------CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  129 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  129 (398)
                      .++|...+.||+|+||.||++...       .....+|+|.+.... ......+..|+.++..+ +||||++++++|.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888999999999999999753       234579999987542 34456788999999999 699999999988764


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                       ...++||||+++|+|.+++......         ......++|..+..++.|++.||.|||+.+   ++||||||+||+
T Consensus        91 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          91 -GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence             4589999999999999999764210         011245899999999999999999999888   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccch
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  279 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  279 (398)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+  
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--  244 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--  244 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999999999986643221111112234567999999988889999999999999999999 889986543221  


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                       ...    .       +...  .....+.   .....+.+++.+||+.+|.+|||+.++++.|....
T Consensus       245 -~~~----~-------~~~~--~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 -LFK----L-------LREG--HRMDKPS---NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             -HHH----H-------HHcC--CCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence             110    0       0000  0011111   11235667888999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=316.84  Aligned_cols=204  Identities=28%  Similarity=0.373  Sum_probs=173.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||++....+++.||+|++.+.   .....+.+..|+.++..++|+||+++++++.+. ..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEE
Confidence            4688899999999999999999988999999999642   223345688899999999999999999987764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             EecCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCcee
Confidence            99999999999997632      45899999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhcc-----CCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ....... .......||+.|+|||++..     ..++.++|||||||++|||++|+.||....
T Consensus       151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         151 RLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             ecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            6543322 11223469999999999863     457889999999999999999999997543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-40  Score=308.77  Aligned_cols=273  Identities=26%  Similarity=0.379  Sum_probs=205.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCC----CCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~  133 (398)
                      ..|...+.||+|+||.||+|.+..    ++..||+|.+...... ....|.+|+++++.++||||+++++++... ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            456777899999999999998643    4788999999765443 567899999999999999999999987653 2347


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccc
Confidence            89999999999999997642      35999999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCcee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      ++........... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ......  ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~--~~~~  231 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQ--GQMI  231 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-cccccc--cccc
Confidence            9987753322111 11234566799999998889999999999999999999999998653321100 000000  0000


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ...+.+.+......+ ........+.+++.+||+.+|.+|||+.||+++|+.+
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         232 VTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            001111111111111 0111224577888999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.4e-41  Score=324.12  Aligned_cols=205  Identities=29%  Similarity=0.368  Sum_probs=175.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|+..+.||+|+||.||++....+++.||+|++...   .......+..|+.++..++||||+++++.+.+. +.+++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-RNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence            3688889999999999999999988999999999643   223456688899999999999999999987664 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          80 MEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             EeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCCc---------------------------------eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHH
Q 015931          217 WTSAPSVP---------------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL  263 (398)
Q Consensus       217 ~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~el  263 (398)
                      ........                                 .......||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel  229 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence            54321100                                 001235699999999999998999999999999999999


Q ss_pred             HcCCCCCccccc
Q 015931          264 LTGRKPIEARRL  275 (398)
Q Consensus       264 ltG~~Pf~~~~~  275 (398)
                      ++|+.||.....
T Consensus       230 ~tG~~Pf~~~~~  241 (360)
T cd05627         230 LIGYPPFCSETP  241 (360)
T ss_pred             ccCCCCCCCCCH
Confidence            999999976543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.1e-40  Score=307.77  Aligned_cols=251  Identities=23%  Similarity=0.332  Sum_probs=196.2

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      |+..+.||+|+||+||+|....+++.||+|.+....   ......+.+|+++++.++|+|++++.+.+... +..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-DALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-CEEEEEEE
Confidence            566789999999999999998889999999986542   22334578899999999999999999887664 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....     ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++...
T Consensus        81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          81 IMNGGDLKFHIYNMG-----NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             eccCccHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            999999999887542     146999999999999999999999888   999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....   .....|+..|+|||++.+..++.++|+||||+++|||++|..||..........  ...           ..
T Consensus       153 ~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~-----------~~  216 (285)
T cd05632         153 PEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVD-----------RR  216 (285)
T ss_pred             CCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-----------Hh
Confidence            43221   134568999999999988889999999999999999999999997543221100  000           00


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                      ............   ...+.+++..||+.+|.+||+     +.+++.
T Consensus       217 ~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         217 VLETEEVYSAKF---SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             hhccccccCccC---CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            111111111111   234567778899999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.1e-40  Score=303.39  Aligned_cols=253  Identities=27%  Similarity=0.419  Sum_probs=198.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|.....||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++|||++++++++..  ...++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEc
Confidence            4578888999999999999988653 569999886543 234678899999999999999999997643  347899999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++....     ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++....
T Consensus        82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          82 MGKGSLLDFLKEGD-----GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             CCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            99999999997642     245899999999999999999999888   9999999999999999999999999998664


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......++..|+|||...+..++.++||||||+++|||++ |..||.......   ...+           +..
T Consensus       154 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~-----------~~~  218 (260)
T cd05069         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQ-----------VER  218 (260)
T ss_pred             CCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------HHc
Confidence            33211 1122346778999999988889999999999999999999 899997543221   1000           000


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...  ...+   ......+.+++.+||..+|.+||++.+|++.|+.
T Consensus       219 ~~~--~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 GYR--MPCP---QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCC--CCCC---cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            000  1111   1223456777789999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-40  Score=307.64  Aligned_cols=240  Identities=23%  Similarity=0.427  Sum_probs=186.6

Q ss_pred             eecccCceEEEEeeeCC------------------------CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeece
Q 015931           67 VLGRGALSFVFKGKVGL------------------------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL  122 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  122 (398)
                      .||+|+||.||+|.+..                        ....|++|.+..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997531                        124589999876555555678899999999999999999


Q ss_pred             eeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC
Q 015931          123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  202 (398)
Q Consensus       123 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~  202 (398)
                      +++|.+.. ..++||||+++|+|..++....      ..+++..+..++.|+++||+|||+.+   |+||||||+||+++
T Consensus        82 ~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~  151 (274)
T cd05076          82 HGVCVRGS-ENIMVEEFVEHGPLDVCLRKEK------GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLA  151 (274)
T ss_pred             EEEEEeCC-ceEEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEe
Confidence            99988754 4789999999999999986532      46899999999999999999999887   99999999999997


Q ss_pred             CCC-------CeeEeccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHH-cCCCCCccc
Q 015931          203 SKK-------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELL-TGRKPIEAR  273 (398)
Q Consensus       203 ~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~ell-tG~~Pf~~~  273 (398)
                      ..+       .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||...
T Consensus       152 ~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         152 RLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             ccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            643       3799999987643221      12357888999998875 46899999999999999995 699998754


Q ss_pred             ccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      .......                  ........+...   ...+.+++.+||+.+|.+|||+.+|++.|.
T Consensus       226 ~~~~~~~------------------~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         226 TPSEKER------------------FYEKKHRLPEPS---CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ChHHHHH------------------HHHhccCCCCCC---ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            3321100                  000011111111   134777888999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-40  Score=317.55  Aligned_cols=204  Identities=28%  Similarity=0.368  Sum_probs=174.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||++....+++.||+|.+...   .......+..|..++..++|+||+++++++.+. +..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-NYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence            4788899999999999999999988999999998652   223345578899999999999999999987664 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EeCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecccee
Confidence            99999999999997642      45899999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhcc-----CCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ....... .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||....
T Consensus       151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         151 KMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             eccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            6654322 11234569999999999875     467889999999999999999999997543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-40  Score=304.09  Aligned_cols=250  Identities=26%  Similarity=0.442  Sum_probs=198.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh---------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      +|.....||+|++|.||+|....++..||+|.+.....         ...+.+.+|+.++++++||||+++++++.+. .
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-D   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-C
Confidence            36778899999999999999988889999998865422         1235688999999999999999999987775 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~d  149 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISD  149 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecc
Confidence            578999999999999999764       45899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCc----eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          212 FGLATWTSAPSVP----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       212 fGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      ||+++........    .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......  ..    . 
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~----~-  222 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI----F-  222 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH----H-
Confidence            9999866532110    01112457889999999998889999999999999999999999997532210  00    0 


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             .+.....+.+.     ......+.+++.+||+.+|.+||++.+|++
T Consensus       223 -------~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         223 -------KIGENASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -------HHhccCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                   01111111111     122345667778999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.3e-40  Score=309.44  Aligned_cols=268  Identities=23%  Similarity=0.283  Sum_probs=194.2

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhC---CCCCeeceeeEEEcC----CC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSL---HHPNIVPLVGFCIDP----EQ  131 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~----~~  131 (398)
                      +|...+.||+|+||+||+|....+++.||+|.+.....  .....+.+|+.++..+   +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47788999999999999999998999999999875321  2223455677766655   799999999987642    23


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||++ ++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP-----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence            4789999996 589888876432     45899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhH-HHHhh-HHH
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAK-PIL  289 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~-~~~~~-~~~  289 (398)
                      ||++........   .....||..|+|||++.+..++.++|||||||++|||++|++||......+.... ..... +..
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07863         152 FGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence            999986643321   2345689999999999988899999999999999999999999976443211100 00000 000


Q ss_pred             hhchhhh---hhhcCcccCCC--CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAV---EELLDPRLKCT--SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~---~~~~d~~l~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .......   .....+.....  ...+.....+.+++.+||+.||.+|||+.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000   00000000000  000112234678888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-40  Score=327.04  Aligned_cols=196  Identities=21%  Similarity=0.261  Sum_probs=168.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ..+|...+.||+|+||.||+|.+..+++.||||....      ..+.+|++++++++|+|||++++++...+ ..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGG-LTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECC-EEEEEEE
Confidence            3578999999999999999999998899999996432      23568999999999999999999887654 4789999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      ++ .++|..++....      ..++|..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       241 ~~-~~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        241 KY-RSDLYTYLGARL------RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             cc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            99 578988886532      36999999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCc
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE  271 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~  271 (398)
                      .............||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            44322222234579999999999999899999999999999999999887654

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.6e-40  Score=304.50  Aligned_cols=256  Identities=22%  Similarity=0.351  Sum_probs=185.9

Q ss_pred             eecccCceEEEEeeeCC--CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCC
Q 015931           67 VLGRGALSFVFKGKVGL--LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      .||+|+||.||+|....  ....+++|.+.... ......+.+|++.++.++||||+++++++.+.. ..++||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-PYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-ceEEEEEeCCCC
Confidence            58999999999997532  34578889876443 334567889999999999999999999887654 589999999999


Q ss_pred             CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC
Q 015931          144 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  223 (398)
Q Consensus       144 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  223 (398)
                      +|.+++......  .....++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........
T Consensus        81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          81 DLKNYLRSNRGM--VAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             cHHHHHHhcccc--ccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh
Confidence            999999765321  1134578888999999999999999988   99999999999999999999999999875433221


Q ss_pred             ceeeeccccCCCcccchhhcc-------CCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          224 PFLCKTVKGTFGYLAPEYFQH-------GKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||.......   ..   .......   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~---~~~~~~~---  226 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VL---KQVVREQ---  226 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH---HHHhhcc---
Confidence            111223346778999998743       356889999999999999999 788886543211   00   0000000   


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      .....++.+     .......+.+++..|+ .+|++|||+.+|++.|.
T Consensus       227 ~~~~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            011111111     1112233444556687 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.9e-40  Score=354.83  Aligned_cols=261  Identities=28%  Similarity=0.525  Sum_probs=210.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ..|...++||+|+||.||+|....++..||||++......    ...|++.+++++|||||+++|+|.+.+ ..++||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK-GAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC-CCEEEEeC
Confidence            4577888999999999999999888999999998654321    224688899999999999999998765 47999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|.+++..          ++|..+.+|+.|+++||+|||..+.++|+||||||+||+++.++.+++. ||......
T Consensus       765 ~~~g~L~~~l~~----------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        765 IEGKNLSEVLRN----------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             CCCCcHHHHHhc----------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            999999999952          8999999999999999999997655669999999999999999988876 66554322


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ..      ....||..|+|||++.+..++.++|||||||++|||+||+.||..... .......|........  .....
T Consensus       834 ~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~--~~~~~  904 (968)
T PLN00113        834 TD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDC--HLDMW  904 (968)
T ss_pred             cC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCcc--chhhe
Confidence            11      223688999999999998999999999999999999999999964332 2334566665443332  34556


Q ss_pred             cCcccCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          300 LDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       300 ~d~~l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      +|+.+... .....+...+.+++.+||+.+|++||||.||++.|+..
T Consensus       905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            67666422 23456777889999999999999999999999999865

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.4e-40  Score=301.92  Aligned_cols=240  Identities=24%  Similarity=0.428  Sum_probs=187.5

Q ss_pred             ceecccCceEEEEeeeCCC------------CcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           66 RVLGRGALSFVFKGKVGLL------------RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      +.||+|+||.||+|.....            ...|++|.+..........+..|+.++..++||||+++++++.+.. ..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~-~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV-EN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-CC
Confidence            3689999999999986421            2358999887665555667889999999999999999999987654 46


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC-------
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-------  206 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~-------  206 (398)
                      ++||||+++|+|..++....      ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.       
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~  150 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPF  150 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCce
Confidence            89999999999999886532      46899999999999999999999888   999999999999987664       


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhc-cCCcCCccchhhHHHHHHHHH-cCCCCCcccccccchhHHHH
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELL-TGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~Gvvl~ell-tG~~Pf~~~~~~~~~~~~~~  284 (398)
                      ++++|||++......      ....++..|+|||++. ...++.++|||||||++|||+ +|..||......+..     
T Consensus       151 ~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-----  219 (262)
T cd05077         151 IKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-----  219 (262)
T ss_pred             eEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-----
Confidence            899999998654322      2345788999999887 456899999999999999998 588887654321100     


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                                   .............   ...+.+++.+||+.+|.+||++.+|++.|
T Consensus       220 -------------~~~~~~~~~~~~~---~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 -------------RFYEGQCMLVTPS---CKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -------------HHHhcCccCCCCC---hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                         0001111101111   23567788899999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.4e-40  Score=307.51  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=204.7

Q ss_pred             cCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEc
Q 015931           50 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  128 (398)
Q Consensus        50 ~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  128 (398)
                      .++.++....+.|+..+.||.|+||.||+|.+..+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            355566667789999999999999999999998889999999986543 3345688899999998 69999999998763


Q ss_pred             C-----CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC
Q 015931          129 P-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  203 (398)
Q Consensus       129 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~  203 (398)
                      .     ....+++|||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~  156 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE  156 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence            2     3457999999999999999976432     45889999999999999999999988   999999999999999


Q ss_pred             CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccc
Q 015931          204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE  278 (398)
Q Consensus       204 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~  278 (398)
                      ++.++|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|..||........
T Consensus       157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA  234 (282)
T ss_pred             CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence            99999999999876543211  123456899999999875     34678899999999999999999999975432111


Q ss_pred             hhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          279 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..              .+.....+....    ......+.+++.+||+.+|.+||++.|+++
T Consensus       235 ~~--------------~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 LF--------------LIPRNPPPKLKS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hh--------------hHhhCCCCCCcc----cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00              001111111111    112245777888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-40  Score=304.02  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=194.1

Q ss_pred             ceecccCceEEEEeeeCCCCc--EEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ++||+|+||.||+|...+++.  .+++|.+... .....+.+..|++++.++ +||||+++++++... +..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-CCceEEEEeCC
Confidence            368999999999999877665  4688888743 344556788999999999 799999999988764 45799999999


Q ss_pred             CCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          142 GGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       142 ~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|+|.+++......         ......+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence            99999999754210         011235899999999999999999999887   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhh
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      |++.......   .......+..|+|||++....++.++||||||+++|||++ |..||.......   ..   ..    
T Consensus       157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~---~~----  223 (270)
T cd05047         157 GLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---EK----  223 (270)
T ss_pred             CCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HH---HH----
Confidence            9986322111   0111224567999999988889999999999999999997 999996543211   00   00    


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                          +....  ....+   ......+.+++.+||+.+|.+|||+.++++.|..+
T Consensus       224 ----~~~~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         224 ----LPQGY--RLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ----HhCCC--CCCCC---CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                00000  11111   11223567888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-40  Score=316.42  Aligned_cols=193  Identities=23%  Similarity=0.329  Sum_probs=165.8

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ...+|...+.||+|+||.||+|....++..||+|......      ...|+.++++++||||+++++++.+.+ ..++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGA-ITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCC-eeEEEE
Confidence            4568999999999999999999998888999999754332      346899999999999999999987754 478999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |++ .++|.+++....      ..+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       137 e~~-~~~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        137 PHY-SSDLYTYLTKRS------RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             Ecc-CCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence            999 568888886542      46899999999999999999999988   99999999999999999999999999975


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCC
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI  270 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf  270 (398)
                      .....   ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       207 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        207 PVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            43221   123456999999999999889999999999999999999866554

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-40  Score=308.47  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=199.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|++++++++||||+++++++... ...++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-TKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-CceEEEEEc
Confidence            3455678999999999999998888999999987543 34456789999999999999999999987764 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        84 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          84 LGGGSALDLLKP--------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             cCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccccc
Confidence            999999998854        35899999999999999999999888   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ......|+..|+|||++.+..++.++||||||+++|||++|+.||........   ..           .+...
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~-----------~~~~~  216 (277)
T cd06642         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LF-----------LIPKN  216 (277)
T ss_pred             Ccch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hh-----------hhhcC
Confidence            3321  11234588899999999988899999999999999999999999875432210   00           00111


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ..+.+     .......+.+++.+||+.+|.+||++.+|++.
T Consensus       217 ~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 SPPTL-----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCC-----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            11111     11223456778889999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.1e-40  Score=302.90  Aligned_cols=251  Identities=30%  Similarity=0.509  Sum_probs=196.5

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC------hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      +|...+.||+|+||.||+|... ++..+|+|.+....      ......+.+|+++++.++|+||+++++++.+. ...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEE
Confidence            4778899999999999999875 58899999886432      22345688999999999999999999998775 5589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +|+||+++++|.+++...       ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        79 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          79 IFMEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             EEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence            999999999999999753       35899999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCC----CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          215 ATWTSAPS----VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       215 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      +.......    .........|+..|+|||++.+..++.++||||||+++|+|++|+.||........  ...     ..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~-----~~  221 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFY-----IG  221 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHH-----hh
Confidence            87653211    11112335689999999999988899999999999999999999999975332110  000     00


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           ......+.+.  .   .....+.+++.+||+.+|.+||++.++++
T Consensus       222 -----~~~~~~~~~~--~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         222 -----AHRGLMPRLP--D---SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----hccCCCCCCC--C---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 0000111111  1   12234567778999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.4e-40  Score=340.58  Aligned_cols=264  Identities=25%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...++||+|+||.||+|.+..+++.||+|++...   .....+.+.+|++++++++||||+++++++.+. +..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEEE
Confidence            5788899999999999999999888999999999753   223456789999999999999999999988765 458999


Q ss_pred             EecCCCCCHHHHHhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          137 YKYVSGGSLERHLHEKKKG----VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      |||++||+|.+++......    ......+++..++.++.|+++||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEec
Confidence            9999999999998753110    001234678888999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCc----------------eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccc
Q 015931          213 GLATWTSAPSVP----------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  276 (398)
Q Consensus       213 Gla~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~  276 (398)
                      |+++........                .......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            999865211100                0011246999999999999989999999999999999999999999763321


Q ss_pred             cchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-CHHHHHHHHhc
Q 015931          277 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-GIEEIIAILRG  344 (398)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~  344 (398)
                      ..   . ..           ....++.-..+  .......+.+++.+|++.+|++|| ++.++++.|+.
T Consensus       238 ki---~-~~-----------~~i~~P~~~~p--~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 KI---S-YR-----------DVILSPIEVAP--YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hh---h-hh-----------hhccChhhccc--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            10   0 00           00011100000  011223466788899999999996 56666666654

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-40  Score=306.84  Aligned_cols=261  Identities=27%  Similarity=0.401  Sum_probs=203.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|+..+.||+|+||+||++....+++.||+|++.... ......+.+|++++..++||||+++++++... ..+++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEe
Confidence            56778889999999999999998889999999886543 34457889999999999999999999998775 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |+++++|.+++...       ..+++..+..++.+++.||.|||+ .+   ++||||||+||++++++.++|+|||++..
T Consensus        84 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          84 FMDCGSLDRIYKKG-------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             cCCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999988653       458999999999999999999997 45   99999999999999999999999999865


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      .....    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||..............  ...    ..+.
T Consensus       154 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~--~~~----~~~~  223 (284)
T cd06620         154 LINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM--GIL----DLLQ  223 (284)
T ss_pred             hhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh--HHH----HHHH
Confidence            43222    1235689999999999888899999999999999999999999986543211000000  000    0111


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      .++..... ..........+.+++.+|++.+|.+|||+.||++..
T Consensus       224 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         224 QIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHhhccCC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            11111110 000111334577788899999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-39  Score=303.64  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=202.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ..|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-TKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEEe
Confidence            35677789999999999999998889999999987543 34567789999999999999999999988764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++..        ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        83 ~~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~  151 (277)
T cd06640          83 YLGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             cCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceec
Confidence            9999999999864        34889999999999999999999888   999999999999999999999999999766


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......++..|+|||++.+..++.++|||||||++|||++|..||..........              .+..
T Consensus       152 ~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------------~~~~  215 (277)
T cd06640         152 TDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--------------LIPK  215 (277)
T ss_pred             cCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------------hhhc
Confidence            44321  1233468889999999988889999999999999999999999997543221000              0000


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ...     +.........+.+++.+||+.+|.+||++.++++.
T Consensus       216 ~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         216 NNP-----PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCC-----CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            001     11122344567788889999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-41  Score=295.33  Aligned_cols=250  Identities=28%  Similarity=0.399  Sum_probs=204.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  130 (398)
                      ++|...+.||.|..++|-++.++.++..+|+|++....        .+-.+.-..|+.+|+++ .||||+++.+++.. +
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-~   95 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-D   95 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-c
Confidence            57888899999999999999999999999999996431        11233456899999997 69999999998654 5


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ..+++|+|.|+.|.|.++|...       ..++++..++|+.|+.+|+.|||..+   |+||||||+|||+|+|.++||+
T Consensus        96 sF~FlVFdl~prGELFDyLts~-------VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK-------VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh-------eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence            6689999999999999999875       56999999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhc------cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      |||+++.+..+..   .+..+||++|+|||.+.      ...|+...|.|++||++|.|+.|.+||.....     +  .
T Consensus       166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----m--l  235 (411)
T KOG0599|consen  166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----M--L  235 (411)
T ss_pred             ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----H--H
Confidence            9999998877653   35789999999999874      23578899999999999999999999975421     1  1


Q ss_pred             hhHHHhhchhhhhhhcCcccCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          285 AKPILHRGMAAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                                .+.-+....+... +...+.....-+|+.+||+.||.+|.|.+|+++
T Consensus       236 ----------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  236 ----------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                      1222222222211 122333455678889999999999999999987

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.4e-40  Score=315.10  Aligned_cols=204  Identities=28%  Similarity=0.375  Sum_probs=173.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||++....+++.||+|++.+.   .......+..|+.++..++|+||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEE
Confidence            4688889999999999999999988999999998642   122334578899999999999999999987664 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~  150 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL  150 (332)
T ss_pred             EeccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchhe
Confidence            99999999999997642      45899999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....
T Consensus       151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~  212 (332)
T cd05623         151 KLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (332)
T ss_pred             ecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence            6543221 1223457999999999986     3467899999999999999999999997543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.8e-41  Score=303.58  Aligned_cols=270  Identities=24%  Similarity=0.328  Sum_probs=205.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh--hHHHHHHHHHHHHhCCCCC-eeceeeEEEcCCC-----
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQ-----  131 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~-----  131 (398)
                      ..|...+.||+|+||+||+|....+|+.||+|++.....+  .-....+|+.+|++++|+| ||++.+++...+.     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3455667899999999999999999999999999765432  3345679999999999999 9999999887653     


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+++|+||+ .-+|..++.......   ..++...+..++.|++.||+|||+++   |+||||||+||||+++|.+||+|
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeec
Confidence            689999999 669999998764210   34777899999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ||+|+....+...  .+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+....+...   .....+.
T Consensus       164 FGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lG  238 (323)
T KOG0594|consen  164 FGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLG  238 (323)
T ss_pred             cchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcC
Confidence            9999976644332  3456789999999999877 68999999999999999999999998765422111   1111110


Q ss_pred             hc----hhhhhhhcCcccCCCC-----CCHH----HHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          291 RG----MAAVEELLDPRLKCTS-----RNSA----QIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       291 ~~----~~~~~~~~d~~l~~~~-----~~~~----~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ..    ...+....+-......     ....    ......+++.+||+.+|.+|.|+...++.
T Consensus       239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            00    0011111111111000     0011    11367888999999999999999999875

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.2e-40  Score=310.69  Aligned_cols=250  Identities=24%  Similarity=0.385  Sum_probs=199.5

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      .|.....||+|+||.||++....++..||+|.+........+.+.+|+..++.++||||+++++.+..++ ..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-ELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-eEEEEEeCC
Confidence            3444567999999999999998889999999997665566677899999999999999999999877654 579999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++++|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.....
T Consensus       102 ~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         102 EGGALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            99999998854        34899999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........   ..           .+...+
T Consensus       171 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~-----------~~~~~~  234 (292)
T cd06658         171 EVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MR-----------RIRDNL  234 (292)
T ss_pred             ccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-----------HHHhcC
Confidence            221  12335689999999999888899999999999999999999999975432110   00           111122


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       301 d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .+.+......+.   .+..++.+||..+|.+|||+.++++.
T Consensus       235 ~~~~~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 PPRVKDSHKVSS---VLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCccccccccCH---HHHHHHHHHccCChhHCcCHHHHhhC
Confidence            222221111222   35566678999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-40  Score=317.27  Aligned_cols=262  Identities=19%  Similarity=0.300  Sum_probs=196.9

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  130 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  130 (398)
                      ..++|...+.||+|+||.||+|....++..||||.+....  ......+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3578999999999999999999998889999999987542  233456778999999999999999998765332     


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...+++++++ +++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC--------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence            2368999998 8899888753        35899999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      |||+++......     ....||..|+|||++.+ ..++.++|||||||++|+|++|+.||........  +.... ...
T Consensus       161 Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-~~~  232 (343)
T cd07878         161 DFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIM-EVV  232 (343)
T ss_pred             CCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHh
Confidence            999998654322     34568999999999876 4689999999999999999999999975432111  00000 000


Q ss_pred             hhc-hh--------hhhhhcCcccCC-CCCCH-----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRG-MA--------AVEELLDPRLKC-TSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~-~~--------~~~~~~d~~l~~-~~~~~-----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ... ..        .....+. .+.. +....     .....+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         233 GTPSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCCCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000 00        0000000 0000 00000     01123678889999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-39  Score=308.56  Aligned_cols=204  Identities=28%  Similarity=0.481  Sum_probs=163.8

Q ss_pred             CceecccCceEEEEeeeC--CCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcEEEEEecCC
Q 015931           65 GRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVS  141 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~~~  141 (398)
                      +++||+|+||+||+|...  .+++.||+|.+....  ....+.+|+.++++++||||+++++++... +..+++||||+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence            468999999999999865  356889999987542  234577899999999999999999987643 34578999999 


Q ss_pred             CCCHHHHHhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe----CCCCCeeEeccccc
Q 015931          142 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLA  215 (398)
Q Consensus       142 ~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DfGla  215 (398)
                      +++|.+++......  ......+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            56888887643211  111235899999999999999999999988   9999999999999    45678999999999


Q ss_pred             cccCCCCCc-eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          216 TWTSAPSVP-FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       216 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      +........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876543211 112345789999999998764 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=314.89  Aligned_cols=250  Identities=29%  Similarity=0.389  Sum_probs=207.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh---hHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---SSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  134 (398)
                      ...|...+.||.|.||.||+++.+.+|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+.+.+.. .++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~~  112 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SVY  112 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eEE
Confidence            45788889999999999999999999999999999876432   3468899999999998 999999999977654 589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC----CCeeEe
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPKLC  210 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~  210 (398)
                      +|||++.||.|.+.+...        .+++..+..++.|++.+++|||+.+   |+||||||+|+|+...    +.+|++
T Consensus       113 lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             EEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEe
Confidence            999999999999999874        2899999999999999999999988   9999999999999643    479999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      |||++......   ......+||+.|+|||++....|+..+||||+||++|.|++|..||..........          
T Consensus       182 DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----------  248 (382)
T KOG0032|consen  182 DFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----------  248 (382)
T ss_pred             eCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------
Confidence            99999988762   23467889999999999999999999999999999999999999999866433211          


Q ss_pred             hchhhhhhhcCcccCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          291 RGMAAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             .+....+... .........+-+++..|+..||.+|+|+.++++
T Consensus       249 -------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  249 -------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                   1222111111 111222344556667899999999999999998

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.2e-40  Score=310.62  Aligned_cols=257  Identities=24%  Similarity=0.348  Sum_probs=199.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||++.+..+++.|++|.+....   ......+.+|+++++.++||||+++++.+... +..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-RHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-CEEEEE
Confidence            46888999999999999999999889999999987653   23345788999999999999999999987654 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++
T Consensus        80 ~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          80 MEYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             EecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            9999999999999664       45899999999999999999999888   9999999999999999999999999986


Q ss_pred             ccCCCCC-------------ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH
Q 015931          217 WTSAPSV-------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  283 (398)
Q Consensus       217 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  283 (398)
                      .......             ........|+..|+|||.+....++.++||||||+++|||++|..||.......      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------  223 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------  223 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence            4211100             001112457889999999988889999999999999999999999997543221      


Q ss_pred             HhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       284 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .......      .....+..     .......+.+++.+||+.+|.+||+..++.+.|+.
T Consensus       224 ~~~~~~~------~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 LFGQVIS------DDIEWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHh------cccCCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1000000      00011111     01122346777889999999999998777776654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=297.37  Aligned_cols=252  Identities=27%  Similarity=0.360  Sum_probs=201.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      +++|+..+.||+|.|+.||++.++.+|+.+|+|++...  +....+.+.+|+.+.+.++||||++|.+.+. .++..|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-ccceeEEE
Confidence            45788888999999999999999999999999988643  3446778999999999999999999998744 46678999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeEeccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFG  213 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DfG  213 (398)
                      +|+|.|++|..-+-.+       ...++..+-..+.||++||.|+|.++   |||||+||.|++|-.   ..-+||+|||
T Consensus        89 Fe~m~G~dl~~eIV~R-------~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-------EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             EecccchHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccc
Confidence            9999999997766654       34788888899999999999999998   999999999999953   3468999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +|..++...   .....+||++|||||++...+|+..+|||+.||+||-|+.|+.||.+.+...   +.       ++  
T Consensus       159 vAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---ly-------e~--  223 (355)
T KOG0033|consen  159 LAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LY-------EQ--  223 (355)
T ss_pred             eEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HH-------HH--
Confidence            999887433   3346789999999999999999999999999999999999999998743221   11       00  


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ......|-.-.......+   ...+|+.+||..||.+|.|+.|.++
T Consensus       224 -I~~g~yd~~~~~w~~is~---~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  224 -IKAGAYDYPSPEWDTVTP---EAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -HhccccCCCCcccCcCCH---HHHHHHHHHhccChhhhccHHHHhC
Confidence             011111111111122233   3455667899999999999999876

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-39  Score=300.51  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=197.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~  133 (398)
                      ++|...+.||+|+||.||+|....++..||+|.+....     ......+.+|+.++++++||||+++++++.+.. ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999998889999999885321     233567889999999999999999999876643 457


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCc
Confidence            8999999999999998754       34789999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      ++......... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......     .         
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~---------  217 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A---------  217 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H---------
Confidence            98765432111 11223458899999999988889999999999999999999999997532111     0         


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         +.+...... .+.........+.+++.+|+. +|.+||++.+|++
T Consensus       218 ---~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         218 ---IFKIATQPT-NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---HHHHhcCCC-CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               001000000 011122233445666777884 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-40  Score=301.68  Aligned_cols=255  Identities=28%  Similarity=0.428  Sum_probs=201.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.... +..||+|.+..... ....+.+|+.++++++|+||+++++++... ...++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   81 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-EPIYIVTE   81 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecC-CceEEEEe
Confidence            4688999999999999999999764 57899999875433 346789999999999999999999987654 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....     ...+++..+..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++...
T Consensus        82 ~~~~~~L~~~i~~~~-----~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          82 YMSKGSLLDFLKSGE-----GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             ccCCCCHHHHHhccc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence            999999999997643     146899999999999999999999988   999999999999999999999999998866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ....           +.
T Consensus       154 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~-----------~~  218 (261)
T cd05034         154 EDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ-----------VE  218 (261)
T ss_pred             cchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------HH
Confidence            532111 1112234568999999998889999999999999999998 999996543211   1000           00


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...  ....+...   ...+.+++.+|++.+|.+||+++++++.|+.
T Consensus       219 ~~~--~~~~~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 RGY--RMPRPPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             cCC--CCCCCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            000  11111111   2456778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.5e-40  Score=310.55  Aligned_cols=265  Identities=23%  Similarity=0.364  Sum_probs=197.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||+|+||.||+|....++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-CeEEEEEe
Confidence            57888999999999999999998889999999987543 22344677899999999999999999997764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ ++|.+++....      ..+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||++...
T Consensus        85 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          85 YLD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             ccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            996 69988887642      45889999999999999999999988   999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch-hhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM-AAV  296 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~  296 (398)
                      .....  ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+......   .......... ...
T Consensus       155 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~  229 (301)
T cd07873         155 SIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETW  229 (301)
T ss_pred             CCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhc
Confidence            43221  11234578899999988654 57889999999999999999999997654321111   1000000000 000


Q ss_pred             hhhcC---------cccCCC---CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLD---------PRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d---------~~l~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.+         +.....   .........+.+++.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000         000000   000011234567888999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7e-40  Score=303.44  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=200.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCC---CcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+.||+|+||.||+|.+...   ...||+|...... ....+.+.+|+.+++.++||||+++++++.+  ...++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEE
Confidence            4678889999999999999987543   3469999887654 4556789999999999999999999998765  33689


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus        84 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          84 VMELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence            999999999999997642      35899999999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      +....... .......++..|+|||.+....++.++||||||+++|||++ |..||......+   ....          
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----------  220 (270)
T cd05056         155 RYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR----------  220 (270)
T ss_pred             eecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH----------
Confidence            86654321 11122334568999999988889999999999999999996 999997543221   1110          


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       +...  .....+...   ...+.+++.+|+..+|.+|||+.++++.|+..
T Consensus       221 -~~~~--~~~~~~~~~---~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         221 -IENG--ERLPMPPNC---PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             -HHcC--CcCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             0000  011111112   23566777899999999999999999999764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.3e-40  Score=300.56  Aligned_cols=239  Identities=26%  Similarity=0.461  Sum_probs=190.2

Q ss_pred             ceecccCceEEEEeeeCCCC----------cEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           66 RVLGRGALSFVFKGKVGLLR----------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      +.||+|+||.||+|.+..++          ..+++|.+...... ...+.+|+.+++.++||||+++++++.. . ..++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D-ENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-CcEE
Confidence            46999999999999997655          35888887654333 6788999999999999999999999877 3 4689


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-------Cee
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-------IPK  208 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-------~~k  208 (398)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++       .+|
T Consensus        78 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k  148 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK  148 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence            999999999999998643      25899999999999999999999888   99999999999999887       799


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccC--CcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHh
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  285 (398)
                      |+|||++......      ....++..|+|||++...  .++.++||||||+++|||++ |..||.........   .+.
T Consensus       149 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~  219 (259)
T cd05037         149 LSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFY  219 (259)
T ss_pred             eCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHH
Confidence            9999998865431      234467789999999876  78999999999999999999 57777654321110   000


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                                 .  .......+  .   ...+.+++.+||..+|.+|||+.+|++.|+
T Consensus       220 -----------~--~~~~~~~~--~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 -----------Q--DQHRLPMP--D---CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -----------h--cCCCCCCC--C---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                       0  00011111  1   156778889999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-40  Score=310.66  Aligned_cols=247  Identities=21%  Similarity=0.351  Sum_probs=197.0

Q ss_pred             CCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCC
Q 015931           64 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        64 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      ....||+|+||.||++....+++.||+|.+........+.+.+|+.++..++|||++++++++..+ ...++|+||++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~~~  103 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQGG  103 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCCCC
Confidence            345799999999999999888999999999765545566788999999999999999999987765 4589999999999


Q ss_pred             CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC
Q 015931          144 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  223 (398)
Q Consensus       144 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  223 (398)
                      +|..++..        ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus       104 ~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         104 ALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            99998754        34899999999999999999999888   99999999999999999999999999875543221


Q ss_pred             ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcc
Q 015931          224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR  303 (398)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  303 (398)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......   ...           .+.....+.
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~-----------~~~~~~~~~  236 (297)
T cd06659         173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK-----------RLRDSPPPK  236 (297)
T ss_pred             --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-----------HHhccCCCC
Confidence              1234568999999999988889999999999999999999999997543211   000           011111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          304 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       304 l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .....   .....+.+++.+||+.+|.+||++.++++.
T Consensus       237 ~~~~~---~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 LKNAH---KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccccC---CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11111   112346677789999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-40  Score=303.27  Aligned_cols=258  Identities=26%  Similarity=0.379  Sum_probs=202.1

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC-----
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE-----  130 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  130 (398)
                      ..+++|...+.||+|++|.||+|....+++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356899999999999999999999988889999999876543 346789999999998 6999999999987533     


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRK---KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence            247899999999999999876421   1256899999999999999999999888   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhcc-----CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  285 (398)
                      |||++........  ......|+..|+|||.+..     ..++.++||||||+++|+|++|+.||.......  ...   
T Consensus       156 d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~---  228 (275)
T cd06608         156 DFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALF---  228 (275)
T ss_pred             CCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHH---
Confidence            9999876543221  1234568899999998753     346789999999999999999999997432211  000   


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                               .+.....+.+..   .......+.+++.+||..||.+|||+.++++
T Consensus       229 ---------~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         229 ---------KIPRNPPPTLKS---PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---------HhhccCCCCCCc---hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                     001111111111   1113345677888999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-40  Score=304.78  Aligned_cols=241  Identities=25%  Similarity=0.418  Sum_probs=188.8

Q ss_pred             ceecccCceEEEEeeeCCCC-------cEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           66 RVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +.||+|+||.||+|.....+       ..||+|.+........+.+..|+.+++.++|||++++++++..+.. .++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE-SIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-cEEEEe
Confidence            36999999999999875433       3488898876655566788899999999999999999999887544 789999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC--------eeEe
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--------PKLC  210 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~kl~  210 (398)
                      |+++|+|..++....      ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.        ++++
T Consensus        80 ~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~  150 (258)
T cd05078          80 YVKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLS  150 (258)
T ss_pred             cCCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEec
Confidence            999999999997643      35899999999999999999999888   999999999999987765        6999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCC-CCCcccccccchhHHHHhhHH
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGR-KPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      |||++......      ....++..|+|||++.+. .++.++||||||+++|||++|. .||........   .      
T Consensus       151 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~------  215 (258)
T cd05078         151 DPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L------  215 (258)
T ss_pred             ccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H------
Confidence            99988654332      234578899999999864 5799999999999999999985 55543222110   0      


Q ss_pred             HhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                               .........+.   .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       216 ---------~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 ---------QFYEDRHQLPA---PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------HHHHccccCCC---CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     00001111111   11245678888999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.8e-40  Score=313.24  Aligned_cols=264  Identities=22%  Similarity=0.364  Sum_probs=201.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCC-------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  130 (398)
                      .+|...+.||+|+||.||+|....       .+..||+|.+.... ......+.+|++++.++ +||||++++++|.+.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468889999999999999997532       12368999887542 34457889999999999 7999999999987654


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                       ..++++||+++|+|.+++......         ......++|..+..++.|++.||.|||+.+   ++||||||+||++
T Consensus        92 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          92 -PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             -ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence             589999999999999999763210         011245899999999999999999999888   9999999999999


Q ss_pred             CCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchh
Q 015931          202 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  280 (398)
Q Consensus       202 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  280 (398)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            9999999999999986544321111122334567999999998889999999999999999998 888886543211   


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                         ....+.        ...  .....   ......+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       245 ---~~~~~~--------~~~--~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         245 ---LFKLLK--------EGH--RMDKP---ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ---HHHHHH--------cCC--CCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence               111110        000  00001   112245677888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.2e-40  Score=319.72  Aligned_cols=266  Identities=20%  Similarity=0.257  Sum_probs=197.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeC--CCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ..+|...+.||+|+||.||++...  ..+..||+|.+...     ....+|+++++.++||||+++++++... ...++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK-STVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC-CEEEEE
Confidence            357999999999999999999754  34578999988643     2345799999999999999999987654 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||++ +++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+++
T Consensus       165 ~e~~-~~~l~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        165 MPKY-KCDLFTYVDRS-------GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             ehhc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            9999 57888888432       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch---
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM---  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---  293 (398)
                      ...............||..|+|||++....++.++|||||||++|||++|+.||.......................   
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            66544332223356799999999999988999999999999999999999999976544321111111000000000   


Q ss_pred             ---------hhhhhh---cCcccCCCCC--CHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 ---------AAVEEL---LDPRLKCTSR--NSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ---------~~~~~~---~d~~l~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                               ......   ..+....+..  .......+.+++.+||..+|.+|||+.|++..
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     000000   0010100000  00012345677789999999999999999974

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-39  Score=299.66  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=203.5

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~  137 (398)
                      +|+..+.||.|+||.||++....++..||+|.+...  .....+.+..|+++++.++||||+++++++... +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999999888999999998653  334456788999999999999999999987653 34578999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||+++++|.+++.....   ....+++..++.++.|++.||.|||..+  ..+++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK---ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999999976421   2357999999999999999999999332  233999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......   .+..            
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~------------  220 (265)
T cd08217         158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS------------  220 (265)
T ss_pred             ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH------------
Confidence            87654332  123456899999999999888999999999999999999999999764321   1111            


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                        .+.....  +.........+.+++.+|++.+|.+||++.+|++.
T Consensus       221 --~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         221 --KIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --HHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              0111111  01112233467788889999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.5e-40  Score=300.92  Aligned_cols=247  Identities=29%  Similarity=0.519  Sum_probs=196.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|...+.||+|+||.||++..  .++.||+|.+....  ....+.+|+.++..++|||++++++++...  ..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEEEC
Confidence            4688889999999999999975  47789999986542  345788999999999999999999987653  36899999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++.....     ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        80 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          80 MSKGNLVNFLRTRGR-----ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            999999999976432     45899999999999999999999888   9999999999999999999999999987543


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ...     .....+..|+|||.+.++.++.++||||||+++|||++ |+.||.......      .. .....+      
T Consensus       152 ~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~-~~~~~~------  213 (254)
T cd05083         152 MGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VK-ECVEKG------  213 (254)
T ss_pred             ccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HH-HHHhCC------
Confidence            221     12234567999999988899999999999999999998 999997543221      00 000000      


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                       .  ......   .....+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       214 -~--~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 -Y--RMEPPE---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -C--CCCCCC---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             0  001011   122456678889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.9e-40  Score=304.59  Aligned_cols=269  Identities=22%  Similarity=0.312  Sum_probs=196.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..+.||+|++|.||+|....++..||+|.+....  ......+.+|+.++..++||||+++++++.++ ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-SRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-CeEEEEEe
Confidence            4777889999999999999998889999999986542  22346688999999999999999999998764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ ++|.+++.....    ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++...
T Consensus        80 ~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          80 FLS-MDLKKYLDSLPK----GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             cCC-CCHHHHHhcCCC----CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            996 689888865321    256899999999999999999999888   999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhH-HHHh----hHHHhhc
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWA----KPILHRG  292 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~-~~~~----~~~~~~~  292 (398)
                      .....  ......+++.|+|||++.+. .++.++||||||+++|+|+||+.||........... ....    ...+...
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         152 GIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             CCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence            43321  11234578899999988654 578899999999999999999999976433211000 0000    0000000


Q ss_pred             h--hhhhhhcCcccCC--CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 M--AAVEELLDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~--~~~~~~~d~~l~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .  .......+.....  ..........+.+++.+||+.||.+|||+.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0  0000000000000  0000011234567888999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-39  Score=299.64  Aligned_cols=259  Identities=28%  Similarity=0.399  Sum_probs=204.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|+..+.||.|+||+||+|....++..+|+|++.... ......+.+|++.++.++|+|++++++.+... ...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEEe
Confidence            47888999999999999999988888999999997543 23567789999999999999999999987764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      ++++++|.+++.....    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        80 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          80 YLSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             ccCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            9999999999976421    145899999999999999999999888   999999999999999999999999998766


Q ss_pred             CCCCCce--eeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          219 SAPSVPF--LCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       219 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .......  ......|+..|+|||++... .++.++|+|||||++|+|++|+.||...+...  .....    .      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~----~------  220 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT----L------  220 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH----h------
Confidence            5433221  12334688999999998877 78999999999999999999999997543321  01000    0      


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        ....+.+............+.+++..||+.+|.+||++.+|++
T Consensus       221 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         221 --QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --cCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              0011111111111123355678888999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.3e-40  Score=299.98  Aligned_cols=250  Identities=23%  Similarity=0.375  Sum_probs=200.8

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..+.||+|+||.||++....+++.||+|.+...  ......++.+|+.+++.++||||+++++++.+. +..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-GNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-CeEEEEEe
Confidence            477889999999999999999888999999998643  234456789999999999999999999987654 56899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          80 YCEGGDLYKKINAQRG-----VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             cCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            9999999999876421     35899999999999999999999888   999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......|+..|+|||++.+..++.++|+|||||++++|++|+.||......+      .           +..
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~-----------~~~  212 (256)
T cd08218         152 NSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------L-----------VLK  212 (256)
T ss_pred             Ccchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------H-----------HHH
Confidence            44321  1123458889999999988889999999999999999999999997543211      1           111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ++.....  .........+.+++.+||+.+|.+||++.+|++
T Consensus       213 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         213 IIRGSYP--PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HhcCCCC--CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1111110  011122345677888999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=317.46  Aligned_cols=241  Identities=25%  Similarity=0.324  Sum_probs=184.7

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC---CCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL---HHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ||+|+||+||+|....+++.||+|++....   ......+..|..++...   +||||+++++++.+. ...++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCC
Confidence            799999999999999889999999996432   12233455666777655   699999999987665 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          80 GGELFWHLQKE-------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD  149 (330)
T ss_pred             CChHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence            99999998754       45899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                      ..  ......||..|+|||.+.+. .++.++|||||||++|||++|+.||.......      .           ...+.
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~-----------~~~i~  210 (330)
T cd05586         150 NK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------M-----------YRNIA  210 (330)
T ss_pred             CC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------H-----------HHHHH
Confidence            21  12346799999999998765 47999999999999999999999997643211      0           01111


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHhcccccCCCCC----CHHHHHH
Q 015931          301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRP----GIEEIIA  340 (398)
Q Consensus       301 d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP----t~~evl~  340 (398)
                      ......+..  .....+.+++.+||+.+|.+||    ++.++++
T Consensus       211 ~~~~~~~~~--~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         211 FGKVRFPKN--VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCCCCCCc--cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            111111110  1123455677889999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-39  Score=299.89  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=200.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ..+|...+.||+|+||.||++.... +..+|+|.+.... .....+.+|+++++.++|+||+++.+++.+  ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e   80 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITE   80 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEE
Confidence            3578889999999999999998654 5679999887543 345678899999999999999999998766  45799999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....     ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          81 FMAKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             eCCCCcHHHHHHhCC-----ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence            999999999997642     245899999999999999999999887   999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ...... ......++..|+|||++....++.++|+|||||++|++++ |+.||.......   ...+           +.
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~-----------~~  217 (260)
T cd05073         153 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA-----------LE  217 (260)
T ss_pred             cCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH-----------Hh
Confidence            432211 1122345678999999988889999999999999999999 999997543211   1110           00


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ..  ......   ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       218 ~~--~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         218 RG--YRMPRP---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CC--CCCCCc---ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            00  011111   1222456778889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-39  Score=301.41  Aligned_cols=255  Identities=24%  Similarity=0.435  Sum_probs=199.3

Q ss_pred             CCCCCceecccCceEEEEeeeCC-CCcEEEEEEecCC----------ChhhHHHHHHHHHHHHh-CCCCCeeceeeEEEc
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE----------DKESSKAFCRELMIASS-LHHPNIVPLVGFCID  128 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  128 (398)
                      +|+..+.||+|+||.||+|.+.. .++.+|+|.+...          .......+..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999876 6788999988532          22334567788888865 799999999998876


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCe
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIP  207 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~  207 (398)
                      . +..++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.+
T Consensus        81 ~-~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          81 N-DRLYIVMDLIEGAPLGEHFNSLKE---KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             C-CeEEEEEecCCCCcHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence            4 458999999999999998865321   12568999999999999999999996 45   9999999999999999999


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      +|+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......      ..  
T Consensus       154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~--  222 (269)
T cd08528         154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LA--  222 (269)
T ss_pred             EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HH--
Confidence            999999998765432   2234568999999999998889999999999999999999999997543211      00  


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                               ..+.+.... +.........+.+++.+||+.+|.+||++.||.++++
T Consensus       223 ---------~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 ---------TKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---------HHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                     011111110 0001112245667778999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-39  Score=298.91  Aligned_cols=248  Identities=28%  Similarity=0.427  Sum_probs=198.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      +|+..+.||+|+||.||+|....++..|++|.+....     .+..+.+.+|+.+++.++|+||+++++++.+. ...++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEE
Confidence            4677889999999999999998789999999986543     33556789999999999999999999987765 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |+||+++++|.+++...       ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          80 FLELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             EEEecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999999999999753       35889999999999999999999988   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCC-cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      .......   ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.......      ....       
T Consensus       150 ~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~-------  213 (258)
T cd06632         150 KQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFK-------  213 (258)
T ss_pred             eeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHH-------
Confidence            8654432   123456889999999987766 8999999999999999999999997543111      0000       


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ....  ...  +.........+.+++.+||+.+|.+||++.++++
T Consensus       214 -~~~~--~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         214 -IGRS--KEL--PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -HHhc--ccC--CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             0000  000  0001112244567778999999999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-39  Score=301.61  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=199.9

Q ss_pred             CCCCceecccCceEEEEeeeC---CCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-----
Q 015931           62 FSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  131 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  131 (398)
                      |...+.||+|+||.||+|.+.   .++..||+|.+...  .....+++.+|+++++.++||||+++++++...+.     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999864   34688999998754  33456678899999999999999999998765432     


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..+++++|+++|+|..++...... .....+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence            246889999999999888643211 11235899999999999999999999888   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ||+++...............++..|++||.+....++.++||||||+++|||++ |+.||.......   +..+      
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~------  227 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNY------  227 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHH------
Confidence            999986643322111223345678999999988889999999999999999999 889987543211   1110      


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                           +...  ..+..   .......+.+++.+||+.+|++||++.++++.|+++
T Consensus       228 -----~~~~--~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 -----LIKG--NRLKQ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -----HHcC--CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 0000  00111   112234678888999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-39  Score=304.47  Aligned_cols=253  Identities=24%  Similarity=0.405  Sum_probs=199.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|+..+.||+|+||.||++....++..||+|.+... .......+.+|++++.+++||||+++++.+... +..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-GAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-CeEEEEEe
Confidence            3678889999999999999999888999999998754 334456789999999999999999999987764 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |+++++|..++.....    ...+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||++..
T Consensus        80 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          80 YMDAGSLDKLYAGGVA----TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             ecCCCCHHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999999998876321    2468999999999999999999996 36   99999999999999999999999999876


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCC------cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGK------VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      .....    .....++..|+|||.+.+..      ++.++|||||||++|+|++|+.||........   ..        
T Consensus       153 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~--------  217 (286)
T cd06622         153 LVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FA--------  217 (286)
T ss_pred             ccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HH--------
Confidence            54322    23456888999999985443      48899999999999999999999965322110   00        


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         .+..+.+...  ..........+.+++.+||+.+|.+||++.++++
T Consensus       218 ---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         218 ---QLSAIVDGDP--PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ---HHHHHhhcCC--CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence               1111111111  0111223345667788999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-39  Score=301.66  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=196.8

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh----------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  130 (398)
                      +|...+.||+|+||.||+|....+++.||+|.+.....          ...+.+..|+.+++.++|||++++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence            46778899999999999999888899999998864211          1234678899999999999999999987664 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~  150 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKIS  150 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEe
Confidence            4589999999999999999764       45899999999999999999999888   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccCC--cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      |||+++...............|+..|+|||.+....  ++.++||||||+++|++++|..||.......     .. ...
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~-~~~  224 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AM-FKL  224 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HH-HHh
Confidence            999997654322222223456889999999987654  7899999999999999999999996432111     00 000


Q ss_pred             HhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...   .....+....     .......+.+++.+||+.+|.+|||+.+|++
T Consensus       225 ~~~---~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         225 GNK---RSAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             hcc---ccCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            000   0000011111     1122345677788999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.7e-39  Score=306.47  Aligned_cols=204  Identities=28%  Similarity=0.483  Sum_probs=163.2

Q ss_pred             CceecccCceEEEEeeeCC--CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcEEEEEecCC
Q 015931           65 GRVLGRGALSFVFKGKVGL--LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVS  141 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~~~  141 (398)
                      +..||+|+||.||+|....  ++..||+|.+....  ....+.+|+++++.++||||+++++++... +...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4689999999999998653  45789999987543  234577899999999999999999987643 445789999985


Q ss_pred             CCCHHHHHhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe----CCCCCeeEeccccc
Q 015931          142 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLA  215 (398)
Q Consensus       142 ~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DfGla  215 (398)
                       ++|.+++......  ......+++..++.++.|++.||.|||+.+   |+||||||+||++    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             5888877542211  111245899999999999999999999988   9999999999999    56678999999999


Q ss_pred             cccCCCCCc-eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          216 TWTSAPSVP-FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       216 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      +........ .......||..|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            876543221 112345689999999998764 57999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-39  Score=299.51  Aligned_cols=251  Identities=26%  Similarity=0.481  Sum_probs=197.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|+..+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+++++.++|||++++++++... ...++||||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEEEc
Confidence            467778899999999999998864 67899998865432 345788999999999999999999987664 457999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++....      ..++++.++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          81 MEHGCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            99999999987542      45899999999999999999999888   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......++.+|+|||.+.++.++.++||||||+++|||++ |+.||.......   ...   .. ..+    ..
T Consensus       152 ~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~-~~~----~~  219 (256)
T cd05112         152 DDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE---TI-NAG----FR  219 (256)
T ss_pred             cCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH---HH-hCC----CC
Confidence            32211 1122335678999999988889999999999999999998 999997543211   110   00 000    00


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      ...+.     .   ....+.+++.+||+.+|++|||+.+|++.|
T Consensus       220 ~~~~~-----~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 LYKPR-----L---ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCC-----C---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            11111     1   124577888999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.7e-40  Score=340.25  Aligned_cols=258  Identities=22%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~  134 (398)
                      ..++|.+.+.||+|+||+||++.+..++..||+|.+...  .......|..|+.++..++|||||++++++.+. ...+|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            346899999999999999999999988999999998753  334456789999999999999999999987654 34589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CceeecccccCcEEeCC-------
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE----RCVVHRDIKPSNILLSS-------  203 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~ivHrDlkp~NIll~~-------  203 (398)
                      |||||+++|+|.++|.....   ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.       
T Consensus        91 IVMEY~~gGSL~~lL~k~~~---~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            99999999999999976421   12469999999999999999999998542    34999999999999964       


Q ss_pred             ----------CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc--CCcCCccchhhHHHHHHHHHcCCCCCc
Q 015931          204 ----------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIE  271 (398)
Q Consensus       204 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvvl~elltG~~Pf~  271 (398)
                                .+.+||+|||++........   .....||+.|+|||++..  ..++.++|||||||+||||++|+.||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      23589999999986643321   234569999999999864  458899999999999999999999997


Q ss_pred             ccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          272 ARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....     .....        .+...  +.+... ..   ...+.+++..||+.+|.+||++.|++.
T Consensus       245 ~~~~~-----~qli~--------~lk~~--p~lpi~-~~---S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANNF-----SQLIS--------ELKRG--PDLPIK-GK---SKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCcH-----HHHHH--------HHhcC--CCCCcC-CC---CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            53221     11100        01110  111111 11   234667778899999999999999984

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-39  Score=310.58  Aligned_cols=201  Identities=23%  Similarity=0.317  Sum_probs=166.2

Q ss_pred             CCceeccc--CceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           64 KGRVLGRG--ALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        64 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ..++||+|  +||+||++..+.+++.||+|.+....  ......+.+|+++++.++||||+++++++...+ ..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-EEEEEEec
Confidence            35689999  78999999999999999999997542  334456788999999999999999999987754 58999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++++||+.+....
T Consensus        81 ~~~~~l~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~  152 (327)
T cd08227          81 MAYGSAKDLICTHFM-----DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  152 (327)
T ss_pred             cCCCcHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccc
Confidence            999999999976432     35899999999999999999999988   9999999999999999999999998654332


Q ss_pred             CCCCc-----eeeeccccCCCcccchhhcc--CCcCCccchhhHHHHHHHHHcCCCCCccc
Q 015931          220 APSVP-----FLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEAR  273 (398)
Q Consensus       220 ~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvvl~elltG~~Pf~~~  273 (398)
                      .....     .......++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            11100     01122356778999999976  35889999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-39  Score=299.09  Aligned_cols=254  Identities=23%  Similarity=0.401  Sum_probs=200.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC------hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      +|+..+.||+|+||.||+|....+++.||+|.+....      ......+..|+.++++++|+||+++++++.+.+ ..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-HFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-eEE
Confidence            5788899999999999999998889999999987532      123567899999999999999999999987654 479


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEeccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFG  213 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DfG  213 (398)
                      +|+||+++++|.+++...       .++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||
T Consensus        80 ~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccc
Confidence            999999999999999764       45899999999999999999999988   99999999999998776 59999999


Q ss_pred             cccccCCCCCc--eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          214 LATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       214 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      .+.........  .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||...........   .....  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~--  224 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIA--  224 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHh--
Confidence            98766543111  111234688999999999888899999999999999999999999975432211110   00000  


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           .....     +.........+.+++.+|++.+|.+||++.++++
T Consensus       225 -----~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 -----SATTA-----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -----ccCCC-----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                 00001     1112223355777888999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.7e-39  Score=296.68  Aligned_cols=252  Identities=31%  Similarity=0.515  Sum_probs=199.6

Q ss_pred             CCCCceecccCceEEEEeeeCCCC----cEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      |+..+.||.|+||.||++.....+    ..||+|.+...... ....+..|+..+..++|+||+++++++.+. +..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEE
Confidence            356788999999999999997655    88999999765433 567899999999999999999999988775 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++.....     ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.
T Consensus        80 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             EeccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCce
Confidence            999999999999976431     22899999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ....           
T Consensus       152 ~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-----------  216 (258)
T smart00219      152 DLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEY-----------  216 (258)
T ss_pred             ecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------
Confidence            765442211 112337789999999988889999999999999999998 888887532211   1110           


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      +...  .......   .....+.+++.+|+..+|.+|||+.++++.|
T Consensus       217 ~~~~--~~~~~~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 LKKG--YRLPKPE---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HhcC--CCCCCCC---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0000  0011111   1234577788899999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-41  Score=315.64  Aligned_cols=256  Identities=23%  Similarity=0.384  Sum_probs=207.0

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecC--CChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCc
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  132 (398)
                      .+..+.|++.++||+||.+.||++...+ ...||+|++..  .+......|.+|+..|.+++ |.+||+|++| .-+++.
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-Ev~d~~  434 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-EVTDGY  434 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-eccCce
Confidence            3456789999999999999999998765 56677777643  34556778999999999995 9999999998 445778


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|+|||+= ..+|..+|.+...     ....| .++.+..|++.|++++|.++   |||.||||.|+|+- .|.+||+||
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~-----~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDF  503 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKS-----IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDF  503 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccC-----CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeee
Confidence            99999987 6799999988643     23335 77789999999999999998   99999999999884 578999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccC-----------CcCCccchhhHHHHHHHHHcCCCCCcccccccchhH
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----------KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL  281 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~  281 (398)
                      |+|..+............+||+.||+||.+...           +.+.++||||+||+||+|+.|+.||..-.       
T Consensus       504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------  576 (677)
T KOG0596|consen  504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------  576 (677)
T ss_pred             chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------
Confidence            999988887766666778999999999998532           25789999999999999999999997421       


Q ss_pred             HHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          282 VLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                               .....+..+.||....+......-..+++++..||..||++|||+.++|+
T Consensus       577 ---------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  577 ---------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ---------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                     11235777888865332222222233888899999999999999999997

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-39  Score=297.34  Aligned_cols=249  Identities=29%  Similarity=0.431  Sum_probs=199.4

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|...+.||+|+||.||++....+++.+|+|.+...  .......+.+|+++++.++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence            477889999999999999999888999999998754  23446678999999999999999999998665 455899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DfGla~~  217 (398)
                      |+++++|.+++....     ...+++..+..++.|++.||+|||+++   ++|+||+|+||+++++ +.+||+|||++..
T Consensus        80 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          80 YAPGGTLAEYIQKRC-----NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             cCCCCCHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            999999999997643     245899999999999999999999988   9999999999999855 4689999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......   .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+...   ..   ......      
T Consensus       152 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~---~~~~~~------  216 (256)
T cd08220         152 LSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LV---LKIMSG------  216 (256)
T ss_pred             cCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HH---HHHHhc------
Confidence            654322   123568899999999998889999999999999999999999997643221   11   110000      


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       . ...+  +.   .....+.+++.+||+.+|.+|||+.|+++
T Consensus       217 -~-~~~~--~~---~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 -T-FAPI--SD---RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -C-CCCC--CC---CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             0 0001  11   12234667788999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=309.78  Aligned_cols=254  Identities=26%  Similarity=0.402  Sum_probs=214.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      +-|+..+.||+|.|++|-+|++--+|.+||||++++...  -....+..|+..++.++|||||+||.+ ++....+|||.
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-iDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-IDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-hcccceEEEEE
Confidence            568888999999999999999999999999999987643  334568899999999999999999997 56677799999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DfGla~  216 (398)
                      |.-.+|+|.+++-+..      ..++++...+++.||+.|+.|+|+..   +|||||||+||.+. .-|-+||+|||++-
T Consensus        97 ELGD~GDl~DyImKHe------~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE------EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             EecCCchHHHHHHhhh------ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccc
Confidence            9999999999998765      45999999999999999999999999   99999999999765 56899999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .+.++..   .++.+|+..|-|||++.+..| .++.||||||||||.|++|+.||+..+..+                 .
T Consensus       168 kf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------------T  227 (864)
T KOG4717|consen  168 KFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------------T  227 (864)
T ss_pred             cCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------------h
Confidence            7776543   357889999999999998887 467999999999999999999998765543                 3


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH--HHhcCc
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA--ILRGEE  346 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~~~  346 (398)
                      +..++|-.+..+...+.   +..+|+..||..||++|.+.++|+.  .|++..
T Consensus       228 LTmImDCKYtvPshvS~---eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  228 LTMIMDCKYTVPSHVSK---ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             hhhhhcccccCchhhhH---HHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            55566666654444444   4556667899999999999999986  455443

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-39  Score=303.17  Aligned_cols=268  Identities=25%  Similarity=0.361  Sum_probs=199.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|+..+.||+|+||.||+|....+++.||+|++....  ....+.+.+|+.+++.++|||++++++++... ...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEE
Confidence            46888899999999999999998889999999986432  22345678999999999999999999988764 4579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|..++...       ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (286)
T cd07847          80 EYCDHTVLNELEKNP-------RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARI  149 (286)
T ss_pred             eccCccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccccee
Confidence            999998888776543       35899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH-HHhhHHHhhchhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWAKPILHRGMAA  295 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~  295 (398)
                      ......  ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+..... .............
T Consensus       150 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07847         150 LTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI  227 (286)
T ss_pred             cCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            654332  1223457889999999875 45789999999999999999999999765432211100 0000000000000


Q ss_pred             ------hhhhcCcccCCCCC----CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 ------VEELLDPRLKCTSR----NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ------~~~~~d~~l~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                            ......+.......    .......+.+++.+||+.+|++||++.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                  00000000000000    0011345778889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=307.38  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=200.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||+||+|....+++.||+|.+.....   .....+..|++++..++||||+++++.+.+. ...++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-TYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-CEEEEE
Confidence            368888999999999999999988899999999976532   2456788999999999999999999987664 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+.+++|.+++....     ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        80 ~e~~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          80 MDYCPGGELFRLLQRQP-----GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             EEecCCCCHHHHHHhCC-----CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhh
Confidence            99999999999987542     246899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCc---------------------------eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCC
Q 015931          217 WTSAPSVP---------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP  269 (398)
Q Consensus       217 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~P  269 (398)
                      ........                           .......||..|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence            54322110                           001124588899999999988899999999999999999999999


Q ss_pred             CcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC----HHHHHH
Q 015931          270 IEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG----IEEIIA  340 (398)
Q Consensus       270 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt----~~evl~  340 (398)
                      |.......                 ....+.+.....+. .......+.+++.+||+.+|++|||    +.++++
T Consensus       232 f~~~~~~~-----------------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         232 FKGSNRDE-----------------TFSNILKKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCchHH-----------------HHHHHhcCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            97543221                 11112222221111 1113355777888999999999999    555555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=315.09  Aligned_cols=260  Identities=26%  Similarity=0.374  Sum_probs=207.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ...+++.||+|-||.|.++.... +..||||.++.... ....+|..|+++|.+++|||||+++|+|...+ .+++|+||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI~EY  616 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMITEY  616 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHHHHH
Confidence            44567889999999999999875 68999999987644 45589999999999999999999999999855 48999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      |++|+|.+++.....     ..+.-....+|+.||+.|++||.+.+   +|||||.+.|+|+|.++++||+|||+++-+.
T Consensus       617 mEnGDLnqFl~ahea-----pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  617 MENGDLNQFLSAHEL-----PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HhcCcHHHHHHhccC-----cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence            999999999988642     22345566779999999999999988   9999999999999999999999999999776


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc--CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ..+........+-.+.|||||.+..+++|.++|||+||+++||+++  ...||..-...   ..+.-.           .
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~-----------~  754 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENA-----------G  754 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhh-----------h
Confidence            6554444444556789999999999999999999999999999875  77888654322   122211           1


Q ss_pred             hhcCcc-c-CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          298 ELLDPR-L-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       298 ~~~d~~-l-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ++++.. . ......+.+...+.++++.||..+-.+||+++++...|+.
T Consensus       755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            222111 0 0111223344556788899999999999999999998875

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-39  Score=304.11  Aligned_cols=251  Identities=23%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||.||++....++..||+|.+........+.+.+|+.+++.++|||++++++++...+ ..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-ELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-cEEEEEec
Confidence            68888999999999999999987778999999987655555677899999999999999999999887754 47999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          98 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             CCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            999999999865        34789999999999999999999888   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ......|+..|+|||.+....++.++||||||+++|++++|+.||...+.......              +...
T Consensus       167 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--------------~~~~  230 (293)
T cd06647         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------------IATN  230 (293)
T ss_pred             cccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--------------hhcC
Confidence            3322  12334688899999999888899999999999999999999999975433211000              0000


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      -.+.+.   ........+.+++.+||..+|.+||++.+++..
T Consensus       231 ~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         231 GTPELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000111   111122346678889999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-39  Score=299.99  Aligned_cols=262  Identities=29%  Similarity=0.391  Sum_probs=202.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV~  137 (398)
                      ++|...+.||.|++|.||++.+..+++.+|+|.+.... ......+.+|+++++.++||||++++++|.+.. ..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36777889999999999999998889999999997543 245567899999999999999999999886543 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++.....   ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK---RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EecCCCCHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccc
Confidence            99999999998765321   1256899999999999999999999888   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......    ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... .........        
T Consensus       155 ~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~--------  221 (287)
T cd06621         155 LVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELLSYIV--------  221 (287)
T ss_pred             cccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHHHHHh--------
Confidence            543221    2345788999999999889999999999999999999999999865321111 111111000        


Q ss_pred             hhcCcccCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....+.+... .........+.+++.+||+.+|.+|||+.||++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0000111100 001112345778889999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.3e-39  Score=301.60  Aligned_cols=249  Identities=23%  Similarity=0.381  Sum_probs=199.9

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      .|...+.||+|++|.||++....++..+++|.+........+.+.+|+.+++.++||||+++++++...+ ..++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-ELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-eEEEEEecc
Confidence            4555679999999999999988889999999987655555667889999999999999999999877654 579999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++++|.+++..        ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        99 ~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          99 EGGALTDIVTH--------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            99999999875        24899999999999999999999988   99999999999999999999999998875543


Q ss_pred             CCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+...      ...        .+....
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~--------~~~~~~  231 (285)
T cd06648         168 EVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMK--------RIRDNL  231 (285)
T ss_pred             CCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHH--------HHHhcC
Confidence            221  1133568999999999988889999999999999999999999997543211      100        011111


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       301 d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+.+....   .....+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 PPKLKNLH---KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCCCcccc---cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11111111   12245777888999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=315.03  Aligned_cols=251  Identities=29%  Similarity=0.492  Sum_probs=207.6

Q ss_pred             CCCceecccCceEEEEeeeCC----CCcEEEEEEecC-CChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ...++||.|-||.||+|.+..    ..-.||||..+. ...+..+.|..|..+++.++|||||+++|+|.+  ...+|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~Wivm  469 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIVM  469 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEEE
Confidence            345789999999999998743    234589998876 356678899999999999999999999999976  3489999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |.++-|.|..+|+..+      ..|+......++.||+.||.|||+..   .|||||..+|||+....-+||+|||+++.
T Consensus       470 EL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence            9999999999999865      46899999999999999999999887   99999999999999999999999999998


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      +....... .+...-.+.|||||.++-.++|.++|||-|||++||++. |..||.+-...+..                 
T Consensus       541 ~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------------  602 (974)
T KOG4257|consen  541 LEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------------  602 (974)
T ss_pred             ccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------------
Confidence            87655332 233445778999999999999999999999999999987 99999875544321                 


Q ss_pred             hhhc-CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          297 EELL-DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       297 ~~~~-d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ..+- ..++.+++.++..   +..++.+||.++|.+||+++++...|..+
T Consensus       603 ~~iEnGeRlP~P~nCPp~---LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPA---LYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             EEecCCCCCCCCCCCChH---HHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            1111 1245555555554   45677899999999999999999988654

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=321.20  Aligned_cols=246  Identities=26%  Similarity=0.433  Sum_probs=201.8

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCH
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL  145 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL  145 (398)
                      -+||+|.||+||.|++.++...+|||.+........+-+..|+.+-++++|.|||+++|.|.+ ++.+-|.||.++||+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcH
Confidence            379999999999999999999999999987777777889999999999999999999998655 5567899999999999


Q ss_pred             HHHHhhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeEeccccccccCCCC
Q 015931          146 ERHLHEKKKGVRGNSTL--PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       146 ~~~l~~~~~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla~~~~~~~  222 (398)
                      .++|...-      +++  ++.+.-.+..||++||+|||++.   |||||||-.|||++. .|.+||+|||.++.+..-+
T Consensus       660 SsLLrskW------GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  660 SSLLRSKW------GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             HHHHHhcc------CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            99998753      556  78888889999999999999988   999999999999985 5889999999999875432


Q ss_pred             CceeeeccccCCCcccchhhccC--CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                        ..+.+..||..|||||++..+  .|+.++|||||||++.||.||++||..-....   ...     +.-+..+    .
T Consensus       731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAM-----FkVGmyK----v  796 (1226)
T KOG4279|consen  731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAM-----FKVGMYK----V  796 (1226)
T ss_pred             --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhh-----hhhccee----c
Confidence              234678899999999999876  48899999999999999999999997432210   000     1111000    0


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       301 d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .     ++...+...+.-.++++|+.++|.+||++.++++
T Consensus       797 H-----P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  797 H-----PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             C-----CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            1     2233445566777888999999999999999986

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.9e-40  Score=306.24  Aligned_cols=268  Identities=25%  Similarity=0.382  Sum_probs=198.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|+..+.||+|+||.||+|....+++.||+|.+....  ....+.+.+|+++++.++||||+++++++.. +...++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence            46788899999999999999998889999999986532  2234568899999999999999999998765 45589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|..+....       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~  149 (286)
T cd07846          80 EFVDHTVLDDLEKYP-------NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART  149 (286)
T ss_pred             ecCCccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence            999999988876543       34899999999999999999999888   99999999999999999999999999886


Q ss_pred             cCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH-HhhHHHhhchh-
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL-WAKPILHRGMA-  294 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~-  294 (398)
                      ......  ......++..|+|||++.+ ..++.++||||||+++|||++|+.||............. +.......... 
T Consensus       150 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07846         150 LAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI  227 (286)
T ss_pred             ccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence            644332  1233457889999999875 357889999999999999999999997543211100000 00000000000 


Q ss_pred             -----hhhhhcCcccCCCC----CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 -----AVEELLDPRLKCTS----RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 -----~~~~~~d~~l~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           .......+......    ..+.....+.+++.+||+.+|.+||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                 00000001000000    00112345778889999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.4e-39  Score=300.49  Aligned_cols=261  Identities=27%  Similarity=0.388  Sum_probs=200.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .+|+..+.||+|+||.||+|....     ..+.|++|.+...... ....+.+|++++++++||||+++++++.+. ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-EPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-Ccc
Confidence            578888999999999999998643     3467999988765433 457799999999999999999999987664 457


Q ss_pred             EEEEecCCCCCHHHHHhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGV--RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ++||||+++|+|.+++.......  .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999997643110  01126899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...       
T Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~-------  229 (275)
T cd05046         161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN-------  229 (275)
T ss_pred             cccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH-------
Confidence            999875432211 11223456778999999988888999999999999999998 888986432211   111       


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                             ......+... ........+.+++.+||+.+|.+||++.++++.|.
T Consensus       230 -------~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 -------RLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------HHHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                   0000010000 00112235777888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.3e-39  Score=298.31  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=198.4

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      -|+..+.||+|+||.||+|....++..||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEEe
Confidence            4667789999999999999988788999999986543 33456788999999999999999999988764 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++++|.+++..        ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~~~~l~~~i~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          84 LGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999999864        35899999999999999999999888   9999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......   ..   ..        +...
T Consensus       153 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~---~~--------~~~~  216 (277)
T cd06641         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VL---FL--------IPKN  216 (277)
T ss_pred             cchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HH---HH--------HhcC
Confidence            3321  1233468889999999988888999999999999999999999996533211   00   00        0000


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ..+.+     .......+.+++.+||+.+|.+||++.++++.
T Consensus       217 ~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 NPPTL-----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCC-----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            01111     11122446677888999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=298.71  Aligned_cols=248  Identities=27%  Similarity=0.447  Sum_probs=198.4

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCC---CCCeeceeeEEEcCCCcEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .|+..+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++   |||++++++++.+. ...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-PRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-CEEEEE
Confidence            477788999999999999999888999999998754 3344567889999999986   99999999988764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++..        ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          81 MEYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             EecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence            999999999998864        35899999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........  .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||........   ..           .
T Consensus       150 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~-----------~  213 (277)
T cd06917         150 LLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MM-----------L  213 (277)
T ss_pred             ecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hh-----------c
Confidence            76544321  2345689999999998754 468999999999999999999999975432110   00           0


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +.....+.+...    .....+.+++.+||+.+|.+||++.++++
T Consensus       214 ~~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         214 IPKSKPPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cccCCCCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            001111111111    12345677888999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.9e-39  Score=303.59  Aligned_cols=267  Identities=21%  Similarity=0.307  Sum_probs=198.5

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh-----hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      +|+..+.||+|+||.||+|....+++.||+|.+......     ....+..|+++++.++|+||+++++++.+ +...++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence            477788999999999999999888999999999765322     34557789999999999999999999877 456899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+ +++|.+++....      ..+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        80 v~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             EEccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceee
Confidence            99999 999999997532      36999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH-HHhhHHHhhch
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWAKPILHRGM  293 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~  293 (398)
                      .........  .....++..|+|||.+.+ ..++.++|||||||++|||++|..||............ ...........
T Consensus       150 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         150 RSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW  227 (298)
T ss_pred             eeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence            876543221  123456788999998865 45789999999999999999998877654321110000 00000000000


Q ss_pred             h---hhhhhcCcccCCCCC-----CHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 A---AVEELLDPRLKCTSR-----NSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ~---~~~~~~d~~l~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .   .+........ ....     .......+.+++.+||+.+|++|||+.||++.
T Consensus       228 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         228 PGVTSLPDYVEFKP-FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhcccccccccccc-cCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0   0000000000 0000     01123567788899999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.2e-39  Score=297.01  Aligned_cols=255  Identities=21%  Similarity=0.316  Sum_probs=185.9

Q ss_pred             eecccCceEEEEeeeCCC--CcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCC
Q 015931           67 VLGRGALSFVFKGKVGLL--RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      .||+|+||.||+|.....  ...+++|.+.... ......+.+|+.+++.++||||+++++.|.+.. ..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-PYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-ccEEEEecCCCC
Confidence            699999999999975432  3456777776543 345678999999999999999999999987654 579999999999


Q ss_pred             CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC
Q 015931          144 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  223 (398)
Q Consensus       144 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  223 (398)
                      +|.+++......   ...+++..++.++.|+++||+|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        81 ~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          81 DLKSYLSQEQWH---RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             cHHHHHHhhhcc---cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            999999764321   234677888899999999999999888   99999999999999999999999999864322211


Q ss_pred             ceeeeccccCCCcccchhhcc-------CCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          224 PFLCKTVKGTFGYLAPEYFQH-------GKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........++..|+|||++..       ..++.++||||||+++|||++ |..||......+      ........   .
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~---~  225 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKD---Q  225 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhh---c
Confidence            111234567889999998743       245789999999999999997 566875432211      11111111   1


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      .....++.+..  ...   ..+.+++..|| .+|.+||++.+|++.|.
T Consensus       226 ~~~~~~~~~~~--~~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         226 QVKLFKPQLEL--PYS---ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccccCCCccCC--CCc---HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11223333321  122   23455666799 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.5e-39  Score=300.77  Aligned_cols=245  Identities=28%  Similarity=0.396  Sum_probs=199.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|+..+.||+|+||.||++....+++.||+|.+....   ......+.+|++++++++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-SNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CeEEEE
Confidence            46888899999999999999998889999999986532   23456788999999999999999999987765 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          80 MEYVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .....     .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.......                 ..
T Consensus       150 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------------~~  207 (290)
T cd05580         150 RVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-----------------IY  207 (290)
T ss_pred             ccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HH
Confidence            76543     134568999999999988888999999999999999999999997543110                 01


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ..+.......+...   ...+.+++.+||..+|.+||     ++.++++
T Consensus       208 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         208 EKILEGKVRFPSFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HHHhcCCccCCccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            11111111111112   24556777889999999999     6777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.6e-39  Score=295.26  Aligned_cols=253  Identities=27%  Similarity=0.430  Sum_probs=205.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||+|++|.||+|....+++.|++|++..... .....+.+|+..+.+++|+|++++++++... ...++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEE
Confidence            368888999999999999999998899999999976643 4567899999999999999999999988775 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |+++++|.+++...       ..+++..++.++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~  149 (264)
T cd06623          80 YMDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKV  149 (264)
T ss_pred             ecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcccee
Confidence            99999999999764       458999999999999999999998 77   99999999999999999999999999986


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      .......  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||............              .
T Consensus       150 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~--------------~  213 (264)
T cd06623         150 LENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM--------------Q  213 (264)
T ss_pred             cccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH--------------H
Confidence            6543321  12456888999999999888999999999999999999999999765431111111              1


Q ss_pred             hhcCcccCCCCCCHH-HHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          298 ELLDPRLKCTSRNSA-QIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .+......  ..... ....+.+++.+||+.+|++||++.++++.
T Consensus       214 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         214 AICDGPPP--SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHhcCCCC--CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11111111  01111 23467777888999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.3e-39  Score=301.74  Aligned_cols=247  Identities=26%  Similarity=0.394  Sum_probs=196.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ..|...+.||+|+||.||+|....+++.||+|.+....   ......+.+|+++++.++||||+++.++|.+.+ ..++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-TAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-eEEEE
Confidence            56888899999999999999998889999999986432   334467889999999999999999999988754 47999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||++ |+|.+++....      ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.
T Consensus        94 ~e~~~-g~l~~~~~~~~------~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          94 MEYCL-GSASDILEVHK------KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             HHhhC-CCHHHHHHHcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcce
Confidence            99996 67877776432      45899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      .....      ....++..|+|||++.   ...++.++||||||+++|||++|+.||........      ...      
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~------  225 (307)
T cd06607         164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH------  225 (307)
T ss_pred             ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHH------
Confidence            65432      2345788999999874   45688999999999999999999999865432110      000      


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                        +.....+.+.    .......+.+++.+||+.+|.+||++.+|+..
T Consensus       226 --~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         226 --IAQNDSPTLS----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --HhcCCCCCCC----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0000011111    11223457788889999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-39  Score=302.23  Aligned_cols=266  Identities=23%  Similarity=0.314  Sum_probs=200.4

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|...+.||+|+||.||+|....++..||+|++....  ......+.+|+.++++++||||+++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-SGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-CeeEEEec
Confidence            4778889999999999999998889999999997653  33456789999999999999999999988774 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+ +++|.+++....      ..+++..++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          80 YM-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             cc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            99 999999987643      45999999999999999999999888   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc----h
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----M  293 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----~  293 (398)
                      ..... .......|+..|+|||.+.+. .++.++||||+|+++|||++|..||.......   ............    .
T Consensus       150 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  225 (286)
T cd07832         150 SEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETW  225 (286)
T ss_pred             cCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHH
Confidence            54331 112345689999999998654 46899999999999999999988886543211   111110000000    0


Q ss_pred             hhhh------hhcCcccC---CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 AAVE------ELLDPRLK---CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ~~~~------~~~d~~l~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ..+.      .+..+.-.   ...........+.+++.+||+.+|.+|||++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000      00000000   000001123567788889999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8e-39  Score=294.84  Aligned_cols=253  Identities=27%  Similarity=0.464  Sum_probs=200.2

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..+.||+|+||.||+|....++..|++|.+.....  ...+.+..|+++++.++|+||+++++++... ...++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-EKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-CEEEEEEe
Confidence            47788999999999999999988899999999976544  3667899999999999999999999987654 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        80 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          80 YCSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             cCCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccccc
Confidence            99999999999763       34889999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCcee--eeccccCCCcccchhhccCC---cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          219 SAPSVPFL--CKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       219 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ........  .....++..|+|||++....   ++.++||||||+++|+|++|+.||.......  ... +         
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~-~---------  217 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIM-F---------  217 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHH-H---------
Confidence            54332111  11346788999999998766   8899999999999999999999996432110  000 0         


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .+.....+.+.  . .......+.+++.+||+.+|.+|||+.+++.
T Consensus       218 -~~~~~~~~~~~--~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         218 -HVGAGHKPPIP--D-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -HHhcCCCCCCC--c-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             00111111111  1 1111334567788999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.3e-39  Score=297.71  Aligned_cols=254  Identities=29%  Similarity=0.442  Sum_probs=202.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.... ......+.+|++++++++||||+++++++... ...++|+|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEE
Confidence            35777889999999999999999889999999987653 34556789999999999999999999988775 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |+++++|.+++....      ..+++..+..++.|++.||+|||+ .+   ++|+||||+||++++++.++|+|||.+..
T Consensus        80 ~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          80 YMDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             ecCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchh
Confidence            999999999997642      468999999999999999999998 77   99999999999999999999999999876


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......    ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ...........        
T Consensus       151 ~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--------  217 (265)
T cd06605         151 LVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV--------  217 (265)
T ss_pred             hHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh--------
Confidence            543221    12568889999999998899999999999999999999999997543211 11111111111        


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....+.+.    .......+.+++.+||..+|.+|||+.+++.
T Consensus       218 ~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         218 NEPPPRLP----SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             cCCCCCCC----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            00111111    1112344677888999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.1e-39  Score=298.97  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=193.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHH-HHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMI-ASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.... ......+..|+.. ++..+||||+++++++...+ .+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-DVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEEh
Confidence            46888899999999999999999889999999997643 2334456666665 56678999999999987654 589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||++ |+|.+++.....   ....+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++.
T Consensus        80 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          80 EVMD-TSLDKFYKKVYD---KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             hhhc-ccHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9995 789888865321   125689999999999999999999986 6   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhcc----CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQH----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      .......   .....|+..|+|||.+.+    ..++.++|+||||+++|+|++|+.||....... ..+    ..     
T Consensus       153 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~----~~-----  219 (283)
T cd06617         153 YLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQL----KQ-----  219 (283)
T ss_pred             ccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHH----HH-----
Confidence            6543221   123568899999998864    356889999999999999999999996422110 000    00     


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ......+.+...    .....+.+++.+||..+|.+||++.+|++
T Consensus       220 ---~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         220 ---VVEEPSPQLPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ---HHhcCCCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               001111111111    12245677888999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.1e-38  Score=290.84  Aligned_cols=250  Identities=28%  Similarity=0.427  Sum_probs=203.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      +|...+.||+|++|.||++....+++.+++|++..........+.+|++.++.++|+|++++++++... ...++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence            467788999999999999999888999999999876555667899999999999999999999987765 4579999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++++|.+++....      ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.....
T Consensus        80 ~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          80 SGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             CCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            9999999987642      46899999999999999999999887   99999999999999999999999999887654


Q ss_pred             CCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                      ...   .....++..|+|||.+....++.++||||||+++|+|++|+.||........   ...           .....
T Consensus       151 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~-----------~~~~~  213 (253)
T cd05122         151 TKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFK-----------IATNG  213 (253)
T ss_pred             ccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHH-----------HHhcC
Confidence            431   2345688999999999888899999999999999999999999975432110   000           00000


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       301 d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      -+.+....   .....+.+++.+||+.+|++|||+.++++
T Consensus       214 ~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         214 PPGLRNPE---KWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCcCccc---ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111111   11245777888999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2e-39  Score=302.46  Aligned_cols=265  Identities=22%  Similarity=0.302  Sum_probs=194.4

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|...+.||+|+||.||+|....+|+.||+|.+....  ......+.+|++++++++||||+++++++.+. ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEe
Confidence            4777889999999999999999889999999986532  22234677899999999999999999987664 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ ++|.+++....      ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          80 YCD-QDLKKYFDSCN------GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             cCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            996 58888876532      45899999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh----ch
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR----GM  293 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~  293 (398)
                      .....  ......++..|+|||.+.+. .++.++|||||||++|||+||..|+.......  ............    ..
T Consensus       150 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~  225 (284)
T cd07839         150 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESW  225 (284)
T ss_pred             CCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHh
Confidence            43321  11234578899999998765 46899999999999999999999865332211  000000000000    00


Q ss_pred             hhhhhhcCcc----cCC----CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPR----LKC----TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~----l~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+....+..    ...    ....+.....+.+++.+||+.+|.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0001111100    000    0001112345667888999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.8e-39  Score=299.02  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=203.5

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++.|...+.||+|++|.||+|.+..++..|++|.+..... ....+.+|++.++.++|+|++++++++... ...++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEE
Confidence            45678888999999999999999987889999999986554 566788999999999999999999988775 5589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        95 e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          95 EYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             eccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            9999999999998752      36999999999999999999999888   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........  ..    .....      
T Consensus       166 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~----~~~~~------  231 (286)
T cd06614         166 LTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LF----LITTK------  231 (286)
T ss_pred             hccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhc------
Confidence            543321  11234578899999999888899999999999999999999999875432210  00    00000      


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       . -+....   .......+.+++.+||+.+|.+||++.+|++
T Consensus       232 -~-~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         232 -G-IPPLKN---PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -C-CCCCcc---hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             0 001110   1112245677888999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.9e-39  Score=295.74  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|...+.||+|+||.||+|....++..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+.+. ...++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-GRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-CeEEEEEe
Confidence            4777889999999999999999889999999986542  23446788999999999999999999987664 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DfGla~~  217 (398)
                      |+++++|.+++.....     ..+++..+..++.|+++||.|||+.+   ++|+||||+||++++++ .+||+|||.+..
T Consensus        80 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          80 YCDGGDLMKRINRQRG-----VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             cCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchh
Confidence            9999999999976432     45899999999999999999999888   99999999999999885 469999999886


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......  ......|+..|+|||++.+..++.++||||||+++|||++|..||...+..      .+...          
T Consensus       152 ~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~----------  213 (257)
T cd08225         152 LNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLK----------  213 (257)
T ss_pred             ccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH----------
Confidence            654321  123346889999999998888999999999999999999999999754321      11111          


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .......  ...+.....+.+++.+|+..+|++|||+.+|++
T Consensus       214 -~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         214 -ICQGYFA--PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -HhcccCC--CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             1111111  001112235777788999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=314.76  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=210.8

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ...+....++||-|.||.||.|.++...-.||||.++.+.. ...+|+.|+.+++.++|||+|+|+|+|... ..+|||+
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~E-pPFYIiT  342 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-PPFYIIT  342 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccC-CCeEEEE
Confidence            34456667899999999999999999889999999976544 568899999999999999999999999774 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |||..|+|.++|...++     ..++--..+.++.||+.|++||...+   .|||||..+|+|+.++..+|++|||++++
T Consensus       343 EfM~yGNLLdYLRecnr-----~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNR-----SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             ecccCccHHHHHHHhch-----hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999998764     55777788999999999999999888   99999999999999999999999999998


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      +..+..... ....-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+-+......       ++.+     
T Consensus       415 MtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-------LLEk-----  481 (1157)
T KOG4278|consen  415 MTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-------LLEK-----  481 (1157)
T ss_pred             hcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-------HHhc-----
Confidence            876542111 11223567999999999999999999999999999998 999987654332111       1111     


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                          +-++..+..++.   .+.+|+++||+.+|.+||++.|+-+.++.
T Consensus       482 ----gyRM~~PeGCPp---kVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  482 ----GYRMDGPEGCPP---KVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             ----cccccCCCCCCH---HHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence                123333444444   45667788999999999999999998865

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=303.56  Aligned_cols=266  Identities=27%  Similarity=0.375  Sum_probs=200.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+...  .......+.+|+++++.++|+||+++++++... +..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-GRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-CEEEEEE
Confidence            3688889999999999999999888999999998653  233456789999999999999999999998774 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||++++.+..+....       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~  149 (288)
T cd07833          80 EYVERTLLELLEASP-------GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARA  149 (288)
T ss_pred             ecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccc
Confidence            999887776655432       45899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..   ......+.......
T Consensus       150 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~  225 (288)
T cd07833         150 LRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL---YLIQKCLGPLPPSH  225 (288)
T ss_pred             cCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHH
Confidence            655432 112345678899999999887 7899999999999999999999999754322111   00000000000000


Q ss_pred             hhhc--CcccCC----CC---------CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELL--DPRLKC----TS---------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~--d~~l~~----~~---------~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....  ++....    ..         ........+.+++.+||..+|++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000  000000    00         00011356788888999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.1e-39  Score=301.64  Aligned_cols=204  Identities=25%  Similarity=0.376  Sum_probs=170.3

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++.+|...+.||+|+||.||+|....++..||+|.+..... .....+.+|+.+++.++|+||+++.+++... ...++|
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv   81 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTFV   81 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-CeEEEE
Confidence            45789999999999999999999988899999999875432 2234677899999999999999999987764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+. ++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++
T Consensus        82 ~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          82 FEYMH-TDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             Eeccc-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence            99995 78877765432      35788899999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      .......  ......++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         152 AKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            5433221  11234578899999998754 57889999999999999999999997543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.1e-39  Score=299.22  Aligned_cols=266  Identities=22%  Similarity=0.344  Sum_probs=196.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..+.||.|++|.||+|....+++.||+|.+....  ......+.+|++++++++||||+++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-CcEEEEee
Confidence            4788899999999999999998889999999987542  22345788999999999999999999987664 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+. ++|.+++....     ...+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        80 ~~~-~~l~~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          80 FLH-QDLKKFMDASP-----LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             ccc-cCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            995 68998887643     256899999999999999999999888   999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCC-cCCccchhhHHHHHHHHHcCCCCCcccccccch-hHHHHhh-------HHH
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAK-------PIL  289 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~-------~~~  289 (398)
                      ......  .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||......... .......       +..
T Consensus       151 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         151 GVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence            433211  12345788999999887644 588999999999999999999999754321100 0000000       000


Q ss_pred             hh---chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HR---GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~---~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..   ............+.  ...+.....+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFS--KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hHHHHHHhhcccccccCHH--HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00   00000000000000  000011234567888999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=298.35  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=206.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      +-|++..+||+|+||.||+|.++.+|..+|+|.+..+  .+.+++..|+.++.+++.|++|++||.++...+ +++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVMEY  109 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVMEY  109 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehhh
Confidence            3577788999999999999999999999999998765  456789999999999999999999998887544 8999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      |-.|++.+.+..++      .+|++..+..++...++||+|||...   -+|||||..||||+.+|.+||+|||.|..+.
T Consensus       110 CGAGSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  110 CGAGSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             cCCCcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence            99999999998764      67999999999999999999999877   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ..-.  ...++.||+.|||||++..-.|..++||||||++..||..|++|+.+-.+-.-.    +          .+..-
T Consensus       181 DTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI----F----------MIPT~  244 (502)
T KOG0574|consen  181 DTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI----F----------MIPTK  244 (502)
T ss_pred             hhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee----E----------eccCC
Confidence            4322  224678999999999999999999999999999999999999999764331100    0          00000


Q ss_pred             cCcccCCCCCCHHH-HHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQ-IARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      -.|.+.    .+++ ...+-+++..||-+.|++|-|+.++++
T Consensus       245 PPPTF~----KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  245 PPPTFK----KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCCC----ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            111111    2333 345778888999999999999999887

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-39  Score=298.98  Aligned_cols=266  Identities=24%  Similarity=0.328  Sum_probs=195.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||+|++|.||+|....+++.||+|.+..... .....+.+|+++++.++|+||+++++++.+. ...++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-KTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-CeEEEEEe
Confidence            578889999999999999999988899999999875432 2234567899999999999999999997764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ ++|.+++....      ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~~-~~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          84 YLD-TDLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             cCC-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            997 59999887542      35899999999999999999999888   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh-h-
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA-A-  295 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~-  295 (398)
                      ......  .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........  .............. . 
T Consensus       154 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  229 (291)
T cd07844         154 SVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETW  229 (291)
T ss_pred             CCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhh
Confidence            332211  122346888999999875 4578999999999999999999999975431110  00000000000000 0 


Q ss_pred             --h---hhhcCcccCCC--C------CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 --V---EELLDPRLKCT--S------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 --~---~~~~d~~l~~~--~------~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        +   ...........  .      ........+.+++.+||+.+|.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              0   00000000000  0      00001145678889999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-38  Score=300.23  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=195.2

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .|...+.||+|+||.||+|....++..||+|.+...   .......+..|+++++.++|||++++++++.+.. ..++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-TAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-eEEEEE
Confidence            477788999999999999999888999999998743   2234457889999999999999999999987754 478999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||++ |+|.+.+....      ..++|..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus       105 e~~~-g~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         105 EYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             eCCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccc
Confidence            9996 58877776532      45899999999999999999999888   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ....      ....|+..|+|||++.   .+.++.++|||||||++|||++|+.||........                
T Consensus       175 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----------------  232 (317)
T cd06635         175 ASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------  232 (317)
T ss_pred             cCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----------------
Confidence            4432      2345888999999974   45689999999999999999999999865322110                


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                       +..+...... ..........+.+++.+||+.+|.+||++.+|++.+
T Consensus       233 -~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         233 -LYHIAQNESP-TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -HHHHHhccCC-CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence             0111110000 001112223467788899999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=312.77  Aligned_cols=245  Identities=27%  Similarity=0.408  Sum_probs=199.8

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      -|+..+.||.|+||.||-|.+..+.+.||||+..-..   .+..+++..|+..|.+++|||++.+.|+|... ...||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-HTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-chHHHHH
Confidence            5777889999999999999999999999999987543   34567899999999999999999999987764 4579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||| -||-.+++.-..      .++-+..+..|+.+.+.||+|||+.+   .||||||..||||.+.|.+||+|||.|..
T Consensus       106 EYC-lGSAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             HHH-hccHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh
Confidence            999 678888887664      57899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ..+.      .+++||+.|||||++.   .+.|+-|+||||||++..||...++|....+.-.       +..       
T Consensus       176 ~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALY-------  235 (948)
T KOG0577|consen  176 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALY-------  235 (948)
T ss_pred             cCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHH-------
Confidence            6554      3578999999999985   5789999999999999999999999975433210       001       


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+-.--.|.|. ....++..   ..++-.||++-|.+|||..++++
T Consensus       236 HIAQNesPtLq-s~eWS~~F---~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  236 HIAQNESPTLQ-SNEWSDYF---RNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHhcCCCCCC-CchhHHHH---HHHHHHHHhhCcccCCcHHHHhh
Confidence            11111223333 22334444   44555699999999999999886

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.9e-39  Score=295.67  Aligned_cols=248  Identities=26%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      +|...+.||.|+||.||+|....+++.||+|.+....   ....+.+.+|++++++++||||+++++.+.++ ...++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-ENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-CeEEEEE
Confidence            4778899999999999999998889999999997542   24567889999999999999999999987654 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++...       ..+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||++..
T Consensus        80 e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          80 DLLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             eCCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            999999999999764       36899999999999999999999888   99999999999999999999999999886


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      .....   ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||............    .          
T Consensus       150 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~----------  212 (258)
T cd05578         150 VTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----A----------  212 (258)
T ss_pred             cCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----H----------
Confidence            65432   123456888999999998888999999999999999999999999865432111111    0          


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH--HHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI--EEII  339 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~--~evl  339 (398)
                      .........+.   .....+.+++.+||+.+|.+||+.  .|++
T Consensus       213 ~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         213 KQETADVLYPA---TWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HhccccccCcc---cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            00001111111   122556777889999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9e-39  Score=299.63  Aligned_cols=269  Identities=23%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV  136 (398)
                      ++|...+.||.|+||.||+|....+++.+|+|.+.....  .....+.+|+.++.+++||||+++++++...+ ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            578888999999999999999988899999999975432  22345678999999999999999999877652 568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||++ ++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.
T Consensus        85 ~e~~~-~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          85 MEYVE-HDLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             ehhcC-cCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            99996 59999887643      35899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH-HHh-------hH
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWA-------KP  287 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~-------~~  287 (398)
                      ........  .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||............ ...       ++
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            76543221  2334578899999998754 4689999999999999999999999765432111100 000       00


Q ss_pred             HHhhchh----hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 ILHRGMA----AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 ~~~~~~~----~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+.....    .........+............+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000000    0000000000000000002344667888999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.6e-38  Score=306.16  Aligned_cols=200  Identities=24%  Similarity=0.357  Sum_probs=171.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----C
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  131 (398)
                      .++|+..+.||+|+||.||+|....+++.||+|.+...  .......+.+|+.+++.++||||+++++++....     .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            47899999999999999999999888999999998643  3344566778999999999999999999875432     2


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||+. ++|.+.+..         .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence            4789999994 588887753         2888999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ||+++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus       162 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         162 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             CccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            999986644321   233457889999999998899999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.1e-38  Score=288.33  Aligned_cols=253  Identities=30%  Similarity=0.427  Sum_probs=203.7

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV~  137 (398)
                      +|+..+.||+|++|.||+|....++..|++|.+.....  ...+.+.+|+..+++++||||+++++.+.+.. ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47778899999999999999988899999999876542  45678899999999999999999999887652 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          81 EYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             EecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            999999999999764       36899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ..............++..|+|||.+.....+.++||||||+++|+|++|..||......     ...           +.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~-----------~~  214 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAA-----------LY  214 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHH-----------HH
Confidence            76543211123456889999999998888999999999999999999999999765411     000           01


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........ ..........+.+++.+|+..+|.+||++.++++
T Consensus       215 ~~~~~~~~-~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         215 KIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hccccCCC-cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11110000 0111112345777778999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=297.19  Aligned_cols=209  Identities=28%  Similarity=0.447  Sum_probs=172.0

Q ss_pred             CCCCCceecccCceEEEEeeeCC--CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGL--LRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  134 (398)
                      +|+..+.||+|+||.||+|....  ++..||+|.+....   ......+.+|+.++..++||||+++++++.+.+ ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47778899999999999999987  78999999998632   334466788999999999999999999988752 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC----CCCeeEe
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS----KKIPKLC  210 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~----~~~~kl~  210 (398)
                      +||||++ ++|.+.+......  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQA--KRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccC--CCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEEC
Confidence            9999996 5777777543221  1246899999999999999999999888   999999999999999    8999999


Q ss_pred             ccccccccCCCCC-ceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          211 DFGLATWTSAPSV-PFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       211 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      |||++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||.....
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            9999986644322 1112345678999999988764 578999999999999999999999986544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-39  Score=306.77  Aligned_cols=268  Identities=21%  Similarity=0.311  Sum_probs=198.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----CcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  133 (398)
                      +++|...+.||+|+||.||+|....+++.||+|.+... .......+..|+.++++++||||+++++++....    ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999999888999999998643 2334566888999999999999999999865432    347


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++|+||+. ++|.+.+..        ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        84 ~lv~e~~~-~~l~~~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          84 YIVQELME-TDLYKLIKT--------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             EEEehhcc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccc
Confidence            89999995 588877754        35899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCce-eeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          214 LATWTSAPSVPF-LCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       214 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ++.......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...   ...........
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~  228 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGT  228 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCC
Confidence            998654322111 1123468899999998754 468999999999999999999999997543211   01100000000


Q ss_pred             -chhhhhhhcCcc-------cCC-CC-----CCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          292 -GMAAVEELLDPR-------LKC-TS-----RNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       292 -~~~~~~~~~d~~-------l~~-~~-----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                       .......+.+..       ... ..     ..+.....+.+++.+||+.+|.+|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000111111100       000 00     001123457788899999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-38  Score=301.05  Aligned_cols=269  Identities=23%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~l  135 (398)
                      .++|+..+.||+|+||.||+|....+++.||+|.+.....  .....+.+|+.++++++|+||+++++++.+.. +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4689999999999999999999988899999999875422  22334668999999999999999999876543 45799


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+. ++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        86 v~e~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             EEecCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcccee
Confidence            999995 58988887542      46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-----HHH
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PIL  289 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-----~~~  289 (398)
                      .........  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.-..     ..+
T Consensus       156 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         156 RTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            876543211  123345788999999865 457899999999999999999999997654322111111000     000


Q ss_pred             hhchhhhhhhcCcccCCCC--C----CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTS--R----NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~--~----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ... ..+...-...+....  .    .......+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         234 PGF-SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhh-hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000 000000000000000  0    0011344667888999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-38  Score=298.00  Aligned_cols=245  Identities=22%  Similarity=0.358  Sum_probs=196.4

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ...||+|+||.||++....++..||+|.+..........+.+|+.+++.++|+|++++++++...+ ..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-EEEEEEecCCCCc
Confidence            357999999999999998889999999987655556677899999999999999999999887654 5899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |.+++..        ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus       104 L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657         104 LTDIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             HHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            9998754        34899999999999999999999988   99999999999999999999999999876543221 


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCccc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  304 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  304 (398)
                       ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   ...           .+.....+.+
T Consensus       172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~-----------~~~~~~~~~~  236 (292)
T cd06657         172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK-----------MIRDNLPPKL  236 (292)
T ss_pred             -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-----------HHHhhCCccc
Confidence             1234568899999999988888999999999999999999999987532211   000           1111122222


Q ss_pred             CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          305 KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       305 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ......   ...+.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~~~---~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         237 KNLHKV---SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCcccC---CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            111111   234566778899999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.1e-38  Score=292.47  Aligned_cols=262  Identities=23%  Similarity=0.265  Sum_probs=193.7

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCC-CcEEEEEe
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE-QGLFLIYK  138 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~~lV~e  138 (398)
                      |+..+.||+|+||.||+|....++..||+|.+.... .........|+..+.++. |+|++++++++.+.. +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999998889999999987542 222234457888888885 999999999987752 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ ++|.+.+....      ..++|..++.++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||++...
T Consensus        81 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          81 LMD-MNLYELIKGRK------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             cCC-ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            996 58888876532      45899999999999999999999888   999999999999999 99999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      .....   .....++..|+|||++.. ..++.++|||||||++|||++|..||...+..+   .+.+...........+.
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  223 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVL  223 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence            43321   123457889999997654 457889999999999999999999997654321   11111111111000000


Q ss_pred             hhcCc----ccCCCC--------CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDP----RLKCTS--------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~----~l~~~~--------~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....    ....+.        ........+.+++.+||+++|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000    000000        00122466888899999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-38  Score=289.76  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=196.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~  133 (398)
                      .+|...+.||+|+||.||+|.+..++..||+|.+...     .......+.+|++++++++|+||+++++++.+.. ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999999888999999987532     2234567889999999999999999999877653 347


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccc
Confidence            8999999999999998753       35889999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------  216 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------------  216 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------------
Confidence            99865432111 11123568899999999988889999999999999999999999997532211               


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        .+......... +.........+.+++.+|++ +|..||+..+++.
T Consensus       217 --~~~~~~~~~~~-~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         217 --AIFKIATQPTK-PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --HHHHHHcCCCC-CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              01111100000 00111222345666678999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-38  Score=299.59  Aligned_cols=270  Identities=21%  Similarity=0.296  Sum_probs=196.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-------
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-------  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  130 (398)
                      ++|...+.||+|+||.||+|....+++.||+|.+....  ......+.+|+.++++++||||++++++|...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57899999999999999999998889999999986432  222345678999999999999999999886543       


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...++||||+. ++|.+.+....      ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN------VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEEC
Confidence            23589999995 58888876532      35899999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCc--eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          211 DFGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       211 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |||++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.................
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999866433211  111234578899999988664 468899999999999999999999976543221111111000


Q ss_pred             -----HHhhchhhhhhhcCcccCCCCC--------CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 -----ILHRGMAAVEELLDPRLKCTSR--------NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 -----~~~~~~~~~~~~~d~~l~~~~~--------~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           .+... ......-...+.....        .......+.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGV-DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccc-cchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                 00000 0000000000000000        0001234568889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=298.03  Aligned_cols=261  Identities=15%  Similarity=0.187  Sum_probs=186.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCC---CcEEEEEEecCCChhhH-----------HHHHHHHHHHHhCCCCCeeceee
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESS-----------KAFCRELMIASSLHHPNIVPLVG  124 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~  124 (398)
                      .++|...++||+|+||+||+|....+   +..+|+|..........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999998766   56677776443221110           11223334556678999999998


Q ss_pred             EEEcCCC---cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          125 FCIDPEQ---GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       125 ~~~~~~~---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                      ++.....   ..+++++++ ..++.+.+...       ...++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill  159 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMV  159 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            7655433   236778877 44677666543       23678889999999999999999888   9999999999999


Q ss_pred             CCCCCeeEeccccccccCCCCCc-----eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccc
Q 015931          202 SSKKIPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  276 (398)
Q Consensus       202 ~~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~  276 (398)
                      +.++.++|+|||+++........     .......||+.|+|||+..+..++.++|||||||++|||++|+.||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999999999866432111     1112346999999999999889999999999999999999999999865332


Q ss_pred             cchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          277 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      ..  .......-      .+..+..+.+... ..+   ..+.+++..|++.+|.+||++.++++.|
T Consensus       240 ~~--~~~~~~~~------~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        240 GN--LIHAAKCD------FIKRLHEGKIKIK-NAN---KFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hH--HHHHhHHH------HHHHhhhhhhccC-CCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            21  11100000      0111111111111 122   3456666789999999999999999876

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=313.45  Aligned_cols=249  Identities=29%  Similarity=0.441  Sum_probs=204.5

Q ss_pred             CCCCCceecccCceEEEEeeeCCCC---cEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .....++||+|.||+|++|.|...+   ..||||.+...... ...+|.+|+.+|.+|+|||+++|||+..+  ....+|
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV  188 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMV  188 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHH
Confidence            3445578999999999999986432   45999999876544 67889999999999999999999999776  447899


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      +|.++.|+|.+.|.+..+     ..|.....-.++.|||.|+.||.++.   .|||||..+|+||-....+||+||||.+
T Consensus       189 ~ELaplGSLldrLrka~~-----~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKK-----AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hhhcccchHHHHHhhccc-----cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence            999999999999988432     56888888999999999999999887   9999999999999999999999999999


Q ss_pred             ccCCCCCceee-eccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          217 WTSAPSVPFLC-KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       217 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      -+..+...... ....-.+.|.|||.+...+++.++|||+|||++|||+| |..||.+.....                 
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------  323 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------  323 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------
Confidence            88776544322 22345678999999999999999999999999999998 999998755321                 


Q ss_pred             hhhhhcC--cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLD--PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d--~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       +.+.+|  .+|..+..   +.+++.+++..||..+|.+|||+..|.+
T Consensus       324 -IL~~iD~~erLpRPk~---csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  324 -ILKNIDAGERLPRPKY---CSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             -HHHhccccccCCCCCC---ChHHHHHHHHHhccCCccccccHHHHHH
Confidence             222233  23443433   4456777778999999999999999974

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-38  Score=296.79  Aligned_cols=257  Identities=25%  Similarity=0.343  Sum_probs=193.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|...+.||+|+||.||++....+++.||+|.+.... ......+..|+.++.++. |+||+++++++...+ ..+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-DCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-cEEEEEe
Confidence            4556678999999999999999889999999987543 344567889999999996 999999999887654 4789999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |+. ++|.++......  .....+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.++|+|||++..
T Consensus        84 ~~~-~~l~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          84 LMD-ISLDKFYKYVYE--VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             ccc-CCHHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            985 566554432110  0125689999999999999999999974 6   99999999999999999999999999976


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccC---CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHG---KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ......   .....|+..|+|||.+.+.   .++.++|||||||++|||++|+.||.....     .......       
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~-------  222 (288)
T cd06616         158 LVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQ-------  222 (288)
T ss_pred             hccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhh-------
Confidence            543221   1234588999999998766   689999999999999999999999975431     0000000       


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                       +.....+.+.. .........+.+++.+||+.+|.+|||+.+|++.
T Consensus       223 -~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         223 -VVKGDPPILSN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -hcCCCCCcCCC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00001111211 1111233457788889999999999999999873

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=295.78  Aligned_cols=267  Identities=21%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      |+..+.||.|++|.||+|....++..||+|++....  ......+.+|+++++.++|||++++++++.+. ...++||||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence            567789999999999999998889999999987543  22345688999999999999999999998765 558999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      + +++|.+++.....     ..+++..++.++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        80 ~-~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          80 L-DLDLKKYMDSSPL-----TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             c-CcCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            9 5699999876431     36899999999999999999999887   9999999999999999999999999997654


Q ss_pred             CCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccch-hHHHHhhHHHhh---chh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAKPILHR---GMA  294 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~---~~~  294 (398)
                      .....  .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......... ............   ...
T Consensus       151 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         151 VPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             CCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence            32211  1233568899999988654 5688999999999999999999999764332110 000000000000   000


Q ss_pred             hhhhhcC--cccCC---CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLD--PRLKC---TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d--~~l~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+.+...  +....   ..........+.+++.+|++.+|.+|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000  00000   0000111245778889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.1e-38  Score=291.92  Aligned_cols=269  Identities=21%  Similarity=0.315  Sum_probs=198.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      +|+..+.||.|++|.||+|....++..||+|.+..... .....+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-KLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-cEEEEEec
Confidence            57888999999999999999988899999999976532 23456778999999999999999999987754 57999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      ++ ++|.+++.....    ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++....
T Consensus        80 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          80 MD-KDLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             CC-ccHHHHHHhcCC----CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            97 489888865431    246899999999999999999999888   9999999999999999999999999997654


Q ss_pred             CCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH-HHhhHHHhhchhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWAKPILHRGMAAVE  297 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~  297 (398)
                      ....  ......++..|++||++.+. .++.++||||||+++|+|++|+.||...+..+..... .............+.
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            3221  11234578899999998654 5688999999999999999999999765432211100 000000000000000


Q ss_pred             hh--cCcccCCC------CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 EL--LDPRLKCT------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~--~d~~l~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..  ........      ...+.....+.+++.+|++.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00  00000000      000112345678888999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.9e-38  Score=293.50  Aligned_cols=243  Identities=25%  Similarity=0.358  Sum_probs=184.7

Q ss_pred             eecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHH---HhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           67 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIA---SSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      +||+|+||.||++....+++.+|+|.+.....   .....+.+|..++   ...+|||++.+++++... +..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEEEEecC
Confidence            48999999999999988899999999865421   2223344444433   334799999999887664 4589999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.....
T Consensus        80 ~~~~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          80 NGGDLHYHLSQH-------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            999999998754       45999999999999999999999988   99999999999999999999999999875543


Q ss_pred             CCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ..    .....|+..|+|||.+.+ ..++.++|||||||++|||++|..||............    .        ....
T Consensus       150 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~--------~~~~  213 (279)
T cd05633         150 KK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----R--------MTLT  213 (279)
T ss_pred             cC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----H--------Hhhc
Confidence            22    123468999999999864 45789999999999999999999999754332111100    0        0000


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIAI  341 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  341 (398)
                      .+..+  +.   .....+.+++.+||+.+|.+||     +++++++.
T Consensus       214 ~~~~~--~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 VNVEL--PD---SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCcCC--cc---ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            11111  11   1223566777899999999999     59988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6e-38  Score=289.09  Aligned_cols=241  Identities=26%  Similarity=0.341  Sum_probs=194.5

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ||.|+||.||++....+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.++ ...++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-KYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-CccEEEEecCCCCc
Confidence            699999999999998889999999997542   23456789999999999999999999987765 45899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |.+++...       ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        80 L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          80 LWTILRDR-------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             HHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            99999764       34899999999999999999999888   9999999999999999999999999998765432  


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC--c
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD--P  302 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~  302 (398)
                       ......|+..|+|||.+....++.++|+||||+++|+|++|..||.......    ..           ....+.+  .
T Consensus       148 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-----------~~~~~~~~~~  211 (262)
T cd05572         148 -KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----ME-----------IYNDILKGNG  211 (262)
T ss_pred             -ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HH-----------HHHHHhccCC
Confidence             1233568899999999988889999999999999999999999997654211    01           0111111  1


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          303 RLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       303 ~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                      ....+...   ...+.+++.+||+.+|.+||+     +.|+++
T Consensus       212 ~~~~~~~~---~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         212 KLEFPNYI---DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCCccc---CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            11111111   345777888999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=300.46  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=200.3

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .-+.|+.-++||+||||.||-++.+.+|+.+|.|.+.+.+   .....-.++|-.+|.+++.+.||.+--. ++..+.+|
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-feTkd~LC  261 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-FETKDALC  261 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-ecCCCceE
Confidence            3478899999999999999999999999999999997653   3344567899999999999999988544 55566699


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +|+..|.||+|.-+|....     +..+++..+.-++.+|+.||++||+..   ||.||+||+|||||+.|+++|+|+|+
T Consensus       262 lVLtlMNGGDLkfHiyn~g-----~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHG-----NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             EEEEeecCCceeEEeeccC-----CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccce
Confidence            9999999999999998754     367999999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      |..+.....   .+..+||.+|||||++.+..|+...|.||+||++|||+.|+.||..........-+            
T Consensus       334 Avei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv------------  398 (591)
T KOG0986|consen  334 AVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV------------  398 (591)
T ss_pred             EEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH------------
Confidence            998876543   24568999999999999999999999999999999999999999764432111000            


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE  336 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  336 (398)
                       -+.++......+...+++...+.+   ..|+.||.+|..-+
T Consensus       399 -drr~~~~~~ey~~kFS~eakslc~---~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  399 -DRRTLEDPEEYSDKFSEEAKSLCE---GLLTKDPEKRLGCR  436 (591)
T ss_pred             -HHHHhcchhhcccccCHHHHHHHH---HHHccCHHHhccCC
Confidence             001111111222233455555554   57899999986544

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-38  Score=304.64  Aligned_cols=265  Identities=23%  Similarity=0.359  Sum_probs=199.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----Cc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  132 (398)
                      .++|...+.||+|+||+||+|....+++.||+|.+...  .......+.+|+.+++.++|+||+++++++....    ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788999999999999999999888999999998753  2334456778999999999999999999876433    24


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .++||||+ +++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        84 ~~lv~e~~-~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          84 VYIVYELM-DTDLHQIIRSS-------QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             EEEEEeCC-CCCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcC
Confidence            79999999 47898888653       45999999999999999999999888   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      |++........  ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+........   ......
T Consensus       153 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~  227 (337)
T cd07858         153 GLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI---TELLGS  227 (337)
T ss_pred             ccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHH---HHHhCC
Confidence            99986644321  1234567889999998865 46899999999999999999999999754321111000   000000


Q ss_pred             ch-hh--------hhhhc-------CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          292 GM-AA--------VEELL-------DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       292 ~~-~~--------~~~~~-------d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .. ..        ....+       ++.+.  .........+.+++.+||+.+|.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CChHHhhhcCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00 00        00000       00000  0011223456788899999999999999999975

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-38  Score=291.19  Aligned_cols=247  Identities=26%  Similarity=0.376  Sum_probs=195.4

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ||.|+||.||++....+++.+++|.+.....   .....+.+|++++.+++||||+++++.+.. +...++||||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            6899999999999988899999999976533   455678899999999999999999987665 455899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC-
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV-  223 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  223 (398)
                      |.+++...       ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        80 L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          80 LASLLENV-------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             HHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            99999764       35899999999999999999999888   99999999999999999999999999875443311 


Q ss_pred             -----ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          224 -----PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       224 -----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                           ........++..|+|||.......+.++||||||+++|+|++|..||.......   .              ...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~--------------~~~  212 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---I--------------FQN  212 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---H--------------HHH
Confidence                 011234567889999999988889999999999999999999999997543221   0              011


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      +.......+... .....+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       213 ~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         213 ILNGKIEWPEDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HhcCCcCCCccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            111111111111 01345677888999999999999977766664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-40  Score=313.12  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=202.7

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      -|.+...||.|+||.||+|..+.++...|.|+|...+.+..+.|+-|+++|..++||+||+|++.|+-. +.+++..|||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-nkLwiliEFC  111 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-NKLWILIEFC  111 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-CceEEEEeec
Confidence            345566799999999999999988888899999888888889999999999999999999999865553 3489999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      .||-.+..+..-.      .+|.+.++..++.|++.||.|||++.   |||||||+.|||++-+|.++|+|||++.....
T Consensus       112 ~GGAVDaimlEL~------r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG------RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             CCchHhHHHHHhc------cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh
Confidence            9999999988764      57999999999999999999999998   99999999999999999999999999754322


Q ss_pred             CCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .  .....++.||+.|||||+..     ..+|+.++||||||++|.||..+.+|-..-++-.  .+       +     .
T Consensus       183 t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--Vl-------l-----K  246 (1187)
T KOG0579|consen  183 T--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VL-------L-----K  246 (1187)
T ss_pred             H--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HH-------H-----H
Confidence            1  11234678999999999875     4578999999999999999999999976543210  00       0     1


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +..--.|.|..+...   ...|-+++..||..||..||++.++++
T Consensus       247 iaKSePPTLlqPS~W---s~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  247 IAKSEPPTLLQPSHW---SRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HhhcCCCcccCcchh---hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            122222333333223   344556667899999999999999987

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=292.89  Aligned_cols=268  Identities=21%  Similarity=0.314  Sum_probs=198.7

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcEEEEEe
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYK  138 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e  138 (398)
                      |...+.||+|+||.||+|....+++.+|+|.+....  ......+.+|+++++.++|||++++++++.+. ....++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999998889999999998653  33456788999999999999999999998775 256899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ ++|.+++....      ..+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        81 ~~~-~~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          81 YMD-HDLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             ccc-ccHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            996 48988886542      46899999999999999999999888   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh-hHHHhhchhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-KPILHRGMAAV  296 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~  296 (398)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ..........+
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         151 TKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            554321 1233457888999997764 45789999999999999999999999765432111110000 00000000000


Q ss_pred             h-----hhcCcccCCCC-----CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 E-----ELLDPRLKCTS-----RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~-----~~~d~~l~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .     ....+......     ........+.+++.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0     00000000000     00001456788999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.7e-38  Score=287.66  Aligned_cols=250  Identities=25%  Similarity=0.401  Sum_probs=202.9

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..+.||+|+||.||++....+++.+++|.+...  .......+.+|+++++.++|+||+++.+++.+. ...++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence            477788999999999999999888999999998754  234456788999999999999999999987765 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          80 YAPFGDLSKAISKRKK---KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             hcCCCCHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            9999999999876421   1256899999999999999999999888   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ....    .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......   +..              .
T Consensus       154 ~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~--------------~  212 (256)
T cd08530         154 KKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRY--------------K  212 (256)
T ss_pred             ccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH--------------H
Confidence            5442    223558889999999998889999999999999999999999997543211   000              0


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +.....  +.........+.+++.+|++.+|.+||++.++++
T Consensus       213 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         213 VQRGKY--PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HhcCCC--CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000111  1111233456788889999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.8e-38  Score=294.74  Aligned_cols=253  Identities=24%  Similarity=0.428  Sum_probs=193.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV  136 (398)
                      -++|...+.||+|+||.||+|.+..+++.||||.+.... ......+..|+.++.+.. ||||++++++|.+.. ..++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~~v   92 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-DVFIC   92 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-eEEEE
Confidence            367888999999999999999998889999999997543 234456677877776665 999999999987754 58999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |||+ +++|.+++....      ..+++..+..++.|++.||.|||+ .+   |+||||+|+||++++++.+||+|||++
T Consensus        93 ~e~~-~~~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          93 MELM-STCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             eecc-CcCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccc
Confidence            9998 557877776532      468999999999999999999997 46   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCC----cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK----VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ........   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     ..        
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~--------  226 (296)
T cd06618         163 GRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FE--------  226 (296)
T ss_pred             hhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HH--------
Confidence            76543221   12335788999999987543    788999999999999999999999653211     00        


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                         .+...+................+.+++.+||+.+|.+||++.++++.
T Consensus       227 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         227 ---VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ---HHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               01111111110000000123456778889999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-37  Score=285.25  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=203.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|...+.||.|+||.||++....++..|++|++.....  .....+..|++.++.++|||++++.+.+... ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence            47778899999999999999988899999999976533  5567788999999999999999999987775 56899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++.....   ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+...
T Consensus        80 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          80 YADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             ecCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeec
Confidence            9999999999987431   1256999999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ....  .......|++.|+|||......++.++||||+|+++|+|++|+.||.......      ..           ..
T Consensus       154 ~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~-----------~~  214 (258)
T cd08215         154 SSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LA-----------LK  214 (258)
T ss_pred             ccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HH-----------HH
Confidence            5443  12234568899999999988889999999999999999999999996543211      00           01


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .......  .........+.+++.+||..+|.+|||+.++++
T Consensus       215 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         215 ILKGQYP--PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111110  001112245677788999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.8e-38  Score=307.62  Aligned_cols=201  Identities=26%  Similarity=0.326  Sum_probs=174.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-C-----CCeeceeeEEEcCCCcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-H-----PNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~~  134 (398)
                      +|.+.+.||+|.||.|-+|.+..+++.||||+++... .-..+...|+.+|..++ |     -|+|++++++...+ .+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-HLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-cee
Confidence            5677889999999999999999999999999998653 44566778999999997 4     48999999987754 589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC--CCeeEecc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDF  212 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~Df  212 (398)
                      ||+|.+ ..+|.++++..+.     ..++...++.|+.||+.||.+||+.+   |||+||||+||||.+.  ..+||+||
T Consensus       265 iVfELL-~~NLYellK~n~f-----~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKF-----RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence            999999 7799999998653     56999999999999999999999988   9999999999999754  47999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  277 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~  277 (398)
                      |.+......-     .+...+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.+..+
T Consensus       336 GSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  336 GSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             ccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            9998765432     25567888999999999999999999999999999999988888776544

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4e-38  Score=295.33  Aligned_cols=270  Identities=21%  Similarity=0.294  Sum_probs=195.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCC----c
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQ----G  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----~  132 (398)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+.+++.++ ||||+++++++...+.    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999998889999999986542  223456888999999995 6999999998765433    2


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeEec
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCD  211 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~D  211 (398)
                      .|+||||+++ +|.+++......  ....+++..++.++.|++.||.|||+.+   ++||||+|+||+++. ++.+||+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEee
Confidence            7899999975 898888764321  1246899999999999999999999888   999999999999998 89999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ||++.........  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.........  .... ....
T Consensus       155 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~-~~~~  229 (295)
T cd07837         155 LGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIF-KLLG  229 (295)
T ss_pred             cccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHH-HHhC
Confidence            9998765432211  123356888999998865 45789999999999999999999999754322110  0000 0000


Q ss_pred             hchh----hhhhhcC----cccCC---CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          291 RGMA----AVEELLD----PRLKC---TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       291 ~~~~----~~~~~~d----~~l~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....    ......+    +....   ....+.....+.+++.+||+.+|.+||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000    0000000    00000   0000112344677888999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=285.34  Aligned_cols=248  Identities=30%  Similarity=0.472  Sum_probs=201.2

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..+.||+|++|.||++....+++.|++|.+.....  .....+.+|++++++++|||++++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence            47778999999999999999988889999999976643  4567899999999999999999999987764 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          80 YAENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             cCCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceec
Confidence            99999999998764       45899999999999999999999888   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ......  .....++..|+|||...+..++.++||||||+++|+|++|+.||......    ...+.  .        ..
T Consensus       150 ~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~--~--------~~  213 (254)
T cd06627         150 NDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFR--I--------VQ  213 (254)
T ss_pred             CCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHH--H--------hc
Confidence            544321  23456889999999998878899999999999999999999999753311    00110  0        00


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.+  +...   ...+.+++.+||..+|++|||+.+++.
T Consensus       214 ~~~~~~--~~~~---~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 DDHPPL--PEGI---SPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             cCCCCC--CCCC---CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            001111  1111   235667778999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.2e-38  Score=301.24  Aligned_cols=271  Identities=23%  Similarity=0.330  Sum_probs=198.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC-CcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE-QGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~~  134 (398)
                      .++|...+.||+|+||.||+|.+..+++.+|+|++...  .......+.+|+.++.++ +||||+++++++...+ ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46788889999999999999999888999999988542  233445677899999999 9999999999876543 3579


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||++ ++|..++...        .++|..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        86 lv~e~~~-~~L~~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~  153 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN--------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGL  153 (337)
T ss_pred             EEecccc-cCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccc
Confidence            9999996 5998888652        5889999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCc---eeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH--
Q 015931          215 ATWTSAPSVP---FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI--  288 (398)
Q Consensus       215 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~--  288 (398)
                      +.........   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..................  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS  233 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9866443221   11233568999999998765 45788999999999999999999999754322111100000000  


Q ss_pred             ---Hhhch-hhhhhhcC----cccC-CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          289 ---LHRGM-AAVEELLD----PRLK-CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       289 ---~~~~~-~~~~~~~d----~~l~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                         +.... .....+++    .... ...........+.+++.+||+.+|.+|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               00000 00001111    0000 000001123457788889999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.4e-38  Score=295.88  Aligned_cols=266  Identities=21%  Similarity=0.316  Sum_probs=194.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|++|.||+|....+++.||+|.+.....  .....+.+|++++++++||||+++++++.+. ...++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEE
Confidence            468888999999999999999988899999999865422  2345688999999999999999999998765 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla~  216 (398)
                      ||++ ++|.+++.....     ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++.
T Consensus        81 e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             eccc-ccHHHHHHhCCC-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccc
Confidence            9995 588888765321     34688899999999999999999887   999999999999985 5679999999997


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh-
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA-  294 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  294 (398)
                      .......  ......++..|+|||++.+. .++.++||||||+++|+|+||+.||......+.....   ......... 
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~  226 (294)
T PLN00009        152 AFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEE  226 (294)
T ss_pred             ccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChh
Confidence            6543221  11234578899999988664 5789999999999999999999999764332111000   000000000 


Q ss_pred             ------hhhhhc--CcccCCC---CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 ------AVEELL--DPRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ------~~~~~~--d~~l~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                            .+....  -+.....   .........+.+++.+|++.+|.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  000000  0000000   000111234677888999999999999999986

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=288.69  Aligned_cols=245  Identities=24%  Similarity=0.323  Sum_probs=188.1

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHH-HhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIA-SSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|....+++.||+|.+.....   .....+..|..++ ...+|+|++++++++... ...++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-DYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-CeEEEEEeccC
Confidence            468999999999999988899999999875432   2223344554443 455899999999988764 45899999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  150 (260)
T cd05611          81 GGDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN  150 (260)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc
Confidence            99999999764       45899999999999999999999988   999999999999999999999999998754331


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                            ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+...   .  + .... .      ...+
T Consensus       151 ------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~--~-~~~~-~------~~~~  211 (260)
T cd05611         151 ------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---V--F-DNIL-S------RRIN  211 (260)
T ss_pred             ------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---H--H-HHHH-h------cccC
Confidence                  23458889999999988888999999999999999999999997543221   0  0 0000 0      0000


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                        .. ..........+.+++.+||+.+|++||++.++.+.|.
T Consensus       212 --~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         212 --WP-EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             --CC-CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence              00 0001112345778888999999999998877766554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.1e-38  Score=302.91  Aligned_cols=272  Identities=20%  Similarity=0.306  Sum_probs=200.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC---CCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~  133 (398)
                      .++|...+.||+|+||.||+|....++..||+|++....  ......+.+|+.++++++||||+++++++...   ...+
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368899999999999999999999889999999987542  23456678899999999999999999876532   2357


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+. ++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD-------QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEEehhh-hhHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccc
Confidence            99999994 6898888653       45899999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCc--eeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh----
Q 015931          214 LATWTSAPSVP--FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  286 (398)
Q Consensus       214 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~----  286 (398)
                      ++.........  .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||................    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            99765432211  11123468899999999865 468899999999999999999999997654321111100000    


Q ss_pred             -HHHhh-chhhhhhhcCcccCCCCC-----CHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          287 -PILHR-GMAAVEELLDPRLKCTSR-----NSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       287 -~~~~~-~~~~~~~~~d~~l~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                       ..+.. ....+.+..+..-.....     .+.....+.+++.+||+.+|.+||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             00000 000011111100000000     01123567888889999999999999999873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-37  Score=287.89  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=189.7

Q ss_pred             HHHHhhcCCCCCcee--cccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHh-CCCCCeeceeeEEEcCC
Q 015931           54 EILAATHNFSKGRVL--GRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS-LHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        54 e~~~~~~~f~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~  130 (398)
                      ++....++|...+.+  |+|+||.||++....++..+|+|.+.......   .  |+..... .+|||++++++++...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334444667766666  99999999999998889999999987542211   1  2222221 27999999999887755


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeE
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKL  209 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl  209 (398)
                       ..++||||+++++|.+++...       ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++ .++|
T Consensus        83 -~~~iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         83 -GHVLIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             -eeEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEE
Confidence             589999999999999999764       36999999999999999999999988   99999999999999988 9999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      +|||++.......      ...|+..|+|||++.+..++.++||||||+++|||++|+.||....... .....+..   
T Consensus       152 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~---  221 (267)
T PHA03390        152 CDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK---  221 (267)
T ss_pred             ecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH---
Confidence            9999987654322      3458899999999998889999999999999999999999998443221 11111111   


Q ss_pred             hhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-HHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~  340 (398)
                               .........   ......+.+++.+||+.+|.+||+ ++++++
T Consensus       222 ---------~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        222 ---------RQQKKLPFI---KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---------hhcccCCcc---cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                     011111111   122345667778999999999995 688874

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.1e-38  Score=290.53  Aligned_cols=242  Identities=26%  Similarity=0.345  Sum_probs=188.8

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ||+|+||+||++....+++.||+|.+....   ......+..|+++++.++||||+++++++... +..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCc
Confidence            689999999999998889999999986532   22345677899999999999999999987664 45899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |.+++.....     ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        80 L~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  150 (277)
T cd05577          80 LKYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-  150 (277)
T ss_pred             HHHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc-
Confidence            9999976532     36899999999999999999999988   99999999999999999999999999876543221 


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCccc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  304 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  304 (398)
                        .....++..|+|||++.+..++.++||||||+++|+|++|+.||...........       ..      ........
T Consensus       151 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~------~~~~~~~~  215 (277)
T cd05577         151 --IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------LK------RRTLEMAV  215 (277)
T ss_pred             --cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------HH------hccccccc
Confidence              2334678899999999888899999999999999999999999975443111000       00      00010011


Q ss_pred             CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHH
Q 015931          305 KCTSRNSAQIARVIQAAAACISSEESRRPGIEE  337 (398)
Q Consensus       305 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e  337 (398)
                      ..+.   .....+.+++.+||+.+|.+||+..+
T Consensus       216 ~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         216 EYPD---KFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cCCc---cCCHHHHHHHHHHccCChhHccCCCc
Confidence            1111   12334667778999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-39  Score=310.12  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=195.3

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecC----CChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-cEEEEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK----EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIY  137 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~lV~  137 (398)
                      ....+||+|+|-+||+|.+..+|..||=-.++.    ..+...++|..|+.+|+.|+||||++++.++.+..+ .+.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            344689999999999999988887777433321    234556889999999999999999999998887554 467999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DfGla~  216 (398)
                      |.+..|+|..|+.+..       .++...+..|+.||++||.|||++. +||+|||||-+||||+.+ |.+||+|+|||.
T Consensus       123 EL~TSGtLr~Y~kk~~-------~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-------RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             ecccCCcHHHHHHHhc-------cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHH
Confidence            9999999999999874       4888999999999999999999985 789999999999999854 899999999999


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......    ..+.|||.|||||.+. ..|.+..||||||++++||+|+..||........  +.   +        .+
T Consensus       195 l~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IY---K--------KV  256 (632)
T KOG0584|consen  195 LLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IY---K--------KV  256 (632)
T ss_pred             Hhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HH---H--------HH
Confidence            8765542    4578999999999887 7899999999999999999999999975443211  00   1        11


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.|.--... ...+   +.+++.+|+.. ..+|||+.|+|.
T Consensus       257 ~SGiKP~sl~kV-~dPe---vr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  257 TSGIKPAALSKV-KDPE---VREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HcCCCHHHhhcc-CCHH---HHHHHHHHhcC-chhccCHHHHhh
Confidence            111111110011 1223   45566789999 999999999996

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.9e-38  Score=294.30  Aligned_cols=270  Identities=23%  Similarity=0.299  Sum_probs=198.4

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----  130 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  130 (398)
                      ...++|+..+.||+|+||.||+|....+++.||+|.+....  ......+.+|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999998889999999997542  233456778999999999999999999886543    


Q ss_pred             -----CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          131 -----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       131 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                           ..+++|+||+++ +|...+....      ..+++..++.++.|++.||.|||+.+   |+|+||||+||++++++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~  153 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL------VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKG  153 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence                 358999999965 7777776532      46899999999999999999999988   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      .+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+  
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~--  230 (302)
T cd07864         154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI--  230 (302)
T ss_pred             cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--
Confidence            999999999986654321 11122346788999998864 35789999999999999999999999754322111110  


Q ss_pred             hhHHHhhc-hhhhhhhc--------CcccCCC----CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          285 AKPILHRG-MAAVEELL--------DPRLKCT----SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       285 ~~~~~~~~-~~~~~~~~--------d~~l~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ....... ......+.        ++.-...    .........+.+++..||+.+|.+||++.++++
T Consensus       231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 -SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             -HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0100000 00000000        0000000    000011245778888999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=280.68  Aligned_cols=249  Identities=26%  Similarity=0.443  Sum_probs=197.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++......||.|..|.|+++..+.+|..+|||..... +.+..++++..+.++...+ .|.||+.+|||.... .+++.|
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~IcM  170 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-DVFICM  170 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-hHHHHH
Confidence            3444556799999999999999999999999998754 5667778888888776654 899999999988744 478999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |.| ...++.++....      .++++..+-++...+++||.||.+..  +|+|||+||+|||+|+.|++||||||++-.
T Consensus       171 elM-s~C~ekLlkrik------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  171 ELM-STCAEKLLKRIK------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             HHH-HHHHHHHHHHhc------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccce
Confidence            999 667777777654      56999999999999999999999843  599999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhcc---CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      +-+...   .+..+|-+.|||||.+.-   .+|..++||||||++|+||.||+.||...+..-  .              
T Consensus       242 lvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e--------------  302 (391)
T KOG0983|consen  242 LVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--E--------------  302 (391)
T ss_pred             eecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--H--------------
Confidence            654332   234678999999999863   468889999999999999999999998754321  0              


Q ss_pred             hhhhhc---CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELL---DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~---d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+..++   .|.|.....   ....+.+++..||.+|+.+||...++++
T Consensus       303 ~ltkvln~ePP~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  303 VLTKVLNEEPPLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHhcCCCCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            122222   234433222   3345666667799999999999999987

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-38  Score=291.41  Aligned_cols=263  Identities=22%  Similarity=0.336  Sum_probs=199.0

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      |...+.||+|++|.||+|....+++.+++|.+.....  .....+..|++++++++|+||+++++++..+ ...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEec
Confidence            5667889999999999999988899999999875432  2456788999999999999999999987765 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++ +|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+....
T Consensus        80 ~~~-~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          80 MDT-DLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             cCC-CHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            964 8888887642      46899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch-hhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM-AAVE  297 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~  297 (398)
                      ....  ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+.....   ........ ....
T Consensus       150 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  224 (283)
T cd05118         150 SPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWP  224 (283)
T ss_pred             CCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcc
Confidence            5431  12234578889999998876 7899999999999999999999999765432111000   00000000 0000


Q ss_pred             hhcC------ccc------CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLD------PRL------KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d------~~l------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+      ...      ......+.....+.+++.+||+.+|.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000      000      000001123456788899999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-37  Score=297.10  Aligned_cols=268  Identities=24%  Similarity=0.341  Sum_probs=201.4

Q ss_pred             HHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           54 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        54 e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      ++...+++|+..+.||.|+||.||+|....++..||+|++...  .....+.+..|++++..++||||+++.+++.....
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            4445678999999999999999999999888999999988643  22345678899999999999999999998877666


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++|+||+ +++|..++..        ..+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.++|+|
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d  151 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS--------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD  151 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence            789999998 6789888764        34788899999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhH-HHH-----
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLW-----  284 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~-~~~-----  284 (398)
                      ||++.......     ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... ...     
T Consensus       152 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  226 (328)
T cd07856         152 FGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP  226 (328)
T ss_pred             cccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99987543321     23457888999998765 4689999999999999999999999975433111000 000     


Q ss_pred             ---hhHHHhhchhhhhhhcCcccCCCCCCH-----HHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          285 ---AKPILHRGMAAVEELLDPRLKCTSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       285 ---~~~~~~~~~~~~~~~~d~~l~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                         ........  ...-....... .....     .....+.+++.+||+.+|.+|||+.+++..
T Consensus       227 ~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         227 DDVINTICSEN--TLRFVQSLPKR-EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHHhccchh--hHHHHhhcccc-CCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000000  00000000000 00010     112457788889999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-38  Score=303.91  Aligned_cols=250  Identities=28%  Similarity=0.405  Sum_probs=206.4

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .....|...+.||+|.|+.|.+|.+..++..||+|.+++..  ....+.+.+|++++..++|||||+++.+... ...+|
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeE
Confidence            34578999999999999999999999999999999998763  3344568899999999999999999998654 45599


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+.+|.+.+++...       +.+.+..+..++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||+
T Consensus       132 lV~eya~~ge~~~yl~~~-------gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgf  201 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKH-------GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGF  201 (596)
T ss_pred             EEEEeccCchhHHHHHhc-------ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccc
Confidence            999999999999999886       34667888999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +..+....   ...+.+|++.|.|||++.+..+ ++.+|+||+|++||-|+.|..||++.+..+-.              
T Consensus       202 S~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------------  264 (596)
T KOG0586|consen  202 STFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------------  264 (596)
T ss_pred             ceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc--------------
Confidence            99887443   3467899999999999998766 78999999999999999999999976543211              


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ...+...+..+.+-..   +.-++++++|-.+|.+|+++.++.+
T Consensus       265 ---~rvl~gk~rIp~~ms~---dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  265 ---PRVLRGKYRIPFYMSC---DCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ---chheeeeecccceeec---hhHHHHHHhhccCccccCCHHHhhh
Confidence               1111112222222222   2345566789999999999999886

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.5e-38  Score=296.37  Aligned_cols=272  Identities=21%  Similarity=0.307  Sum_probs=196.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-----
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  131 (398)
                      .++|...+.||+|+||.||+|....+++.+|+|.+.....  .....+.+|+++++.++||||+++++++.+...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999988899999999865422  223456789999999999999999998765433     


Q ss_pred             --cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          132 --GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       132 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                        .+++|+||+. ++|...+....      ..+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~------~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS------VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence              3789999995 47777776432      46999999999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCc---------eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccch
Q 015931          210 CDFGLATWTSAPSVP---------FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  279 (398)
Q Consensus       210 ~DfGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~  279 (398)
                      +|||++.........         .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+.....
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999765432211         111234578889999988654 5789999999999999999999999765432211


Q ss_pred             hHHHHhhH-HHh---hchhhhhhhcCccc--CCCCC----CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          280 NLVLWAKP-ILH---RGMAAVEELLDPRL--KCTSR----NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       280 ~~~~~~~~-~~~---~~~~~~~~~~d~~l--~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........ ...   .....+....+...  ..+..    .......+.+++.+||+.+|.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11110000 000   00000011000000  00000    0011245778889999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-38  Score=301.33  Aligned_cols=269  Identities=19%  Similarity=0.302  Sum_probs=195.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----Cc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  132 (398)
                      ++|...+.||+|+||.||+|....+++.||+|.+....  ......+.+|+.+++.++||||+++++++....     ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            78999999999999999999998889999999986532  223456789999999999999999999876432     23


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .++|+||+. .+|..++.         ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        95 ~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             EEEEecccc-cCHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence            689999995 47766542         34899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH----
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP----  287 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~----  287 (398)
                      |+++......     ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.................    
T Consensus       162 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (342)
T cd07879         162 GLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP  236 (342)
T ss_pred             CCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            9987653321     23457889999999876 4688999999999999999999999986542211110000000    


Q ss_pred             -HHhhchh-hhhhhcC--cccCCC---CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH--HhcCc
Q 015931          288 -ILHRGMA-AVEELLD--PRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI--LRGEE  346 (398)
Q Consensus       288 -~~~~~~~-~~~~~~d--~~l~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~--L~~~~  346 (398)
                       ....... .......  +.....   ...+.....+.+++.+||+.+|.+||++.++++.  +++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence             0000000 0000000  000000   0000122356788899999999999999999953  55443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-38  Score=300.02  Aligned_cols=274  Identities=21%  Similarity=0.268  Sum_probs=201.3

Q ss_pred             CHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEc
Q 015931           51 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCID  128 (398)
Q Consensus        51 ~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  128 (398)
                      ...++...+++|...+.||+|+||.||+|....+++.||+|++....  ....+.+.+|++++.+++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34556677899999999999999999999988889999999997532  2334668889999999999999999998754


Q ss_pred             CC-----CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC
Q 015931          129 PE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  203 (398)
Q Consensus       129 ~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~  203 (398)
                      ..     ...+++++++ +++|.+++..        ..+++..++.++.|+++||+|||+.+   |+||||||+||++++
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~  155 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE  155 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence            22     3367888887 8899888754        34899999999999999999999988   999999999999999


Q ss_pred             CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       204 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                      ++.+||+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus       156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999998765332     123568889999998866 46889999999999999999999999654322111100


Q ss_pred             HHhh-----HHHhhch----hhhhhhcCcccC--CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          283 LWAK-----PILHRGM----AAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       283 ~~~~-----~~~~~~~----~~~~~~~d~~l~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ....     .......    ......+.....  ...........+.+++.+|++.+|.+||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0000     0000000    000000000000  000000112346788889999999999999999873

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.8e-37  Score=291.63  Aligned_cols=245  Identities=25%  Similarity=0.398  Sum_probs=192.1

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      |...+.||+|+||+||+|....++..|++|.+....   ......+.+|+++++.++|||++++++++.+. ...++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEe
Confidence            555678999999999999998889999999987532   23445788999999999999999999998775 45799999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+. |+|.+++....      ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus       102 ~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         102 YCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             cCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            995 68888776532      46899999999999999999999888   999999999999999999999999998643


Q ss_pred             CCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ...      ....|+..|+|||++.   ...++.++|||||||++|+|++|..||........   ..   ..       
T Consensus       172 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~---~~-------  232 (313)
T cd06633         172 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY---HI-------  232 (313)
T ss_pred             CCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HH---HH-------
Confidence            221      2356889999999984   45688899999999999999999999875432110   00   00       


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                       .....+.....    .....+.+++.+||+.+|.+||++.++++.
T Consensus       233 -~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         233 -AQNDSPTLQSN----EWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -HhcCCCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00001111111    111346677789999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.8e-37  Score=291.87  Aligned_cols=247  Identities=26%  Similarity=0.390  Sum_probs=194.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ..|+..+.||+|+||.||+|....++..+|+|.+...   .......+.+|+++++.++|+|++++.+++... ...++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEE
Confidence            3466678899999999999999888999999998642   233456788999999999999999999998775 457999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+. |+|.+.+....      ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.
T Consensus        94 ~e~~~-~~l~~~~~~~~------~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  163 (308)
T cd06634          94 MEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (308)
T ss_pred             EEccC-CCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccce
Confidence            99996 68888776432      45899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      .....      ....|+..|+|||.+.   ...++.++|||||||++|+|++|..||........  ...          
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----------  225 (308)
T cd06634         164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH----------  225 (308)
T ss_pred             eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHH----------
Confidence            65432      2345888999999974   35678899999999999999999999865322110  000          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                        +.....+...    .......+.+++.+||+.+|.+||++.+|++.
T Consensus       226 --~~~~~~~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         226 --IAQNESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             --HhhcCCCCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence              0000011111    11223446778889999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-37  Score=289.68  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=200.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+.||+|+||.||+|....+++.||+|++...   .......+..|++++.+++ ||||+++++++... ...++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-ENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-ceEEE
Confidence            4688889999999999999999888999999998753   2234567889999999998 99999999987654 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        80 v~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          80 VLEYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             EEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccc
Confidence            99999999999999764       36999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCc------------------eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc
Q 015931          216 TWTSAPSVP------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  277 (398)
Q Consensus       216 ~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~  277 (398)
                      .........                  .......++..|+|||.+....++.++||||||++++++++|+.||.......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            866543211                  11223457889999999988889999999999999999999999998643110


Q ss_pred             chhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH----HHHHH
Q 015931          278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI----EEIIA  340 (398)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~----~evl~  340 (398)
                         .              ...+.+.....+...   ...+.+++.+||+.+|.+||++    .++++
T Consensus       230 ---~--------------~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 ---T--------------FQKILKLEYSFPPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---H--------------HHHHHhcCCCCCCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               0              111111111111111   3456777888999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=287.75  Aligned_cols=265  Identities=24%  Similarity=0.289  Sum_probs=194.4

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhC---CCCCeeceeeEEEcCCC----c
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSL---HHPNIVPLVGFCIDPEQ----G  132 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----~  132 (398)
                      |+..+.||+|+||.||+|.+..+++.||+|.+.....  .....+.+|+.++.++   +|||++++++++...+.    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5667899999999999999988899999999974322  2234566787777665   69999999999876543    3


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .+++|||+. ++|.+++.....     ..+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-----PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEecc
Confidence            789999996 589988876432     35899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      |++........   .....++..|+|||.+.+..++.++||||||+++|||++|..||......+  .............
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~  226 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPS  226 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCC
Confidence            99987654322   123457889999999998889999999999999999999999987644321  1111000000000


Q ss_pred             hhh-------hhhhcCcccCC--CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAA-------VEELLDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~-------~~~~~d~~l~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...       ...........  ..........+.+++.+||+.+|.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000       00000000000  0001122355678889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.9e-37  Score=287.49  Aligned_cols=242  Identities=26%  Similarity=0.363  Sum_probs=185.3

Q ss_pred             eecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHH---HHHHhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           67 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCREL---MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      +||+|+||.||+|....+++.||+|.+.....   .....+..|.   ..++...||||+.+++++.+. ...++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecC
Confidence            48999999999999988899999999875421   1122233443   344456799999999887664 4589999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++|+|..++...       ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~g~~L~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          80 NGGDLHYHLSQH-------GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            999999988653       46999999999999999999999888   99999999999999999999999999875543


Q ss_pred             CCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ..    .....|+..|+|||.+.++ .++.++|||||||++|||++|+.||............            .....
T Consensus       150 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~------------~~~~~  213 (278)
T cd05606         150 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------RMTLT  213 (278)
T ss_pred             cC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH------------HHhhc
Confidence            22    1234689999999998755 6899999999999999999999999765322111100            00001


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ..+.+.  ..   ....+.+++.+|+..+|.+||     ++.++++
T Consensus       214 ~~~~~~--~~---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 MAVELP--DS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCCCCC--Cc---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            111111  11   134567777899999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-37  Score=296.41  Aligned_cols=302  Identities=19%  Similarity=0.275  Sum_probs=212.0

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC----
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----  131 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  131 (398)
                      ..++|+..+.||+|+||.||+|....++..||||++...  .......+.+|+.+++.++||||+++++++.....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            357899999999999999999999888999999998643  22334568899999999999999999998765432    


Q ss_pred             -cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          132 -GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       132 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                       ..++||||+ +++|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence             358999999 8899888764        35899999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH-------
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-------  282 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-------  282 (398)
                      |||++.......     ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||............       
T Consensus       161 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         161 DFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             ecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999998654322     23457889999999876 45889999999999999999999999754321110000       


Q ss_pred             --HHhhHHHhhchhhhhhhcC--cccCCC---CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH--HHhcCccchhccc
Q 015931          283 --LWAKPILHRGMAAVEELLD--PRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIA--ILRGEEELIYCTW  353 (398)
Q Consensus       283 --~~~~~~~~~~~~~~~~~~d--~~l~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~~~~~~~~~~  353 (398)
                        .+...+...   .......  +.....   .........+.+++.+|++.+|.+|||+.++++  .++...+..    
T Consensus       236 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~----  308 (343)
T cd07880         236 SKEFVQKLQSE---DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE----  308 (343)
T ss_pred             CHHHHHhhcch---hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc----
Confidence              000000000   0000000  000000   000111234678889999999999999999985  333322211    


Q ss_pred             cCCCCCCCcCCcchhhhchhHhhhhhhhhh
Q 015931          354 KKHNFSGIIDCYPQLQQTKSEMKSHLALAM  383 (398)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (398)
                      .........+.+....++.+++.+-....+
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (343)
T cd07880         309 DETEAPPYDDSFDEVDQSLEEWKRLTFTEI  338 (343)
T ss_pred             cccCCCCccccHHhhccchHHHHHHHHHHH
Confidence            111122234445555566666654433333

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=288.53  Aligned_cols=265  Identities=23%  Similarity=0.313  Sum_probs=196.2

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEEec
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      |...+.||+|++|+||+|....+++.|++|.+..... .......+|+..+.+++ |||++++++++.+ +...++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence            5667899999999999999988889999999875422 22334567999999999 9999999998877 4558999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      + +|+|.+++....     ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++....
T Consensus        80 ~-~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          80 M-EGNLYQLMKDRK-----GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             C-CCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence            9 889999887643     146899999999999999999999988   9999999999999999999999999998664


Q ss_pred             CCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH-HHhh----HHHhhch
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWAK----PILHRGM  293 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~----~~~~~~~  293 (398)
                      ....   .....++..|+|||.+.. ..++.++|+||||+++|||++|+.||......+..... ....    ..+..+.
T Consensus       151 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07830         151 SRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY  227 (283)
T ss_pred             CCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence            4221   123457889999998754 45789999999999999999999999765432211000 0000    0000000


Q ss_pred             hhhhhhcCcccCCCC-C-----CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTS-R-----NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~-~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ......+..+.... .     .......+.+++.+||+.+|.+|||+.|++.
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         228 -KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             -hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             00001111110000 0     0011356788899999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-37  Score=299.13  Aligned_cols=269  Identities=21%  Similarity=0.293  Sum_probs=196.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC---------
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE---------  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  130 (398)
                      .+|...+.||.|+||.||+|....+++.||+|.+........+.+.+|+++++.++||||+++++++....         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999999889999999997766666678889999999999999999998655432         


Q ss_pred             ----CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CCC
Q 015931          131 ----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKK  205 (398)
Q Consensus       131 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~~  205 (398)
                          ...++||||++ ++|.+++..        ..+++..++.++.|++.||.|||+.+   ++||||||+||+++ +++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~  152 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ--------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCc
Confidence                23689999996 589888754        35899999999999999999999888   99999999999997 456


Q ss_pred             CeeEeccccccccCCCCCc-eeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH
Q 015931          206 IPKLCDFGLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  283 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  283 (398)
                      .+||+|||++......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.........
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7899999999765432111 01123457889999998754 457889999999999999999999997654322111110


Q ss_pred             HhhHHH-----hhchhhhhhhcCcccCCCCCC-----HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          284 WAKPIL-----HRGMAAVEELLDPRLKCTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       284 ~~~~~~-----~~~~~~~~~~~d~~l~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+..     ......+..............     ......+.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000000     000000000000000000000     012245678889999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-37  Score=295.62  Aligned_cols=270  Identities=23%  Similarity=0.300  Sum_probs=202.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----CcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~  134 (398)
                      +|...+.||.|+||.||+|....+++.||+|.+....  ....+.+.+|+.+++.++||||+++.+++....    ..+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999998889999999987643  345567899999999999999999999887754    3579


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||++ ++|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        81 lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-------QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             EEecchh-hhHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCc
Confidence            9999996 5888888653       36999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCc-eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH-----
Q 015931          215 ATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP-----  287 (398)
Q Consensus       215 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~-----  287 (398)
                      +......... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.............     
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            9876544210 112334678899999999877 789999999999999999999999976553221111000000     


Q ss_pred             HHh-hchhhhhhhcC---ccc--CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          288 ILH-RGMAAVEELLD---PRL--KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       288 ~~~-~~~~~~~~~~d---~~l--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .+. .......+.+.   ..-  ......+.....+.+++.+||+.+|.+|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000 00000000000   000  0000001123456778889999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=309.37  Aligned_cols=252  Identities=28%  Similarity=0.407  Sum_probs=208.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCC----cEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .....++||+|+||+||+|.+--.|    .+||+|++... ..+...++..|+-+|.+++|||+++|+|+|....  +.|
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~ql  774 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQL  774 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHH
Confidence            3455689999999999999884323    46999988654 4456788999999999999999999999997654  679


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |++||+.|+|.++++..+      ..+--...+.|..|||+|+.|||.+.   ++||||.++|||+.+...+||.|||++
T Consensus       775 vtq~mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             HHHhcccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence            999999999999998864      56888889999999999999999777   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      +.+.............-.+.|||=|.+....++.++|||||||++||++| |..|+......+.                
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------  909 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------  909 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------
Confidence            99887766655555556778999999999999999999999999999998 9999987554332                


Q ss_pred             hhhhhcC--cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          295 AVEELLD--PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       295 ~~~~~~d--~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                        .+++.  .+|..++..   ..++..++.+||..|+..||+++++...+..
T Consensus       910 --~dlle~geRLsqPpiC---tiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  910 --PDLLEKGERLSQPPIC---TIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             --hHHHhccccCCCCCCc---cHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence              22221  134444433   4456667789999999999999999987754

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.5e-37  Score=291.48  Aligned_cols=262  Identities=22%  Similarity=0.327  Sum_probs=190.9

Q ss_pred             eeccc--CceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           67 VLGRG--ALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        67 ~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      .||.|  +||+||++.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++..++ ..++|+||+.+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~~v~e~~~~   83 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-WLWVISPFMAY   83 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-ceEEEEecccC
Confidence            46666  9999999999888999999998754  2334567889999999999999999999987754 57999999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      ++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++||+.+.......
T Consensus        84 ~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          84 GSANSLLKTYFP-----EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             CCHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            999999876532     35899999999999999999999888   9999999999999999999999998654322111


Q ss_pred             Cce-----eeeccccCCCcccchhhccC--CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh---------
Q 015931          223 VPF-----LCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK---------  286 (398)
Q Consensus       223 ~~~-----~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~---------  286 (398)
                      ...     ......++..|+|||++.+.  .++.++|||||||++|||++|+.||........  ......         
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccc
Confidence            100     00112356679999998763  478999999999999999999999975432110  000000         


Q ss_pred             HHHhhchh-------hh----h----------hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 PILHRGMA-------AV----E----------ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 ~~~~~~~~-------~~----~----------~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........       ..    .          ...+..+. ..........+.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00000000       00    0          00001111 1111234456889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=290.65  Aligned_cols=272  Identities=24%  Similarity=0.347  Sum_probs=202.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHh--CCCCCeeceeeEEEcCC---CcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPE---QGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---~~~~  134 (398)
                      ......++||+|.||.||||++.  ++.||||++..   +..+.|.+|-++.+.  ++|+||++++++-..+.   -..+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45566778999999999999997  58999999964   556789999888876  57999999998633222   1378


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCceeecccccCcEEeCCCCCee
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT------ERCVVHRDIKPSNILLSSKKIPK  208 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------~~~ivHrDlkp~NIll~~~~~~k  208 (398)
                      ||++|.+.|+|.++|..        ..++|....+|+..+++||+|||+.-      .++|+|||||++||||.+|++..
T Consensus       285 LVt~fh~kGsL~dyL~~--------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKA--------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             EEeeeccCCcHHHHHHh--------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence            99999999999999987        46999999999999999999999743      56799999999999999999999


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccC-CcC-----CccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVS-----DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                      |+|||+|..+.........-..+||.+|||||++.+. .+.     .+.||||+|.|||||++...-+...... +..+.
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp-~Yqlp  435 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP-EYQLP  435 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC-cccCc
Confidence            9999999988765444444457899999999999754 222     2689999999999999976554321111 11110


Q ss_pred             HH----hhHHHhhch-hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          283 LW----AKPILHRGM-AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       283 ~~----~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .-    ..+.+.+.. ..+.+...|.+.........+..+.+.+..||+.||+.|.|+.=|-+.+...
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            00    000010000 0233334444432222235567788888899999999999999888877654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=283.84  Aligned_cols=242  Identities=26%  Similarity=0.334  Sum_probs=196.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      -++|+..++||+|.||.|.+++-+.+++.+|+|+++++   .++....-..|-.+|...+||.+..|.-. ++...++|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-FQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-FQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-hccCceEEE
Confidence            37899999999999999999999999999999999875   23444556788899999999998888654 555677999


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||..||.|.-+|...       ..+++...+-+...|+.||.|||+.+   ||.||||.+|+|||.+|++||+|||++
T Consensus       246 VMeyanGGeLf~HLsre-------r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE-------RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             EEEEccCceEeeehhhh-------hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccc
Confidence            99999999999999875       45888888889999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +.--...  ....+.+||+.|+|||++....|....|+|.+||++|||++|+.||...+...-.                
T Consensus       316 KE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF----------------  377 (516)
T KOG0690|consen  316 KEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF----------------  377 (516)
T ss_pred             hhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH----------------
Confidence            8532221  2356789999999999999999999999999999999999999999875433111                


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP  333 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  333 (398)
                       .-++-..+..+...+++...   |+...|.+||.+|.
T Consensus       378 -eLIl~ed~kFPr~ls~eAkt---LLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  378 -ELILMEDLKFPRTLSPEAKT---LLSGLLKKDPKKRL  411 (516)
T ss_pred             -HHHHhhhccCCccCCHHHHH---HHHHHhhcChHhhc
Confidence             11222233333333444444   44568899999995

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.7e-37  Score=290.28  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=185.6

Q ss_pred             CceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHH
Q 015931           72 ALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL  149 (398)
Q Consensus        72 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l  149 (398)
                      ++|.||.+....+++.||+|++...  .......+..|+++++.++|+||+++++++.+. +..+++|||+++|+|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-CeEEEEEeccCCCCHHHHH
Confidence            3344555555557899999999754  345567899999999999999999999987765 4589999999999999999


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC-----c
Q 015931          150 HEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV-----P  224 (398)
Q Consensus       150 ~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~-----~  224 (398)
                      .....     ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+........     .
T Consensus        91 ~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          91 KTHFP-----EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            86432     45889999999999999999999988   99999999999999999999999998865432211     0


Q ss_pred             eeeeccccCCCcccchhhccC--CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH----HHhhc-----h
Q 015931          225 FLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP----ILHRG-----M  293 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~-----~  293 (398)
                      .......++..|+|||++...  .++.++|||||||++|||++|+.||.......  ........    .....     .
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhc
Confidence            111234577889999998753  57899999999999999999999997543211  11100000    00000     0


Q ss_pred             hhhhh----hcCcccC---CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEE----LLDPRLK---CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~----~~d~~l~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+..    ..++...   ...........+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            00000    0000000   00111222346778889999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-37  Score=311.21  Aligned_cols=274  Identities=18%  Similarity=0.211  Sum_probs=186.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCC-cEEEEE------------------EecCCChhhHHHHHHHHHHHHhCCCCCe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIK------------------RLDKEDKESSKAFCRELMIASSLHHPNI  119 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni  119 (398)
                      .++|...+.||+|+||+||++..+... ...+.|                  .+. ........+.+|+.++.+++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            468999999999999999998764322 111111                  111 122334568899999999999999


Q ss_pred             eceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcE
Q 015931          120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  199 (398)
Q Consensus       120 v~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NI  199 (398)
                      +++++++...+ ..|+|++++ +++|..++......  .........+..++.|++.||.|||+.+   |+||||||+||
T Consensus       226 v~l~~~~~~~~-~~~lv~e~~-~~~l~~~l~~~~~~--~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI  298 (501)
T PHA03210        226 LKIEEILRSEA-NTYMITQKY-DFDLYSFMYDEAFD--WKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI  298 (501)
T ss_pred             CcEeEEEEECC-eeEEEEecc-ccCHHHHHhhcccc--ccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            99999987654 478999998 56788877653211  1122345667789999999999999988   99999999999


Q ss_pred             EeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCC-Ccccccccc
Q 015931          200 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP-IEARRLQGE  278 (398)
Q Consensus       200 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~P-f~~~~~~~~  278 (398)
                      |++.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..| +........
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            9999999999999999876543221 12345799999999999998999999999999999999998754 433221111


Q ss_pred             hhHHHHhhHH------HhhchhhhhhhcCc-ccCC-CCCCHH------HHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          279 ENLVLWAKPI------LHRGMAAVEELLDP-RLKC-TSRNSA------QIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       279 ~~~~~~~~~~------~~~~~~~~~~~~d~-~l~~-~~~~~~------~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ..+.......      +......+.+.++. .+.. ......      ....+.+++.+||+.||.+|||+.|+++.
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111110000      00000001111110 0000 000001      11245667889999999999999999873

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.6e-38  Score=319.78  Aligned_cols=256  Identities=26%  Similarity=0.371  Sum_probs=195.0

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc-------
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCID-------  128 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  128 (398)
                      .-..+|....+||+||||.||+++++-+|..||||+|... .......+.+|+..|++++|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3456888899999999999999999999999999999755 33445678899999999999999999832210       


Q ss_pred             -----------------------------------------------------------------------C--------
Q 015931          129 -----------------------------------------------------------------------P--------  129 (398)
Q Consensus       129 -----------------------------------------------------------------------~--------  129 (398)
                                                                                             +        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             ------------------------C--------CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 015931          130 ------------------------E--------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES  177 (398)
Q Consensus       130 ------------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~a  177 (398)
                                              +        ..+||=||||+...|.+++.....      .-.-...|+++.+|++|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~------~~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF------NSQRDEAWRLFREILEG  709 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc------chhhHHHHHHHHHHHHH
Confidence                                    0        116788999999888888776431      01466789999999999


Q ss_pred             HHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC----------------CCCCceeeeccccCCCcccchh
Q 015931          178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS----------------APSVPFLCKTVKGTFGYLAPEY  241 (398)
Q Consensus       178 L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~  241 (398)
                      |.|+|+.+   ||||||||.|||||++..+||+|||+|+...                ........+..+||.-|+|||.
T Consensus       710 LaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            99999988   9999999999999999999999999998611                0011113356789999999999


Q ss_pred             hccC---CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCC-CCCHHHHHHH
Q 015931          242 FQHG---KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCT-SRNSAQIARV  317 (398)
Q Consensus       242 ~~~~---~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~l  317 (398)
                      +.+.   +|+.|+|+||+|||++||+.   ||......                ...+..+-++.+..+ .....+...-
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER----------------a~iL~~LR~g~iP~~~~f~~~~~~~e  847 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER----------------ASILTNLRKGSIPEPADFFDPEHPEE  847 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchHHH----------------HHHHHhcccCCCCCCcccccccchHH
Confidence            9754   59999999999999999985   46543211                012333334444322 1123334445


Q ss_pred             HHHHHhcccccCCCCCCHHHHHH
Q 015931          318 IQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       318 ~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..++.++++.||.+|||+.|+|.
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHhh
Confidence            67778999999999999999986

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.3e-37  Score=292.48  Aligned_cols=269  Identities=23%  Similarity=0.285  Sum_probs=193.2

Q ss_pred             CCCCCceecccCceEEEEeeeCCC--CcEEEEEEecCC--ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcC---CCc
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLL--RTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP---EQG  132 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---~~~  132 (398)
                      +|...+.||+|+||.||++....+  +..||+|.+...  .....+.+.+|+.++.++ +||||+++++.+...   ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            467788999999999999999877  889999998643  223356788899999999 599999999875432   234


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      ++++++|+ +++|.+.+...       ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        81 ~~~~~e~~-~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          81 LYLYEELM-EADLHQIIRSG-------QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             EEEEEecc-cCCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcC
Confidence            78899998 47899888653       45899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCc--eeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH-----
Q 015931          213 GLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW-----  284 (398)
Q Consensus       213 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~-----  284 (398)
                      |+++........  .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||..............     
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            999865432211  11123468999999998765 4689999999999999999999999976442111000000     


Q ss_pred             ----hhHHHhhchh-hhhhh-cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          285 ----AKPILHRGMA-AVEEL-LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       285 ----~~~~~~~~~~-~~~~~-~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                          .......... ..... ..+........+.....+.+++.+|++.+|.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                0000000000 00000 00000000000011245778888999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.4e-37  Score=281.92  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=193.9

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      +|...+.||+|+||.||++.....+..+++|.++..     .......+..|+.+++.++||||+++++++.+.. ..++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-AFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-ceEE
Confidence            477888999999999999998776666777766532     2223445778999999999999999999877654 4799


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||++
T Consensus        80 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKH---TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence            9999999999999875321   1256999999999999999999999888   999999999999975 56999999998


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......      .....        
T Consensus       153 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~--------  216 (260)
T cd08222         153 RLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLR--------  216 (260)
T ss_pred             eecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH--------
Confidence            76643322  123456888999999998888899999999999999999999999643211      11000        


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +.....+.+     .......+.+++.+||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         217 IVEGPTPSL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHcCCCCCC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            000011111     1223345677888999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-37  Score=284.59  Aligned_cols=263  Identities=24%  Similarity=0.362  Sum_probs=198.5

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      |+..+.||+|++|.||+|....+++.||+|.+....  ......+..|+.+++.++|+|++++++++.+. ...++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence            456778999999999999999889999999998653  33446778899999999999999999987765 558999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      ++ ++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++....
T Consensus        80 ~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          80 CD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             cC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            96 59999998742      35899999999999999999999988   9999999999999999999999999988665


Q ss_pred             CCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc----hh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----MA  294 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~  294 (398)
                      ....  ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+..   ..........    ..
T Consensus       150 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  224 (282)
T cd07829         150 IPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESWP  224 (282)
T ss_pred             CCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHHH
Confidence            4322  11234467789999998766 7899999999999999999999999765432111   0000000000    00


Q ss_pred             hhhhh--cCcccCCC------CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEEL--LDPRLKCT------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~--~d~~l~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+...  .+..+...      ...+.....+.+++.+||..+|.+||++.+|+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000  01011000      000111346788899999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=319.37  Aligned_cols=211  Identities=30%  Similarity=0.373  Sum_probs=185.0

Q ss_pred             HHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC
Q 015931           53 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  129 (398)
Q Consensus        53 ~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  129 (398)
                      .+++-..++|.+.++||+|+||.|..++++.+++.||+|++.+.   ......-|..|-.+|..-+.+.|+.+.-.|.+ 
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-  146 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-  146 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence            34555678999999999999999999999999999999999873   33455678899999999899999999876665 


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                      +.++|+||||++||+|-.++...       .++|+..++.++..++.||.-||+.|   +|||||||+|||||.+|++||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~-------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF-------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc-------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEee
Confidence            56699999999999999999875       35999999999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhc----c-CCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ----H-GKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      +|||.+-.+..+.. ..+...+|||.|++||++.    + +.|++.+|+||+||++|||+.|..||+.+..
T Consensus       217 ADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl  286 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL  286 (1317)
T ss_pred             ccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH
Confidence            99999988875443 3456678999999999985    2 5789999999999999999999999997643

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8e-37  Score=292.07  Aligned_cols=266  Identities=24%  Similarity=0.278  Sum_probs=193.7

Q ss_pred             cCCC-CCceecccCceEEEEeeeCCCCcEEEEEEecCCChhh--------------HHHHHHHHHHHHhCCCCCeeceee
Q 015931           60 HNFS-KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES--------------SKAFCRELMIASSLHHPNIVPLVG  124 (398)
Q Consensus        60 ~~f~-~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  124 (398)
                      ++|. ..+.||.|+||+||+|....+++.||+|.+.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999998889999999986542211              124778999999999999999999


Q ss_pred             EEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       125 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      ++... ...++||||+. |+|.+++...       ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.+
T Consensus        88 ~~~~~-~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~  155 (335)
T PTZ00024         88 VYVEG-DFINLVMDIMA-SDLKKVVDRK-------IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSK  155 (335)
T ss_pred             EEecC-CcEEEEEeccc-cCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCC
Confidence            98764 45899999995 6999988653       45899999999999999999999888   9999999999999999


Q ss_pred             CCeeEeccccccccCCCCC------------ceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCc
Q 015931          205 KIPKLCDFGLATWTSAPSV------------PFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIE  271 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~  271 (398)
                      +.++|+|||++........            ........++..|+|||.+.+. .++.++||||||+++|||++|..||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999976541110            0111223468889999998764 46899999999999999999999998


Q ss_pred             ccccccchhHHHHhhHHHhhchh-hhhhh--------cCcccCC--CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          272 ARRLQGEENLVLWAKPILHRGMA-AVEEL--------LDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--------~d~~l~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+..+..   ............ .....        .......  ..........+.+++.+||+.+|.+|||+.|++.
T Consensus       236 ~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        236 GENEIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCHHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            65432211   111000000000 00000        0000000  0000111345678888999999999999999986

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=304.41  Aligned_cols=204  Identities=33%  Similarity=0.504  Sum_probs=174.9

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----CcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~  134 (398)
                      .+...+.||+|+||.||+|+++.+|..||||.+... .....+...+|+++|++++|+|||++++.=.+..     ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            445567899999999999999999999999999764 3345677889999999999999999998632222     1247


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC--CCC--CeeEe
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKK--IPKLC  210 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~--~~~--~~kl~  210 (398)
                      +|||||.+|||...+.+...    ...|++...+.+..+++.||.|||+++   |+||||||.||++-  ++|  .-||+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN----~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPEN----AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             EEEeecCCCcHHHHhcCccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeee
Confidence            99999999999999987543    367999999999999999999999988   99999999999884  333  46999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      |||.|+.++.+.   ...+.+||..|++||.+.. ..|+..+|.|||||++|+++||..||....
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            999999887655   4578899999999999984 788999999999999999999999997643

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-36  Score=282.95  Aligned_cols=252  Identities=25%  Similarity=0.311  Sum_probs=191.8

Q ss_pred             CCCCCceecccCceEEEEeeeC---CCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           61 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      +|+..+.||+|+||.||++...   .++..||+|++....    ....+.+.+|+.++..+ +|+||+++++++.. +..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence            4777889999999999999873   368899999987532    22346678899999999 59999999987655 456


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          80 LHLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeC
Confidence            89999999999999999764       35889999999999999999999888   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccC--CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      |++......... ......|+..|+|||.+...  .++.++||||||+++|+|++|..||.......  ........   
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~---  223 (290)
T cd05613         150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRR---  223 (290)
T ss_pred             ccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHH---
Confidence            999865443211 11235588999999998753  46889999999999999999999996432211  11111111   


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                              +.......+   ......+.+++.+||+.+|.+||     +..+++.
T Consensus       224 --------~~~~~~~~~---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         224 --------ILKSEPPYP---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --------hhccCCCCC---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                    111000111   11223466777899999999997     6666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=275.36  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=200.7

Q ss_pred             hhcCCCCC-ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEc---CCCc
Q 015931           58 ATHNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID---PEQG  132 (398)
Q Consensus        58 ~~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---~~~~  132 (398)
                      .+++|++. ++||-|-.|.|-.+.++.+++++|+|++...     ....+|+++--.. .|||||.+++++..   +...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677654 6899999999999999999999999998643     2345777765544 69999999998753   3345


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeE
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKL  209 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl  209 (398)
                      +++|||.|+||.|...++....     ..+++.++-.|+.||+.|+.|||+.+   |.||||||+|+|...   |..+||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~-----~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD-----QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc-----ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEe
Confidence            7899999999999999988653     67999999999999999999999999   999999999999964   557899


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      +|||+|+....+.   ...+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......   +..-     
T Consensus       206 tDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispg-----  274 (400)
T KOG0604|consen  206 TDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPG-----  274 (400)
T ss_pred             cccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChh-----
Confidence            9999999765432   2356788999999999999999999999999999999999999998765421   1110     


Q ss_pred             hhchhhhhhhcCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           .-..+....+.++.. .....+..-++++..|..+|.+|.|+.+++.
T Consensus       275 -----Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  275 -----MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             -----HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                 111222222332221 2233455667788899999999999999987

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-36  Score=283.72  Aligned_cols=256  Identities=27%  Similarity=0.307  Sum_probs=195.7

Q ss_pred             CCCCCceecccCceEEEEeeeC---CCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           61 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      +|...+.||+|+||.||++...   .++..||||.+....    ......+.+|+.++.++ +||||+++++.+.. +..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence            4677889999999999998753   356889999987532    22345688999999999 59999999987655 455


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .++||||+++|+|.+++...       ..+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++.++|+||
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQR-------EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhc-------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEEC
Confidence            89999999999999998753       35899999999999999999999887   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCC--cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      |+++........ ......|+..|+|||.+.+..  .+.++||||||+++|||++|..||.......  .......    
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~----  222 (288)
T cd05583         150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISR----  222 (288)
T ss_pred             cccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHH----
Confidence            998765443221 112345889999999987655  7889999999999999999999996432211  0011111    


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                             .+.......+..   ....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       223 -------~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         223 -------RILKSKPPFPKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -------HHHccCCCCCcc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                   111111111111   12345677789999999999999999887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-37  Score=294.43  Aligned_cols=266  Identities=21%  Similarity=0.297  Sum_probs=197.9

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC----
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----  131 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  131 (398)
                      ..++|...+.||+|++|.||+|....+++.||+|++...  .......+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            357899999999999999999999888999999998653  23344667889999999999999999987654332    


Q ss_pred             -cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          132 -GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       132 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                       ..++|+||+ +++|.+++..        ..+++..++.++.|+++||.|||+.+   |+||||||+||++++++.++|+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEc
Confidence             378999999 7799998864        35899999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH-HHhh--
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWAK--  286 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~--  286 (398)
                      |||++......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ....  
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~  235 (343)
T cd07851         161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP  235 (343)
T ss_pred             ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence            99999866433     133467889999999865 36789999999999999999999999754432111000 0000  


Q ss_pred             --HHHhhc-hhhhhhhcCcccCCCCC-----CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 --PILHRG-MAAVEELLDPRLKCTSR-----NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 --~~~~~~-~~~~~~~~d~~l~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        ..+... .......+.........     .......+.+++.+||+.+|.+|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence              000000 00000000000000000     0012356778889999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=283.11  Aligned_cols=266  Identities=24%  Similarity=0.333  Sum_probs=204.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHh--CCCCCeeceeeEEEcCCC---cEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPEQ---GLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~---~~~  134 (398)
                      .+....+.||+|.||.||+|.++  |+.||||++...   +++.+.+|.++...  ++|+||+.+++.-..+.+   .++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            56677789999999999999998  889999999754   34567788888876  599999999986433332   379


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCceeecccccCcEEeCCCCCeeE
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-----GTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                      ||.+|.++|||.++|..        ..++-+..++++..+|.||++||.     ++.+.|.|||||+.|||+..|+...|
T Consensus       286 LvTdYHe~GSL~DyL~r--------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNR--------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EeeecccCCcHHHHHhh--------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            99999999999999987        458999999999999999999995     56788999999999999999999999


Q ss_pred             eccccccccCCCCCc--eeeeccccCCCcccchhhccCC----c--CCccchhhHHHHHHHHHcC----------CCCCc
Q 015931          210 CDFGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHGK----V--SDKTDVYAFGVVLLELLTG----------RKPIE  271 (398)
Q Consensus       210 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--s~ksDv~S~Gvvl~elltG----------~~Pf~  271 (398)
                      +|+|||...+.....  ......+||.+|||||++...-    +  -..+||||||.|+||+...          +.||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            999999876654221  2234578999999999986431    1  2359999999999998752          25665


Q ss_pred             ccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          272 ARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      +..+.+. +..+..+.       ...+-+.|.+.......+.+..+.+++..||..+|.-|-|+-.|-+.|.++.
T Consensus       438 d~Vp~DP-s~eeMrkV-------VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  438 DVVPSDP-SFEEMRKV-------VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             cCCCCCC-CHHHHhcc-------eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            5433321 11110000       1122233444434446688899999999999999999999999988887654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=273.52  Aligned_cols=273  Identities=21%  Similarity=0.308  Sum_probs=202.5

Q ss_pred             cCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEc
Q 015931           50 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCID  128 (398)
Q Consensus        50 ~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  128 (398)
                      -++.++.+.|+     +.||+|+|+.|-.+....++..||||++.+.......++.+|++++.+.+ |+||+.|++|+.+
T Consensus        73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            34666666553     57999999999999999999999999999998888889999999999985 9999999998766


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC---
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---  205 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---  205 (398)
                       +.++|||||-|.||+|..++++.       ..+++..+.++..+|+.||.+||..+   |.||||||+|||.....   
T Consensus       148 -d~~FYLVfEKm~GGplLshI~~~-------~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vs  216 (463)
T KOG0607|consen  148 -DTRFYLVFEKMRGGPLLSHIQKR-------KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVS  216 (463)
T ss_pred             -cceEEEEEecccCchHHHHHHHh-------hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcC
Confidence             55689999999999999999986       45999999999999999999999888   99999999999996543   


Q ss_pred             CeeEeccccccccCCC-----CCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          206 IPKLCDFGLATWTSAP-----SVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      -+|||||.+..-....     .......+.+|+..|||||+..     ...|+.++|.||||||||-|++|..||.+...
T Consensus       217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence            4899999887533211     1111224577999999999764     23578899999999999999999999987654


Q ss_pred             ccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCH-HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNS-AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+-.--....-+..++.  ....+-+..+.++..+- ......-+++...+..++.+|-++.+++.
T Consensus       297 ~dCGWdrGe~Cr~CQ~~--LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  297 ADCGWDRGEVCRVCQNK--LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CcCCccCCCccHHHHHH--HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            32100000000111110  11222233333322111 11122334555677799999999998887

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.3e-36  Score=312.39  Aligned_cols=146  Identities=28%  Similarity=0.395  Sum_probs=130.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+..+++.||+|++....   ......+..|+.++..++||||+++++++... ..+|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-NNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-CEEEEE
Confidence            57888999999999999999999889999999997532   33446788999999999999999999877654 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++...       ..+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999754       35889999999999999999999987   9999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=273.74  Aligned_cols=237  Identities=29%  Similarity=0.382  Sum_probs=191.6

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      ||.|+||.||++....+++.+|+|.+.....   .....+..|+.+++.++||||+++++.+.. +...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            6999999999999988899999999876432   245678899999999999999999988765 455899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  224 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  224 (398)
                      |.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        80 L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-  148 (250)
T cd05123          80 LFSHLSKE-------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-  148 (250)
T ss_pred             HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence            99999764       35899999999999999999999888   99999999999999999999999999886644321 


Q ss_pred             eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCccc
Q 015931          225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  304 (398)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  304 (398)
                       ......++..|+|||...+...+.++|+||||+++|+|++|..||......   ..              ...+....+
T Consensus       149 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~--------------~~~~~~~~~  210 (250)
T cd05123         149 -RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EI--------------YEKILKDPL  210 (250)
T ss_pred             -cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH--------------HHHHhcCCC
Confidence             123456888999999998888899999999999999999999999654321   00              111111222


Q ss_pred             CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHH
Q 015931          305 KCTSRNSAQIARVIQAAAACISSEESRRPGIEE  337 (398)
Q Consensus       305 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e  337 (398)
                      ..+...   ...+.+++.+||..+|.+||++.+
T Consensus       211 ~~~~~~---~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 RFPEFL---SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCC---CHHHHHHHHHHhcCCHhhCCCccc
Confidence            222222   244567778899999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=322.59  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=198.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      +-++..+..||.|.||.||.|...++|...|+|-+....  ......+.+|..++..++|||+|+++|+=.+.+ .++|.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-kv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-KVYIF 1312 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-HHHHH
Confidence            456778889999999999999999999999999886543  334456789999999999999999999865544 47899


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||++|+|.+.+...       ...++.....+..|++.|+.|||+++   ||||||||.||+|+.+|.+|++|||.|.
T Consensus      1313 MEyC~~GsLa~ll~~g-------ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG-------RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHhccCcHHHHHHhc-------chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence            9999999999999875       34677777888999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCC--CceeeeccccCCCcccchhhccCC---cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          217 WTSAPS--VPFLCKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       217 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ....+.  ...-.....||+.|||||++.+.+   ..-++||||+|||++||+||++||..-+..       |+...   
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy--- 1452 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMY--- 1452 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHh---
Confidence            876542  111123467999999999997643   466899999999999999999999754321       21100   


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                         .+...-.|.+.  ..   ....-.+++..||..||++|-++.|+++.
T Consensus      1453 ---~V~~gh~Pq~P--~~---ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 ---HVAAGHKPQIP--ER---LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ---HHhccCCCCCc--hh---hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence               11111222221  11   22334455668999999999888877764

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.3e-37  Score=274.44  Aligned_cols=210  Identities=29%  Similarity=0.460  Sum_probs=176.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCC----cEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      -..|.....||+|.||.||+|...+++    +.+|+|.++.+..  .......+|+.+++.++|||++.|..++...+..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            357888899999999999999665433    3699999976532  2335567899999999999999999998887778


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC----CCee
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPK  208 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~----~~~k  208 (398)
                      +++++||.+. +|...++......  ...++-..+..|+.||+.|+.|||++-   |+||||||.|||+..+    |.+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~--~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASK--AKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccch--hccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            9999999966 8999887654322  247899999999999999999999999   9999999999999876    8999


Q ss_pred             EeccccccccCCCCCce-eeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          209 LCDFGLATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      |+|||+++.+..+-.+. ....++-|+.|.|||.+.+. .||.+.||||.||++.||+|-.+-|....
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            99999999987764433 33457789999999999876 58999999999999999999888886543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=285.50  Aligned_cols=244  Identities=26%  Similarity=0.418  Sum_probs=198.9

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      .++||+|.||+||-|+++.+|+.||||++++.+  .....++.+|+.+|.+++||.||.+.-.|.. .+++++|||-+ +
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl-~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKL-H  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhh-c
Confidence            478999999999999999999999999998753  3455789999999999999999999876655 45699999999 6


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeEeccccccccC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGLATWTS  219 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DfGla~~~~  219 (398)
                      |+..+.+....+     +.|++.....++.||+.||.|||..+   |+|+||||+||||..   ...+||||||.|+.++
T Consensus       647 GDMLEMILSsEk-----gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  647 GDMLEMILSSEK-----GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             chHHHHHHHhhc-----ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            677777665543     67999999999999999999999988   999999999999964   4589999999999987


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      +...   .+.++||+.|+|||++.+..|...-|+||.||++|--++|..||..+..-.                   ..+
T Consensus       719 EksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-------------------dQI  776 (888)
T KOG4236|consen  719 EKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-------------------DQI  776 (888)
T ss_pred             hhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-------------------HHh
Confidence            7543   357899999999999999999999999999999999999999997543210                   111


Q ss_pred             cCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      -+..+..+.. ..+.....++++...|+..-.+|-|..+-+.
T Consensus       777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            1222222222 2333455778888889999999999887665

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=272.64  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=193.9

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +.+....||.|+||+|+|-.++.+|+..|||++..... ...+++..|.+...+- +.||||+++|.++..+. .|+.||
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-cWiCME  143 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-CWICME  143 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-eeeeHH
Confidence            33445679999999999999999999999999986543 5567888888776554 68999999999887554 799999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      .| ..||+.+-..-..  -.+..+++...-.|....+.||.||-..  ..|||||+||+|||||..|.+||||||++-.+
T Consensus       144 LM-d~SlDklYk~vy~--vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYS--VQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HH-hhhHHHHHHHHHH--HHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            99 7788776543211  1125699999999999999999999874  34999999999999999999999999998766


Q ss_pred             CCCCCceeeeccccCCCcccchhhccC--CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ...-   ..+..+|-..|||||.+...  .|..+|||||||++|||+.||..|+...+..     ..           .+
T Consensus       219 v~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----fe-----------ql  279 (361)
T KOG1006|consen  219 VDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FE-----------QL  279 (361)
T ss_pred             HHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HH-----------HH
Confidence            5432   12345788899999998643  4889999999999999999999999765431     00           11


Q ss_pred             hhhc--Cc-ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          297 EELL--DP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       297 ~~~~--d~-~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ..++  || .+.....+......+...+..|+.+|-..||+..++.++
T Consensus       280 ~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  280 CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1111  21 122111212233445566667999999999999998763

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=300.15  Aligned_cols=264  Identities=28%  Similarity=0.484  Sum_probs=203.1

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCC-------CCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEc
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCID  128 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  128 (398)
                      ..++....+.||+|.||.|++|....       ....||||.++... ....+.+..|+++++.+ +|+||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            34455566799999999999997531       14579999997653 34567899999999998 59999999999988


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhc--cCCCCC-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcE
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKK--KGVRGN-------STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  199 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~-------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NI  199 (398)
                       .+.+++|+||+..|+|.+++....  ......       ..++....+.++.|||.|++||++..   ++||||..+||
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV  449 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV  449 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence             566899999999999999998865  011111       24899999999999999999999877   99999999999


Q ss_pred             EeCCCCCeeEeccccccccCCCCCceeeecccc--CCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccc
Q 015931          200 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG--TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ  276 (398)
Q Consensus       200 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~  276 (398)
                      |+.++..+||+|||+|+......... .....|  ...|||||.+....++.|||||||||+|||++| |..|+.+....
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999655443221 122222  445999999999999999999999999999999 88998652211


Q ss_pred             cchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          277 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .  .+..    .+..+         .++..+.....+   +.+++..||+.+|++||++.++++.+..
T Consensus       529 ~--~l~~----~l~~G---------~r~~~P~~c~~e---iY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  529 E--ELLE----FLKEG---------NRMEQPEHCSDE---IYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             H--HHHH----HHhcC---------CCCCCCCCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            1  1111    11111         122233344444   4466678999999999999999999876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2e-35  Score=268.59  Aligned_cols=221  Identities=21%  Similarity=0.267  Sum_probs=175.0

Q ss_pred             cCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHh
Q 015931           71 GALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH  150 (398)
Q Consensus        71 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~  150 (398)
                      |.+|.||++.+..+++.||+|.+....     .+..|...+....||||+++++++.+. ...++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999997643     233455555566799999999987765 45899999999999999987


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeecc
Q 015931          151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV  230 (398)
Q Consensus       151 ~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  230 (398)
                      ..       ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||.+.......     ...
T Consensus        78 ~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~  142 (237)
T cd05576          78 KF-------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGE  142 (237)
T ss_pred             Hh-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccC
Confidence            64       34899999999999999999999888   9999999999999999999999999876554321     233


Q ss_pred             ccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCC
Q 015931          231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN  310 (398)
Q Consensus       231 ~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  310 (398)
                      .++..|+|||......++.++||||+|+++|||++|+.|+.......                   .....  +..+.. 
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~--~~~~~~-  200 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTT--LNIPEW-  200 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------ccccc--cCCccc-
Confidence            46778999999988889999999999999999999998875322110                   00000  011111 


Q ss_pred             HHHHHHHHHHHHhcccccCCCCCCHH
Q 015931          311 SAQIARVIQAAAACISSEESRRPGIE  336 (398)
Q Consensus       311 ~~~~~~l~~l~~~cl~~~p~~RPt~~  336 (398)
                        ....+.+++.+|++.||.+||++.
T Consensus       201 --~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         201 --VSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             --CCHHHHHHHHHHccCCHHHhcCCC
Confidence              123466778899999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=275.00  Aligned_cols=242  Identities=24%  Similarity=0.360  Sum_probs=191.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  134 (398)
                      ..+|....+||+|+||.|-+|..+.+.+.+|||+++++-   ..+.+--+.|-.+|... +-|.++++..+ ++.-+++|
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-FQTmDRLy  426 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-FQTMDRLY  426 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-hhhhhhee
Confidence            357888999999999999999999999999999998752   12223334566666554 46788888775 44456699


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+.||+|.-++++-       +.+-+..+.-++..||-||-+||+.+   |+.||||..||+||.+|++||+|||+
T Consensus       427 FVMEyvnGGDLMyhiQQ~-------GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQV-------GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             eEEEEecCchhhhHHHHh-------cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccc
Confidence            999999999999999886       45788889999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++.---+.  ..+.+.+||+.|+|||++...+|+.++|+|||||+||||+.|++||++.+..+                 
T Consensus       497 cKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-----------------  557 (683)
T KOG0696|consen  497 CKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----------------  557 (683)
T ss_pred             ccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-----------------
Confidence            98533222  24567899999999999999999999999999999999999999999865432                 


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP  333 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  333 (398)
                      ....+.+.....+...+   .+.+.+....+.+.|.+|.
T Consensus       558 lF~aI~ehnvsyPKslS---kEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  558 LFQAIMEHNVSYPKSLS---KEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHHHHccCcCccccc---HHHHHHHHHHhhcCCcccc
Confidence            23334444444333233   3344455567788888874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-34  Score=261.62  Aligned_cols=239  Identities=30%  Similarity=0.421  Sum_probs=192.4

Q ss_pred             CceEEEEeeeCCCCcEEEEEEecCCChhh-HHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHh
Q 015931           72 ALSFVFKGKVGLLRTSVAIKRLDKEDKES-SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH  150 (398)
Q Consensus        72 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~  150 (398)
                      +||.||+|....+++.+++|++....... ...+.+|++.+++++|+|++++++++... ...++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHH
Confidence            58999999998888999999998665443 67899999999999999999999988765 45799999999999999987


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeecc
Q 015931          151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV  230 (398)
Q Consensus       151 ~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  230 (398)
                      ...       .+++..++.++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   .....
T Consensus        80 ~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~  146 (244)
T smart00220       80 KRG-------RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTF  146 (244)
T ss_pred             hcc-------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccc
Confidence            642       3899999999999999999999987   9999999999999999999999999998765542   12345


Q ss_pred             ccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCC
Q 015931          231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN  310 (398)
Q Consensus       231 ~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  310 (398)
                      .++..|++||.+....++.++||||||+++++|++|..||......  ....              ..............
T Consensus       147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~--------------~~~~~~~~~~~~~~  210 (244)
T smart00220      147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELF--------------KKIGKPKPPFPPPE  210 (244)
T ss_pred             cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH--------------HHHhccCCCCcccc
Confidence            6888999999998888999999999999999999999999753111  0111              11111111101110


Q ss_pred             HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          311 SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       311 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ......+.+++.+|+..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            003346778888999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=273.04  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCC--CC----eeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--PN----IVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~~~~~~~~~~  132 (398)
                      +++|.+...+|+|.||.|-.+.+..++..||||+++..... .+...-|+++|.++.+  |+    +|.+.+| ++-.+.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~w-Fdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDW-FDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehh-hhccCc
Confidence            67899999999999999999999888999999999765432 3455679999999842  22    5666665 455667


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---------
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---------  203 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---------  203 (398)
                      .|||+|.+ |.|+.+++...+-     .+++..+++.++.|+++++++||+.+   ++|.||||+|||+.+         
T Consensus       166 iCivfell-G~S~~dFlk~N~y-----~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNY-----IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCc-----cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence            99999999 8899999987543     67899999999999999999999988   999999999999832         


Q ss_pred             -----------CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          204 -----------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       204 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                                 +..+||+|||.|+......     ...+.|..|.|||++.+-.++.++||||+||||+|+.||..-|..
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                       2368999999998765543     456789999999999999999999999999999999999999987


Q ss_pred             cccccchhHHHHhhHHHhhchh-hhhhh----------cC---------------ccc---CCCCCCHHHHHHHHHHHHh
Q 015931          273 RRLQGEENLVLWAKPILHRGMA-AVEEL----------LD---------------PRL---KCTSRNSAQIARVIQAAAA  323 (398)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~----------~d---------------~~l---~~~~~~~~~~~~l~~l~~~  323 (398)
                      ....+...+   +..++..... .+...          +|               +..   ........+...|++|+..
T Consensus       312 Hen~EHLaM---MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~  388 (415)
T KOG0671|consen  312 HENLEHLAM---MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR  388 (415)
T ss_pred             CCcHHHHHH---HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence            653332222   1112211110 00000          11               100   1112344667789999999


Q ss_pred             cccccCCCCCCHHHHHH
Q 015931          324 CISSEESRRPGIEEIIA  340 (398)
Q Consensus       324 cl~~~p~~RPt~~evl~  340 (398)
                      +|..||.+|+|+.|++.
T Consensus       389 mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  389 MLEFDPARRITLREALS  405 (415)
T ss_pred             HHccCccccccHHHHhc
Confidence            99999999999999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=287.05  Aligned_cols=240  Identities=28%  Similarity=0.380  Sum_probs=190.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      +..|.....+|.|+|+.|-.+.+..+++..++|++.....    +-.+|+.++... +||||+++.+.+.++. ..|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~-~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGK-EIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCc-eeeeee
Confidence            5677777889999999999999999999999999986522    223566555554 7999999999987754 489999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe-CCCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll-~~~~~~kl~DfGla~  216 (398)
                      |.+.++-|.+.+....        .....+..|+.+|+.|+.|||+++   ++||||||+|||+ ++.++++|+|||.++
T Consensus       396 e~l~g~ell~ri~~~~--------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP--------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             hhccccHHHHHHHhcc--------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999998888876642        223677789999999999999988   9999999999999 588999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .....     ....+-|..|.|||++....+++++||||||++||+|++|+.||.....+  ..+              .
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei--------------~  523 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI--------------H  523 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH--------------H
Confidence            77554     23456788999999999889999999999999999999999999865433  111              1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+-.+...     ........+|+.+||+.||.+||+|.++..
T Consensus       524 ~~i~~~~~s-----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  524 TRIQMPKFS-----ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HhhcCCccc-----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            111112111     222234556667899999999999999876

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=241.83  Aligned_cols=204  Identities=25%  Similarity=0.405  Sum_probs=173.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +|+..++||+|.||+||+|+...+++.||+|++..++  ...-....+|+-+|+.+.|.|||+++++... ++.+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHH
Confidence            4666788999999999999999999999999987543  3334567899999999999999999998544 556889999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      || ..+|..+....+      +.++.+..+.++.|+++||.++|+++   +.|||+||.|.||+.||.+|++|||+++-+
T Consensus        82 ~c-dqdlkkyfdsln------g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLN------GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             Hh-hHHHHHHHHhcC------CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhc
Confidence            99 668988887754      56999999999999999999999998   999999999999999999999999999977


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCC-cCCccchhhHHHHHHHHHc-CCCCCccccccc
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLT-GRKPIEARRLQG  277 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~  277 (398)
                      +.+-.  .....+-|..|.+|.++.+.+ |+...|+||-||++.|+.. |++-|.+.+..+
T Consensus       152 gipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd  210 (292)
T KOG0662|consen  152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD  210 (292)
T ss_pred             CCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH
Confidence            65431  223456799999999998765 7889999999999999987 666676655443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=287.53  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=206.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcC----CCc
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP----EQG  132 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~  132 (398)
                      -+..|.+..+||.|.+|.||+++...+++..|+|+...... ..+++..|.++|+.. .|||++.++|++.-.    ++.
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            35678888999999999999999999999999999876543 345677888898877 699999999987632    234


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|||||||.+||..++++...     ...+.|+.+..|++.++.||.+||.+.   ++|||||-.|||++.++.+||+||
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~-----g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTK-----GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhc-----ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence            899999999999999998765     267999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhcc-----CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |++..+...-  ....+..||+.|||||++.-     ..|+..+|+||||++..||.-|.+|+.+..+-.      .   
T Consensus       168 GvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------a---  236 (953)
T KOG0587|consen  168 GVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------A---  236 (953)
T ss_pred             eeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------h---
Confidence            9998776532  22356789999999999863     247779999999999999999999998754321      0   


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ++     .+..--.|.+.   ....-.+.+.+++..||.+|-.+||++.++++
T Consensus       237 LF-----~IpRNPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  237 LF-----LIPRNPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hc-----cCCCCCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            00     00111122232   13344567888888999999999999999987

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=274.48  Aligned_cols=258  Identities=27%  Similarity=0.407  Sum_probs=196.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--h-----hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--K-----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      ++|-..++||+|||+.||+|.+-.....||||+-....  .     .-.+...+|..+-+.++||.||++++|+.-..+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            45666789999999999999987778889999865321  1     1123456899999999999999999998766677


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC---CCCCeeE
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKL  209 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl  209 (398)
                      +|-|+|||+|.+|+-+|+..       ..+++..++.|+.||+.||.||.+.. ++|||-||||.||||-   ..|.+||
T Consensus       543 FCTVLEYceGNDLDFYLKQh-------klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH-------KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh-------hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence            89999999999999999886       45899999999999999999999875 7799999999999995   4578999


Q ss_pred             eccccccccCCCCCc-----eeeeccccCCCcccchhhccC----CcCCccchhhHHHHHHHHHcCCCCCcccccccchh
Q 015931          210 CDFGLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHG----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  280 (398)
Q Consensus       210 ~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~  280 (398)
                      +|||+++.+......     ..+...+||.+|++||++.-+    +++.|.||||+||++|+++.|++||..+..+.   
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---  691 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---  691 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---
Confidence            999999988764332     223456899999999998643    57899999999999999999999998654321   


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHH
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII  339 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl  339 (398)
                            .++..+  .+...-.-.+...+....+.   -.++++||++.-++|....++.
T Consensus       692 ------dILqeN--TIlkAtEVqFP~KPvVsseA---kaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 ------DILQEN--TILKATEVQFPPKPVVSSEA---KAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ------HHHhhh--chhcceeccCCCCCccCHHH---HHHHHHHHHhhhhhhhhHHHHc
Confidence                  111111  11111111111112223333   4456789999999997666554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.9e-34  Score=290.21  Aligned_cols=269  Identities=18%  Similarity=0.239  Sum_probs=170.8

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCC----CcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEE-----Ec
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC-----ID  128 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-----~~  128 (398)
                      ..++|...+.||+|+||.||+|.+..+    +..||+|++......  +.+..+  .+....+.+++.++..+     ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999887    889999988643221  111111  12222222222222111     12


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccC-------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccc
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKG-------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  195 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlk  195 (398)
                      .+...++||||+.+++|.+++......             ........+..+..++.|++.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            344589999999999999998753210             000011223456689999999999999888   9999999


Q ss_pred             cCcEEeCC-CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccC----------------------CcCCccc
Q 015931          196 PSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG----------------------KVSDKTD  252 (398)
Q Consensus       196 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD  252 (398)
                      |+|||+++ ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 57999999999986543321 122456789999999965322                      2345679


Q ss_pred             hhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch--hhhhhhcCcccCCC-----CCCHHHHHHHHHHHHhcc
Q 015931          253 VYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM--AAVEELLDPRLKCT-----SRNSAQIARVIQAAAACI  325 (398)
Q Consensus       253 v~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~l~~~-----~~~~~~~~~l~~l~~~cl  325 (398)
                      ||||||+||||+++..|+....       ..+...+.....  ......+.+.....     ...........+++.+||
T Consensus       362 VwSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            9999999999999776654321       111111000000  00111111110000     000001123447888999


Q ss_pred             cccCCCCCCHHHHHHH
Q 015931          326 SSEESRRPGIEEIIAI  341 (398)
Q Consensus       326 ~~~p~~RPt~~evl~~  341 (398)
                      +.||.+|||+.++++.
T Consensus       435 ~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        435 RFKGRQRISAKAALAH  450 (566)
T ss_pred             cCCcccCCCHHHHhCC
Confidence            9999999999999973

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-35  Score=279.03  Aligned_cols=208  Identities=26%  Similarity=0.341  Sum_probs=176.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .-|...+.||-|+||.|.++.-.++...||+|.+.+.+.   ........|-.||...+.+.||+|+-.|.+.+ .+|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEE
Confidence            457778899999999999999888899999999987543   33445678999999999999999998776654 59999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |+|++||++..+|-+.       +.++++.++.++..+..|+++.|..|   .|||||||+|||||.+|++||+||||+.
T Consensus       708 MdYIPGGDmMSLLIrm-------gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRM-------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             EeccCCccHHHHHHHh-------ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccc
Confidence            9999999999999875       56899999999999999999999888   9999999999999999999999999984


Q ss_pred             cc---------CCCCCc-------------------------------eeeeccccCCCcccchhhccCCcCCccchhhH
Q 015931          217 WT---------SAPSVP-------------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAF  256 (398)
Q Consensus       217 ~~---------~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~  256 (398)
                      -+         ..++..                               ......+||..|+|||++....++..+|+||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            22         111000                               00123569999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCcccccccc
Q 015931          257 GVVLLELLTGRKPIEARRLQGE  278 (398)
Q Consensus       257 Gvvl~elltG~~Pf~~~~~~~~  278 (398)
                      |||||||+.|+.||..+.+.+.
T Consensus       858 gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcc
Confidence            9999999999999998877653

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=276.65  Aligned_cols=243  Identities=25%  Similarity=0.325  Sum_probs=198.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++.....||-||||.|=++........+|+|++++.   +....+.+..|-.+|...+.|.||++|..+.+ +.++|+.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhh
Confidence            4556667899999999999988765556899988764   33445667899999999999999999998766 5668999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||-|-||.|+..+..+       +.++..+..-++..+++|++|||+.+   ||+|||||+|.+||.+|-+||.|||+|+
T Consensus       499 mEaClGGElWTiLrdR-------g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  499 MEACLGGELWTILRDR-------GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             HHhhcCchhhhhhhhc-------CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence            9999999999999875       56888899999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .+..+..   +-+.+||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++-...+++...          +
T Consensus       569 ki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG----------i  635 (732)
T KOG0614|consen  569 KIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG----------I  635 (732)
T ss_pred             HhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh----------h
Confidence            9877653   45789999999999999999999999999999999999999999987664333332211          1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG  334 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  334 (398)
                      ..+--|        ....+...+++.+.+..+|.+|..
T Consensus       636 d~i~~P--------r~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  636 DKIEFP--------RRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhhhcc--------cccchhHHHHHHHHHhcCcHhhhc
Confidence            111111        112234556667778889999976

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-35  Score=256.43  Aligned_cols=272  Identities=21%  Similarity=0.316  Sum_probs=199.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-------
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-------  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  130 (398)
                      +.|....+||+|.||.||+|..+++++.||+|++-.+.  ..--....+|+.+|..+.|+|++.++..|....       
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45556678999999999999999999999998775432  222345678999999999999999998875322       


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ..+|+||++|+. +|.-+|....      ..++..++.+++.++..||.|+|.+.   |+|||+||.|+||+.++.+||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEee
Confidence            238999999965 8888887653      56899999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCc--eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh--
Q 015931          211 DFGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA--  285 (398)
Q Consensus       211 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~--  285 (398)
                      |||+++.+......  ...+..+-|..|.+||.+.+. .++++.|||.-||++.||+||.+-+.+........++.-.  
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            99999866543321  123445679999999998875 6899999999999999999999999887655443332211  


Q ss_pred             ---hHHHhhch--hhhhhhcCcccCCCCC--CHHHH------HHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          286 ---KPILHRGM--AAVEELLDPRLKCTSR--NSAQI------ARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       286 ---~~~~~~~~--~~~~~~~d~~l~~~~~--~~~~~------~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                         ...|+...  .....+--+.+.....  ....+      ...++|+..++..||.+||...+++..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence               01111100  0011110010110000  00111      135566677999999999999999874

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-34  Score=255.29  Aligned_cols=201  Identities=28%  Similarity=0.448  Sum_probs=174.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|+..++||+|+|++|-.+.+..+.+.+|+|+++++   ..+...-.+.|-.+..+. +||.+|-+..+ ++.+.+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-fqtesrlf  327 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-FQTESRLF  327 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-hcccceEE
Confidence            46899999999999999999999999999999999864   233444456666666554 79999999874 56677799


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +|.||++||+|.-++++.       ..++++.++.+...|..||.|||+.+   |+.||||..|||||..|++||+|+|+
T Consensus       328 fvieyv~ggdlmfhmqrq-------rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             EEEEEecCcceeeehhhh-------hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccch
Confidence            999999999998888775       35999999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                      ++.--.+..  .+.+.+||+.|.|||++.+..|....|+|++||+++||+.|+.||+.
T Consensus       398 cke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  398 CKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             hhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            985433322  34678999999999999999999999999999999999999999984

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=272.38  Aligned_cols=211  Identities=23%  Similarity=0.315  Sum_probs=156.4

Q ss_pred             hhcCCCCCceecccCceEEEEeeeC----------------CCCcEEEEEEecCCChhhHHHH--------------HHH
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVG----------------LLRTSVAIKRLDKEDKESSKAF--------------CRE  107 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E  107 (398)
                      ..++|+..++||+|+||+||+|...                ..+..||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4679999999999999999999742                2346799999876543333333              346


Q ss_pred             HHHHHhCCCCCe-----eceeeEEEcC-------CCcEEEEEecCCCCCHHHHHhhhccCC-----------------CC
Q 015931          108 LMIASSLHHPNI-----VPLVGFCIDP-------EQGLFLIYKYVSGGSLERHLHEKKKGV-----------------RG  158 (398)
Q Consensus       108 ~~~l~~l~h~ni-----v~l~~~~~~~-------~~~~~lV~e~~~~gsL~~~l~~~~~~~-----------------~~  158 (398)
                      +.++.+++|.++     ++++++|...       ++..++||||+++++|.++++......                 ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766554     6777776531       234799999999999999997532100                 01


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCccc
Q 015931          159 NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA  238 (398)
Q Consensus       159 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  238 (398)
                      ...++|..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ .......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            134678899999999999999999888   99999999999999999999999999976543221 11122335789999


Q ss_pred             chhhccCC----------------------cCCccchhhHHHHHHHHHcCCC-CCcc
Q 015931          239 PEYFQHGK----------------------VSDKTDVYAFGVVLLELLTGRK-PIEA  272 (398)
Q Consensus       239 PE~~~~~~----------------------~s~ksDv~S~Gvvl~elltG~~-Pf~~  272 (398)
                      ||.+....                      ...+.||||+||++|+|++|.. ||..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            99875432                      1235799999999999999875 6653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=239.08  Aligned_cols=209  Identities=27%  Similarity=0.404  Sum_probs=172.4

Q ss_pred             HHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           55 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        55 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      +....+.......||+|++|.|-+-++..+|+..|+|.+... +.+..++.++|+.+..+. ..|.+|.++|..++.. .
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-d  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-D  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-c
Confidence            444455566667899999999999999999999999999764 345566788898877654 7999999999877644 4


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +++.||.| ..||+.+-.+--+   .+..+++..+-+|+..+++||.|||++-  .++|||+||+|||++.+|++|+|||
T Consensus       120 vwIcME~M-~tSldkfy~~v~~---~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  120 VWICMELM-DTSLDKFYRKVLK---KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             EEEeHHHh-hhhHHHHHHHHHh---cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence            89999999 7799887765322   2367999999999999999999999953  4999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhcc----CCcCCccchhhHHHHHHHHHcCCCCCccc
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH----GKVSDKTDVYAFGVVLLELLTGRKPIEAR  273 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~  273 (398)
                      |++-.+.+.-.   .+...|-..|||||.+..    ..|+-|+||||||+++.||.+++.|+...
T Consensus       194 GIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  194 GISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            99987654321   233568889999998863    36899999999999999999999999754

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=256.23  Aligned_cols=270  Identities=21%  Similarity=0.293  Sum_probs=212.8

Q ss_pred             HHHHHhhcCCCCCceecccCceEEEEeeeCCC-----CcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEE
Q 015931           53 GEILAATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFC  126 (398)
Q Consensus        53 ~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  126 (398)
                      .++.....+++...++-+|.||.||.|.++..     .+.|-+|.++.. +.-....+..|...+..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            34555567788888999999999999977532     234666666543 233456688999999999999999999999


Q ss_pred             EcCCCcEEEEEecCCCCCHHHHHhhhcc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          127 IDPEQGLFLIYKYVSGGSLERHLHEKKK-GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       127 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      .+.....+++|.++.-|+|..++...+. .......+.-.+...++.|++.|++|||+.+   |||.||..+|.+||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            9887778999999999999999984322 1222356777788889999999999999988   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHH
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  284 (398)
                      ++||+|=.+++.+-+.+........-.+..||+||.+.+..|+..+|||||||++|||+| |+.|+..-++.+...... 
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-  512 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-  512 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-
Confidence            999999999987766655555555556778999999999999999999999999999998 999987655543221111 


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                            .+         .++..+..++++   ++.++..||...|++||++.|++.-|.+
T Consensus       513 ------dG---------yRlaQP~NCPDe---Lf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  513 ------DG---------YRLAQPFNCPDE---LFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ------cc---------ceecCCCCCcHH---HHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                  11         133334445555   5667778999999999999999988764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=276.49  Aligned_cols=246  Identities=25%  Similarity=0.359  Sum_probs=184.9

Q ss_pred             CCCCceecccCce-EEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEec
Q 015931           62 FSKGRVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        62 f~~~~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      |...+++|.|+-| .||+|...  ++.||||++-.+   ...-..+|+..|+.- +|||||++++. ....+..||..|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~-E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS-EQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee-ccCCceEEEEehH
Confidence            5556788999987 57999987  789999998543   334467899999887 59999999864 4445668999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---C--CCeeEecccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---K--KIPKLCDFGL  214 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~--~~~kl~DfGl  214 (398)
                      | ..+|.+++.......   ....-...+.+..|+++||++||+.+   ||||||||.||||+.   +  ..++|+|||+
T Consensus       585 C-~~sL~dlie~~~~d~---~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  585 C-ACSLQDLIESSGLDV---EMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             h-hhhHHHHHhccccch---hhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccc
Confidence            9 669999998741111   11111345678899999999999988   999999999999975   2  4789999999


Q ss_pred             ccccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcC-CCCCcccccccchhHHHHhhHHHhhc
Q 015931          215 ATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG-RKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       215 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      ++.+..+.... ......||.||+|||.+....-+.++||||+||++|+.++| ..||......+.. +           
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-I-----------  725 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-I-----------  725 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-h-----------
Confidence            99887654332 23457799999999999988888899999999999999995 9999865433211 0           


Q ss_pred             hhhhhhhcCc-ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~-~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         +....+- .+. +  ..++  ...+|+.+|++++|..||++.+|+.
T Consensus       726 ---l~~~~~L~~L~-~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  726 ---LTGNYTLVHLE-P--LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ---hcCccceeeec-c--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence               1110000 111 1  1111  5677888999999999999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.3e-34  Score=248.23  Aligned_cols=270  Identities=22%  Similarity=0.316  Sum_probs=199.5

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC----cEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~  134 (398)
                      +....+.||.|+||.||...+..+|+.||+|++..-  +-...+.+.+|+.+|..++|.|++..++...-..-    .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            456678999999999999999999999999998653  33445678899999999999999999886443321    267


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +++|.| ..+|.+.+...       ..++-..+.-+.+||++||+|||+.+   |.||||||.|+|++.|..+||||||+
T Consensus       134 V~TELm-QSDLHKIIVSP-------Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSP-------QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHH-HhhhhheeccC-------CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccc
Confidence            888988 55888888664       56888899999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh--hHHHhh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA--KPILHR  291 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~  291 (398)
                      ++.-...+..+ .+..+-|..|.|||.+++. .|+...||||.||++.||+..+.-|...++-....++.-.  .+..+.
T Consensus       203 ARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  203 ARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             ccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            99765544333 3445678899999999976 6899999999999999999888888876665443332211  011100


Q ss_pred             chh----hhhhhcCcccCCCC--------CCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          292 GMA----AVEELLDPRLKCTS--------RNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       292 ~~~----~~~~~~d~~l~~~~--------~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      .+.    .-..++....+.+.        .....-...+.+...++..||++|.+..+.+..+
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            000    01112221111110        0001122345566778999999999999888754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.6e-30  Score=229.60  Aligned_cols=211  Identities=36%  Similarity=0.582  Sum_probs=182.2

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCHH
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE  146 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~  146 (398)
                      ||+|++|.||++....+++.+++|++...... ....+.+|++.++.++|++++++++++... ...++++|++++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence            68999999999999877899999999865432 356789999999999999999999987764 4579999999999999


Q ss_pred             HHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeEeccccccccCCCCCce
Q 015931          147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPF  225 (398)
Q Consensus       147 ~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~  225 (398)
                      +++....      ..+++..++.++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  
T Consensus        80 ~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--  148 (215)
T cd00180          80 DLLKENE------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--  148 (215)
T ss_pred             HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence            9997642      35899999999999999999999987   999999999999999 89999999999986654421  


Q ss_pred             eeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCccc
Q 015931          226 LCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  304 (398)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  304 (398)
                      ......+...|++||.+... ..+.++|+|++|+++++|                                         
T Consensus       149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------  187 (215)
T cd00180         149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------  187 (215)
T ss_pred             hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence            12335578889999999877 788999999999999999                                         


Q ss_pred             CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          305 KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       305 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                                ..+.+++..|++.+|.+||++.++++.
T Consensus       188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                      246677788999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=243.85  Aligned_cols=266  Identities=21%  Similarity=0.323  Sum_probs=195.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-----C---CCeeceeeEEEcC--
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----H---PNIVPLVGFCIDP--  129 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~--  129 (398)
                      .+|...++||.|.|++||++.+....+.||+|+.+.. ..-.+..+.|+++|++++     |   ..||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            5777889999999999999999988899999998643 334556789999999884     2   4699999987643  


Q ss_pred             -CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC---
Q 015931          130 -EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---  205 (398)
Q Consensus       130 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---  205 (398)
                       +..+|+|+|++ |-+|..+|.....     ..++...+.+|+.||+.||.|||..+  +|||.||||+|||+..+.   
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Y-----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNY-----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCC-----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccch
Confidence             24589999999 8899999987653     56999999999999999999999965  599999999999994320   


Q ss_pred             --------------------------------------------------------------------------------
Q 015931          206 --------------------------------------------------------------------------------  205 (398)
Q Consensus       206 --------------------------------------------------------------------------------  205 (398)
                                                                                                      
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 015931          206 --------------------------------------------------------------------------------  205 (398)
Q Consensus       206 --------------------------------------------------------------------------------  205 (398)
                                                                                                      
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                                                                            


Q ss_pred             ---CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc----c
Q 015931          206 ---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG----E  278 (398)
Q Consensus       206 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~----~  278 (398)
                         .+||+|||-|+.....     .+....|..|.|||++.+..|++.+||||++|++|||+||..-|+......    +
T Consensus       389 ~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             cceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence               1334444444332211     122336778999999999999999999999999999999999998654432    2


Q ss_pred             hhHHHH---h----hHHHhhchhhhhhhcCcc--------cCC----------CCCCHHHHHHHHHHHHhcccccCCCCC
Q 015931          279 ENLVLW---A----KPILHRGMAAVEELLDPR--------LKC----------TSRNSAQIARVIQAAAACISSEESRRP  333 (398)
Q Consensus       279 ~~~~~~---~----~~~~~~~~~~~~~~~d~~--------l~~----------~~~~~~~~~~l~~l~~~cl~~~p~~RP  333 (398)
                      .++...   .    +.+...++ .-+++++.+        |+.          -....++..++.+++.-||+.+|.+||
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk-~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~  542 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGK-YSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP  542 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCc-chHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence            222111   0    11111111 122233321        111          113456778889999999999999999


Q ss_pred             CHHHHHH
Q 015931          334 GIEEIIA  340 (398)
Q Consensus       334 t~~evl~  340 (398)
                      |+.+.++
T Consensus       543 tA~~cl~  549 (590)
T KOG1290|consen  543 TAAQCLK  549 (590)
T ss_pred             cHHHHhc
Confidence            9999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5e-30  Score=229.90  Aligned_cols=200  Identities=40%  Similarity=0.585  Sum_probs=172.8

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      |...+.||+|++|.||++....+++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++... ...++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEecc
Confidence            55678999999999999999887899999999876544 667899999999999999999999987664 4579999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++++|.+++....      ..+++..++.++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+.....
T Consensus        80 ~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       80 EGGDLFDYLRKKG------GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             CCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            9999999998642      11889999999999999999999887   99999999999999999999999999987654


Q ss_pred             CCCceeeeccccCCCcccchhh-ccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                      .... ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       151 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4210 12345678889999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=253.17  Aligned_cols=197  Identities=26%  Similarity=0.355  Sum_probs=170.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhCC---CCCeeceeeEEEc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLH---HPNIVPLVGFCID  128 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  128 (398)
                      .+|+..+.+|+|+||.|+.|.++.....|+||.+.+++-        ...-.+-.|+.+|..++   |+||+++++++.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            468889999999999999999998889999999987532        11123557999999997   9999999998766


Q ss_pred             CCCcEEEEEecC-CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCe
Q 015931          129 PEQGLFLIYKYV-SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  207 (398)
Q Consensus       129 ~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~  207 (398)
                       +++.||+||.. ++.+|.+++..+       ..+++..+..|+.|++.|+++||+++   |||||||-+||.++.+|-+
T Consensus       641 -dd~yyl~te~hg~gIDLFd~IE~k-------p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  641 -DDYYYLETEVHGEGIDLFDFIEFK-------PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             -CCeeEEEecCCCCCcchhhhhhcc-------CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeE
Confidence             55679999874 466899999875       56999999999999999999999998   9999999999999999999


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCc
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIE  271 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~  271 (398)
                      ||+|||.|.....+.    ....+||.+|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       710 klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999998765543    246789999999999998876 667899999999999999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=6.7e-31  Score=224.34  Aligned_cols=262  Identities=23%  Similarity=0.315  Sum_probs=193.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCC-cEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQ-GLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-~~~lV  136 (398)
                      .++|++.+.+|+|-|+.||.|....++++++||+++..   ..+.+.+|+.+|..+. ||||+++++...++.. ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46888899999999999999998888999999999754   3456889999999997 9999999998877654 35799


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla  215 (398)
                      +||+.+.+...+..          .++...+..++.+++.||.|+|+.|   |+|||+||.|++||. .-.++|+|+|+|
T Consensus       114 FE~v~n~Dfk~ly~----------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP----------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             hhhhccccHHHHhh----------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchH
Confidence            99999988766653          4777788889999999999999988   999999999999995 467999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH----Hh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI----LH  290 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~----~~  290 (398)
                      .+......   ....+.+..|--||.+... .|..+-|+|||||+|..|+..+.||-..... ..+++..++-+    +.
T Consensus       181 EFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~  256 (338)
T KOG0668|consen  181 EFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELY  256 (338)
T ss_pred             hhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHH
Confidence            98766542   2334567778899998765 4788999999999999999999998643322 12233222110    00


Q ss_pred             hchhhhhhhcCcccCC---------------CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          291 RGMAAVEELLDPRLKC---------------TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~---------------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .......--+||++..               .....-...+.++++-..|..|-.+|||++|...
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0000000012222110               0000011234667777899999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-32  Score=259.96  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=204.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .+|.....+|+|.||-|||+++..+++..|+|+++........-+..|+-+++..+||||+.++|.+...+. ++++|||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-lwicMEy   93 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-LWICMEY   93 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-cEEEEEe
Confidence            688889999999999999999999999999999998877778888899999999999999999998877544 8999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      |-+|+|.+.-+-.       .++++.++...++..++||+|||+.+   -+|||||-.||++++.+.+|++|||.+-.+.
T Consensus        94 cgggslQdiy~~T-------gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   94 CGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             cCCCcccceeeec-------ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence            9999998877653       67999999999999999999999988   9999999999999999999999999987665


Q ss_pred             CCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ..-.  ......||+.|||||+..   .+.|..++|||+.|+...|+---++|-....+..  .+...           -
T Consensus       164 ati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~Lm-----------T  228 (829)
T KOG0576|consen  164 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLM-----------T  228 (829)
T ss_pred             hhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHh-----------h
Confidence            4322  234678999999999874   5678999999999999999988888854433221  11110           1


Q ss_pred             hhhc-CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELL-DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~-d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .... .|.++......+.+-.   ++..|+-++|++||+.+.+++
T Consensus       229 kS~~qpp~lkDk~kws~~fh~---fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  229 KSGFQPPTLKDKTKWSEFFHN---FVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccCCCCCcccCCccchHHHHH---HHHHHhcCCCccCCChhhhee
Confidence            1112 2344444444444444   445699999999999998765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=5.5e-31  Score=247.79  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=204.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC------CCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH------HPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~  132 (398)
                      ...|.+....|+|-|++|.+|.+...|..||||+|..... -.+.=+.|+++|.+|+      --|.++|+..|.. .+.
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-knH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-KNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-cce
Confidence            4567777778999999999999988899999999986532 2344568999999985      3478888887665 455


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeEec
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCD  211 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~D  211 (398)
                      +|||+|.+ ..+|.++|.....    +..|....+..++.|+.-||..|-..+   |+|.||||.|||+++. ..+||||
T Consensus       509 LClVFE~L-slNLRevLKKyG~----nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGR----NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCc----ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeecc
Confidence            99999999 7799999998654    367889999999999999999999988   9999999999999976 4679999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH----
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP----  287 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~----  287 (398)
                      ||.|.....+..    +...-+..|.|||++.+-.|+...|+||.||+||||.||+..|.+.+......+..-.+.    
T Consensus       581 fGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  581 FGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             Cccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            999987765542    233446679999999999999999999999999999999999988765543333222111    


Q ss_pred             -HHhhchhhhhhhcC--------------------------c------cc----CCCCCCHHHHHHHHHHHHhcccccCC
Q 015931          288 -ILHRGMAAVEELLD--------------------------P------RL----KCTSRNSAQIARVIQAAAACISSEES  330 (398)
Q Consensus       288 -~~~~~~~~~~~~~d--------------------------~------~l----~~~~~~~~~~~~l~~l~~~cl~~~p~  330 (398)
                       ++..+. -...-+|                          |      .+    ..+......+..|.+|+-.||..||+
T Consensus       657 KmlRKgq-F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  657 KMLRKGQ-FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHhhhcc-hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence             111110 0000011                          1      01    01223445567788999999999999


Q ss_pred             CCCCHHHHHH
Q 015931          331 RRPGIEEIIA  340 (398)
Q Consensus       331 ~RPt~~evl~  340 (398)
                      +|.|..+.|+
T Consensus       736 KRit~nqAL~  745 (752)
T KOG0670|consen  736 KRITVNQALK  745 (752)
T ss_pred             hcCCHHHHhc
Confidence            9999998876

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-30  Score=228.55  Aligned_cols=260  Identities=22%  Similarity=0.332  Sum_probs=196.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----Cc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  132 (398)
                      .+|...+.+|.|.- .|..+.+.-.++.||+|+....  .....++..+|...+..+.|+||++++.++.-..     ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777788999988 7888888778899999988543  2334566779999999999999999998764221     23


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|+|||+| ..+|...+...         ++-+++..|..|++.|++|||+.+   |+||||||+||++..+..+||.||
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e---------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME---------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh---------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccc
Confidence            78999999 77999998743         778889999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh------
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK------  286 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~------  286 (398)
                      |+|+.-+..   ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+...     +.+|.+      
T Consensus       163 g~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lg  234 (369)
T KOG0665|consen  163 GLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLG  234 (369)
T ss_pred             hhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhc
Confidence            999865433   234556789999999999988899999999999999999999998875433     333322      


Q ss_pred             --------HHHhhchhh-----------hhhh-cCcccCC-CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          287 --------PILHRGMAA-----------VEEL-LDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       287 --------~~~~~~~~~-----------~~~~-~d~~l~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                              .+...+..-           ..+. -|..+.. ............+++.+||-.+|++|-++.++|+.
T Consensus       235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                    111111000           0000 1111110 01111233445677889999999999999999873

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-30  Score=224.80  Aligned_cols=255  Identities=20%  Similarity=0.336  Sum_probs=190.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .+.|.+.+.||+|.||.+-++.++.+.+.+++|.+...- ....+|.+|...--.+ .|.||+.-+++.++..+...+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            368999999999999999999999999999999987542 3457899998765555 59999999998888777778999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC--CCCCeeEeccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKLCDFGLA  215 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DfGla  215 (398)
                      ||+|.|+|...+..        ..+-+....+++.|+++|+.|+|+.+   +||||||.+||||-  +..++||||||+.
T Consensus       102 E~aP~gdL~snv~~--------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA--------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             ccCccchhhhhcCc--------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccc
Confidence            99999999988865        34778888999999999999999998   99999999999994  4458999999998


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhcc---C--CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQH---G--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      +..+..     ......+..|.+||....   +  ...+.+|||.||+++|.++||..||......+ .  ..|.+..+.
T Consensus       171 ~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~--~Y~~~~~w~  242 (378)
T KOG1345|consen  171 RKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-K--PYWEWEQWL  242 (378)
T ss_pred             cccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-c--hHHHHHHHh
Confidence            754321     223445667999997643   2  35788999999999999999999998433222 2  223333333


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      ++.       .+.+...  ......+++++-.+-+.++|++|=.+.++-++-
T Consensus       243 ~rk-------~~~~P~~--F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  243 KRK-------NPALPKK--FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccc-------CccCchh--hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            331       1122110  111122344444567888998886666665543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=2.1e-28  Score=226.12  Aligned_cols=201  Identities=27%  Similarity=0.364  Sum_probs=164.4

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCC---CCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCc
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  132 (398)
                      ...+.|...++||+|.|++||++.+..   .+..||+|.+...+  ....+.+|+++|..+. +.||+++.+++. .++.
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r-nnd~  109 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR-NNDQ  109 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc-cCCe
Confidence            345678899999999999999998866   67889999997653  3356889999999985 899999998654 4556


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeEec
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCD  211 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~D  211 (398)
                      +.+|+||+++....++...          ++...+..++..++.||.++|.+|   ||||||||+|+|.+.. +.-.|.|
T Consensus       110 v~ivlp~~~H~~f~~l~~~----------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS----------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             eEEEecccCccCHHHHHhc----------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence            8999999999998888854          778889999999999999999999   9999999999999854 6678999


Q ss_pred             cccccccCCC-------------CCc-----------------------------eeeeccccCCCcccchhhccC-CcC
Q 015931          212 FGLATWTSAP-------------SVP-----------------------------FLCKTVKGTFGYLAPEYFQHG-KVS  248 (398)
Q Consensus       212 fGla~~~~~~-------------~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~s  248 (398)
                      ||+|...+..             ...                             ......+||+||.|||++... ..+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            9999621100             000                             001135699999999998764 568


Q ss_pred             CccchhhHHHHHHHHHcCCCCCccc
Q 015931          249 DKTDVYAFGVVLLELLTGRKPIEAR  273 (398)
Q Consensus       249 ~ksDv~S~Gvvl~elltG~~Pf~~~  273 (398)
                      ++.||||.||+++-+++++.||...
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             CccceeeccceeehhhccccccccC
Confidence            9999999999999999999998643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=6.2e-29  Score=262.83  Aligned_cols=196  Identities=20%  Similarity=0.258  Sum_probs=137.7

Q ss_pred             CCC-CCeeceeeEEEc------CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 015931          114 LHH-PNIVPLVGFCID------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE  186 (398)
Q Consensus       114 l~h-~niv~l~~~~~~------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~  186 (398)
                      ++| +||++++++|..      ....++.++|++ +++|.+++....      ..+++..++.++.||++||.|||+++ 
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~g-  100 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD------RSVDAFECFHVFRQIVEIVNAAHSQG-  100 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc------ccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence            344 577777776511      123467788987 779999997532      45999999999999999999999988 


Q ss_pred             CceeecccccCcEEeCC-------------------CCCeeEeccccccccCCCCC--------------ceeeeccccC
Q 015931          187 RCVVHRDIKPSNILLSS-------------------KKIPKLCDFGLATWTSAPSV--------------PFLCKTVKGT  233 (398)
Q Consensus       187 ~~ivHrDlkp~NIll~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt  233 (398)
                        |+||||||+||||+.                   ++.+|++|||+++.......              ........||
T Consensus       101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence              999999999999954                   44566777777654221000              0001124588


Q ss_pred             CCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHH
Q 015931          234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQ  313 (398)
Q Consensus       234 ~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  313 (398)
                      +.|+|||++.+..++.++|||||||+||||++|..|+.....    ....    .       ....+.+..      ...
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~----~-------~~~~~~~~~------~~~  237 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS----L-------RHRVLPPQI------LLN  237 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH----H-------HHhhcChhh------hhc
Confidence            999999999999999999999999999999999888653211    0000    0       001111111      111


Q ss_pred             HHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          314 IARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       314 ~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ......++.+||+++|.+||++.||++
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            233456778899999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.8e-27  Score=206.11  Aligned_cols=166  Identities=25%  Similarity=0.298  Sum_probs=124.4

Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |+|.+++....      ..++|..++.|+.|++.||.|||+.+         ||+|||++.++.+|+  ||++.......
T Consensus         1 GsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~   63 (176)
T smart00750        1 VSLADILEVRG------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ   63 (176)
T ss_pred             CcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc
Confidence            78999997642      46999999999999999999999865         999999999999999  99988664422


Q ss_pred             CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCc
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  302 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  302 (398)
                             ..||+.|+|||++.+..++.++|||||||++|||+||+.||........ .+..    ....    .... ++
T Consensus        64 -------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~----~~~~----~~~~-~~  126 (176)
T smart00750       64 -------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEI----LLNG----MPAD-DP  126 (176)
T ss_pred             -------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHH----HHHH----hccC-Cc
Confidence                   2588999999999999999999999999999999999999965432110 0100    0000    0000 00


Q ss_pred             ccCCCCCCHHHH--HHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          303 RLKCTSRNSAQI--ARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       303 ~l~~~~~~~~~~--~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .-  ........  ..+.+++.+||+.+|.+||++.++++.+..
T Consensus       127 ~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      127 RD--RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cc--cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            00  00111111  258889999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=7.1e-26  Score=215.30  Aligned_cols=178  Identities=19%  Similarity=0.180  Sum_probs=135.2

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCC-CCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  129 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  129 (398)
                      ....++|...+.||+|+||+||+|.+.. +++.||||++...     .......|.+|+++|.+++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3446789999999999999999998865 5777899987533     223356689999999999999999643221   


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccc-ccCcEEeCCCCCee
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI-KPSNILLSSKKIPK  208 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDl-kp~NIll~~~~~~k  208 (398)
                       +..++||||++|++|... ..          ..   ...++.|+++||.|||+.+   |+|||| ||+|||++.++.+|
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~----------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RP----------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cc----------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence             236999999999999622 11          01   1357889999999999988   999999 99999999999999


Q ss_pred             EeccccccccCCCCCcee------eeccccCCCcccchhhccCC------cCCccchh
Q 015931          209 LCDFGLATWTSAPSVPFL------CKTVKGTFGYLAPEYFQHGK------VSDKTDVY  254 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~s~ksDv~  254 (398)
                      |+|||+|+.+........      .+...+++.|+|||++....      .+..+|-|
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999987654321111      13567888999999986432      23346666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.9e-24  Score=204.05  Aligned_cols=261  Identities=21%  Similarity=0.252  Sum_probs=191.4

Q ss_pred             CCCCCceecccCceEEEEeeeCCCC-cEEEEEEecCCChhhHHHHHHHHHHHHhCCC----CCeeceeeEEEcCCCcEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHH----PNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~l  135 (398)
                      +|...+.||+|+||.||.+.....+ ..+|+|............+..|+.++..+..    +++..+++.....+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999987653 5788888766533322367788888888863    5788888765334555789


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-----CCeeEe
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLC  210 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~  210 (398)
                      ||+.+ |.+|.++.....     ...++..+...|+.|++.+|++||+.+   ++||||||.|+.+...     ..+.|.
T Consensus        99 VM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             EEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEE
Confidence            99998 999999886543     257999999999999999999999988   9999999999999754     468999


Q ss_pred             cccccc--ccCCCCCc----e-e-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          211 DFGLAT--WTSAPSVP----F-L-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       211 DfGla~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                      |||+++  ........    . . .....||..|.++....+...+.+.|+||++.++.|++.|..||............
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999998  33222110    0 1 12355999999999999999999999999999999999999999654432211100


Q ss_pred             HHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          283 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .   ..      ........   .....+.+...+...   +-..+...+|....+...|+..
T Consensus       250 ~---~~------~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  250 E---KD------PRKLLTDR---FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             H---HH------hhhhcccc---ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHH
Confidence            0   00      00001111   112234455554443   4457999999999999887653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=5.7e-23  Score=193.07  Aligned_cols=258  Identities=33%  Similarity=0.476  Sum_probs=193.6

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh---hHHHHHHHHHHHHhCCCC-CeeceeeEEEcCCCcEEEEE
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---SSKAFCRELMIASSLHHP-NIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~lV~  137 (398)
                      |.....||.|+||.||++...   ..+++|.+......   ....+.+|+..+..+.|+ +++++.+.+.. ....++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEE
Confidence            566788999999999999887   67999998765332   467899999999999988 79999998744 34468999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DfGla~  216 (398)
                      +++.++++.+++......    ..++......+..|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.+.
T Consensus        78 ~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             ecCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            999999999776653210    25889999999999999999999988   99999999999999988 79999999998


Q ss_pred             ccCCCCCce----eeeccccCCCcccchhhcc---CCcCCccchhhHHHHHHHHHcCCCCCcccccc-cchhHHHHhhHH
Q 015931          217 WTSAPSVPF----LCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ-GEENLVLWAKPI  288 (398)
Q Consensus       217 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~  288 (398)
                      .........    ......||..|+|||.+..   ...+...|+||+|++++++++|..||...... .......     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~-----  225 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK-----  225 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH-----
Confidence            655433221    2356789999999999987   57889999999999999999999997654421 0000000     


Q ss_pred             HhhchhhhhhhcCcccCCCCCC---HHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          289 LHRGMAAVEELLDPRLKCTSRN---SAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                            .+.....+........   ......+.+++..|+..+|..|.+..+....
T Consensus       226 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 ------IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ------HHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                  0111111100000000   1122456677778999999999999987764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=8.1e-25  Score=221.11  Aligned_cols=255  Identities=23%  Similarity=0.246  Sum_probs=187.3

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEec----C-CChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD----K-EDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ....++|.|++|.|+........+..+.|...    . .... ....+..|+.+-..+.|||++..+..+.+.... +-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-LQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-hhh
Confidence            45678999999988887766555555555443    1 1111 112266677777889999998888776665553 445


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||++ +|..++...       ..+....+-.++.|++.|++|+|+.+   |.|||+|++|+++..++.+||+|||.+.
T Consensus       400 mE~~~~-Dlf~~~~~~-------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~  468 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSN-------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAAS  468 (601)
T ss_pred             hhcccH-HHHHHHhcc-------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcce
Confidence            999999 999999764       34788888899999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCc--eeeeccccCCCcccchhhccCCcCC-ccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVP--FLCKTVKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      .+..+...  .......|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......+... ..      ..+ 
T Consensus       469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~------~~~-  540 (601)
T KOG0590|consen  469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT------NNY-  540 (601)
T ss_pred             eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh------hcc-
Confidence            77655443  4456788999999999999988876 5899999999999999999998655443211 00      000 


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ..-.+..................++.++|+.+|.+|-|+.+|++
T Consensus       541 ---~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  541 ---SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ---ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence               00000000000011223344567788999999999999999987

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.1e-24  Score=187.21  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=182.9

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      ..+|.+...|..|+|++.  |..+++|++...  .....+.|..|.-.|+-+.||||+.++|.|..+.+ +.++..||+.
T Consensus       195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn-lv~isq~mp~  271 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN-LVIISQYMPF  271 (448)
T ss_pred             hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC-ceEeeeeccc
Confidence            346788899999999997  445666877543  33445678899999998999999999999988755 7899999999


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCC
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |+|...++....     ...+-.++.+++.++|+|++|||+.. +-|.---|.+..|++|++.+++|+- +-+++     
T Consensus       272 gslynvlhe~t~-----vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf-----  339 (448)
T KOG0195|consen  272 GSLYNVLHEQTS-----VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----  339 (448)
T ss_pred             hHHHHHHhcCcc-----EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----
Confidence            999999998643     56788899999999999999999975 3344446899999999999888752 11111     


Q ss_pred             CceeeeccccCCCcccchhhccCCc---CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHGKV---SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                       ..........+.||+||.+...+.   -.++|+|||.+++|||.|...||....+-+..      ..+       -.+-
T Consensus       340 -sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mki-------aleg  405 (448)
T KOG0195|consen  340 -SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKI-------ALEG  405 (448)
T ss_pred             -eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhh-------hhcc
Confidence             111223456788999999987653   34799999999999999999999875542210      000       1111


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      +...  .++..+..+.+++.   -|...||.+||.+..|+-+|+..
T Consensus       406 lrv~--ippgis~hm~klm~---icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  406 LRVH--IPPGISRHMNKLMN---ICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cccc--CCCCccHHHHHHHH---HHhcCCCCcCCCcceehhhHHHh
Confidence            2222  23344444445554   59999999999999999998753

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=2.9e-23  Score=184.18  Aligned_cols=172  Identities=16%  Similarity=0.158  Sum_probs=132.5

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhH---HH------HHHHHHHHHhCCCCCeeceeeEEEc
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KA------FCRELMIASSLHHPNIVPLVGFCID  128 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~niv~l~~~~~~  128 (398)
                      ..++|...++||.|+||.||.+..  ++..+|+|.+........   ..      +.+|+..+.++.|++|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            358999999999999999999755  366899999975432222   22      6789999999999999999988654


Q ss_pred             CC-------CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          129 PE-------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       129 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                      ..       +..++||||++|.+|.++..           ++.    ....+++.+|..+|+.+   ++|||+||+||++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili  168 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIV  168 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEE
Confidence            32       34689999999999977632           222    24558999999999988   9999999999999


Q ss_pred             CCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHH
Q 015931          202 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL  264 (398)
Q Consensus       202 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ell  264 (398)
                      ++++ ++|+|||...........              ..++....+..++|+||||+++..+.
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9988 999999987655322210              11334445667999999999887664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=8.4e-23  Score=176.18  Aligned_cols=206  Identities=21%  Similarity=0.227  Sum_probs=165.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCC-CCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||-+|.|....+|..||+|.-.....  ..++..|..+...+++ ..|..+..| ......-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-GTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-ccccccceeee
Confidence            3689999999999999999999999999999998765433  2456778888888876 344444444 33345567999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeEecccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGL  214 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DfGl  214 (398)
                      +.+ |.||++++.-..      ..++..+.+-++-|++.-++|+|..+   .+||||||+|+|..-   ...+.++|||+
T Consensus        91 dLL-GPsLEdLfnfC~------R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS------RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             ecc-CccHHHHHHHHh------hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccc
Confidence            999 999999998765      35888999999999999999999888   999999999999863   34689999999


Q ss_pred             ccccCCCCCce-----eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc
Q 015931          215 ATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  277 (398)
Q Consensus       215 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~  277 (398)
                      |+.+-+.....     ..+...||..|.+--...+...+.+.|+-|+|.+|..+.-|..||.+-....
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t  228 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT  228 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence            98765432221     1234679999999887777778889999999999999999999998765543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=1.2e-22  Score=177.82  Aligned_cols=141  Identities=13%  Similarity=0.109  Sum_probs=108.8

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChh--h-------H-----------------HHHHHHHHHHHhCCCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--S-------S-----------------KAFCRELMIASSLHHPN  118 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n  118 (398)
                      ...||+|+||.||+|.+. +|+.||||++......  .       .                 .....|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999987 7999999999754211  0       1                 12235999999998877


Q ss_pred             eeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceeecccccC
Q 015931          119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL-HNGTERCVVHRDIKPS  197 (398)
Q Consensus       119 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~ivHrDlkp~  197 (398)
                      +.....+..  .. .++||||++++++.......       ..+++..+..++.|++.+|.|+ |+.+   |+||||||+
T Consensus        81 v~~p~~~~~--~~-~~iVmE~i~g~~l~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~  147 (190)
T cd05147          81 IPCPEPILL--KS-HVLVMEFIGDDGWAAPRLKD-------APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY  147 (190)
T ss_pred             CCCCcEEEe--cC-CEEEEEEeCCCCCcchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence            644333221  22 37999999888776553322       4588999999999999999999 6777   999999999


Q ss_pred             cEEeCCCCCeeEeccccccccCC
Q 015931          198 NILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ||+++ ++.++|+|||+|.....
T Consensus       148 NIli~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             HEEEE-CCcEEEEEccccccCCC
Confidence            99998 47899999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=6.3e-22  Score=178.05  Aligned_cols=204  Identities=23%  Similarity=0.320  Sum_probs=168.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .-.|.++++||+|+||..+.|+.--+++.||||.-...  ....++..|....+.+. .++|-..+-+..++. +-.||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-YNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccc-hhhhhh
Confidence            35799999999999999999999888999999976543  23356677877777764 678887775544443 346999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-----CCeeEecc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLCDF  212 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~Df  212 (398)
                      |.+ |.||++++.-..      ..++.+++.-+|.|++.-++|+|++.   +|.|||||+|+||...     ..+.++||
T Consensus       104 dLL-GPSLEDLFD~Cg------R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCG------RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             hhh-CcCHHHHHHHhc------CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEec
Confidence            999 999999998664      46999999999999999999999988   9999999999999643     35899999


Q ss_pred             ccccccCCCCCcee-----eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          213 GLATWTSAPSVPFL-----CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       213 Gla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      |+|+.+.++.....     .....||..||+-....+...+.+.|.-|+|-+++..+-|..||.+-..
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            99998766543321     1346799999999988888899999999999999999999999987543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.5e-21  Score=171.19  Aligned_cols=142  Identities=15%  Similarity=0.144  Sum_probs=111.7

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChh--------------------------hHHHHHHHHHHHHhCCCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--------------------------SSKAFCRELMIASSLHHPN  118 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n  118 (398)
                      ...||+|+||.||+|.+. +|+.||||++......                          ....+..|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 7999999999764211                          0122457889999999998


Q ss_pred             eeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccC
Q 015931          119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPS  197 (398)
Q Consensus       119 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~  197 (398)
                      +.....+...  . .++||||++++++.......       ..++......++.|++.++.++|+ .+   |+||||||+
T Consensus        81 i~~p~~~~~~--~-~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~  147 (190)
T cd05145          81 VPVPEPILLK--K-NVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEY  147 (190)
T ss_pred             CCCceEEEec--C-CEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChh
Confidence            7555444332  2 37999999888654432221       347788899999999999999999 77   999999999


Q ss_pred             cEEeCCCCCeeEeccccccccCCC
Q 015931          198 NILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      ||+++ ++.++|+|||++.....+
T Consensus       148 NIll~-~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         148 NILYH-DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             hEEEE-CCCEEEEEcccceecCCC
Confidence            99999 789999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=8.8e-22  Score=179.86  Aligned_cols=239  Identities=19%  Similarity=0.248  Sum_probs=150.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCC----------CCeeceeeEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHH----------PNIVPLVGFCI  127 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  127 (398)
                      .+..+..||.|+++.||.+++..+++.+|||++....   ....+++.+|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3445678999999999999999999999999885432   2345666666655544322          11222222111


Q ss_pred             -cC-------C--C------cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceee
Q 015931          128 -DP-------E--Q------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH  191 (398)
Q Consensus       128 -~~-------~--~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH  191 (398)
                       .+       .  .      ..+++|+-+ .++|.+++..-.........+....++.+..|+++.+++||+.+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence             10       0  0      136778777 67998886642211111233556667788899999999999999   999


Q ss_pred             cccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc--------CCcCCccchhhHHHHHHHH
Q 015931          192 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--------GKVSDKTDVYAFGVVLLEL  263 (398)
Q Consensus       192 rDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~S~Gvvl~el  263 (398)
                      +||+|+|++++.+|.++|+||+.....+...     .....+..|.+||....        -.++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999876554311     11345577999997743        2478899999999999999


Q ss_pred             HcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCC
Q 015931          264 LTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR  332 (398)
Q Consensus       264 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~R  332 (398)
                      ++|+.||....+......                     .+. .  +....+.+-.|+..+|+.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~---------------------~f~-~--C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW---------------------DFS-R--CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG---------------------GGT-T--SS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc---------------------cch-h--cCCcCHHHHHHHHHHccCCcccC
Confidence            999999986544321110                     111 1  11333445566678999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=4.2e-21  Score=166.94  Aligned_cols=190  Identities=17%  Similarity=0.105  Sum_probs=142.0

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh----hHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE----SSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .....|++|+||+||.+..  .+.+++.+.+.....-    ....+.+|+++|.++. |+++.+++++    + ..+++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~-~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D-GRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c-CEEEEE
Confidence            4567899999999997765  4778887777654331    1225789999999995 5889999886    2 268999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccc-ccCcEEeCCCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI-KPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||+.|.+|...+..        .      ...++.|++.+|.++|+++   |+|||| ||+|||++.++.++|+|||++.
T Consensus        78 eyI~G~~L~~~~~~--------~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         78 SYLAGAAMYQRPPR--------G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             eeecCccHHhhhhh--------h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            99999998654321        0      1347789999999999988   999999 7999999999999999999998


Q ss_pred             ccCCCCCc----e---e----eeccccCCCcccchhhccC-CcC-CccchhhHHHHHHHHHcCCCCCcccccc
Q 015931          217 WTSAPSVP----F---L----CKTVKGTFGYLAPEYFQHG-KVS-DKTDVYAFGVVLLELLTGRKPIEARRLQ  276 (398)
Q Consensus       217 ~~~~~~~~----~---~----~~~~~gt~~y~aPE~~~~~-~~s-~ksDv~S~Gvvl~elltG~~Pf~~~~~~  276 (398)
                      ........    .   .    .....+++.|++|+...-- ..+ ...+.++-|.-+|.++|++.|...++..
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence            65543210    0   0    0123467888888754322 233 4678999999999999999998766543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=8.3e-21  Score=167.83  Aligned_cols=137  Identities=20%  Similarity=0.214  Sum_probs=107.8

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-----CCCCeeceeeEEEcCCC--cEE
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-----HHPNIVPLVGFCIDPEQ--GLF  134 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~--~~~  134 (398)
                      .+..++||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     +||||++++|++....+  .++
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34567899999999996  6555555 69998765445567899999999999     57999999999876542  333


Q ss_pred             -EEEec--CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCceeecccccCcEEeCC----CCC
Q 015931          135 -LIYKY--VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV-AYLHNGTERCVVHRDIKPSNILLSS----KKI  206 (398)
Q Consensus       135 -lV~e~--~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~ivHrDlkp~NIll~~----~~~  206 (398)
                       +|+||  +++|+|.+++...        .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +..
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCc
Confidence             78999  6679999999652        25555  35677888777 9999988   999999999999974    348


Q ss_pred             eeEecccc
Q 015931          207 PKLCDFGL  214 (398)
Q Consensus       207 ~kl~DfGl  214 (398)
                      ++|+||+.
T Consensus       148 ~~LiDg~G  155 (210)
T PRK10345        148 PVVCDNIG  155 (210)
T ss_pred             EEEEECCC
Confidence            99999543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=4.5e-22  Score=202.30  Aligned_cols=252  Identities=23%  Similarity=0.295  Sum_probs=178.8

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHH--HHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMI--ASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++...+.||++.|=+|.+|+++. |. |+||++-+.. .-..+.|.++++-  ...++|||.+++.-+ ...+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-LVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-HHhhHHHHHHH
Confidence            67778899999999999999875 54 8999986654 2233444433322  455689999998776 44455568898


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      +|..+ +|.+.+..+       .-+..-+..-|+.|++.||..+|..+   |+|+|||.+||||+.=.-+.|+||...+.
T Consensus       101 qyvkh-nLyDRlSTR-------PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTR-------PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHhh-hhhhhhccc-------hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence            99844 898888764       44667777779999999999999988   99999999999999999999999987653


Q ss_pred             cC--CCC---CceeeeccccCCCcccchhhccC-----------CcCCccchhhHHHHHHHHHc-CCCCCcccccccchh
Q 015931          218 TS--APS---VPFLCKTVKGTFGYLAPEYFQHG-----------KVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  280 (398)
Q Consensus       218 ~~--~~~---~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  280 (398)
                      .-  +++   ......+...-.+|+|||.+...           ..+++.||||+||++.||++ |++||.....     
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----  244 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----  244 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----
Confidence            22  211   11112233344579999988542           26789999999999999998 7899875321     


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       ..+...........+.++-|.             .+..+++.|++.||.+|-++++.|+.-+|.
T Consensus       245 -~aYr~~~~~~~e~~Le~Ied~-------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  245 -LAYRSGNADDPEQLLEKIEDV-------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -HhHhccCccCHHHHHHhCcCc-------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence             111000000000012222222             355677889999999999999999986664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=4.8e-21  Score=185.70  Aligned_cols=216  Identities=26%  Similarity=0.444  Sum_probs=160.7

Q ss_pred             HHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015931          111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVV  190 (398)
Q Consensus       111 l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iv  190 (398)
                      |+.+.|.|+.+++|.+.++. ..++|.+||..|+|.+.+....      ..++|.....+..+++.||.|||+..  ...
T Consensus         1 l~~l~h~n~~~f~g~~~~~~-~~~~i~~~c~rGsl~D~i~~~~------~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP-EMIVIWEYCSRGSLLDILSNED------IKLDYFFILSFIRDISKGLAYLHNSP--IGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecCC-ceEEEEeeecCccHHhHHhccc------cCccHHHHHHHHHHHHHHHHHHhcCc--cee
Confidence            35688999999999999984 4789999999999999998743      57999999999999999999999854  239


Q ss_pred             ecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccC-------CcCCccchhhHHHHHHHH
Q 015931          191 HRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-------KVSDKTDVYAFGVVLLEL  263 (398)
Q Consensus       191 HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~S~Gvvl~el  263 (398)
                      |+.+++.|.++|..+.+||+|||+.................-..-|.|||.+...       ..+.++||||||++++|+
T Consensus        72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            9999999999999999999999998766431111111122244569999998753       146789999999999999


Q ss_pred             HcCCCCCcccccccch-hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          264 LTGRKPIEARRLQGEE-NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       264 ltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      ++.+.||......... .++.....   .    -...+.|.+...  . +....++.++..||..+|.+||++.+|-..+
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~---~----~~~~~rP~i~~~--~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~  221 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKK---G----GSNPFRPSIELL--N-ELPPELLLLVARCWEEIPEKRPSIEQIRSKL  221 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHh---c----CCCCcCcchhhh--h-hcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence            9999999875443322 22222111   0    111122222211  0 2223688889999999999999999999888


Q ss_pred             hcC
Q 015931          343 RGE  345 (398)
Q Consensus       343 ~~~  345 (398)
                      +..
T Consensus       222 ~~~  224 (484)
T KOG1023|consen  222 LTI  224 (484)
T ss_pred             hhh
Confidence            654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=6e-22  Score=192.21  Aligned_cols=187  Identities=29%  Similarity=0.368  Sum_probs=152.2

Q ss_pred             eecccCceEEEEeee---CCCCcEEEEEEecCCChh--hHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEEecC
Q 015931           67 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      ++|+|.||.|+.+.-   .+.+..+|+|++.+....  .......|..++..++ ||.+|++.. +++.+...+++.++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhy-afqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHY-AFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeee-eeccccchhHhhhhc
Confidence            379999999997542   345777999988764221  1114456777888887 999999875 455666789999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      .+|.|...+...       ..+.+.....+...++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-.
T Consensus        80 rgg~lft~l~~~-------~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   80 RGGDLFTRLSKE-------VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             ccchhhhccccC-------CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh
Confidence            999998888764       34666667777788999999999988   99999999999999999999999999986654


Q ss_pred             CCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                      ...      .+||..|||||++.  .....+|.||||++.+||+||..||..
T Consensus       150 ~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  150 EKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            332      27999999999998  567889999999999999999999986

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=7.2e-20  Score=189.26  Aligned_cols=201  Identities=20%  Similarity=0.189  Sum_probs=155.2

Q ss_pred             HHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCCeeceeeEEEcCC
Q 015931           54 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPE  130 (398)
Q Consensus        54 e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  130 (398)
                      ++......|.+.+.||+|+||+||+|...+ |+.||+|+-+......   |.--.+++.+|+   -+-|..+...+.-.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            344556788999999999999999999987 9999999876554321   222223333333   122333333222223


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-------C
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-------S  203 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-------~  203 (398)
                       ..+||+||.+.|+|.+++...       ..++|.....++.|++..++.||..+   |||+||||+|+||.       +
T Consensus       768 -~S~lv~ey~~~Gtlld~~N~~-------~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  768 -ASVLVSEYSPYGTLLDLINTN-------KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             -cceeeeeccccccHHHhhccC-------CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCc
Confidence             357999999999999999843       57999999999999999999999988   99999999999993       3


Q ss_pred             CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCC
Q 015931          204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP  269 (398)
Q Consensus       204 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~P  269 (398)
                      +..++|+|||.+-.+.--........+.+|-++-.+|...+..++..+|.|.|..+++-|+.|+.-
T Consensus       837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            446899999998654322222345677899999999999999999999999999999999999753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=9.2e-20  Score=185.41  Aligned_cols=171  Identities=31%  Similarity=0.478  Sum_probs=127.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ..+|...++|..|+||.||...++.+.+.+|+| +.+.+.           +++     ||..+-+      + .+.|  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----------ilR-----nilt~a~------n-pfvv--  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----------ILR-----NILTFAG------N-PFVV--  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----------hhh-----ccccccC------C-ccee--
Confidence            478999999999999999999999899999994 433211           111     1222211      1 2233  


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                          |+-...++..       ++++-..        +.+++|||+.+   |+|||+||+|.+|..-|++|++|||+.+..
T Consensus       136 ----gDc~tllk~~-------g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 ----GDCATLLKNI-------GPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ----chhhhhcccC-------CCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence                3434444332       2333332        78899999988   999999999999999999999999998643


Q ss_pred             CCCC-------------CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc
Q 015931          219 SAPS-------------VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  277 (398)
Q Consensus       219 ~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~  277 (398)
                      ....             .......++||+.|.|||++....|....|+|++|+++||.+-|..||.++.+.+
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee  265 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE  265 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence            2110             0112245689999999999999999999999999999999999999999887653

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=9.6e-19  Score=158.26  Aligned_cols=147  Identities=14%  Similarity=0.105  Sum_probs=111.9

Q ss_pred             hcCCCCCceecccCceEEEEee-eCCCCcEEEEEEecCCChh------------------------hHHHHHHHHHHHHh
Q 015931           59 THNFSKGRVLGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKE------------------------SSKAFCRELMIASS  113 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  113 (398)
                      ..-|...+.||+|+||.||+|. ...+|+.||+|++......                        ....+..|+..+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458888999999999999998 5567999999998754210                        11235689999999


Q ss_pred             CCCCC--eeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceee
Q 015931          114 LHHPN--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH  191 (398)
Q Consensus       114 l~h~n--iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH  191 (398)
                      +.+.+  +.+++++    .. .++||||+++++|.......       ..+.......++.|++.+|.+||+.+  .++|
T Consensus       107 L~~~~i~~p~~~~~----~~-~~lV~E~~~g~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH  172 (237)
T smart00090      107 LYEAGVPVPKPIAW----RR-NVLVMEFIGGDGLPAPRLKD-------VEPEEEEEFELYDDILEEMRKLYKEG--ELVH  172 (237)
T ss_pred             HHhcCCCCCeeeEe----cC-ceEEEEEecCCccccccccc-------CCcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence            97533  3334432    22 47999999998886654321       23556667889999999999999654  2999


Q ss_pred             cccccCcEEeCCCCCeeEeccccccccCC
Q 015931          192 RDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       192 rDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      |||||+||+++ ++.++|+|||.+.....
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            99999999999 88999999999875543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.4e-18  Score=153.43  Aligned_cols=134  Identities=25%  Similarity=0.389  Sum_probs=110.8

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      +.||+|++|.||+|..  .+..+++|+......        .....+.+|+.++..++|+++.....++.+.+. .++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-FIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-CEEEE
Confidence            5799999999999987  367899998654321        112457789999999999998877777665444 68999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||++|++|.+.+...          .+ .+..++.+++.+|.++|+.+   ++|+|++|.||+++ ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999998642          12 78889999999999999988   99999999999999 78999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=3.6e-18  Score=150.86  Aligned_cols=146  Identities=18%  Similarity=0.124  Sum_probs=112.2

Q ss_pred             HHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh----------------------hhHHHHHHHHHH
Q 015931           53 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----------------------ESSKAFCRELMI  110 (398)
Q Consensus        53 ~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~  110 (398)
                      +++......|...+.||+|+||.||++... +|+.||||++.....                      .....+..|..+
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            345555556888899999999999999886 689999998764321                      011235678888


Q ss_pred             HHhCCCCC--eeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 015931          111 ASSLHHPN--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC  188 (398)
Q Consensus       111 l~~l~h~n--iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~  188 (398)
                      +..+.|++  +...++.     ...++||||+++++|......             .....++.+++.++.++|+.+   
T Consensus        87 l~~l~~~~i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh~~g---  145 (198)
T cd05144          87 LKALYEEGFPVPKPIDW-----NRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAYKHG---  145 (198)
T ss_pred             HHHHHHcCCCCCceeec-----CCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHHHCC---
Confidence            88888774  4444432     235899999999998765321             234578899999999999987   


Q ss_pred             eeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          189 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       189 ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++||||||+||++++++.++|+|||++.....
T Consensus       146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         146 IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999999999975544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.7e-19  Score=172.01  Aligned_cols=124  Identities=31%  Similarity=0.495  Sum_probs=106.8

Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+|+.|++|...+|.+++.....    ....++.....++.|++.|++|   .+   .+|+|+||.||+...+..+||+|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~----~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT----GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc----ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence            37899999999999999986543    2567889999999999999999   55   99999999999999999999999


Q ss_pred             cccccccCCCC----CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc
Q 015931          212 FGLATWTSAPS----VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT  265 (398)
Q Consensus       212 fGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt  265 (398)
                      ||+........    .....+...||..||+||.+.+..|+.|+||||||++|+|+++
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            99987655433    1112245679999999999999999999999999999999997

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=3.3e-18  Score=157.55  Aligned_cols=198  Identities=26%  Similarity=0.320  Sum_probs=134.9

Q ss_pred             CCCCeeceeeEEEcC--------------------------CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHH
Q 015931          115 HHPNIVPLVGFCIDP--------------------------EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY  168 (398)
Q Consensus       115 ~h~niv~l~~~~~~~--------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~  168 (398)
                      +|||||++.++|.+.                          ...+|+||.-. ..+|..++-..        ..+.....
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--------~~s~r~~~  344 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR--------HRSYRTGR  344 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC--------CCchHHHH
Confidence            599999999876531                          12378999887 45999999764        35566667


Q ss_pred             HHHHHHHHHHHHHHcCCCCceeecccccCcEEeC--CC--CCeeEeccccccccCCCC--Cce--eeeccccCCCcccch
Q 015931          169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SK--KIPKLCDFGLATWTSAPS--VPF--LCKTVKGTFGYLAPE  240 (398)
Q Consensus       169 ~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~--~~--~~~kl~DfGla~~~~~~~--~~~--~~~~~~gt~~y~aPE  240 (398)
                      -++.|+++|+.|||.++   |.|||+|++||||.  ++  ..+.|+|||++--.....  .+.  ......|....||||
T Consensus       345 ~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE  421 (598)
T KOG4158|consen  345 VILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE  421 (598)
T ss_pred             HHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence            78899999999999999   99999999999993  33  357899999874322210  000  012345778899999


Q ss_pred             hhccCC------cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHH
Q 015931          241 YFQHGK------VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQI  314 (398)
Q Consensus       241 ~~~~~~------~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  314 (398)
                      +....+      -..|+|.|+.|.+.||+++...||....   +..+...          ..++---|.+.  ...+   
T Consensus       422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~~r----------~Yqe~qLPalp--~~vp---  483 (598)
T KOG4158|consen  422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLDTR----------TYQESQLPALP--SRVP---  483 (598)
T ss_pred             hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hheechh----------hhhhhhCCCCc--ccCC---
Confidence            986432      2458999999999999999999998622   1111110          01111111121  1122   


Q ss_pred             HHHHHHHHhcccccCCCCCCHHHHHHHH
Q 015931          315 ARVIQAAAACISSEESRRPGIEEIIAIL  342 (398)
Q Consensus       315 ~~l~~l~~~cl~~~p~~RPt~~evl~~L  342 (398)
                      ..+.+++...|+.||++||+..-....|
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            2345666778999999999977655544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=6.3e-18  Score=171.26  Aligned_cols=139  Identities=23%  Similarity=0.328  Sum_probs=110.4

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--C------hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--D------KESSKAFCRELMIASSLHHPNIVPLVGFCIDP  129 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  129 (398)
                      ....|...+.||+|+||+||+|.+..  ..+++|+....  .      ......+.+|++++..++|++++....++.+.
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            34556778999999999999998764  33444433211  1      11235688999999999999998887776664


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                      .. .++||||+++++|.+++.               ....++.+++++|.|||+.+   ++||||||+||++ +++.++|
T Consensus       409 ~~-~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        409 EE-KTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             CC-CEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence            44 589999999999998875               23568999999999999988   9999999999999 6789999


Q ss_pred             ecccccccc
Q 015931          210 CDFGLATWT  218 (398)
Q Consensus       210 ~DfGla~~~  218 (398)
                      +|||+++..
T Consensus       469 iDFGla~~~  477 (535)
T PRK09605        469 IDFGLGKYS  477 (535)
T ss_pred             EeCcccccC
Confidence            999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=7.3e-18  Score=148.90  Aligned_cols=130  Identities=22%  Similarity=0.358  Sum_probs=104.2

Q ss_pred             eecccCceEEEEeeeCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           67 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .||+|+||.||+|.+.  +..|++|.......        .....+.+|++++..++|+++.....++...+. .++|||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-KTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-CEEEEE
Confidence            4899999999999854  67899998653211        123567789999999998876555555554433 589999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |++|++|.+.+....        .      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.+++.|||++..
T Consensus        78 ~~~g~~l~~~~~~~~--------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN--------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH--------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998875421        1      78999999999999988   99999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=3e-16  Score=142.26  Aligned_cols=136  Identities=17%  Similarity=0.175  Sum_probs=105.5

Q ss_pred             Cceec-ccCceEEEEeeeCCCCcEEEEEEecCCC-------------hhhHHHHHHHHHHHHhCCCCCe--eceeeEEEc
Q 015931           65 GRVLG-RGALSFVFKGKVGLLRTSVAIKRLDKED-------------KESSKAFCRELMIASSLHHPNI--VPLVGFCID  128 (398)
Q Consensus        65 ~~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~  128 (398)
                      ..+|| .||.|+||.+...  +..++||.+....             ......+.+|++++..++|+++  ...+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45788 8999999999875  6789999885321             1223467889999999998875  666666443


Q ss_pred             CCCc---EEEEEecCCC-CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          129 PEQG---LFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       129 ~~~~---~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      ....   .++|||+++| .+|.+++..        ..++..    .+.+++.+|.+||+.+   |+||||||.|||++.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~  178 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE--------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD  178 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc--------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence            3332   2599999997 699888754        234443    3568999999999988   9999999999999998


Q ss_pred             CCeeEeccccccc
Q 015931          205 KIPKLCDFGLATW  217 (398)
Q Consensus       205 ~~~kl~DfGla~~  217 (398)
                      +.++|+|||.+..
T Consensus       179 ~~v~LIDfg~~~~  191 (239)
T PRK01723        179 GKFWLIDFDRGEL  191 (239)
T ss_pred             CCEEEEECCCccc
Confidence            9999999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2e-16  Score=138.25  Aligned_cols=137  Identities=19%  Similarity=0.205  Sum_probs=97.5

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChh--hHHH----------------------HHHHHHHHHhCCCCC--
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKA----------------------FCRELMIASSLHHPN--  118 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--  118 (398)
                      .+.||+|+||+||+|... +++.||||++......  ....                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 6899999998754211  1111                      134555666654433  


Q ss_pred             eeceeeEEEcCCCcEEEEEecCCCCCHHH-HHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeeccccc
Q 015931          119 IVPLVGFCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKP  196 (398)
Q Consensus       119 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp  196 (398)
                      +.+.++.    . ..++||||++++.+.. .+....        .. .....++.+++.++.++|. .+   |+|+||||
T Consensus        81 ~~~~~~~----~-~~~lv~e~~~g~~~~~~~l~~~~--------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p  143 (187)
T cd05119          81 VPKPIDL----N-RHVLVMEFIGGDGIPAPRLKDVR--------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSE  143 (187)
T ss_pred             CCceEec----C-CCEEEEEEeCCCCccChhhhhhh--------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence            3444432    1 2489999999855422 121110        11 5677899999999999998 77   99999999


Q ss_pred             CcEEeCCCCCeeEeccccccccCC
Q 015931          197 SNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       197 ~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      +||+++ ++.++|+|||.+.....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             hhEEEE-CCcEEEEECcccccccC
Confidence            999999 89999999999875544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=1.1e-15  Score=127.87  Aligned_cols=135  Identities=21%  Similarity=0.234  Sum_probs=110.4

Q ss_pred             CCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCC--CCeeceeeEEEcCCCcEEEEEecCC
Q 015931           64 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        64 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      ..+.||+|.++.||++....  ..+++|.......  ...+..|+..+..++|  .++.+++++.... +..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecC
Confidence            35689999999999999863  6799999865433  4678899999999976  5888888875543 45799999998


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ++.+..+              +......++.+++++++++|.....+++|+|++|.||++++.+.+++.|||.+..
T Consensus        77 g~~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8776432              4456677899999999999986555699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.9e-17  Score=167.79  Aligned_cols=256  Identities=25%  Similarity=0.311  Sum_probs=185.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKED--KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  134 (398)
                      ...|...+.||+|+|+.|-..... .....+|+|.+....  .........|..+-..+. |+|++.+++...+++ ..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-SYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-ccc
Confidence            346777788999999999887763 334557777765443  223334445666666666 999999999766554 468


Q ss_pred             EEEecCCCCCHHHHHh-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceeecccccCcEEeCCCC-CeeEec
Q 015931          135 LIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-NGTERCVVHRDIKPSNILLSSKK-IPKLCD  211 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~-~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~ivHrDlkp~NIll~~~~-~~kl~D  211 (398)
                      ++.+|..++++.+.+. ...      ...+....-.++.|+..++.|+| ..+   +.|||+||+|.+++..+ .++++|
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~d  168 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDS------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIAD  168 (601)
T ss_pred             cccCcccccccccccccCCc------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCC
Confidence            9999999999988883 321      13555666778999999999999 777   99999999999999999 999999


Q ss_pred             cccccccCC-CCCceeeecccc-CCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH
Q 015931          212 FGLATWTSA-PSVPFLCKTVKG-TFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       212 fGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      ||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|....
T Consensus       169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~  247 (601)
T KOG0590|consen  169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK  247 (601)
T ss_pred             chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc
Confidence            999988776 444445556778 9999999998874 557889999999999999999999876544331 111111000


Q ss_pred             HhhchhhhhhhcCc-ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          289 LHRGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       289 ~~~~~~~~~~~~d~-~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                                  +. ...   ..........++..+++..+|..|.+.+++-.
T Consensus       248 ------------~~~~~~---~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 ------------GRFTQL---PWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ------------cccccC---ccccCChhhhhcccccccCCchhccccccccc
Confidence                        00 000   01111233455666788899999999888764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=3e-14  Score=140.11  Aligned_cols=146  Identities=21%  Similarity=0.216  Sum_probs=101.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhH---------------------------------------
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---------------------------------------  101 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------  101 (398)
                      .|+ .+.||+|++|.||+|++. +|+.||||+.........                                       
T Consensus       119 ~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            344 468999999999999987 489999999865421110                                       


Q ss_pred             -HHHHHHHHHHHhC----CCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHH
Q 015931          102 -KAFCRELMIASSL----HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE  176 (398)
Q Consensus       102 -~~~~~E~~~l~~l----~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~  176 (398)
                       -+|.+|+..+.++    +|.+-+.+-.++.+.....+|||||++|++|.+.......      ..+   +..++..++.
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~------~~~---~~~ia~~~~~  267 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA------GLD---RKALAENLAR  267 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc------CCC---HHHHHHHHHH
Confidence             0244455555544    2333333333343333446899999999999887754321      122   3456666666


Q ss_pred             -HHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          177 -SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       177 -aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                       .+..+|..+   ++|+|++|.||++++++.++++|||++..++.
T Consensus       268 ~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       268 SFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             478889887   99999999999999999999999999876653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=4.1e-14  Score=127.94  Aligned_cols=204  Identities=21%  Similarity=0.272  Sum_probs=138.4

Q ss_pred             HHHHhCCCCCeeceeeEEEcCC----CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 015931          109 MIASSLHHPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG  184 (398)
Q Consensus       109 ~~l~~l~h~niv~l~~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~  184 (398)
                      ..|-.+.|.|||++..|+.+.+    .+..++.|||..|+|..+|++..+.   ...+....-.+|+.||..||.|||+.
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~---~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN---QKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh---hhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            3445567999999998865433    2467999999999999999876432   35677788888999999999999997


Q ss_pred             CCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc----eeeeccccCCCcccchhhccCCcCCccchhhHHHHH
Q 015931          185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVL  260 (398)
Q Consensus       185 ~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl  260 (398)
                      . ++|+|+++.-+.|++..++-+|++---  .........    .-.....+-++|.+||+-...+.+-.+|||+||+..
T Consensus       196 ~-PpiihgnlTc~tifiq~ngLIkig~~a--p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA  272 (458)
T KOG1266|consen  196 D-PPIIHGNLTCDTIFIQHNGLIKIGSVA--PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA  272 (458)
T ss_pred             C-CccccCCcchhheeecCCceEEecccC--ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence            5 779999999999999999988885311  100000000    001123467899999998877888899999999999


Q ss_pred             HHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          261 LELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       261 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +||.-|..--......-   .+...      +...+...-++ +.            ..++..|++..|..||+|++++.
T Consensus       273 lemailEiq~tnseS~~---~~ee~------ia~~i~~len~-lq------------r~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  273 LEMAILEIQSTNSESKV---EVEEN------IANVIIGLENG-LQ------------RGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHheeccCCCccee---ehhhh------hhhheeeccCc-cc------------cCcCcccccCCCCCCcchhhhhc
Confidence            99988765321111100   00000      00000100111 11            12345799999999999999876

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=2.7e-13  Score=135.07  Aligned_cols=149  Identities=17%  Similarity=0.153  Sum_probs=96.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhh----------------------------------HH---
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES----------------------------------SK---  102 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~---  102 (398)
                      ..|+. +.||+|++|.||+|++.++|+.||||+..+.-...                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 79999999999999998779999999997542110                                  11   


Q ss_pred             ---HHHHHHHHHHhCC----CCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHH
Q 015931          103 ---AFCRELMIASSLH----HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  175 (398)
Q Consensus       103 ---~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia  175 (398)
                         ++.+|+..+.+++    +.+.+.+-.++.+-....+|||||++|+.+.+.-.-...+. ....+.......++.|+ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHH-
Confidence               1344444444442    44444444444443344689999999999987532111100 00112233333333333 


Q ss_pred             HHHHHHHcCCCCceeecccccCcEEeCCCC----CeeEeccccccccCC
Q 015931          176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKLCDFGLATWTSA  220 (398)
Q Consensus       176 ~aL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DfGla~~~~~  220 (398)
                            ...+   ++|+|+||.||+++.++    .+++.|||++..++.
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  4456   99999999999999888    999999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=1.2e-13  Score=134.70  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=176.7

Q ss_pred             cCCCCCceecc--cCceEEEEeee--CCCCcEEEEEEecC--CChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCc
Q 015931           60 HNFSKGRVLGR--GALSFVFKGKV--GLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        60 ~~f~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  132 (398)
                      ..|...+.+|.  |.+|.||.+..  ..++..+|+|.-+.  ........=.+|+.....++ |+|.++....+.. .+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCc
Confidence            35566778999  99999999988  77888999998432  22222233345666666664 8999997776444 455


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCceeecccccCcEEeCCC-CCe
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE----SVAYLHNGTERCVVHRDIKPSNILLSSK-KIP  207 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~  207 (398)
                      .++-+|.| +.+|..+.+...      ..++....+.+..+..+    ||.++|+..   ++|-|+||.||+...+ ...
T Consensus       193 lfiqtE~~-~~sl~~~~~~~~------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHTPC------NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             ceeeeccc-cchhHHhhhccc------ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccccee
Confidence            77888888 688888887754      33677778888888888    999999988   9999999999999999 889


Q ss_pred             eEeccccccccCCCCCcee---eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          208 KLCDFGLATWTSAPSVPFL---CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      +++|||+...+........   .....|...|++||... +.++..+|+|++|.+..+..+|..+........      |
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W  335 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W  335 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------c
Confidence            9999999988876542211   12235778899999775 578899999999999999999887765432111      1


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .         .+.....+.    .++..-...+...+.++++.+|..|++...+..
T Consensus       336 ~---------~~r~~~ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 S---------QLRQGYIPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c---------ccccccCch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0         011111110    011111112223566799999999999887665

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=1.3e-12  Score=112.05  Aligned_cols=131  Identities=18%  Similarity=0.170  Sum_probs=95.8

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCH
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL  145 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL  145 (398)
                      +.|+.|.++.||++...  +..|++|....... ....+..|+.++..+.+.++++-+-.+.. .. .++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-~~-~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-ET-GVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-CC-CeEEEEecCCCcc
Confidence            56888999999999875  67899998765432 22346789999988876565543322222 22 3799999999887


Q ss_pred             HHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       146 ~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ...  .          .   ....++.+++++|..||..+  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~--~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE--D----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc--c----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            542  0          0   11235678999999999876  23469999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.36  E-value=1.1e-11  Score=122.40  Aligned_cols=171  Identities=20%  Similarity=0.259  Sum_probs=127.2

Q ss_pred             EeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCC
Q 015931           78 KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR  157 (398)
Q Consensus        78 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~  157 (398)
                      .|..+.++.+|.|+.++..+........+-++.|+.++||||++++.... .++.+|||+|-+  .-|..++...     
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV--~Pl~~~lk~l-----  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERV--RPLETVLKEL-----  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeecc--ccHHHHHHHh-----
Confidence            56667778999999998766644556778889999999999999998654 456799999988  4577777653     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcc
Q 015931          158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL  237 (398)
Q Consensus       158 ~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  237 (398)
                           ......-.+.||+.||.|||+.+.  ++|++|.-..|+++..|.-||++|.++.........  .....--..|.
T Consensus       102 -----~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~  172 (690)
T KOG1243|consen  102 -----GKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFD  172 (690)
T ss_pred             -----HHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhccc
Confidence                 234445577899999999986543  999999999999999999999999887644332210  01111222366


Q ss_pred             cchhhccCCcCCccchhhHHHHHHHHHcCC
Q 015931          238 APEYFQHGKVSDKTDVYAFGVVLLELLTGR  267 (398)
Q Consensus       238 aPE~~~~~~~s~ksDv~S~Gvvl~elltG~  267 (398)
                      .|+.+....  -..|.|-||++++|++.|.
T Consensus       173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  173 DPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            676543222  3469999999999999993

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=8.4e-11  Score=102.38  Aligned_cols=140  Identities=16%  Similarity=0.192  Sum_probs=98.0

Q ss_pred             CceecccCceEEEEeeeCC------CCcEEEEEEecCCC----------------------hhhHHHH----HHHHHHHH
Q 015931           65 GRVLGRGALSFVFKGKVGL------LRTSVAIKRLDKED----------------------KESSKAF----CRELMIAS  112 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~  112 (398)
                      ...||.|--+.||.|...+      .+..+|||+.....                      ......+    .+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999997643      24789999875321                      0011223    37888888


Q ss_pred             hCCC--CCeeceeeEEEcCCCcEEEEEecCCCCCHHH-HHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCc
Q 015931          113 SLHH--PNIVPLVGFCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL-HNGTERC  188 (398)
Q Consensus       113 ~l~h--~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~  188 (398)
                      ++..  -++-..+++    .. -+|||||+.+..+.. .+..        ..++......+..+++.+|..| |..+   
T Consensus        82 rl~~~Gv~vP~pi~~----~~-~~lvME~Ig~~~~~~~~Lkd--------~~~~~~~~~~i~~~i~~~l~~l~H~~g---  145 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KK-HVLVMSFIGDDQVPAPKLKD--------AKLNDEEMKNAYYQVLSMMKQLYKECN---  145 (197)
T ss_pred             HHHHcCCCCCeEEEe----cC-CEEEEEEcCCCCccchhhhc--------cccCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence            8753  344445543    22 379999996654422 2221        2345556677889999999999 8877   


Q ss_pred             eeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          189 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       189 ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      ++|+||++.||+++ ++.+.|+|||.+.....+
T Consensus       146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             eecCCCCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence            99999999999997 467999999998766544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=5e-12  Score=123.41  Aligned_cols=248  Identities=21%  Similarity=0.171  Sum_probs=167.2

Q ss_pred             hhcCCCCCceecccCceEEEEeeeC-CCCcEEEEEEecCCChhhHHH--HHHHHHHHHhC-CCCCeeceeeEEEcCCCcE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKEDKESSKA--FCRELMIASSL-HHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  133 (398)
                      .+.+|.....||.|.|+.|+....+ .++..|++|.+.........+  -..|+-+...+ .|.+++.+...+....+ .
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-G  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-c
Confidence            3467888999999999999987755 567889999886653222222  23444444444 47777876655444343 5


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeEecc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDF  212 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Df  212 (398)
                      |+=-|||+++++...+.-.       ..++...++++..|++.++.++|+..   ++|+|+||+||++..+ +.-+++||
T Consensus       342 ~ip~e~~~~~s~~l~~~~~-------~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS-------QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             cCchhhhcCcchhhhhHHH-------HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence            7889999999987776332       45788889999999999999999877   9999999999999876 78899999


Q ss_pred             ccccccCCCCCceeeeccccCCCcc--cchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYL--APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      |++..+....     ......-++.  +|+......+-.+.|+||||..+.|.++|..--....        .|      
T Consensus       412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~------  472 (524)
T KOG0601|consen  412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS------  472 (524)
T ss_pred             ccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc------
Confidence            9986432211     1112233344  5555556678899999999999999998865322110        11      


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                            ..+....+........+   +..++..+..+++..||.+.++......
T Consensus       473 ------~~i~~~~~p~~~~~~~~---~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  473 ------LTIRSGDTPNLPGLKLQ---LQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ------eeeecccccCCCchHHh---hhhhhhhhcCCccccchhhhhhcccchh
Confidence                  11111111111112233   3344445889999999999887765443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.28  E-value=1e-10  Score=112.26  Aligned_cols=176  Identities=18%  Similarity=0.278  Sum_probs=135.2

Q ss_pred             CceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc---CCCcEEEEEecCCC-CCHHH
Q 015931           72 ALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID---PEQGLFLIYKYVSG-GSLER  147 (398)
Q Consensus        72 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~~~lV~e~~~~-gsL~~  147 (398)
                      -..+.|++....+|..|++|++...+.........-++.++++.|+|+|++..++..   ++..+++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            346889999999999999999955444443344556889999999999999887652   34458999999986 57766


Q ss_pred             HHhhhcc-C-------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          148 HLHEKKK-G-------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       148 ~l~~~~~-~-------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +-..... .       ..++...+++.+|.++.|+..||.++|+.|   ...+-|.|.+|+++.+.+++|+.+|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6543221 1       233456889999999999999999999998   9999999999999999999999988876655


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCC
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP  269 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~P  269 (398)
                      .+...              |  +..   -.+-|.=.||.+++.|.||..-
T Consensus       445 ~d~~~--------------~--le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPTE--------------P--LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCCc--------------c--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            43310              0  111   1257888999999999999764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.25  E-value=1.9e-12  Score=132.79  Aligned_cols=208  Identities=25%  Similarity=0.272  Sum_probs=149.7

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ..+.|.+.+-+-+|.++.++.+.-..++...+.|.....   .....+....+-.++-..++|-++...--+. .....+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~  880 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLP  880 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcc
Confidence            446777778888999999998876666644555544322   1222233333444444445676665543311 233478


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      ||++|..+++|...++..       .+.+.+..+.....+..+++|||...   +.|+|++|.|++...++..+++|||+
T Consensus       881 L~~~~~~~~~~~Skl~~~-------~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS-------GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             hhhHHhccCCchhhhhcC-------CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence            999999999999999874       34566666667777899999999876   99999999999999999999999985


Q ss_pred             ccccCCC---------CC--------------------ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc
Q 015931          215 ATWTSAP---------SV--------------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT  265 (398)
Q Consensus       215 a~~~~~~---------~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt  265 (398)
                      ......-         ..                    ........||+.|.+||...+......+|+|++|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            4321100         00                    001123568999999999999999999999999999999999


Q ss_pred             CCCCCcccccc
Q 015931          266 GRKPIEARRLQ  276 (398)
Q Consensus       266 G~~Pf~~~~~~  276 (398)
                      |..||....++
T Consensus      1031 g~pp~na~tpq 1041 (1205)
T KOG0606|consen 1031 GIPPFNAETPQ 1041 (1205)
T ss_pred             CCCCCCCcchh
Confidence            99999887654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1e-10  Score=104.67  Aligned_cols=143  Identities=23%  Similarity=0.347  Sum_probs=106.3

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCC--CeeceeeEEEcCC--CcEEEEEecC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHP--NIVPLVGFCIDPE--QGLFLIYKYV  140 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~--~~~~lV~e~~  140 (398)
                      +.||.|..+.||++...+ |..+++|....... .....+..|++++..+.+.  ++.+++.+..+..  +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998764 57899998765432 1345688999999998763  4566676654422  2458999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----------------------------------  185 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----------------------------------  185 (398)
                      +|.++...+..        ..++......++.+++++|..||+..                                   
T Consensus        83 ~G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          83 DGRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             CCEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            99888665431        23667777778888888888888531                                   


Q ss_pred             ------------------CCceeecccccCcEEeCC--CCCeeEeccccccc
Q 015931          186 ------------------ERCVVHRDIKPSNILLSS--KKIPKLCDFGLATW  217 (398)
Q Consensus       186 ------------------~~~ivHrDlkp~NIll~~--~~~~kl~DfGla~~  217 (398)
                                        ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                              245899999999999998  56689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.15  E-value=1.3e-09  Score=91.73  Aligned_cols=144  Identities=24%  Similarity=0.301  Sum_probs=103.1

Q ss_pred             CCceecccCceEEEEeeeCCCCcEEEEEEe-cCC-------ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           64 KGRVLGRGALSFVFKGKVGLLRTSVAIKRL-DKE-------DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        64 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ...+|-+|+-+.|+++...  |+...||.= .+.       ..-...+..+|+..|.+++--.|.-..-++.+..+. .|
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~-~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG-QI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC-eE
Confidence            5678899999999999876  677777743 221       112234567899999887654544444445555553 79


Q ss_pred             EEecCCC-CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC---CeeEec
Q 015931          136 IYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCD  211 (398)
Q Consensus       136 V~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~D  211 (398)
                      +|||++| .++.+++.....     ..........++..+-+.+.-||.+.   |+|+||..+||+|..++   .+.++|
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~-----~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId  159 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTME-----DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID  159 (229)
T ss_pred             EEEeccchhHHHHHHHHHcc-----CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence            9999966 488888876532     12222333678888899999999998   99999999999997554   458999


Q ss_pred             ccccccc
Q 015931          212 FGLATWT  218 (398)
Q Consensus       212 fGla~~~  218 (398)
                      ||++...
T Consensus       160 fgls~~s  166 (229)
T KOG3087|consen  160 FGLSSVS  166 (229)
T ss_pred             ecchhcc
Confidence            9997543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=1e-09  Score=92.79  Aligned_cols=132  Identities=23%  Similarity=0.394  Sum_probs=95.9

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEe-cCC--Chh-----hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRL-DKE--DKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~-~~~--~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ..+++|+-+.+|.+.+.  |..+.+|.= .+.  .+.     ....-.+|+.++.+++--.|...+-+..+++. ..|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-GLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CEEEE
Confidence            35789999999999764  445566642 221  111     12345688999988865555444445566665 46999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||++|..|.+.+...              ...++..+-.-+.-||..+   |+|+||.++||++.... +.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA--------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999999888753              2346666777788899988   99999999999997765 99999999874


Q ss_pred             c
Q 015931          218 T  218 (398)
Q Consensus       218 ~  218 (398)
                      .
T Consensus       141 s  141 (204)
T COG3642         141 S  141 (204)
T ss_pred             c
Confidence            3

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.03  E-value=8.7e-09  Score=94.67  Aligned_cols=141  Identities=17%  Similarity=0.069  Sum_probs=97.5

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCChh-hH----------HHHHHHHHHHHhCCCCC--eeceeeEEEcC---
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SS----------KAFCRELMIASSLHHPN--IVPLVGFCIDP---  129 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~n--iv~l~~~~~~~---  129 (398)
                      +.+-......|.+....  |+.|.||........ ..          ..+.+|...+..+...+  ...++++....   
T Consensus        28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            34444444456677664  678999977543211 11          13678888887774322  23334444322   


Q ss_pred             -CCcEEEEEecCCCC-CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC----
Q 015931          130 -EQGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS----  203 (398)
Q Consensus       130 -~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~----  203 (398)
                       ...-+||+|++++. +|.+++.....     ...+...+..++.+++..+.-||..+   |+|+|++++|||++.    
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~-----~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~  177 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT-----NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG  177 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence             12357999999886 89999864311     33566777889999999999999999   999999999999975    


Q ss_pred             ---CCCeeEecccccc
Q 015931          204 ---KKIPKLCDFGLAT  216 (398)
Q Consensus       204 ---~~~~kl~DfGla~  216 (398)
                         +..+.++||+.+.
T Consensus       178 ~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        178 REEDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCCCceEEEEECCccc
Confidence               4689999999875

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=1.2e-08  Score=96.01  Aligned_cols=199  Identities=19%  Similarity=0.197  Sum_probs=132.0

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEE------EcCCCcEEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFC------IDPEQGLFL  135 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~~~~~l  135 (398)
                      ..++.||+|+-+.+|..-.-  +..|| |++.........+-   +..|... .||-+..-+.|-      -+....+-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VA-KIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVA-KIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhh-eeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            45678999999999975322  23344 77766544332222   2233333 465443312211      122222557


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      .|..+++..--..+.........-...+|...++.+..+|.+.+-||+.|   .+-+|++++|+|+.+++.+.|.|=...
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence            78777765332222222111122355789999999999999999999988   899999999999999999999985543


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcC-CCCCccc
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTG-RKPIEAR  273 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG-~~Pf~~~  273 (398)
                      ....++   ......+|...|.+||.-.     +..-+...|-|.|||++++++.| +.||.+-
T Consensus       165 qi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         165 QINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            332221   2234567999999999754     33457789999999999999985 9999764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=7.1e-09  Score=89.96  Aligned_cols=126  Identities=21%  Similarity=0.226  Sum_probs=81.2

Q ss_pred             EEEeeeCCCCcEEEEEEecCCC--------------h------------hhHHHHHHHHHHHHhCCCC--CeeceeeEEE
Q 015931           76 VFKGKVGLLRTSVAIKRLDKED--------------K------------ESSKAFCRELMIASSLHHP--NIVPLVGFCI  127 (398)
Q Consensus        76 Vy~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  127 (398)
                      ||.|...+ +..+|||+.....              .            .......+|.+.|.++..-  ++-+.+++  
T Consensus         2 Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    2 VYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             EEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            88998764 7899999875421              0            0123356899999999765  45555544  


Q ss_pred             cCCCcEEEEEecCC--CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCceeecccccCcEEeCCC
Q 015931          128 DPEQGLFLIYKYVS--GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY-LHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       128 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      . .+  +|||||++  |..+..+....         ++.+....++.+++..+.. +|..+   |+|+||.+.||+++++
T Consensus        79 ~-~~--~ivME~I~~~G~~~~~l~~~~---------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   79 N-RN--VIVMEYIGEDGVPLPRLKDVD---------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG  143 (188)
T ss_dssp             E-TT--EEEEE--EETTEEGGCHHHCG---------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT
T ss_pred             e-CC--EEEEEecCCCccchhhHHhcc---------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc
Confidence            2 22  69999998  55554443321         2233455677778785555 57777   9999999999999988


Q ss_pred             CCeeEeccccccccCC
Q 015931          205 KIPKLCDFGLATWTSA  220 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~  220 (398)
                       .+.++|||.+.....
T Consensus       144 -~~~iIDf~qav~~~~  158 (188)
T PF01163_consen  144 -KVYIIDFGQAVDSSH  158 (188)
T ss_dssp             -CEEE--GTTEEETTS
T ss_pred             -eEEEEecCcceecCC
Confidence             999999998876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.74  E-value=1.4e-07  Score=84.72  Aligned_cols=138  Identities=22%  Similarity=0.146  Sum_probs=96.4

Q ss_pred             CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh----------------------hhHHHHHHHHHHHHhCCCC--
Q 015931           62 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----------------------ESSKAFCRELMIASSLHHP--  117 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--  117 (398)
                      ...+..||.|--+.||.|.... |.++|||.-.....                      -......+|.+.|.++.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            4566899999999999999874 88999997543210                      1123356889999888654  


Q ss_pred             CeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccC
Q 015931          118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  197 (398)
Q Consensus       118 niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~  197 (398)
                      .+.+.+++    +. -.+|||+++|-.|...-            ++-+..-.++..|++-+.-+-..|   ++|+|+.+-
T Consensus       172 ~VP~P~~~----nR-HaVvMe~ieG~eL~~~r------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSef  231 (304)
T COG0478         172 KVPKPIAW----NR-HAVVMEYIEGVELYRLR------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEF  231 (304)
T ss_pred             CCCCcccc----cc-ceeeeehcccceeeccc------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence            56666664    22 37999999886664432            122223344444555555444566   999999999


Q ss_pred             cEEeCCCCCeeEeccccccccCC
Q 015931          198 NILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ||+++++|.+.++||--+...+.
T Consensus       232 NIlV~~dg~~~vIDwPQ~v~~~h  254 (304)
T COG0478         232 NILVTEDGDIVVIDWPQAVPISH  254 (304)
T ss_pred             eEEEecCCCEEEEeCcccccCCC
Confidence            99999999999999976654443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.71  E-value=3.7e-09  Score=105.07  Aligned_cols=151  Identities=22%  Similarity=0.371  Sum_probs=98.9

Q ss_pred             HHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCce-------eeeccccCCCcccchhhccC
Q 015931          173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF-------LCKTVKGTFGYLAPEYFQHG  245 (398)
Q Consensus       173 qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  245 (398)
                      +++.|+.|+|..  ..+||++|.|++|.++.++..||+.|+.+.....+....       ......-...|.|||++...
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            455999999985  459999999999999999999999999876544321110       01112234579999999998


Q ss_pred             CcCCccchhhHHHHHHHHHcCCCC-CcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhc
Q 015931          246 KVSDKTDVYAFGVVLLELLTGRKP-IEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAAC  324 (398)
Q Consensus       246 ~~s~ksDv~S~Gvvl~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~c  324 (398)
                      ..+.++|+||+|+++|-+..|..+ +.............              ...+....  ........++.+-+.+.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--------------~~~~~~~~--~~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--------------NLLNAGAF--GYSNNLPSELRESLKKL  248 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--------------cccccccc--cccccCcHHHHHHHHHH
Confidence            889999999999999999954444 44332221111110              00111110  01112223344445568


Q ss_pred             ccccCCCCCCHHHHHHH
Q 015931          325 ISSEESRRPGIEEIIAI  341 (398)
Q Consensus       325 l~~~p~~RPt~~evl~~  341 (398)
                      +..++..||++.++...
T Consensus       249 l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             hcCCcccCcchhhhhcc
Confidence            99999999988887764

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=5.8e-07  Score=78.72  Aligned_cols=138  Identities=16%  Similarity=0.141  Sum_probs=100.8

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCC-----C-hhhHHHHHHHHHHHHhCCCC--CeeceeeEEEcC----CCcEEE
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-----D-KESSKAFCRELMIASSLHHP--NIVPLVGFCIDP----EQGLFL  135 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~~l  135 (398)
                      -|+||-+.|+.....  |+.+-+|.-...     . +.....|.+|+..|.++..-  .+.+.+ ++...    ...-+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            466899999998776  446888876521     1 33567899999999887532  233333 33211    112579


Q ss_pred             EEecCCC-CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC--eeEecc
Q 015931          136 IYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDF  212 (398)
Q Consensus       136 V~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~Df  212 (398)
                      |+|-+.| -+|.+++.....     .+.+...+..++.+++..+.-||+.+   +.|+|+.+.||+++.++.  ++++||
T Consensus       103 VTe~L~g~~~L~~~l~~~~~-----~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAV-----SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCc-----CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEh
Confidence            9997753 589888865421     34677778899999999999999988   999999999999986666  999999


Q ss_pred             cccc
Q 015931          213 GLAT  216 (398)
Q Consensus       213 Gla~  216 (398)
                      .-++
T Consensus       175 Ek~r  178 (216)
T PRK09902        175 EKSR  178 (216)
T ss_pred             hccc
Confidence            7655

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.66  E-value=3.8e-07  Score=80.87  Aligned_cols=107  Identities=23%  Similarity=0.265  Sum_probs=80.2

Q ss_pred             HHHHHHHHHHHhCCCC--CeeceeeEEEcCC---CcEEEEEecCCCC-CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHH
Q 015931          102 KAFCRELMIASSLHHP--NIVPLVGFCIDPE---QGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  175 (398)
Q Consensus       102 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia  175 (398)
                      ....+|...+..+...  ...+.+++.....   ...++|+|++++. +|.+++....       ..+......++.+++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-------~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-------QLDPSQRRELLRALA  128 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-------ccchhhHHHHHHHHH
Confidence            4566777776666422  2344444444322   2347999999884 8999987642       255667788999999


Q ss_pred             HHHHHHHcCCCCceeecccccCcEEeCCCC---CeeEecccccccc
Q 015931          176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWT  218 (398)
Q Consensus       176 ~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DfGla~~~  218 (398)
                      ..+.-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       129 ~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  129 RLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999998   99999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=2e-07  Score=92.82  Aligned_cols=147  Identities=18%  Similarity=0.186  Sum_probs=95.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhH------------------------------H-------
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS------------------------------K-------  102 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------~-------  102 (398)
                      ..|+. ..|+.++-|.||+|++.+ |+.||||+..+.-....                              .       
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            34543 689999999999999986 99999999876421110                              0       


Q ss_pred             ---HHHHHHHHHHhCC----CCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHH
Q 015931          103 ---AFCRELMIASSLH----HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  175 (398)
Q Consensus       103 ---~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia  175 (398)
                         ++.+|...+.+++    ...-+++=.+|.+-.+...|+|||++|..+.+...-..      ..++-+.   ++..++
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~------~g~d~k~---ia~~~~  274 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS------AGIDRKE---LAELLV  274 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh------cCCCHHH---HHHHHH
Confidence               1334444444432    22222222334443344579999999999988854332      2244333   333333


Q ss_pred             HH-HHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          176 ES-VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       176 ~a-L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++ +..+-..+   .+|.|.+|.||+++.++.+.+.|||+...++.
T Consensus       275 ~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         275 RAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            32 23333355   99999999999999999999999999876654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.44  E-value=1.2e-06  Score=76.94  Aligned_cols=138  Identities=17%  Similarity=0.217  Sum_probs=90.1

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHH---------HHHHHHHHhCCC---CCeeceeeE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---------CRELMIASSLHH---PNIVPLVGF  125 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~~~  125 (398)
                      ..++|...+++-......|.+-...  +..+.+|..........+.|         .+++..+.+++.   -..+.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3578888888888777888777665  78899998866543322222         233333333332   222222222


Q ss_pred             EEcC----CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          126 CIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       126 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                      +...    ....+++|||++|..|.+...           ++.    .++..+++++.-||..|   ++|+|.+|+|+++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv  168 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLV  168 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-----------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEE
Confidence            2111    122458999999988866532           222    24556778899999998   9999999999999


Q ss_pred             CCCCCeeEecccccc
Q 015931          202 SSKKIPKLCDFGLAT  216 (398)
Q Consensus       202 ~~~~~~kl~DfGla~  216 (398)
                      ++++ +++.||+..+
T Consensus       169 ~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  169 SNNG-IRIIDTQGKR  182 (229)
T ss_pred             ECCc-EEEEECcccc
Confidence            8655 9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.42  E-value=5.4e-06  Score=74.54  Aligned_cols=141  Identities=18%  Similarity=0.188  Sum_probs=80.0

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe--eceeeEEEcCCCcEEEEEecCCCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI--VPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      ..||+|..+.||+..    +..+++|......  ......+|.+.+..+..-++  .+.++++.. .+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCc
Confidence            578999999999842    4457788876533  23446788888888754333  445555444 34467899999886


Q ss_pred             C-HHHHH--------------hh----hccCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHcC-CCCceee
Q 015931          144 S-LERHL--------------HE----KKKGVRGNSTLPWSVRYK-VAL----------GIAE-SVAYLHNG-TERCVVH  191 (398)
Q Consensus       144 s-L~~~l--------------~~----~~~~~~~~~~l~~~~~~~-i~~----------qia~-aL~yLH~~-~~~~ivH  191 (398)
                      . +...+              ..    -.....  ...+...... +..          .+.. ...+|... ....++|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~--~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC--DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC--CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            3 21111              11    000000  0111111100 000          0111 12222221 2345789


Q ss_pred             cccccCcEEeCCCCCeeEecccccc
Q 015931          192 RDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       192 rDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      +|+.|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.35  E-value=3.4e-06  Score=83.93  Aligned_cols=144  Identities=18%  Similarity=0.140  Sum_probs=90.6

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhH-------------------------------------HHHHHH
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------------------------------------KAFCRE  107 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~E  107 (398)
                      .+.||..+.|.||+|+++. |+.||||+-++.-....                                     -+|.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3689999999999999987 99999998765421110                                     014455


Q ss_pred             HHHHHh----CCCCCe---eceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 015931          108 LMIASS----LHHPNI---VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY  180 (398)
Q Consensus       108 ~~~l~~----l~h~ni---v~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~y  180 (398)
                      ++-..+    +.|-++   |.+=.++.+-.....|+||||+|..+.+.-.-..      ..++-..+..-+.+...  .-
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~------~gi~~~~i~~~l~~~~~--~q  316 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK------RGISPHDILNKLVEAYL--EQ  316 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH------cCCCHHHHHHHHHHHHH--HH
Confidence            543333    234441   1122333444445689999999988766644332      23444433333322221  12


Q ss_pred             HHcCCCCceeecccccCcEEeCC----CCCeeEeccccccccCC
Q 015931          181 LHNGTERCVVHRDIKPSNILLSS----KKIPKLCDFGLATWTSA  220 (398)
Q Consensus       181 LH~~~~~~ivHrDlkp~NIll~~----~~~~kl~DfGla~~~~~  220 (398)
                      +=..|   .+|+|-.|.||+++.    ++.+.+.|||+...+..
T Consensus       317 If~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  317 IFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22234   999999999999983    67899999999876654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.34  E-value=2.5e-06  Score=74.26  Aligned_cols=104  Identities=25%  Similarity=0.316  Sum_probs=81.8

Q ss_pred             HHHHHHHHhCCC-CCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 015931          105 CRELMIASSLHH-PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN  183 (398)
Q Consensus       105 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~  183 (398)
                      ..|..++..+++ +++.+++|+|.     .++|.||...+++...-..    ...-..-+|..|.+|+.++++.+.+|++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~----l~~~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRP----LSQFLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccc----cccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            357788888876 69999999983     2689999987766432000    0001236899999999999999999998


Q ss_pred             CCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       184 ~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      .....+.-.|++++|+-+++++++|+.|...+..
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            7655699999999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.26  E-value=2.9e-07  Score=91.05  Aligned_cols=185  Identities=22%  Similarity=0.184  Sum_probs=129.6

Q ss_pred             CCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC-eeceeeEEEcCCCcEEEEEecCCC
Q 015931           64 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        64 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      ..+-+++|++++++|.+...+.. ...+.+...     ....-++++|.+++||| .+..++-+ +.+...+++++++.+
T Consensus       246 ~fh~fvK~altknpKkRptaekl-L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~-~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKL-LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDY-DGEDYLWIPMRICST  318 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhh-eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccC-CcccccchhhhhhcC
Confidence            34457889999999987654332 335555432     33446889999999999 55555543 445567899999977


Q ss_pred             C-CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          143 G-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       143 g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      + +-.......      ...+...+...+...-++++++||+..   -+|+|    ||+..+ +..+.+||+....+...
T Consensus       319 ~rs~~~~~~~s------e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  319 GRSSALEMTVS------EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             CccccccCChh------hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            6 211111110      122334444556666778899999865   58888    777655 67899999998776554


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                      .   ..+...+|+.++|||+...+.+..+.|+|++|+-..++--|..|-..
T Consensus       385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            3   23466799999999999999999999999999988888888777543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.25  E-value=1.6e-05  Score=70.82  Aligned_cols=154  Identities=16%  Similarity=0.171  Sum_probs=97.5

Q ss_pred             cCHHHHHHhhcCCCCCcee---cccCceEEEEeeeCCCCcEEEEEEecCCChhhH-------------------HH----
Q 015931           50 LSYGEILAATHNFSKGRVL---GRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------------------KA----  103 (398)
Q Consensus        50 ~~~~e~~~~~~~f~~~~~l---G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~~----  103 (398)
                      .++..|....++..+....   .+|--+.||+|... ++..+|||++........                   .+    
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            4555566555555555554   45666789999875 378999999875421111                   00    


Q ss_pred             -HHHHHHHHHhCC--CCCeeceeeEEEcCCCcEEEEEecCCCCCH-HHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 015931          104 -FCRELMIASSLH--HPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA  179 (398)
Q Consensus       104 -~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~  179 (398)
                       ...|+..|.++.  +-.+-+-+++.   +  ..|||||+..... .-.|.        ..++..+....+..++++.+.
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~---~--nVLvMEfIg~~g~pAP~Lk--------Dv~~e~~e~~~~~~~~v~~~~  180 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR---N--NVLVMEFIGDDGLPAPRLK--------DVPLELEEAEGLYEDVVEYMR  180 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec---C--CeEEEEeccCCCCCCCCcc--------cCCcCchhHHHHHHHHHHHHH
Confidence             235666666653  22333444431   2  2699999944310 01111        122333356677788888888


Q ss_pred             HHHc-CCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          180 YLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       180 yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      -|-. .+   +||+||..-|||+. ++.+.++|||-|....++
T Consensus       181 ~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         181 RLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             HHHHhcC---cccccchhhheEEE-CCeEEEEECccccccCCC
Confidence            7776 55   99999999999999 889999999988766544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.22  E-value=1.7e-05  Score=71.18  Aligned_cols=147  Identities=18%  Similarity=0.204  Sum_probs=83.5

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eeceeeEEEcC--CCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGFCIDP--EQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~--~~~~~lV~e~~~  141 (398)
                      +.|+.|..+.||+....+  ..+++|.....  .....+..|..++..+....  +.+++.++...  ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            578999999999999875  48999997654  45567778888887775332  44555533222  223689999999


Q ss_pred             CCCHHH----------------HHhhhccCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHc
Q 015931          142 GGSLER----------------HLHEKKKGVRGNSTLPWSVR---------YKV------------ALGIAE-SVAYLHN  183 (398)
Q Consensus       142 ~gsL~~----------------~l~~~~~~~~~~~~l~~~~~---------~~i------------~~qia~-aL~yLH~  183 (398)
                      |..+..                .+..-...........+...         ...            ...+.+ .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                12111110000111221110         000            011222 2333332


Q ss_pred             ----CCCCceeecccccCcEEeC-CCCCeeEecccccc
Q 015931          184 ----GTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT  216 (398)
Q Consensus       184 ----~~~~~ivHrDlkp~NIll~-~~~~~kl~DfGla~  216 (398)
                          .....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                2356699999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.14  E-value=9.1e-05  Score=64.89  Aligned_cols=133  Identities=24%  Similarity=0.324  Sum_probs=89.9

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCCC----------------hhhHHHHHHHHHHHHhCC------CCCee
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----------------KESSKAFCRELMIASSLH------HPNIV  120 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv  120 (398)
                      +....||+|+.=.||.--.   +....||+.....                .....+..+|+.....+.      +.+|.
T Consensus         4 ~~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             CCCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            3456899999999997533   3457789887654                123456667776665555      78999


Q ss_pred             ceeeEEEcCCCcEEEEEecCCC------CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccc
Q 015931          121 PLVGFCIDPEQGLFLIYKYVSG------GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  194 (398)
Q Consensus       121 ~l~~~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDl  194 (398)
                      +++|+... +...-+|+|.+.+      .+|.+++..        ..++. ...+.   +-+-..||-++.   |+.+|+
T Consensus        81 r~~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~--------~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl  144 (199)
T PF10707_consen   81 RFYGFVET-NLGLGLVVELIRDADGNISPTLEDYLKE--------GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDL  144 (199)
T ss_pred             cEeEEEec-CCceEEEEEEEECCCCCcCccHHHHHHc--------CCccH-HHHHH---HHHHHHHHHHcC---CeecCC
Confidence            99998544 5557888887654      367888854        23555 33333   334456677666   999999


Q ss_pred             ccCcEEeCCCC----CeeEec-ccc
Q 015931          195 KPSNILLSSKK----IPKLCD-FGL  214 (398)
Q Consensus       195 kp~NIll~~~~----~~kl~D-fGl  214 (398)
                      +|.||++..+.    .+.|+| ||.
T Consensus       145 ~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  145 NPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             CcccEEEEecCCCceEEEEEeCCCC
Confidence            99999996332    577777 454

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.13  E-value=2.3e-05  Score=66.22  Aligned_cols=130  Identities=23%  Similarity=0.301  Sum_probs=90.6

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCC
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      ...+.||+|.+|.||+|.+.  +..+|+|+-..++  ....+..|+++|..+.-.++.+=+-.+-  .  .++.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg--~--~~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG--E--DFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec--h--hhhhhhhhcC
Confidence            34568999999999999987  5689999876553  3467889999999888766665432221  2  2467999988


Q ss_pred             CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccccc--CcEEeCCCCCeeEecccccccc
Q 015931          143 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP--SNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       143 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp--~NIll~~~~~~kl~DfGla~~~  218 (398)
                      -.|.+.-...          +-    +-...+++.---|...+   |-|..|.-  .||++.+ ..+.|+||.-|+.-
T Consensus        97 ~~L~~~~~~~----------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~k  156 (201)
T COG2112          97 RPLGKLEIGG----------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATFK  156 (201)
T ss_pred             cchhhhhhcc----------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence            8887765431          11    22334556655566666   99999874  4555544 49999999988743

>PLN02876 acyl-CoA dehydrogenase

Probab=98.09  E-value=4.6e-05  Score=81.49  Aligned_cols=80  Identities=21%  Similarity=0.319  Sum_probs=55.9

Q ss_pred             CceecccCceEEEEeeeCCCC--cEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCe--eceeeEEEcCC--CcEEEE
Q 015931           65 GRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNI--VPLVGFCIDPE--QGLFLI  136 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~~--~~~~lV  136 (398)
                      .+.++.|.++.+|+......+  ..+++|+..... ......+.+|+.+++.+. |.++  .+++.+|.+..  +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            467889999999998765422  467777764432 123356889999999985 6664  67777776532  346899


Q ss_pred             EecCCCCC
Q 015931          137 YKYVSGGS  144 (398)
Q Consensus       137 ~e~~~~gs  144 (398)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.05  E-value=7.2e-05  Score=68.06  Aligned_cols=143  Identities=16%  Similarity=0.126  Sum_probs=80.3

Q ss_pred             ecccCc-eEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEEecCCCCCH
Q 015931           68 LGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSL  145 (398)
Q Consensus        68 lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~~gsL  145 (398)
                      |-.|.+ ..||+....  +..+.+|+.....   ...+..|++++..+. +--+.+++++.... +..++|||+++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCCccH
Confidence            444555 789998764  3578888875442   334667888887774 33344556654443 346899999999877


Q ss_pred             HHHHh----------------hhccCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHc----
Q 015931          146 ERHLH----------------EKKKGVRGNSTLPW--SVRYKVAL--------------------GIAESVAYLHN----  183 (398)
Q Consensus       146 ~~~l~----------------~~~~~~~~~~~l~~--~~~~~i~~--------------------qia~aL~yLH~----  183 (398)
                      .....                .-........++..  ........                    .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            64321                00000000011110  00000000                    01111222211    


Q ss_pred             CCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       184 ~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      .....++|+|+.|.||+++++..+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            123569999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.92  E-value=4.6e-05  Score=80.65  Aligned_cols=198  Identities=19%  Similarity=0.201  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHHhCCCCCeeceeeEEEcCCCc---EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 015931          102 KAFCRELMIASSLHHPNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV  178 (398)
Q Consensus       102 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL  178 (398)
                      ..-..|.+.+..+.|+|++.++.|..+....   ..+..+++..-++...+...       ..++.++.+.+..++.+||
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-------~~i~~~~~r~~~~~~~~GL  299 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-------GSIPLETLRILHQKLLEGL  299 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-------cccCHHHHHHHHHHHhhhH
Confidence            3345677788889999999999987654332   23456788888888888764       5688999999999999999


Q ss_pred             HHHHcCCCCceeecccccC---cEEeCCCCCeeEe--ccccccccCCCCCceeeeccccCCCcccchhhccCCcC--Ccc
Q 015931          179 AYLHNGTERCVVHRDIKPS---NILLSSKKIPKLC--DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS--DKT  251 (398)
Q Consensus       179 ~yLH~~~~~~ivHrDlkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~ks  251 (398)
                      .|+|+..   ..|.-+..+   +.-.+..+....+  ||+..+.+......   ....-+..+.+||......++  ...
T Consensus       300 ~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~  373 (1351)
T KOG1035|consen  300 AYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLT  373 (1351)
T ss_pred             HHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhh
Confidence            9999875   666555554   4444555666666  88887766554322   222345557888877655443  447


Q ss_pred             chhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCC
Q 015931          252 DVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESR  331 (398)
Q Consensus       252 Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~  331 (398)
                      |+|.+|..+..+..|..+-....                    .+..+++...     ..    .+.+....|+.-++++
T Consensus       374 dL~~lgll~~~~~~~~~i~~~~~--------------------~~~~~l~~~~-----~~----~~~d~~~~~~~~~~~~  424 (1351)
T KOG1035|consen  374 DLWCLGLLLLQLSQGEDISEKSA--------------------VPVSLLDVLS-----TS----ELLDALPKCLDEDSEE  424 (1351)
T ss_pred             HHHHHHHHHhhhhhcCccccccc--------------------chhhhhcccc-----ch----hhhhhhhhhcchhhhh
Confidence            99999999999998876533211                    1111111111     11    3455566899999999


Q ss_pred             CCCHHHHHHH
Q 015931          332 RPGIEEIIAI  341 (398)
Q Consensus       332 RPt~~evl~~  341 (398)
                      |++..+++..
T Consensus       425 Rl~~~~ll~~  434 (1351)
T KOG1035|consen  425 RLSALELLTH  434 (1351)
T ss_pred             ccchhhhhhc
Confidence            9999999974

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.92  E-value=0.00011  Score=66.45  Aligned_cols=73  Identities=11%  Similarity=0.137  Sum_probs=43.1

Q ss_pred             ceecccCce-EEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCC---CeeceeeEEEcCC--CcEEEEEec
Q 015931           66 RVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP---NIVPLVGFCIDPE--QGLFLIYKY  139 (398)
Q Consensus        66 ~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~--~~~~lV~e~  139 (398)
                      +.|+.||.. .||+.     +..+.+|.....  .....+.+|.+.+..+...   -+.++++.....+  ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457777766 58975     234677765432  2344688899888877531   2233333222211  234789999


Q ss_pred             CCCCCH
Q 015931          140 VSGGSL  145 (398)
Q Consensus       140 ~~~gsL  145 (398)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            998766

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.81  E-value=0.00023  Score=64.20  Aligned_cols=145  Identities=19%  Similarity=0.233  Sum_probs=80.0

Q ss_pred             ceecccCceEEEEeeeCC-CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeec-eeeEEEcCCCcEEEEEecCCCC
Q 015931           66 RVLGRGALSFVFKGKVGL-LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP-LVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      +.|..|-...+|+..... .+..|.+|+....... .....+|+.++..+...++++ +++. .+  +  .+||||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~-~~--~--~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYAT-FQ--N--GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEE-eC--C--cEEEEeeCCC
Confidence            457778888999987653 2467888977543221 122346888888875444443 3332 22  2  3799999987


Q ss_pred             CHHHH--------------Hhhhcc-CCCC-------CCCCCHHHHHHHHH----------------------HHH---H
Q 015931          144 SLERH--------------LHEKKK-GVRG-------NSTLPWSVRYKVAL----------------------GIA---E  176 (398)
Q Consensus       144 sL~~~--------------l~~~~~-~~~~-------~~~l~~~~~~~i~~----------------------qia---~  176 (398)
                      ++...              +.+-.. ....       ...-.|+.+..+..                      .+.   .
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            65211              111110 0000       01111222222211                      111   1


Q ss_pred             HH-HHHHcC-CCCceeecccccCcEEeCC-CCCeeEecccccc
Q 015931          177 SV-AYLHNG-TERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  216 (398)
Q Consensus       177 aL-~yLH~~-~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla~  216 (398)
                      .| +.+-.. ....++|+|+.+.|||+++ ++.+.+.||..|.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            11 112221 2346999999999999998 5789999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.77  E-value=0.00048  Score=64.65  Aligned_cols=79  Identities=10%  Similarity=-0.008  Sum_probs=54.9

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCC---CCeeceeeEEEcC--CCcEEEEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH---PNIVPLVGFCIDP--EQGLFLIY  137 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--~~~~~lV~  137 (398)
                      ...+.||.|..+.||.....+ + .+.+|..+..  .....+..|.+.|+.+.-   -.+.+++++|...  .+..++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            345679999999999986543 3 4666774331  123578899999988753   3567777776543  24469999


Q ss_pred             ecCCCCCH
Q 015931          138 KYVSGGSL  145 (398)
Q Consensus       138 e~~~~gsL  145 (398)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.64  E-value=0.0007  Score=59.04  Aligned_cols=126  Identities=22%  Similarity=0.291  Sum_probs=88.6

Q ss_pred             cCCCCCceecccCc-eEEEEeeeCCCCcEEEEEEecC---CCh------------------hhHHHHHHHHHHHHhCC--
Q 015931           60 HNFSKGRVLGRGAL-SFVFKGKVGLLRTSVAIKRLDK---EDK------------------ESSKAFCRELMIASSLH--  115 (398)
Q Consensus        60 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--  115 (398)
                      .+++..+.||.|.- |.||++...  |..+|+|.+..   ...                  .-...|..|.....+++  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78888999999999 999999986  77999999321   100                  11234778887777664  


Q ss_pred             -CCCe--eceeeEEEcCC-----------------CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHH
Q 015931          116 -HPNI--VPLVGFCIDPE-----------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  175 (398)
Q Consensus       116 -h~ni--v~l~~~~~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia  175 (398)
                       +.++  |+++||..-..                 ....||.||.+...                .+.-    +-+.++.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~----~~~~~~~  174 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQI----RDIPQML  174 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccch----hHHHHHH
Confidence             5566  99999863220                 11357888776543                1222    2344567


Q ss_pred             HHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       176 ~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      +-+..+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       175 ~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  175 RDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            7788899988   999999999986     4589999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.60  E-value=0.0013  Score=60.34  Aligned_cols=141  Identities=18%  Similarity=0.204  Sum_probs=77.4

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeec-eeeEEEcCCCcEEEEEecCCCCCHH
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP-LVGFCIDPEQGLFLIYKYVSGGSLE  146 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~~lV~e~~~~gsL~  146 (398)
                      +..|-.+.+|+...  ++..+.+|..............+|..+++.+....+++ ++..  . .+  ++||||++|..+.
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~-~~--~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV--N-EH--WLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE--e-CC--EEEEEeccCcccc
Confidence            45577789998874  36678888765432221123567888888876444433 3332  2 22  6899999986653


Q ss_pred             H--------------HHhhhccCCCCCCCCCHHHH-HHHHHHH---------HHHHHHHHcC-----CCCceeecccccC
Q 015931          147 R--------------HLHEKKKGVRGNSTLPWSVR-YKVALGI---------AESVAYLHNG-----TERCVVHRDIKPS  197 (398)
Q Consensus       147 ~--------------~l~~~~~~~~~~~~l~~~~~-~~i~~qi---------a~aL~yLH~~-----~~~~ivHrDlkp~  197 (398)
                      .              .+.+-........+++.... ..+..++         ...+..+-..     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            2              11111110001122222211 1111111         1112222211     1345899999999


Q ss_pred             cEEeCCCCCeeEecccccc
Q 015931          198 NILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~  216 (398)
                      ||++++++ +.|.||..+.
T Consensus       157 Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC-CEEEeccccC
Confidence            99999877 7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.51  E-value=0.00078  Score=63.33  Aligned_cols=145  Identities=21%  Similarity=0.237  Sum_probs=81.4

Q ss_pred             ceecccCceEEEEeeeCC------CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCee-ceeeEEEcCCCcEEEEEe
Q 015931           66 RVLGRGALSFVFKGKVGL------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~lV~e  138 (398)
                      +.|..|-...+|+.....      .++.+++|+..... .......+|.+++..+...++. ++++++ . +   .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-~-~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIF-P-N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEe-C-C---Cchhh
Confidence            345556677899887643      25788899876543 2223456788787777543344 344432 2 2   26899


Q ss_pred             cCCCCCHHHH--------------H---hhhccCC--CC--CCCCCHHHHHHH--------------------------H
Q 015931          139 YVSGGSLERH--------------L---HEKKKGV--RG--NSTLPWSVRYKV--------------------------A  171 (398)
Q Consensus       139 ~~~~gsL~~~--------------l---~~~~~~~--~~--~~~l~~~~~~~i--------------------------~  171 (398)
                      |++|..+...              +   +......  ..  ..+.-|.....+                          .
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9988766431              1   1111000  00  001112111111                          1


Q ss_pred             HHHHHHHHHHHc------CCCCceeecccccCcEEeCCC----CCeeEecccccc
Q 015931          172 LGIAESVAYLHN------GTERCVVHRDIKPSNILLSSK----KIPKLCDFGLAT  216 (398)
Q Consensus       172 ~qia~aL~yLH~------~~~~~ivHrDlkp~NIll~~~----~~~kl~DfGla~  216 (398)
                      ..+...+..|-.      .....++|+|+.+.||+++++    +.++++||..|.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122223334432      234579999999999999985    889999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.50  E-value=0.0039  Score=59.08  Aligned_cols=31  Identities=29%  Similarity=0.530  Sum_probs=26.1

Q ss_pred             CCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ..+++|+|+.|.||+++++...-|.||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            3469999999999999976556899999765

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.40  E-value=0.0049  Score=57.68  Aligned_cols=147  Identities=16%  Similarity=0.175  Sum_probs=83.1

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eeceeeE-----EEcCCCcEEEEE
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGF-----CIDPEQGLFLIY  137 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~~lV~  137 (398)
                      .+.|..|....+|+....  +..+++|+....   .......|+.++..+.+.+  +.+++..     ....++..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            456777777899998764  346888987642   2344566777777664322  3343321     112233468999


Q ss_pred             ecCCCCCHHH-----------H---HhhhccCCC----CCCCCCHHHHHH----------HHHHHHHHHHHHHc----CC
Q 015931          138 KYVSGGSLER-----------H---LHEKKKGVR----GNSTLPWSVRYK----------VALGIAESVAYLHN----GT  185 (398)
Q Consensus       138 e~~~~gsL~~-----------~---l~~~~~~~~----~~~~l~~~~~~~----------i~~qia~aL~yLH~----~~  185 (398)
                      +|++|..+..           .   ++.......    ......|.....          ....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999866421           1   111110000    001123322210          11123344555543    12


Q ss_pred             CCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ..+++|+|+.|.||+++++..+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3459999999999999998777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.35  E-value=4.1e-05  Score=82.88  Aligned_cols=163  Identities=12%  Similarity=-0.074  Sum_probs=118.1

Q ss_pred             HHHHHHHHHhCCCCCeeceeeEEEcC-CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015931          104 FCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH  182 (398)
Q Consensus       104 ~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH  182 (398)
                      ...|...++...|+++.....-.... +...+.+++++.+|.+.+.+-++..   ....++.........+...+..-+|
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e---e~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE---ESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc---cCCcchhchHHHHHHHHHhccchhh
Confidence            34555566667899888766532221 2235799999999999999987532   2345555555544444455555555


Q ss_pred             cC--CCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHH
Q 015931          183 NG--TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVL  260 (398)
Q Consensus       183 ~~--~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl  260 (398)
                      +.  .....+|+++|+-|.+|..+.++|++++|+.+...+...  ......+++.|++|+..+.-.++.++|+|..|+-+
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence            43  344589999999999999999999999999984333221  12345678889999999988999999999999999


Q ss_pred             HHHHcCCCCCc
Q 015931          261 LELLTGRKPIE  271 (398)
Q Consensus       261 ~elltG~~Pf~  271 (398)
                      |+...|..+|-
T Consensus      1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred             HHHhcccHHHH
Confidence            99988887763

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.35  E-value=0.0062  Score=59.21  Aligned_cols=76  Identities=17%  Similarity=0.086  Sum_probs=51.2

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC------C-hhhHHHHHHHHHHHHhCC---CCCeeceeeEEEcCCCcEEE
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------D-KESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~l  135 (398)
                      +.||.|.+..||++...+.++.|.||.-...      . +-....+..|.+.|..+.   ..++.+++.+  +.+. .++
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~-~~l  108 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL-AVT  108 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC-CEE
Confidence            5789999999999998753358999985321      1 123456677888887753   2345556654  3333 579


Q ss_pred             EEecCCCCC
Q 015931          136 IYKYVSGGS  144 (398)
Q Consensus       136 V~e~~~~gs  144 (398)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.24  E-value=0.013  Score=55.16  Aligned_cols=148  Identities=16%  Similarity=0.200  Sum_probs=79.9

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eeceeeE-----EEcCCCcEEEEE
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGF-----CIDPEQGLFLIY  137 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~~lV~  137 (398)
                      .+.++.|....+|+....  +..+.+|+......  ......|.+++..+...+  +.+++..     +...++..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            445677777899998754  33577887754321  233445666666653222  3333321     112234468999


Q ss_pred             ecCCCCCHH-----------HH---HhhhccCCCCCC-----CCCHHHHHH------------HHHHHHHHHHHHHc---
Q 015931          138 KYVSGGSLE-----------RH---LHEKKKGVRGNS-----TLPWSVRYK------------VALGIAESVAYLHN---  183 (398)
Q Consensus       138 e~~~~gsL~-----------~~---l~~~~~~~~~~~-----~l~~~~~~~------------i~~qia~aL~yLH~---  183 (398)
                      +|++|..+.           ..   ++....+.....     .-.|.....            ....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885431           11   111111110000     112221110            01123334555542   


Q ss_pred             -CCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          184 -GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       184 -~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                       ....+++|+|+++.||++++++...|.||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             224569999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.20  E-value=0.0056  Score=56.78  Aligned_cols=33  Identities=27%  Similarity=0.425  Sum_probs=26.4

Q ss_pred             CCceeecccccCcEEeCCCCC-eeEecccccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKKI-PKLCDFGLATWT  218 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~-~kl~DfGla~~~  218 (398)
                      ...++|+|++|.||++++++. .-|.||+.+..-
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            345999999999999997555 459999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.14  E-value=0.0056  Score=57.50  Aligned_cols=134  Identities=20%  Similarity=0.309  Sum_probs=73.9

Q ss_pred             CcEEEEEEecC--CChhhHHHHHHHHHHHHhCCC--CCeeceeeEEEcCC-CcEEEEEecCCCCCHHH------------
Q 015931           85 RTSVAIKRLDK--EDKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPE-QGLFLIYKYVSGGSLER------------  147 (398)
Q Consensus        85 ~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~~~lV~e~~~~gsL~~------------  147 (398)
                      ++++.+. ...  ..........+|..+++.+.-  .-+-..+++|.++. +..+.||+|++|..+.+            
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            6777777 321  222344555677777776532  22344566776665 55799999998842221            


Q ss_pred             ------HHhhhccC-------------CCCCCCCCHHHHHHHH--------HHHHHHHHHHHcC-----CCCceeecccc
Q 015931          148 ------HLHEKKKG-------------VRGNSTLPWSVRYKVA--------LGIAESVAYLHNG-----TERCVVHRDIK  195 (398)
Q Consensus       148 ------~l~~~~~~-------------~~~~~~l~~~~~~~i~--------~qia~aL~yLH~~-----~~~~ivHrDlk  195 (398)
                            +|..-..-             ....+.-.|...++.+        -....-..+|+.+     +..+++|+|+.
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                  11110000             0000111122222100        0111223444443     24569999999


Q ss_pred             cCcEEeCCCCCeeEeccccccccC
Q 015931          196 PSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       196 p~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +.|++++++..+=|.||+++..-+
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccCC
Confidence            999999998889999999987543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.99  E-value=0.001  Score=61.72  Aligned_cols=138  Identities=17%  Similarity=0.114  Sum_probs=90.7

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh----------------------hHHHHHHHHHHHHhCC-CC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE----------------------SSKAFCRELMIASSLH-HP  117 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~-h~  117 (398)
                      -++.++.||-|--+-||.+.... |...++|.-...+..                      +.-...+|...|+.+. |-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            46788999999999999998864 788888854322100                      0112446777777764 22


Q ss_pred             C-eeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccccc
Q 015931          118 N-IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  196 (398)
Q Consensus       118 n-iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp  196 (398)
                      . +.+.+++    + +-++|||++.+-.|...-+-          .+..++   ...+..-+--|-.+|   +||+|.+-
T Consensus       172 fpVPkpiD~----~-RH~Vvmelv~g~Pl~~v~~v----------~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNE  230 (465)
T KOG2268|consen  172 FPVPKPIDH----N-RHCVVMELVDGYPLRQVRHV----------EDPPTL---YDDLMGLIVRLANHG---LIHGDFNE  230 (465)
T ss_pred             CCCCCcccc----c-ceeeHHHhhcccceeeeeec----------CChHHH---HHHHHHHHHHHHHcC---ceecccch
Confidence            2 3334443    2 24799999988777554322          222333   333333444555666   99999999


Q ss_pred             CcEEeCCCCCeeEeccccccccCC
Q 015931          197 SNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       197 ~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      -||++++++.++++||--....+.
T Consensus       231 FNimv~dd~~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  231 FNIMVKDDDKIVVIDFPQMVSTSH  254 (465)
T ss_pred             heeEEecCCCEEEeechHhhccCC
Confidence            999999999999999976554443

>PLN02236 choline kinase

Probab=96.96  E-value=0.0074  Score=57.88  Aligned_cols=144  Identities=16%  Similarity=0.188  Sum_probs=79.4

Q ss_pred             eecccCceEEEEeeeCC----CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCee-ceeeEEEcCCCcEEEEEecCC
Q 015931           67 VLGRGALSFVFKGKVGL----LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      .|-.|-...+|+.....    .++.|.+|+......... .-.+|..++..+...++. ++++. .. ++   .|++|++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~-~~-~g---~v~efi~  116 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGR-FP-NG---RVEEFIH  116 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEE-EC-Cc---eEEEeeC
Confidence            44447778899886532    236788998765432222 235688887777544444 33443 22 22   5799998


Q ss_pred             CCCHHHH--------------Hhhhcc-CCCC-CCCCCHHHHHHHHHHH-----------------HHHHHH----HHc-
Q 015931          142 GGSLERH--------------LHEKKK-GVRG-NSTLPWSVRYKVALGI-----------------AESVAY----LHN-  183 (398)
Q Consensus       142 ~gsL~~~--------------l~~~~~-~~~~-~~~l~~~~~~~i~~qi-----------------a~aL~y----LH~-  183 (398)
                      +.+|...              +.+-.. .... .....|..+.++..++                 ...+..    +.. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7666321              111010 0000 1122344443433222                 111222    222 


Q ss_pred             CCCCceeecccccCcEEeCC-CCCeeEecccccc
Q 015931          184 GTERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  216 (398)
Q Consensus       184 ~~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla~  216 (398)
                      .....++|+|+++.||++++ ++.+.++||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            22346999999999999986 4689999998765

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.80  E-value=0.02  Score=54.65  Aligned_cols=74  Identities=18%  Similarity=0.108  Sum_probs=46.5

Q ss_pred             eecccCceEEEEeeeCCCCcEEEEEEecC-------CChhhHHHHHHHHHHHHhCC--CCCeec-eeeEEEcCCCcEEEE
Q 015931           67 VLGRGALSFVFKGKVGLLRTSVAIKRLDK-------EDKESSKAFCRELMIASSLH--HPNIVP-LVGFCIDPEQGLFLI  136 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~niv~-l~~~~~~~~~~~~lV  136 (398)
                      .||.|....||++.....++.|+||.-..       .-+-...+...|.+.|....  -|..|+ ++.  .+.+. ..+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~-~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEM-AVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ecccc-ceeh
Confidence            47999999999999764336899997532       11223344556777776653  354444 443  34333 4699


Q ss_pred             EecCCCC
Q 015931          137 YKYVSGG  143 (398)
Q Consensus       137 ~e~~~~g  143 (398)
                      ||+++..
T Consensus        79 MEdL~~~   85 (370)
T TIGR01767        79 MEDLSHH   85 (370)
T ss_pred             HhhCccc
Confidence            9999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.53  E-value=0.025  Score=53.63  Aligned_cols=143  Identities=14%  Similarity=0.092  Sum_probs=92.8

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCC------------------------hhh--HHHHHHHHHHHHhCCCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------------------------KES--SKAFCRELMIASSLHHPN  118 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------------~~~--~~~~~~E~~~l~~l~h~n  118 (398)
                      ...|..|--+-||.+...+ |..+|||+++.+-                        +..  .--...|+.-|.+++...
T Consensus       149 nGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            3567788889999998764 8889999985420                        000  011345667777776544


Q ss_pred             eeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCc
Q 015931          119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  198 (398)
Q Consensus       119 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~N  198 (398)
                      |.-.--....  + -.|||+|+ |.+=+-.-.-      ....++...+..+..|++.-+.-|.+.+  ++||.||.--|
T Consensus       228 IP~PePIlLk--~-hVLVM~Fl-Grdgw~aPkL------Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN  295 (520)
T KOG2270|consen  228 IPCPEPILLK--N-HVLVMEFL-GRDGWAAPKL------KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFN  295 (520)
T ss_pred             CCCCCceeee--c-ceEeeeec-cCCCCcCccc------ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhh
Confidence            3221111111  2 26999999 4332111110      1245777788889999999988888755  49999999999


Q ss_pred             EEeCCCCCeeEeccccccccCCC
Q 015931          199 ILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       199 Ill~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+- +|.+.++|.+-+.....+
T Consensus       296 ~Lyh-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  296 LLYH-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             heEE-CCEEEEEEccccccCCCh
Confidence            9985 468899998877655444

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.45  E-value=0.0045  Score=60.84  Aligned_cols=51  Identities=20%  Similarity=0.236  Sum_probs=41.3

Q ss_pred             HHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhh
Q 015931          101 SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK  152 (398)
Q Consensus       101 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~  152 (398)
                      ..++.-...+++.+.|+|+..++.+......+..+|+|++ +.||.+.+..+
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            3456677889999999999999987655555678999999 88999998765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.44  E-value=0.022  Score=53.76  Aligned_cols=32  Identities=19%  Similarity=0.313  Sum_probs=28.1

Q ss_pred             CCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ..+++|+|+.+.||++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44699999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.44  E-value=0.073  Score=50.08  Aligned_cols=30  Identities=33%  Similarity=0.379  Sum_probs=25.5

Q ss_pred             CCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            356999999999999987 678999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.41  E-value=0.056  Score=52.62  Aligned_cols=73  Identities=15%  Similarity=0.126  Sum_probs=47.7

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCC-----C--hhhHHHHHHHHHHHHhCC---CCCeeceeeEEEcCCCcEE
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----D--KESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~  134 (398)
                      .+.||.|....||+....  +..+.||.-...     .  +....+-..|.+.|..+.   ..++.+++.+|.+  . -+
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~-~v  111 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--M-AL  111 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--C-CE
Confidence            467899999999998764  456889976521     1  113333445566666553   2467777777643  2 47


Q ss_pred             EEEecCCC
Q 015931          135 LIYKYVSG  142 (398)
Q Consensus       135 lV~e~~~~  142 (398)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            89999976

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.41  E-value=0.01  Score=56.05  Aligned_cols=117  Identities=17%  Similarity=0.182  Sum_probs=75.3

Q ss_pred             CCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccccc
Q 015931          117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  196 (398)
Q Consensus       117 ~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp  196 (398)
                      ++..+.+-+-.++..+.|++|++. |++|...           ....|++...|+.+.+..++-+...  -+.-|||+.-
T Consensus       285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i-----------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~  350 (488)
T COG5072         285 VFLETLKVVSLDETLYLYLHFKDH-GTPISII-----------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTL  350 (488)
T ss_pred             hhhhcceEEecCCceEEEEEEecC-Cceeeee-----------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccc
Confidence            334443333234444567788876 5555322           2356889999999988888888763  4589999999


Q ss_pred             CcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhH
Q 015931          197 SNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAF  256 (398)
Q Consensus       197 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~  256 (398)
                      .||||+ +|++.|+||-+++.-.....       .-....--|-.+. |.-+..-+||-+
T Consensus       351 ~niLId-~GnvtLIDfklsRl~~~q~~-------isy~rldhp~lF~-G~dd~QFeIYrl  401 (488)
T COG5072         351 DNILID-EGNVTLIDFKLSRLSYSQGI-------ISYNRLDHPDLFN-GVDDYQFEIYRL  401 (488)
T ss_pred             cceeee-cCceEEEEeeeeecccCCce-------eeccccCchhhhc-CccceeeeHHHH
Confidence            999999 99999999999984333221       1111223344444 333566677754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.23  E-value=0.039  Score=52.59  Aligned_cols=144  Identities=16%  Similarity=0.250  Sum_probs=78.1

Q ss_pred             eecccCceEEEEeeeCCC---CcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCee-ceeeEEEcCCCcEEEEEecCCC
Q 015931           67 VLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYKYVSG  142 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~lV~e~~~~  142 (398)
                      .|..|-...+|+......   +..|.+|+....... .-.-.+|..++..+..-++. ++++++ . ++   +|.+|+++
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G---~i~~fi~g   94 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-G-NG---MIQSFINA   94 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-C-Cc---EeehhhcC
Confidence            444466778888865432   237888887654322 22235688888877655554 344433 2 22   58999977


Q ss_pred             CCHHH--------------HHhhhcc-CCCC-CCCCCHHHHHHHHHHH----------------------HHHHHH---H
Q 015931          143 GSLER--------------HLHEKKK-GVRG-NSTLPWSVRYKVALGI----------------------AESVAY---L  181 (398)
Q Consensus       143 gsL~~--------------~l~~~~~-~~~~-~~~l~~~~~~~i~~qi----------------------a~aL~y---L  181 (398)
                      ..|..              .+..-.. .... ..+-.|..+.++..++                      .+-+..   +
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65521              1111111 0000 1112344443333222                      111111   1


Q ss_pred             H-c-CCCCceeecccccCcEEeCC-CCCeeEecccccc
Q 015931          182 H-N-GTERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  216 (398)
Q Consensus       182 H-~-~~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla~  216 (398)
                      . . ..+...+|.|+.+.||++++ ++.++++||..|.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            1 1 12345899999999999974 5789999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.15  E-value=0.014  Score=51.74  Aligned_cols=30  Identities=37%  Similarity=0.548  Sum_probs=21.5

Q ss_pred             CceeecccccCcEEe-CCCCCeeEecccccc
Q 015931          187 RCVVHRDIKPSNILL-SSKKIPKLCDFGLAT  216 (398)
Q Consensus       187 ~~ivHrDlkp~NIll-~~~~~~kl~DfGla~  216 (398)
                      ..++|.|+.|.||++ +.++.++++||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            468999999999999 888999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.15  E-value=0.072  Score=49.62  Aligned_cols=74  Identities=12%  Similarity=0.128  Sum_probs=44.2

Q ss_pred             CCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCCeeceeeEEEcCCCcEEEEEecC
Q 015931           64 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        64 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      ..+.++.|....+|+..  .+++.+-||.-..   .....|..|.+-|+.+.   --.+.+.+++....+. .+||+||+
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-~fLlle~l   94 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-AFLLLEFL   94 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-CEEEEE--
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-ceEEEEee
Confidence            34578889999999987  3477899998762   23345778888887773   3345667776554333 48999999


Q ss_pred             CCC
Q 015931          141 SGG  143 (398)
Q Consensus       141 ~~g  143 (398)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.11  E-value=0.038  Score=53.49  Aligned_cols=75  Identities=23%  Similarity=0.230  Sum_probs=48.0

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecC------CChhhHHHHHHHHHHHHhCC--CCCeec-eeeEEEcCCCcEEE
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLH--HPNIVP-LVGFCIDPEQGLFL  135 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~niv~-l~~~~~~~~~~~~l  135 (398)
                      .+.||-|....||++.+...+..|+||.-..      +-+-...+...|.+.|+...  -|..|+ ++.  .+++. ..+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~-~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVM-NCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHH-hhH
Confidence            4578999999999998753356799986432      11233455566777777653  354444 543  34333 469


Q ss_pred             EEecCCC
Q 015931          136 IYKYVSG  142 (398)
Q Consensus       136 V~e~~~~  142 (398)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            9999864

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.93  E-value=0.12  Score=49.14  Aligned_cols=145  Identities=19%  Similarity=0.265  Sum_probs=79.6

Q ss_pred             eecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCC---CC---eeceeeEE---EcCCCcEEEEE
Q 015931           67 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH---PN---IVPLVGFC---IDPEQGLFLIY  137 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~n---iv~l~~~~---~~~~~~~~lV~  137 (398)
                      .|.+ .-..||+....+ | .+++|+....  ....++..|...+..+.-   +=   +..+-|-.   ..+..+.+-++
T Consensus        33 ~l~s-~eN~~f~~~~~~-g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTED-G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecC-C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            3444 556788888764 3 3488988765  334555666666666531   11   22222211   11112567899


Q ss_pred             ecCCCCCHHH---------------HHhhhccC-----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHcC
Q 015931          138 KYVSGGSLER---------------HLHEKKKG-----VRGNSTLPWSV-------------RYKVALGIAESVAYLHNG  184 (398)
Q Consensus       138 e~~~~gsL~~---------------~l~~~~~~-----~~~~~~l~~~~-------------~~~i~~qia~aL~yLH~~  184 (398)
                      +|++|..+..               .++...++     ........|..             ......++...+..+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999987772               11111111     11112344541             011223333444444432


Q ss_pred             ----CCC---ceeecccccCcEEeCCCCC-eeEecccccc
Q 015931          185 ----TER---CVVHRDIKPSNILLSSKKI-PKLCDFGLAT  216 (398)
Q Consensus       185 ----~~~---~ivHrDlkp~NIll~~~~~-~kl~DfGla~  216 (398)
                          -..   .+||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                122   2999999999999998875 8899999764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.87  E-value=0.058  Score=47.68  Aligned_cols=153  Identities=16%  Similarity=0.202  Sum_probs=91.1

Q ss_pred             cCceEEEEeeeCCCCcEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHH
Q 015931           71 GALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL  149 (398)
Q Consensus        71 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l  149 (398)
                      |+-++.-.+.... | +..+|++....-. ...-|.++..++.+++  .|+++..   +.....-++.|.|.....    
T Consensus        73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i----  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI----  141 (308)
T ss_pred             CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc----
Confidence            3444444444432 2 3556666543333 3455778888888875  4677762   323335688998843211    


Q ss_pred             hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeec
Q 015931          150 HEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT  229 (398)
Q Consensus       150 ~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  229 (398)
                                   ..   ..++..=+.+|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+...  .          
T Consensus       142 -------------~~---~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~----------  192 (308)
T PF07387_consen  142 -------------NF---SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E----------  192 (308)
T ss_pred             -------------ch---hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--h----------
Confidence                         11   112222246788889653 459999999999999999999999976432  1          


Q ss_pred             cccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCC
Q 015931          230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK  268 (398)
Q Consensus       230 ~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~  268 (398)
                        .+..|.--|+   ...|.++.+-+|=.-++++....+
T Consensus       193 --~~V~~vN~~Y---~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  193 --NQVNMVNIEY---ESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             --heeeEEeeec---cccChHHHHHHHHHHHHHHHHHHh
Confidence              0111222222   234667777777777777776443

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.43  E-value=0.055  Score=52.07  Aligned_cols=61  Identities=28%  Similarity=0.320  Sum_probs=44.3

Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceeecccccCcEEeCCC
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL-HNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      ..++-+|.+|.++..++....        .+++...+++.--++|+--+ --.+   .+|.|+.|.||++.-+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~--------~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS--------QPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhccc--------ChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEec
Confidence            457788999999999997643        45566677776666665433 2334   9999999999999543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.33  E-value=0.37  Score=45.82  Aligned_cols=72  Identities=17%  Similarity=0.068  Sum_probs=40.4

Q ss_pred             cCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCC--Ceecee---e-EEEcCCCcEEEEEecCCCCC
Q 015931           71 GALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP--NIVPLV---G-FCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        71 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---~-~~~~~~~~~~lV~e~~~~gs  144 (398)
                      +.-..||+....+ +..+++|+..... .....+..|++.+..+...  .++...   | ....-++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~-~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDED-GRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCC-CCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            4456789887643 6679999875432 2345566677666655321  122211   1 11111344678999998764

>PRK06148 hypothetical protein; Provisional

Probab=95.17  E-value=0.46  Score=52.30  Aligned_cols=31  Identities=35%  Similarity=0.456  Sum_probs=25.9

Q ss_pred             CCceeecccccCcEEeCCCC--Cee-Eecccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKK--IPK-LCDFGLAT  216 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~--~~k-l~DfGla~  216 (398)
                      ...+||+|+++.||+++.+.  .+. |+|||-+.
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            34599999999999999775  555 99999875

>PTZ00384 choline kinase; Provisional

Probab=94.42  E-value=0.43  Score=46.43  Aligned_cols=76  Identities=20%  Similarity=0.178  Sum_probs=44.4

Q ss_pred             ceecccCceEEEEeeeCCCC-c-----EEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           66 RVLGRGALSFVFKGKVGLLR-T-----SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      +.|..|-...+|++...... .     .|.++..... ....-.-.+|++++..+...++.+-+-.+..  +  .+|+||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--~--g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--D--FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC--C--EEEEEE
Confidence            35555888899998754321 1     2444443221 1111223468888888876666665433332  2  599999


Q ss_pred             CCCCCHH
Q 015931          140 VSGGSLE  146 (398)
Q Consensus       140 ~~~gsL~  146 (398)
                      ++|-+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987663

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=94.36  E-value=0.012  Score=57.60  Aligned_cols=73  Identities=25%  Similarity=0.409  Sum_probs=60.5

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEc
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCID  128 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  128 (398)
                      ....++|..+..+|.|+||+|+.+....++..+|||+|.... .....+..+|+..+.++.|++++++...+..
T Consensus        45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence            344578999999999999999999998777789999997553 3455677889999999999999998766554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	398
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-40
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-37
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-37
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-33
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-33
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-30
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-30
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-30
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-23
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-20
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-18
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-18
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-17
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-15
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-14
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-13
3soa_A	444	Full-Length Human Camkii Length = 444		8e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-07
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 104/303 (34%), Positives = 165/303 (54%), Gaps = 12/303 (3%)
Query: 46  SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AF 104
            L R S  E+  A+ NFS   +LGRG    V+KG++    T VA+KRL +E  +  +  F
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERXQGGELQF 82
Query: 105 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
             E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       L W
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPPLDW 138
Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
             R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA         
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX- 197
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL- 283
            +   V+GT G++APEY   GK S+KTDV+ +GV+LLEL+TG++  +  RL  +++++L 
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 257
Query: 284 -WAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAIL 342
            W K +L      +E L+D  L+   ++             C  S    RP + E++ +L
Sbjct: 258 DWVKGLLKE--KKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPMERPKMSEVVRML 314
Query: 343 RGE 345
            G+
Sbjct: 315 EGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 103/305 (33%), Positives = 164/305 (53%), Gaps = 16/305 (5%)
Query: 46  SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKEDKESSK- 102
            L R S  E+  A+ NF    +LGRG    V+KG++  G L   VA+KRL +E  +  + 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL---VAVKRLKEERTQGGEL 72
Query: 103 AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL 162
            F  E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       L
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPPL 128
Query: 163 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
            W  R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA       
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 282
              +   V+G  G++APEY   GK S+KTDV+ +GV+LLEL+TG++  +  RL  +++++
Sbjct: 189 X-HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 283 L--WAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIA 340
           L  W K +L      +E L+D  L+   ++             C  S    RP + E++ 
Sbjct: 248 LLDWVKGLLKE--KKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 341 ILRGE 345
           +L G+
Sbjct: 305 MLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 142/263 (53%), Gaps = 24/263 (9%)
Query: 49  RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCR 106
           R+   ++  AT+NF    ++G G    V+KG   +LR    VA+KR   E  +  + F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKG---VLRDGAKVALKRRTPESSQGIEEFET 84
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--- 163
           E+   S   HP++V L+GFC D    + LIYKY+  G+L+RHL+         S LP   
Sbjct: 85  EIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLY--------GSDLPTMS 135
Query: 164 --WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
             W  R ++ +G A  + YLH    R ++HRD+K  NILL    +PK+ DFG++   +  
Sbjct: 136 MSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
               L   VKGT GY+ PEYF  G++++K+DVY+FGVVL E+L  R  I     +   NL
Sbjct: 193 DQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 282 VLWAKPILHRGMAAVEELLDPRL 304
             WA    + G   +E+++DP L
Sbjct: 253 AEWAVESHNNGQ--LEQIVDPNL 273

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 96/263 (36%), Positives = 142/263 (53%), Gaps = 24/263 (9%)
Query: 49  RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCR 106
           R+   ++  AT+NF    ++G G    V+KG   +LR    VA+KR   E  +  + F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKG---VLRDGAKVALKRRTPESSQGIEEFET 84
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--- 163
           E+   S   HP++V L+GFC D    + LIYKY+  G+L+RHL+         S LP   
Sbjct: 85  EIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLY--------GSDLPTMS 135
Query: 164 --WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
             W  R ++ +G A  + YLH    R ++HRD+K  NILL    +PK+ DFG++   +  
Sbjct: 136 MSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
               L   VKGT GY+ PEYF  G++++K+DVY+FGVVL E+L  R  I     +   NL
Sbjct: 193 GQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 282 VLWAKPILHRGMAAVEELLDPRL 304
             WA    + G   +E+++DP L
Sbjct: 253 AEWAVESHNNGQ--LEQIVDPNL 273

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 156/304 (51%), Gaps = 26/304 (8%)
Query: 50  LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 99
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 100 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 159
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 127
Query: 160 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 219
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 279
             +   +   + GT  Y+APE  + G+++ K+D+Y+FGVVLLE++TG   ++  R   E 
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 240
Query: 280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 339
            L+L  K  +      +E+ +D ++     +S            C+  ++++RP I+++ 
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 340 AILR 343
            +L+
Sbjct: 299 QLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 156/304 (51%), Gaps = 26/304 (8%)
Query: 50  LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 99
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 100 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 159
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 127
Query: 160 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 219
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 279
             +   +   + GT  Y+APE  + G+++ K+D+Y+FGVVLLE++TG   ++  R   E 
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 240
Query: 280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 339
            L+L  K  +      +E+ +D ++     +S            C+  ++++RP I+++ 
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 340 AILR 343
            +L+
Sbjct: 299 QLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 156/304 (51%), Gaps = 26/304 (8%)
Query: 50  LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 99
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 66
Query: 100 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 159
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 121
Query: 160 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 219
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 279
             +   +   + GT  Y+APE  + G+++ K+D+Y+FGVVLLE++TG   ++  R   E 
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 234
Query: 280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 339
            L+L  K  +      +E+ +D ++     +S            C+  ++++RP I+++ 
Sbjct: 235 QLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 292
Query: 340 AILR 343
            +L+
Sbjct: 293 QLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 96/304 (31%), Positives = 151/304 (49%), Gaps = 26/304 (8%)
Query: 50  LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 99
            S+ E+   T+NF +      G   G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 63
Query: 100 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 159
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y   GSL   L      + G 
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDD-LCLVYVYXPNGSLLDRL----SCLDGT 118
Query: 160 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 219
             L W  R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 279
             +       + GT  Y APE  + G+++ K+D+Y+FGVVLLE++TG   ++  R   E 
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 231
Query: 280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 339
            L+L  K  +      +E+ +D   K    +S            C+  ++++RP I+++ 
Sbjct: 232 QLLLDIKEEIEDEEKTIEDYIDK--KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQ 289
Query: 340 AILR 343
            +L+
Sbjct: 290 QLLQ 293

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 143/282 (50%), Gaps = 44/282 (15%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G C
Sbjct: 16  VVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---ALGIAESVAYLHN 183
           ++P   + L+ +Y  GGSL   LH       G   LP+          L  ++ VAYLH+
Sbjct: 72  LNP---VCLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 184 GTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
              + ++HRD+KP N+LL +   + K+CDFG A       +       KG+  ++APE F
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVF 176
Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM--AAVEELL 300
           +    S+K DV+++G++L E++T RKP +   + G    ++WA   +H G     ++ L 
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA---VHNGTRPPLIKNLP 231
Query: 301 DPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAIL 342
            P     +R              C S + S+RP +EEI+ I+
Sbjct: 232 KPIESLMTR--------------CWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 143/282 (50%), Gaps = 44/282 (15%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G C
Sbjct: 15  VVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---ALGIAESVAYLHN 183
           ++P   + L+ +Y  GGSL   LH       G   LP+          L  ++ VAYLH+
Sbjct: 71  LNP---VCLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 184 GTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
              + ++HRD+KP N+LL +   + K+CDFG A       +       KG+  ++APE F
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVF 175
Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM--AAVEELL 300
           +    S+K DV+++G++L E++T RKP +   + G    ++WA   +H G     ++ L 
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA---VHNGTRPPLIKNLP 230
Query: 301 DPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAIL 342
            P     +R              C S + S+RP +EEI+ I+
Sbjct: 231 KPIESLMTR--------------CWSKDPSQRPSMEEIVKIM 258

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/201 (37%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCID 128
           GA SF    +     + VA+K L ++D   E    F RE+ I   L HPNIV  +G    
Sbjct: 46  GAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 188
           P   L ++ +Y+S GSL R LH  K G R    L    R  +A  +A+ + YLHN     
Sbjct: 106 PPN-LSIVTEYLSRGSLYRLLH--KSGAR--EQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 189 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 248
           +VHRD+K  N+L+  K   K+CDFGL+   +  S     K   GT  ++APE  +    +
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--SXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 249 DKTDVYAFGVVLLELLTGRKP 269
           +K+DVY+FGV+L EL T ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCID 128
           GA SF    +     + VA+K L ++D   E    F RE+ I   L HPNIV  +G    
Sbjct: 46  GAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 188
           P   L ++ +Y+S GSL R LH  K G R    L    R  +A  +A+ + YLHN     
Sbjct: 106 PPN-LSIVTEYLSRGSLYRLLH--KSGAR--EQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 189 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 248
           +VHR++K  N+L+  K   K+CDFGL+   +  S     K+  GT  ++APE  +    +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 249 DKTDVYAFGVVLLELLTGRKP 269
           +K+DVY+FGV+L EL T ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 112/211 (53%), Gaps = 27/211 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           LG G +S V+  +  +L   VAIK +    +E +E+ K F RE+  +S L H NIV ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 125 FCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAYL 181
             +D E    +L+ +Y+ G +L  ++          S  P SV   +     I + + + 
Sbjct: 79  --VDEEDDCYYLVMEYIEGPTLSEYIE---------SHGPLSVDTAINFTNQILDGIKHA 127
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT--VKGTFGYLAP 239
           H   +  +VHRDIKP NIL+ S K  K+ DFG+A   S  S   L +T  V GT  Y +P
Sbjct: 128 H---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS---LTQTNHVLGTVQYFSP 181
Query: 240 EYFQHGKVSDK-TDVYAFGVVLLELLTGRKP 269
           E  + G+ +D+ TD+Y+ G+VL E+L G  P
Sbjct: 182 EQAK-GEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------KAFCRELMI 110
           A +     + +G+G    V KG++   ++ VAIK L   D E         + F RE+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
            S+L+HPNIV L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRL 127
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFGLATWTSAPSVPF 225
            L IA  + Y+ N     +VHRD++  NI L S  +  P   K+ DFGL+   S  SV  
Sbjct: 128 MLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSG 185
Query: 226 LCKTVKGTFGYLAPEYF--QHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
           L     G F ++APE    +    ++K D Y+F ++L  +LTG  P +
Sbjct: 186 LL----GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------KAFCRELMI 110
           A +     + +G+G    V KG++   ++ VAIK L   D E         + F RE+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
            S+L+HPNIV L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRL 127
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFGLATWTSAPSVPF 225
            L IA  + Y+ N     +VHRD++  NI L S  +  P   K+ DFG    TS  SV  
Sbjct: 128 MLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----TSQQSVHS 182
Query: 226 LCKTVKGTFGYLAPEYF--QHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
           +   + G F ++APE    +    ++K D Y+F ++L  +LTG  P +
Sbjct: 183 VSGLL-GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 83  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITEL 134
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 135 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 187
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL-------DKEDKESSKAFCRELMI 110
           A +     + +G+G    V KG++   ++ VAIK L       + E  E  + F RE+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
            S+L+HPNIV L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRL 127
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFGLATWTSAPSVPF 225
            L IA  + Y+ N     +VHRD++  NI L S  +  P   K+ DF L+   S  SV  
Sbjct: 128 MLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-QSVHSVSG 185
Query: 226 LCKTVKGTFGYLAPEYF--QHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
           L     G F ++APE    +    ++K D Y+F ++L  +LTG  P +
Sbjct: 186 LL----GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 173
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 68  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 119
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 120 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTL 172
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 214

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 63  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 114
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 115 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 167
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 209

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 170
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTL 173
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 175
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 86  MGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 137
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 173
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 173
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTL 171
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 17  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 73
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 74  MGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 125
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 126 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 175
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTL 170
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 92  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITEL 143
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 144 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 196
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 238

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTL 170
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTL 170
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 170
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 70  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 121
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 122 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 174
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 216

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 86  MGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 137
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 65  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 116
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 117 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 169
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 211

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGT 233
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG   W+  APS      T+ GT
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFG---WSCHAPSS--RRTTLSGT 170
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
             YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 170
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 171
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 92  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITEL 143
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 144 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTL 196
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 238

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 175
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 170
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTL 173
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDSTR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 170
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 17/213 (7%)
Query: 66  RVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 120
           +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ HP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA+ + Y
Sbjct: 81  RLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 132
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           L    ER +VHRD+   N+L+ S    K+ DFGLA         +     K    ++A E
Sbjct: 133 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
              + K + ++DV+++GV + EL+T G KP + 
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G + + L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRTA-------TYITEL 122
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 175
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 17/213 (7%)
Query: 66  RVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 120
           +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ HP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA+ + Y
Sbjct: 104 RLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 155
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           L    ER +VHRD+   N+L+ S    K+ DFGLA         +     K    ++A E
Sbjct: 156 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
              + K + ++DV+++GV + EL+T G KP + 
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ +FG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTL 173
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 68  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 119
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ +FG +    +     LC    GT 
Sbjct: 120 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTL 172
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 214

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 27  QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 137
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
               VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  +  
Sbjct: 138 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 189
Query: 246 KVSDKTDVYAFGVVLLELLT-GRKP 269
           K S K+DV++FG++L E+ + GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 117
           +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L HP
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NI+ L G+  D  + ++LI +Y   G++ R L +  +     +             +A +
Sbjct: 73  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANA 124
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           ++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT  YL
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC----GTLDYL 177
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            PE  +     +K D+++ GV+  E L G  P EA   Q
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ 216

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 12  QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 122
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
               VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  +  
Sbjct: 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 174
Query: 246 KVSDKTDVYAFGVVLLELLT-GRKP 269
           K S K+DV++FG++L E+ + GR P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 95/185 (51%), Gaps = 23/185 (12%)
Query: 94  DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 153
           D++  ++ +   +E  + + L HPNI+ L G C+  E  L L+ ++  GG L R L  K+
Sbjct: 43  DEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLCLVMEFARGGPLNRVLSGKR 101
Query: 154 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--------K 205
                   +P  +    A+ IA  + YLH+     ++HRD+K SNIL+  K        K
Sbjct: 102 --------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153
Query: 206 IPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
           I K+ DFGLA  W     +     +  G + ++APE  +    S  +DV+++GV+L ELL
Sbjct: 154 ILKITDFGLAREWHRTTKM-----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208
Query: 265 TGRKP 269
           TG  P
Sbjct: 209 TGEVP 213

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 117
           +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L HP
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NI+ L G+  D  + ++LI +Y   G++ R L +  +     +             +A +
Sbjct: 73  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANA 124
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           ++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT  YL
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYL 177
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            PE  +     +K D+++ GV+  E L G  P EA   Q
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ 216

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 199 QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 309
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
               VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  +  
Sbjct: 310 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 361
Query: 246 KVSDKTDVYAFGVVLLELLT-GRKP 269
           K S K+DV++FG++L E+ + GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 41  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 98  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 149
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 18  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 75  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 126
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 40  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 96
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 97  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 148
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 149 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 33  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 89
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 90  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 141
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 142 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 41  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 98  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 149
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 18  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 75  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 126
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 15  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 71
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 72  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 123
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 124 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTAPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 243 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 114
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L G+  D  + ++LI +Y   G + + L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRTA-------TYITEL 122
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    APS       + GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSS--RRXXLXGTL 175
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 18  QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 128
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
               VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  +  
Sbjct: 129 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREA 180
Query: 246 KVSDKTDVYAFGVVLLELLT-GRKP 269
             S K+DV++FG++L E+ + GR P
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+L+ +Y SGG +  +L  H + K     +             I  
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---------IVS 124
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+  
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPP 177
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 178 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+L+ +Y SGG +  +L  H + K     +             I  
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---------IVS 124
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+  
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPP 177
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 178 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VAIK +DK   +  S +   RE+ I   L+HPN
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+LI +Y SGG +  +L  H + K     S             I  
Sbjct: 73  IVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ---------IVS 122
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+  
Sbjct: 123 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC----GSPP 175
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 176 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 227

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VAIK +DK   +  S +   RE+ I   L+HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+LI +Y SGG +  +L  H + K     S             I  
Sbjct: 76  IVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ---------IVS 125
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G   
Sbjct: 126 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPP 178
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 179 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+L+ +Y SGG +  +L  H + K     +             I  
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---------IVS 124
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G   
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC----GAPP 177
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 178 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+L+ +Y SGG +  +L  H + K     +             I  
Sbjct: 75  IVKLFE-VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ---------IVS 124
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G   
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC----GAPP 177
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 178 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 119 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 140
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 233
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 141 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 199
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 22/221 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNI 119
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 120 VPL-VGFCIDPEQGLFLIYKYVSGGS---LERHL---HEKKKGVRGNSTLPWSVRYKVAL 172
           V     F +  E  L+L+ K +SGGS   + +H+    E K GV   ST+   +R     
Sbjct: 76  VSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 129
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP---SVPFLCKT 229
            + E + YLH   +   +HRD+K  NILL      ++ DFG++ + +     +   + KT
Sbjct: 130 -VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 230 VKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 269
             GT  ++APE  +  +  D K D+++FG+  +EL TG  P
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VA++ +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+L+ +Y SGG +  +L  H + K     +             I  
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---------IVS 124
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+  
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPP 177
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 178 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 119 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 233
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 182
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 68  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-----------QI 115
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 233
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+
Sbjct: 116 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GS 168
Query: 234 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 169 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 222

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VA+K +DK   +  S +   RE+ I   L+HPN
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+L+ +Y SGG +  +L  H + K     +             I  
Sbjct: 76  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---------IVS 125
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL      K+ DFG +  +T    +   C    G+  
Sbjct: 126 AVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC----GSPP 178
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 179 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 119 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 233
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 182
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 64  KGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPN 118
           K +VLG G    V KG    +   ++  V IK + DK  ++S +A    ++   SL H +
Sbjct: 35  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W V+      IA+ +
Sbjct: 95  IVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGM 146
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    E  +VHR++   N+LL S    ++ DFG+A          L    K    ++A
Sbjct: 147 YYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRL 275
            E    GK + ++DV+++GV + EL+T G +P    RL
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 241

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 64  KGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPN 118
           K +VLG G    V KG    +   ++  V IK + DK  ++S +A    ++   SL H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W V+      IA+ +
Sbjct: 77  IVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGM 128
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    E  +VHR++   N+LL S    ++ DFG+A          L    K    ++A
Sbjct: 129 YYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRL 275
            E    GK + ++DV+++GV + EL+T G +P    RL
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 22/221 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNI 119
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 120 VPL-VGFCIDPEQGLFLIYKYVSGGS---LERHL---HEKKKGVRGNSTLPWSVRYKVAL 172
           V     F +  E  L+L+ K +SGGS   + +H+    E K GV   ST+   +R     
Sbjct: 71  VSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 124
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP---SVPFLCKT 229
            + E + YLH   +   +HRD+K  NILL      ++ DFG++ + +     +   + KT
Sbjct: 125 -VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 230 VKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 269
             GT  ++APE  +  +  D K D+++FG+  +EL TG  P
Sbjct: 181 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 103/188 (54%), Gaps = 24/188 (12%)
Query: 106 RELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
           REL +    + P IV   G F  D E  + +  +++ GGSL++ L E K+       +P 
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKR-------IPE 113
Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
            +  KV++ +   +AYL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   + 
Sbjct: 114 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLID 167
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQGEENL 281
            +  +  GT  Y+APE  Q    S ++D+++ G+ L+EL  GR PI   +A+ L+     
Sbjct: 168 SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEA---- 223
Query: 282 VLWAKPIL 289
            ++ +P++
Sbjct: 224 -IFGRPVV 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           G VLG+G      K         + +K L + D+E+ + F +E+ +   L HPN++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
             +  ++ L  I +Y+ GG+L   +         +S  PWS R   A  IA  +AYLH+ 
Sbjct: 75  -VLYKDKRLNFITEYIKGGTLRGIIKSM------DSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-----TSAPSVPFLCK-------TVKG 232
               ++HRD+   N L+   K   + DFGLA       T    +  L K       TV G
Sbjct: 128 N---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
              ++APE        +K DV++FG+VL E++
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 118
           N+   + +G+G  + V   +  L    VA++ +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           IV L    I+ E+ L+L+ +Y SGG +  +L  H + K     +             I  
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---------IVS 124
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 235
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+  
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC----GSPP 177
Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 178 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 35/226 (15%)
Query: 65  GRVLGRGALSFVFK---GKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSL 114
           G V+    L+FV +   G+ GL+       +  VAIK + +E   S + F  E  +   L
Sbjct: 1   GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 59
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HP +V L G C++ +  + L+++++  G L  +L   ++G+    TL       + L +
Sbjct: 60  SHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDV 112
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK 228
            E +AYL    E CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K
Sbjct: 113 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 169
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
                  + +PE F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 170 -------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G G+   V+KGK       VA+K L   D   E  +AF  E+ +     H NI+  +G+
Sbjct: 44  IGSGSFGTVYKGK---WHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
               +  L ++ ++  G SL +HLH ++   +    +       +A   A+ + YLH   
Sbjct: 101 MT--KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLI------DIARQTAQGMDYLH--- 149
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-- 243
            + ++HRD+K +NI L      K+ DFGLAT  S  S     +   G+  ++APE  +  
Sbjct: 150 AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 244 -HGKVSDKTDVYAFGVVLLELLTGRKP 269
            +   S ++DVY++G+VL EL+TG  P
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 117
           +F  GR LG+G    V+  +       VA+K L K   E         RE+ I + LHHP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NI+ L  +  D  + ++LI +Y   G L + L +       + T        +   +A++
Sbjct: 84  NILRLYNYFYD-RRRIYLILEYAPRGELYKELQK-------SCTFDEQRTATIMEELADA 135
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGTFGY 236
           + Y H    + V+HRDIKP N+LL  K   K+ DFG   W+  APS+    KT+ GT  Y
Sbjct: 136 LMYCHG---KKVIHRDIKPENLLLGLKGELKIADFG---WSVHAPSL--RRKTMCGTLDY 187
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           L PE  +    ++K D++  GV+  ELL G  P E+
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           +G G    V  G   L +  VAIK + KE   S   F  E  +   L HP +V L G C+
Sbjct: 35  IGSGQFGLVHLG-YWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 93  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 142
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
           CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 143 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WASPEV 195
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
           F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 196 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 228

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 18  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 76  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 125
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
           CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 126 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WASPEV 178
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
           F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 179 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 13  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 71  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 120
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
           CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WASPEV 173
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
           F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 119 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 233
           ++   L+   +  ++HRD+KP+NIL+S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSV-XQTAAVIGT 182
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 119 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 233
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 182
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             YL+PE  +   V  ++DVY+ G VL E+LTG  P 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNI 119
           + K   +G G    V+K K    R  VA+KR  LD ED+       RE+ +   LHHPNI
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESV 178
           V L+   I  E+ L L+++++    L++ L E K G++ +       + K+ L  +   V
Sbjct: 82  VSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-------QIKIYLYQLLRGV 132
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           A+ H   +  ++HRD+KP N+L++S    KL DFGLA     P   +  + V  T  Y A
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRA 187
Query: 239 PEYFQHG-KVSDKTDVYAFGVVLLELLTGR 267
           P+      K S   D+++ G +  E++TG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 119 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 233
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 182
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNI 119
           + K   +G G    V+K K    R  VA+KR  LD ED+       RE+ +   LHHPNI
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESV 178
           V L+   I  E+ L L+++++    L++ L E K G++ +       + K+ L  +   V
Sbjct: 82  VSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-------QIKIYLYQLLRGV 132
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           A+ H   +  ++HRD+KP N+L++S    KL DFGLA     P   +  + V  T  Y A
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRA 187
Query: 239 PEYFQHG-KVSDKTDVYAFGVVLLELLTGR 267
           P+      K S   D+++ G +  E++TG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IAE
Sbjct: 74  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAE 125
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 126 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 219

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 16  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           + +  + L+ +++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 74  E-QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 123
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
           CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WASPEV 176
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
           F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 123
           G  +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG-IAESVAYLH 182
           G C   +Q ++++ + V GG     L  + +G R        +R K  L  + ++ A + 
Sbjct: 179 GVCTQ-KQPIYIVMELVQGGDFLTFL--RTEGAR--------LRVKTLLQMVGDAAAGME 227
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGL----ATWTSAPSVPFLCKTVKGTFGYLA 238
               +C +HRD+   N L++ K + K+ DFG+    A    A S       VK T    A
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT----A 283
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT 265
           PE   +G+ S ++DV++FG++L E  +
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 78  PHVCRLLGICLT--STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAK 129
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 130 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 60  HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 115
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 112 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 163
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+      P       T  GT  
Sbjct: 164 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPN 218
Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
           Y+APE  +        D +A GV++ E++ GR P +
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 117
           +F  GR LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NI+ +  +  D  + ++L+ ++   G L + L +  +     S          A  + E 
Sbjct: 76  NILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRS----------ATFMEEL 124
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
              LH   ER V+HRDIKP N+L+  K   K+ DFG +    +     +C    GT  YL
Sbjct: 125 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYL 180
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
            PE  +     +K D++  GV+  E L G  P ++
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 123
           G  +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG-IAESVAYLH 182
           G C   +Q ++++ + V GG     L  + +G R        +R K  L  + ++ A + 
Sbjct: 179 GVCTQ-KQPIYIVMELVQGGDFLTFL--RTEGAR--------LRVKTLLQMVGDAAAGME 227
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGL----ATWTSAPSVPFLCKTVKGTFGYLA 238
               +C +HRD+   N L++ K + K+ DFG+    A    A S       VK T    A
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----A 283
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT 265
           PE   +G+ S ++DV++FG++L E  +
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 78  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 129
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 130 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 80  PHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 35/226 (15%)
Query: 65  GRVLGRGALSFVFK---GKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSL 114
           G V+    L+FV +   G+ GL+       +  VAIK + +E   S + F  E  +   L
Sbjct: 1   GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 59
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HP +V L G C++ +  + L+++++  G L  +L   ++G+    TL       + L +
Sbjct: 60  SHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDV 112
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK 228
            E +AYL    E  V+HRD+   N L+   ++ K+ DFG+        +TS+    F  K
Sbjct: 113 CEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 169
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
                  + +PE F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 170 -------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 17/212 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 86  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 136
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 137 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 190
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  Q    S ++D+++ G+ L+E+  GR PI
Sbjct: 191 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 113
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 170
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 63  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 112
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V
Sbjct: 113 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 231 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
             T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 84  PHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 81  PHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 132
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 133 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 83  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 134
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 135 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 228

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+   YK  L +   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKDLYKDFLTLEHL 146
Query: 178 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
           + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA               
Sbjct: 147 ICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
           +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 255

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 113
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 170
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 111
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V
Sbjct: 112 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 231 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
             T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 80  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 80  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 80  PHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 71  PHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 122
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 87  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 138
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 139 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 232

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 81  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 131
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-------WTAPES 184
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 102 PHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 153
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 154 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 247

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-------WTAPES 185
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 60  HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 115
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 80  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 131
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGT 233
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+      P  +    C    GT
Sbjct: 132 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC----GT 184
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
             Y+APE  +        D +A GV++ E++ GR P +
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 109/218 (50%), Gaps = 12/218 (5%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 117
           NF   + +GRG  S V++    L    VA+K++   D   +KA     +E+ +   L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           N++      I+ +  L ++ +    G L R +   KK  R    +P    +K  + +  +
Sbjct: 93  NVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKR---LIPERTVWKYFVQLCSA 148
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT  Y+
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 203
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
           +PE       + K+D+++ G +L E+   + P    ++
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 122
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 123 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 142
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 196
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 197 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 15/228 (6%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCR---ELMIASSLHHP 117
           +F  G +LG+G+ + V++ +       VAIK +DK+    +    R   E+ I   L HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           +I+ L  +  D    ++L+ +    G + R+L  + K    N    +  +      I   
Sbjct: 72  SILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ------IITG 124
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH+     ++HRD+  SN+LL+     K+ DFGLAT    P       T+ GT  Y+
Sbjct: 125 MLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYI 179
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA 285
           +PE         ++DV++ G +   LL GR P +   ++   N V+ A
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 17/212 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 94  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 144
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 198
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  Q    S ++D+++ G+ L+E+  GR PI
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 185
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 93  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 143
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 196
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 188
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 129/294 (43%), Gaps = 50/294 (17%)
Query: 63  SKGRVLGRGALSFVFKGKVGLLRTS-------VAIKRLDKEDKESSKA-FCRELMIASSL 114
           ++ +V+G G    V+KG   +L+TS       VAIK L     E  +  F  E  I    
Sbjct: 47  TRQKVIGAGEFGEVYKG---MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-- 172
            H NI+ L G  I   + + +I +Y+  G+L++ L EK           +SV   V +  
Sbjct: 104 SHHNIIRLEG-VISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLR 154
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVK 231
           GIA  + YL N      VHRD+   NIL++S  + K+ DFGL+      P   +     K
Sbjct: 155 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH 290
               + APE   + K +  +DV++FG+V+ E++T G +P              + +   H
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP--------------YWELSNH 257
Query: 291 RGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAIL 342
             M A+ +   L   + C S               C   E +RRP   +I++IL
Sbjct: 258 EVMKAINDGFRLPTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 276
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 185
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L+++         H+H+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFE---------HVHQDLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 167
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 276
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 129 VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 179
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 180 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 233
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 276
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 234 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 274

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 276
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 276
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 135
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 188
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 188
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 130
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 122
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 123 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 115 YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 165
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 166 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 219
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 220 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  FC   ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 149
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 150 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 248

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 188
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 113
           L    NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 170
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 63  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 112
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V
Sbjct: 113 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 231 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
             T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 122
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 123 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 116 YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 166
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 167 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 220
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 221 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 251

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 84  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 134
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 187
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 130
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 60  HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 115
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 65  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 116
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGT 233
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+      P  +    C    GT
Sbjct: 117 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC----GT 169
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
             Y+APE  +        D +A GV++ E++ GR P +
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLH 115
           +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVAL 172
           HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +      
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  
Sbjct: 111 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 233 TFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 71  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 121 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 175
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 17/212 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  Q    S ++D+++ G+ L+E+  GR PI
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 122
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 123 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 98  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 148
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 149 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 202
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           PE   HG   +K DV++ GV+L  LL+G  P   
Sbjct: 203 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNG 235

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 167
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 21/198 (10%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           + I R+  +++E S+   RE+ + +++ HPNIV       +    L+++  Y  GG L +
Sbjct: 57  INISRMSSKEREESR---REVAVLANMKHPNIVQYRE-SFEENGSLYIVMDYCEGGDLFK 112
Query: 148 HLHEKKKGV--RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
            ++ +K GV  + +  L W V+  +AL       ++H   +R ++HRDIK  NI L+   
Sbjct: 113 RINAQK-GVLFQEDQILDWFVQICLAL------KHVH---DRKILHRDIKSQNIFLTKDG 162
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             +L DFG+A   +  S   L +   GT  YL+PE  ++   ++K+D++A G VL EL T
Sbjct: 163 TVQLGDFGIARVLN--STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
Query: 266 GRKPIEARRLQGEENLVL 283
            +   EA  ++   NLVL
Sbjct: 221 LKHAFEAGSMK---NLVL 235

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 171
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 167
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 78  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-------WTAPES 181
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 171
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKTFMDASALTGIPLPLIKSYL 112
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 113 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 167
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 60  HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 115
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 69  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 120
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGT 233
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+      P  +    C    GT
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC----GT 173
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
             Y+APE  +        D +A GV++ E++ GR P +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 113
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L+HPNIV L+   I  E  L+L+++++S         +K       + +P  +       
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEFLSMDL------KKFMDASALTGIPLPLIKSYLFQ 114
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T
Sbjct: 115 LLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 169
Query: 234 FGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
             Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 167
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 65  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 115 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 169
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 171
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 171
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 171
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 171
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 113 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 171
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 166
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 171
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 71  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 121 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 175
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 59  THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 116
Query: 177 SVAYLH-NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 232
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA   +            G
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           T GYL+PE  +    S   D++A GV+L  LL G  P 
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 173
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 174 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 250

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 59  THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 64  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 115
Query: 177 SVAYLH-NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 232
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA   +            G
Sbjct: 116 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 168
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           T GYL+PE  +    S   D++A GV+L  LL G  P 
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 173
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 174 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 78  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T T+     F  K       + APE 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-------WTAPES 181
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 22/210 (10%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 123
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
               D     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EILEDS-SSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMH- 138
Query: 184 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
             +  +VHRD+KP NILL SK+     K+ DFGL+T     +     K   GT  Y+APE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE 193
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             + G   +K DV++ GV+L  LL+G  P 
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 59  THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 116
Query: 177 SVAYLH-NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 232
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA   +            G
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           T GYL+PE  +    S   D++A GV+L  LL G  P 
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 173
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 174 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 250

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 84  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAI  L +    +++K    E  + +S+ +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 111 PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 162
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 163 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 256

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 113
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L+HPNIV L+   I  E  L+L+++++S   ++         + G   +P  +       
Sbjct: 61  LNHPNIVKLLD-VIHTENKLYLVFEFLS---MDLKDFMDASALTG---IPLPLIKSYLFQ 113
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T
Sbjct: 114 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 168
Query: 234 FGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
             Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 84  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 81  PHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 132
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 133 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 173
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 174 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF-CRELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE       S  +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 243

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 84  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 81  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 131
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T T+     F  K       + APE 
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-------WTAPES 184
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 59  THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 88  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 139
Query: 177 SVAYLH-NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 232
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA   +            G
Sbjct: 140 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 192
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           T GYL+PE  +    S   D++A GV+L  LL G  P 
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 113
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L+HPNIV L+   I  E  L+L+++++S   ++         + G   +P  +       
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEFLS---MDLKDFMDASALTG---IPLPLIKSYLFQ 114
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T
Sbjct: 115 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 169
Query: 234 FGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
             Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 62  FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 78  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T T+     F  K       + APE 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-------WTAPES 181
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +++ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLSFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 15/214 (7%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           +HPNIV L+   I  E  L+L+++++S         +K       + +P  +       +
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEFLSMDL------KKFMDASALTGIPLPLIKSYLFQL 113
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
            + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T 
Sbjct: 114 LQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 168
Query: 235 GYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
            Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-------WTAPES 188
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 37/246 (15%)
Query: 39  SISPV--ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE 96
           S+ PV   N  +   + EIL         R +G+G+   V   +    +   A+K ++K+
Sbjct: 1   SMPPVFDENEDVNFDHFEIL---------RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 97  ---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 153
              ++   +   +EL I   L HP +V L  +    E+ +F++   + GG L  HL +  
Sbjct: 52  KCVERNEVRNVFKELQIMQGLEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQQ-- 108
Query: 154 KGVRGNSTLPWSVRYK---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
                      +V +K   V L I E V  L     + ++HRD+KP NILL       + 
Sbjct: 109 -----------NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHIT 157
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGR 267
           DF +A      +      T+ GT  Y+APE F   K    S   D ++ GV   ELL GR
Sbjct: 158 DFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
Query: 268 KPIEAR 273
           +P   R
Sbjct: 215 RPYHIR 220

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 146
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 152
Query: 207 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            K+ DFGL          F  K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 173
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 174 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 173
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 183
Query: 174 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 244 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 287 R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 337
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HR++   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 390
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
             + K S K+DV+AFGV+L E+ T
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV-----P 121
           LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+V     P
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVA 179
                + P     L  +Y  GG L ++L++ +   G++        +R  ++  I+ ++ 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-----IRTLLS-DISSALR 136
Query: 180 YLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
           YLH   E  ++HRD+KP NI+L     + I K+ D G A          LC    GT  Y
Sbjct: 137 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 190
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           LAPE  +  K +   D ++FG +  E +TG +P 
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV-----P 121
           LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+V     P
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVA 179
                + P     L  +Y  GG L ++L++ +   G++        +R  ++  I+ ++ 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-----IRTLLS-DISSALR 135
Query: 180 YLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
           YLH   E  ++HRD+KP NI+L     + I K+ D G A          LC    GT  Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 189
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           LAPE  +  K +   D ++FG +  E +TG +P 
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 173
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 174 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 250

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 117
           +F   R LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NI+ +  +  D  + ++L+ ++   G L + L +  +     S          A  + E 
Sbjct: 75  NILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRS----------ATFMEEL 123
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGTFGY 236
              LH   ER V+HRDIKP N+L+  K   K+ DFG   W+  APS+    + + GT  Y
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG---WSVHAPSL--RRRXMCGTLDY 178
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           L PE  +     +K D++  GV+  E L G  P ++
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +F +  ++G G    VFK K  +   +  IKR+    K +++   RE+   + L H NIV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIV 67
Query: 121 PL----VGFCIDPEQG-----------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
                  GF  DPE             LF+  ++   G+LE+ + EK++G + +  L   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 166 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 225
           +  ++  G    V Y+H+   + +++RD+KPSNI L   K  K+ DFGL T         
Sbjct: 127 LFEQITKG----VDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX 179
Query: 226 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
                KGT  Y++PE         + D+YA G++L ELL
Sbjct: 180 RS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 114
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST--LPWSVRYKVAL 172
           +HPNIV L+   I  E  L+L++++V          + KK +  ++   +P  +      
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEHVD--------QDLKKFMDASALTGIPLPLIKSYLF 113
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 233 TFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 173
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 174 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 250

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 22/213 (10%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 123
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              ++     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHK 139
Query: 184 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                +VHRD+KP NILL SK+     K+ DFGL+T     +     K   GT  Y+APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE 193
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
             + G   +K DV++ GV+L  LL+G  P   +
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYGK 225

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKVALGIA 175
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+     YK  L + 
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKPEDLYKDFLTLE 148
Query: 176 ESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
             + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA             
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
             +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 109/232 (46%), Gaps = 23/232 (9%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGI 174
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+      YK  L +
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKTPEDLYKDFLTL 147
Query: 175 AESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
              + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA            
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
              +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 70  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 120
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +     GT  Y++
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDEMANEFVGTRSYMS 174
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE  Q    S ++D+++ G+ L+E+  GR P
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 127 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 184
              E G   I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH+ 
Sbjct: 89  --SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN 141
Query: 185 TERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
               +VHRDIK  N+L+++   + K+ DFG  T      +    +T  GT  Y+APE   
Sbjct: 142 Q---IVHRDIKGDNVLINTYSGVLKISDFG--TSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 244 HGK--VSDKTDVYAFGVVLLELLTGRKPI 270
            G        D+++ G  ++E+ TG+ P 
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 122
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI  L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 123 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y 
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYX 142
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---XKDKIGTAYYIA 196
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 197 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 121/260 (46%), Gaps = 24/260 (9%)
Query: 22  DSRAQELKWRKIQSLERSISPVANSLIR---LSYGEILAATHNFSKGRVLGRGALSFVFK 78
           D   + L ++ + S+  S +P   SL+    +      A +  F     LGRGA S V++
Sbjct: 12  DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71
Query: 79  GKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY 137
            K    +   A+K L K  DK+  +    E+ +   L HPNI+ L      P + + L+ 
Sbjct: 72  CKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEIFETPTE-ISLVL 127
Query: 138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS 197
           + V+GG L   + EK  G         +V+      I E+VAYLH   E  +VHRD+KP 
Sbjct: 128 ELVTGGELFDRIVEK--GYYSERDAADAVK-----QILEAVAYLH---ENGIVHRDLKPE 177
Query: 198 NILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVY 254
           N+L ++       K+ DFGL+          L KTV GT GY APE  +      + D++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 255 AFGVVLLELLTGRKPIEARR 274
           + G++   LL G +P    R
Sbjct: 235 SVGIITYILLCGFEPFYDER 254

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 22/213 (10%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 123
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              ++     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHK 139
Query: 184 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                +VHRD+KP NILL SK+     K+ DFGL+T     +     K   GT  Y+APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE 193
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
             + G   +K DV++ GV+L  LL+G  P   +
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYGK 225

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+   RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+   RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 175
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 167
Query: 236 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 267
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 326 R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 376
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HR++   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 429
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
             + K S K+DV+AFGV+L E+ T
Sbjct: 430 LAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 127 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 184
              E G   I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH+ 
Sbjct: 75  --SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN 127
Query: 185 TERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
               +VHRDIK  N+L+++   + K+ DFG  T      +    +T  GT  Y+APE   
Sbjct: 128 Q---IVHRDIKGDNVLINTYSGVLKISDFG--TSKRLAGINPCTETFTGTLQYMAPEIID 182
Query: 244 HGK--VSDKTDVYAFGVVLLELLTGRKPI 270
            G        D+++ G  ++E+ TG+ P 
Sbjct: 183 KGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 20/225 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHH 116
           NF   RVLG+G+   V   +V       A+K L K+    D +       + +++ + +H
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +  L   C      LF + ++V+GG L  H+ + ++     +          A  I  
Sbjct: 84  PFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEIIS 135
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
           ++ +LH+   + +++RD+K  N+LL  +   KL DFG+        V     T  GT  Y
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDY 190
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
           +APE  Q        D +A GV+L E+L G  P EA   + E++L
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA---ENEDDL 232

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 141
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  Y+
Sbjct: 142 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 240

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF-CRELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA----GNEGLIF 243

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+   YK  L +   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKDLYKDFLTLEHL 146
Query: 178 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
           + Y   +  G E    R  +HRD+   NILLS K + K+ DFGLA               
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
           +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 255

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF-CRELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 145
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  Y+
Sbjct: 146 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 244

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 16/229 (6%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           N+V L+G C  P   L +I ++   G+L  +L  K+         P  + YK  L +   
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL-YKDFLTLEHL 152
Query: 178 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
           + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA               
Sbjct: 153 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
           +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 261

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEGLIF 243

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 241

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 75  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 126
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 127 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 225

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 141
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 142 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 240

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 241

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 241

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y++ GSL   L    KG  G    LP  V   ++  IA  +AY+     
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFL----KGETGKYLRLPQLV--DMSAQIASGMAYVERMN- 131
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       WT+     F  K       + APE
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-------WTAPE 182
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 243

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           R LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 122 LVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
             G C     + L LI +++  GSL  +L + K+ +     L ++ +      I + + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ------ICKGMEY 132
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAP 239
           L  GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + AP
Sbjct: 133 L--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT 265
           E     K S  +DV++FGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 133
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 134 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 243

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF-CRELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 145
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 146 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 244

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 129
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 130 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 130
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 131 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 135
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 136 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT 217

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF-CRELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 243

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGLA      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 69  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 120
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 219

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 137
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 138 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 134
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 135 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 136
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 137 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 128
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 129 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 68  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 119
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 120 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 218

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 31/222 (13%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED----KESSKAFCREL 108
           +  +F   R LG G+      G+V L+R+       A+K L KE     K+        L
Sbjct: 4   SLQDFQILRTLGTGSF-----GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           M+ S + HP I+ + G   D +Q +F+I  Y+ GG L   L       R +   P  V  
Sbjct: 59  ML-SIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLL-------RKSQRFPNPVAK 109
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
             A  +  ++ YLH+   + +++RD+KP NILL      K+ DFG A +     VP +  
Sbjct: 110 FYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTY 161
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            + GT  Y+APE       +   D ++FG+++ E+L G  P 
Sbjct: 162 XLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 96  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 147
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 148 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 246

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 146
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 170
Query: 207 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E   +++ +Y+  G+L  +L E  +       +   V   +A  I+ ++ YL    ++
Sbjct: 99  -LEPPFYIVTEYMPYGNLLDYLRECNR-----EEVTAVVLLYMATQISSAMEYLE---KK 149
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 202
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +   S K+DV+AFGV+L E+ T G  P
Sbjct: 203 LAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 70  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 121
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 122 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 220

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 146
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 170
Query: 207 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 161
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 162 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 71  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 122
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 123 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 221

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 130
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 131 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L + K+ +     L ++ +      I + + YL 
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL- 131
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HR++   NIL+ ++   K+ DFGL          +  K   +    + APE 
Sbjct: 132 -GTKR-YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 103/228 (45%), Gaps = 24/228 (10%)
Query: 49  RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRE 107
           R    E +   ++F    VLG GA S V   +    +  VAIK + KE  E  + +   E
Sbjct: 9   RWKQAEDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           + +   + HPNIV L       E G  L+LI + VSGG L   + EK      +++    
Sbjct: 67  IAVLHKIKHPNIVALDDIY---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---- 119
Query: 166 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPS 222
              ++   + ++V YLH+     +VHRD+KP N+L   L       + DFGL+      S
Sbjct: 120 ---RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 173
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           V     T  GT GY+APE       S   D ++ GV+   LL G  P 
Sbjct: 174 V---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 85  RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG 143
           +  VAIK L +  +K  ++   RE  I   L +P IV L+G C    + L L+ +   GG
Sbjct: 37  QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGG 94
Query: 144 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS 203
            L + L  K++ +  ++     + ++V++G+     YL    E+  VHRD+   N+LL +
Sbjct: 95  PLHKFLVGKREEIPVSNVA--ELLHQVSMGMK----YLE---EKNFVHRDLAARNVLLVN 145
Query: 204 KKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 262
           +   K+ DFGL+    A    +  ++  K    + APE     K S ++DV+++GV + E
Sbjct: 146 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 205
Query: 263 LLT-GRKPIEARRLQGEENLVL 283
            L+ G+KP   ++++G E +  
Sbjct: 206 ALSYGQKPY--KKMKGPEVMAF 225

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 103/228 (45%), Gaps = 24/228 (10%)
Query: 49  RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRE 107
           R    E +   ++F    VLG GA S V   +    +  VAIK + KE  E  + +   E
Sbjct: 9   RWKQAEDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           + +   + HPNIV L       E G  L+LI + VSGG L   + EK      +++    
Sbjct: 67  IAVLHKIKHPNIVALDDIY---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---- 119
Query: 166 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPS 222
              ++   + ++V YLH+     +VHRD+KP N+L   L       + DFGL+      S
Sbjct: 120 ---RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 173
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           V     T  GT GY+APE       S   D ++ GV+   LL G  P 
Sbjct: 174 V---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 68  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 118
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 119 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 230
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 231 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 342 L 342
           L
Sbjct: 275 L 275

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 103/228 (45%), Gaps = 24/228 (10%)
Query: 49  RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRE 107
           R    E +   ++F    VLG GA S V   +    +  VAIK + KE  E  + +   E
Sbjct: 9   RWKQAEDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           + +   + HPNIV L       E G  L+LI + VSGG L   + EK      +++    
Sbjct: 67  IAVLHKIKHPNIVALDDIY---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---- 119
Query: 166 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPS 222
              ++   + ++V YLH+     +VHRD+KP N+L   L       + DFGL+      S
Sbjct: 120 ---RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 173
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           V     T  GT GY+APE       S   D ++ GV+   LL G  P 
Sbjct: 174 V---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 16  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 71
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 72  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 123
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 176
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +G  + K+DV++FG++L E++T GR P
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 128 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 351
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 128 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 351
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 26  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 82  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 133
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 186
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +G  + K+DV++FG++L E++T GR P
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF-CRELMIASSLHHP 117
           +F  G++LG G+ S     +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 241

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 36  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 94
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 95  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 145
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 146 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 257
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 258 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 301
Query: 342 L 342
           L
Sbjct: 302 L 302

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 181
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +G  + K+DV++FG++L E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 27  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 83  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 134
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 187
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +G  + K+DV++FG++L E++T GR P
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 26  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 85  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 135
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 136 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 247
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 248 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 291
Query: 342 L 342
           L
Sbjct: 292 L 292

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 31  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 86
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 87  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 138
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 191
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +G  + K+DV++FG++L E++T GR P
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 43/232 (18%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +F +  ++G G    VFK K  +   +  I+R+    K +++   RE+   + L H NIV
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV----KYNNEKAEREVKALAKLDHVNIV 68
Query: 121 PL----VGFCIDPEQG------------------------LFLIYKYVSGGSLERHLHEK 152
                  GF  DPE                          LF+  ++   G+LE+ + EK
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EK 127
Query: 153 KKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF 212
           ++G + +  L   +  ++  G    V Y+H+   + ++HRD+KPSNI L   K  K+ DF
Sbjct: 128 RRGEKLDKVLALELFEQITKG----VDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
           GL T              KGT  Y++PE         + D+YA G++L ELL
Sbjct: 181 GLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSL 114
           HN    R LG GA   VF  +   L     +  VA+K L      + K F RE  + ++L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG----VRGN--STLPWSVRY 168
            H +IV   G C++ +  L ++++Y+  G L + L            GN  + L  S   
Sbjct: 73  QHEHIVKFYGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +A  IA  + YL     +  VHRD+   N L+    + K+ DFG++    +     +  
Sbjct: 132 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                  ++ PE   + K + ++DV++ GVVL E+ T G++P
Sbjct: 189 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 72
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 125
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 126 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 176
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 74
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFL----KGETGKYLRLPQLV--DMAAQIASGMAYVERMN- 127
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 128 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 178
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL       P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 128 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 351
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 70
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 123
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 124 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 174
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 119
           +F   + LGRG    VF+ K  +   + AIKR+   ++E + +   RE+   + L HP I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 120 VPLVGFCIDPEQGLFL------IYKYVSGGSLERHLHEKKKGVRGNSTLP---WSVRYKV 170
           V      ++      L      +Y Y+      +     K  + G  T+     SV   +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKE--NLKDWMNGRCTIEERERSVCLHI 123
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-----------WTS 219
            L IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFGL T            T 
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
            P+       V GT  Y++PE       S K D+++ G++L ELL
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 108/211 (51%), Gaps = 30/211 (14%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 330
Query: 128 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+    E
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYV----E 380
Query: 187 RC-VVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAP 239
           R   VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + AP
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAP 433
Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           E   +G+ + K+DV++FG++L EL T GR P
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           NF K   +G G+   V           VA+K++D   ++  +    E++I    HH N+V
Sbjct: 49  NFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVV 105
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            +    +  ++ L+++ +++ GG+L   +   +      +T        V L +  +++Y
Sbjct: 106 DMYSSYLVGDE-LWVVMEFLEGGALTDIVTHTRMNEEQIAT--------VCLSVLRALSY 156
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LHN   + V+HRDIK  +ILL+S    KL DFG     S   VP   K + GT  ++APE
Sbjct: 157 LHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVP-KRKXLVGTPYWMAPE 211
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                    + D+++ G++++E++ G  P
Sbjct: 212 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 59  THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           T ++     LG+GA S V +   K      +  I    K      +   RE  I   L H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 90  PNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIHQILE 141
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           SV ++H   +  +VHRD+KP N+LL+SK      KL DFGLA         +      GT
Sbjct: 142 SVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF--GFAGT 196
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            GYL+PE  +        D++A GV+L  LL G  P 
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVP 121
           RV+G+G    V+ G+       R   AIK L +  + +  +AF RE ++   L+HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L+G  + PE    ++  Y+  G L + +   ++    N T+   + +   L +A  + YL
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISF--GLQVARGMEYL 140
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFG 235
               E+  VHRD+   N +L      K+ DFGLA       + S          VK T  
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195
Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             A E  Q  + + K+DV++FGV+L ELLT   P
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 27/229 (11%)
Query: 60  HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIK---RLDKEDKESSK--AFCRELMIASS 113
            N   G+VLG GA   V      G+ +T V+I+   ++ KE  +SS+  A   EL + + 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 114 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN------------- 159
           L  H NIV L+G C      ++LI++Y   G L  +L  K++    +             
Sbjct: 105 LGSHENIVNLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 160 ---STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 216
              + L +      A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              + S   +    +    ++APE    G  + K+DV+++G++L E+ +
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   + H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD+  +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 12/215 (5%)
Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 113
           ++++  F +   LG G  + V+KG        VA+K  +LD E+   S A  RE+ +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKE 59
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L H NIV L    I  E  L L+++++    L++++  +  G          V+Y     
Sbjct: 60  LKHENIVRLYD-VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY-FQWQ 116
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + + +A+ H   E  ++HRD+KP N+L++ +   KL DFGLA     P   F  + V  T
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--T 171
Query: 234 FGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGR 267
             Y AP+     +  S   D+++ G +L E++TG+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 146
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 115 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 165
Query: 207 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            K+ DFGLA         ++ +   +    + APE       S ++DV++FGVVL EL T
Sbjct: 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 146
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 101
Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 102 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 152
Query: 207 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            K+ DFGLA         ++ +   +    + APE       S ++DV++FGVVL EL T
Sbjct: 153 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTF 187
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L E++T GR P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 22  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 77
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 78  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 129
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTF 188
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L E++T GR P
Sbjct: 189 TIKSDVWSFGILLTEIVTHGRIP 211

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK 246
              VHRD++ +NIL+    + K+ DFGLA            +  K    + APE   +G+
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGR 191
Query: 247 VSDKTDVYAFGVVLLELLT-GRKP 269
            + K+DV++FG++L EL T GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 193 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQL--YAV 248
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 301
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGL        +T+     F  K       + APE
Sbjct: 302 --YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK-------WTAPE 352
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 124 GFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           G C     + L LI +Y+  GSL  +L    + +     L ++ +      I + + YL 
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ------ICKGMEYL- 133
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEY 241
            GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + APE 
Sbjct: 134 -GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT 265
               K S  +DV++FGVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K    S +AF  E  +  +L H  +V L    +
Sbjct: 21  LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VV 77
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E+ +++I +Y++ GSL   L   K    G   LP  + +     IAE +AY+     +
Sbjct: 78  TREEPIYIITEYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIER---K 129
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD++ +N+L+S   + K+ DFGLA       +T+     F  K       + APE 
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEA 182
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
              G  + K+DV++FG++L E++T G+ P   R
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGR 215

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 146
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 102
Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 103 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 153
Query: 207 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            K+ DFGLA         ++ +   +    + APE       S ++DV++FGVVL EL T
Sbjct: 154 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 123
           VLG GA S V   +    +  VAIK + K   E KE S     E+ +   + HPNIV L 
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIAVLHKIKHPNIVALD 82
Query: 124 GFCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
                 E G  L+LI + VSGG L   + EK      +++       ++   + ++V YL
Sbjct: 83  DIY---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYL 132
Query: 182 HNGTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H+     +VHRD+KP N+L   L       + DFGL+      SV     T  GT GY+A
Sbjct: 133 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVA 186
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE       S   D ++ GV+   LL G  P 
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTF 187
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L E++T GR P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 17  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 72
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 73  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 124
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HR+++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 177
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +G  + K+DV++FG++L E++T GR P
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 23  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 78
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 79  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 130
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTF 189
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L E++T GR P
Sbjct: 190 TIKSDVWSFGILLTEIVTHGRIP 212

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 27  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 83  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 134
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTF 193
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L E++T GR P
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 30  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 85
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 86  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 137
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTF 196
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L E++T GR P
Sbjct: 197 TIKSDVWSFGILLTEIVTHGRIP 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 29  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 84
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 85  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 136
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTF 195
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L E++T GR P
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIP 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 41  SPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES 100
           S  A S   L YG       + +  + LG G    V  GK    +  VAIK + KE   S
Sbjct: 5   SKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMS 62
Query: 101 SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS 160
              F  E  +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +   
Sbjct: 63  EDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQTQQ 121
Query: 161 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----- 215
            L      ++   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+     
Sbjct: 122 LL------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
Query: 216 -TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
             +TS+    F  +       +  PE   + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 173 DEYTSSVGSKFPVR-------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S G L   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 41  SPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES 100
           S  A S   L YG       + +  + LG G    V  GK    +  VAIK + KE   S
Sbjct: 5   SKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMS 62
Query: 101 SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS 160
              F  E  +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +   
Sbjct: 63  EDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQTQQ 121
Query: 161 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW--- 217
            L      ++   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+ +   
Sbjct: 122 LL------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
Query: 218 ---TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
              TS+    F  +       +  PE   + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 173 DEETSSVGSKFPVR-------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S L
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 267

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S L
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 253

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y++ GSL   L    KG  G    LP  V   ++  IA  +AY+     
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFL----KGETGKYLRLPQLV--DMSAQIASGMAYVERMN- 131
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 182
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 26/229 (11%)
Query: 50  LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 109
           L YG       + +  + LG G    V  GK    +  VAIK + KE   S   F  E  
Sbjct: 5   LGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAK 62
Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +    L      +
Sbjct: 63  VMMNLSHEKLVQLYGVCT-KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------E 115
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSV 223
           +   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+       +TS+   
Sbjct: 116 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 172
Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
            F  +       +  PE   + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 173 KFPVR-------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQAGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYGTF 187
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L E++T GR P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 186
             E+ ++++ +Y+S G L   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 240
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 22/234 (9%)
Query: 54  EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELM 109
           +I     +F   ++LG+G+   VF  +        AIK L K+    D +       + +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 110 IASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           ++ +  HP +  +  FC    ++ LF + +Y++GG L  H+    K     +T       
Sbjct: 72  LSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF------ 123
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
             A  I   + +LH+   + +V+RD+K  NILL      K+ DFG+              
Sbjct: 124 -YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TN 177
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 282
              GT  Y+APE     K +   D ++FGV+L E+L G+ P      Q EE L 
Sbjct: 178 EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELF 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKR-LDKEDKESSKAFC-RELMIASSLHHPNIVPLVGF 125
           +G G+   VFK +       VAIK+ L+ ED    K    RE+ +   L HPN+V L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE- 69
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
               ++ L L+++Y     L    HE  +  RG   +P  +   +     ++V + H   
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL----HELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN 122
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF--- 242
               +HRD+KP NIL++   + KLCDFG A   + PS  +  +    T  Y +PE     
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--ATRWYRSPELLVGD 177
Query: 243 -QHGKVSDKTDVYAFGVVLLELLTG 266
            Q+G      DV+A G V  ELL+G
Sbjct: 178 TQYGP---PVDVWAIGCVFAELLSG 199

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 68  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 118
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 119 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 230
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 231 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 342 L 342
           L
Sbjct: 275 L 275

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSK-AFCRE 107
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 147
Query: 168 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 224
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 284 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 341
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 342 L 342
           L
Sbjct: 304 L 304

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V  GK    +  VA+K + KE   S   F +E      L HP +V   G C 
Sbjct: 16  LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC- 72
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E  ++++ +Y+S G L  +L    KG+  +  L      ++   + E +A+L +    
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL------EMCYDVCEGMAFLESHQ-- 124
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD+   N L+      K+ DFG+  +           T K    + APE F + K 
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYFKY 182
Query: 248 SDKTDVYAFGVVLLELLT-GRKPIE 271
           S K+DV+AFG+++ E+ + G+ P +
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 24/220 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 114
           ++  G  LG G  + V K +        A K + K    SS+         RE+ I   +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L     + +  + LI + VSGG L   L EK+      +T       +    I
Sbjct: 66  RHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQI 117
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTV 230
            + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A +     K +
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 26/236 (11%)
Query: 54  EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELM 109
           +I     +F   ++LG+G+   VF  +        AIK L K+    D +       + +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 110 IASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           ++ +  HP +  +  FC    ++ LF + +Y++GG L  H+    K     +T       
Sbjct: 71  LSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF------ 122
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFL 226
             A  I   + +LH+   + +V+RD+K  NILL      K+ DFG+              
Sbjct: 123 -YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 282
           C    GT  Y+APE     K +   D ++FGV+L E+L G+ P      Q EE L 
Sbjct: 179 C----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELF 227

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGC 205
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 253

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 267

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 267

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 71
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 186
             E+ + ++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFL----KGETGKYLRLPQLV--DMAAQIASGMAYVERMN- 124
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK 246
              VHRD++ +NIL+    + K+ DFGLA            +  K    + APE   +G+
Sbjct: 125 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGR 181
Query: 247 VSDKTDVYAFGVVLLELLT-GRKP 269
            + K+DV++FG++L EL T GR P
Sbjct: 182 FTIKSDVWSFGILLTELTTKGRVP 205

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           LG+GA S V +    L     A K ++  K      +   RE  I   L HPNIV L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            I  E   +LI+  V+GG L   +  ++     +++            I E+V + H   
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCH--- 138
Query: 186 ERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
           +  VVHRD+KP N+LL+SK      KL DFGLA         +      GT GYL+PE  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLSPEVL 196
Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           +        D++A GV+L  LL G  P 
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 25/229 (10%)
Query: 52  YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFC 105
           Y + +   H +  G  LG G  + V K +        A K + K    SS+         
Sbjct: 19  YFQSMVEDH-YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 106 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           RE+ I   + HPNI+ L     + +  + LI + VSGG L   L EK+      +T    
Sbjct: 78  REVNILREIRHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---- 132
Query: 166 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAP 221
              +    I + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A 
Sbjct: 133 ---QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 186
Query: 222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           +     K + GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 187 NE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 24/220 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 114
           ++  G  LG G  + V K +        A K + K    SS+         RE+ I   +
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L     + +  + LI + VSGG L   L EK+      +T       +    I
Sbjct: 73  RHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQI 124
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTV 230
            + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A +     K +
Sbjct: 125 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 178
Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 16  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 74  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 123
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L++ + + K+ DFGL+       +TS+    F  +       +  PE 
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 176
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
             + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 91  NHQNIVRCIGVSL---QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 112/221 (50%), Gaps = 18/221 (8%)
Query: 68  LGRGALSFVFKG--KVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVG 124
           LG G    V +G  ++   +  VAIK L +  +K  ++   RE  I   L +P IV L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C    + L L+ +   GG L + L  K++ +  ++     + ++V++G+     YL   
Sbjct: 404 VCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA--ELLHQVSMGMK----YLE-- 453
Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQ 243
            E+  VHR++   N+LL ++   K+ DFGL+    A    +  ++  K    + APE   
Sbjct: 454 -EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 244 HGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
             K S ++DV+++GV + E L+ G+KP   ++++G E +  
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAF 551

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 118 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 174
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 175 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 231
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 232 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 279

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 62  FSKGRVLGRGALSFVF--KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
           + + + LG GA   V   + KV  +  ++ I R       S+     E+ +   L HPNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           + L  F  D ++  +L+ +   GG L   +  + K    ++ +       +   +   V 
Sbjct: 99  MKLYDFFED-KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-------IIKQVLSGVT 150
Query: 180 YLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGL-ATWTSAPSVPFLCKTVKGTFG 235
           YLH   +  +VHRD+KP N+LL SK+   + K+ DFGL A + +   +    K   GT  
Sbjct: 151 YLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM----KERLGTAY 203
Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           Y+APE  +  K  +K DV++ GV+L  LL G  P 
Sbjct: 204 YIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 91  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 17  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 75  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 124
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L++ + + K+ DFGL+       +TS+    F  +       +  PE 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-------WSPPEV 177
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
             + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 108 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 164
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 165 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 221
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 222 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 269

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 253

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 106 RELMIASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
           RE   A  L  P++VP+  F  ID +  L++  + ++G  L   L  +     G    P 
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQ--LYVDXRLINGVDLAAXLRRQ-----GPLAPPR 135
Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
           +V     +G A   A+    T     HRD+KP NIL+S+     L DFG+A+ T+   + 
Sbjct: 136 AVAIVRQIGSALDAAHAAGAT-----HRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
            L  TV GT  Y APE F     + + D+YA   VL E LTG  P +  +L
Sbjct: 191 QLGNTV-GTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 68  LGRGALSFV---FKGKVGLLRTS--VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 122
           LG+GA S V    K   G    +  +  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 68
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
               I  E   +L++  V+GG L   +  ++     +++            I ESV + H
Sbjct: 69  HD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCH 120
Query: 183 -NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            NG    +VHRD+KP N+LL+SK      KL DFGLA         +      GT GYL+
Sbjct: 121 LNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF--GFAGTPGYLS 174
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  +        D++A GV+L  LL G  P 
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 17  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 75  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 124
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L++ + + K+ DFGL+       +TS+    F  +       +  PE 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 177
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
             + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 70  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 119
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD+   N L++ + + K+ DFGL+       +TS+    F  +       +  PE 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 172
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 271
             + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 98  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 154
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 155 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 211
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 212 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 259

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 83  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 139
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 140 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 196
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 197 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 244

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 118
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 125
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+     GT  
Sbjct: 126 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV-----GTPY 176
Query: 236 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           ++APE       G+   K DV++ G+  +EL   + P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 68  LGRGALSFV---FKGKVGLLRTS--VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 122
           LG+GA S V    K   G    +  +  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 68
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
               I  E   +L++  V+GG L   +  ++     +++            I ESV + H
Sbjct: 69  HD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCH 120
Query: 183 -NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            NG    +VHRD+KP N+LL+SK      KL DFGLA         +      GT GYL+
Sbjct: 121 LNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF--GFAGTPGYLS 174
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  +        D++A GV+L  LL G  P 
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VAIK L K    S ++F  E  I   L H  +V L  + +
Sbjct: 17  LGNGQFGEVWMGTWNG-NTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQL--YAV 72
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E+ ++++ +Y++ GSL   L   K G      LP  V   +A  +A  +AY+      
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFL---KDGEGRALKLPNLV--DMAAQVAAGMAYIERMN-- 125
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRD++ +NIL+ +  I K+ DFGLA            +  K    + APE   +G+ 
Sbjct: 126 -YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYGRF 183
Query: 248 SDKTDVYAFGVVLLELLT-GRKP 269
           + K+DV++FG++L EL+T GR P
Sbjct: 184 TIKSDVWSFGILLTELVTKGRVP 206

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           ++G G+   V K +       VAIK+     +DK   K   RE+ +   L H N+V L+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C   ++  +L++++V    L+  L     G      L + V  K    I   + + H+ 
Sbjct: 92  VC-KKKKRWYLVFEFVDHTILD-DLELFPNG------LDYQVVQKYLFQIINGIGFCHSH 143
Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF-- 242
               ++HRDIKP NIL+S   + KLCDFG A   +AP   +  +    T  Y APE    
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAPELLVG 198
Query: 243 --QHGKVSDKTDVYAFGVVLLELLTG 266
             ++GK     DV+A G ++ E+  G
Sbjct: 199 DVKYGKA---VDVWAIGCLVTEMFMG 221

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 60  HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSKA-FCRELMIASS 113
           +N    R +G GA   VF+ +  GLL     T VA+K L +E     +A F RE  + + 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE-----------------KKKGV 156
             +PNIV L+G C    + + L+++Y++ G L   L                    +   
Sbjct: 107 FDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 157 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 216
            G   L  + +  +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+ 
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +               ++ PE   + + + ++DV+A+GVVL E+ + G +P
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 25/191 (13%)
Query: 86  TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 213 TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 269
Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 270 LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 321
Query: 206 IPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 259
           + K+ DFGLA       +T+     F  K       + APE    G  + K+DV++FG++
Sbjct: 322 VCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGIL 374
Query: 260 LLELLT-GRKP 269
           L+E++T GR P
Sbjct: 375 LMEIVTYGRIP 385

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 118
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 164
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+     GT  
Sbjct: 165 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV-----GTPY 215
Query: 236 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           ++APE       G+   K DV++ G+  +EL   + P+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 68  LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 121
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ + L HPN+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTL-----PWSVRYKVA 171
           L+G  +  +Q L +I+ Y S G L   L     H        + T+     P    + VA
Sbjct: 94  LLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             IA  + YL   +   VVH+D+   N+L+  K   K+ D GL     A     L     
Sbjct: 153 -QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               ++APE   +GK S  +D++++GVVL E+ + G +P
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASS 113
           A  +    R+LG G    V++G     +    +VA+K   K+   ++ + F  E +I  +
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 66  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 117
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +       +     +  
Sbjct: 118 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLP 173
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPI 270
             +++PE     + +  +DV+ F V + E+L+ G++P 
Sbjct: 174 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 25/191 (13%)
Query: 86  TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 40  TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 96
Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 97  LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 148
Query: 206 IPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 259
           + K+ DFGLA       +T+     F  K       + APE    G  + K+DV++FG++
Sbjct: 149 VCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGIL 201
Query: 260 LLELLT-GRKP 269
           L+E++T GR P
Sbjct: 202 LMEIVTYGRIP 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G    V+ G      T VA+K L K    S +AF  E  +  +L H  +V L    +
Sbjct: 20  LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VV 76
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             E+ +++I ++++ GSL   L   K    G   LP  + +     IAE +AY+     +
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIER---K 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 241
             +HRD++ +N+L+S   + K+ DFGLA       +T+     F  K       + APE 
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEA 181
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
              G  + K++V++FG++L E++T G+ P   R
Sbjct: 182 INFGCFTIKSNVWSFGILLYEIVTYGKIPYPGR 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 31/231 (13%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIK-----RLDK----EDKESSKAF----CREL 108
           + K R LG GA   V   K     +  AIK     + DK    +D ++ + F      E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            +  SL HPNI+ L     + ++  +L+ ++  GG L   +  + K    ++        
Sbjct: 98  SLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA------- 149
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFGLATWTSAPSVPF 225
            +   I   + YLH   +  +VHRDIKP NILL +K      K+ DFGL+++ S     +
Sbjct: 150 NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DY 203
Query: 226 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
             +   GT  Y+APE  +  K ++K DV++ GV++  LL G  P   +  Q
Sbjct: 204 KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 51  SYGEILAATHNFSKG---------RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDK 98
           +Y +   A H F+K          RV+G G    V  G++   G     VAIK L     
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 99  ESSK-AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 157
           E  +  F  E  I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +K  G  
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEG-VVTKSKPVMIVTEYMENGSLDTFL-KKNDGQF 121
Query: 158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-T 216
               L   +R     GI+  + YL   ++   VHRD+   NIL++S  + K+ DFGL+  
Sbjct: 122 TVIQLVGMLR-----GISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173
Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               P   +  +  K    + APE     K +  +DV+++G+V+ E+++ G +P
Sbjct: 174 LEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 8/169 (4%)
Query: 107 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 166 VRYKVALGIAESVAYLHNGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
              +V   +  ++   H  ++    V+HRD+KP+N+ L  K+  KL DFGLA   +  + 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               KT  GT  Y++PE       ++K+D+++ G +L EL     P  A
Sbjct: 172 --FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASS 113
           A  +    R+LG G    V++G     +    +VA+K   K+   ++ + F  E +I  +
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 70  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 121
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +       +     +  
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPI 270
             +++PE     + +  +DV+ F V + E+L+ G++P 
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 62  FSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKEDKESSKAFCRE-----LMIASS 113
           +  G  LG G  + V K +    GL   +  IK+  ++ + S +  CRE     + I   
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK--RQSRASRRGVCREEIEREVSILRQ 71
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           + HPNI+ L     +    + LI + VSGG L   L +K+      +T            
Sbjct: 72  VLHPNIITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQ 123
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKT 229
           I + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K 
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KN 177
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           + GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 19/223 (8%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIAS 112
           A   +F   +V+G+G+   V   +        A+K L K+     KE         ++  
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           ++ HP +V L  F       L+ +  Y++GG L  HL       R    L    R+  A 
Sbjct: 95  NVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAA- 146
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            IA ++ YLH+     +V+RD+KP NILL S+    L DFGL       +      T  G
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCG 201
Query: 233 TFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARR 274
           T  YLAPE   H +  D+T D +  G VL E+L G  P  +R 
Sbjct: 202 TPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASS 113
           A  +    R+LG G    V++G     +    +VA+K   K+   ++ + F  E +I  +
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 82  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 133
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +       +     +  
Sbjct: 134 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLP 189
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPI 270
             +++PE     + +  +DV+ F V + E+L+ G++P 
Sbjct: 190 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 126
           LG G  + V+KGK  L    VA+K +  E +E +     RE+ +   L H NIV L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI- 68
Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 186
           I  E+ L L+++Y+    L+++L +      GN     +V+      +   +AY H    
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDC-----GNIINMHNVKL-FLFQLLRGLAYCHR--- 118
Query: 187 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-YFQHG 245
           + V+HRD+KP N+L++ +   KL DFGLA   S P+  +  + V  T  Y  P+      
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGST 176
Query: 246 KVSDKTDVYAFGVVLLELLTGR 267
             S + D++  G +  E+ TGR
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 68  LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 121
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ + L HPN+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTL-----PWSVRYKVA 171
           L+G  +  +Q L +I+ Y S G L   L     H        + T+     P    + VA
Sbjct: 77  LLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             IA  + YL   +   VVH+D+   N+L+  K   K+ D GL     A     L     
Sbjct: 136 -QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               ++APE   +GK S  +D++++GVVL E+ + G +P
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
            VLG GA S VF  K  L     A+K + K       +   E+ +   + H NIV L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
             +     +L+ + VSGG L   + E+      +++L       V   +  +V YLH   
Sbjct: 75  -YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAVKYLH--- 123
Query: 186 ERCVVHRDIKPSNIL-LSSKKIPKL--CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
           E  +VHRD+KP N+L L+ ++  K+   DFGL+       +   C    GT GY+APE  
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----GTPGYVAPEVL 179
Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                S   D ++ GV+   LL G  P 
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 109 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 165
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A              
Sbjct: 166 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 222
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 223 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 270

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 18/228 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSK-AFCRELMIASSL 114
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 115 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 132 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 229
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A              
Sbjct: 189 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 276
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 66  RVLGRGALSFVFKGKVGLLR---------TSVAIKRLDKEDKESSKA-FCRELMIASSLH 115
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 27  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 116 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H NIV   G C  D   G+ LI +++  GSL+ +L + K  +     L ++V+      I
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ------I 135
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT- 233
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL             K  + + 
Sbjct: 136 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 192
Query: 234 -FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            F Y APE     K    +DV++FGV L ELLT
Sbjct: 193 VFWY-APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 66  RVLGRGALSFVFKGKVGLLR---------TSVAIKRLDKEDKESSKA-FCRELMIASSLH 115
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 15  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 69
Query: 116 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H NIV   G C  D   G+ LI +++  GSL+ +L + K  +     L ++V+      I
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ------I 123
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT- 233
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL             K  + + 
Sbjct: 124 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 180
Query: 234 -FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            F Y APE     K    +DV++FGV L ELLT
Sbjct: 181 VFWY-APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 72  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 130 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 179
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 182
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 78  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 135
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 136 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 185
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 186 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 32/226 (14%)
Query: 62  FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 110
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P   RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEP-EARYFM 148
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT           KT+
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKTL 202
Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            GT  Y+APE       S + D+++ G +L  LL G+ P E   L+
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 182
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 77  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 134
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 135 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 184
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 185 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 23/185 (12%)
Query: 86  TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 207 TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 263
Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 264 LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 315
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + K+ DFGLA               K    + APE    G  + K+DV++FG++L+E++T
Sbjct: 316 VCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364
Query: 266 -GRKP 269
            GR P
Sbjct: 365 YGRIP 369

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 68  LGRGALSFV---FKGKVGLLRTSVAI--KRLDKEDKESSKAFCRELMIASSLHHPNIVPL 122
           LG+GA S V    K   G    ++ I  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 75
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
               I  E   +LI+  V+GG L   +  ++     +++            I E+V + H
Sbjct: 76  HD-SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCH 127
Query: 183 NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
              +  VVHR++KP N+LL+SK      KL DFGLA         +      GT GYL+P
Sbjct: 128 ---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLSP 182
Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           E  +        D++A GV+L  LL G  P 
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 80  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 138 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 187
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 11/180 (6%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG-LFLIYKYVSGGSLE 146
           VA+K+L     +  + F RE+ I  +LH   IV   G    P +  L L+ +Y+  G L 
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLR 98
Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 99  DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 149
Query: 207 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            K+ DFGLA          + +   +    + APE       S ++DV++FGVVL EL T
Sbjct: 150 VKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 103 KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 160
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 161 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 210
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 211 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 66  RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           R LG GA   VF  +   L  +     VA+K L      + K F RE  + ++L H +IV
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVA 171
              G C D +  L ++++Y+  G L + L                +    L  S    +A
Sbjct: 81  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             IA  + YL     +  VHRD+   N L+ +  + K+ DFG++    +     +     
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               ++ PE   + K + ++DV++FGV+L E+ T G++P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 55  ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 110
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 111 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA   S         
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 348
Query: 229 TVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 281
              GT GY+APE  Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 55  ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 110
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 111 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA   S         
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 348
Query: 229 TVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 281
              GT GY+APE  Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 13/210 (6%)
Query: 65  GRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
           G++LG G    V +G +       L+ +V   +LD   +   + F  E        HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 120 VPLVGFCID-PEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           + L+G CI+   QG+    +I  ++  G L  +L   +    G   +P     K  + IA
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET-GPKHIPLQTLLKFMVDIA 157
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
             + YL N   R  +HRD+   N +L       + DFGL+    +       +  K    
Sbjct: 158 LGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           ++A E       + K+DV+AFGV + E+ T
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 55  ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 110
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 111 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA   S         
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 348
Query: 229 TVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 281
              GT GY+APE  Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 163
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 82  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 164 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 141 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 191
Query: 223 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           +F+   VLG+G+   V            AIK L K+     +  +    E  + + L  P
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             +  +  C      L+ + +YV+GG L  H+ +      G    P +V Y   + I   
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISIG-- 132
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + +LH   +R +++RD+K  N++L S+   K+ DFG+        V    +   GT  Y+
Sbjct: 133 LFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYI 187
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           APE   +       D +A+GV+L E+L G+ P + 
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 222

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 163
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 164 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 202
Query: 223 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 16  LENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEIL---------AATHNFSKGR 66
           LE G C    QEL     + L  S++P A+ L  + +   L            + F + R
Sbjct: 133 LEQGPCKDLFQELTRLTHEYL--SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           VLG+G    V   +V   G +     +++   + ++       E  I   ++   +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
            +  + +  L L+   ++GG L+ H++       G +  P +     A  I   +  LH 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHM-----GQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG---TFGYLAPE 240
             ER +V+RD+KP NILL      ++ D GLA       VP   +T+KG   T GY+APE
Sbjct: 305 --ER-IVYRDLKPENILLDDHGHIRISDLGLAV-----HVP-EGQTIKGRVGTVGYMAPE 355
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
             ++ + +   D +A G +L E++ G+ P + R+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 100/231 (43%), Gaps = 31/231 (13%)
Query: 60  HNFSKGRVLGRGALSFVFK-------GKVGLLRTSVAIKRLDKED-KESSKAFCRELMIA 111
             +    V+GRG  S V +        +  +    V  +RL  E  +E  +A  RE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 112 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             +  HP+I+ L+    +    +FL++  +  G L  +L EK         L       +
Sbjct: 154 RQVAGHPHIITLID-SYESSSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSI 205
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKT 229
              + E+V++LH      +VHRD+KP NILL      +L DFG +        +  LC  
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC-- 260
Query: 230 VKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
             GT GYLAPE  +      H     + D++A GV+L  LL G  P   RR
Sbjct: 261 --GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 55  ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 110
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 111 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 243 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 295
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA   S         
Sbjct: 296 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 347
Query: 229 TVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 281
              GT GY+APE  Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 348 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 45  NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKE 99
           N  +R    EI A+     K  V+G G    V  G++   G     VAIK L     DK+
Sbjct: 16  NQAVREFAKEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 73
Query: 100 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 159
             + F  E  I     HPNI+ L G  +   + + +I +Y+  GSL+  L +      G 
Sbjct: 74  R-RDFLSEASIMGQFDHPNIIHLEG-VVTKCKPVMIITEYMENGSLDAFLRKND----GR 127
Query: 160 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWT 218
            T+   V   +  GI   + YL   ++   VHRD+   NIL++S  + K+ DFG++    
Sbjct: 128 FTVIQLV--GMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             P   +  +  K    + APE   + K +  +DV+++G+V+ E+++ G +P
Sbjct: 183 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 45  NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKE 99
           N  +R    EI A+     K  V+G G    V  G++   G     VAIK L     DK+
Sbjct: 1   NQAVREFAKEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 58
Query: 100 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 159
             + F  E  I     HPNI+ L G  +   + + +I +Y+  GSL+  L +      G 
Sbjct: 59  R-RDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMIITEYMENGSLDAFLRKND----GR 112
Query: 160 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWT 218
            T+   V   +  GI   + YL   ++   VHRD+   NIL++S  + K+ DFG++    
Sbjct: 113 FTVIQLV--GMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE 167
Query: 219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             P   +  +  K    + APE   + K +  +DV+++G+V+ E+++ G +P
Sbjct: 168 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 163
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 86  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 164 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 145 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 195
Query: 223 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 196 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLH 115
           +  + + + LG GA   V   K  L     AIK + K       +S A   E+ +   L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPNI+ L  F  D ++  +L+ +   GG L   +  ++K     S +  +V  K  L   
Sbjct: 63  HPNIMKLYEFFED-KRNYYLVMEVYRGGELFDEIILRQK----FSEVDAAVIMKQVLS-- 115
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 232
               YLH      +VHRD+KP N+LL SK    + K+ DFGL   ++   V    K   G
Sbjct: 116 -GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGL---SAHFEVGGKMKERLG 168
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           T  Y+APE  +  K  +K DV++ GV+L  LL G  P 
Sbjct: 169 TAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 163
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 85  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 164 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 144 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 194
Query: 223 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 195 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF--GYLA 238
                    VHRDI   N+L+SS    KL DFGL+ +    +     K  KG     ++A
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTX---XKASKGKLPIKWMA 180
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
           PE     + +  +DV+ FGV + E+L  G KP + 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 16  LENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEIL---------AATHNFSKGR 66
           LE G C    QEL     + L  S++P A+ L  + +   L            + F + R
Sbjct: 133 LEQGPCKDLFQELTRLTHEYL--SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           VLG+G    V   +V   G +     +++   + ++       E  I   ++   +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
            +  + +  L L+   ++GG L+ H++       G +  P +     A  I   +  LH 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHM-----GQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG---TFGYLAPE 240
             ER +V+RD+KP NILL      ++ D GLA       VP   +T+KG   T GY+APE
Sbjct: 305 --ER-IVYRDLKPENILLDDHGHIRISDLGLAV-----HVP-EGQTIKGRVGTVGYMAPE 355
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
             ++ + +   D +A G +L E++ G+ P + R+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 163
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 164 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 202
Query: 223 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 8/169 (4%)
Query: 107 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 166 VRYKVALGIAESVAYLHNGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
              +V   +  ++   H  ++    V+HRD+KP+N+ L  K+  KL DFGLA   +  + 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               K   GT  Y++PE       ++K+D+++ G +L EL     P  A
Sbjct: 172 --FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I + L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 62  FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH   +R +++RD+KP N+LL      ++ D GLA    A       K   GT G++A
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA 357
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           PE     +     D +A GV L E++  R P  AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + Y
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 147
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 62  FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH   +R +++RD+KP N+LL      ++ D GLA    A       K   GT G++A
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA 357
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           PE     +     D +A GV L E++  R P  AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 25/234 (10%)
Query: 51  SYGEILAATHNFSKG---------RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDK 98
           +Y +   A H F+K          RV+G G    V  G++   G    +VAIK L     
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 99  ESSK-AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 157
           E  +  F  E  I     HPN+V L G  +   + + ++ +++  G+L+  L +      
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEG-VVTRGKPVMIVIEFMENGALDAFLRKHD---- 139
Query: 158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-T 216
           G  T+   V   +  GIA  + YL    +   VHRD+   NIL++S  + K+ DFGL+  
Sbjct: 140 GQFTVIQLV--GMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 194
Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               P   +     K    + APE  Q+ K +  +DV+++G+V+ E+++ G +P
Sbjct: 195 IEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLH 115
           +  + + + LG GA   V   K  L     AIK + K       +S A   E+ +   L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPNI+ L  F  D ++  +L+ +   GG L   +  ++K    ++ +       +   + 
Sbjct: 80  HPNIMKLYEFFED-KRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-------IMKQVL 131
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 232
               YLH      +VHRD+KP N+LL SK    + K+ DFGL   ++   V    K   G
Sbjct: 132 SGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGL---SAHFEVGGKMKERLG 185
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           T  Y+APE  +  K  +K DV++ GV+L  LL G  P 
Sbjct: 186 TAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 62  FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH   +R +++RD+KP N+LL      ++ D GLA    A       K   GT G++A
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA 357
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           PE     +     D +A GV L E++  R P  AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 66  RVLGRGALSFVFK---------GKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASS 113
           RVLG+G    VF+         GK+    +L+ ++ ++  + +D   +KA   E  I   
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKA---ERNILEE 77
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           + HP IV L+ +       L+LI +Y+SGG L   L  +++G+    T   +  Y   + 
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDT---ACFYLAEIS 131
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           +A  + +LH   ++ +++RD+KP NI+L+ +   KL DFGL   +       +  T  GT
Sbjct: 132 MA--LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGT 184
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             Y+APE       +   D ++ G ++ ++LTG  P 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 62  FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH   +R +++RD+KP N+LL      ++ D GLA    A       K   GT G++A
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA 357
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           PE     +     D +A GV L E++  R P  AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 163
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 134 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 164 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 193 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 243
Query: 223 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIV 120
           +V+G G    V  G++   G     VAIK L     DK+  + F  E  I     HPNI+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNII 72
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L G  +   + + +I +Y+  GSL+  L +      G  T+   V   +  GI   + Y
Sbjct: 73  HLEGV-VTKCKPVMIITEYMENGSLDAFLRKND----GRFTVIQLV--GMLRGIGSGMKY 125
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAP 239
           L   ++   VHRD+   NIL++S  + K+ DFG++      P   +  +  K    + AP
Sbjct: 126 L---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           E   + K +  +DV+++G+V+ E+++ G +P
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHPNIVP 121
           G  LG G    V  GK  L    VA+K L+++   S        RE+       HP+I+ 
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L      P   +F++ +YVSGG L  ++ +       N  L      ++   I   V Y 
Sbjct: 81  LYQVISTPSD-IFMVMEYVSGGELFDYICK-------NGRLDEKESRRLFQQILSGVDYC 132
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H      VVHRD+KP N+LL +    K+ DFGL+   S     FL  +  G+  Y APE 
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSC-GSPNYAAPEV 186
Query: 242 FQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 271
              G++    + D+++ GV+L  LL G  P +
Sbjct: 187 IS-GRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 455 KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 513 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 562
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + Y
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 148
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + Y
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 146
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 33/230 (14%)
Query: 66  RVLGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLV 123
           RVL  G  +FV++ + VG  R   A+KRL   ++E ++A  +E+     L  HPNIV   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGR-EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 124 GFCI---------DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            FC          D  Q  FL+   +  G L   L  KK   RG   L      K+    
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRG--PLSCDTVLKIFYQT 145
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS-APSVPFLCK----- 228
             +V ++H   +  ++HRD+K  N+LLS++   KLCDFG AT  S  P   +  +     
Sbjct: 146 CRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 229 ----TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
               T   T  Y  PE    + +  + +K D++A G +L  L   + P E
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 64  KGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPN 118
           K +VLG GA   V+KG        ++  VAIK L +    +++K    E  + + +  P 
Sbjct: 21  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 80
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +  L+G C+     + L+ + +  G L  H+ E +  +     L W ++      IA+ +
Sbjct: 81  VSRLLGICL--TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGM 132
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           +YL +     +VHRD+   N+L+ S    K+ DFGLA         +     K    ++A
Sbjct: 133 SYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
            E     + + ++DV+++GV + EL+T G KP + 
Sbjct: 190 LESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG 224

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 67  VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 122
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 123 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 173
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 82  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              VK T
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 189
Query: 234 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            G     ++A E   +   +  +DV+++GV+L E+++
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-------GVRGNSTLPWSVRY 168
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++            N     S + 
Sbjct: 78  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 169 KV--ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            V  A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA       + + 
Sbjct: 137 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHHIDYY 191
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + Y
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 145
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 71  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L       +  +R  +  P +V+  +  G  +A+ + Y
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDL-------RNFIRNETHNP-TVKDLIGFGLQVAKGMKY 148
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L       +  +R  +  P +V+  +  G  +A+ + Y
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDL-------RNFIRNETHNP-TVKDLIGFGLQVAKGMKY 143
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + Y
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 147
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + Y
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 166
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-------GVRGNSTLPWSVRY 168
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++            N     S + 
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 169 KV--ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            V  A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA       + + 
Sbjct: 152 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHHIDYY 206
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 67  VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 122
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 123 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 173
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 92  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              VK T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 199
Query: 234 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            G     ++A E   +   +  +DV+++GV+L E+++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 67  VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 120
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 56  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 178
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 165
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 236
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 166 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 62  FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 110
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P   RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEP-EARYFM 148
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--SAPSVPFLCK 228
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT           LC 
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC- 203
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              GT  Y+APE       S + D+++ G +L  LL G+ P E   L+
Sbjct: 204 ---GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + Y
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 140
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA             KT  K    ++A
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 26/256 (10%)
Query: 31  RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 90
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 47  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 104
Query: 91  KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 105 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 161
Query: 148 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 162 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 210
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLL 261
             KL DFG     +   +   C T  GT  Y++PE  +     G    + D ++ GV L 
Sbjct: 211 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 269
Query: 262 ELLTGRKPIEARRLQG 277
           E+L G  P  A  L G
Sbjct: 270 EMLVGDTPFYADSLVG 285

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 62  FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 110
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 79
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P   RY +
Sbjct: 80  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEP-EARYFM 132
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT           K +
Sbjct: 133 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDL 186
Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
            GT  Y+APE       S + D+++ G +L  LL G+ P E 
Sbjct: 187 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 128 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYL 237
           LH+     ++HRD+K  NIL +     KL DFG++   T T      F+     GT  ++
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWM 202
Query: 238 APEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 269
           APE        D     K DV++ G+ L+E+     P
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 26/256 (10%)
Query: 31  RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 90
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 42  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 91  KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 156
Query: 148 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 157 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 205
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLL 261
             KL DFG     +   +   C T  GT  Y++PE  +     G    + D ++ GV L 
Sbjct: 206 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 262 ELLTGRKPIEARRLQG 277
           E+L G  P  A  L G
Sbjct: 265 EMLVGDTPFYADSLVG 280

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+S+    KL DFGL+ +    S  +     K    ++APE
Sbjct: 133 ---------VHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 182
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 26/256 (10%)
Query: 31  RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 90
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 47  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 104
Query: 91  KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 105 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 161
Query: 148 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 162 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 210
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLL 261
             KL DFG     +   +   C T  GT  Y++PE  +     G    + D ++ GV L 
Sbjct: 211 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 269
Query: 262 ELLTGRKPIEARRLQG 277
           E+L G  P  A  L G
Sbjct: 270 EMLVGDTPFYADSLVG 285

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 128 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+     ++HRD+K  NIL +     KL DFG+    SA +   + +  +  GT  ++A
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDSFIGTPYWMA 203
Query: 239 PEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 269
           PE        D     K DV++ G+ L+E+     P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 8/169 (4%)
Query: 107 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 166 VRYKVALGIAESVAYLHNGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
              +V   +  ++   H  ++    V+HRD+KP+N+ L  K+  KL DFGLA   +    
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               K   GT  Y++PE       ++K+D+++ G +L EL     P  A
Sbjct: 172 --FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 32/226 (14%)
Query: 62  FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 110
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P   RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEP-EARYFM 148
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT           K +
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDL 202
Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            GT  Y+APE       S + D+++ G +L  LL G+ P E   L+
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 28/240 (11%)
Query: 57  AATHNFSKGRVLGRGALSFVF---KGKVGLLRTSVAIKRLDK-----EDKESSKAFCREL 108
           A    F   +VLG+G+   VF   K      R   A+K L K      D+  +K    E 
Sbjct: 21  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ER 77
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I   ++HP IV L  +    E  L+LI  ++ GG L   L ++      +      V++
Sbjct: 78  DILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED------VKF 130
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL    S  S+    K
Sbjct: 131 YLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKK 182
Query: 229 TVK--GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
                GT  Y+APE       +   D ++FGV++ E+LTG  P + +  +    ++L AK
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 33/236 (13%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF- 125
           +  RG    V+K +  L+   VA+K    +DK+S ++  RE+     + H N++  +   
Sbjct: 22  IKARGRFGCVWKAQ--LMNDFVAVKIFPLQDKQSWQSE-REIFSTPGMKHENLLQFIAAE 78
Query: 126 --CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
               + E  L+LI  +   GSL  +L       +GN  + W+    VA  ++  ++YLH 
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYL-------KGN-IITWNELCHVAETMSRGLSYLHE 130
Query: 184 GTERC--------VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
               C        + HRD K  N+LL S     L DFGLA        P       GT  
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRR 190
Query: 236 YLAPEYFQHGKVSD------KTDVYAFGVVLLELLTGRK----PIEARRLQGEENL 281
           Y+APE  + G ++       + D+YA G+VL EL++  K    P++   L  EE +
Sbjct: 191 YMAPEVLE-GAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEI 245

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 61  NFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           +F+   VLG+G+   V     KG   L    +  K +  +D +       + ++A     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +  L   C      L+ + +YV+GG L  H+ +      G    P +V Y  A  IA 
Sbjct: 81  PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFY--AAEIAI 132
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGT 233
            + +L +   + +++RD+K  N++L S+   K+ DFG+     W    +  F      GT
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-----GT 184
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
             Y+APE   +       D +AFGV+L E+L G+ P E 
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 28/240 (11%)
Query: 57  AATHNFSKGRVLGRGALSFVF---KGKVGLLRTSVAIKRLDK-----EDKESSKAFCREL 108
           A    F   +VLG+G+   VF   K      R   A+K L K      D+  +K    E 
Sbjct: 22  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ER 78
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I   ++HP IV L  +    E  L+LI  ++ GG L   L ++      +      V++
Sbjct: 79  DILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED------VKF 131
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL    S  S+    K
Sbjct: 132 YLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKK 183
Query: 229 TVK--GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
                GT  Y+APE       +   D ++FGV++ E+LTG  P + +  +    ++L AK
Sbjct: 184 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 243

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 125 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 244 HGKV-SDKTDVYAFGVVLLELLTGRKP 269
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 27  ELKWRKIQSLERSISPVANSLIRLSYGEILAATHN-FSKGRVLGRGALSFVFKGKV-GLL 84
           E++W+ ++ +  + + V     +L Y        N  S G+ LG GA   V +    GL+
Sbjct: 6   EVQWKVVEEINGN-NXVXIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLI 64
Query: 85  RTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 138
           ++  A+    K  K S+     +A   EL + S L +H NIV L+G C      L +I +
Sbjct: 65  KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL-VITE 123
Query: 139 YVSGGSLERHLHEKKKGVRGNSTLP---------------WSVRYKVALGIAESVAYLHN 183
           Y   G L   L  K+     + T P                S  Y+VA G+A    +L  
Sbjct: 124 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA----FL-- 177
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
            ++ C+ HRD+   NILL+  +I K+CDFGLA      S   +    +    ++APE   
Sbjct: 178 ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 236
Query: 244 HGKVSDKTDVYAFGVVLLELLT-GRKP 269
           +   + ++DV+++G+ L EL + G  P
Sbjct: 237 NCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 128 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+     ++HRD+K  NIL +     KL DFG+    SA +   + +     GT  ++A
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDXFIGTPYWMA 203
Query: 239 PEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 269
           PE        D     K DV++ G+ L+E+     P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 28/240 (11%)
Query: 57  AATHNFSKGRVLGRGALSFVF---KGKVGLLRTSVAIKRLDK-----EDKESSKAFCREL 108
           A    F   +VLG+G+   VF   K      R   A+K L K      D+  +K    E 
Sbjct: 21  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ER 77
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I   ++HP IV L  +    E  L+LI  ++ GG L   L ++      +      V++
Sbjct: 78  DILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED------VKF 130
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL    S  S+    K
Sbjct: 131 YLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKK 182
Query: 229 TVK--GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
                GT  Y+APE       +   D ++FGV++ E+LTG  P + +  +    ++L AK
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED---KESSKAFCRELMIASSLHHP 117
           +V+GRGA      G+V L+R        A+K L K +   +  S  F  E  I +  + P
Sbjct: 81  KVIGRGAF-----GEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 118 NIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGI 174
            +V L  FC    ++ L+++ +Y+ GG L          +  N  +P  W+  Y      
Sbjct: 136 WVVQL--FCAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDVPEKWAKFY-----T 180
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           AE V  L       ++HRD+KP N+LL      KL DFG         +   C T  GT 
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VHCDTAVGTP 239
Query: 235 GYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
            Y++PE  +     G    + D ++ GV L E+L G  P  A  L G
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 286

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 122 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+     V+HRDIK  NILL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 184
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE         K D+++ G++ +E++ G  P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 65  GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 120
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 455 KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                    VHRDI   N+L+S+    KL DFGL+ +    S  +     K    ++APE
Sbjct: 513 ---------VHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 562
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 272
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 69  KYYGSYLK-DTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILR-----EILKGLDY 119
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +     T  GT  ++APE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPE 174
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +      K D+++ G+  +EL  G  P
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVP 121
           +V+G G    V  G +   G     VAIK L     E  +  F  E  I     HPN++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  +     + +I +++  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 99  LEG-VVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL 151
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGTFG--YLA 238
               +   VHRD+   NIL++S  + K+ DFGL+ +     S P     + G     + A
Sbjct: 152 ---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           PE  Q+ K +  +DV+++G+V+ E+++ G +P
Sbjct: 209 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 68  LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 122
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR----GNSTLPWSVRYKVALGIAESV 178
            G C +  + L ++++Y+  G L R L       +    G    P  +     L +A  V
Sbjct: 86  FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 179 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A    YL        VHRD+   N L+    + K+ DFG++    +     +        
Sbjct: 145 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            ++ PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 68  LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 122
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR----GNSTLPWSVRYKVALGIAESV 178
            G C +  + L ++++Y+  G L R L       +    G    P  +     L +A  V
Sbjct: 80  FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 179 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A    YL        VHRD+   N L+    + K+ DFG++    +     +        
Sbjct: 139 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            ++ PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 89  KYYGSYLK-DTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILR-----EILKGLDY 139
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +     T  GT  ++APE
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPE 194
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +      K D+++ G+  +EL  G  P
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 61  NFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 116
           +F+   VLG+G+   V     KG   L    +  K +  +D +       + ++A     
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +  L   C      L+ + +YV+GG L  H+ +      G    P +V Y  A  IA 
Sbjct: 402 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFY--AAEIAI 453
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WTSAPSVPFLCKTVKGT 233
            + +L +   + +++RD+K  N++L S+   K+ DFG+     W    +  F      GT
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-----GT 505
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
             Y+APE   +       D +AFGV+L E+L G+ P E 
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 68  LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 122
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR----GNSTLPWSVRYKVALGIAESV 178
            G C +  + L ++++Y+  G L R L       +    G    P  +     L +A  V
Sbjct: 109 FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 179 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A    YL        VHRD+   N L+    + K+ DFG++    +     +        
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            ++ PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 89
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 145
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 200
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 201 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--FCRELMIASSLH-HPNIVPLVG 124
           LG+GA   V+K         VA+K++    + S+ A    RE+MI + L  H NIV L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 125 FC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
               D ++ ++L++ Y     +E  LH     +R N   P   +Y V   + + + YLH+
Sbjct: 77  VLRADNDRDVYLVFDY-----METDLH---AVIRANILEPVHKQY-VVYQLIKVIKYLHS 127
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------------------TWTSAPSV 223
           G    ++HRD+KPSNILL+++   K+ DFGL+                    T       
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 224 PFLCKTVKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           P L   V  T  Y APE      K +   D+++ G +L E+L G KPI
Sbjct: 185 PILTDYV-ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 122/256 (47%), Gaps = 30/256 (11%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 120 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 137
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA      S  F+      T 
Sbjct: 138 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTASTNFMMTPYVVTR 187
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            Y APE        +  D+++ G ++ EL+ G     +   QG +++  W K I   G  
Sbjct: 188 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG-----SVIFQGTDHIDQWNKVIEQLGTP 242
Query: 295 AVEELLDPRLKCTSRN 310
           + E +    L+ T RN
Sbjct: 243 SAEFM--AALQPTVRN 256

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 34/225 (15%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 163
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 164 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 202
Query: 223 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           +    KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 203 IDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 67  VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 120
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 178
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGY 236
            +L     +  VHRD+   N +L  K   K+ DFGLA          +      K    +
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 24/238 (10%)
Query: 57  AATHNFSKGRVLGRGALSFVF------KGKVGLLRTSVAIKR--LDKEDKESSKAFCREL 108
           A   +F   +VLG+G+   VF      +   G L     +K+  L   D+  +K    E 
Sbjct: 25  ADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM---ER 81
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I + ++HP +V L  +    E  L+LI  ++ GG L   L ++      +      V++
Sbjct: 82  DILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED------VKF 134
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +A  +A  + +LH+     +++RD+KP NILL  +   KL DFGL+    A        
Sbjct: 135 YLA-ELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAY 188
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
           +  GT  Y+APE       S   D +++GV++ E+LTG  P + +  +    L+L AK
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAK 246

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 66  RVLGRGALSFVFK---------GKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASS 113
           RVLG+G    VF+         GK+    +L+ ++ ++  + +D   +KA   E  I   
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKA---ERNILEE 77
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           + HP IV L+ +       L+LI +Y+SGG L   L  +++G+    T   +  Y   + 
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDT---ACFYLAEIS 131
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           +A  + +LH   ++ +++RD+KP NI+L+ +   KL DFGL   +       +     GT
Sbjct: 132 MA--LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGT 184
Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             Y+APE       +   D ++ G ++ ++LTG  P 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + +
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKF 149
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA          +      K    ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 104
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 160
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 215
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 216 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + +
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKF 146
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA          +      K    ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 27  ELKWRKIQSLERSISPVANSLIRLSYGEILAATHN-FSKGRVLGRGALSFVFKGKV-GLL 84
           E++W+ ++ +  + + V     +L Y        N  S G+ LG GA   V +    GL+
Sbjct: 13  EVQWKVVEEINGN-NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLI 71
Query: 85  RTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 138
           ++  A+    K  K S+     +A   EL + S L +H NIV L+G C      L +I +
Sbjct: 72  KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL-VITE 130
Query: 139 YVSGGSLERHLHEKKKGVRGNSTLP---------------WSVRYKVALGIAESVAYLHN 183
           Y   G L   L  K+     + T P                S  Y+VA G+A    +L  
Sbjct: 131 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA----FL-- 184
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
            ++ C+ HRD+   NILL+  +I K+CDFGLA      S   +    +    ++APE   
Sbjct: 185 ASKNCI-HRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIF 243
Query: 244 HGKVSDKTDVYAFGVVLLELLT-GRKP 269
           +   + ++DV+++G+ L EL + G  P
Sbjct: 244 NCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 117
           ++  G  LG G    V  G+  L    VA+K L+++   S        RE+       HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIA 175
           +I+ L      P    F++ +YVSGG L  ++  H + + +            ++   I 
Sbjct: 72  HIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEAR---------RLFQQIL 121
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
            +V Y H      VVHRD+KP N+LL +    K+ DFGL+   S        +T  G+  
Sbjct: 122 SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPN 175
Query: 236 YLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 271
           Y APE    G++    + D+++ GV+L  LL G  P +
Sbjct: 176 YAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 67  VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 122
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 123 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 173
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 89  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           +A  + YL   +++  +HR++   NIL+    + K+ DFGL+              VK T
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 196
Query: 234 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            G     ++A E   +   +  +DV+++GV+L E+++
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 67  VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 120
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 96  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 178
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 205
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGY 236
            +L     +  VHRD+   N +L  K   K+ DFGLA          +      K    +
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 119
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 120 VPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVK 231
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C    
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 232 GTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
               Y APE  F     +   DV++ G VL ELL G+
Sbjct: 188 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 155
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV     E      +   R   TLP          + 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 266
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 267 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 301

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 110
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 166
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 81
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV     E      +   R   TLP          + 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 192
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 193 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 227

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 170
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIITLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 171 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 67  VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 120
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 38  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 178
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 147
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGY 236
            +L     +  VHRD+   N +L  K   K+ DFGLA          +      K    +
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 27  ELKWRKIQSLERSISPVANSLIRLSYGEILAATHN-FSKGRVLGRGALSFVFKGKV-GLL 84
           E++W+ ++ +  + + V     +L Y        N  S G+ LG GA   V +    GL+
Sbjct: 8   EVQWKVVEEINGN-NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLI 66
Query: 85  RTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 138
           ++  A+    K  K S+     +A   EL + S L +H NIV L+G C      L +I +
Sbjct: 67  KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL-VITE 125
Query: 139 YVSGGSLERHLHEKKKGVRGNSTLP---------------WSVRYKVALGIAESVAYLHN 183
           Y   G L   L  K+     + T P                S  Y+VA G+A    +L  
Sbjct: 126 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA----FL-- 179
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
            ++ C+ HRD+   NILL+  +I K+CDFGLA      S   +    +    ++APE   
Sbjct: 180 ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 238
Query: 244 HGKVSDKTDVYAFGVVLLELLT-GRKP 269
           +   + ++DV+++G+ L EL + G  P
Sbjct: 239 NCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 119
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 120 VPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVK 231
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C    
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 232 GTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
               Y APE  F     +   DV++ G VL ELL G+
Sbjct: 188 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + +
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKF 153
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA          +      K    ++A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 119/248 (47%), Gaps = 22/248 (8%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 126 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
              P++ L      Y+    ++ +L +  +    +  + + + Y++ +GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSA 145
Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 302
               +  D+++ GV++ E++ G          G +++  W K I   G  + E +  L P
Sbjct: 200 MGYKENVDIWSVGVIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 303 RLKCTSRN 310
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 112
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 168
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 223
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 224 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 114
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 170
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 225
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 226 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPL 122
           V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAY 180
           +G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ + +
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKF 148
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGYLA 238
           L     +  VHRD+   N +L  K   K+ DFGLA          +      K    ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+M+ +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 121 --------------PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
                         P+    +  +  LF+  +Y   G+L   +H +    + +       
Sbjct: 66  RYYAAWLERRNFVKPMT--AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY----- 118
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------- 215
            +++   I E+++Y+H+   + ++HRD+KP NI +   +  K+ DFGLA           
Sbjct: 119 -WRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 216 -TWTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELL 264
               + P       +  GT  Y+A E     G  ++K D+Y+ G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 30/230 (13%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 111
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 112 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 78  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 129
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              + E +  LH      +VHRD+KP NILL      KL DFG +            ++V
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRSV 183
Query: 231 KGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
            GT  YLAPE  +      H     + D+++ GV++  LL G  P   R+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 27  ELKWRKIQSLERSISPVANSLIRLSYGEILAATHN-FSKGRVLGRGALSFVFKGKV-GLL 84
           E++W+ ++ +  + + V     +L Y        N  S G+ LG GA   V +    GL+
Sbjct: 13  EVQWKVVEEINGN-NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLI 71
Query: 85  RTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 138
           ++  A+    K  K S+     +A   EL + S L +H NIV L+G C      L +I +
Sbjct: 72  KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL-VITE 130
Query: 139 YVSGGSLERHLHEKKKGVRGNSTLP---------------WSVRYKVALGIAESVAYLHN 183
           Y   G L   L  K+     + T P                S  Y+VA G+A    +L  
Sbjct: 131 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA----FL-- 184
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
            ++ C+ HRD+   NILL+  +I K+CDFGLA      S   +    +    ++APE   
Sbjct: 185 ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 243
Query: 244 HGKVSDKTDVYAFGVVLLELLT-GRKP 269
           +   + ++DV+++G+ L EL + G  P
Sbjct: 244 NCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 31/233 (13%)
Query: 60  HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASS 113
           +  S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 114 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--------- 163
           L +H NIV L+G C      L +I +Y   G L   L  K+     + T P         
Sbjct: 83  LGNHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 164 ------WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 217
                  S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA  
Sbjct: 142 LDLEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARD 194
Query: 218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               S   +    +    ++APE   +   + ++DV+++G+ L EL + G  P
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYK- 169
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIIHLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 170 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 117/258 (45%), Gaps = 28/258 (10%)
Query: 27  ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 81
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 82  -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 134
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 126
Query: 135 LIYKYVSGGSLERHLHEKKKGVR-------GNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           +I +Y   G L   L  K + +         NSTL        +  +A+ +A+L   ++ 
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL--ASKN 184
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
           C+ HRD+   N+LL++  + K+ DFGLA      S   +    +    ++APE       
Sbjct: 185 CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 248 SDKTDVYAFGVVLLELLT 265
           + ++DV+++G++L E+ +
Sbjct: 244 TVQSDVWSYGILLWEIFS 261

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 123/254 (48%), Gaps = 23/254 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVGF 125
           LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 119 LF--REGDVWICMELMDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 171
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFGYLAPEYF-- 242
           +  V+HRD+KPSN+L+++    K+CDFG++ +     V  + KT+  G   Y+APE    
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDSVAKTIDAGCKPYMAPERINP 227
Query: 243 ---QHGKVSDKTDVYAFGVVLLELLTGRKPIEA--RRLQGEENLVLWAKPILHRGMAAVE 297
              Q G  S K+D+++ G+ ++EL   R P ++     Q  + +V    P L     +  
Sbjct: 228 ELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA- 285
Query: 298 ELLDPRLKCTSRNS 311
           E +D   +C  +NS
Sbjct: 286 EFVDFTSQCLKKNS 299

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 88  VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 145
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D  E+ L L+ +YV  GSL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
             +L     G+        +     A  I E +AYLH+   +  +HR++   N+LL + +
Sbjct: 106 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDR 154
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
           + K+ DFGLA         +  +    +  F Y APE  +  K    +DV++FGV L EL
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYEL 213
Query: 264 LT--------GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXX 315
           LT          K +E   +   +  VL    +L RG    E L  P  KC         
Sbjct: 214 LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG----ERLPRPD-KCPCE------ 262
Query: 316 XXXXXXXXCISSEESRRPGIEEIIAILRGEEE 347
                   C  +E S RP  E +I IL+   E
Sbjct: 263 -VYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 223
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 224 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 276
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 172 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 277 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 311
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 230 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 272

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 223
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 224 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 276
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 172 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 277 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 311
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 230 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 272

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 223
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 224 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 276
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 172 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 277 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 311
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 230 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 272

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 122 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 83  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 132
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+     V+HR+IK  NILL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 133 LHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 185
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE         K D+++ G++ +E++ G  P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 23/230 (10%)
Query: 66  RVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVP 121
           R LG GA      V +   GL R    IK ++K+  +   +    E+ +  SL HPNI+ 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           +     D    ++++ +   GG L ER +  + +G      L      ++   +  ++AY
Sbjct: 85  IFEVFED-YHNMYIVMETCEGGELLERIVSAQARG----KALSEGYVAELMKQMMNALAY 139
Query: 181 LHNGTERCVVHRDIKPSNILL--SSKKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
            H+   + VVH+D+KP NIL   +S   P K+ DFGLA    +           GT  Y+
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYM 193
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 287
           APE F+   V+ K D+++ GVV+  LLTG  P     L+  +    + +P
Sbjct: 194 APEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 119
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 223
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 120 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 170
Query: 224 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 276
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 171 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 228
Query: 277 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 311
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 229 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 271

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           +  K+L   D +  +   RE  I   L H NIV L    I  E   +L++  V+GG L  
Sbjct: 37  INTKKLSARDHQKLE---REARICRLLKHSNIVRLHD-SISEEGFHYLVFDLVTGGELFE 92
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--- 204
            +  ++     +++            I E+V + H   +  VVHRD+KP N+LL+SK   
Sbjct: 93  DIVAREYYSEADAS-------HCIQQILEAVLHCH---QMGVVHRDLKPENLLLASKCKG 142
Query: 205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
              KL DFGLA         +      GT GYL+PE  +        D++A GV+L  LL
Sbjct: 143 AAVKLADFGLAIEVQGDQQAWF--GFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILL 200
Query: 265 TGRKPI 270
            G  P 
Sbjct: 201 VGYPPF 206

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 41/232 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 59  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 114 RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 167
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL------ATWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG       ATWT    
Sbjct: 168 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT---- 218
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A +
Sbjct: 219 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 122 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+     V+HRDIK  NILL      KL DFG     + P      + V GT  ++APE
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSEMV-GTPYWMAPE 186
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                    K D+++ G++ +E++ G  P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 170
           H NI+ L+G C   +  L++I  Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 171 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 126
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 223
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 127 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 177
Query: 224 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 276
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 178 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 235
Query: 277 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 311
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 236 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 278

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 122 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 83  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 132
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+     V+HRDIK  NILL      KL DFG      A   P   K   + GT  ++A
Sbjct: 133 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMA 185
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE         K D+++ G++ +E++ G  P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 79  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 128
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 129 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 222

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 30/230 (13%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 111
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 112 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 65  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 116
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              + E +  LH      +VHRD+KP NILL      KL DFG +            + V
Sbjct: 117 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREV 170
Query: 231 KGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
            GT  YLAPE  +      H     + D+++ GV++  LL G  P   R+
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 39/276 (14%)
Query: 61  NFSKGRVLGRGALSFVF------KGKVGLLRTSVAIKRLDKEDKESSKAFCR-ELMIASS 113
           NF   +VLG GA   VF          G L     +K+     K  +    R E  +   
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           +     +  + +    E  L LI  Y++GG L  HL ++++             ++V + 
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----------FTEHEVQIY 164
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E V  L +  +  +++RDIK  NILL S     L DFGL+    A           GT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223
Query: 234 FGYLAPEYFQHGKVS-DK-TDVYAFGVVLLELLTGRKPIEARRLQGEEN-------LVLW 284
             Y+AP+  + G    DK  D ++ GV++ ELLTG  P     + GE+N        +L 
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF---TVDGEKNSQAEISRRILK 280
Query: 285 AKPILHRGMAA-----VEELL--DP--RLKCTSRNS 311
           ++P   + M+A     ++ LL  DP  RL C  R++
Sbjct: 281 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 316

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 119
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 120 VPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVK 231
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C    
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 232 GTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
               Y APE  F     +   DV++ G VL ELL G+
Sbjct: 188 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 259
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 223
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 260 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 310
Query: 224 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 276
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 311 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 368
Query: 277 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 311
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 369 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 411

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 69  KYYGSYLK-DTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILR-----EILKGLDY 119
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +        GT  ++APE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPE 174
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +      K D+++ G+  +EL  G  P
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 122 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+     V+HRDIK  NILL      KL DFG      A   P   K   + GT  ++A
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMA 184
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE         K D+++ G++ +E++ G  P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 85  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 134
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 135 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 228

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 126 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
              P++ L      Y+    ++ +L +  +    +  + + + Y++ +GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSA 145
Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYLAPEYF 242
               ++HRD+KPSNI++ S    K+ DFGLA    TS    P++      T  Y APE  
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-----TRYYRAPEVI 197
Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--L 300
                 +  D+++ GV++ E++ G          G +++  W K I   G  + E +  L
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 301 DPRLKCTSRN 310
            P ++    N
Sbjct: 253 QPTVRTYVEN 262

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---S 177
              G  +   + L++I +Y+ GGS    L             P+   +++A  + E    
Sbjct: 85  KYYGSYLKGSK-LWIIMEYLGGGSALDLLRAG----------PFD-EFQIATMLKEILKG 132
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH+  +   +HRDIK +N+LLS +   KL DFG+A   +   +     T  GT  ++
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWM 187
Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           APE  Q      K D+++ G+  +EL  G  P
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 73  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 122
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 123 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 216

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 170
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 171 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            +     +A  + YL   +++C+ HRD+   N+L++   + ++ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMRIADFGLA--RDINNIDYY 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 30/230 (13%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 111
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 112 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 78  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 129
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              + E +  LH      +VHRD+KP NILL      KL DFG +            + V
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREV 183
Query: 231 KGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
            GT  YLAPE  +      H     + D+++ GV++  LL G  P   R+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 95  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 144
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 145 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 238

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 95  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 144
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 145 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 238

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 75  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 124
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 218

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 84  KYYGSYLK-DTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILR-----EILKGLDY 134
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +        GT  ++APE
Sbjct: 135 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPE 189
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +      K D+++ G+  +EL  G  P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 245
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 223
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 246 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 296
Query: 224 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 276
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 297 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354
Query: 277 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 311
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 355 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 397

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 72  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 123
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 72  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 123
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 92/183 (50%), Gaps = 14/183 (7%)
Query: 87  SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 146
            VA+K +D   ++  +    E++I     H N+V +    +  E+ L+++ +++ GG+L 
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-LWVLMEFLQGGALT 130
Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
             + + +      +T        V   + +++AYLH    + V+HRDIK  +ILL+    
Sbjct: 131 DIVSQVRLNEEQIAT--------VCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGR 179
Query: 207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG 266
            KL DFG     S   VP   K + GT  ++APE       + + D+++ G++++E++ G
Sbjct: 180 VKLSDFGFCAQISK-DVPKR-KXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
Query: 267 RKP 269
             P
Sbjct: 238 EPP 240

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 170
           H NI+ L+G C   +  L++I  Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 171 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 117/272 (43%), Gaps = 36/272 (13%)
Query: 88  VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 145
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D     L L+ +YV  GSL
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
             +L     G+        +     A  I E +AYLH    +  +HRD+   N+LL + +
Sbjct: 123 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDR 171
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
           + K+ DFGLA         +  +    +  F Y APE  +  K    +DV++FGV L EL
Sbjct: 172 LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYEL 230
Query: 264 LT--------GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXX 315
           LT          K +E   +   +  VL    +L RG    E L  P  KC +       
Sbjct: 231 LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG----ERLPRPD-KCPAE------ 279
Query: 316 XXXXXXXXCISSEESRRPGIEEIIAILRGEEE 347
                   C  +E S RP  E +I IL+   E
Sbjct: 280 -VYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 79  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 128
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 129 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 93  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 142
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 143 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 236

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 22/235 (9%)
Query: 41  SPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFK---GKVGLLRTSVAIKRLDKED 97
           +P  + ++    G +  + +  SK  +LG G    V K      GL   +  IK    +D
Sbjct: 71  APFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 98  KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 157
           KE  K    E+ + + L H N++ L     + +  + L+ +YV GG L   + ++   + 
Sbjct: 130 KEEVK---NEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLA 215
              T+ +  +      I E + ++H   +  ++H D+KP NIL  ++  K  K+ DFGLA
Sbjct: 186 ELDTILFMKQ------ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                P      K   GT  +LAPE   +  VS  TD+++ GV+   LL+G  P 
Sbjct: 237 R-RYKPREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 80
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 136
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 191
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 192 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 185
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H   
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCH--- 117
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
           +R V+HRD+KP N+L++ +   K+ DFGLA     P   +  + V  T  Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGS 175
Query: 246 -KVSDKTDVYAFGVVLLELLTG 266
            K S   D+++ G +  E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           K + LG G+ S   K        + A+K + K  + +++     L +     HPNIV L 
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLH 72
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
               D +   FL+ + ++GG L   + +KK      ++        +   +  +V+++H+
Sbjct: 73  EVFHD-QLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAVSHMHD 124
Query: 184 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
                VVHRD+KP N+L + +      K+ DFG A      + P   KT   T  Y APE
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPE 179
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
                   +  D+++ GV+L  +L+G+ P ++ 
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 68  LGRGALSFVFKGKVGLLR---TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 80  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 131
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 240
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 132 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +    S  +D + FGV L E+ T G++P
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 36/272 (13%)
Query: 88  VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 145
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D  E+ L L+ +YV  GSL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
             +L     G+        +     A  I E +AYLH    +  +HR++   N+LL + +
Sbjct: 106 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDR 154
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
           + K+ DFGLA         +  +    +  F Y APE  +  K    +DV++FGV L EL
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYEL 213
Query: 264 LT--------GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXX 315
           LT          K +E   +   +  VL    +L RG    E L  P  KC         
Sbjct: 214 LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG----ERLPRPD-KCPCE------ 262
Query: 316 XXXXXXXXCISSEESRRPGIEEIIAILRGEEE 347
                   C  +E S RP  E +I IL+   E
Sbjct: 263 -VYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 185
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H   
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCH--- 117
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
           +R V+HRD+KP N+L++ +   K+ DFGLA     P   +  + V  T  Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGS 175
Query: 246 -KVSDKTDVYAFGVVLLELLTG 266
            K S   D+++ G +  E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 77
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 133
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 188
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 189 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 88
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 144
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 200 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 95
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 151
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 206
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 207 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 116/253 (45%), Gaps = 31/253 (12%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 112
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 25  GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 81
Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
              H N+V +    +  ++ L+++ +++ GG+L          +  ++ +       V L
Sbjct: 82  DYQHENVVEMYNSYLVGDE-LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVCL 132
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + G
Sbjct: 133 AVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVG 187
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG 292
           T  ++APE         + D+++ G++++E++ G  P              + +P L + 
Sbjct: 188 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KA 233
Query: 293 MAAVEELLDPRLK 305
           M  + + L PRLK
Sbjct: 234 MKMIRDNLPPRLK 246

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 116/253 (45%), Gaps = 31/253 (12%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 112
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 20  GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 76
Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
              H N+V +    +  ++ L+++ +++ GG+L          +  ++ +       V L
Sbjct: 77  DYQHENVVEMYNSYLVGDE-LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVCL 127
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + G
Sbjct: 128 AVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVG 182
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG 292
           T  ++APE         + D+++ G++++E++ G  P              + +P L + 
Sbjct: 183 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KA 228
Query: 293 MAAVEELLDPRLK 305
           M  + + L PRLK
Sbjct: 229 MKMIRDNLPPRLK 241

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 88
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 144
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 200 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +++ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 170
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 171 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 110
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 166
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 221
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 84
Query: 121 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 140
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 195
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 196 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 185
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H   
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCH--- 117
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
           +R V+HRD+KP N+L++ +   K+ DFGLA     P   +  + V  T  Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGS 175
Query: 246 -KVSDKTDVYAFGVVLLELLTG 266
            K S   D+++ G +  E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVRG----NSTLPWSVRYKV 170
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++  G+      N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 171 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++   
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDXX 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 37  ERSISP--VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 94
           +R I P  +  +L   S+G++  ATH  ++ +V    AL F+ +    LL+ S    R++
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKV----ALKFISRQ---LLKKSDMHMRVE 57
Query: 95  KEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 154
                      RE+     L HP+I+ L      P   + ++ +Y +GG L  ++ EKK+
Sbjct: 58  -----------REISYLKLLRHPHIIKLYDVITTP-TDIVMVIEY-AGGELFDYIVEKKR 104
Query: 155 GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 214
                         +    I  ++ Y H      +VHRD+KP N+LL      K+ DFGL
Sbjct: 105 MTEDEGR-------RFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL 154
Query: 215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 271
           +   +  +     KT  G+  Y APE   +GK+    + DV++ G+VL  +L GR P +
Sbjct: 155 SNIMTDGN---FLKTSCGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 116/253 (45%), Gaps = 31/253 (12%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 112
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 16  GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 72
Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
              H N+V +    +  ++ L+++ +++ GG+L          +  ++ +       V L
Sbjct: 73  DYQHENVVEMYNSYLVGDE-LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVCL 123
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + G
Sbjct: 124 AVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVG 178
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG 292
           T  ++APE         + D+++ G++++E++ G  P              + +P L + 
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KA 224
Query: 293 MAAVEELLDPRLK 305
           M  + + L PRLK
Sbjct: 225 MKMIRDNLPPRLK 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TWT       LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 68  LGRGALSFVFKGKVGLLR---TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 80  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 131
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 240
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 132 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +    S  +D + FGV L E+ T G++P
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 170
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 171 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             T  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 112
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 27  GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 83
Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
              H N+V +    +  ++ L+++ +++ GG+L   +   +      +         V L
Sbjct: 84  DYQHENVVEMYNSYLVGDE-LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCL 134
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + G
Sbjct: 135 AVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVG 189
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG 292
           T  ++APE         + D+++ G++++E++ G  P              + +P L + 
Sbjct: 190 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KA 235
Query: 293 MAAVEELLDPRLK 305
           M  + + L PRLK
Sbjct: 236 MKMIRDNLPPRLK 248

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 117
           ++  G  LG G    V  G+  L    VA+K L+++   S        RE+       HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIA 175
           +I+ L      P    F++ +YVSGG L  ++  H + + +            ++   I 
Sbjct: 72  HIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEAR---------RLFQQIL 121
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
            +V Y H      VVHRD+KP N+LL +    K+ DFGL+   S     FL  +  G+  
Sbjct: 122 SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRDSC-GSPN 175
Query: 236 YLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 271
           Y APE    G++    + D+++ GV+L  LL G  P +
Sbjct: 176 YAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 24  AHLDQFERIKTLGTGSF-----GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y
Sbjct: 79  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY 132
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TWT    
Sbjct: 133 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---- 183
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 184 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 226

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           F     LG GA S V   +        A+K + K+    KESS     E+ +   + H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L      P   L+L+ + VSGG L   + EK  G          +R      + ++V
Sbjct: 82  IVALEDIYESPNH-LYLVMQLVSGGELFDRIVEK--GFYTEKDASTLIR-----QVLDAV 133
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPK---LCDFGLATWTSAPSVPFLCKTVKGTFG 235
            YLH      +VHRD+KP N+L  S+       + DFGL+       V     T  GT G
Sbjct: 134 YYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTACGTPG 187
Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           Y+APE       S   D ++ GV+   LL G  P 
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL---HHPN 118
           F   R+ G+G    V  GK      SVAIK++ ++ +  +    REL I   L   HHPN
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN----RELQIMQDLAVLHHPN 80
Query: 119 IVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAE 176
           IV L   F    E+    IY  V    +   LH   +        P  +  KV L  +  
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGT 233
           S+  LH  +   V HRDIKP N+L++ +    KLCDFG A     S P+V ++C      
Sbjct: 141 SIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--- 196
Query: 234 FGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             Y APE  F +   +   D+++ G +  E++ G +PI
Sbjct: 197 --YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 116/253 (45%), Gaps = 31/253 (12%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 112
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 70  GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 126
Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
              H N+V +    +  ++ L+++ +++ GG+L          +  ++ +       V L
Sbjct: 127 DYQHENVVEMYNSYLVGDE-LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVCL 177
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + G
Sbjct: 178 AVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVG 232
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG 292
           T  ++APE         + D+++ G++++E++ G  P              + +P L + 
Sbjct: 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KA 278
Query: 293 MAAVEELLDPRLK 305
           M  + + L PRLK
Sbjct: 279 MKMIRDNLPPRLK 291

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVP 121
           +V+G G    V  G +   G     VAIK L     E  +  F  E  I     HPN++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  +     + +I +++  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 73  LEG-VVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL 125
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGTFG--YLA 238
               +   VHR +   NIL++S  + K+ DFGL+ +     S P     + G     + A
Sbjct: 126 ---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           PE  Q+ K +  +DV+++G+V+ E+++ G +P
Sbjct: 183 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           ++  +V+G G+   VF+ K+ +    VAIK++ ++ +  +    REL I   + HPN+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKL-VESDEVAIKKVLQDKRFKN----RELQIMRIVKHPNVVD 96
Query: 122 LVGFCI---DPEQGLFL--IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           L  F     D +  +FL  + +YV         H  K       T+P  +       +  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL----KQTMPMLLIKLYMYQLLR 152
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSA--PSVPFLCKTVKGT 233
           S+AY+H+     + HRDIKP N+LL     + KL DFG A    A  P+V  +C      
Sbjct: 153 SLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--- 206
Query: 234 FGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
             Y APE  F     +   D+++ G V+ EL+ G+
Sbjct: 207 --YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYK- 169
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 87  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 170 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 146 LVSCTYQLARGMEYL--ASQKCI-HRDLTARNVLVTENNVMKIADFGLA--RDINNIDYY 200
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 201 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 68  LGRGALSFVFKGKVGLLR---TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 86  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 137
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 240
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +    S  +D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 68  LGRGALSFVFKGKVGLLR---TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 240
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +    S  +D + FGV L E+ T G++P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 68  LGRGALSFVFKGKVGLLR---TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 240
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +    S  +D + FGV L E+ T G++P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 170
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 171 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++   
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDXX 213
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYK- 169
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 92  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 170 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 151 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 205
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 206 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           LG G  S+V   +        A+KR+   +++D+E ++   RE  +    +HPNI+ LV 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ---READMHRLFNHPNILRLVA 93
Query: 125 FCIDPEQGL----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           +C+  E+G     +L+  +   G+L   +   K   +GN      + + + LGI   +  
Sbjct: 94  YCLR-ERGAKHEAWLLLPFFKRGTLWNEIERLKD--KGNFLTEDQILW-LLLGICRGLEA 149
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG-------- 232
           +H    +   HRD+KP+NILL  +  P L D G        S+   C  V+G        
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLG--------SMNQACIHVEGSRQALTLQ 198
Query: 233 -------TFGYLAPEYF---QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 278
                  T  Y APE F    H  + ++TDV++ G VL  ++ G  P +    +G+
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYK- 169
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 89  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 170 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 148 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 202
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 203 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 231
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 116/253 (45%), Gaps = 31/253 (12%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 112
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 147 GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 203
Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
              H N+V +    +  ++ L+++ +++ GG+L          +  ++ +       V L
Sbjct: 204 DYQHENVVEMYNSYLVGDE-LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVCL 254
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + G
Sbjct: 255 AVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVG 309
Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG 292
           T  ++APE         + D+++ G++++E++ G  P              + +P L + 
Sbjct: 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KA 355
Query: 293 MAAVEELLDPRLK 305
           M  + + L PRLK
Sbjct: 356 MKMIRDNLPPRLK 368

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 120/256 (46%), Gaps = 30/256 (11%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 120 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 139
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA         F+      T 
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTR 189
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            Y APE       +   D+++ G ++ EL+ G         QG +++  W K I   G  
Sbjct: 190 YYRAPEVILGMGYAANVDIWSVGCIMGELVKG-----CVIFQGTDHIDQWNKVIEQLGTP 244
Query: 295 AVEELLDPRLKCTSRN 310
           + E +    L+ T RN
Sbjct: 245 SAEFM--AALQPTVRN 258

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 121 PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F     +      L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 232
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 233 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
              Y APE  F     +   DV++ G VL ELL G+
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 65  GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 115
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYK- 169
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 146 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 170 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 205 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 259
Query: 227 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + R LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 39  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 94  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 147
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 148 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 198
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 199 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 111
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 5   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 60  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 111
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL       S     KT  
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 166
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 41/232 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A +
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 25  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 79
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 80  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 133
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 134 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWX---- 184
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 185 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 227

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 111
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 5   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 60  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 111
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL       S     KT  
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 166
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 111
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 8   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 63  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 114
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL       S     KT  
Sbjct: 115 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 169
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 170 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPL 122
           V+G G    V +G++   G   + VAIK L     E  +  F  E  I     HPNI+ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            G   +    + ++ +++  G+L+  L        G  T+   V   +  GIA  + YL 
Sbjct: 81  EGVVTN-SMPVMILTEFMENGALDSFLRLND----GQFTVIQLV--GMLRGIASGMRYL- 132
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV-PFLCKTVKGTFG--YLAP 239
              E   VHRD+   NIL++S  + K+ DFGL+ +    S  P    ++ G     + AP
Sbjct: 133 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           E     K +  +D +++G+V+ E+++ G +P
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 120
           F+K   +G+G+   V+KG     +  VAIK +D +E ++  +   +E+ + S    P I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G  +   + L++I +Y+ GGS    L   K G    + +   +R      I + + Y
Sbjct: 81  RYFGSYLKSTK-LWIIMEYLGGGSA---LDLLKPGPLEETYIATILR-----EILKGLDY 131
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH  +ER + HRDIK +N+LLS +   KL DFG+A   +   +        GT  ++APE
Sbjct: 132 LH--SERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPE 186
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             +      K D+++ G+  +EL  G  P
Sbjct: 187 VIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 121
           V+G+GA S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 91  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H+     ++HRD+KP N+LL+SK+     KL DFG+A       +  +     GT  ++A
Sbjct: 147 HDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAGGRVGTPHFMA 201
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  +        DV+  GV+L  LL+G  P 
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 68  LGRGALSFVFKGKVGLLR---TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 86  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 137
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 240
            +   +  +HRD+   N+LL+++ + K+ DFGL            + +  K  F + APE
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +    S  +D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKIL 79
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 68  LGRGALSFVFKGKVGLLR---TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 240
            +   +  +HRD+   N+LL+++ + K+ DFGL            + +  K  F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +    S  +D + FGV L E+ T G++P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 28/258 (10%)
Query: 27  ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 81
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 82  -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 134
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 126
Query: 135 LIYKYVSGGSLERHLHEKKKGVR-------GNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           +I +Y   G L   L  K + +         NST         +  +A+ +A+L   ++ 
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKN 184
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
           C+ HRD+   N+LL++  + K+ DFGLA      S   +    +    ++APE       
Sbjct: 185 CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 248 SDKTDVYAFGVVLLELLT 265
           + ++DV+++G++L E+ +
Sbjct: 244 TVQSDVWSYGILLWEIFS 261

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 89  AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 147
           A+K +DK  ++ ++    E+++     HPNI+ L     D  + ++++ + + GG L ++
Sbjct: 51  AVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLKD-VYDDGKYVYVVTELMKGGELLDK 106
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 203
            L +K    R  S         V   I ++V YLH    + VVHRD+KPSNIL      +
Sbjct: 107 ILRQKFFSEREASA--------VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155
Query: 204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
            +  ++CDFG A    A +   L  T   T  ++APE  +        D+++ GV+L  +
Sbjct: 156 PESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 264 LTGRKPI 270
           LTG  P 
Sbjct: 214 LTGYTPF 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 437 GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 486
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 487 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 580

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 231
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 111
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 5   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 60  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 111
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKT 229
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   C  
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-- 166
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 123
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 438 GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 487
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 242
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 488 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 243 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 279
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 581

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 231
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFAEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 10  TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANS-----LIRLSYGEILAATHNFSK 64
           T  +  + +GL    A E+ +R       S SP  NS      + L+  +     + F  
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFR-------SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 152
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
            ++LG+G    V   K        A+K L KE    K+       E  +  +  HP +  
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L  +       L  + +Y +GG L  HL  ++      +             I  ++ YL
Sbjct: 213 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALDYL 264
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H  +E+ VV+RD+K  N++L      K+ DFGL             KT  GT  YLAPE 
Sbjct: 265 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEV 320
Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            +        D +  GVV+ E++ GR P 
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 111
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 10  NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 65  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 116
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKT 229
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   C  
Sbjct: 117 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-- 171
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 172 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 122/254 (48%), Gaps = 23/254 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVGF 125
           LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 75  LF--REGDVWICMELMDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 127
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFGYLAPEYF-- 242
           +  V+HRD+KPSN+L+++    K+CDFG++ +     V  + K +  G   Y+APE    
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERINP 183
Query: 243 ---QHGKVSDKTDVYAFGVVLLELLTGRKPIEA--RRLQGEENLVLWAKPILHRGMAAVE 297
              Q G  S K+D+++ G+ ++EL   R P ++     Q  + +V    P L     +  
Sbjct: 184 ELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA- 241
Query: 298 ELLDPRLKCTSRNS 311
           E +D   +C  +NS
Sbjct: 242 EFVDFTSQCLKKNS 255

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 27/222 (12%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVGF 125
           VLG GA + V      +     A+K ++K+         RE+ M+     H N++ L+ F
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
             + ++  +L+++ + GGS+  H+H++    R  + L  SV   V   +A ++ +LHN  
Sbjct: 80  FEEEDR-FYLVFEKMRGGSILSHIHKR----RHFNELEASV---VVQDVASALDFLHN-- 129
Query: 186 ERCVVHRDIKPSNILLS--SKKIP-KLCDFGLATW------TSAPSVPFLCKTVKGTFGY 236
            + + HRD+KP NIL    ++  P K+CDFGL +        S  S P L  T  G+  Y
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL-TPCGSAEY 187
Query: 237 LAPE----YFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEAR 273
           +APE    + +   + DK  D+++ GV+L  LL+G  P   R
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW  A  
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-- 199
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
                    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ---------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 231
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 33  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 87
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 88  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 141
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 142 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 192
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 193 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 118/248 (47%), Gaps = 22/248 (8%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 126 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
              P++ L      Y+    ++ +L +  +    +  + + + Y++ +GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSA 145
Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 302
               +  D+++ G ++ E++ G          G +++  W K I   G  + E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 303 RLKCTSRN 310
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 107/237 (45%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
            +  H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 188 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 10  TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANS-----LIRLSYGEILAATHNFSK 64
           T  +  + +GL     +E+ +R       S SP  NS      + L+  +     + F  
Sbjct: 103 TTAIQTVADGLKKQEEEEMDFR-------SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 155
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
            ++LG+G    V   K        A+K L KE    K+       E  +  +  HP +  
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L  +       L  + +Y +GG L  HL  ++      +             I  ++ YL
Sbjct: 216 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALDYL 267
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H  +E+ VV+RD+K  N++L      K+ DFGL             KT  GT  YLAPE 
Sbjct: 268 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEV 323
Query: 242 FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            +        D +  GVV+ E++ GR P 
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 67  VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPL 122
           V+G G    V +G++   G   + VAIK L     E  +  F  E  I     HPNI+ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            G   +    + ++ +++  G+L+  L        G  T+   V   +  GIA  + YL 
Sbjct: 83  EGVVTN-SMPVMILTEFMENGALDSFLRLND----GQFTVIQLV--GMLRGIASGMRYL- 134
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGTFG--YLAP 239
              E   VHRD+   NIL++S  + K+ DFGL+ +     S P    ++ G     + AP
Sbjct: 135 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           E     K +  +D +++G+V+ E+++ G +P
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 231
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 39/231 (16%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+M+ +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 121 --------------PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
                         P+    +  +  LF+  +Y    +L   +H +    + +       
Sbjct: 66  RYYAAWLERRNFVKPMT--AVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY----- 118
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------- 215
            +++   I E+++Y+H+   + ++HRD+KP NI +   +  K+ DFGLA           
Sbjct: 119 -WRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 216 -TWTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELL 264
               + P       +  GT  Y+A E     G  ++K D+Y+ G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 41/232 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 59  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 114 RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 167
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 168 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 218
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A +
Sbjct: 219 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
            +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L    
Sbjct: 33  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-T 91
Query: 127 IDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            +    ++L+ +  +GG L ER +H  K+  R +         ++   +  +VAY H   
Sbjct: 92  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAA------RIMKDVLSAVAYCHKLN 143
Query: 186 ERCVVHRDIKPSNILL--SSKKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
              V HRD+KP N L    S   P KL DFGLA          + +T  GT  Y++P+  
Sbjct: 144 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVL 197
Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           + G    + D ++ GV++  LL G  P  A
Sbjct: 198 E-GLYGPECDEWSAGVMMYVLLCGYPPFSA 226

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 111
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 5   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 60  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 111
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKT 229
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   C  
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-- 166
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 14  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 73
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 130
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 131 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 184 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+++  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 14  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 73
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 130
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 131 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 184 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 21  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 80
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 137
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 138 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 191 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 22  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 81
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 82  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 138
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 139 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 192 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 13  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 72
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 73  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 129
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 130 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 183 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 91  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 142
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 143 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 192
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 193 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 233

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 231
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAPE       +   D +A GV++ ++  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFA 240

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 36/237 (15%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG-- 124
           V  RG    V+K +  LL   VA+K    +DK+S +    E+     + H NI+  +G  
Sbjct: 31  VKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNE-YEVYSLPGMKHENILQFIGAE 87
Query: 125 ---FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
                +D +  L+LI  +   GSL   L          + + W+    +A  +A  +AYL
Sbjct: 88  KRGTSVDVD--LWLITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYL 137
Query: 182 H-------NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           H       +G +  + HRDIK  N+LL +     + DFGLA    A           GT 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 235 GYLAPEYFQHGKVSD------KTDVYAFGVVLLELLT----GRKPIEARRLQGEENL 281
            Y+APE  + G ++       + D+YA G+VL EL +       P++   L  EE +
Sbjct: 198 RYMAPEVLE-GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 119 VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 170
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 171 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 220
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 221 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 126
            +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-T 74
Query: 127 IDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            +    ++L+ +  +GG L ER +H  K+  R +         ++   +  +VAY H   
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAA------RIMKDVLSAVAYCHKLN 126
Query: 186 ERCVVHRDIKPSNILL--SSKKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
              V HRD+KP N L    S   P KL DFGLA          + +T  GT  Y++P+  
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVL 180
Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
           + G    + D ++ GV++  LL G  P  A
Sbjct: 181 E-GLYGPECDEWSAGVMMYVLLCGYPPFSA 209

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-----AFCRELMIASSLHH 116
           + K   LG G  + V+K +       VAIK++    +  +K        RE+ +   L H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--RGNSTL--PWSVRYKVAL 172
           PNI+           GL   + + S  SL     E    V  + NS +  P  ++  + +
Sbjct: 72  PNII-----------GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + + + YLH   +  ++HRD+KP+N+LL    + KL DFGLA    +P+  +  + V  
Sbjct: 121 TL-QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-- 174
Query: 233 TFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELL 264
           T  Y APE     ++     D++A G +L ELL
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 111
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 5   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 60  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 111
Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKT 229
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   C  
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-- 166
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 189
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 190 EXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 61  NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 111
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 158
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 159 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 214
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           +               +    ++A E       + ++DV++FGV+L E++T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 21  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 80
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 137
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 138 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 190
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 191 EXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 115/250 (46%), Gaps = 16/250 (6%)
Query: 27  ELKWRKIQSLERSISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV-GLL 84
           +++W+ I+S E +     +   +L Y E      +N   G+ LG GA   V +    GL 
Sbjct: 13  QVRWKIIESYEGNSYTFIDP-TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLG 71
Query: 85  RTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 138
           +      VA+K L        K A   EL I S L  H NIV L+G C      + +I +
Sbjct: 72  KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVITE 130
Query: 139 YVSGGSLERHLHEKKKG-VRGNSTLPWSVR--YKVALGIAESVAYLHNGTERCVVHRDIK 195
           Y   G L   L  K +  +      P  +R     +  +A+ +A+L   ++ C+ HRD+ 
Sbjct: 131 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCI-HRDVA 187
Query: 196 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYA 255
             N+LL++  + K+ DFGLA      S   +    +    ++APE       + ++DV++
Sbjct: 188 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 247
Query: 256 FGVVLLELLT 265
           +G++L E+ +
Sbjct: 248 YGILLWEIFS 257

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----- 196
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
                  + GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 197 ------XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 115/250 (46%), Gaps = 16/250 (6%)
Query: 27  ELKWRKIQSLERSISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV-GLL 84
           +++W+ I+S E +     +   +L Y E      +N   G+ LG GA   V +    GL 
Sbjct: 5   QVRWKIIESYEGNSYTFIDP-TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLG 63
Query: 85  RTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 138
           +      VA+K L        K A   EL I S L  H NIV L+G C      + +I +
Sbjct: 64  KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVITE 122
Query: 139 YVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALG--IAESVAYLHNGTERCVVHRDIK 195
           Y   G L   L  K +  +      P  +R  +     +A+ +A+L   ++ C+ HRD+ 
Sbjct: 123 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCI-HRDVA 179
Query: 196 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYA 255
             N+LL++  + K+ DFGLA      S   +    +    ++APE       + ++DV++
Sbjct: 180 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 239
Query: 256 FGVVLLELLT 265
           +G++L E+ +
Sbjct: 240 YGILLWEIFS 249

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 55  ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 114
           I+  +  +   + +G G        +  L +  VA+K +++      +   RE++   SL
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSL 73
Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNIV      + P   L +I +Y SGG L   +    +     +   +         +
Sbjct: 74  RHPNIVRFKEVILTPTH-LAIIMEYASGGELYERICNAGRFSEDEARFFFQ-------QL 125
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKG 232
              V+Y H+     + HRD+K  N LL     P  K+CDFG +  +   S P   K+  G
Sbjct: 126 LSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 179
Query: 233 TFGYLAPEYFQHGKVSDK-TDVYAFGVVLLELLTGRKPIE 271
           T  Y+APE     +   K  DV++ GV L  +L G  P E
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ 136
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 26/256 (10%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 88  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 142
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGY 236
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA    TS   VPF+      T  Y
Sbjct: 143 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV-----TRYY 193
Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 296
            APE        +  D+++ G ++ E++ G          G +++  W K I   G    
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPCP 248
Query: 297 EEL--LDPRLKCTSRN 310
           E +  L P ++    N
Sbjct: 249 EFMKKLQPTVRTYVEN 264

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   K+ DFGLA      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 22/187 (11%)
Query: 89  AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 147
           A+K +DK  ++ S+    E+++     HPNI+ L     D  + ++L+ + + GG L ++
Sbjct: 56  AVKVIDKSKRDPSEEI--EILLRYG-QHPNIITLKD-VYDDGKHVYLVTELMRGGELLDK 111
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 203
            L +K    R  S         V   I ++V YLH+   + VVHRD+KPSNIL      +
Sbjct: 112 ILRQKFFSEREASF--------VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGN 160
Query: 204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
            +  ++CDFG A    A +   L  T   T  ++APE  +     +  D+++ G++L  +
Sbjct: 161 PECLRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTM 218
Query: 264 LTGRKPI 270
           L G  P 
Sbjct: 219 LAGYTPF 225

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 31/227 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
               GT  YLAPE       +   D +A GV++ E+  G  P  A +
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 22/187 (11%)
Query: 89  AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 147
           A+K +DK  ++ S+    E+++     HPNI+ L     D  + ++L+ + + GG L ++
Sbjct: 56  AVKVIDKSKRDPSEEI--EILLRYG-QHPNIITLKD-VYDDGKHVYLVTELMRGGELLDK 111
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 203
            L +K    R  S         V   I ++V YLH+   + VVHRD+KPSNIL      +
Sbjct: 112 ILRQKFFSEREASF--------VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGN 160
Query: 204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
            +  ++CDFG A    A +   L  T   T  ++APE  +     +  D+++ G++L  +
Sbjct: 161 PECLRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTM 218
Query: 264 LTGRKPI 270
           L G  P 
Sbjct: 219 LAGYTPF 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 186 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             +  L+++ ++  GG+++  + E  +G+             V   + E++ +LH+   +
Sbjct: 87  H-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI------QVVCRQMLEALNFLHS---K 136
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQHG 245
            ++HRD+K  N+L++ +   +L DFG+    SA ++  L K  +  GT  ++APE     
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 246 KVSD-----KTDVYAFGVVLLELLTGRKP 269
            + D     K D+++ G+ L+E+     P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 35/223 (15%)
Query: 67  VLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVG 124
           +LG GA + V +G V L      A+K ++K+   S     RE+  +     + NI+ L+ 
Sbjct: 20  LLGEGAYAKV-QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
           F  D  +  +L+++ + GGS+  H+ ++K      ++       +V   +A ++ +LH  
Sbjct: 79  FFEDDTR-FYLVFEKLQGGSILAHIQKQKHFNEREAS-------RVVRDVAAALDFLHT- 129
Query: 185 TERCVVHRDIKPSNILLSS--KKIP-KLCDFGLA---------TWTSAPSVPFLCKTVKG 232
             + + HRD+KP NIL  S  K  P K+CDF L          T  + P +   C    G
Sbjct: 130 --KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC----G 183
Query: 233 TFGYLAPE----YFQHGKVSDK-TDVYAFGVVLLELLTGRKPI 270
           +  Y+APE    +       DK  D+++ GVVL  +L+G  P 
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVP 121
           +++G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G        + ++ +Y+  GSL+  L        G  T+   V   +  G+   + YL
Sbjct: 115 LEGVVTRGRLAM-IVTEYMENGSLDTFLRTHD----GQFTIMQLV--GMLRGVGAGMRYL 167
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 240
              ++   VHRD+   N+L+ S  + K+ DFGL+      P   +     K    + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                  S  +DV++FGVV+ E+L  G +P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 91  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 142
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 143 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 192
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 193 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 233

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
             +  L+++ ++  GG+++  + E  +G+             V   + E++ +LH+   +
Sbjct: 79  H-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI------QVVCRQMLEALNFLHS---K 128
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQHG 245
            ++HRD+K  N+L++ +   +L DFG+    SA ++  L K  +  GT  ++APE     
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMAPEVVMCE 184
Query: 246 KVSD-----KTDVYAFGVVLLELLTGRKP 269
            + D     K D+++ G+ L+E+     P
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 107/237 (45%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
            +  H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 188 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 21/239 (8%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 36  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 95
Query: 112 SSLHHPNIVPLVGF----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
               H NI+ +        I+  + ++L+  ++ G  L + L   K     N  + + + 
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLL---KTQHLSNDHICYFL- 150
Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPF 225
           Y++  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           F
Sbjct: 151 YQILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 203
Query: 226 LCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           L + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 204 LTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 18/187 (9%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           VA+K +++ +K ++    RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEKIAANV-KREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 154
Query: 208 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 264
             K+CDFG +  +   S P   K+  GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 155 RLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 265 TGRKPIE 271
            G  P E
Sbjct: 212 VGAYPFE 218

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 226
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFL 184
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 126 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 244
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 245 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 302
               +  D+++ G ++ E++ G          G +++  W K I   G  + E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 303 RLKCTSRN 310
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 86  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK--- 140
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y A
Sbjct: 141 -HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRA 193
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE        +  D+++ G ++ E++ G          G +++  W K I   G  + E 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEF 248
Query: 299 L--LDPRLKCTSRN 310
           +  L P ++    N
Sbjct: 249 MKKLQPTVRTYVEN 262

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 61  NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 111
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 158
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 159 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 214
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           +               +    ++A E       + ++DV++FGV+L E++T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y+ GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y+ GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      L +  VAI+++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKIL 79
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 84/187 (44%), Gaps = 18/187 (9%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           VA+K +++ +K   +   RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 46  VAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 103
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 104 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 153
Query: 208 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 264
             K+CDFG +  +   S P   K+  GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 154 RLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 210
Query: 265 TGRKPIE 271
            G  P E
Sbjct: 211 VGAYPFE 217

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 24  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 83
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 84  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 140
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 141 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 193
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 194 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 186 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT  YLAP        +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 61  NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 111
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 158
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 159 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 214
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 215 A---------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           +            S   +P     ++  F ++          + ++DV++FGV+L E++T
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVT 247

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 85/180 (47%), Gaps = 12/180 (6%)
Query: 98  KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 157
           K     F  EL I + + +   +   G   + ++ +++IY+Y+   S+ +   E    + 
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILK-FDEYFFVLD 141
Query: 158 GNST--LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
            N T  +P  V   +   +  S +Y+HN  E+ + HRD+KPSNIL+      KL DFG +
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEAR 273
            +     +    K  +GT+ ++ PE+F +    +  K D+++ G+ L  +     P   +
Sbjct: 200 EYMVDKKI----KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 226
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 184
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 188 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 111/254 (43%), Gaps = 37/254 (14%)
Query: 106 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
           RE+ I  +L+H +IV   G C D  E+ + L+ +YV  GSL  +L     G+        
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL-------- 111
Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
           +     A  I E +AYLH    +  +HR +   N+LL + ++ K+ DFGLA         
Sbjct: 112 AQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 168
Query: 225 FLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL- 281
           +  +    +  F Y APE  +  K    +DV++FGV L ELLT     ++   +  E + 
Sbjct: 169 YRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIG 227
Query: 282 -------VLWAKPILHRGMAAVEELLDP-RLKCTSRNSXXXXXXXXXXXXCISSEESRRP 333
                  VL    +L RG    E L  P R  C   +             C  +E S RP
Sbjct: 228 HTQGQMTVLRLTELLERG----ERLPRPDRCPCEIYH---------LMKNCWETEASFRP 274
Query: 334 GIEEIIAILRGEEE 347
             + ++ IL+  +E
Sbjct: 275 TFQNLVPILQTAQE 288

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 20/177 (11%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I + LHHP ++ L     + +  + LI +++SGG L   +  +   +     + +  
Sbjct: 98  EISIMNQLHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVP 224
           +        E + ++H   E  +VH DIKP NI+  +KK    K+ DFGLAT  +   + 
Sbjct: 157 Q------ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 206
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
              K    T  + APE      V   TD++A GV+   LL+G  P       GE++L
Sbjct: 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDL 256

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 111/254 (43%), Gaps = 37/254 (14%)
Query: 106 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
           RE+ I  +L+H +IV   G C D  E+ + L+ +YV  GSL  +L     G+        
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL-------- 110
Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
           +     A  I E +AYLH    +  +HR +   N+LL + ++ K+ DFGLA         
Sbjct: 111 AQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 167
Query: 225 FLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL- 281
           +  +    +  F Y APE  +  K    +DV++FGV L ELLT     ++   +  E + 
Sbjct: 168 YRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIG 226
Query: 282 -------VLWAKPILHRGMAAVEELLDP-RLKCTSRNSXXXXXXXXXXXXCISSEESRRP 333
                  VL    +L RG    E L  P R  C   +             C  +E S RP
Sbjct: 227 HTQGQMTVLRLTELLERG----ERLPRPDRCPCEIYH---------LMKNCWETEASFRP 273
Query: 334 GIEEIIAILRGEEE 347
             + ++ IL+  +E
Sbjct: 274 TFQNLVPILQTAQE 287

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 89  AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 147
           A+K +DK  ++ ++    E+++     HPNI+ L     D  + ++++ +   GG L ++
Sbjct: 51  AVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLKD-VYDDGKYVYVVTELXKGGELLDK 106
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 203
            L +K    R  S         V   I ++V YLH    + VVHRD+KPSNIL      +
Sbjct: 107 ILRQKFFSEREASA--------VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155
Query: 204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
            +  ++CDFG A    A +   L  T   T  ++APE  +        D+++ GV+L   
Sbjct: 156 PESIRICDFGFAKQLRAEN--GLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTX 213
Query: 264 LTGRKPI 270
           LTG  P 
Sbjct: 214 LTGYTPF 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   ++ DFGLA      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 36  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 95
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 152
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 227
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 153 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 205
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 206 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLXGIK----HLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 86  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK--- 140
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y A
Sbjct: 141 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRA 193
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE        +  D+++ G ++ E++ G          G +++  W K I   G  + E 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEF 248
Query: 299 L--LDPRLKCTSRN 310
           +  L P ++    N
Sbjct: 249 MKKLQPTVRTYVEN 262

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 11/219 (5%)
Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
           +G  +GRG    V+K K    +          E    S + CRE+ +   L HPN++ L 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 84
Query: 124 G-FCIDPEQGLFLIYKYVSGGSLE-RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             F    ++ ++L++ Y           H   K  +    LP  +   +   I + + YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 182 HNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFL-CKTVKGTFGY 236
           H      V+HRD+KP+NIL+      +   K+ D G A   ++P  P      V  TF Y
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 237 LAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARR 274
            APE     +   K  D++A G +  ELLT       R+
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 122
           G ++G+G    V+ G+       VAI+ +D  +++++  KAF RE+M      H N+V  
Sbjct: 38  GELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G C+ P   L +I     G +L   + + K  +  N T       ++A  I + + YLH
Sbjct: 95  MGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKT------RQIAQEIVKGMGYLH 147
Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT---SAPSVPFLCKTVKGTFGYLAP 239
               + ++H+D+K  N+   + K+  + DFGL + +    A       +   G   +LAP
Sbjct: 148 ---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 240 EYFQHGK---------VSDKTDVYAFGVVLLELLTGRKPIEAR 273
           E  +             S  +DV+A G +  EL     P + +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 117
             + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NIV L    +  ++ L L++++            KK     N  L   +       + + 
Sbjct: 62  NIVRLHD-VLHSDKKLTLVFEFCDQDL-------KKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFGY 236
           + + H+   R V+HRD+KP N+L++     KL DFGLA    A  +P  C + +  T  Y
Sbjct: 114 LGFCHS---RNVLHRDLKPQNLLINRNGELKLADFGLA---RAFGIPVRCYSAEVVTLWY 167
Query: 237 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 270
             P+     K+ S   D+++ G +  EL    +P+
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 64/278 (23%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 25  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 84
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 163
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 85  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 144
Query: 164 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 185
             ++                                   YK  L +   + Y   +  G 
Sbjct: 145 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 204
Query: 186 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           E    R  +HRD+   NILLS K + K+CDFGLA               +    ++APE 
Sbjct: 205 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 264
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
                 + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 265 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 302

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 64/278 (23%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 163
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 151
Query: 164 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 185
             ++                                   YK  L +   + Y   +  G 
Sbjct: 152 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 211
Query: 186 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           E    R  +HRD+   NILLS K + K+CDFGLA               +    ++APE 
Sbjct: 212 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 271
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
                 + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 272 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 309

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLXGIK----HLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA----FCRELMIASSLHHPNIVPLV 123
           +GRG+   V+KG      T+V +   + +D++ +K+    F  E      L HPNIV   
Sbjct: 34  IGRGSFKTVYKGLD--TETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 124 GF---CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
                 +  ++ + L+ +  + G+L+ +L ++ K  +      W  +      I + + +
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYL-KRFKVXKIKVLRSWCRQ------ILKGLQF 144
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           LH  T   ++HRD+K  NI ++      K+ D GLAT   A       K V GT  + AP
Sbjct: 145 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFXAP 199
Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           E ++  K  +  DVYAFG   LE  T   P
Sbjct: 200 EXYEE-KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 64/278 (23%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 163
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 164 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 185
             ++                                   YK  L +   + Y   +  G 
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 186 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           E    R  +HRD+   NILLS K + K+CDFGLA               +    ++APE 
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
                 + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 27/222 (12%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVGF 125
           VLG GA + V      +     A+K ++K+         RE+ M+     H N++ L+ F
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
             + ++  +L+++ + GGS+  H+H++    R  + L  SV   V   +A ++ +LHN  
Sbjct: 80  FEEEDR-FYLVFEKMRGGSILSHIHKR----RHFNELEASV---VVQDVASALDFLHN-- 129
Query: 186 ERCVVHRDIKPSNILLS--SKKIP-KLCDFGLATW------TSAPSVPFLCKTVKGTFGY 236
            + + HRD+KP NIL    ++  P K+CDF L +        S  S P L  T  G+  Y
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL-TPCGSAEY 187
Query: 237 LAPE----YFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEAR 273
           +APE    + +   + DK  D+++ GV+L  LL+G  P   R
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 64/278 (23%)
Query: 65  GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 117
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 163
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 153
Query: 164 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 185
             ++                                   YK  L +   + Y   +  G 
Sbjct: 154 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 213
Query: 186 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           E    R  +HRD+   NILLS K + K+CDFGLA               +    ++APE 
Sbjct: 214 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 273
Query: 242 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
                 + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 274 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 311

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAFC--RELMIA---SSLHHPNI 119
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +     +  HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 120 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 174
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
              + +LH+     VVHRD+KP NIL++S    KL DFGLA      S      +V  T 
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            Y APE       +   D+++ G +  E+   RKP+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y  GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 85/177 (48%), Gaps = 23/177 (12%)
Query: 106 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
           +E+ I   L HPN+V LV    DP E  L+++++ V+ G +          +   +  P 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----------MEVPTLKPL 134
Query: 165 S---VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
           S    R+     + + + YLH    + ++HRDIKPSN+L+      K+ DFG++      
Sbjct: 135 SEDQARFYFQ-DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG- 189
Query: 222 SVPFLCKTVKGTFGYLAPEYFQHGK--VSDKT-DVYAFGVVLLELLTGRKPIEARRL 275
           S   L  TV GT  ++APE     +   S K  DV+A GV L   + G+ P    R+
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 116/251 (46%), Gaps = 17/251 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIAS-SLHHPNIVPLVGF 125
           LGRGA   V K +        A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 102 LF--REGDVWICXELXDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 154
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---TSAPSVPFLCKTVKGTFGYLAPEYF 242
           +  V+HRD+KPSN+L+++    K CDFG++ +     A  +   CK        + PE  
Sbjct: 155 KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAP-ERINPELN 213
Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEA--RRLQGEENLVLWAKPILHRGMAAVEELL 300
           Q G  S K+D+++ G+  +EL   R P ++     Q  + +V    P L     +  E +
Sbjct: 214 QKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA-EFV 271
Query: 301 DPRLKCTSRNS 311
           D   +C  +NS
Sbjct: 272 DFTSQCLKKNS 282

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAFC--RELMIA---SSLHHPNI 119
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +     +  HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 120 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 174
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
              + +LH+     VVHRD+KP NIL++S    KL DFGLA      S      +V  T 
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            Y APE       +   D+++ G +  E+   RKP+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIA 111
           A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  + 
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV 170
              +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   +
Sbjct: 73  KEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 171 ALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  K
Sbjct: 132 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK 186
Query: 229 TVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 187 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 66  RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVP 121
           +++G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L G        + ++ +Y+  GSL+  L        G  T+   V   +  G+   + YL
Sbjct: 115 LEGVVTRGRLAM-IVTEYMENGSLDTFLRTHD----GQFTIMQLV--GMLRGVGAGMRYL 167
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 240
              ++   VHRD+   N+L+ S  + K+ DFGL+      P         K    + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE 224
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                  S  +DV++FGVV+ E+L  G +P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIA 111
           A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  + 
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV 170
              +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   +
Sbjct: 83  KEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 171 ALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  K
Sbjct: 142 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK 196
Query: 229 TVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 108
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
              LC    GT   LAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 22/222 (9%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 115
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA   S     F   
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF--- 169
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 86  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 140
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y A
Sbjct: 141 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRA 193
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE        +  D+++ G ++ E++ G          G +++  W K I   G  + E 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEF 248
Query: 299 L--LDPRLKCTSRN 310
           +  L P ++    N
Sbjct: 249 MKKLQPTVRTYVEN 262

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIA 111
           A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  + 
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV 170
              +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   +
Sbjct: 76  KEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 171 ALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  K
Sbjct: 135 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK 189
Query: 229 TVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 110
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 169
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 69  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 170 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 128 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 182
Query: 228 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 68  LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAFC--RELMIA---SSLHHPNI 119
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +     +  HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 120 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 174
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
              + +LH+     VVHRD+KP NIL++S    KL DFGLA      S      +V  T 
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            Y APE       +   D+++ G +  E+   RKP+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V +        + A K +    +   +   +E+   S L HP +V L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AF 223
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           + +  + +IY+++SGG L   + ++   +  +  + +  +      + + + ++H   E 
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCHMH---EN 274
Query: 188 CVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
             VH D+KP NI+ ++K+    KL DFGL             K   GT  + APE  +  
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK 331
Query: 246 KVSDKTDVYAFGVVLLELLTGRKPI 270
            V   TD+++ GV+   LL+G  P 
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIA 111
           A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  + 
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV 170
              +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   +
Sbjct: 76  KEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 171 ALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  K
Sbjct: 135 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK 189
Query: 229 TVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIA 111
           A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  + 
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV 170
              +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   +
Sbjct: 83  KEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 171 ALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  K
Sbjct: 142 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK 196
Query: 229 TVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIA 111
           A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  + 
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV 170
              +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   +
Sbjct: 77  KEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 171 ALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  K
Sbjct: 136 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK 190
Query: 229 TVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIA 111
           A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  + 
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV 170
              +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   +
Sbjct: 74  KEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 171 ALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  K
Sbjct: 133 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK 187
Query: 229 TVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 188 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG GA   V +        + A K +    +   +   +E+   S L HP +V L     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AF 117
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           + +  + +IY+++SGG L   + ++   +  +  + +  +      + + + ++H   E 
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCHMH---EN 168
Query: 188 CVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
             VH D+KP NI+ ++K+    KL DFGL             K   GT  + APE  +  
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK 225
Query: 246 KVSDKTDVYAFGVVLLELLTGRKPI 270
            V   TD+++ GV+   LL+G  P 
Sbjct: 226 PVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +  L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH-PNIVPLVGF 125
           +G G    V+K +       +A+K++ +  +KE +K    +L +    H  P IV   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            I     +F+  + +  G+    L ++ +G      +P  +  K+ + I +++ YL    
Sbjct: 93  FI-TNTDVFIAMELM--GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKE-- 142
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
           +  V+HRD+KPSNILL  +   KLCDFG++                G   Y+APE     
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPP 199
Query: 246 KVSD-----KTDVYAFGVVLLELLTGRKP 269
             +      + DV++ G+ L+EL TG+ P
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +  L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKIL 168
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 115
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA      S      
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALD 169
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 118/254 (46%), Gaps = 22/254 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 87  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 141
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y A
Sbjct: 142 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRA 194
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE        +  D+++ G ++ E++ G          G +++  W K I   G    E 
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPCPEF 249
Query: 299 L--LDPRLKCTSRN 310
           +  L P ++    N
Sbjct: 250 MKKLQPTVRTYVEN 263

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 29/260 (11%)
Query: 30  WRKIQSLERSISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV-GLLRTS 87
           W+ I+S E +     +   +L Y E      +N   G+ LG GA   V +    GL +  
Sbjct: 1   WKIIESYEGNSYTFIDP-TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKED 59
Query: 88  ----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS 141
               VA+K L        K A   EL I S L  H NIV L+G C      + +I +Y  
Sbjct: 60  AVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVITEYCC 118
Query: 142 GGSLERHLHEKKKGVRGNSTLP--------------WSVRYKVALG--IAESVAYLHNGT 185
            G L   L  K + + G S  P                +R  +     +A+ +A+L   +
Sbjct: 119 YGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL--AS 176
Query: 186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 245
           + C+ HRD+   N+LL++  + K+ DFGLA      S   +    +    ++APE     
Sbjct: 177 KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC 235
Query: 246 KVSDKTDVYAFGVVLLELLT 265
             + ++DV+++G++L E+ +
Sbjct: 236 VYTVQSDVWSYGILLWEIFS 255

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 118/254 (46%), Gaps = 22/254 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 86  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 140
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y A
Sbjct: 141 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRA 193
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE        +  D+++ G ++ E++ G          G +++  W K I   G    E 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPCPEF 248
Query: 299 L--LDPRLKCTSRN 310
           +  L P ++    N
Sbjct: 249 MKKLQPTVRTYVEN 262

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 110
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 169
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 104 MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 170 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 163 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 217
Query: 228 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 85/368 (23%), Positives = 143/368 (38%), Gaps = 57/368 (15%)
Query: 39  SISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK 98
           S SP A SL  +    +      F    ++G G    V+KG+        AIK +D    
Sbjct: 4   SDSP-ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 99  ESSKAFCRELMIASSLHHPNIVPLVGFCI--DP---EQGLFLIYKYVSGGSLERHLHEKK 153
           E  +      M+    HH NI    G  I  +P   +  L+L+ ++   GS+   +    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---- 118
Query: 154 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 213
           K  +GN+     + Y +   I   +++LH   +  V+HRDIK  N+LL+     KL DFG
Sbjct: 119 KNTKGNTLKEEWIAY-ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD-----KTDVYAFGVVLLELLTGRK 268
           ++             T  GT  ++APE     +  D     K+D+++ G+  +E+  G  
Sbjct: 175 VS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 269 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSE 328
           P+                P+  R +  +     PRLK    +             C+   
Sbjct: 233 PL------------CDMHPM--RALFLIPRNPAPRLKSKKWSK----KFQSFIESCLVKN 274
Query: 329 ESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSE 388
            S+RP  E+++               KH F   I   P  +Q + ++K H+        E
Sbjct: 275 HSQRPATEQLM---------------KHPF---IRDQPNERQVRIQLKDHIDRTKKKRGE 316
Query: 389 FEEDDHLY 396
            +E ++ Y
Sbjct: 317 KDETEYEY 324

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 28/199 (14%)
Query: 159 NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT 218
           +  +P  +  K+ L   +++ +L    +  ++HRDIKPSNILL      KLCDFG+    
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI---- 172
Query: 219 SAPSVPFLCKTVK-GTFGYLAPEYFQHGKVSD----KTDVYAFGVVLLELLTGRKPIEAR 273
           S   V  + KT   G   Y+APE             ++DV++ G+ L EL TGR P    
Sbjct: 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP-- 230
Query: 274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRP 333
               + N V      + +G        DP     S               C++ +ES+RP
Sbjct: 231 ----KWNSVFDQLTQVVKG--------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
Query: 334 GIEEIIA---ILRGEEELI 349
             +E++    IL  EE  +
Sbjct: 279 KYKELLKHPFILMYEERAV 297

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 114/252 (45%), Gaps = 21/252 (8%)
Query: 40  ISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDK 98
           + P     + +  G+       +++ + +G GA   V      + +T VAIK++   E +
Sbjct: 23  VGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQ 82
Query: 99  ESSKAFCRELMIASSLHHPNIVP----LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 154
              +   RE+ I     H N++     L    ++  + ++++        +E  L++  K
Sbjct: 83  TYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDL-----METDLYKLLK 137
Query: 155 GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 214
             + ++       Y++  G+     Y+H+     V+HRD+KPSN+L+++    K+CDFGL
Sbjct: 138 SQQLSNDHICYFLYQILRGLK----YIHSAN---VLHRDLKPSNLLINTTCDLKICDFGL 190
Query: 215 ATWTSA--PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIE 271
           A           FL + V  T  Y APE   + K   K+ D+++ G +L E+L+ R    
Sbjct: 191 ARIADPEHDHTGFLTEXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 249
Query: 272 ARRLQGEENLVL 283
            +    + N +L
Sbjct: 250 GKHYLDQLNHIL 261

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 115
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA      S      
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALA 169
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 119/256 (46%), Gaps = 30/256 (11%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 120 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           + L+        ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLL-----YQMLXGI 132
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T 
Sbjct: 133 K----HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTS--FMMTPYVVTR 182
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            Y APE        +  D+++ G ++ E++  +         G + +  W K I   G  
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-----LFPGRDYIDQWNKVIEQLGTP 237
Query: 295 AVEELLDPRLKCTSRN 310
             E +   +L+ T RN
Sbjct: 238 CPEFM--KKLQPTVRN 251

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 175
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 176 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 233 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 169
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 227 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 15/106 (14%)
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-----------WT 218
           + + IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFGL T            T
Sbjct: 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 264
             P+       V GT  Y++PE       S K D+++ G++L ELL
Sbjct: 226 PMPAYATHXGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 110
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 169
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 69  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 170 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
           + +   IA+ +AYL+       VHRD+   N  ++     K+ DFG+          +  
Sbjct: 128 IQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYYR 182
Query: 228 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 113
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           ++ P +  L  F       L+++ +Y  GG +  HL        G    P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 150
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 227
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 200
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 110
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 169
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 67  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 170 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+             
Sbjct: 126 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR 180
Query: 228 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 118/254 (46%), Gaps = 22/254 (8%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 86  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 140
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y A
Sbjct: 141 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPEVVTRYYRA 193
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE        +  D+++ G ++ E++ G          G +++  W K I   G    E 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPCPEF 248
Query: 299 L--LDPRLKCTSRN 310
           +  L P ++    N
Sbjct: 249 MKKLQPTVRTYVEN 262

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 183 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 20/224 (8%)
Query: 53  GEILAATHN-FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCREL 108
           G +   T N F   ++LG+G    V   K        A+K L KE    K+       E 
Sbjct: 1   GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 60
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 61  RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF------ 113
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFL 226
                I  ++ YLH  +E+ VV+RD+K  N++L      K+ DFGL         ++   
Sbjct: 114 -YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 170
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           C    GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 171 C----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 130
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 131 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 187
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 188 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 183 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 16/142 (11%)
Query: 133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 192
           L ++ + + GG L   + +     RG+         ++   I E++ YLH+     + HR
Sbjct: 94  LLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 145
Query: 193 DIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 248
           D+KP N+L +SK+   I KL DFG A   TS  S+   C T      Y+APE     K  
Sbjct: 146 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYD 201
Query: 249 DKTDVYAFGVVLLELLTGRKPI 270
              D+++ GV++  LL G  P 
Sbjct: 202 KSCDMWSLGVIMYILLCGYPPF 223

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 123
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 124 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 181 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 16/142 (11%)
Query: 133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 192
           L ++ + + GG L   + +     RG+         ++   I E++ YLH+     + HR
Sbjct: 104 LLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 155
Query: 193 DIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 248
           D+KP N+L +SK+   I KL DFG A   TS  S+   C T      Y+APE     K  
Sbjct: 156 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYD 211
Query: 249 DKTDVYAFGVVLLELLTGRKPI 270
              D+++ GV++  LL G  P 
Sbjct: 212 KSCDMWSLGVIMYILLCGYPPF 233

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 58  ATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIA 111
           A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  + 
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV 170
              +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   +
Sbjct: 77  KEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 171 ALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   IA+ +AYL+       VHRD+   N +++     K+ DFG+             K
Sbjct: 136 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXRK 190
Query: 229 TVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
             KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 131
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 132 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 188
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 189 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 124
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 125 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 182 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 35/282 (12%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 100 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 158
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 159 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206
Query: 211 DFGLA--TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK 268
           DFGLA    TS    P++      T  Y APE        +  D+++ G ++ E++  R 
Sbjct: 207 DFGLARTAGTSFMMTPYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RH 259
Query: 269 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
            I      G + +  W K I   G    E +   +L+ T RN
Sbjct: 260 KI---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 296

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 19/216 (8%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHH 116
           + F   ++LG+G    V   K        A+K L KE    K+       E  +  +  H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +  L  +       L  + +Y +GG L  HL  ++      +             I  
Sbjct: 68  PFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVS 119
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGTF 234
           ++ YLH  +E+ VV+RD+K  N++L      K+ DFGL         ++   C    GT 
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC----GTP 173
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 116/235 (49%), Gaps = 39/235 (16%)
Query: 68  LGRGALSFVFKG---KVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           LG+G  + +FKG   +VG    L  T V +K LDK  +  S++F     + S L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G C+  ++ + L+ ++V  GSL+ +L + K  +     + W  + +VA  +A ++ +
Sbjct: 76  LNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCI----NILW--KLEVAKQLAAAMHF 128
Query: 181 LHNGTERCVVHRDIKPSNILL--------SSKKIPKLCDFGLATWTSAPSVPFLCKTV-K 231
           L   T   ++H ++   NILL         +    KL D G+       S+  L K + +
Sbjct: 129 LEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-------SITVLPKDILQ 178
Query: 232 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLT-GRKPIEA----RRLQGEEN 280
               ++ PE  ++ K ++  TD ++FG  L E+ + G KP+ A    R+LQ  E+
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 15/141 (10%)
Query: 133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 192
           L +I + + GG L   + E     RG+         ++   I  ++ +LH+     + HR
Sbjct: 82  LLIIMECMEGGELFSRIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHR 133
Query: 193 DIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 249
           D+KP N+L +SK+   + KL DFG A  T+  ++   C T      Y+APE     K   
Sbjct: 134 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY----YVAPEVLGPEKYDK 189
Query: 250 KTDVYAFGVVLLELLTGRKPI 270
             D+++ GV++  LL G  P 
Sbjct: 190 SCDMWSLGVIMYILLCGFPPF 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 19/216 (8%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHH 116
           + F   ++LG+G    V   K        A+K L KE    K+       E  +  +  H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +  L  +       L  + +Y +GG L  HL  ++      +             I  
Sbjct: 70  PFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVS 121
Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGTF 234
           ++ YLH  +E+ VV+RD+K  N++L      K+ DFGL         ++   C    GT 
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC----GTP 175
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 62
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 63  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 121
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 122 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 170 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 224
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 225 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 259

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 115/256 (44%), Gaps = 22/256 (8%)
Query: 27  ELKWRKIQSLERSISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV-GLL 84
           +++W+ I+S E +     +   +L Y E      +N   G+ LG GA   V +    GL 
Sbjct: 13  QVRWKIIESYEGNSYTFIDP-TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLG 71
Query: 85  RTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 138
           +      VA+K L        K A   EL I S L  H NIV L+G C      + +I +
Sbjct: 72  KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVITE 130
Query: 139 YVSGGSLERHLHEKKKGVRGNSTLP-------WSVR--YKVALGIAESVAYLHNGTERCV 189
           Y   G L   L  K+      S  P        S R     +  +A+ +A+L   ++ C+
Sbjct: 131 YCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL--ASKNCI 188
Query: 190 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 249
            HRD+   N+LL++  + K+ DFGLA      S   +    +    ++APE       + 
Sbjct: 189 -HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 247
Query: 250 KTDVYAFGVVLLELLT 265
           ++DV+++G++L E+ +
Sbjct: 248 QSDVWSYGILLWEIFS 263

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 117
             + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NIV L    +  ++ L L++++            KK     N  L   +       + + 
Sbjct: 62  NIVRLHD-VLHSDKKLTLVFEFCDQDL-------KKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFGY 236
           + + H+   R V+HRD+KP N+L++     KL +FGLA    A  +P  C + +  T  Y
Sbjct: 114 LGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLA---RAFGIPVRCYSAEVVTLWY 167
Query: 237 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 270
             P+     K+ S   D+++ G +  EL    +P+
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 15/141 (10%)
Query: 133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 192
           L +I + + GG L   + E     RG+         ++   I  ++ +LH+     + HR
Sbjct: 101 LLIIMECMEGGELFSRIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHR 152
Query: 193 DIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 249
           D+KP N+L +SK+   + KL DFG A  T+  ++   C T      Y+APE     K   
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY----YVAPEVLGPEKYDK 208
Query: 250 KTDVYAFGVVLLELLTGRKPI 270
             D+++ GV++  LL G  P 
Sbjct: 209 SCDMWSLGVIMYILLCGFPPF 229

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 83/187 (44%), Gaps = 18/187 (9%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           VA+K +++ +K   +   RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYAHAMQ---VAHRDLKLENTLLDGSPAP 154
Query: 208 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 264
             K+ DFG +  +   S P   K+  GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 155 RLKIADFGYSKASVLHSQP---KSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 265 TGRKPIE 271
            G  P E
Sbjct: 212 VGAYPFE 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 67  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 120
Query: 167 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 121 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 172
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              KT+ GT  Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 173 -RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 1   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 60
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 61  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 119
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 120 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 167
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 168 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 222
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 223 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 257

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 123
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 124 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 181 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 62
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 63  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 121
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 122 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 170 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 224
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 225 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 259

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 67  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 120
Query: 167 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 121 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 172
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              KT+ GT  Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 173 -RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 223

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 71  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 124
Query: 167 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 125 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 176
Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              KT+ GT  Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 177 -RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 227

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 39  SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 95
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 96  EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 150
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 100 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 158
Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 159 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206
Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 207 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--- 260
Query: 271 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 261 --ILFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 296

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 83/187 (44%), Gaps = 18/187 (9%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           VA+K +++ +K   +   RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 154
Query: 208 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 264
             K+C FG +  +   S P   K+  GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 155 RLKICAFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 265 TGRKPIE 271
            G  P E
Sbjct: 212 VGAYPFE 218

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 19/151 (12%)
Query: 133 LFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH 191
           + LI +Y +GG +    L E  + V  N  +      ++   I E V YLH      +VH
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVI------RLIKQILEGVYYLHQNN---IVH 154
Query: 192 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC--KTVKGTFGYLAPEYFQHGKVSD 249
            D+KP NILLSS  I  L D  +  +  +  +   C  + + GT  YLAPE   +  ++ 
Sbjct: 155 LDLKPQNILLSS--IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212
Query: 250 KTDVYAFGVVLLELLTGRKPIEARRLQGEEN 280
            TD++  G++   LLT   P       GE+N
Sbjct: 213 ATDMWNIGIIAYMLLTHTSP-----FVGEDN 238

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 31/275 (11%)
Query: 44  ANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKES 100
           AN    +  G+        +   + +G GA   V      +L  +VAIK+L +  +++  
Sbjct: 1   ANQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 60
Query: 101 SKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKG 155
           +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + +  +   
Sbjct: 61  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDH 119
Query: 156 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
            R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 120 ERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 167
Query: 216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
             T+  S  F+      T  Y APE        +  D+++ G ++ E++  +        
Sbjct: 168 R-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-----LF 219
Query: 276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 310
            G + +  W K I   G    E +   +L+ T RN
Sbjct: 220 PGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 252

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 110/272 (40%), Gaps = 24/272 (8%)
Query: 54  EILAATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSKAFCREL 108
           ++L     F+ GR+LG+G    V + ++       ++ +V + + D       + F RE 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 109 MIASSLHHPNIVPLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 163
                  HP++  LVG  +            +I  ++  G L   L   + G      LP
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLP 135
Query: 164 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
                +  + IA  + YL   + R  +HRD+   N +L+      + DFGL+    +   
Sbjct: 136 LQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLV 282
                  K    +LA E       +  +DV+AFGV + E++T G+ P       G EN  
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-----YAGIENAE 247
Query: 283 LWAKPI----LHRGMAAVEELLDPRLKCTSRN 310
           ++   I    L +    +EE+ D   +C S +
Sbjct: 248 IYNYLIGGNRLKQPPECMEEVYDLMYQCWSAD 279

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 19/238 (7%)
Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 112 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 226
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+ DFGLA   + P      FL
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFL 184
Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 41/236 (17%)
Query: 68  LGRGALSFVFKG---KVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           LG+G  + +FKG   +VG    L  T V +K LDK  +  S++F     + S L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G C   ++ + L+ ++V  GSL+ +L + K  +     + W       L +A+ +A+
Sbjct: 76  LNYGVCFCGDENI-LVQEFVKFGSLDTYLKKNKNCI----NILWK------LEVAKQLAW 124
Query: 181 -LHNGTERCVVHRDIKPSNILL--------SSKKIPKLCDFGLATWTSAPSVPFLCKTV- 230
            +H   E  ++H ++   NILL         +    KL D G+       S+  L K + 
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-------SITVLPKDIL 177
Query: 231 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLT-GRKPIEA----RRLQGEEN 280
           +    ++ PE  ++ K ++  TD ++FG  L E+ + G KP+ A    R+LQ  E+
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 82/187 (43%), Gaps = 18/187 (9%)
Query: 88  VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           VA+K +++ +K   +   RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 154
Query: 208 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 264
             K+C FG +  +   S P   K   GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 155 RLKICAFGYSKSSVLHSQP---KDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 265 TGRKPIE 271
            G  P E
Sbjct: 212 VGAYPFE 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 119/256 (46%), Gaps = 30/256 (11%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 120 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           + L+        ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL-----YQMLCGI 132
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T 
Sbjct: 133 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTR 182
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            Y APE        +  D+++ G ++ E++  +         G + +  W K I   G  
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-----LFPGRDYIDQWNKVIEQLGTP 237
Query: 295 AVEELLDPRLKCTSRN 310
             E +   +L+ T RN
Sbjct: 238 CPEFM--KKLQPTVRN 251

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 119/256 (46%), Gaps = 30/256 (11%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 120 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           + L+        ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL-----YQMLCGI 133
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T 
Sbjct: 134 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTR 183
Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            Y APE        +  D+++ G ++ E++  +         G + +  W K I   G  
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-----LFPGRDYIDQWNKVIEQLGTP 238
Query: 295 AVEELLDPRLKCTSRN 310
             E +   +L+ T RN
Sbjct: 239 CPEFM--KKLQPTVRN 252

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 65  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 118
Query: 167 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--SAPS 222
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 119 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              LC    GT  Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 172 KKVLC----GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 117/294 (39%), Gaps = 74/294 (25%)
Query: 42  PVANSLIRLSYGEILAATHNFSK-----GRVLGRGALSFVFKGKVGLLRTS-----VAIK 91
           P+     RL Y    A+   F++     G+ LGRGA   V +     ++ S     VA+K
Sbjct: 7   PLDEQCERLPYD---ASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVK 63
Query: 92  RLDKEDKESS--KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER- 147
            L KE   +S  KA   EL I + + HH N+V L+G C      L +I +Y   G+L   
Sbjct: 64  ML-KEGATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNY 122
Query: 148 ----------------HLHEKKKGV-----RGNSTLPWSVR------------------- 167
                           H+  KK+ +     +G      SV                    
Sbjct: 123 LKSKRDLFFLNKDAALHMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDV 182
Query: 168 ---------YKVALGIAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCD 211
                    YK  + + + ++Y   +  G E    R  +HRD+   NILLS   + K+CD
Sbjct: 183 EEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICD 242
Query: 212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
           FGLA               +    ++APE       S K+DV+++GV+L E+ +
Sbjct: 243 FGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQD-----RGDQAFTEREASEIXKS 169
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 229
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 Y+APE     K     D ++ GV+   LL G  P 
Sbjct: 227 PY----YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 118
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
            +  + +    +  L+L+  Y  GG L   L + +  +       +     +A+   +SV
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI---DSV 191
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG-----LATWTSAPSVPFLCKTVKGT 233
             LH       VHRDIKP NIL+      +L DFG     +   T   SV        GT
Sbjct: 192 HQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV------GT 239
Query: 234 FGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
             Y++PE  Q      G+   + D ++ GV + E+L G  P  A  L
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 109/225 (48%), Gaps = 15/225 (6%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 86  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 140
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+ +    T  Y A
Sbjct: 141 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMEPEVVTRYYRA 193
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           PE        +  D+++ G ++ E++  +     R    + N V+
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 113 SLHHPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           +  HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 123
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA      S      
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177
Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+ + +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVV 65
Query: 121 PLVG------------FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
                             +  +  LF+  +Y    +L   +H +    + +        +
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY------W 119
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------------T 216
           ++   I E+++Y+H+   + ++HR++KP NI +   +  K+ DFGLA             
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELL 264
             + P       +  GT  Y+A E     G  ++K D Y+ G++  E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 89  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 142
Query: 167 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--SAPS 222
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 143 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 195
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              LC    GT  Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 196 KKVLC----GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 245

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 107 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 91  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 144
Query: 167 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--SAPS 222
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 145 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              LC    GT  Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 198 KKVLC----GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 108/225 (48%), Gaps = 15/225 (6%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 80  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 134
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y A
Sbjct: 135 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRA 187
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           PE        +  D+++ G ++ E++  +     R    + N V+
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 232

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 109/225 (48%), Gaps = 15/225 (6%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 86  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 140
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+ +    T  Y A
Sbjct: 141 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMEPEVVTRYYRA 193
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           PE        +  D+++ G ++ E++  +     R    + N V+
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 88/222 (39%), Gaps = 17/222 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 118
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       I E V
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLLS------KFEDKLPEDM---ARFYIGEMV 185
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
             + +  +   VHRDIKP N+LL      +L DFG     +            GT  Y++
Sbjct: 186 LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVAVGTPDYIS 244
Query: 239 PEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
           PE  Q      GK   + D ++ GV + E+L G  P  A  L
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 286

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 28/222 (12%)
Query: 54  EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 113
           E+  ATH       LGRG+   V + +        A+K++  E   +      ELM  + 
Sbjct: 72  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA-----EELMACAG 122
Query: 114 LHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           L  P IVPL G   + P   +F+  + + GGSL + + E+         LP   R    L
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQ-------GCLP-EDRALYYL 172
Query: 173 GIA-ESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVP---FLC 227
           G A E + YLH+   R ++H D+K  N+LLSS      LCDFG A       +       
Sbjct: 173 GQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTG 229
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             + GT  ++APE         K DV++   ++L +L G  P
Sbjct: 230 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 80
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 81  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+          +  K  KG  
Sbjct: 139 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 193
Query: 235 G--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+          +  K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAYYRKGGKGLL 194
Query: 235 G--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+          +  K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 194
Query: 235 G--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 88/222 (39%), Gaps = 17/222 (7%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 118
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       I E V
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLLS------KFEDKLPEDM---ARFYIGEMV 201
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
             + +  +   VHRDIKP N+LL      +L DFG     +            GT  Y++
Sbjct: 202 LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVAVGTPDYIS 260
Query: 239 PEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 275
           PE  Q      GK   + D ++ GV + E+L G  P  A  L
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 302

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 108/225 (48%), Gaps = 15/225 (6%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 119
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 120 VPLVGFCIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L+     P++ L      Y+    ++ +L +  +    +  + + + Y++  GI    
Sbjct: 91  IGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK--- 145
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y A
Sbjct: 146 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRA 198
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
           PE        +  D+++ G ++ E++  +     R    + N V+
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 243

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 28/222 (12%)
Query: 54  EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 113
           E+  ATH       LGRG+   V + +        A+K++  E   +      ELM  + 
Sbjct: 91  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA-----EELMACAG 141
Query: 114 LHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           L  P IVPL G   + P   +F+  + + GGSL + + E+         LP   R    L
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQ-------GCLP-EDRALYYL 191
Query: 173 GIA-ESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVP---FLC 227
           G A E + YLH+   R ++H D+K  N+LLSS      LCDFG A       +       
Sbjct: 192 GQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTG 248
Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             + GT  ++APE         K DV++   ++L +L G  P
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 121
           V+G+G  S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 91  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H+     ++HRD+KP  +LL+SK+     KL  FG+A       +  +     GT  ++A
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMA 201
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  +        DV+  GV+L  LL+G  P 
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 121
           V+G+G  S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 93  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           H+     ++HRD+KP  +LL+SK+     KL  FG+A       +  +     GT  ++A
Sbjct: 149 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMA 203
Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           PE  +        DV+  GV+L  LL+G  P 
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 127
           LG G+   V+K         VAIK++  E     +   +E+ I      P++V   G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
                L+++ +Y   GS+   +  +      N TL       +     + + YLH   + 
Sbjct: 95  K-NTDLWIVMEYCGAGSVSDIIRLR------NKTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
             +HRDIK  NILL+++   KL DFG+A   +          V GT  ++APE  Q    
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK--RNXVIGTPFWMAPEVIQEIGY 202
Query: 248 SDKTDVYAFGVVLLELLTGRKP 269
           +   D+++ G+  +E+  G+ P
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP 224

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 78
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 79  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+             K  KG  
Sbjct: 137 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLL 191
Query: 235 G--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+             K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLL 194
Query: 235 G--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           LG G    V+K    +   +VAIKR  L+ E++       RE+ +   L H NI+ L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS- 100
Query: 126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 185
            I     L LI++Y          ++ KK +  N  +   V       +   V + H  +
Sbjct: 101 VIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH--S 150
Query: 186 ERCVVHRDIKPSNILL-----SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
            RC+ HRD+KP N+LL     S   + K+ DFGLA     P   F  + +  T  Y  PE
Sbjct: 151 RRCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRPPE 207
Query: 241 YFQHGK-VSDKTDVYAFGVVLLELL 264
                +  S   D+++   +  E+L
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+             K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLL 194
Query: 235 G--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 12  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 65
Query: 126 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 117
Query: 182 HN---GTER--CVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 234
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 235 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 263
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 14  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 67
Query: 126 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 119
Query: 182 HN---GTER--CVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 234
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 235 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 263
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 17  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 70
Query: 126 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 122
Query: 182 HN---GTER--CVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 234
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 235 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 263
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHR++   N +++     K+ DFG+          +  K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 194
Query: 235 G--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 11  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 64
Query: 126 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 116
Query: 182 HN---GTER--CVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 234
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 235 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 263
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 66  RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 117
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 82
Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 174
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 83  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 140
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+    +  VHR++   N +++     K+ DFG+          +  K  KG  
Sbjct: 141 ADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 195
Query: 235 G--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 265
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 37  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 90
Query: 126 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 142
Query: 182 HN---GTER--CVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 234
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 235 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 263
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 50  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 103
Query: 126 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 155
Query: 182 HN---GTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 234
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 235 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 263
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L   +  +K        L +         I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ--------ILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 37/247 (14%)
Query: 55  ILAATHNFSKGRVLGRGAL-SFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCREL 108
           ++    +F    VLG GA  + V++G        VA+KR+  E     D+E         
Sbjct: 19  VIVGKISFCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRILPECFSFADREVQ------- 69
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           ++  S  HPN++    FC + ++    I   +   +L+ ++ +K     G    P ++  
Sbjct: 70  LLRESDEHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE--PITLLQ 125
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-----SKKIPKLCDFGLATWTSAPSV 223
           +   G+A    +LH+     +VHRD+KP NIL+S      K    + DFGL    +    
Sbjct: 126 QTTSGLA----HLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 224 PFLCKT-VKGTFGYLAPEYFQHGKVSDKT---DVYAFGVVLLELLT-GRKPIEARRLQGE 278
            F  ++ V GT G++APE        + T   D+++ G V   +++ G  P   + LQ +
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQ 237
Query: 279 ENLVLWA 285
            N++L A
Sbjct: 238 ANILLGA 244

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 16/175 (9%)
Query: 106 RELMIASSLHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLE--RHLHEKKKGVRGNSTL 162
           +E+ +   L H N++ LV    + E Q ++++ +Y   G  E    + EK+         
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--------F 106
Query: 163 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
           P    +     + + + YLH+   + +VH+DIKP N+LL++    K+   G+A      +
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRL 275
               C+T +G+  +  PE           K D+++ GV L  + TG  P E   +
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 42  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 97
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 98  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 150 AD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 201
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 41  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 96
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 97  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 149 AD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 200
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 47  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 102
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 103 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 154
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 155 AD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIML 206
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 38  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 93
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 94  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 146 AD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 197
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 41  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 96
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 97  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 149 AD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 200
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 64  KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 114
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 26  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 85  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 135
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 136 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 234 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 271
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 64  KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 114
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 113 QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 163
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 164 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 219
Query: 234 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 271
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L K  +    +K   REL +   + H N++ L+     
Sbjct: 48  GSVCAAFDTKTGL---RVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 103
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 104 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 207
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L   +  +K        L +         I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ--------ILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 64  KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 114
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 6   KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 64
Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 65  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 115
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 116 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 171
Query: 234 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 271
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 172 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 64  KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 114
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 10  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 68
Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 69  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 119
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 120 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 175
Query: 234 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 271
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 176 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCREL 108
           A   N+   + LG G+      GKV L   +     VA+K ++K+    S       RE+
Sbjct: 1   AHIGNYQIVKTLGEGSF-----GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI 55
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
                L HP+I+ L    I  +  + ++ +Y +G  L  ++ ++ K     +        
Sbjct: 56  SYLRLLRHPHIIKLYD-VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR------- 106
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
           +    I  +V Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     K
Sbjct: 107 RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 160
Query: 229 TVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 271
           T  G+  Y APE    GK+    + DV++ GV+L  +L  R P +
Sbjct: 161 TSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 126
           LGRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 133
Query: 127 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 184
            + P   +F+  + + GGSL + + +          LP   R    LG A E + YLH  
Sbjct: 134 REGPWVNIFM--ELLEGGSLGQLIKQM-------GCLP-EDRALYYLGQALEGLEYLHT- 182
Query: 185 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVP---FLCKTVKGTFGYLAPE 240
             R ++H D+K  N+LLSS      LCDFG A       +         + GT  ++APE
Sbjct: 183 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                    K D+++   ++L +L G  P
Sbjct: 241 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE---DKESSKAFCREL 108
           A   N+   + LG G+      GKV L   +     VA+K ++K+     +      RE+
Sbjct: 11  AHIGNYQIVKTLGEGSF-----GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI 65
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
                L HP+I+ L    I  +  + ++ +Y +G  L  ++ ++ K     +        
Sbjct: 66  SYLRLLRHPHIIKLYD-VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR------- 116
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
           +    I  +V Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     K
Sbjct: 117 RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 170
Query: 229 TVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 271
           T  G+  Y APE    GK+    + DV++ GV+L  +L  R P +
Sbjct: 171 TSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 64  KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 114
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 66  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 116
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 117 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 234 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 271
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 64  KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 114
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 113 QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 163
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 164 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 219
Query: 234 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 271
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 43  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 98
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 99  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T+     ++      T  Y APE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIML 202
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCREL 108
           A   N+   + LG G+      GKV L   +     VA+K ++K+    S       RE+
Sbjct: 5   AHIGNYQIVKTLGEGSF-----GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI 59
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
                L HP+I+ L    I  +  + ++ +Y +G  L  ++ ++ K     +        
Sbjct: 60  SYLRLLRHPHIIKLYD-VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR------- 110
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
           +    I  +V Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     K
Sbjct: 111 RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 164
Query: 229 TVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 271
           T  G+  Y APE    GK+    + DV++ GV+L  +L  R P +
Sbjct: 165 TSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE---DKESSKAFCREL 108
           A   N+   + LG G+      GKV L   +     VA+K ++K+     +      RE+
Sbjct: 10  AHIGNYQIVKTLGEGSF-----GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI 64
Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
                L HP+I+ L    I  +  + ++ +Y +G  L  ++ ++ K     +        
Sbjct: 65  SYLRLLRHPHIIKLYD-VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR------- 115
Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
           +    I  +V Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     K
Sbjct: 116 RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 169
Query: 229 TVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 271
           T  G+  Y APE    GK+    + DV++ GV+L  +L  R P +
Sbjct: 170 TSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 43  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 98
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 99  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T+     ++      T  Y APE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIML 202
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L   +  +K        L +         I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQ--------ILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGL   T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 43  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 98
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 99  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T+     ++      T  Y APE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIML 202
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 42  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 97
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 98  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 150 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 201
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 42  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 97
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 98  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 150 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 201
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 41  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 96
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 97  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 149 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 200
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 35  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 90
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 91  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 142
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 143 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 194
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 195 NWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 16/183 (8%)
Query: 88  VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           VAIK+L +  + +  +K   REL++   + H N++ L+     P   L   Y +      
Sbjct: 52  VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPF 110
Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
            +   +K  G++ +      + Y++  G+     Y+H+     VVHRD+KP N+ ++   
Sbjct: 111 MQTDLQKIMGLKFSEEKIQYLVYQMLKGLK----YIHSA---GVVHRDLKPGNLAVNEDC 163
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 264
             K+ DFGLA    A    ++      T  Y APE        ++T D+++ G ++ E+L
Sbjct: 164 ELKILDFGLARHADAEMTGYVV-----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 265 TGR 267
           TG+
Sbjct: 219 TGK 221

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 43  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 98
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 99  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 202
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 48  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 103
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 104 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 207
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 48  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 103
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 104 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 207
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 38  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 93
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 94  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 146 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 197
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 47  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 102
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 103 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 154
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 155 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 206
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 38  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 93
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 94  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 146 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 197
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 41  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 96
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 97  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 149 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 200
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 38  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 93
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 94  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 146 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 197
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 59  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 114
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 115 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 166
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 167 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 218
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 68/288 (23%)
Query: 57  AATHNFSKGRVLGRGALSFV---FKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 113
            ++  +S G+ LG G+   V   F  + G      A+K++ ++ +  +    REL I   
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESG---KRFALKKVLQDPRYKN----RELDIMKV 56
Query: 114 LHHPNIVPLVGF-----------------------------------CIDPEQGLFL--I 136
           L H NI+ LV +                                    ++P Q  +L  I
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP 196
            +YV   +L + L   K  +R   ++P ++       +  +V ++H+     + HRDIKP
Sbjct: 117 MEYVPD-TLHKVL---KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKP 169
Query: 197 SNILLSSK-KIPKLCDFGLAT--WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTD 252
            N+L++SK    KLCDFG A     S PSV  +C        Y APE      + +   D
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF-----YRAPELMLGATEYTPSID 224
Query: 253 VYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
           +++ G V  EL+ G KP+      GE ++    + I   G    E+++
Sbjct: 225 LWSIGCVFGELILG-KPL----FSGETSIDQLVRIIQIMGTPTKEQMI 267

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 55  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 110
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 111 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 162
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 163 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 214
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 56  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 111
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 112 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 215
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 33  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 88
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 89  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 140
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 141 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 192
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 33  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 88
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 89  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 140
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 141 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 192
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 32  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 87
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 88  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 191
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 34  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 89
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 90  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 141
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 142 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 193
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 64  KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 114
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 26  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 85  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 135
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A          +  +  GT
Sbjct: 136 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGT 191
Query: 234 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 271
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 59  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 114
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 115 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 166
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 167 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV-----ATRWYRAPEIML 218
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 126
           +GRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 135
Query: 127 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 184
            + P   +F+  + + GGSL +        ++    LP   R    LG A E + YLH  
Sbjct: 136 REGPWVNIFM--ELLEGGSLGQL-------IKQMGCLP-EDRALYYLGQALEGLEYLHT- 184
Query: 185 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVP---FLCKTVKGTFGYLAPE 240
             R ++H D+K  N+LLSS      LCDFG A       +         + GT  ++APE
Sbjct: 185 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                    K D+++   ++L +L G  P
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 126
           +GRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 119
Query: 127 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 184
            + P   +F+  + + GGSL + + +          LP   R    LG A E + YLH  
Sbjct: 120 REGPWVNIFM--ELLEGGSLGQLIKQM-------GCLP-EDRALYYLGQALEGLEYLHT- 168
Query: 185 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVP---FLCKTVKGTFGYLAPE 240
             R ++H D+K  N+LLSS      LCDFG A       +         + GT  ++APE
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                    K D+++   ++L +L G  P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 88  VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 145
           VAIK+L +  + +  +K   REL++   + H N++ L+     P   L   Y +      
Sbjct: 70  VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPF 128
Query: 146 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
            +   +K  G+  +      + Y++  G+     Y+H+     VVHRD+KP N+ ++   
Sbjct: 129 MQTDLQKIMGMEFSEEKIQYLVYQMLKGLK----YIHSA---GVVHRDLKPGNLAVNEDC 181
Query: 206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 264
             K+ DFGLA    A    ++      T  Y APE        ++T D+++ G ++ E+L
Sbjct: 182 ELKILDFGLARHADAEMTGYVV-----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236
Query: 265 TGR 267
           TG+
Sbjct: 237 TGK 239

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 57  AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--L 114
              H  +    +G+G    V++G       +VA+K     D+   K++ RE  + ++  L
Sbjct: 5   TVAHQITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDE---KSWFRETELYNTVML 59
Query: 115 HHPNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            H NI+  +   +        L+LI  Y   GSL  +L          +TL      ++ 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--------TTLDTVSCLRIV 111
Query: 172 LGIAESVAYLH---NGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
           L IA  +A+LH    GT+    + HRD+K  NIL+       + D GLA   S  +    
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 227 CKTVK--GTFGYLAPEYFQHGKVSD------KTDVYAFGVVLLEL 263
                  GT  Y+APE        D      + D++AFG+VL E+
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      F+      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      F+      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++G       SVA+K     D++S   + RE  I ++  L H NI+  +  
Sbjct: 16  VGKGRYGEVWRGL--WHGESVAVKIFSSRDEQS---WFRETEIYNTVLLRHDNILGFIAS 70
Query: 126 CI---DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            +   +    L+LI  Y   GSL   L  +        TL   +  ++A+  A  +A+LH
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQ--------TLEPHLALRLAVSAACGLAHLH 122
Query: 183 ---NGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS--VPFLCKTVKGTFG 235
               GT+    + HRD K  N+L+ S     + D GLA   S  S  +        GT  
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182
Query: 236 YLAPEYFQHGKVSD------KTDVYAFGVVLLEL 263
           Y+APE       +D       TD++AFG+VL E+
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLV 123
           R +G GA   V       LR  VA+K+L +  +    ++   REL +   L H N++ L+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 124 GF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                   I+    ++L+   + G  L          V+  +     V++ V   +   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM-GADL-------NNIVKSQALSDEHVQFLV-YQLLRGL 144
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            Y+H+     ++HRD+KPSN+ ++     ++ DFGLA         ++      T  Y A
Sbjct: 145 KYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA-----TRWYRA 196
Query: 239 PEYFQHGKVSDKT-DVYAFGVVLLELLTGR 267
           PE   +    ++T D+++ G ++ ELL G+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ D+GLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 32  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 87
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 88  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      F+      T  Y APE   
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-----ATRWYRAPEIML 191
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 64  KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 114
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 113 QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 163
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  G 
Sbjct: 164 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 234 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 271
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++G       +VA+K     D+   K++ RE  + ++  L H NI+  +  
Sbjct: 16  VGKGRYGEVWRG--SWQGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 126 CIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            +        L+LI  Y   GSL  +L          +TL      ++ L IA  +A+LH
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLH 122
Query: 183 ---NGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK--GTFG 235
               GT+    + HRD+K  NIL+       + D GLA   S  +           GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 236 YLAPEYFQHGKVSD------KTDVYAFGVVLLEL 263
           Y+APE        D      + D++AFG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 96/235 (40%), Gaps = 21/235 (8%)
Query: 47  LIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF 104
           ++RL   E+     +F   +V+GRGA S V   K+       A+K ++K D  K    + 
Sbjct: 50  VVRLK--EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 105 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 164
            RE            +  + F    E  L+L+ +Y  GG L   L   K G R  + +  
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM-- 163
Query: 165 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 224
             R+     +AE V  + +      VHRDIKP NILL      +L DFG      A    
Sbjct: 164 -ARFY----LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 225 FLCKTVKGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
                V GT  YL+PE  Q        G    + D +A GV   E+  G+ P  A
Sbjct: 219 RSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 29/225 (12%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 119
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           + +      P+        Y+    ++  LH   + +         ++Y +   +  +V 
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTL-RAVK 126
Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-------------TWTSAPSVPFL 226
            LH      V+HRD+KPSN+L++S    K+CDFGLA             T   +  V F+
Sbjct: 127 VLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 227 CKTVKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                 T  Y APE      K S   DV++ G +L EL   R+PI
Sbjct: 184 -----ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 42  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 97
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 98  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 150 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 201
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 31/231 (13%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +LG+GA + VF+G+        AIK  +            RE  +   L+H NIV L  F
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 126 CIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            I+ E       LI ++   GSL   L E          LP S   +  + + + V  ++
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY----GLPES---EFLIVLRDVVGGMN 126
Query: 183 NGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           +  E  +VHR+IKP NI+       + + KL DFG A         F+  ++ GT  YL 
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFV--SLYGTEEYLH 183
Query: 239 PEYFQHG--------KVSDKTDVYAFGVVLLELLTGR---KPIEARRLQGE 278
           P+ ++          K     D+++ GV      TG    +P E  R   E
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 125
           +G+G    V++G       +VA+K     D+   K++ RE  + ++  L H NI+  +  
Sbjct: 45  VGKGRYGEVWRG--SWQGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 99
Query: 126 CIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            +        L+LI  Y   GSL  +L          +TL      ++ L IA  +A+LH
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLH 151
Query: 183 ---NGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK--GTFG 235
               GT+    + HRD+K  NIL+       + D GLA   S  +           GT  
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 236 YLAPEYFQHGKVSD------KTDVYAFGVVLLEL 263
           Y+APE        D      + D++AFG+VL E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T       +      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 46  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 101
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 102 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 153
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 154 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 205
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 19/220 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 119
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           + +      P+        Y+    ++  LH   + +         ++Y +   +  +V 
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTL-RAVK 126
Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-------- 231
            LH      V+HRD+KPSN+L++S    K+CDFGLA      +      T +        
Sbjct: 127 VLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 232 GTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            T  Y APE      K S   DV++ G +L EL   R+PI
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 56  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 111
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 112 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 215
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 19/220 (8%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 119
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           + +      P+        Y+    ++  LH   + +         ++Y +   +  +V 
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTL-RAVK 126
Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-------- 231
            LH      V+HRD+KPSN+L++S    K+CDFGLA      +      T +        
Sbjct: 127 VLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 232 GTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
            T  Y APE      K S   DV++ G +L EL   R+PI
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 55  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 110
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 111 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 162
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 163 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 214
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 102 KAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLFLIYKYVSGGSLERHLHEKKKGVR 157
           K   RE+ + +  HHPNI+ L    +  E+     L+L+ + +    L + +H+++  + 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 217
                 +   Y + LG       LH   E  VVHRD+ P NILL+      +CDF LA  
Sbjct: 133 PQHIQYFM--YHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 218 TSAPSVPFLCKTVKGTFG-YLAPEYFQHGKVSDK-TDVYAFGVVLLELLT 265
            +A +     KT   T   Y APE     K   K  D+++ G V+ E+  
Sbjct: 184 DTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLV 123
           R +G GA   V       LR  VA+K+L +  +    ++   REL +   L H N++ L+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 124 GF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                   I+    ++L+   + G  L          V+  +     V++ V   +   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM-GADL-------NNIVKCQALSDEHVQFLV-YQLLRGL 144
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            Y+H+     ++HRD+KPSN+ ++     ++ DFGLA         ++      T  Y A
Sbjct: 145 KYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA-----TRWYRA 196
Query: 239 PEYFQHGKVSDKT-DVYAFGVVLLELLTGR 267
           PE   +    ++T D+++ G ++ ELL G+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 90  IKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL 149
           I++++ +D E  K    E+ +   LHHPNI  L     D EQ + L+ +   GG L   L
Sbjct: 64  IRQINPKDVERIKT---EVRLMKKLHHPNIARLYEVYED-EQYICLVMELCHGGHLLDKL 119
Query: 150 HE------------------------KKKGVRGN-----STLPWSVRYKVALGIAESV-- 178
           +                          ++ + G+      +L +  R K+   I   +  
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 179 --AYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDFGLAT-WTSAPSVPFLCKTVK-G 232
              YLHN   + + HRDIKP N L S+ K    KL DFGL+  +    +  +   T K G
Sbjct: 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 233 TFGYLAPEYFQHGKVS--DKTDVYAFGVVLLELLTGRKPI 270
           T  ++APE       S   K D ++ GV+L  LL G  P 
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 33/237 (13%)
Query: 116 HPNIVPLVGFCI------DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           HP+IV +  F        DP    +++ +YV G SL+R   +K         LP +    
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVG--YIVMEYVGGQSLKRSKGQK---------LPVAEAIA 186
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
             L I  +++YLH+     +V+ D+KP NI+L+ +++ KL D G  +  ++         
Sbjct: 187 YLLEILPALSYLHS---IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS------FGY 236
Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG--EENLVLWAKP 287
           + GT G+ APE  + G     TD+Y  G  L  L         R + G  E++ VL    
Sbjct: 237 LYGTPGFQAPEIVRTGPTV-ATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYD 295
Query: 288 ILHRGM-AAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAILR 343
              R +  A++   DPR + T+                       RPG+  I +  R
Sbjct: 296 SYGRLLRRAIDP--DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSR 350

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 102 KAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLFLIYKYVSGGSLERHLHEKKKGVR 157
           K   RE+ + +  HHPNI+ L    +  E+     L+L+ + +    L + +H+++  + 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 217
                 +   Y + LG       LH   E  VVHRD+ P NILL+      +CDF LA  
Sbjct: 133 PQHIQYFM--YHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 218 TSAPSVPFLCKTVKGTFG-YLAPEYFQHGKVSDK-TDVYAFGVVLLELLT 265
            +A +     KT   T   Y APE     K   K  D+++ G V+ E+  
Sbjct: 184 DTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 31/231 (13%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +LG+GA + VF+G+        AIK  +            RE  +   L+H NIV L  F
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 126 CIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
            I+ E       LI ++   GSL   L E          LP S   +  + + + V  ++
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY----GLPES---EFLIVLRDVVGGMN 126
Query: 183 NGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           +  E  +VHR+IKP NI+       + + KL DFG A         F+   + GT  YL 
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFV--XLYGTEEYLH 183
Query: 239 PEYFQHG--------KVSDKTDVYAFGVVLLELLTGR---KPIEARRLQGE 278
           P+ ++          K     D+++ GV      TG    +P E  R   E
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 32  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 87
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 88  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 191
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 118
           N+    ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAES 177
           I+ L    I PE  L     Y+     +  L +  K  +        ++ Y + LG    
Sbjct: 89  IIRLHDLII-PEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG---- 143
Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
             ++H   E  ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 144 EKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 32  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 87
Query: 129 PEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 187
           P + L      Y+    +   L+   K  +        + Y++  G+     Y+H+    
Sbjct: 88  PARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLK----YIHSAD-- 141
Query: 188 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
            ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   +   
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNWMH 195
Query: 248 SDKT-DVYAFGVVLLELLTGR 267
            ++T D+++ G ++ ELLTGR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ D GLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+  FGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 40/161 (24%)
Query: 117 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTV 230
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T+           
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------- 171
Query: 231 KGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 270
                         G+  DK+ D+++ GV++  LL G  P 
Sbjct: 172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ D GLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLV 123
           R +G GA   V       LR  VA+K+L +  +    ++   REL +   L H N++ L+
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 124 GF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                   I+    ++L+   + G  L          V+  +     V++ V   +   +
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM-GADL-------NNIVKCQALSDEHVQFLV-YQLLRGL 136
Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            Y+H+     ++HRD+KPSN+ ++     ++ DFGLA         ++      T  Y A
Sbjct: 137 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV-----ATRWYRA 188
Query: 239 PEYFQHGKVSDKT-DVYAFGVVLLELLTGR 267
           PE   +    ++T D+++ G ++ ELL G+
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 13/134 (9%)
Query: 130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV 189
           E G+  +   + G SL++H           ++LP +  +        ++A+LH+   + +
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAW------GASLPEAQVWGYLRDTLLALAHLHS---QGL 178
Query: 190 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 249
           VH D+KP+NI L  +   KL DFGL             +  +G   Y+APE  Q G    
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQ-GSYGT 234
Query: 250 KTDVYAFGVVLLEL 263
             DV++ G+ +LE+
Sbjct: 235 AADVFSLGLTILEV 248

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ D GLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 17/210 (8%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVG 124
            +G GA   V   +  L    VAIK++    +   ++K   REL I     H NI+ +  
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGIAESVAYL 181
                         YV    +E  LH+       +S+ P +   VRY +   +   + Y+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQII-----HSSQPLTLEHVRYFL-YQLLRGLKYM 174
Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTFGYLAP 239
           H+     V+HRD+KPSN+L++     K+ DFG+A    TS     +       T  Y AP
Sbjct: 175 HSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 240 E-YFQHGKVSDKTDVYAFGVVLLELLTGRK 268
           E      + +   D+++ G +  E+L  R+
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIV---- 120
            +G GA   V   +  L    VAIK++    +   ++K   REL I     H NI+    
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 121 ---PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGI 174
              P V +      G F    YV    +E  LH+       +S+ P +   VRY +   +
Sbjct: 122 ILRPTVPY------GEFKSV-YVVLDLMESDLHQII-----HSSQPLTLEHVRYFL-YQL 168
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKG 232
              + Y+H+     V+HRD+KPSN+L++     K+ DFG+A    TS     +       
Sbjct: 169 LRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 233 TFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRK 268
           T  Y APE      + +   D+++ G +  E+L  R+
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 106 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
           +E+ I +   H NI+ L     +  + L +I++++SG  +   +          S    +
Sbjct: 50  KEISILNIARHRNILHLHE-SFESMEELVMIFEFISGLDIFERI--------NTSAFELN 100
Query: 166 VRYKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAP 221
            R  V+    + E++ +LH+     + H DI+P NI+  +++    K+ +FG A     P
Sbjct: 101 EREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-P 156
Query: 222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              F  + +     Y APE  QH  VS  TD+++ G ++  LL+G  P  A   Q
Sbjct: 157 GDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 28/224 (12%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELM-----I 110
            +  G +LG+G    VF G     R  VAIK + +         S    C   +     +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
            +   HP ++ L+ +    E  + ++ + +    L  ++ EK     G S        + 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS--------RC 143
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGL-ATWTSAPSVPFLCK 228
             G  + VA + +   R VVHRDIK  NIL+  ++   KL DFG  A     P   F   
Sbjct: 144 FFG--QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--- 198
Query: 229 TVKGTFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
              GT  Y  PE+  +H   +    V++ G++L +++ G  P E
Sbjct: 199 --DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 40/224 (17%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI--ASSLHHPNIVPLV- 123
           ++GRG    V+KG   L    VA+K     ++++   F  E  I     + H NI   + 
Sbjct: 20  LIGRGRYGAVYKG--SLDERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIV 74
Query: 124 ---GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
                  D      L+ +Y   GSL ++L           T  W    ++A  +   +AY
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL--------SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 181 LHNGTER------CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV------PFLCK 228
           LH    R       + HRD+   N+L+ +     + DFGL+   +   +           
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 229 TVKGTFGYLAPEYFQHGKVS--------DKTDVYAFGVVLLELL 264
           +  GT  Y+APE  + G V+         + D+YA G++  E+ 
Sbjct: 187 SEVGTIRYMAPEVLE-GAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 119
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 120 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 170
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 130
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCK 228
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S    S P    
Sbjct: 131 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 229 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 270
               T  Y  PE     +      D++  G ++ E+ T R PI
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 56  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 111
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 112 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DFGLA  T       +      T  Y APE   
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV-----ATRWYRAPEIML 215
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           I   + Y+H+     ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T
Sbjct: 163 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----AT 214
Query: 234 FGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGR 267
             Y APE   +    + T D+++ G ++ ELLTGR
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 24/222 (10%)
Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---------DKESSKAFCRELM 109
           +  +S    LG GA  FV+          V +K + KE         D +  K    E+ 
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV-TLEIA 81
Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           I S + H NI+ ++   I   QG F +     G  L+      +          +  R  
Sbjct: 82  ILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
           V+     +V YL     + ++HRDIK  NI+++     KL DFG A +        L  T
Sbjct: 140 VS-----AVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYT 188
Query: 230 VKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 270
             GT  Y APE          + ++++ GV L  L+    P 
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 118
           N+    ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 119 IVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           I+ L    I  +      L+++ + ++   L++     K  +        ++ Y + LG 
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLF---KTPIFLTEEHIKTILYNLLLG- 141
Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
                ++H   E  ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 142 ---ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 125
           +G GA   V     G     VAIK+L +  + +  +K   REL +   + H N++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 126 -----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
                 +D     +L+  ++     +   HEK     G   + + V Y++  G+     Y
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLV-YQMLKGLR----Y 143
Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           +H      ++HRD+KP N+ ++     K+ DFGLA    +     +      T  Y APE
Sbjct: 144 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV-----TRWYRAPE 195
Query: 241 YFQHG-KVSDKTDVYAFGVVLLELLTGR 267
              +  + +   D+++ G ++ E++TG+
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 119
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 120 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 170
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 130
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCK 228
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S    S P    
Sbjct: 131 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 229 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 270
               T  Y  PE     +      D++  G ++ E+ T R PI
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 119
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 120 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 170
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 129
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCK 228
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S    S P    
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 229 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 270
               T  Y  PE     +      D++  G ++ E+ T R PI
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 119
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 120 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 170
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 130
Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCK 228
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S    S P    
Sbjct: 131 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 229 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 270
               T  Y  PE     +      D++  G ++ E+ T R PI
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 71  GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 128
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 129 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                ++HRD+KPSN+ ++     K+ DF LA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 244 HGKVSDKT-DVYAFGVVLLELLTGR 267
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 98/247 (39%), Gaps = 22/247 (8%)
Query: 60  HNFSKG------RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 113
           H F  G      + LG G    VF          VAIK++   D +S K   RE+ I   
Sbjct: 5   HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR 64
Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVR 167
           L H NIV +  F I    G  L     S   L      + ++      V     L     
Sbjct: 65  LDHDNIVKV--FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA 122
Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFL 226
                 +   + Y+H+     V+HRD+KP+N+ ++++  + K+ DFGLA     P     
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD-PHYSHK 178
Query: 227 CKTVKG--TFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
               +G  T  Y +P         +   D++A G +  E+LTG+          +  L+L
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 284 WAKPILH 290
            + P++H
Sbjct: 239 ESIPVVH 245

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 59/134 (44%), Gaps = 36/134 (26%)
Query: 189 VVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFL-----------CKTVK----- 231
           +VHRD+KPSN L + + K   L DFGLA  T    +  L           C   K     
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 232 ----------GTFGYLAPEYFQHGKVSDKT---DVYAFGVVLLELLTGRKPIEARRLQGE 278
                     GT G+ APE     K  ++T   D+++ GV+ L LL+GR P      +  
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLT--KCPNQTTAIDMWSAGVIFLSLLSGRYPF----YKAS 251
Query: 279 ENLVLWAKPILHRG 292
           ++L   A+ +  RG
Sbjct: 252 DDLTALAQIMTIRG 265

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVG 124
           ++G G+   V +    L +  VAIK++ +  ED    K   RE+ I + L+H ++V ++ 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
             I  +   F     V    LE    + KK  R    L       +   +   V Y+H+ 
Sbjct: 120 IVIPKDVEKFDELYVV----LEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA 175
Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
               ++HRD+KP+N L++     K+CDFGLA     P
Sbjct: 176 G---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 97/250 (38%), Gaps = 44/250 (17%)
Query: 105 CRELMIASSLHHPNIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 163
           C  L I S   HPN++P++G C  P      LI  ++  GSL   LHE    V   S   
Sbjct: 58  CPRLRIFS---HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA- 113
Query: 164 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
                K AL +A  +A+LH        H         L+S+ +  + D  +    S   V
Sbjct: 114 ----VKFALDMARGMAFLHTLEPLIPRH--------ALNSRSV--MIDEDMTARISMADV 159
Query: 224 PFLCKTVKGTF--GYLAPEYFQHGKVSDKT----DVYAFGVVLLELLTGRKPIEARRLQG 277
            F  ++    +   ++APE  Q  K  D      D+++F V+L EL+T   P        
Sbjct: 160 KFSFQSPGRMYAPAWVAPEALQ-KKPEDTNRRSADMWSFAVLLWELVTREVP-----FAD 213
Query: 278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEE 337
             N+ +        GM    E L P +                   C++ + ++RP  + 
Sbjct: 214 LSNMEI--------GMKVALEGLRPTIP-----PGISPHVSKLMKICMNEDPAKRPKFDM 260
Query: 338 IIAILRGEEE 347
           I+ IL   ++
Sbjct: 261 IVPILEKMQD 270
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	398
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-105
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-102
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-101
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-68
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-64
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-55
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-48
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-44
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-44
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-40
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-39
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-39
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-38
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-37
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-37
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-37
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-37
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-36
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-36
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-36
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-35
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-35
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-35
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-33
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-32
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-32
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-32
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-31
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-31
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-30
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-30
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-30
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-30
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-29
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-29
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-29
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-29
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-28
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-27
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-27
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-26
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-26
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-22
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-22
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-22
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-21
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  313 bits (805), Expect = e-105
 Identities = 108/307 (35%), Positives = 168/307 (54%), Gaps = 26/307 (8%)

Query: 49  RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKA-FC 105
           R S  E+  A+ NFS   +LGRG    V+KG+   L   T VA+KRL +E  +  +  F 
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGR---LADGTLVAVKRLKEERTQGGELQFQ 75

Query: 106 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
            E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       L W 
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPPLDWP 131

Query: 166 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 225
            R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA          
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY----- 186

Query: 226 LCKT-----VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE- 279
              T     V+GT G++APEY   GK S+KTDV+ +GV+LLEL+TG++  +  RL  ++ 
Sbjct: 187 -KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 280 -NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 338
             L+ W K +L      +E L+D  L+  +    ++ ++IQ A  C  S    RP + E+
Sbjct: 246 VMLLDWVKGLLKEKK--LEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 339 IAILRGE 345
           + +L G+
Sbjct: 303 VRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  305 bits (783), Expect = e-102
 Identities = 99/317 (31%), Positives = 157/317 (49%), Gaps = 25/317 (7%)

Query: 39  SISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKE 96
           S   V     R+   ++  AT+NF    ++G G    V+KG +  G     VA+KR   E
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG---AKVALKRRTPE 74

Query: 97  DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV 156
             +  + F  E+   S   HP++V L+GFC +  + + LIYKY+  G+L+RHL+      
Sbjct: 75  SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE-MILIYKYMENGNLKRHLYGSDLPT 133

Query: 157 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 216
               ++ W  R ++ +G A  + YLH      ++HRD+K  NILL    +PK+ DFG++ 
Sbjct: 134 ---MSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 217 WTSAPSVPFLCKT-----VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 271
                    L +T     VKGT GY+ PEYF  G++++K+DVY+FGVVL E+L  R  I 
Sbjct: 188 -----KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

Query: 272 ARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESR 331
               +   NL  WA    + G   +E+++DP L         + +    A  C++     
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQ--LEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSED 299

Query: 332 RPGIEEIIAILRGEEEL 348
           RP + +++  L     L
Sbjct: 300 RPSMGDVLWKLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  302 bits (776), Expect = e-101
 Identities = 92/321 (28%), Positives = 156/321 (48%), Gaps = 36/321 (11%)

Query: 37  ERSISPVANSLIRLSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAI 90
            +S+          S+ E+   T+NF +      G  +G G    V+KG V    T+VA+
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAV 59

Query: 91  KRLDKEDKESS----KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 146
           K+L      ++    + F +E+ + +   H N+V L+GF  D +    L+Y Y+  GSL 
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLL 118

Query: 147 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 206
             L      + G   L W +R K+A G A  + +LH   E   +HRDIK +NILL     
Sbjct: 119 DRLS----CLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFT 171

Query: 207 PKLCDFGLATWTSAPSVPFLCKT-----VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLL 261
            K+ DFGLA            +T     + GT  Y+APE    G+++ K+D+Y+FGVVLL
Sbjct: 172 AKISDFGLARA-----SEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLL 225

Query: 262 ELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAA 321
           E++TG   ++  R    + L+   + I       +E+ +D ++      S +   +   A
Sbjct: 226 EIITGLPAVDEHR--EPQLLLDIKEEIEDEEK-TIEDYIDKKMNDADSTSVE--AMYSVA 280

Query: 322 AACISSEESRRPGIEEIIAIL 342
           + C+  ++++RP I+++  +L
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  218 bits (557), Expect = 2e-68
 Identities = 68/316 (21%), Positives = 112/316 (35%), Gaps = 29/316 (9%)

Query: 45  NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF 104
           +S + L    +   +       V  RG    V+K ++      VA+K    +D + S   
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQN 65

Query: 105 CRELMIASSLHHPNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNST 161
             E+     + H NI+  +G           L+LI  +   GSL   L          + 
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--------ANV 117

Query: 162 LPWSVRYKVALGIAESVAYLHNGTER-------CVVHRDIKPSNILLSSKKIPKLCDFGL 214
           + W+    +A  +A  +AYLH             + HRDIK  N+LL +     + DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----KVSDKTDVYAFGVVLLELLTGRKP 269
           A    A           GT  Y+APE  +           + D+YA G+VL EL +    
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 270 IEARRLQGEENL--VLWAKPILHRGMAAV-EELLDPRLKCTSRNSAQIARVIQAAAACIS 326
            +    +        +   P L      V  +   P L+   +  A +A + +    C  
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 327 SEESRRPGIEEIIAIL 342
            +   R     +   +
Sbjct: 298 HDAEARLSAGCVGERI 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (526), Expect = 4e-64
 Identities = 89/280 (31%), Positives = 135/280 (48%), Gaps = 34/280 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
             V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G
Sbjct: 13  EEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 68

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C++P   + L+ +Y  GGSL   LH  +           +      L  ++ VAYLH+ 
Sbjct: 69  ACLNP---VCLVMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 185 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
             + ++HRD+KP N+LL +   + K+CDFG A               KG+  ++APE F+
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFE 176

Query: 244 HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR 303
               S+K DV+++G++L E++T RKP         + +   A  I    M AV      R
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPF--------DEIGGPAFRI----MWAVHN--GTR 222

Query: 304 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
                     I  ++     C S + S+RP +EEI+ I+ 
Sbjct: 223 PPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (502), Expect = 1e-60
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 47/294 (15%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------KAFCRELMIASSLHHP 117
            + +G+G    V KG++   ++ VAIK L   D E         + F RE+ I S+L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NIV L G   +P     ++ ++V  G L   L +K         + WSV+ ++ L IA  
Sbjct: 84  NIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLDKAH------PIKWSVKLRLMLDIALG 134

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLCDFGLATWTSAPSVPFLCKTVKG 232
           + Y+ N     +VHRD++  NI L S         K+ DFGL+  +           + G
Sbjct: 135 IEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLG 188

Query: 233 TFGYLAPEYF--QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPIL 289
            F ++APE    +    ++K D Y+F ++L  +LTG  P +           + +   I 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EYSYGKIKFINMIR 243

Query: 290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
             G+         R         ++  VI+    C S +  +RP    I+  L 
Sbjct: 244 EEGL---------RPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (503), Expect = 1e-60
 Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 32/282 (11%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 122
              +G G+   V + +     + VA+K L ++D   E    F RE+ I   L HPNIV  
Sbjct: 42  KEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G    P   L ++ +Y+S GSL R LH+          L    R  +A  +A+ + YLH
Sbjct: 100 MGAVTQPPN-LSIVTEYLSRGSLYRLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLH 154

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
           N     +VHR++K  N+L+  K   K+CDFGL+   +  S     K+  GT  ++APE  
Sbjct: 155 NRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVL 211

Query: 243 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPILHRGMAAVEELLD 301
           +    ++K+DVY+FGV+L EL T ++P             V+ A  +  +          
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWG-----NLNPAQVVAA--VGFKCK-------- 256

Query: 302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
            RL+     + Q+A +I+    C ++E  +RP    I+ +LR
Sbjct: 257 -RLEIPRNLNPQVAAIIEG---CWTNEPWKRPSFATIMDLLR 294

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  193 bits (492), Expect = 2e-59
 Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 47/292 (16%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKESSKAFCRELMIASSLHHPNIV 120
             ++G G    V++     +   VA+K      D++  ++ +   +E  + + L HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L G C+     L L+ ++  GG L R L  K+        +P  +    A+ IA  + Y
Sbjct: 70  ALRGVCLKEPN-LCLVMEFARGGPLNRVLSGKR--------IPPDILVNWAVQIARGMNY 120

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIP--------KLCDFGLATWTSAPSVPFLCKTVKG 232
           LH+     ++HRD+K SNIL+  K           K+ DFGLA      +      +  G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAG 176

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPILHR 291
            + ++APE  +    S  +DV+++GV+L ELLTG  P       G + L V +   +   
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-----GIDGLAVAYG--VAMN 229

Query: 292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
            +          L   S      A++++    C + +   RP    I+  L 
Sbjct: 230 KL---------ALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  190 bits (486), Expect = 2e-58
 Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 41/286 (14%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 122
              L       ++KG+       + +K L   D     S+ F  E        HPN++P+
Sbjct: 15  LTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 123 VGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           +G C  P      LI  ++  GSL   LHE       N  +  S   K AL +A  +A+L
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-----NFVVDQSQAVKFALDMARGMAFL 127

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 241
           H   E  +    +   ++++      ++    +          F          ++APE 
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179

Query: 242 FQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-PILHRGMAAVE 297
            Q           D+++F V+L EL+T   P              +A    +  GM    
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP--------------FADLSNMEIGMKVAL 225

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
           E L  R       S  ++++++    C++ + ++RP  + I+ IL 
Sbjct: 226 EGL--RPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  188 bits (480), Expect = 5e-57
 Identities = 65/294 (22%), Positives = 121/294 (41%), Gaps = 48/294 (16%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 122
           G ++G+G    V+ G+       VAI+ +D E   ++  KAF RE+M      H N+V  
Sbjct: 38  GELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G C+ P   L +I     G +L   + + K        L  +   ++A  I + + YLH
Sbjct: 95  MGACMSPPH-LAIITSLCKGRTLYSVVRDAKI------VLDVNKTRQIAQEIVKGMGYLH 147

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WTSAPSVPFLCKTVKGTFGYLAP 239
               + ++H+D+K  N+   + K+  + DFGL +      A       +   G   +LAP
Sbjct: 148 A---KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 240 EYFQHGKV---------SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPIL 289
           E  +             S  +DV+A G +  EL     P +      +    ++W    +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-----TQPAEAIIWQ---M 255

Query: 290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
             GM    +    ++        +I+ ++     C + E+  RP   +++ +L 
Sbjct: 256 GTGM----KPNLSQIGM----GKEISDILL---FCWAFEQEERPTFTKLMDMLE 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  186 bits (475), Expect = 9e-57
 Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 37/286 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPL 122
           G+ +G G+   V+KGK       VA+K L       +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G+   P+  L ++ ++  G SL  HLH  +                +A   A  + YLH
Sbjct: 86  MGYSTAPQ--LAIVTQWCEGSSLYHHLHASET------KFEMKKLIDIARQTARGMDYLH 137

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-- 240
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 241 -YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL--VLWAKPILHRGMAAVE 297
                   S ++DVYAFG+VL EL+TG+ P          N   ++     + RG     
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIEM---VGRG----- 241

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
            L     K  S    ++ R++     C+  +   RP    I+A + 
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  183 bits (466), Expect = 4e-55
 Identities = 72/327 (22%), Positives = 118/327 (36%), Gaps = 48/327 (14%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           G VLG+G      K         + +K L + D+E+ + F +E+ +   L HPN++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                ++ L  I +Y+ GG+L   +         +S  PWS R   A  IA  +AYLH  
Sbjct: 75  VLYKDKR-LNFITEYIKGGTLRGIIKSM------DSQYPWSQRVSFAKDIASGMAYLH-- 125

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------------TWTSAPSVPFLCKTVKG 232
               ++HRD+   N L+   K   + DFGLA              +          TV G
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG 292
              ++APE        +K DV++FG+VL E++                       +    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------DPDYLPRTM 230

Query: 293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCT 352
              +         C          +      C   +  +RP   ++   L   E L    
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITV---RCCDLDPEKRPSFVKLEHWL---ETLR--- 281

Query: 353 WKKHNFSGIIDCYPQLQQTKSEMKSHL 379
               + +G +   PQL+Q         
Sbjct: 282 ---MHLAGHLPLGPQLEQLDRGFWETY 305

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  175 bits (444), Expect = 1e-51
 Identities = 60/326 (18%), Positives = 107/326 (32%), Gaps = 44/326 (13%)

Query: 48  IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 107
           +  +  E      N     ++GRG    V+KG   L    VA+K     ++++   F  E
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQN---FINE 55

Query: 108 LMIA--SSLHHPNIVPLVGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNST 161
             I     + H NI   +               L+ +Y   GSL ++L           T
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------T 107

Query: 162 LPWSVRYKVALGIAESVAYLHN------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
             W    ++A  +   +AYLH         +  + HRD+   N+L+ +     + DFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 216 ------TWTSAPSVPFLCKTVKGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLE 262
                              +  GT  Y+APE  +             + D+YA G++  E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 263 LLTGRKPIEARRLQGEENL----VLWAKPILHRGMAAV-EELLDPRL-KCTSRNSAQIAR 316
           +      +       E  +     +   P        V  E   P+  +    NS  +  
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 317 VIQAAAACISSEESRRPGIEEIIAIL 342
           + +    C   +   R   +     +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERM 313

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 1e-48
 Identities = 62/299 (20%), Positives = 108/299 (36%), Gaps = 33/299 (11%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA--SSLHHPNIVPL 122
            + +G+G    V+ GK       VA+K     ++ S   + RE  I     + H NI+  
Sbjct: 42  VKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGF 96

Query: 123 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           +   I        L+LI  Y   GSL  +L         ++TL      K+A      + 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLK--------STTLDAKSMLKLAYSSVSGLC 148

Query: 180 YLHNGTER-----CVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVK-G 232
           +LH           + HRD+K  NIL+       + D GLA  + S  +   +    + G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 233 TFGYLAPE------YFQHGKVSDKTDVYAFGVVLLELLTGRKPIE-ARRLQGEENLVLWA 285
           T  Y+ PE         H +     D+Y+FG++L E+             Q   + ++ +
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268

Query: 286 KPILHRGMAAV-EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
            P        V  + L P       +   + ++ +    C +   + R     +   L 
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  159 bits (405), Expect = 3e-46
 Identities = 57/223 (25%), Positives = 86/223 (38%), Gaps = 31/223 (13%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE--LMIASSLHHPNIVPL 122
              +G+G    V++G       +VA+K     D++S   + RE  L     L H NI+  
Sbjct: 13  LECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKS---WFRETELYNTVMLRHENILGF 67

Query: 123 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           +   +        L+LI  Y   GSL  +L           TL      ++ L IA  +A
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--------TLDTVSCLRIVLSIASGLA 119

Query: 180 YLHNGTERC-----VVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKG 232
           +LH           + HRD+K  NIL+       + D GLA     S   +        G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 233 TFGYLAPE------YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           T  Y+APE               + D++AFG+VL E+      
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  156 bits (397), Expect = 1e-44
 Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 31/223 (13%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA--SSLHHPNIVPL 122
              +G+G    V++GK       VA+K     ++ S   + RE  I     L H NI+  
Sbjct: 47  QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGF 101

Query: 123 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           +            L+L+  Y   GSL  +L+          T+      K+AL  A  +A
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLA 153

Query: 180 YLHNGTERC-----VVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKG 232
           +LH           + HRD+K  NIL+       + D GLA    ++  ++        G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 233 TFGYLAPE------YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           T  Y+APE        +H +   + D+YA G+V  E+      
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  154 bits (391), Expect = 5e-44
 Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 19/232 (8%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
            ++   + LG G  S+V   +        A+KR+   +++  +   RE  +    +HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 120 VPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           + LV +C+         +L+  +   G+L   +   ++     + L       + LGI  
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICR 145

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVK---- 231
            +  +H    +   HRD+KP+NILL  +  P L D G                T++    
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 232 --GTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 278
              T  Y APE F    H  + ++TDV++ G VL  ++ G  P +    +G+
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  144 bits (366), Expect = 2e-40
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 29/215 (13%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
            R++GRG +  V++ +  +    VA+K + +    D        RE   A  L  P++VP
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 122 L--VGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +   G       G L++  + ++G  L   L       +G    P +V   +   I  ++
Sbjct: 99  IHDFG----EIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVA--IVRQIGSAL 147

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT----VKGTF 234
              H        HRD+KP NIL+S+     L DFG+A+ T+   +     T      GT 
Sbjct: 148 DAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNTVGTL 199

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            Y+APE F     + + D+YA   VL E LTG  P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  143 bits (364), Expect = 2e-40
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 12/223 (5%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           ++     +G G+     K +       +  K LD     + E       E+ +   L HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHP 65

Query: 118 NIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           NIV      ID     L+++ +Y  GG L   +    KG +    L      +V   +  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTL 122

Query: 177 SVAYLH--NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           ++   H  +     V+HRD+KP+N+ L  K+  KL DFGLA   +  +     KT  GT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTP 180

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
            Y++PE       ++K+D+++ G +L EL     P  A   + 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (364), Expect = 4e-40
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 12/212 (5%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHP 117
           NF   + +GRG  S V++    L    VA+K++   D   +KA     +E+ +   L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           N++      I+  + L ++ +    G L R +   KK       +P    +K  + +  +
Sbjct: 93  NVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSA 148

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + ++H    R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT  Y+
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 203

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +PE       + K+D+++ G +L E+   + P
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  144 bits (365), Expect = 6e-40
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 15/220 (6%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 117
            + + + +G G+       K         IK ++      KE  ++  RE+ + +++ HP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLANMKHP 83

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NIV       +    L+++  Y  GG L + ++ +K                  + I  +
Sbjct: 84  NIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGV-----LFQEDQILDWFVQICLA 137

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + ++H   +R ++HRDIK  NI L+     +L DFG+A   ++     L +   GT  YL
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYL 192

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
           +PE  ++   ++K+D++A G VL EL T +   EA  ++ 
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  142 bits (360), Expect = 1e-39
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 29/225 (12%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 117
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 28  RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 118 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 87  SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 137

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT  
Sbjct: 138 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVN 193

Query: 236 YLAPEYFQ-----------HGKVSDKTDVYAFGVVLLELLTGRKP 269
           Y+ PE  +             K+S K+DV++ G +L  +  G+ P
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  141 bits (359), Expect = 1e-39
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
              LG G +S V+  +  +L   VAIK +       +E+ K F RE+  +S L H NIV 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 122 L--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +  V      E    +L+ +Y+ G +L  ++            L           I + +
Sbjct: 76  MIDVDE----EDDCYYLVMEYIEGPTLSEYIESHGP-------LSVDTAINFTNQILDGI 124

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            + H   +  +VHRDIKP NIL+ S K  K+ DFG+A   S  S+      V GT  Y +
Sbjct: 125 KHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFS 180

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE  +     + TD+Y+ G+VL E+L G  P
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  140 bits (356), Expect = 6e-39
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 19/213 (8%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 121
           G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP IV 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 122 L--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +   G    P   L +++ +YV G +L   +H +         +      +V     +++
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADACQAL 129

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT--VKGTFGY 236
            + H   +  ++HRD+KP+NI++S+    K+ DFG+A   +      + +T  V GT  Y
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS-VTQTAAVIGTAQY 185

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           L+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  141 bits (357), Expect = 8e-39
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 29/225 (12%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 117
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 118 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 68  SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 118

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT  
Sbjct: 119 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 236 YLAPEYFQ-----------HGKVSDKTDVYAFGVVLLELLTGRKP 269
           Y+ PE  +             K+S K+DV++ G +L  +  G+ P
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  145 bits (367), Expect = 2e-38
 Identities = 57/283 (20%), Positives = 111/283 (39%), Gaps = 43/283 (15%)

Query: 65  GRVLGRGALSFVFKGK-VGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPL 122
              +  G L +++      +    V +K L    D E+      E    + + HP+IV +
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 123 VGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
             F    ++      +++ +YV G SL+R   +K         LP +      L I  ++
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---------LPVAEAIAYLLEILPAL 195

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           +YLH      +V+ D+KP NI+L+ +++ KL D G  +  ++         + GT G+ A
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFG------YLYGTPGFQA 245

Query: 239 PEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           PE        +  TD+Y  G  L  L         R + G     L     + +   +  
Sbjct: 246 PE--IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----LPEDDPVLKTYDSYG 298

Query: 298 ELLDPRLKCTSRN------SAQ-IARVIQAAAACISSEESRRP 333
            LL    +    +      +A+ ++  +      + ++++  P
Sbjct: 299 RLL---RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (350), Expect = 2e-38
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 30/224 (13%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +F +  ++G G    VFK K  +   +  IKR+   ++++     RE+   + L H NIV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67

Query: 121 PLVGFCIDPEQG---------------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 165
              G     +                 LF+  ++   G+LE+ + +++        L   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKV 122

Query: 166 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 225
           +  ++   I + V Y+H    + +++RD+KPSNI L   K  K+ DFGL T         
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--- 176

Query: 226 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                KGT  Y++PE         + D+YA G++L ELL     
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  141 bits (356), Expect = 3e-38
 Identities = 50/225 (22%), Positives = 96/225 (42%), Gaps = 29/225 (12%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 117
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 118 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 115 SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 165

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  G   
Sbjct: 166 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVN 221

Query: 236 YLAPEYFQ-----------HGKVSDKTDVYAFGVVLLELLTGRKP 269
           Y+ PE  +             K+S K+DV++ G +L  +  G+ P
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  137 bits (348), Expect = 4e-38
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 25/224 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA---FCRELMIAS 112
           +F  G +LG+G  SF     V           VAIK +DK+    +        E+ I  
Sbjct: 12  DFKVGNLLGKG--SF---AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
            L HP+I+ L  +  D    ++L+ +    G + R+L  + K            R+ +  
Sbjct: 67  QLKHPSILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFS-----ENEARHFMH- 119

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            I   + YLH      ++HRD+  SN+LL+     K+ DFGLAT    P       T+ G
Sbjct: 120 QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCG 174

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
           T  Y++PE         ++DV++ G +   LL GR P +   ++
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  137 bits (347), Expect = 9e-38
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 35/233 (15%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
             +F +  VLG+GA   V K +  L     AIK++   +++ S     E+M+ +SL+H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-SEVMLLASLNHQY 63

Query: 119 IVPLVGFCIDPEQG------------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 166
           +V      ++                LF+  +Y   G+L   +H +    + +       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---------- 216
           +      I E+++Y+H    + ++HRD+KP NI +   +  K+ DFGLA           
Sbjct: 124 Q------ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 217 --WTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELLTG 266
               + P       +  GT  Y+A E     G  ++K D+Y+ G++  E++  
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (345), Expect = 1e-37
 Identities = 73/302 (24%), Positives = 121/302 (40%), Gaps = 50/302 (16%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNI 119
           +F   + LGRG    VF+ K  +   + AIKR+   ++E ++    RE+   + L HP I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 120 VPLVGFCID-----------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           V      ++           P+  L++  +     +L+  ++ +            SV  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC----TIEERERSVCL 121

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---------WTS 219
            + L IAE+V +LH    + ++HRD+KPSNI  +   + K+ DFGL T            
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 220 APSVPFLCKTVK-GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 278
            P   +   T + GT  Y++PE       S K D+++ G++L ELL    P         
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST----QM 231

Query: 279 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 338
           E +              V  L  P L   ++       ++Q     +S     RP    I
Sbjct: 232 ERVRTLTD---------VRNLKFPPLF--TQKYPCEYVMVQ---DMLSPSPMERPEAINI 277

Query: 339 IA 340
           I 
Sbjct: 278 IE 279

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  142 bits (360), Expect = 2e-37
 Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 24/237 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNI 119
            +     LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 120 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           V           + P     L  +Y  GG L ++L++ +        L       +   I
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDI 130

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 231
           + ++ YLH   E  ++HRD+KP NI+L       I K+ D G A          LC    
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFV 184

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 288
           GT  YLAPE  +  K +   D ++FG +  E +TG +P            V W   +
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-----PNWQPVQWHGKV 236

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  137 bits (346), Expect = 2e-37
 Identities = 60/233 (25%), Positives = 94/233 (40%), Gaps = 25/233 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPN 118
                 RVL  G  +FV++ +        A+KRL   ++E ++A  +E+     L  HPN
Sbjct: 28  LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87

Query: 119 IVPLVGFCI------DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           IV             D  Q  FL+   +  G L   L + +        L      K+  
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP----LSCDTVLKIFY 143

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK---- 228
               +V ++H   +  ++HRD+K  N+LLS++   KLCDFG AT  S             
Sbjct: 144 QTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 229 ------TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
                 T   T  Y  PE    + +  + +K D++A G +L  L   + P E 
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  135 bits (341), Expect = 4e-37
 Identities = 70/221 (31%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRT-----SVAIKRLDKEDKESSKA---FCRELMIAS 112
           +F  GR LG+G   F   G V L R       +A+K L K   E +       RE+ I S
Sbjct: 10  DFEIGRPLGKG--KF---GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
            L HPNI+ L G+  D  + ++LI +Y   G++ R L +  K                  
Sbjct: 65  HLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSK-------FDEQRTATYIT 116

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            +A +++Y H    + V+HRDIKP N+LL S    K+ DFG     S  +       + G
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCG 169

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           T  YL PE  +     +K D+++ GV+  E L G+ P EA 
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  135 bits (342), Expect = 8e-37
 Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 18/221 (8%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHH 116
             + +GR LG+G  +  F+      +   A K + K              E+ I  SL H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIA 175
            ++V   G   +    +F++ +     SL      +K        L     RY +   I 
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKA-------LTEPEARYYLR-QIV 151

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
               YLH      V+HRD+K  N+ L+     K+ DFGLAT           K + GT  
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPN 206

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
           Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (340), Expect = 1e-36
 Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 23/242 (9%)

Query: 31  RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 90
            + ++ E   SP  +     S+ +      +F +   LG G+   VFK +        A+
Sbjct: 33  FRGEASETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87

Query: 91  KRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 147
           KR        K+ ++             HP  V L     +    L+L  +   G SL++
Sbjct: 88  KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI-LYLQTEL-CGPSLQQ 145

Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
           H   +  G      LP +  +        ++A+LH    + +VH D+KP+NI L  +   
Sbjct: 146 HC--EAWGAS----LPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRC 196

Query: 208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
           KL DFGL             +  +G   Y+APE  Q G      DV++ G+ +LE+    
Sbjct: 197 KLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNM 252

Query: 268 KP 269
           + 
Sbjct: 253 EL 254

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  134 bits (339), Expect = 1e-36
 Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 18/220 (8%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHP 117
            + +GR LG+G  +  F+      +   A K + K              E+ I  SL H 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIAE 176
           ++V   G   +    +F++ +     SL      +K        L     RY +   I  
Sbjct: 76  HVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKA-------LTEPEARYYLR-QIVL 126

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
              YLH      V+HRD+K  N+ L+     K+ DFGLAT           K + GT  Y
Sbjct: 127 GCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNY 181

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
           +APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (338), Expect = 1e-36
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 19/212 (8%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVP 121
               +GRG+   V+KG        VA    +  K  K   + F  E  +   L HPNIV 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 122 LVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                    +G   + L+ + ++ G+L+ +L   K        +   V       I + +
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGL 142

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
            +LH      ++HRD+K  NI ++      K+ D GLAT   A       K V GT  ++
Sbjct: 143 QFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFM 197

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           APE ++     +  DVYAFG+ +LE+ T   P
Sbjct: 198 APEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  134 bits (340), Expect = 1e-36
 Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 24/224 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPN 118
           H +    +LG+GA + VF+G+        AIK  +            RE  +   L+H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 119 IVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           IV L     +   +   LI ++   GSL   L E          LP S    V   +   
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGG 124

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 233
           + +L    E  +VHR+IKP NI+    +      KL DFG A             ++ GT
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGT 178

Query: 234 FGYLAPEYFQHGKVSD--------KTDVYAFGVVLLELLTGRKP 269
             YL P+ ++   +            D+++ GV      TG  P
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  134 bits (340), Expect = 2e-36
 Identities = 51/232 (21%), Positives = 96/232 (41%), Gaps = 35/232 (15%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDKESSKAFC------------ 105
           ++   R L +G   F    K+ L        A+K+ +K   E  + F             
Sbjct: 32  DYRIIRTLNQG--KF---NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 106 -----RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVRGN 159
                 EL I + + +   +   G   + ++ +++IY+Y+   S+ +             
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 160 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 219
             +P  V   +   +  S +Y+HN  E+ + HRD+KPSNIL+      KL DFG + +  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
                   K  +GT+ ++ PE+F +    +  K D+++ G+ L  +     P
Sbjct: 204 DK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  132 bits (335), Expect = 3e-36
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 28/221 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA---FCRELMIAS 112
           +F  GR LG+G   F   G V L R       +A+K L K   E         RE+ I S
Sbjct: 15  DFDIGRPLGKG--KF---GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
            L HPNI+ +  +  D ++ ++L+ ++   G L + L +  +                  
Sbjct: 70  HLRHPNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGR-------FDEQRSATFME 121

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            +A+++ Y H   ER V+HRDIKP N+L+  K   K+ DFG     S  +     +T+ G
Sbjct: 122 ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRTMCG 174

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           T  YL PE  +     +K D++  GV+  E L G  P ++ 
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  132 bits (335), Expect = 2e-35
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 118
           +   G  +GRG    VF G++    T VA+K   +E    +    F +E  I     HPN
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPN 173

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L+G C   +Q ++++ + V GG     L  +         L      ++    A  +
Sbjct: 174 IVRLIGVCTQ-KQPIYIVMELVQGGDFLTFLRTEGA------RLRVKTLLQMVGDAAAGM 226

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---------TSAPSVPFLCKT 229
            YL     +C +HRD+   N L++ K + K+ DFG++                VP     
Sbjct: 227 EYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP----- 278

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           VK T    APE   +G+ S ++DV++FG++L E  + G  P
Sbjct: 279 VKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  134 bits (339), Expect = 3e-35
 Identities = 68/268 (25%), Positives = 109/268 (40%), Gaps = 27/268 (10%)

Query: 31  RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 90
           R+    +  +       I    G +   +  + + + LG GA   V   +  +     AI
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67

Query: 91  KRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERH 148
           K + K      S+     E+ +   L HPNI+ L  F  D ++  +L+ +   GG L   
Sbjct: 68  KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVMECYKGGELFDE 126

Query: 149 LHEKKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK- 205
           +  + K         ++      +   +   V YLH   +  +VHRD+KP N+LL SK+ 
Sbjct: 127 IIHRMK---------FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEK 174

Query: 206 --IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
             + K+ DFGL+            K   GT  Y+APE  +  K  +K DV++ GV+L  L
Sbjct: 175 DALIKIVDFGLSAVFE-NQKKM--KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230

Query: 264 LTGRKPIEARRLQGEENLVLWAKPILHR 291
           L G  P   +  Q     V   K     
Sbjct: 231 LAGYPPFGGQTDQEILRKVEKGKYTFDS 258

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  132 bits (334), Expect = 3e-35
 Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 24/224 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPN 118
           H +    +LG+GA + VF+G+        AIK  +            RE  +   L+H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 119 IVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           IV L     +   +   LI ++   GSL   L E          LP S    V   +   
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGG 124

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 233
           + +L    E  +VHR+IKP NI+    +      KL DFG A             ++ GT
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGT 178

Query: 234 FGYLAPEYFQHGKVSD--------KTDVYAFGVVLLELLTGRKP 269
             YL P+ ++   +            D+++ GV      TG  P
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  133 bits (337), Expect = 6e-35
 Identities = 68/265 (25%), Positives = 111/265 (41%), Gaps = 28/265 (10%)

Query: 35  SLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 94
           S+   +       ++ S       +  +   RVLG+G+   V   K  +     A+K + 
Sbjct: 4   SMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60

Query: 95  K---EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE 151
           K   + K   ++  RE+ +   L HPNI+ L  F  D     +L+ +  +GG L   +  
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIIS 119

Query: 152 KKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---I 206
           +K+         +S     ++   +   + Y+H   +  +VHRD+KP N+LL SK     
Sbjct: 120 RKR---------FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDAN 167

Query: 207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG 266
            ++ DFGL+T     S     K   GT  Y+APE    G   +K DV++ GV+L  LL+G
Sbjct: 168 IRIIDFGLSTHFE-ASKKM--KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

Query: 267 RKPIEARRLQGEENLVLWAKPILHR 291
             P            V   K     
Sbjct: 224 CPPFNGANEYDILKKVEKGKYTFEL 248

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  130 bits (329), Expect = 1e-34
 Identities = 40/365 (10%), Positives = 81/365 (22%), Gaps = 55/365 (15%)

Query: 17  ENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFV 76
             G C   A +     ++++  ++ P        S   +            L  G  S V
Sbjct: 21  LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVV 78

Query: 77  FKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPNIV------------- 120
           F  +        A+K      + S    +        A+ L   +               
Sbjct: 79  FLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138

Query: 121 -------PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
                  P        +         L+    S   LE                     +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELLFSTLDFVYVFRGDEGILALH 197

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
            +   +    A L     + +VH    P N+ +       L D                 
Sbjct: 198 ILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGP 249

Query: 229 TVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
                  Y   E+        +   + +  G+ +  +     P        +        
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG------- 302

Query: 287 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA---ILR 343
               R    V           +     +  +I      ++ +  RR    E +     L+
Sbjct: 303 -SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAMETPEFLQ 358

Query: 344 GEEEL 348
            + E+
Sbjct: 359 LQNEI 363

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  128 bits (323), Expect = 2e-34
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 13/209 (6%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 123
              VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G   +    + +  + V GGSL   L  K   ++ N      +       I E + YLH 
Sbjct: 86  GSFSENGF-IKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IG-FYTKQILEGLKYLH- 139

Query: 184 GTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 242
             +  +VHRDIK  N+L+++   + K+ DFG +   +  +     +T  GT  Y+APE  
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEII 195

Query: 243 QHGKV--SDKTDVYAFGVVLLELLTGRKP 269
             G        D+++ G  ++E+ TG+ P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  128 bits (325), Expect = 2e-34
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 37/226 (16%)

Query: 60  HNFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 113
             F K +VLG GA   V+KG    +   ++  VAIK L +E    +++K    E  + +S
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           + +P++  L+G C      + LI + +  G L  ++ E K  +     L W       + 
Sbjct: 74  VDNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---------TSAPSVP 224
           IA+ + YL    +R +VHRD+   N+L+ + +  K+ DFGLA                VP
Sbjct: 126 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                +K      A E   H   + ++DV+++GV + EL+T G KP
Sbjct: 183 -----IKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (325), Expect = 1e-33
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 29/221 (13%)

Query: 61  NFSKGRVLGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE--LMIASSLHHP 117
           +F    VLG GA  + V++G        VA+KR+  E    +    RE  L+  S   HP
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRILPECFSFAD---REVQLLRESD-EHP 78

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           N++       D  Q  ++  +     +L+ ++ +K     G   +       +       
Sbjct: 79  NVIRYFCTEKD-RQFQYIAIELC-AATLQEYVEQKDFAHLGLEPI------TLLQQTTSG 130

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKK-----IPKLCDFGLATWTSAPSVPFLC-KTVK 231
           +A+LH      +VHRD+KP NIL+S           + DFGL    +     F     V 
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 232 GTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           GT G++APE          +   D+++ G V   +++    
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  125 bits (316), Expect = 1e-33
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 26/210 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
            + +G+G    V  G        VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 26  LQTIGKGEFGDVMLGD--YRGNKVAVKCI-KND-ATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
             ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ YL   
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA----TWTSAPSVPFLCKTVKGTFGYLAPE 240
                VHRD+   N+L+S   + K+ DFGL     +      +P     VK T    APE
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWT----APE 184

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +  K S K+DV++FG++L E+ + GR P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  126 bits (318), Expect = 3e-33
 Identities = 59/243 (24%), Positives = 94/243 (38%), Gaps = 20/243 (8%)

Query: 31  RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 90
           R     E +   +    ++    E     H  +    +GRG+   V + K        A+
Sbjct: 29  RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88

Query: 91  KRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH 150
           K++  E          EL+  + L  P IVPL G   +    + +  + + GGSL + + 
Sbjct: 89  KKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPW-VNIFMELLEGGSLGQLI- 141

Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KL 209
            K+ G      LP            E + YLH    R ++H D+K  N+LLSS      L
Sbjct: 142 -KQMG-----CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAAL 192

Query: 210 CDFGLA---TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG 266
           CDFG A                 + GT  ++APE         K D+++   ++L +L G
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

Query: 267 RKP 269
             P
Sbjct: 253 CHP 255

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  123 bits (311), Expect = 7e-33
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 30/219 (13%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
              +  + +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 65

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L G C++ +  + L+ +++  G L  +L  +    RG       +     L + E +A
Sbjct: 66  VQLYGVCLE-QAPICLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGM--CLDVCEGMA 118

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVK 231
           YL    E CV+HRD+   N L+   ++ K+ DFG+         T ++    P     VK
Sbjct: 119 YL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VK 170

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                 +PE F   + S K+DV++FGV++ E+ + G+ P
Sbjct: 171 WA----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  127 bits (322), Expect = 9e-33
 Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 46/269 (17%)

Query: 45  NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------- 95
              +R   G+I     ++ K R LG GA   V   K     +  AIK + K         
Sbjct: 24  GMYVRKKEGKI---GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80

Query: 96  ----EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER--- 147
                 ++  +    E+ +  SL HPNI+ L     D ++  +L+ ++  GG L E+   
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED-KKYFYLVTEFYEGGELFEQIIN 139

Query: 148 --HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 205
                E                  +   I   + YLH   +  +VHRDIKP NILL +K 
Sbjct: 140 RHKFDECDAA-------------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKN 183

Query: 206 ---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 262
                K+ DFGL+++ S        +   GT  Y+APE  +  K ++K DV++ GV++  
Sbjct: 184 SLLNIKIVDFGLSSFFS-KDYKL--RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYI 239

Query: 263 LLTGRKPIEARRLQGEENLVLWAKPILHR 291
           LL G  P   +  Q     V   K     
Sbjct: 240 LLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  126 bits (319), Expect = 1e-32
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 26/210 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
            + +G+G    V  G        VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 198 LQTIGKGEFGDVMLGD--YRGNKVAVKCI-KND-ATAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
             ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ YL   
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYLE-- 306

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA----TWTSAPSVPFLCKTVKGTFGYLAPE 240
                VHRD+   N+L+S   + K+ DFGL     +      +P     VK T    APE
Sbjct: 307 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWT----APE 356

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +  K S K+DV++FG++L E+ + GR P
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  123 bits (312), Expect = 1e-32
 Identities = 73/300 (24%), Positives = 110/300 (36%), Gaps = 39/300 (13%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 115
            +      LG+G    V   +   L       VA+K+L     +  + F RE+ I  +LH
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 116 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
              IV   G    P  Q L L+ +Y+  G L   L   +  +  +  L +      +  I
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQI 136

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVP 224
            + + YL     R  VHRD+   NIL+ S+   K+ DFGLA                  P
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 283
                +       APE       S ++DV++FGVVL EL T   K               
Sbjct: 194 -----IFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244

Query: 284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
              P L R +  +EE    RL       A++  +++    C +     RP    +   L 
Sbjct: 245 RDVPALSRLLELLEE--GQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLD 299

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (312), Expect = 2e-32
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 15/212 (7%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 120
           F K   LG G    VFK         +A K +  E K +      REL +    + P IV
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
              G     +  + +  +++ GGSL++ L +          +P  +  KV++ + + + Y
Sbjct: 95  GFYG-AFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTY 146

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           L    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++PE
Sbjct: 147 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPE 200

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
             Q    S ++D+++ G+ L+E+  GR PI  
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  126 bits (318), Expect = 3e-32
 Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 32/244 (13%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHH 116
              ++   +LG+G+   V K K  + +   A+K ++K     + +    RE+ +   L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKV 170
           PNI+ L     D     +++ +  +GG L +         E                 ++
Sbjct: 81  PNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------------RI 126

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLC 227
              +   + Y+H   +  +VHRD+KP NILL SK+     K+ DFGL+T     +     
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKM-- 180

Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 287
           K   GT  Y+APE  + G   +K DV++ GV+L  LL+G  P   +        V   K 
Sbjct: 181 KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

Query: 288 ILHR 291
               
Sbjct: 240 AFDL 243

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  122 bits (309), Expect = 4e-32
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 61  NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 114
            F K +VLG GA   V+KG    +   ++  VAIK L +E    +++K    E  + +S+
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 74

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            +P++  L+G C      + LI + +  G L  ++ E K  +     L W       + I
Sbjct: 75  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQI 126

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---------TSAPSVPF 225
           A+ + YL    +R +VHRD+   N+L+ + +  K+ DFGLA                VP 
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP- 182

Query: 226 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               +K      A E   H   + ++DV+++GV + EL+T G KP
Sbjct: 183 ----IKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  121 bits (306), Expect = 4e-32
 Identities = 61/236 (25%), Positives = 91/236 (38%), Gaps = 30/236 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
              +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L  
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 125 FCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
              D    ++L+ +  +GG L ER        E                 ++   +  +V
Sbjct: 74  TFEDNTD-IYLVMELCTGGELFERVVHKRVFRESDAA-------------RIMKDVLSAV 119

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           AY H   +  V HRD+KP N L  +       KL DFGLA     P      +T  GT  
Sbjct: 120 AYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMM--RTKVGTPY 173

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR 291
           Y++P+  + G    + D ++ GV++  LL G  P  A         +         
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  125 bits (315), Expect = 6e-32
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 24/212 (11%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
              LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
            C   E   ++I ++++ G+L  +L E          +   V   +A  I+ ++ YL   
Sbjct: 284 VCTR-EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLE-- 335

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLA 238
            ++  +HR++   N L+    + K+ DFGL+      T+T+     F    +K T    A
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWT----A 387

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           PE   + K S K+DV+AFGV+L E+ T G  P
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  121 bits (305), Expect = 7e-32
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
            + +    LG G    V++G       +VA+K L KED    + F +E  +   + HPN+
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L+G C   E   ++I ++++ G+L  +L E          +   V   +A  I+ ++ 
Sbjct: 72  VQLLGVCTR-EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAME 125

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVK 231
           YL    ++  +HRD+   N L+    + K+ DFGL+        T  +    P     +K
Sbjct: 126 YL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-----IK 177

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            T    APE   + K S K+DV+AFGV+L E+ T G  P
Sbjct: 178 WT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  123 bits (310), Expect = 8e-32
 Identities = 30/241 (12%), Positives = 62/241 (25%), Gaps = 37/241 (15%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL---- 114
             +G VLG+       +        S  +      ++  S   K    E++    L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 115 ---------------------HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 153
                                    ++ +     D               +L+       
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 154 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 213
                + +L    R ++ L +   +A LH      +VH  ++P +I+L  +    L  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 214 LATWTSAPSVPFLCKTVKGTFGYLAPE-----YFQHGKVSDKTDVYAFGVVLLELLTGRK 268
                 A +V              A             ++   D +  G+ +  +     
Sbjct: 257 HLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 269 P 269
           P
Sbjct: 316 P 316

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  120 bits (304), Expect = 1e-31
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 18/213 (8%)

Query: 65  GRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 119
            RV+G+G    V+ G+           AIK L       +  +AF RE ++   L+HPN+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           + L+G  + PE    ++  Y+  G L + +       + N T+   + +   L +A  + 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISF--GLQVARGME 138

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF--GYL 237
           YL    E+  VHRD+   N +L      K+ DFGLA          + +         + 
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           A E  Q  + + K+DV++FGV+L ELLT G  P
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  121 bits (305), Expect = 2e-31
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)

Query: 60  HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 113
               K +VLG G    V KG        ++  V IK + ++   ++S +A    ++   S
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS 71

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L H +IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W       + 
Sbjct: 72  LDHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQ 123

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTSAPSVP 224
           IA+ + YL    E  +VHR++   N+LL S    ++ DFG+A            S    P
Sbjct: 124 IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                +K      A E    GK + ++DV+++GV + EL+T G +P
Sbjct: 181 -----IKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  119 bits (301), Expect = 2e-31
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 34/221 (15%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCRELMIASSLHHP 117
              +  + LG G    V  GK    +    VA+K + KE   S   F +E      L HP
Sbjct: 8   EEITLLKELGSGQFGVVKLGK---WKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHP 63

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +V   G C   E  ++++ +Y+S G L  +L    KG+         +       + E 
Sbjct: 64  KLVKFYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGKGL----EPSQLLEM--CYDVCEG 116

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKT 229
           +A+L        +HRD+   N L+      K+ DFG+           +     P     
Sbjct: 117 MAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP----- 168

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           VK +    APE F + K S K+DV+AFG+++ E+ + G+ P
Sbjct: 169 VKWS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  121 bits (304), Expect = 2e-31
 Identities = 58/255 (22%), Positives = 88/255 (34%), Gaps = 48/255 (18%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASS 113
              +     +G+G+   V        R   AIK ++K      + +  +    E+ +   
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           LHHPNI  L     D +  + L+ +   GG L   L+       G   +           
Sbjct: 85  LHHPNIARLYEVYEDEQY-ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 174 ---------------------------------IAESVAYLHNGTERCVVHRDIKPSNIL 200
                                            I  ++ YLH    + + HRDIKP N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFL 200

Query: 201 LSSKK--IPKLCDFGLATWTSA--PSVPFLCKTVKGTFGYLAPE--YFQHGKVSDKTDVY 254
            S+ K    KL DFGL+           +   T  GT  ++APE     +     K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 255 AFGVVLLELLTGRKP 269
           + GV+L  LL G  P
Sbjct: 261 SAGVLLHLLLMGAVP 275

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  119 bits (301), Expect = 3e-31
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)

Query: 61  NFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKEDKESS----KAFCRELMIASS 113
           +      LG G+   V +G+         SVA+K L K D  S       F RE+    S
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHS 77

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L H N++ L G  +     + ++ +    GSL   L + +    G+  L    RY  A+ 
Sbjct: 78  LDHRNLIRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQ 129

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSV 223
           +AE + YL     +  +HRD+   N+LL+++ + K+ DFGL                  V
Sbjct: 130 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           P             APE  +    S  +D + FGV L E+ T G++P
Sbjct: 187 P-----FAWC----APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  119 bits (301), Expect = 3e-31
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
            + +  + LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 81

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L G C   ++ +F+I +Y++ G L  +L E     R        +       + E++ 
Sbjct: 82  VQLYGVCTK-QRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEM--CKDVCEAME 134

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVK 231
           YL     +  +HRD+   N L++ + + K+ DFGL+        T +     P     V+
Sbjct: 135 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VR 186

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            +     PE   + K S K+D++AFGV++ E+ + G+ P
Sbjct: 187 WS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  119 bits (302), Expect = 3e-31
 Identities = 65/215 (30%), Positives = 87/215 (40%), Gaps = 32/215 (14%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
             VLG GA S VF  K  L     A+K + K       +   E+ +   + H NIV L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 125 FCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                    +L+ + VSGG L     ER    EK                 V   +  +V
Sbjct: 74  IYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDAS-------------LVIQQVLSAV 119

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
            YLH   E  +VHRD+KP N+L  +     KI  + DFGL+          +  T  GT 
Sbjct: 120 KYLH---ENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKMEQ----NGIMSTACGTP 171

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           GY+APE       S   D ++ GV+   LL G  P
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  121 bits (305), Expect = 3e-31
 Identities = 34/264 (12%), Positives = 68/264 (25%), Gaps = 48/264 (18%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--------------- 103
                +G VLG+       +        S  +      ++  S A               
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 104 -------------FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH 150
                        F     +        ++ +     D               +L+    
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 151 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 210
                   + +L    R ++ L +   +A LH+     +VH  ++P +I+L  +    L 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----------GKVSDKTDVYAFGVV 259
            F       A            + G+  PE                 ++   D +A G+V
Sbjct: 249 GFEHLVRDGARV------VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 260 LLELLTGRKPIEARRLQGEENLVL 283
           +  +     PI      G    + 
Sbjct: 303 IYWIWCADLPITKDAALGGSEWIF 326

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  119 bits (300), Expect = 4e-31
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 45/232 (19%)

Query: 61  NFSKGRVLGRGALSFVFKGK-------VGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 113
           +      LG+G  + +FKG          L  T V +K LDK  +  S++F     + S 
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L H ++V   G C+       L+ ++V  GSL+ +L +     +    + W +    A  
Sbjct: 69  LSHKHLVLNYGVCVC-GDENILVQEFVKFGSLDTYLKKN----KNCINILWKLEV--AKQ 121

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--------KLCDFGLATWTSAPSVPF 225
           +A ++ +L    E  ++H ++   NILL  ++          KL D G++          
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------- 168

Query: 226 LCKTVKGTFGY------LAPEYFQHGKV-SDKTDVYAFGVVLLELLT-GRKP 269
              TV            + PE  ++ K  +  TD ++FG  L E+ + G KP
Sbjct: 169 --ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (306), Expect = 5e-31
 Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 34/232 (14%)

Query: 62  FSKGRVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNI 119
               ++LG G+    VF+G        VA+KR+  +  + +     E+ +   S  HPN+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNV 71

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           +            L++  +     +L+  +  K                 +   IA  VA
Sbjct: 72  IRYYCSETTDRF-LYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIP-------------KLCDFGLAT--WTSAPSVP 224
           +LH      ++HRD+KP NIL+S+                  + DFGL     +   S  
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 225 FLCKTVKGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLELLTGRKP 269
                  GT G+ APE  +         +++   D+++ G V   +L+  K 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  122 bits (307), Expect = 5e-31
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
            + LG G    V+        T VA+K + K    S +AF  E  +  +L H  +V L  
Sbjct: 193 EKKLGAGQFGEVWMAT-YNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                ++ +++I ++++ GSL   L          S  P       +  IAE +A++   
Sbjct: 251 VVT--KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEGMAFI--- 300

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLA 238
            +R  +HRD++ +NIL+S+  + K+ DFGLA       +T+     F    +K T    A
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIKWT----A 353

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           PE    G  + K+DV++FG++L+E++T GR P
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  120 bits (303), Expect = 6e-31
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 22/215 (10%)

Query: 65  GRVLGRGALSFVFKGKV---GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIV 120
             V+GRG    V+ G +      +   A+K L    D      F  E +I     HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G C+  E    ++  Y+  G L   +  +      N T+   + +   L +A+ + +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGF--GLQVAKGMKF 207

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL--- 237
           L     +  VHRD+   N +L  K   K+ DFGLA                 T   L   
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD---SVHNKTGAKLPVK 261

Query: 238 --APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             A E  Q  K + K+DV++FGV+L EL+T G  P
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  118 bits (299), Expect = 6e-31
 Identities = 73/305 (23%), Positives = 112/305 (36%), Gaps = 50/305 (16%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKED--KESSKAFCRELMIASS 113
               + R LG G    V   +           VA+K L K +          +E+ I  +
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRN 79

Query: 114 LHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           L+H NIV   G C +    G+ LI +++  GSL+ +L + K  +     L +      A+
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AV 133

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPS 222
            I + + YL     R  VHRD+   N+L+ S+   K+ DFGL           T      
Sbjct: 134 QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENL 281
            P     V       APE     K    +DV++FGV L ELLT                L
Sbjct: 191 SP-----VFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFL 237

Query: 282 VLWAKPILHRGMAAVE--ELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEE 337
            +      H  M        L    RL C      ++ ++++    C   + S R   + 
Sbjct: 238 KMIGPT--HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMR---KCWEFQPSNRTSFQN 292

Query: 338 IIAIL 342
           +I   
Sbjct: 293 LIEGF 297

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  118 bits (297), Expect = 1e-30
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 34/221 (15%)

Query: 65  GRVLGRGALSFVFKGKV---GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIV 120
             V+GRG    V+ G +      +   A+K L    D      F  E +I     HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G C+  E    ++  Y+  G L   +  +      N T+   + +   L +A+ + Y
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGF--GLQVAKGMKY 143

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-----------TWTSAPSVPFLCKT 229
           L     +  VHRD+   N +L  K   K+ DFGLA              +   +P     
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP----- 195

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           VK      A E  Q  K + K+DV++FGV+L EL+T G  P
Sbjct: 196 VKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  119 bits (300), Expect = 1e-30
 Identities = 33/227 (14%), Positives = 71/227 (31%), Gaps = 22/227 (9%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASS 113
           +       +LG GA + V++   G L  +       +K     +        + +     
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
                 +      +    G  L+ +  S G+L   ++  K        +P  +    A+ 
Sbjct: 124 SMQHMFMKFYSAHLFQ-NGSVLVGELYSYGTLLNAINLYKN--TPEKVMPQGLVISFAMR 180

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-----------KLCDFGLATWTSAPS 222
           +   +  +H   +  ++H DIKP N +L +  +             L D G +       
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
              +      T G+   E   +   + + D +     +  +L G   
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  118 bits (299), Expect = 1e-30
 Identities = 70/223 (31%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 117
            + +G+G  +F    KV L R       VAIK +DK   +  S +   RE+ I   L+HP
Sbjct: 20  LKTIGKG--NF---AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 118 NIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           NIV L  V   I+ E+ L+LI +Y SGG +  +L    +       +           I 
Sbjct: 75  NIVKLFEV---IETEKTLYLIMEYASGGEVFDYLVAHGR-------MKEKEARSKFRQIV 124

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
            +V Y H    + +VHRD+K  N+LL +    K+ DFG +   +            G   
Sbjct: 125 SAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPP 178

Query: 236 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQ 276
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+
Sbjct: 179 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  119 bits (300), Expect = 1e-30
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 33/215 (15%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
              LGRGA S V++ K    +   A+K L K   +  K    E+ +   L HPNI+ L  
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKE 115

Query: 125 FCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
               P + + L+ + V+GG L     E+ +  E+                     I E+V
Sbjct: 116 IFETPTE-ISLVLELVTGGELFDRIVEKGYYSERDAA-------------DAVKQILEAV 161

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           AYLH   E  +VHRD+KP N+L ++      + K+ DFGL+       +    KTV GT 
Sbjct: 162 AYLH---ENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVL---MKTVCGTP 214

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           GY APE  +      + D+++ G++   LL G +P
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  117 bits (296), Expect = 1e-30
 Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 21/236 (8%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHP 117
              F   R LG GA   V   +         IK ++K+  +   +    E+ +  SL HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRY--KVALGI 174
           NI+ +     D    ++++ +   GG L ER +  + +G         S  Y  ++   +
Sbjct: 81  NIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKA------LSEGYVAELMKQM 133

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 231
             ++AY H    + VVH+D+KP NIL          K+ DFGLA                
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHS--TNAA 187

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 287
           GT  Y+APE F+   V+ K D+++ GVV+  LLTG  P     L+  +    + +P
Sbjct: 188 GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  117 bits (296), Expect = 1e-30
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 44/302 (14%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 115
            +    + LG+G    V   +   L+      VA+K+L    +E  + F RE+ I  SL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 116 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H NIV   G C     + L LI +Y+  GSL  +L + K+ +     L +         I
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQI 123

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVP 224
            + + YL     +  +HRD+   NIL+ ++   K+ DFGL                   P
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW 284
                +       APE     K S  +DV++FGVVL EL T  +  ++   +    +   
Sbjct: 181 -----IFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

Query: 285 AKPILHRGMAAVE--ELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
            +      M      ELL    RL        +I  ++     C ++  ++RP   ++  
Sbjct: 232 KQG----QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLAL 284

Query: 341 IL 342
            +
Sbjct: 285 RV 286

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  121 bits (305), Expect = 2e-30
 Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 30/214 (14%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
              LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  
Sbjct: 272 EVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                E+ ++++ +Y+S GSL   L            L       +A  IA  +AY+   
Sbjct: 330 VV--SEEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVE-- 380

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVKGTFGY 236
                VHRD++ +NIL+    + K+ DFGLA        T       P     +K T   
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-----IKWT--- 431

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            APE   +G+ + K+DV++FG++L EL T GR P
Sbjct: 432 -APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  120 bits (303), Expect = 2e-30
 Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 30/214 (14%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
              LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  
Sbjct: 189 EVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                E+ ++++ +Y+S GSL   L            L       +A  IA  +AY+   
Sbjct: 247 VV--SEEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVE-- 297

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVKGTFGY 236
                VHRD++ +NIL+    + K+ DFGLA        T       P     +K T   
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-----IKWT--- 348

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            APE   +G+ + K+DV++FG++L EL T GR P
Sbjct: 349 -APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  118 bits (297), Expect = 2e-30
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 44/302 (14%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 115
            +    + LG+G    V   +   L+      VA+K+L    +E  + F RE+ I  SL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 116 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           H NIV   G C     + L LI +Y+  GSL  +L + K+ +     L +         I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQI 154

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVP 224
            + + YL     +  +HRD+   NIL+ ++   K+ DFGL                   P
Sbjct: 155 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 225 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW 284
                +       APE     K S  +DV++FGVVL EL T  +  ++   +    +   
Sbjct: 212 -----IFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262

Query: 285 AKPILHRGMAAVE--ELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
            +      M      ELL    RL        +I  ++     C ++  ++RP   ++  
Sbjct: 263 KQG----QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLAL 315

Query: 341 IL 342
            +
Sbjct: 316 RV 317

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  117 bits (295), Expect = 2e-30
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 36/221 (16%)

Query: 64  KGRVLGRGALSFVFKG--KVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNI 119
           + + LG G    V KG  ++  +  +VA+K L  +  D         E  +   L +P I
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V ++G C    +   L+ +    G L ++L       + N  +      ++   ++  + 
Sbjct: 81  VRMIGICE--AESWMLVMEMAELGPLNKYL-------QQNRHVKDKNIIELVHQVSMGMK 131

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVPFLCKT 229
           YL    E   VHRD+   N+LL ++   K+ DFGL+             +    P     
Sbjct: 132 YL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP----- 183

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           VK      APE   + K S K+DV++FGV++ E  + G+KP
Sbjct: 184 VKWY----APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  116 bits (294), Expect = 2e-30
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
              LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  
Sbjct: 18  VERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                ++ +++I +Y+  GSL   L            L  +    +A  IAE +A++   
Sbjct: 76  VVT--QEPIYIITEYMENGSLVDFLKT-----PSGIKLTINKLLDMAAQIAEGMAFI--- 125

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLA 238
            ER  +HRD++ +NIL+S     K+ DFGLA       +T+     F    +K T    A
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---PIKWT----A 178

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           PE   +G  + K+DV++FG++L E++T GR P
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  118 bits (297), Expect = 3e-30
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 23/216 (10%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-----EDKESSKAFCRELMIASSLHHPNI 119
             V+G+G  S V +          A+K +D          S++   RE  I   L HP+I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRY--KVALGIAE 176
           V L+      +  L+++++++ G  L    +       R ++   +S          I E
Sbjct: 89  VELLETYSS-DGMLYMVFEFMDGADLCFEIVK------RADAGFVYSEAVASHYMRQILE 141

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGT 233
           ++ Y H   +  ++HRD+KP  +LL+SK+     KL  FG+A       +        GT
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             ++APE  +        DV+  GV+L  LL+G  P
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  116 bits (292), Expect = 4e-30
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 32/234 (13%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 122
             +LG+G+   V K K  + +   A+K ++K     + +    RE+ +   L HPNI+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 123 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
                D     +++ +  +GG L       +   E                 ++   +  
Sbjct: 87  FEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAA-------------RIIKQVFS 132

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGT 233
            + Y+H   +  +VHRD+KP NILL SK+     K+ DFGL+T     +     K   GT
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKM--KDRIGT 186

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 287
             Y+APE  + G   +K DV++ GV+L  LL+G  P   +        V   K 
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  118 bits (299), Expect = 5e-30
 Identities = 64/216 (29%), Positives = 88/216 (40%), Gaps = 30/216 (13%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 122
              LG+GA S V +    L     A   ++ +       +   RE  I   L HPNIV L
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 123 VGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
                +     +LI+  V+GG L E      +  E                      I E
Sbjct: 76  HDSISEEGH-HYLIFDLVTGGELFEDIVAREYYSEADAS-------------HCIQQILE 121

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGT 233
           +V + H   +  VVHR++KP N+LL+SK      KL DFGLA         +      GT
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGT 176

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            GYL+PE  +        D++A GV+L  LL G  P
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  115 bits (291), Expect = 6e-30
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 35/224 (15%)

Query: 60  HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 114
            +    R+LG G    V++G        + +VA+K   K+D   ++ + F  E +I  +L
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNL 70

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HP+IV L+G     E+  ++I +    G L  +L       + +  +   V Y  +L I
Sbjct: 71  DHPHIVKLIGIIE--EEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLY--SLQI 122

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFL 226
            +++AYL        VHRDI   NIL++S +  KL DFGL+           S   +P  
Sbjct: 123 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-- 177

Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +K      +PE     + +  +DV+ F V + E+L+ G++P
Sbjct: 178 ---IKWM----SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  116 bits (293), Expect = 6e-30
 Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 27/222 (12%)

Query: 65  GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPN 118
           GR+LG+G    V + ++         VA+K L K D  +S   + F RE        HP+
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPH 86

Query: 119 IVPLVGFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           +  LVG  +            +I  ++  G L   L   + G    + LP     +  + 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN-LPLQTLVRFMVD 145

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           IA  + YL   + R  +HRD+   N +L+      + DFGL+    +          +G 
Sbjct: 146 IACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY-----YRQGC 197

Query: 234 FGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              L     A E       +  +DV+AFGV + E++T G+ P
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (291), Expect = 7e-30
 Identities = 55/232 (23%), Positives = 86/232 (37%), Gaps = 36/232 (15%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSL-HHP 117
            F +   +G G    VFK    L     AIKR  K    S   +   RE+   + L  H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           ++V       + +  + +  +Y +GGSL   + E     R  S    +    + L +   
Sbjct: 72  HVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENY---RIMSYFKEAELKDLLLQVGRG 127

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIP-------------------KLCDFGLATWT 218
           + Y+H      +VH DIKPSNI +S   IP                   K+ D G  T  
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 269
           S+P      +  +G   +LA E  Q       K D++A  + ++        
Sbjct: 185 SSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  115 bits (290), Expect = 1e-29
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 118
           G  LG G  + V K +        A K + K          S +   RE+ I   + HPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVAL 172
           I+ L     +    + LI + VSGG L +       L E +               +   
Sbjct: 70  IITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEAT-------------QFLK 115

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCK 228
            I + V YLH    + + H D+KP NI+L  K +P    KL DFG+A         F  K
Sbjct: 116 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF--K 169

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            + GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  114 bits (288), Expect = 2e-29
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 36/217 (16%)

Query: 68  LGRGALSFVFKG--KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLV 123
           LG G    V +G  ++   +  VAIK L K+   K  ++   RE  I   L +P IV L+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
           G C    + L L+ +   GG L + L  K++       +P S   ++   ++  + YL  
Sbjct: 77  GVCQ--AEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYL-- 126

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVPFLCKTVKGT 233
             E+  VHRD+   N+LL ++   K+ DFGL+          T  SA   P     +K  
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP-----LKWY 180

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
               APE     K S ++DV+++GV + E L+ G+KP
Sbjct: 181 ----APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  114 bits (288), Expect = 2e-29
 Identities = 68/226 (30%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 59  THNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIAS 112
           +  FS        LG+GA S V +          A K ++ +       +   RE  I  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSV 166
            L HPNIV L     +     +L++  V+GG L      R    E               
Sbjct: 61  KLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADAS----------- 108

Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSV 223
                  I ES+AY H      +VHR++KP N+LL+SK      KL DFGLA   +  S 
Sbjct: 109 --HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 162

Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            +      GT GYL+PE  +    S   D++A GV+L  LL G  P
Sbjct: 163 AW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  115 bits (290), Expect = 2e-29
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 26/221 (11%)

Query: 65  GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHPN 118
           G++LG G    V +G +         VA+K + K D  S +    F  E        HPN
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 119 IVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           ++ L+G CI+          +I  ++  G L  +L   +        +P     K  + I
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH-IPLQTLLKFMVDI 156

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A  + YL   + R  +HRD+   N +L       + DFGL+    +          +G  
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY-----YRQGRI 208

Query: 235 GYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +     A E       + K+DV+AFGV + E+ T G  P
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  115 bits (290), Expect = 2e-29
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 63  SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVP 121
            K + LG G+ S   K        + A+K + K  + +++   +E+        HPNIV 
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVK 70

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIA 175
           L     D     FL+ + ++GG L   + +KK              +       +   + 
Sbjct: 71  LHEVFHDQLH-TFLVMELLNGGELFERIKKKKH-------------FSETEASYIMRKLV 116

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 232
            +V+++H   +  VVHRD+KP N+L + +      K+ DFG A      + P   KT   
Sbjct: 117 SAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCF 171

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           T  Y APE        +  D+++ GV+L  +L+G+ P
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  116 bits (293), Expect = 2e-29
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 41/225 (18%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLHH 116
            + LG GA   V           VAI+ + K         + + +     E+ I   L+H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKV 170
           P I+ +  F    +   +++ + + GG L ++      L E                   
Sbjct: 200 PCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCK-------------LY 244

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLC 227
              +  +V YLH   E  ++HRD+KP N+LLSS++     K+ DFG +      S+    
Sbjct: 245 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--- 298

Query: 228 KTVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +T+ GT  YLAPE          +   D ++ GV+L   L+G  P
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  113 bits (286), Expect = 3e-29
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 23/218 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 114
                GR +G G    V +G          +VAIK   K        + F +E +     
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQF 73

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HP+IV L+G     E  +++I +  + G L   L  +    + +  L   + Y  A  +
Sbjct: 74  DHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR----KYSLDLASLILY--AYQL 125

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           + ++AYL     +  VHRDI   N+L+SS    KL DFGL+ +    +     K  KG  
Sbjct: 126 STALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKL 179

Query: 235 --GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              ++APE     + +  +DV+ FGV + E+L  G KP
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  114 bits (288), Expect = 4e-29
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPL 122
              LGRG    V +      + +   K +     D+   K   +E+ I +   H NI+ L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHL 66

Query: 123 VGFCIDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
                  E+ L +I++++SG  +          L+E++                    + 
Sbjct: 67  HESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIV-------------SYVHQVC 112

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGT 233
           E++ +LH      + H DI+P NI+  +++    K+ +FG A     P   F  + +   
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF--RLLFTA 166

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             Y APE  QH  VS  TD+++ G ++  LL+G  P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  118 bits (296), Expect = 4e-29
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 29/217 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +     LG GA   V +        + A K +    +   +   +E+   S L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSL-ER------HLHEKKKGVRGNSTLPWSVRYKVALGI 174
           L     D  + + +IY+++SGG L E+       + E +           +V Y     +
Sbjct: 219 LHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDE-----------AVEY--MRQV 264

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKG 232
            + + ++H   E   VH D+KP NI+ ++K+    KL DFGL      P      K   G
Sbjct: 265 CKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSV--KVTTG 318

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           T  + APE  +   V   TD+++ GV+   LL+G  P
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  113 bits (286), Expect = 4e-29
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE----DKESSKAFCRELMIASSLH 115
           G +LG G  S+   GKV  +         A+K L K+             +E+ +   L 
Sbjct: 10  GDLLGEG--SY---GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64

Query: 116 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE--RHLHEKKKGVRGNSTLPWSVRYKVAL 172
           H N++ LV    +  +Q ++++ +Y   G  E    + EK+                 A 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR------------FPVCQAH 112

Query: 173 G----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
           G    + + + YLH+   + +VH+DIKP N+LL++    K+   G+A      +    C+
Sbjct: 113 GYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169

Query: 229 TVKGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
           T +G+  +  PE           K D+++ GV L  + TG  P
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (290), Expect = 5e-29
 Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 29/220 (13%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
              +     LG GA   V +            K ++            E+ I + LHHP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSL-ER------HLHEKKKGVRGNSTLPWSVRYKVA 171
           ++ L     D  + + LI +++SGG L +R       + E +                  
Sbjct: 110 LINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVI-------------NYM 155

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKT 229
               E + ++H   E  +VH DIKP NI+  +KK    K+ DFGLAT  + P      K 
Sbjct: 156 RQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIV--KV 209

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
              T  + APE      V   TD++A GV+   LL+G  P
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  114 bits (287), Expect = 6e-29
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 27/222 (12%)

Query: 60  HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 113
              ++ +V+G G    V+KG      G     VAIK L K    ++    F  E  I   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 102

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
             H NI+ L G      + + +I +Y+  G+L++ L EK     G  ++   V      G
Sbjct: 103 FSHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGM--LRG 155

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT---- 229
           IA  + YL        VHRD+   NIL++S  + K+ DFGL+             +    
Sbjct: 156 IAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212

Query: 230 -VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            ++ T    APE   + K +  +DV++FG+V+ E++T G +P
Sbjct: 213 PIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  114 bits (288), Expect = 6e-29
 Identities = 63/221 (28%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 118
           G  LG G  + V K +        A K + K            +   RE+ I   + HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           I+ L     +    + LI + VSGG L      +  L E++                   
Sbjct: 77  IITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEAT-------------SFIK 122

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCK 228
            I + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--K 176

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            + GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (286), Expect = 7e-29
 Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 40/231 (17%)

Query: 59  THNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCREL 108
             N       G  LG G  + V K +        A K + K          S +   RE+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTL 162
            I   + HPN++ L     +    + LI + V+GG L      +  L E++         
Sbjct: 66  SILKEIQHPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEAT------- 117

Query: 163 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWT 218
                 +    I   V YLH      + H D+KP NI+L  + +P    K+ DFGLA   
Sbjct: 118 ------EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168

Query: 219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                 F  K + GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 169 D-FGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (284), Expect = 1e-28
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 26/216 (12%)

Query: 65  GRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 119
            +++G G    V  G+    G     VAIK L K    +   + F  E  I     HPNI
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           + L G      +   ++ +Y+  GSL+  L        G  T+   V      G+   + 
Sbjct: 113 IRLEGVVTR-GRLAMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGM--LRGVGAGMR 165

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-----VKGTF 234
           YL   ++   VHRD+   N+L+ S  + K+ DFGL+             T     ++ T 
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT- 221

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              APE       S  +DV++FGVV+ E+L  G +P
Sbjct: 222 ---APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (284), Expect = 1e-28
 Identities = 79/305 (25%), Positives = 119/305 (39%), Gaps = 50/305 (16%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKED--KESSKAFCRELMIASS 113
               K R LG G    V               VA+K L K D   +    + +E+ I  +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRT 89

Query: 114 LHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           L+H +I+   G C D     L L+ +YV  GSL  +L            +  +     A 
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--------IGLAQLLLFAQ 141

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            I E +AYLH    +  +HRD+   N+LL + ++ K+ DFGLA            K V  
Sbjct: 142 QICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLA------------KAVPE 186

Query: 233 TFGY-------------LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 278
              Y              APE  +  K    +DV++FGV L ELLT             E
Sbjct: 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

Query: 279 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 338
              +   +  + R    +E     RL    +  A++  +++    C  +E S RP  E +
Sbjct: 247 LIGIAQGQMTVLRLTELLER--GERLPRPDKCPAEVYHLMK---NCWETEASFRPTFENL 301

Query: 339 IAILR 343
           I IL+
Sbjct: 302 IPILK 306

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (286), Expect = 1e-28
 Identities = 69/230 (30%), Positives = 96/230 (41%), Gaps = 35/230 (15%)

Query: 55  ILAATHNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCREL 108
           ++ A+  FS        LG+GA S V +          A K ++ +       +   RE 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTL 162
            I   L HPNIV L     +     +L++  V+GG L      R    E           
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADAS------- 131

Query: 163 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTS 219
                      I ES+AY H      +VHR++KP N+LL+SK      KL DFGLA   +
Sbjct: 132 ------HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             S  +      GT GYL+PE  +    S   D++A GV+L  LL G  P
Sbjct: 183 -DSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  116 bits (292), Expect = 1e-28
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 36/218 (16%)

Query: 67  VLGRGALSFVFKG--KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 122
            LG G    V +G  ++   +  VAIK L K+   K  ++   RE  I   L +P IV L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 182
           +G C    + L L+ +   GG L + L  K++       +P S   ++   ++  + YL 
Sbjct: 402 IGVCQ--AEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYL- 452

Query: 183 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVPFLCKTVKG 232
              E+  VHR++   N+LL ++   K+ DFGL+          T  SA   P     +K 
Sbjct: 453 --EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP-----LKW 505

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                APE     K S ++DV+++GV + E L+ G+KP
Sbjct: 506 Y----APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  112 bits (283), Expect = 2e-28
 Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 118
           G  LG G  + V K +        A K + K          S +   RE+ I   + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           ++ L     +    + LI + VSGG L      +  L E++                   
Sbjct: 77  VITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEAT-------------SFIK 122

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCK 228
            I + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--K 176

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            + GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  112 bits (283), Expect = 2e-28
 Identities = 51/221 (23%), Positives = 86/221 (38%), Gaps = 36/221 (16%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIK-----RLDKEDKESSKAFCRELMIASSL-HHP 117
             + LGRG  + V +          A K     R  ++ +        E+ +       P
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL---HEIAVLELAKSCP 89

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVA 171
            ++ L     +  + + LI +Y +GG +      +                      ++ 
Sbjct: 90  RVINLHEVYENTSE-IILILEYAAGGEIFSLCLPELAE-----------MVSENDVIRLI 137

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCK 228
             I E V YLH   +  +VH D+KP NILLSS       K+ DFG++      +     +
Sbjct: 138 KQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACEL--R 191

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            + GT  YLAPE   +  ++  TD++  G++   LLT   P
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  113 bits (285), Expect = 2e-28
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 65  GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 119
            +V+G G    V  G++        SVAIK L K    ++  + F  E  I     HPNI
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           + L G      + + ++ +Y+  GSL+  L +         T+   V      GIA  + 
Sbjct: 109 IRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGM--LRGIASGMK 161

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVPFLCKT 229
           YL   ++   VHRD+   NIL++S  + K+ DFGL             T    +P     
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP----- 213

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           ++ T    +PE   + K +  +DV+++G+VL E+++ G +P
Sbjct: 214 IRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  113 bits (285), Expect = 2e-28
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 30/238 (12%)

Query: 41  SPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES 100
           +P  + ++    G +  + +  SK  +LG G    V K +       +A K +     + 
Sbjct: 71  APFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 101 SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGN 159
            +    E+ + + L H N++ L          + L+ +YV GG L +R + E        
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKND-IVLVMEYVDGGELFDRIIDES------- 181

Query: 160 STLPWSVRY--KVALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCD 211
                         +     I E + ++H   +  ++H D+KP NIL  ++     K+ D
Sbjct: 182 ------YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIID 232

Query: 212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           FGLA     P      K   GT  +LAPE   +  VS  TD+++ GV+   LL+G  P
Sbjct: 233 FGLARRYK-PREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  115 bits (290), Expect = 3e-28
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 35/224 (15%)

Query: 60  HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 114
                GR +G G    V +G          +VAIK   K        + F +E +     
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQF 448

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HP+IV L+G     E  +++I +  + G L   L  +    + +  L   + Y  A  +
Sbjct: 449 DHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR----KFSLDLASLILY--AYQL 500

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFL 226
           + ++AYL     +  VHRDI   N+L+SS    KL DFGL+           S   +P  
Sbjct: 501 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-- 555

Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +K      APE     + +  +DV+ FGV + E+L  G KP
Sbjct: 556 ---IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  112 bits (281), Expect = 5e-28
 Identities = 62/220 (28%), Positives = 90/220 (40%), Gaps = 42/220 (19%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
            + +G G  +F   G   L+R       VA+K +++          RE++   SL HPNI
Sbjct: 25  VKDIGSG--NF---GVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNI 78

Query: 120 VPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG---- 173
           V    V   I     L +I +Y SGG L   +    +                A      
Sbjct: 79  VRFKEV---ILTPTHLAIIMEYASGGELYERICNAGR-----------FSEDEARFFFQQ 124

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVK 231
           +   V+Y H+     + HRD+K  N LL     P  K+CDFG +  +   S P   K+  
Sbjct: 125 LLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTV 178

Query: 232 GTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
           GT  Y+APE     +  D    DV++ GV L  +L G  P
Sbjct: 179 GTPAYIAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (276), Expect = 6e-28
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 118
            + LG G  ++   G+V L        +VA+K +D +          +E+ I   L+H N
Sbjct: 12  VQTLGEG--AY---GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +V   G         +L  +Y SGG L   +            +P     +    +   V
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGV 118

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 239 PEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
           PE  +  +       DV++ G+VL  +L G  P
Sbjct: 176 PELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (279), Expect = 8e-28
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 39/230 (16%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESS--KAFCRELMIASSL-HH 116
           G+ LG GA   V +     L        VA+K L K    +   +A   EL I S L  H
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQH 109

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY-------K 169
            NIV L+G C      + +I +Y   G L   L  K + +  +     +           
Sbjct: 110 ENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTSA 220
            +  +A+ +A+L     +  +HRD+   N+LL++  + K+ DFGLA              
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 221 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             +P     VK      APE       + ++DV+++G++L E+ + G  P
Sbjct: 226 ARLP-----VKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  110 bits (278), Expect = 9e-28
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 26/221 (11%)

Query: 65  GRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 117
            R LG+G+   V++G    +      T VAIK +  E         F  E  +    +  
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCH 88

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY---KVALGI 174
           ++V L+G      Q   +I + ++ G L+ +L   +  +  N  L         ++A  I
Sbjct: 89  HVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
           A+ +AYL+       VHRD+   N +++     K+ DFG+                KG  
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-----YRKGGK 199

Query: 235 GYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           G L     +PE  + G  +  +DV++FGVVL E+ T   +P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  110 bits (278), Expect = 1e-27
 Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 34/216 (15%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 123
              +G G+ S   +          A+K +DK  K        E+ I      HPNI+ L 
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPT---EEIEILLRYGQHPNIITLK 82

Query: 124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAES 177
               D  + ++++ + + GG L   +  +K              +       V   I ++
Sbjct: 83  DVYDD-GKYVYVVTELMKGGELLDKILRQKF-------------FSEREASAVLFTITKT 128

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 233
           V YLH    + VVHRD+KPSNIL   +       ++CDFG A    A +      T   T
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYT 183

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             ++APE  +        D+++ GV+L  +LTG  P
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  110 bits (277), Expect = 1e-27
 Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 26/221 (11%)

Query: 65  GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 117
            R LG GA   V++G+V           VA+K L  E   ++    F  E +I S  +H 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQ 93

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NIV  +G  +      F++ + ++GG L+  L E +      S+L       VA  IA  
Sbjct: 94  NIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
             YL    E   +HRDI   N LL+     ++ K+ DFG+A      S        KG  
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-----YRKGGC 204

Query: 235 GYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             L      PE F  G  + KTD ++FGV+L E+ + G  P
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  111 bits (279), Expect = 1e-27
 Identities = 66/221 (29%), Positives = 97/221 (43%), Gaps = 26/221 (11%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKED--KESSKAFCRELMIASSLHHP 117
            R LG GA   V++G+V  +        VA+K L  E   ++    F  E +I S  +H 
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQ 134

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NIV  +G  +      F++ + ++GG L+  L E +      S+L       VA  IA  
Sbjct: 135 NIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
             YL    E   +HRDI   N LL+     ++ K+ DFG+A               KG  
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-----YRKGGC 245

Query: 235 GYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
             L      PE F  G  + KTD ++FGV+L E+ + G  P
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  110 bits (277), Expect = 1e-27
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 118
            + LG G  ++   G+V L        +VA+K +D +          +E+ I   L+H N
Sbjct: 12  VQTLGEG--AY---GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +V   G         +L  +Y SGG L   +            +P     +    +   V
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGV 118

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 239 PEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
           PE  +  +       DV++ G+VL  +L G  P
Sbjct: 176 PELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  109 bits (275), Expect = 2e-27
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 41/225 (18%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLHH 116
            + LG GA   V           VAIK + K         + + +     E+ I   L+H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKV 170
           P I+ +  F    +   +++ + + GG L ++      L E                   
Sbjct: 75  PCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCK-------------LY 119

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLC 227
              +  +V YLH   E  ++HRD+KP N+LLSS++     K+ DFG +      S+    
Sbjct: 120 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---M 173

Query: 228 KTVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           +T+ GT  YLAPE          +   D ++ GV+L   L+G  P
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  109 bits (274), Expect = 2e-27
 Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 46/238 (19%)

Query: 58  ATHNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---------EDKESSKAF 104
           +TH F +      +LGRG  S V +          A+K +D          E +E  +A 
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 105 CRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVR 157
            +E+ I   +  HPNI+ L           FL++  +  G L     E+  L EK+    
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127

Query: 158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 217
                      K+   + E +  LH   +  +VHRD+KP NILL      KL DFG +  
Sbjct: 128 -----------KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT------DVYAFGVVLLELLTGRKP 269
                     + V GT  YLAPE  +     +        D+++ GV++  LL G  P
Sbjct: 174 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  109 bits (274), Expect = 2e-27
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 30/220 (13%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 112
           +F  G++LG G  SF     V L R   TS   AIK L+K     +       RE  + S
Sbjct: 31  DFKFGKILGEG--SF---STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
            L HP  V L     D E+ L+    Y   G L +++  +K G    +      R+  A 
Sbjct: 86  RLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYI--RKIGSFDETC----TRFYTA- 137

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            I  ++ YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 233 TFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           T  Y++PE        K S   D++A G ++ +L+ G  P
Sbjct: 195 TAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGLPP 231

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  108 bits (273), Expect = 2e-27
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 40/231 (17%)

Query: 65  GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 117
              LG      V+KG +     G    +VAIK L K+       + F  E M+ + L HP
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHP 72

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---------Y 168
           N+V L+G     +Q L +I+ Y S G L   L  +       ST                
Sbjct: 73  NVVCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTS 219
            +   IA  + YL   +   VVH+D+   N+L+  K   K+ D GL              
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
              +P     ++      APE   +GK S  +D++++GVVL E+ + G +P
Sbjct: 189 NSLLP-----IRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  109 bits (274), Expect = 2e-27
 Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 40/237 (16%)

Query: 60  HNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIAS 112
                G+ LGRGA   V +             +VA+K L KE       +A   EL I  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILI 85

Query: 113 SL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV- 170
            + HH N+V L+G C  P   L +I ++   G+L  +L  K+         P  +     
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 171 --------ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------- 215
                   +  +A+ + +L     R  +HRD+   NILLS K + K+CDFGLA       
Sbjct: 146 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

Query: 216 --TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                    +P     +K      APE       + ++DV++FGV+L E+ + G  P
Sbjct: 203 DYVRKGDARLP-----LKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (277), Expect = 2e-27
 Identities = 51/221 (23%), Positives = 81/221 (36%), Gaps = 24/221 (10%)

Query: 62  FSKGRVLGRGALSF--VFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 117
           +    V+G+G      V   +       V ++R  L+    E       EL ++   +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 118 NIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           NIVP    F  D E  L+++  +++ GS  + L         N      +   V   +  
Sbjct: 87  NIVPYRATFIADNE--LWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD- 142

Query: 177 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA-----PSVPFLCKTV 230
              Y+H  G     VHR +K S+IL+S      L          +       V    K  
Sbjct: 143 ---YIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 231 KGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKP 269
                +L+PE  Q        K+D+Y+ G+   EL  G  P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  109 bits (275), Expect = 3e-27
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 36/216 (16%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLVGF 125
           VLG G    V +          A+K L       S    +E+     +   P+IV ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90

Query: 126 CIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAE 176
             +   G   L +I + + GG L   + E+               +      ++   I  
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERG-----------DQAFTEREAAEIMRDIGT 139

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           ++ +LH      + HRD+KP N+L +SK+   + KL DFG A  T+  ++    +T   T
Sbjct: 140 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYT 192

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             Y+APE     K     D+++ GV++  LL G  P
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  108 bits (272), Expect = 4e-27
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 37/229 (16%)

Query: 65  GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 118
            R LG GA   VF  +         +  VA+K L K+   +++  F RE  + ++L H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEH 78

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--------- 169
           IV   G C D    L ++++Y+  G L + L                             
Sbjct: 79  IVKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFL 226
           +A  IA  + YL     +  VHRD+   N L+ +  + K+ DFG++     T        
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY------ 188

Query: 227 CKTVKGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                G    L      PE   + K + ++DV++FGV+L E+ T G++P
Sbjct: 189 --YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  108 bits (272), Expect = 6e-27
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 33/225 (14%)

Query: 65  GRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKED--KESSKAFCRELMIASSL-HHPNI 119
             V+G G    V K ++    LR   AIKR+ KE   K+  + F  EL +   L HHPNI
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR---------GNSTLPWSVRYKV 170
           + L+G C      L+L  +Y   G+L   L + +               STL        
Sbjct: 89  INLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
           A  +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              V
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YV 196

Query: 231 KGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           K T G L     A E   +   +  +DV+++GV+L E+++ G  P
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  108 bits (272), Expect = 6e-27
 Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 30/225 (13%)

Query: 65  GRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 118
              LG GA   VF  +   LL       VA+K L KE  ES++  F RE  + + L H +
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQH 104

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--------YKV 170
           IV   G C +  + L ++++Y+  G L R L       +  +                 V
Sbjct: 105 IVRFFGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
           A  +A  + YL        VHRD+   N L+    + K+ DFG++    +          
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-----YR 215

Query: 231 KGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            G    L      PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  107 bits (270), Expect = 7e-27
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 22/215 (10%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVG 124
            LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                   +++  + +   SL++     K+ +    T+P  +  K+A+ I +++ +LH+ 
Sbjct: 74  ALFREGD-VWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHS- 127

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYLAPE- 240
            +  V+HRD+KPSN+L+++    K+CDFG++       A           G   Y+APE 
Sbjct: 128 -KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA------KDIDAGCKPYMAPER 180

Query: 241 ---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 272
                     S K+D+++ G+ ++EL   R P ++
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  109 bits (273), Expect = 1e-26
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 35/218 (16%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLV 123
            +VLG G    V +      +   A+K L    K       RE+ +       P+IV +V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPHIVRIV 121

Query: 124 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGI 174
               +   G   L ++ + + GG L   + ++               +      ++   I
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-----------DQAFTEREASEIMKSI 170

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 231
            E++ YLH      + HRD+KP N+L +SK+   I KL DFG A  T+         T  
Sbjct: 171 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSL--TTPC 224

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            T  Y+APE     K     D+++ GV++  LL G  P
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (270), Expect = 2e-26
 Identities = 67/272 (24%), Positives = 106/272 (38%), Gaps = 45/272 (16%)

Query: 23  SRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSK----GRVLGRGALSFVFK 78
           +   E K       + + +    S+         AA   F +      V+GRG  S V +
Sbjct: 53  NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112

Query: 79  GKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP 129
                     A+K ++         + +E  +A  RE  I   +  HP+I+ L+      
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172

Query: 130 EQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 183
              +FL++  +  G L     E+  L EK+                +   + E+V++LH 
Sbjct: 173 SF-MFLVFDLMRKGELFDYLTEKVALSEKETR-------------SIMRSLLEAVSFLH- 217

Query: 184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 243
                +VHRD+KP NILL      +L DFG +     P      + + GT GYLAPE  +
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKL--RELCGTPGYLAPEILK 272

Query: 244 HGKVSDKT------DVYAFGVVLLELLTGRKP 269
                         D++A GV+L  LL G  P
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  107 bits (268), Expect = 3e-26
 Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 26/221 (11%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--------DKESSKAFCRELMIA 111
             +S    LG GA  FV+          V +K + KE        +         E+ I 
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
           S + H NI+ ++    + +    L+  K+ SG  L   +    +       L   +   +
Sbjct: 84  SRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPR-------LDEPLASYI 135

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              +  +V YL     + ++HRDIK  NI+++     KL DFG A +        L  T 
Sbjct: 136 FRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTF 189

Query: 231 KGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
            GT  Y APE    G      + ++++ GV L  L+    P
Sbjct: 190 CGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  106 bits (267), Expect = 3e-26
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 37/226 (16%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPL 122
           +  VLG GA + V      +     A+K ++K+         RE+ +      H N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAE 176
           + F  + ++  +L+++ + GGS+  H+H+++              +       V   +A 
Sbjct: 77  IEFFEEEDR-FYLVFEKMRGGSILSHIHKRRH-------------FNELEASVVVQDVAS 122

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT-----WTSAPSVPFLCK 228
           ++ +LHN   + + HRD+KP NIL          K+CDF L +        +P       
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 229 TVKGTFGYLAPEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKP 269
           T  G+  Y+APE  +             D+++ GV+L  LL+G  P
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  106 bits (266), Expect = 3e-26
 Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 43/239 (17%)

Query: 60  HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKED--KESSKAFCRELMIAS 112
           +  S G+ LG GA   V +    GL++     +VA+K L K        +A   EL + S
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLS 81

Query: 113 SL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---- 167
            L +H NIV L+G C        +I +Y   G L   L  K+     + T P  +     
Sbjct: 82  YLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 168 -------YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----- 215
                     +  +A+ +A+L     +  +HRD+   NILL+  +I K+CDFGLA     
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 216 ----TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                      +P     VK      APE   +   + ++DV+++G+ L EL + G  P
Sbjct: 198 DSNYVVKGNARLP-----VKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (266), Expect = 4e-26
 Identities = 41/183 (22%), Positives = 75/183 (40%), Gaps = 18/183 (9%)

Query: 94  DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 153
                    A   ++         N V  +     P+  L++  +     +L+  ++ + 
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQL-QPSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 154 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 213
                   +       + + IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFG
Sbjct: 157 SLEDREHGVCL----HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 209

Query: 214 LAT---------WTSAPSVPFLCKTVK-GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 263
           L T             P   +   T + GT  Y++PE       S K D+++ G++L EL
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

Query: 264 LTG 266
           L  
Sbjct: 270 LYS 272

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  105 bits (264), Expect = 5e-26
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 16/218 (7%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 119
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 120 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 176
           V     F +  E  L+L+ K +SGGS+   +  H   KG   +  L  S    +   + E
Sbjct: 76  VSYYTSFVVKDE--LWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 177 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC---KTVKG 232
            + YLH NG     +HRD+K  NILL      ++ DFG++ + +           KT  G
Sbjct: 133 GLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 233 TFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 269
           T  ++APE  +  +  D K D+++FG+  +EL TG  P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  104 bits (263), Expect = 5e-26
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 34/217 (15%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 116
           G  LG G  +F   GKV +         VA+K L+++   S        RE+       H
Sbjct: 16  GDTLGVG--TF---GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 117 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           P+I+ L  V   I      F++ +YVSGG L  ++ +  +       +      ++   I
Sbjct: 71  PHIIKLYQV---ISTPTDFFMVMEYVSGGELFDYICKHGR-------VEEMEARRLFQQI 120

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
             +V Y H      VVHRD+KP N+LL +    K+ DFGL+   S        +T  G+ 
Sbjct: 121 LSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSP 174

Query: 235 GYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
            Y APE    G++    + D+++ GV+L  LL G  P
Sbjct: 175 NYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLP 210

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  105 bits (263), Expect = 8e-26
 Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 34/231 (14%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASS 113
             +  G +LG+G    VF G     R  VAIK + +           S     E+ +   
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 114 LH----HPNIVPLVGFCIDPEQGLFLIYKY-VSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           +     HP ++ L+ +  + ++G  L+ +  +    L  ++ EK         L      
Sbjct: 91  VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGP-------LGEGPSR 142

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLC 227
                +  ++ + H+   R VVHRDIK  NIL+  ++   KL DFG          P+  
Sbjct: 143 CFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPY-- 195

Query: 228 KTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 274
               GT  Y  PE+      H        V++ G++L +++ G  P E  +
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQ 243

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  105 bits (265), Expect = 9e-26
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 47/227 (20%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CRELMIA 111
             F + + LG G  SF   G+V L++        A+K LDK+     K       E  I 
Sbjct: 41  DQFDRIKTLGTG--SF---GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95

Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            +++ P +V L     D    L+++ +YV+GG +  HL  ++ G           R+  A
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHL--RRIGRFSEPH----ARFYAA 148

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPF 225
             I  +  YLH      +++RD+KP N+L+  +   ++ DFG A      TWT       
Sbjct: 149 -QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------- 197

Query: 226 LCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
           LC    GT   LAPE      + K     D +A GV++ E+  G  P
Sbjct: 198 LC----GTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  105 bits (263), Expect = 1e-25
 Identities = 56/239 (23%), Positives = 99/239 (41%), Gaps = 43/239 (17%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKED--KESSKAFCRELMI 110
              + G+ LG GA   V   +   +         +VA+K L K+D  ++       E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEM 93

Query: 111 ASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL---------HEKKKGVRGNS 160
              +  H NI+ L+G C   +  L++I +Y S G+L  +L         +          
Sbjct: 94  MKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 161 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----- 215
            + +         +A  + YL     +  +HRD+   N+L++   + K+ DFGLA     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 216 ----TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                 T+   +P     VK      APE       + ++DV++FGV++ E+ T G  P
Sbjct: 210 IDYYKKTTNGRLP-----VKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  104 bits (262), Expect = 2e-25
 Identities = 48/224 (21%), Positives = 86/224 (38%), Gaps = 32/224 (14%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASS 113
             +  G +LG G    V+ G        VAIK ++K+      +  +      E+++   
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 114 LHH--PNIVPLVGFCIDPEQGLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKV 170
           +      ++ L+ +  +      LI +       L   + E+         L   +    
Sbjct: 103 VSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGA-------LQEELARSF 154

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLCKT 229
              + E+V + HN     V+HRDIK  NIL+   +   KL DFG           +    
Sbjct: 155 FWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVY--TD 207

Query: 230 VKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKP 269
             GT  Y  PE+ +    HG+      V++ G++L +++ G  P
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP 248

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  104 bits (261), Expect = 2e-25
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 21/212 (9%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIA-SSLHHPNIVPLVG 124
            +GRGA   V K         +A+KR+     E   K    +L +   S   P IV   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                E   ++  + +   S ++        +     +P  +  K+ L   +++ +L   
Sbjct: 89  ALFR-EGDCWICMELM-STSFDKFYKYVYSVLDD--VIPEEILGKITLATVKALNHLKE- 143

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYLAPEY 241
               ++HRDIKPSNILL      KLCDFG++     + A       +   G   Y+APE 
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-----TRDA-GCRPYMAPER 196

Query: 242 FQHGKVSD----KTDVYAFGVVLLELLTGRKP 269
                       ++DV++ G+ L EL TGR P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  103 bits (259), Expect = 2e-25
 Identities = 35/278 (12%), Positives = 74/278 (26%), Gaps = 67/278 (24%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPNIVP 121
               G       ++     L   VA+  +D       +  +      +  S +  P +  
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 122 L--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           +  V        G  ++ +++ GGSL+              +       +    +A +  
Sbjct: 96  VLDVV---HTRAGGLVVAEWIRGGSLQEVADT---------SPSPVGAIRAMQSLAAAAD 143

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
             H      V      PS + +S      L                           +  
Sbjct: 144 AAH---RAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPD 178

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA-----------RRLQGEENLVLWAKPI 288
                   + + D+   G  L  LL  R P+             R   G+          
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231

Query: 289 LHRGMAA-VEELL--DPRLKCTSRNSAQIARVIQAAAA 323
           +   ++A     +  D  +    R+++ +  ++Q A A
Sbjct: 232 IPFQISAVAARSVQGDGGI----RSASTLLNLMQQATA 265

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  104 bits (261), Expect = 2e-25
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)

Query: 65  GRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKED--KESSKAFCRELMIASSLHHP 117
            R +G GA   VF+ +  GLL     T VA+K L KE+   +    F RE  + +   +P
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNP 110

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--------- 168
           NIV L+G C    + + L+++Y++ G L   L         + +                
Sbjct: 111 NIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 169 --------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 220
                    +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+     
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS----- 221

Query: 221 PSVPFLCKTV-------KGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GR 267
                  + +             +      PE   + + + ++DV+A+GVVL E+ + G 
Sbjct: 222 -------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274

Query: 268 KP 269
           +P
Sbjct: 275 QP 276

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  104 bits (262), Expect = 3e-25
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 44/226 (19%)

Query: 66  RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           R +G+G  SF   GKV +++   T    A+K ++K+   ++   +   +EL I   L HP
Sbjct: 21  RAIGKG--SF---GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA-LGIAE 176
            +V L     D E  +F++   + GG L  HL  ++       T    V+  +  L +A 
Sbjct: 76  FLVNLWYSFQDEED-MFMVVDLLLGGDLRYHL--QQNVHFKEET----VKLFICELVMA- 127

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTV 230
            + YL     + ++HRD+KP NILL       + DF +A      T  +         T+
Sbjct: 128 -LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT---------TM 174

Query: 231 KGTFGYLAPEYFQHGKVS--DKT-DVYAFGVVLLELLTGRKPIEAR 273
            GT  Y+APE F   K +      D ++ GV   ELL GR+P   R
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  103 bits (259), Expect = 4e-25
 Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 40/240 (16%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESS--KAFCRELMIAS 112
            N   G+ LG G    V K     L+     T+VA+K L KE+   S  +    E  +  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLK 81

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY---- 168
            ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G      S       
Sbjct: 82  QVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 169 -------------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
                          A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 216 TWTSAPSVPFLCKTVKGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                         VK + G +     A E       + ++DV++FGV+L E++T G  P
Sbjct: 198 RDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  103 bits (260), Expect = 5e-25
 Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 35/235 (14%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKED--KESSKAFCRELMI 110
              + G+ LG G    V   +   +         +VA+K L K+D  ++       E+ +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEM 139

Query: 111 ASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL---------HEKKKGVRGNS 160
              +  H NI+ L+G C   +  L++I +Y S G+L  +L         +          
Sbjct: 140 MKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 161 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 220
            + +         +A  + YL     +  +HRD+   N+L++   + K+ DFGLA   + 
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 221 PSVPFLCKTVKGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                     K T G L     APE       + ++DV++FGV++ E+ T G  P
Sbjct: 256 IDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  105 bits (263), Expect = 9e-25
 Identities = 75/285 (26%), Positives = 115/285 (40%), Gaps = 58/285 (20%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFC--RELM 109
           +FS  R++GRG   F   G+V   R +      A+K LDK+     +  + A      L 
Sbjct: 190 DFSVHRIIGRG--GF---GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           + S+   P IV +  +       L  I   ++GG L  HL +      G  +      Y 
Sbjct: 245 LVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFY- 297

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-------TWTSAPS 222
            A  I   + ++H    R VV+RD+KP+NILL      ++ D GLA              
Sbjct: 298 -AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---- 349

Query: 223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 281
                    GT GY+APE  Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 350 ---SV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

Query: 282 ---VLWAKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQI 314
               L     L    +      +E LL  D   RL C  R + ++
Sbjct: 403 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  102 bits (256), Expect = 1e-24
 Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 53/230 (23%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE------DKESSKAFCREL 108
            +F   R LG G  SF   G+V L+R        A+K L KE        E +     E 
Sbjct: 6   QDFQILRTLGTG--SF---GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND---ER 57

Query: 109 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
           ++ S + HP I+ + G   D +Q +F+I  Y+ GG L   L  +K     N       ++
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLL--RKSQRFPNPV----AKF 110

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 222
             A  +  ++ YLH    + +++RD+KP NILL      K+ DFG A      T+T    
Sbjct: 111 YAA-EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---- 162

Query: 223 VPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
              LC    GT  Y+APE      + K     D ++FG+++ E+L G  P
Sbjct: 163 ---LC----GTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTP 202

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  104 bits (261), Expect = 1e-24
 Identities = 73/279 (26%), Positives = 117/279 (41%), Gaps = 41/279 (14%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMI 110
             F   RVLGRG   F   G+V   +        A K+L+K+     K    A   E  I
Sbjct: 185 DWFLDFRVLGRG--GF---GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-EKKI 238

Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY-- 168
            + +H   IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y  
Sbjct: 239 LAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTA 296

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 228
           ++  G+     +LH   +R +++RD+KP N+LL      ++ D GLA    A       K
Sbjct: 297 QIVSGLE----HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTK 347

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR--RLQGEE--NLVLW 284
              GT G++APE     +     D +A GV L E++  R P  AR  +++ +E    VL 
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407

Query: 285 AKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQI 314
                    +       E LL  DP  RL     +   +
Sbjct: 408 QAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (254), Expect = 2e-24
 Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 48/239 (20%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESS--KAFCRELMIASSL-HH 116
           G+VLG GA   V       +        VA+K L KE  +SS  +A   EL + + L  H
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSH 108

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY-------- 168
            NIV L+G C      ++LI++Y   G L  +L  K++    +     + +         
Sbjct: 109 ENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 169 --------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----- 215
                     A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA     
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 216 ----TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
                      +P     VK      APE    G  + K+DV+++G++L E+ + G  P
Sbjct: 225 DSNYVVRGNARLP-----VKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (253), Expect = 3e-24
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
            + K   LG G  + V+KGK  L    VA+K  RL+ E+     A  RE+ +   L H N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L       E+ L L+++Y+    L+++L +          +           +   +
Sbjct: 62  IVTLHDIIHT-EKSLTLVFEYLDK-DLKQYLDDCGNI------INMHNVKLFLFQLLRGL 113

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           AY H    + V+HRD+KP N+L++ +   KL DFGLA   S P+  +  + V  T  Y  
Sbjct: 114 AYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRP 168

Query: 239 PEYFQHGKV-SDKTDVYAFGVVLLELLTGR 267
           P+        S + D++  G +  E+ TGR
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  100 bits (251), Expect = 4e-24
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 24/221 (10%)

Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 113
           ++++  F +   LG G  + V+KG        VA+K  +LD E+   S A  RE+ +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKE 59

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           L H NIV L       E  L L+++++    L++++  +  G          V+      
Sbjct: 60  LKHENIVRLYDVIHT-ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK-YFQWQ 116

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           + + +A+ H   E  ++HRD+KP N+L++ +   KL DFGLA     P   F  + V  T
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--T 171

Query: 234 FGYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 267
             Y AP+       Y      S   D+++ G +L E++TG+
Sbjct: 172 LWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  101 bits (253), Expect = 5e-24
 Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 43/234 (18%)

Query: 65  GRVLGRGALSFVFKGKV-GLLR------TSVAIKRLDKEDKESS--KAFCRELMIASSL- 114
           G+ LG GA   V   +  GL +      T VA+K L K D           E+ +   + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIG 132

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---- 170
            H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P     +     
Sbjct: 133 KHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 171 -----ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------T 216
                A  +A  + YL     +  +HRD+   N+L++   + K+ DFGLA          
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
            T+   +P     VK      APE       + ++DV++FGV+L E+ T G  P
Sbjct: 249 KTTNGRLP-----VKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (250), Expect = 6e-24
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 30/215 (13%)

Query: 67  VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMI-ASSLHHPNIVPLVG 124
            +G G    V+K +       +A+K++ +  +KE +K    +L +   S   P IV   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
                   +F+  + +   + +     +         +P  +  K+ + I +++ YL   
Sbjct: 92  -TFITNTDVFIAMELMGTCAEKLKKRMQG-------PIPERILGKMTVAIVKALYYLKE- 142

Query: 185 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-----GTFGYLAP 239
            +  V+HRD+KPSNILL  +   KLCDFG++          L          G   Y+AP
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISG--------RLVDDKAKDRSAGCAAYMAP 193

Query: 240 EYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 269
           E       +      + DV++ G+ L+EL TG+ P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 99.3 bits (248), Expect = 8e-24
 Identities = 65/255 (25%), Positives = 98/255 (38%), Gaps = 69/255 (27%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC-------------- 105
              +G+G  S+   G V L       T  A+K L K+       F               
Sbjct: 18  KDEIGKG--SY---GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 106 ------------RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL-----ER 147
                       +E+ I   L HPN+V LV    DP E  L+++++ V+ G +      +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132

Query: 148 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 207
            L E +           +  Y   L     + YLH    + ++HRDIKPSN+L+      
Sbjct: 133 PLSEDQ-----------ARFYFQDLIKG--IEYLHY---QKIIHRDIKPSNLLVGEDGHI 176

Query: 208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLL 261
           K+ DFG++      S   L     GT  ++APE          GK     DV+A GV L 
Sbjct: 177 KIADFGVSNE-FKGSDALL-SNTVGTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLY 231

Query: 262 ELLTGRKPIEARRLQ 276
             + G+ P    R+ 
Sbjct: 232 CFVFGQCPFMDERIM 246

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  101 bits (253), Expect = 1e-23
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 42/221 (19%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 116
           G  LG G  +F   GKV + +       VA+K L+++   S        RE+       H
Sbjct: 21  GDTLGVG--TF---GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 117 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG- 173
           P+I+ L  V   I     +F++ +YVSGG L  ++ +  +           +  K +   
Sbjct: 76  PHIIKLYQV---ISTPSDIFMVMEYVSGGELFDYICKNGR-----------LDEKESRRL 121

Query: 174 ---IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              I   V Y H      VVHRD+KP N+LL +    K+ DFGL+   S        +T 
Sbjct: 122 FQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTS 175

Query: 231 KGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
            G+  Y APE    G++    + D+++ GV+L  LL G  P
Sbjct: 176 CGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLP 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 1e-23
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 44/279 (15%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMI 110
           + F + RVLG+G   F   G+V   +        A K+L+K+     K  + A   E  I
Sbjct: 184 NTFRQYRVLGKG--GF---GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQI 237

Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
              ++   +V L  +  + +  L L+   ++GG L+ H++   +          +V Y  
Sbjct: 238 LEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG---FPEARAVFY-- 291

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCK 228
           A  I   +  LH      +V+RD+KP NILL      ++ D GLA               
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-V- 346

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR--RLQGEE--NLVLW 284
              GT GY+APE  ++ + +   D +A G +L E++ G+ P + R  +++ EE   LV  
Sbjct: 347 ---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403

Query: 285 AKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQI 314
                    +        +LL  DP  RL C   ++ ++
Sbjct: 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 120
           F+K   +G+G+   VFKG     +  VAIK +D E+ E       +E+ + S    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
              G     +  L++I +Y+ GGS         L E +            +  ++  G+ 
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---------ILREILKGLD 133

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGT 233
               YLH+      +HRDIK +N+LLS     KL DFG+A   +        K  T  GT
Sbjct: 134 ----YLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----QIKRNTFVGT 182

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             ++APE  +      K D+++ G+  +EL  G  P
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 20/215 (9%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKE--SSKAFCRELMIASSLHH 116
            + K   +G G    VFK K       VA+K  RLD +  E   S A  RE+ +   L H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSAL-REICLLKELKH 60

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
            NIV L       ++ L L++++     L+++             L   +       + +
Sbjct: 61  KNIVRLHDVLHS-DKKLTLVFEFCDQ-DLKKYFDSCNGD------LDPEIVKSFLFQLLK 112

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + + H    R V+HRD+KP N+L++     KL +FGLA     P   +  + V  T  Y
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWY 167

Query: 237 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 270
             P+     K+ S   D+++ G +  EL    +P+
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 64/234 (27%), Positives = 88/234 (37%), Gaps = 37/234 (15%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 112
           +F   +V+GRG  +F    +V +++   T    A+K ++K D   +     F  E  +  
Sbjct: 62  DFEILKVIGRG--AF---SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +     I  L  F    E  L+L+ +Y  GG L   L   K G R       +  Y    
Sbjct: 117 NGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGER--IPAEMARFY---- 167

Query: 173 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
            +AE V     +H       VHRDIKP NILL      +L DFG                
Sbjct: 168 -LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL-KLRADGTVRSLV 222

Query: 230 VKGTFGYLAPEYFQHGKVSDKTDVY-------AFGVVLLELLTGRKPIEARRLQ 276
             GT  YL+PE  Q       T  Y       A GV   E+  G+ P  A    
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 35/217 (16%)

Query: 65  GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 116
              LG G  SF   GKV L         VA+K + ++  + S       RE+     L H
Sbjct: 14  RETLGEG--SF---GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 117 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           P+I+ L  V   I     + ++ +Y  GG L  ++ EKK+       +      +    I
Sbjct: 69  PHIIKLYDV---ITTPTDIVMVIEYA-GGELFDYIVEKKR-------MTEDEGRRFFQQI 117

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
             ++ Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     KT  G+ 
Sbjct: 118 ICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSP 171

Query: 235 GYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
            Y APE    GK+    + DV++ G+VL  +L GR P
Sbjct: 172 NYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 42/234 (17%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIASS 113
           +   +V+GRG  +F   G+V L+R   T    A+K L K +   +  S  F  E  I + 
Sbjct: 71  YEVVKVIGRG--AF---GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
            + P +V L     D    L+++ +Y+ GG L   +              W+  Y     
Sbjct: 126 ANSPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMSNYD------VPEKWARFY----- 173

Query: 174 IAESVA---YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
            AE V     +H       +HRD+KP N+LL      KL DFG             C T 
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDTA 229

Query: 231 KGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
            GT  Y++PE  +       +G+     D ++ GV L E+L G  P  A  L G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVG 280

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 98.3 bits (245), Expect = 7e-23
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 36/234 (15%)

Query: 64  KGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +G  +GRG    V+K K    +     A+K+++      S   CRE+ +   L HPN++ 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVIS 82

Query: 122 LVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KVALGIAESV 178
           L    +   ++ ++L++ Y     L   +   +        +         +   I + +
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPF--LCKTVKG 232
            YLH      V+HRD+KP+NIL+  +       K+ D G A   ++P  P   L   V  
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 233 TFGYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 279
           TF Y APE       Y      +   D++A G +  ELLT  +PI        +
Sbjct: 198 TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT-SEPI----FHCRQ 240

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 122 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            +  + +  E  L+++ +Y++GGSL   + E        +         V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAA--------VCRECLQALEF 131

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+     V+HRDIK  NILL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWMA 184

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           PE         K D+++ G++ +E++ G  P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 72/227 (31%), Positives = 102/227 (44%), Gaps = 38/227 (16%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHH 116
             +++  +V+G G+   V++ K+      VAIK+   DK  K       REL I   L H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDH 106

Query: 117 PNIVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV----R 167
            NIV L  F         E  L L+  YV   ++ R     +   R   TLP        
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVA---RHYSRAKQTLPVIYVKLYM 162

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA--TWTSAPSVP 224
           Y++   +A    Y+H+     + HRDIKP N+LL     + KLCDFG A       P+V 
Sbjct: 163 YQLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

Query: 225 FLCKTVKGTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           ++C     +  Y APE  F     +   DV++ G VL ELL G+ PI
Sbjct: 216 YIC-----SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 95.3 bits (238), Expect = 3e-22
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 28/216 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
            + K   +G G+   VFK +       VAIK     ++D    K   RE+ +   L HPN
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +V L+      ++ L L+++Y    ++   L   ++G      +P  +   +     ++V
Sbjct: 64  LVNLLE-VFRRKRRLHLVFEYCDH-TVLHELDRYQRG------VPEHLVKSITWQTLQAV 115

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            + H   +   +HRD+KP NIL++   + KLCDFG A   + PS  +  +    T  Y +
Sbjct: 116 NFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRS 170

Query: 239 PE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 267
           PE       Y          DV+A G V  ELL+G 
Sbjct: 171 PELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 55/231 (23%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 116
           ++LG+G  SF   GKV L          AIK L K+    D +       + +++ +  H
Sbjct: 23  KMLGKG--SF---GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--VALGI 174
           P +  +       ++ LF + +Y++GG L  H+    K       L  +  Y   + LG+
Sbjct: 78  PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGL 131

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTSAPSVPF 225
                +LH    + +V+RD+K  NILL      K+ DFG+          T T       
Sbjct: 132 Q----FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT------- 177

Query: 226 LCKTVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
            C    GT  Y+APE     ++       D ++FGV+L E+L G+ P   +
Sbjct: 178 FC----GTPDYIAPEILLGQKYNHS---VDWWSFGVLLYEMLIGQSPFHGQ 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 68/239 (28%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDKE-------DKESSKAFCRELMI 110
           RVLG+G   +   GKV  +R           A+K L K        D   +KA   E  I
Sbjct: 23  RVLGKG--GY---GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNI 74

Query: 111 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
              + HP IV L+ +       L+LI +Y+SGG L   L  +            +  Y  
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI-----FMEDTACFY-- 126

Query: 171 ALGIAE---SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
              +AE   ++ +LH   ++ +++RD+KP NI+L+ +   KL DFG            LC
Sbjct: 127 ---LAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFG------------LC 168

Query: 228 K----------TVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           K          T  GT  Y+APE      H +     D ++ G ++ ++LTG  P    
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPPFTGE 224

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 44/221 (19%)

Query: 66  RVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKE------DKESSKAFCRELMIASSL 114
           ++LG+G  +F   GKV L+R   T    A+K L KE      +   +     E  +  + 
Sbjct: 11  KLLGKG--TF---GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HP +  L  +       L  + +Y +GG L  HL  ++       T   +  Y     I
Sbjct: 63  RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY--GAEI 114

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVK 231
             ++ YLH    R VV+RDIK  N++L      K+ DFGL        A    F C    
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-C---- 166

Query: 232 GTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
           GT  YLAPE      +G+     D +  GVV+ E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLP 204

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 37/218 (16%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE------DKESSKAFCRELMIASSL 114
           ++LG+G  +F   GKV L++        A+K L KE      +   +     E  +  + 
Sbjct: 154 KLLGKG--TF---GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNS 205

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HP +  L  +       L  + +Y +GG L  HL  ++       +   +  Y     I
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY--GAEI 257

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
             ++ YLH+  E+ VV+RD+K  N++L      K+ DFGL             KT  GT 
Sbjct: 258 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTP 313

Query: 235 GYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 269
            YLAPE  +   +G+     D +  GVV+ E++ GR P
Sbjct: 314 EYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLP 348

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 97.4 bits (242), Expect = 4e-22
 Identities = 72/285 (25%), Positives = 115/285 (40%), Gaps = 62/285 (21%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMIA 111
           +F+   VLG+G  SF   GKV L          A+K L K+    D +       + ++A
Sbjct: 342 DFNFLMVLGKG--SF---GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396

Query: 112 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
                P +  L   C      L+ + +YV+GG L  H+ +  +        P +V Y   
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAE 450

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--- 228
           + I   + +L     + +++RD+K  N++L S+   K+ DFG            +CK   
Sbjct: 451 IAIG--LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG------------MCKENI 493

Query: 229 -------TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 278
                  T  GT  Y+APE   Y  +GK     D +AFGV+L E+L G+ P E       
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

Query: 279 ENLVLWAKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQI 314
              ++       + M+       + L+   P  RL C       I
Sbjct: 551 FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 595

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 57/232 (24%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE------DKESSKAFCRELMIASSL 114
            VLG+G  SF   GKV L          A+K L K+      D E +    R L +    
Sbjct: 26  MVLGKG--SF---GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-- 78

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
             P +  L   C      L+ + +YV+GG L  H+ +  +        P +V Y   + I
Sbjct: 79  KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAEIAI 132

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK------ 228
              + +L     + +++RD+K  N++L S+   K+ DFG            +CK      
Sbjct: 133 G--LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG------------MCKENIWDG 175

Query: 229 ----TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
               T  GT  Y+APE   Y  +GK     D +AFGV+L E+L G+ P E  
Sbjct: 176 VTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQAPFEGE 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 68/232 (29%), Positives = 101/232 (43%), Gaps = 57/232 (24%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE------DKESSKAFCRELMIASSL 114
           RVLG+G  SF   GKV L R        A+K L K+      D E +    R L +A + 
Sbjct: 29  RVLGKG--SF---GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN- 82

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HP +  L   C      LF + ++V+GG L  H+ + ++          +  Y   +  
Sbjct: 83  -HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEIIS 135

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK------ 228
           A  + +LH   ++ +++RD+K  N+LL  +   KL DFG            +CK      
Sbjct: 136 A--LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG------------MCKEGICNG 178

Query: 229 ----TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
               T  GT  Y+APE      +G      D +A GV+L E+L G  P EA 
Sbjct: 179 VTTATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAPFEAE 227

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 94.2 bits (235), Expect = 8e-22
 Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 66/237 (27%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDKE-----DKESSKAFCRELMIAS 112
           +VLG+G  SF   GKV L++           A+K L K      D+  +K    E  I  
Sbjct: 30  KVLGQG--SF---GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILV 81

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
            ++HP IV L  +    E  L+LI  ++ GG L   L ++        T      Y    
Sbjct: 82  EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFY---- 131

Query: 173 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK- 228
            +AE      +LH      +++RD+KP NILL  +   KL DFG            L K 
Sbjct: 132 -LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG------------LSKE 175

Query: 229 ---------TVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
                    +  GT  Y+APE      H +     D ++FGV++ E+LTG  P + +
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLPFQGK 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.2 bits (235), Expect = 9e-22
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 28/216 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
            +    ++G G+   V K +       VAIK      +DK   K   RE+ +   L H N
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +V L+  C   ++  +L++++V   ++   L     G      L + V  K    I   +
Sbjct: 86  LVNLLEVCKK-KKRWYLVFEFVDH-TILDDLELFPNG------LDYQVVQKYLFQIINGI 137

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            + H      ++HRDIKP NIL+S   + KLCDFG A   +AP   +  +    T  Y A
Sbjct: 138 GFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRA 192

Query: 239 PE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 267
           PE       Y          DV+A G ++ E+  G 
Sbjct: 193 PELLVGDVKY------GKAVDVWAIGCLVTEMFMGE 222

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 94.6 bits (236), Expect = 9e-22
 Identities = 70/232 (30%), Positives = 101/232 (43%), Gaps = 57/232 (24%)

Query: 66  RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE------DKESSKAFCRELMI-ASS 113
           +V+G+G  SF   GKV L R     V  A+K L K+      +++   +   E  +   +
Sbjct: 44  KVIGKG--SF---GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS---ERNVLLKN 95

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           + HP +V L  F       L+ +  Y++GG L  HL  ++         P +  Y  A  
Sbjct: 96  VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC-----FLEPRARFY--AAE 147

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTSAPSVP 224
           IA ++ YLH      +V+RD+KP NILL S+    L DFGL          T T      
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST------ 198

Query: 225 FLCKTVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
             C    GT  YLAPE      + +     D +  G VL E+L G  P  +R
Sbjct: 199 -FC----GTPEYLAPEVLHKQPYDRT---VDWWCLGAVLYEMLYGLPPFYSR 242

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 53/226 (23%)

Query: 66  RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE----DKESSKAFCRELMIASSLHH 116
           RV+GRG  S+    KV L+R   T    A+K + KE    D++       + +   + +H
Sbjct: 15  RVIGRG--SY---AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +V L   C   E  LF + +YV+GG L  H+  ++K          +  Y   + +A 
Sbjct: 70  PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLA- 122

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK-------- 228
            + YLH   ER +++RD+K  N+LL S+   KL D+G            +CK        
Sbjct: 123 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG------------MCKEGLRPGDT 166

Query: 229 --TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             T  GT  Y+APE      +G      D +A GV++ E++ GR P
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 209

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 40/222 (18%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRT-SVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           ++  +V+G G+   VF+ K  L+ +  VAIK    DK  K       REL I   + HPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAK--LVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPN 93

Query: 119 IVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV----RYK 169
           +V L  F         E  L L+ +YV   ++ R      K      T+P  +     Y+
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKL---KQTMPMLLIKLYMYQ 149

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA--TWTSAPSVPFL 226
           +   +A    Y+H+     + HRDIKP N+LL     + KL DFG A       P+V ++
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202

Query: 227 CKTVKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGR 267
           C     +  Y APE  F     +   D+++ G V+ EL+ G+
Sbjct: 203 C-----SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 54/216 (25%), Positives = 108/216 (50%), Gaps = 23/216 (10%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +     LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 122 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           L+G +  D +  L+++ ++  GG+++  + E  +G+         ++  V   + E++ +
Sbjct: 81  LLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTEP-----QIQV-VCRQMLEALNF 132

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 238
           LH+   + ++HRD+K  N+L++ +   +L DFG+    SA ++  L K  +  GT  ++A
Sbjct: 133 LHS---KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMA 185

Query: 239 PEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 269
           PE      + D     K D+++ G+ L+E+     P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 50/216 (23%), Positives = 99/216 (45%), Gaps = 30/216 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
                 +G G+   V   +       VA+K +D   ++  +    E++I     H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 122 LVG-FCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           +   + +  E  L+++ +++ GG+L     +  L+E++                V   + 
Sbjct: 107 MYKSYLVGEE--LWVLMEFLQGGALTDIVSQVRLNEEQIAT-------------VCEAVL 151

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGT 233
           +++AYLH    + V+HRDIK  +ILL+     KL DFG      A     + K  ++ GT
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGF----CAQISKDVPKRKSLVGT 204

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             ++APE       + + D+++ G++++E++ G  P
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 35/232 (15%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 112
           +F   +V+GRG  +F   G+V +++        A+K L+K +   +  +  F  E  +  
Sbjct: 75  DFEILKVIGRG--AF---GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           +     I  L  +    +  L+L+  Y  GG L   L +             +  Y    
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFY---- 180

Query: 173 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 229
            +AE V     +H       VHRDIKP NIL+      +L DFG                
Sbjct: 181 -LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL-KLMEDGTVQSSV 235

Query: 230 VKGTFGYLAPEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKPIEARRLQ 276
             GT  Y++PE  Q  +          D ++ GV + E+L G  P  A  L 
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 92.2 bits (230), Expect = 2e-21
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 25/214 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRELMIASSL 114
            +     +G G    V+K +          A+K  RL+KED E   S    RE+ I   L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN---NYGETFALKKIRLEKED-EGIPSTTI-REISILKEL 57

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            H NIV L       ++ L L+++++    L++ L   + G      L         L +
Sbjct: 58  KHSNIVKLYDVIHT-KKRLVLVFEHLDQ-DLKKLLDVCEGG------LESVTAKSFLLQL 109

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
              +AY H   +R V+HRD+KP N+L++ +   K+ DFGLA     P   +  + V  T 
Sbjct: 110 LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TL 164

Query: 235 GYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGR 267
            Y AP+     K  S   D+++ G +  E++ G 
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 53/226 (23%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 116
           RV+GRG  S+    KV L+R        A++ + KE    D++       + +   + +H
Sbjct: 58  RVIGRG--SY---AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +V L   C   E  LF + +YV+GG L  H+  ++K          +  Y   + +A 
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLA- 165

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK-------- 228
            + YLH   ER +++RD+K  N+LL S+   KL D+G            +CK        
Sbjct: 166 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG------------MCKEGLRPGDT 209

Query: 229 --TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             T  GT  Y+APE      +G      D +A GV++ E++ GR P
Sbjct: 210 TSTFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 252

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 37/220 (16%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRELMIASSL 114
            + K   +G G    V+K K         VA+K  RLD E  E   S A  RE+ +   L
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKD---SQGRIVALKRIRLDAE-DEGIPSTAI-REISLLKEL 76

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           HHPNIV L+      E+ L L+++++    L++ L E K G      L  S        +
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEK-DLKKVLDENKTG------LQDSQIKIYLYQL 128

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
              VA+ H   +  ++HRD+KP N+L++S    KL DFGLA     P   +  + V  T 
Sbjct: 129 LRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TL 183

Query: 235 GYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 267
            Y AP+       Y      S   D+++ G +  E++TG+
Sbjct: 184 WYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 66/235 (28%), Positives = 98/235 (41%), Gaps = 64/235 (27%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDK-------EDKESSKAFCRELMI 110
           +VLG G  ++   GKV L+R           A+K L K       +  E ++    E  +
Sbjct: 60  KVLGTG--AY---GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQV 111

Query: 111 -ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
                  P +V L  +    E  L LI  Y++GG L  HL ++++      T      Y 
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY- 164

Query: 170 VALGIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------T 216
               + E V    +LH   +  +++RDIK  NILL S     L DFGL+           
Sbjct: 165 ----VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217

Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS-DKT-DVYAFGVVLLELLTGRKP 269
           +         C    GT  Y+AP+  + G    DK  D ++ GV++ ELLTG  P
Sbjct: 218 YD-------FC----GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 34/219 (15%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
            F     LG G+   V+K         VAIK++  E         +E+ I      P++V
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCDSPHVV 87

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALG 173
              G        L+++ +Y   GS+        + L E +                +   
Sbjct: 88  KYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------------ILQS 133

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTV 230
             + + YLH       +HRDIK  NILL+++   KL DFG+A   T T A        TV
Sbjct: 134 TLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-----NTV 185

Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            GT  ++APE  Q    +   D+++ G+  +E+  G+ P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 27/223 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAF----CRELMIASSL 114
            +     +G GA   V+K +       VA+K  R+                RE+ +   L
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGLPISTVREVALLRRL 68

Query: 115 H---HPNIVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
               HPN+V L         D E  + L++++V    L  +L +          LP    
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-----APPPGLPAETI 122

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
             +       + +LH     C+VHRD+KP NIL++S    KL DFGLA   S   +    
Sbjct: 123 KDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTP 178

Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 179 VVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 26/225 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKES----SKAFCRELMIASSL 114
            + K   LG G  + V+K +       VAIK  +L    +        A  RE+ +   L
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL-REIKLLQEL 69

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            HPNI+ L+      +  + L++ ++    LE  + +          L  S      L  
Sbjct: 70  SHPNIIGLLD-AFGHKSNISLVFDFME-TDLEVIIKDNSLV------LTPSHIKAYMLMT 121

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
            + + YLH   +  ++HRD+KP+N+LL    + KL DFGLA    +P+  +  + V  T 
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TR 176

Query: 235 GYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGE 278
            Y APE     ++     D++A G +L ELL  R P     L G+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPF----LPGD 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 58/223 (26%), Positives = 87/223 (39%), Gaps = 38/223 (17%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKE--SSKAFCRELMIASSLHH 116
            + +   LG G    V+K    +   +VAIK  RL+ E +E     A  RE+ +   L H
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAI-REVSLLKELQH 92

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
            NI+ L          L LI++Y          ++ KK +  N  +   V       +  
Sbjct: 93  RNIIELKSVIHH-NHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLIN 143

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP-----KLCDFGLATWTSAPSVPFLCKTVK 231
            V + H    R  +HRD+KP N+LLS          K+ DFGLA     P   F  + + 
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199

Query: 232 GTFGYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 267
            T  Y  PE       Y      S   D+++   +  E+L   
Sbjct: 200 -TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 67/231 (29%), Positives = 100/231 (43%), Gaps = 40/231 (17%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMI---ASS 113
              F   R+ G+G    V  GK      SVAIK+   D   +       REL I    + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN------RELQIMQDLAV 75

Query: 114 LHHPNIVPL------VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW--- 164
           LHHPNIV L      +G     +  L ++ +YV   +L R     +   R     P    
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC---RNYYRRQVAPPPILI 131

Query: 165 -SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA--TWTSA 220
               ++    +  S+  LH  +   V HRDIKP N+L++      KLCDFG A     S 
Sbjct: 132 KVFLFQ----LIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 221 PSVPFLCKTVKGTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
           P+V ++C     +  Y APE  F +   +   D+++ G +  E++ G +PI
Sbjct: 187 PNVAYIC-----SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 56/218 (25%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 123
            +VLG G    V +      +   A+K L    K       RE+ +   +   P+IV +V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPHIVRIV 77

Query: 124 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGI 174
               +   G   L ++ + + GG L   + ++               +      ++   I
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREASEIMKSI 126

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 231
            E++ YLH      + HRD+KP N+L +SK+   I KL DFG                  
Sbjct: 127 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG------------------ 165

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
                 A E     K     D+++ GV++  LL G  P
Sbjct: 166 -----FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPP 197

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 51/242 (21%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKES--SKAFCRELMIASSLHH 116
            + K   +G+G    VFK +       VA+K   ++ E KE     A  RE+ I   L H
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITAL-REIKILQLLKH 75

Query: 117 PNIVPLVGFCIDPEQG-------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY- 168
            N+V L+  C             ++L++ +      E  L     G+  N  + +++   
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDL----AGLLSNVLVKFTLSEI 126

Query: 169 -KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP----SV 223
            +V   +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S        
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 224 PFLCKTVKGTFGYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
            +  + V  T  Y  PE       Y          D++  G ++ E+ T R PI    +Q
Sbjct: 184 RYTNRVV--TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWT-RSPI----MQ 230

Query: 277 GE 278
           G 
Sbjct: 231 GN 232

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 29/223 (13%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRE---LMIA 111
            +     +G GA   VFK +  L      VA+K  R+    +E        RE   L   
Sbjct: 12  QYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTG-EEGMPLSTI-REVAVLRHL 68

Query: 112 SSLHHPNIVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
            +  HPN+V L         D E  L L++++V    L  +L +  +       +P    
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-----VPTETI 122

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
             +   +   + +LH      VVHRD+KP NIL++S    KL DFGLA   S   +    
Sbjct: 123 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTS 178

Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
             V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 179 VVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 22/219 (10%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIV 120
           F    ++G G    V+KG+        AIK +D    E  +   +E+ +     HH NI 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84

Query: 121 P-----LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
                 +       +  L+L+ ++   GS+   +   K       TL       +   I 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREIL 139

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
             +++LH   +  V+HRDIK  N+LL+     KL DFG++             T  GT  
Sbjct: 140 RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 194

Query: 236 YLAPEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 269
           ++APE     +  D     K+D+++ G+  +E+  G  P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPN 118
           FS  R +G G+   V+  +       VAIK++    K+  E  +   +E+     L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 172
            +   G C   E   +L+ +Y  G +       ++ L E +                V  
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-------------VTH 161

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TV 230
           G  + +AYLH+     ++HRD+K  NILLS   + KL DFG A+         +    + 
Sbjct: 162 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANSF 210

Query: 231 KGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            GT  ++APE       G+   K DV++ G+  +EL   + P
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 53/216 (24%), Positives = 104/216 (48%), Gaps = 23/216 (10%)

Query: 59  THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHH 116
              +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 117 PNIVPLV-----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
            NI+ L+        ++  Q ++++ + +   +L + +  +    R +  L     Y++ 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL-----YQML 137

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 231
            GI     +LH+     ++HRD+KPSNI++ S    K+ DFGLA   +A +   +   V 
Sbjct: 138 CGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYV- 187

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
            T  Y APE        +  D+++ G ++ E++ G 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 27/216 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNI 119
           ++   R LGRG  S VF+         V +K L    K+  K   RE+ I  +L   PNI
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPNI 93

Query: 120 VPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIAES 177
           + L     DP      L++++V+    ++             TL  + +R+ +   I ++
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYM-YEILKA 142

Query: 178 VAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFG 235
           + Y H      ++HRD+KP N+++    +  +L D+GLA +   P   +    V+  +  
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEY---NVRVASRY 195

Query: 236 YLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 270
           +  PE     ++ D + D+++ G +L  ++  ++P 
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 51/209 (24%), Positives = 104/209 (49%), Gaps = 23/209 (11%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
           + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 124 -----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                   ++  Q ++L+ +      ++ +L +  +    +  + + + Y++  GI    
Sbjct: 128 NVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLL-YQMLCGIK--- 178

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA   +A +   +   V  T  Y A
Sbjct: 179 -HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYV-VTRYYRA 231

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
           PE        +  D+++ G ++ E++  +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 30/219 (13%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL--- 122
           + LG G    VF          VAIK++   D +S K   RE+ I   L H NIV +   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76

Query: 123 ----------VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
                         +     ++++ +Y     +E  L      +     L    R     
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLA---NVLEQGPLLEEHARL-FMY 127

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLA--TWTSAPSVPFLCKT 229
            +   + Y+H+     V+HRD+KP+N+ ++++ +  K+ DFGLA            L + 
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 230 VKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGR 267
           +  T  Y +P         +   D++A G +  E+LTG+
Sbjct: 185 L-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 57/250 (22%), Positives = 93/250 (37%), Gaps = 56/250 (22%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNI 119
            +S G+ LG G+   V +          A+K++ ++ +     +  REL I   L H NI
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNI 62

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR------------ 167
           + L         G              +   +       + ++  +              
Sbjct: 63  IKL--VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 168 ----YKVALGIAES-------------------VAYLHNGTERCVVHRDIKPSNILLSSK 204
               +KV      S                   V ++H+     + HRDIKP N+L++SK
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177

Query: 205 K-IPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVL 260
               KLCDFG A     S PSV ++C     +  Y APE      + +   D+++ G V 
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYIC-----SRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 261 LELLTGRKPI 270
            EL+ G KP+
Sbjct: 233 GELILG-KPL 241

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 61/279 (21%), Positives = 99/279 (35%), Gaps = 74/279 (26%)

Query: 60  HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRL-DKEDKESSKAFCRELMIASS 113
                G+ LGRGA   V +    G+ +     +VA+K L +       +A   EL I   
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 114 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----Y 168
           + HH N+V L+G C  P   L +I ++   G+L  +L  K+       T     R    Y
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 169 KVALGI----------------------AESVAYLHNGTERCVVHRDIKPSNIL------ 200
             A+ +                       +S++ +        +++D      L      
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201

Query: 201 -------LSSKKIP-----------------KLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
                  L+S+K                   K+CDFGLA              V+     
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDAR 256

Query: 237 L-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 269
           L     APE       + ++DV++FGV+L E+ + G  P
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 36/221 (16%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVG 124
            +LG GA   V           VAIK+++  +    +    RE+ I     H NI+ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76

Query: 125 FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIA 175
                       +++I +      ++  LH   + +         ++Y +     A+   
Sbjct: 77  IQRPDSFENFNEVYIIQEL-----MQTDLH---RVISTQMLSDDHIQYFIYQTLRAV--- 125

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
                LH      V+HRD+KPSN+L++S    K+CDFGLA      +      T + +  
Sbjct: 126 ---KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 236 --------YLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
                   Y APE      K S   DV++ G +L EL   R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 31/215 (14%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVG 124
             +G GA   V      L +  VAIK++   E +   +   RE+ I     H NI+ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92

Query: 125 FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIA 175
               P     + ++++        +E  L+   K ++        + Y +      L   
Sbjct: 93  IIRAPTIEQMKDVYIVQDL-----METDLY---KLLKTQHLSNDHICYFLYQILRGL--- 141

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGT 233
               Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL + V  T
Sbjct: 142 ---KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-AT 194

Query: 234 FGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
             Y APE        +   D+++ G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 26/210 (12%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
             +G GA   V           VAIK+L +  + +  +K   REL++   + H N++ L+
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 124 GFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                          +L+  +     ++  L +          + + V Y++  G+    
Sbjct: 90  DVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLV-YQMLKGLK--- 140

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            Y+H+     VVHRD+KP N+ ++     K+ DFGLA          +   V  T  Y A
Sbjct: 141 -YIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYV-VTRWYRA 191

Query: 239 PE-YFQHGKVSDKTDVYAFGVVLLELLTGR 267
           PE        +   D+++ G ++ E+LTG+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 25/210 (11%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
             +G GA   V           VA+K+L +  +    +K   REL +   + H N++ L+
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 124 GFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                         ++L+        +   L+     V+        V++ +   I   +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHL-----MGADLN---NIVKCQKLTDDHVQFLI-YQILRGL 145

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            Y+H+     ++HRD+KPSN+ ++     K+ DFGLA  T+      +   V  T  Y A
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYV-ATRWYRA 197

Query: 239 PE-YFQHGKVSDKTDVYAFGVVLLELLTGR 267
           PE        +   D+++ G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 47/210 (22%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
           + +G GA   V     G     VAIK+L +  + +  +K   REL +   + H N++ L+
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 124 -----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
                   +D     +L+  +     +   L    K ++        +++ V   + + +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPF-----MGTDLG---KLMKHEKLGEDRIQFLV-YQMLKGL 141

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            Y+H      ++HRD+KP N+ ++     K+ DFGLA          +   V  T  Y A
Sbjct: 142 RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYV-VTRWYRA 193

Query: 239 PEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
           PE      + +   D+++ G ++ E++TG+
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 25/165 (15%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 118
            +    ++G G+   V +    L +  VAIK++ +  ED    K   RE+ I + L+H +
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113

Query: 119 IVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW----SVRYKV 170
           +V ++   I  +      L+++ +       +       K  R    L      ++ Y +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFK---KLFRTPVYLTELHIKTLLYNL 165

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
            +G+     Y+H+     ++HRD+KP+N L++     K+CDFGLA
Sbjct: 166 LVGVK----YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 29/162 (17%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 123
            ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    I+ L 
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 124 GFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV-----ALG 173
              I  +      L+++ +       +  L    K  +    L    ++  +        
Sbjct: 92  DLIIPDDLLKFDELYIVLEI-----ADSDLK---KLFKTPIFLTEEHIKTILYNLLLGE- 142

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 215
                 ++H      ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 143 -----NFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 36/221 (16%)

Query: 66  RVLGRGALSFVFKG--KVGLLRTSVAIKRLDKEDKE-------SSKAFC----RELMIAS 112
           R +  G+   V  G    G     VAIKR+     +       S    C    RE+ + +
Sbjct: 28  RFISSGSYGAVCAGVDSEG---IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84

Query: 113 SLHHPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
             HHPNI+ L    +  E      L+L+ +      +   L    + +     +      
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLA---QVIHDQRIVISPQHI 136

Query: 169 KVAL-GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
           +  +  I   +  LH      VVHRD+ P NILL+      +CDF LA      +     
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA--REDTADANKT 191

Query: 228 KTVKGTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 267
             V     Y APE   Q    +   D+++ G V+ E+   +
Sbjct: 192 HYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 47/234 (20%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPL 122
           + LG+GA   V+K         VA+K++    ++   ++   RE+MI + L  H NIV L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 123 VGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIAE 176
           +        + ++L++ Y     +E  LH     +R N   P   +Y V      +    
Sbjct: 75  LNVLRADNDRDVYLVFDY-----METDLH---AVIRANILEPVHKQYVVYQLIKVI---- 122

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFG 235
              YLH+G    ++HRD+KPSNILL+++   K+ DFGL+ ++ +   V            
Sbjct: 123 --KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 236 ------------------YLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 270
                             Y APE      K +   D+++ G +L E+L   KPI
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 44/240 (18%), Positives = 87/240 (36%), Gaps = 59/240 (24%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIK--------------------RLDKEDKESSKAFC 105
            ++G+G+   V K    + +  VAIK                     ++K D E      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 106 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE--KKKGVRGNSTLP 163
              +    +   ++      C+  E              L  +L++  +    RG   + 
Sbjct: 120 H--LKRHFMFRNHL------CLVFE-------------MLSYNLYDLLRNTNFRG---VS 155

Query: 164 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAP 221
            ++  K A  +  ++ +L       ++H D+KP NILL + K    K+ DFG +      
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

Query: 222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
              ++      +  Y +PE           D+++ G +L+E+ TG +P+      G   +
Sbjct: 215 IYQYIQ-----SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPL----FSGANEV 264

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 47/233 (20%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL------HHPNI 119
           +V+G+G+   V K     +   VA+K + + +K   +    E+ I   L      +  N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 120 VPLVGF-------CIDPEQGLFLIYKYVSGGSLERHLHE--KKKGVRGNSTLPWSVRYKV 170
           + ++         C+  E              L  +L+E  KK   +G       +  K 
Sbjct: 162 IHMLENFTFRNHICMTFE-------------LLSMNLYELIKKNKFQG---FSLPLVRKF 205

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCK 228
           A  I + +  LH   +  ++H D+KP NILL  +     K+ DFG + +       ++  
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ- 261

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
               +  Y APE     +     D+++ G +L ELLTG  P+    L GE+  
Sbjct: 262 ----SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPL----LPGEDEG 305

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 38/224 (16%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---------- 115
           R LG G  S V+  K  +  T VA+K + + DK  ++A   E+ +   ++          
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 116 -HPNIVPLVG-FCIDPEQG--LFLIYKYVSGGSLERHLHE--KKKGVRGNSTLPWSVRYK 169
              +I+ L+  F      G  + ++++      L  +L    KK   RG   +P     +
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRG---IPLIYVKQ 135

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP------KLCDFGLATWTSAPSV 223
           ++  +   + Y+H      ++H DIKP N+L+     P      K+ D G A W      
Sbjct: 136 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193

Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 267
             +      T  Y +PE           D+++   ++ EL+TG 
Sbjct: 194 NSIQ-----TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.3 bits (127), Expect = 5e-08
 Identities = 30/213 (14%), Positives = 52/213 (24%), Gaps = 58/213 (27%)

Query: 56  LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAF--------- 104
              T    +   +G G    VF+       T VAIK   ++  D  +             
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73

Query: 105 ------CRELMIASSLHHPNIVPLVGFCI-----------------------------DP 129
                    L           + L                                    
Sbjct: 74  IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133

Query: 130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV 189
           +  LF++ ++  GG     +  K            +    +   +  S+A          
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSS--------LATAKSILHQLTASLAVAEASLR--F 183

Query: 190 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
            HRD+   N+LL    + KL        ++ PS
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 57/295 (19%), Positives = 98/295 (33%), Gaps = 82/295 (27%)

Query: 68  LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-----ASSLHHPN---I 119
           LG G  S V+       +  VA+K + K  +  ++    E+ +      S  + PN   +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 120 VPLVG-FCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           V L+  F I    G  + ++++ V G  L + + +          LP     K+   + +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIK-----SNYQGLPLPCVKKIIQQVLQ 157

Query: 177 SVAYLHNGTERCVVHRDIKPSNILL----------------------------------- 201
            + YLH  T+  ++H DIKP NILL                                   
Sbjct: 158 GLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 202 --------------SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 247
                         + K   K+ D G A W        +      T  Y + E       
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGY 270

Query: 248 SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP 302
           +   D+++   +  EL TG    E    +       + +   H  +A + ELL  
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEE------YTRDEDH--IALIIELLGK 317

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 35/193 (18%), Positives = 64/193 (33%), Gaps = 31/193 (16%)

Query: 45  NSLIRLSYGEILAAT--HNFSKGRVLGRGALSFVFKG--------KVGLLRTSVAIK--- 91
            SL  L  G +L       +       R     +++           G  +   ++K   
Sbjct: 25  TSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA 84

Query: 92  ---RLDKEDK----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 144
              RL  E       +      +     S     I   +GF +  ++  FL+   + G S
Sbjct: 85  KDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRS 143

Query: 145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 204
           L+  L    K       L      +VA  + +++ +LH   E   VH ++   NI +  +
Sbjct: 144 LQSALDVSPKH-----VLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPE 195

Query: 205 KIPK--LCDFGLA 215
              +  L  +G A
Sbjct: 196 DQSQVTLAGYGFA 208

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 31/170 (18%), Positives = 63/170 (37%), Gaps = 30/170 (17%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--------------KAFCRELMI 110
           G+ +G G    ++           A   +  E +E+               K   ++ + 
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 111 ASSLHHPNIVPLVGFCIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
              L +  I    G  +   +G    F++ + + G  L++   +             S  
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT-------FKKSTV 153

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK--LCDFGLA 215
            ++ + + + + Y+H   E   VH DIK +N+LL  K   +  L D+GL+
Sbjct: 154 LQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 18/38 (47%), Positives = 23/38 (60%), Gaps = 5/38 (13%)

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPK--LCDFGLA 215
           Y+H   E   VH DIK SN+LL+ K   +  L D+GLA
Sbjct: 167 YIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 39/169 (23%), Positives = 61/169 (36%), Gaps = 33/169 (19%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           NF  G+ +G G    +  GK       VAIK    + +        E      L   + +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--LHLEYRFYKQLGSGDGI 67

Query: 121 PLVGFCIDPEQGLFLIYKYVS----GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA- 175
           P V +      G    Y  +     G SLE  L +            +S+  K  L IA 
Sbjct: 68  PQVYYF-----GPCGKYNAMVLELLGPSLE-DLFDLCDRT-------FSL--KTVLMIAI 112

Query: 176 ---ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK-----LCDFGLAT 216
                + Y+H+   + +++RD+KP N L+            + DF LA 
Sbjct: 113 QLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 29/138 (21%), Positives = 48/138 (34%), Gaps = 44/138 (31%)

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-------------------KL 209
            +A  +  ++ +LH   E  + H D+KP NIL  + +                     ++
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPE------YFQHGKVSDKTDVYAFGVVLLEL 263
            DFG AT+        +      T  Y  PE      +      +   DV++ G +L E 
Sbjct: 184 ADFGSATFDHEHHTTIVA-----TRHYRPPEVILELGW------AQPCDVWSIGCILFEY 232

Query: 264 LTGRKPIEARRLQGEENL 281
             G   +     Q  EN 
Sbjct: 233 YRG-FTL----FQTHENR 245

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 32/138 (23%), Positives = 48/138 (34%), Gaps = 44/138 (31%)

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-------------------KL 209
           K+A  I +SV +LH      + H D+KP NIL                          K+
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPE------YFQHGKVSDKTDVYAFGVVLLEL 263
            DFG AT+        +      T  Y APE      +      S   DV++ G +L+E 
Sbjct: 179 VDFGSATYDDEHHSTLVS-----TRHYRAPEVILALGW------SQPCDVWSIGCILIEY 227

Query: 264 LTGRKPIEARRLQGEENL 281
             G   +        ++ 
Sbjct: 228 YLG-FTV----FPTHDSK 240

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 34/144 (23%), Positives = 52/144 (36%), Gaps = 50/144 (34%)

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--------------------- 207
              + I +++ YL    +  + H D+KP NILL                           
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 208 ----KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE------YFQHGKVSDKTDVYAFG 257
               KL DFG AT+ S      +      T  Y APE      +         +D+++FG
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIIN-----TRQYRAPEVILNLGW------DVSSDMWSFG 246

Query: 258 VVLLELLTGRKPIEARRLQGEENL 281
            VL EL TG   +     +  E++
Sbjct: 247 CVLAELYTG-SLL----FRTHEHM 265

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 5e-05
 Identities = 60/431 (13%), Positives = 112/431 (25%), Gaps = 161/431 (37%)

Query: 30  WRKIQSLERSISPVANSLIRLSYGEILAATHN----FSKGRV--------LGRGAL---- 73
              I+       P   S++   Y E     +N    F+K  V        L R AL    
Sbjct: 95  MSPIK--TEQRQP---SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL-RQALLELR 148

Query: 74  --SFVF-KGKVGLLRTSVAIKRLDKEDKESSKAF---------CRE----LMIASSLHHP 117
               V   G +G  +T VA+        +    F         C      L +   L + 
Sbjct: 149 PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY- 207

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
            I P   +    +    +  +  S    L R L  K               Y+  L    
Sbjct: 208 QIDP--NWTSRSDHSSNIKLRIHSIQAELRRLLKSK--------------PYENCL---- 247

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
                       +V  ++        + K     +               CK +  T   
Sbjct: 248 ------------LVLLNV-------QNAKAWNAFNLS-------------CKILLTT--- 272

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLE-LLTGRKPIEARRLQGEENLVLWAK--------- 286
                 +  +V+D         + L+       P E + L     L+ +           
Sbjct: 273 ------RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL-----LLKYLDCRPQDLPRE 321

Query: 287 -----PILHRGMAAVEELLDPRLKCTSRNSAQI-----ARVIQAAAACISSEESRR---- 332
                P     + A E + D     T  N   +       +I+++   +   E R+    
Sbjct: 322 VLTTNP-RRLSIIA-ESIRDG--LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377

Query: 333 ----------PGIEEIIAIL-----RGEEELI------YCTWKKHNFSGII---DCYPQL 368
                     P    +++++     + +  ++      Y   +K      I     Y +L
Sbjct: 378 LSVFPPSAHIP--TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL 435

Query: 369 QQTKSEMKS-H 378
           +       + H
Sbjct: 436 KVKLENEYALH 446

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 2e-04
 Identities = 50/330 (15%), Positives = 88/330 (26%), Gaps = 126/330 (38%)

Query: 1   MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATH 60
           +N+    S   ++  L+  L                + S +      I+L    I     
Sbjct: 187 LNLKNCNSPETVLEMLQK-LLYQIDPNWT----SRSDHSSN------IKLRIHSI----- 230

Query: 61  NFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAF---CRELMI--- 110
                    +  L  + K K     LL     +  L   ++ ++  AF   C+ L+    
Sbjct: 231 ---------QAELRRLLKSKPYENCLL-----V--LLNVQNAKAWNAFNLSCKILLTTRF 274

Query: 111 --------ASSLHHPNIVPLV-GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST 161
                   A++  H ++          P++   L+ KY         L  +         
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTL--TPDEVKSLLLKY---------LDCRP------QD 317

Query: 162 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
           LP                      E    +    P    LS   I +    GLATW +  
Sbjct: 318 LP---------------------REVLTTN----P--RRLSI--IAESIRDGLATWDNWK 348

Query: 222 SVPF--LCKTVKGTFGYLAPEYFQHGKVSDKTDVY-AFGV----VLLELLTGRKPIEARR 274
            V    L   ++ +   L P  ++         ++    V               I    
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRK--------MFDRLSVFPPSA---------HIPTIL 391

Query: 275 LQGEENLVLWAKPILHRGMAAVEELLDPRL 304
           L      ++W   I    M  V +L    L
Sbjct: 392 LS-----LIWFDVIKSDVMVVVNKLHKYSL 416

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.1 bits (102), Expect = 8e-05
 Identities = 53/224 (23%), Positives = 82/224 (36%), Gaps = 32/224 (14%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           ++  GR +G G+   +F+G   L    VAIK   +           E      L     +
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGI 68

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---- 176
           P V +         L+   + G SLE  L +     R  S        K     A+    
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL-GPSLE-DLLDLCG--RKFSV-------KTVAMAAKQMLA 117

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPK-----LCDFGLAT-WTSAPS---VPFL- 226
            V  +H   E+ +V+RDIKP N L+            + DFG+   +    +   +P+  
Sbjct: 118 RVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174

Query: 227 CKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKP 269
            K + GT  Y        G+  S + D+ A G V +  L G  P
Sbjct: 175 KKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 57/222 (25%), Positives = 83/222 (37%), Gaps = 38/222 (17%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           GR +G G+   ++ G        VAIK  + + K        E  I   L     +P V 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVR 69

Query: 125 FCIDPEQGLFLIYKYVS----GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA----E 176
           +      G+   Y  +     G SLE  L               S+  K  L +A     
Sbjct: 70  WF-----GVEGDYNVLVMDLLGPSLE-DLFNFCSR-------KLSL--KTVLMLADQMIN 114

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPK---LCDFGLATWTSAPS----VPFL-CK 228
            V ++H    +  +HRDIKP N L+   +      + DFGLA      S    +P+   K
Sbjct: 115 RVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 229 TVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKP 269
            + GT  Y A      G   S + D+ + G VL+  L G  P
Sbjct: 172 NLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 22/214 (10%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
           GR +G G+   ++ G        VAIK    + K        E  I   +     +P + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIR 71

Query: 125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 184
           +C        ++ + + G SLE   +   +     + L       +A  +   + Y+H+ 
Sbjct: 72  WCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVL------LLADQMISRIEYIHS- 123

Query: 185 TERCVVHRDIKPSNILLSSKKIPK---LCDFGLAT-WTSAPS---VPFL-CKTVKGTFGY 236
             +  +HRD+KP N L+   K      + DFGLA  +  A +   +P+   K + GT  Y
Sbjct: 124 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 237 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKP 269
            A      G   S + D+ + G VL+    G  P
Sbjct: 182 -ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	398
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.78
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.72
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.52
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.47
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.21
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.21
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.13
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.73
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.71
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.55
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.52
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.44
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.31
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.21
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.16
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.14
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.46
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.39
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.96
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.52
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.16
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.62
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.2

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.2e-60  Score=440.23  Aligned_cols=263  Identities=25%  Similarity=0.390  Sum_probs=210.9

Q ss_pred             cCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++|...+.||+|+||+||+|.+.     .++..||||+++.......++|.+|++++++++|||||+++|+|.+++ .++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-PLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EEE
Confidence            56778899999999999999874     347889999998877777889999999999999999999999988754 489


Q ss_pred             EEEecCCCCCHHHHHhhhcc------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCee
Q 015931          135 LIYKYVSGGSLERHLHEKKK------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  208 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~------~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  208 (398)
                      ||||||++|+|.++|.....      .......++|..++.|+.|+|+||+|||+++   |+||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            99999999999999976420      0112357999999999999999999999988   99999999999999999999


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+   +..   .
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~---~  242 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE---C  242 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---H
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---H
Confidence            999999987655433333344679999999999999999999999999999999999 999998654321   111   0


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                              +...  ..+..+...+   ..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       243 --------i~~~--~~~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          243 --------ITQG--RVLQRPRTCP---QEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             --------HHHT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------HHcC--CCCCCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                    1110  1111222233   3466777899999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-59  Score=442.41  Aligned_cols=264  Identities=24%  Similarity=0.361  Sum_probs=204.8

Q ss_pred             cCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++|...+.||+|+||+||+|.+.     .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+ .++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-PLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEE
Confidence            46677789999999999999864     357889999998877777889999999999999999999999988754 489


Q ss_pred             EEEecCCCCCHHHHHhhhccC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          135 LIYKYVSGGSLERHLHEKKKG--------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      ||||||++|+|.+++......        .....+++|..++.|+.|+|+||+|||+.+   |+||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            999999999999999864321        012356999999999999999999999988   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+   +..  
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~--  271 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AID--  271 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHH--
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHH--
Confidence            99999999997755443333455679999999999999999999999999999999999 999997644321   111  


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                               .+....  ++..+...+   ..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       272 ---------~i~~g~--~~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          272 ---------CITQGR--ELERPRACP---PEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             ---------HHHHTC--CCCCCTTCC---HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---------HHHcCC--CCCCccccc---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence                     111111  122222233   34667778999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-58  Score=433.44  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=201.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .+++...+.||+|+||+||+|.+..   .||||+++..  .....+.|.+|+.++++++|||||+++|+|.+  +.++||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEE
Confidence            3577788999999999999998753   5999998643  34556789999999999999999999998754  347999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||++|+|.++|....      ..++|..+..|+.|+|+||+|||+++   |+||||||+||||++++.+||+|||+|+
T Consensus       110 mEy~~gGsL~~~l~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             EECCSSCBHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             EEcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCce
Confidence            99999999999997643      46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhcc---CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ...............||+.|||||++..   +.++.++|||||||+||||+||+.||...+....  +.    ....   
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~----~~~~---  251 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--II----FMVG---  251 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHH---
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HH----HHHh---
Confidence            7655433333456789999999999863   4689999999999999999999999976432211  10    0110   


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                         .....|.+..  ........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       252 ---~~~~~p~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          252 ---RGYASPDLSK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             ---TTCCCCCSTT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             ---cCCCCCCccc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               1112222211  1112234566777899999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7e-59  Score=436.06  Aligned_cols=262  Identities=28%  Similarity=0.374  Sum_probs=207.6

Q ss_pred             CCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++...+.||+|+||+||+|.+.     .+++.||||++.... ....+.|.+|+.++++++|||||+++|+|.+.+ .++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-PLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-EEE
Confidence            3445678999999999999863     356789999997543 344678999999999999999999999987754 479


Q ss_pred             EEEecCCCCCHHHHHhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          135 LIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      ||||||++|+|.++|.......         .....++|..++.|+.|||+||+|||+++   |+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999997642110         11246999999999999999999999988   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHH
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  284 (398)
                      .+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||...+..+   +...
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999987654433333445679999999999999999999999999999999998 899998654321   1110


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                                 +..  ...+..+...+   ..+.+++.+||+.||.+||||.||++.|+..
T Consensus       260 -----------i~~--~~~~~~p~~~~---~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 -----------IRN--RQVLPCPDDCP---AWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -----------HHT--TCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------HHc--CCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                       111  01111222233   4466778899999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7e-58  Score=433.36  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=208.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ..|+..+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+|+.++|||||++++++.+. +.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeC
Confidence            4588889999999999999999999999999999765545556788999999999999999999998775 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      |+||+|.+++..        ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+.
T Consensus       153 ~~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          153 LEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             CTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            999999999975        35999999999999999999999998   9999999999999999999999999999775


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+....   .   .        .+...
T Consensus       222 ~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~---~--------~i~~~  285 (346)
T 4fih_A          222 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M---K--------MIRDN  285 (346)
T ss_dssp             SSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---H--------HHHHS
T ss_pred             CCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H---H--------HHHcC
Confidence            4432  23567899999999999999999999999999999999999999976543211   0   0        11222


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.+......+   ..+.+++.+||+.||++|||+.|+++
T Consensus       286 ~~~~~~~~~~~s---~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 LPPRLKNLHKVS---PSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCCCCSCGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCccccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222222211122   34667778999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7e-58  Score=434.01  Aligned_cols=251  Identities=23%  Similarity=0.367  Sum_probs=201.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||+||+|.+..+|+.||||++...  .....+.+.+|+.++++++|||||++++++.+. +.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEE
Confidence            6889999999999999999999999999999999765  344567899999999999999999999998774 5589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |||+||+|.+++.....     ..+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.
T Consensus       103 Ey~~gg~L~~~i~~~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-----VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             eCCCCCcHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccccee
Confidence            99999999999976432     56899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      .....  ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+...      ....+..       
T Consensus       175 ~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~-------  239 (350)
T 4b9d_A          175 LNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIIS-------  239 (350)
T ss_dssp             CCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHH-------
T ss_pred             ecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHc-------
Confidence            64321  12345679999999999999999999999999999999999999998654321      1111111       


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ... +.+  +...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~-~~~--~~~~s---~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          240 GSF-PPV--SLHYS---YDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TCC-CCC--CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC-CCC--CccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            101 111  11122   34667778999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.8e-57  Score=418.19  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=197.9

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC---CCcEEEEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLFLIY  137 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~lV~  137 (398)
                      ...+.||+|+||+||+|.+..++..||+|++...  .....+.|.+|++++++++|||||++++++.+.   +..+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4556799999999999999999999999999653  344567899999999999999999999987642   34579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DfGla~  216 (398)
                      |||++|+|.+++...       ..+++..+..|+.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+
T Consensus       109 Ey~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            999999999999875       46999999999999999999999865 3599999999999998 47999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......    ....+||+.|||||++. ++++.++|||||||++|||+||+.||.......  .+.   .        .+
T Consensus       181 ~~~~~~----~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~---~--------~i  242 (290)
T 3fpq_A          181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY---R--------RV  242 (290)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH---H--------HH
T ss_pred             eCCCCc----cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHH---H--------HH
Confidence            654322    34678999999999886 469999999999999999999999997533211  010   0        01


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....+... +...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~-~~~~~---~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          243 TSGVKPASF-DKVAI---PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTTCCCGGG-GGCCC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HcCCCCCCC-CccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111100 11112   24567778999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-57  Score=424.71  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=208.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||+||+|.+..+++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+. +.+|+|
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence            57999999999999999999999999999999997532   23456789999999999999999999987764 568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||+||+|.+++...       ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus       111 mEy~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence            9999999999999875       45999999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .+..........+.+||+.|||||++.+..++.++||||+||++|||+||+.||...+...   +              +
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~--------------~  243 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---I--------------F  243 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--------------H
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H--------------H
Confidence            8765443334456789999999999999999999999999999999999999998654321   1              1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII  339 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl  339 (398)
                      ..+....+..+...+.   .+.+++.+||+.||.+|||+.|++
T Consensus       244 ~~i~~~~~~~p~~~s~---~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          244 AKIIKLEYDFPEKFFP---KARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHHTCCCCCTTCCH---HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHHcCCCCCCcccCH---HHHHHHHHHccCCHhHCcChHHHc
Confidence            1111111222222233   456677899999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.1e-57  Score=426.19  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=202.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .+.|...+.||+|+||+||+|.+..+|+.||||+++....     ..+|+.+++.++|||||++++++.+. +.+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREG-PWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEe
Confidence            4567778899999999999999999999999999976432     24699999999999999999998774 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEeccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW  217 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DfGla~~  217 (398)
                      ||+||+|.+++...       ..+++..+..++.|++.||+|||+++   |+||||||+||||+.++ .+||+|||+|+.
T Consensus       131 y~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             CCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             ccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence            99999999999875       45999999999999999999999988   99999999999999887 699999999997


Q ss_pred             cCCCCCc---eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          218 TSAPSVP---FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       218 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      .......   ......+||+.|||||++.+..++.++|||||||++|||+||+.||...+.......+      ....  
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~--  272 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEP--  272 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSC--
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCC--
Confidence            7543211   1223467999999999999999999999999999999999999999875543321111      1000  


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                            .+....+...+   ..+.+++.+||+.||.+|||+.|+++.|..
T Consensus       273 ------~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          273 ------PPIREIPPSCA---PLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             ------CGGGGSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCchhcCccCC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                  00001112222   345667788999999999999999988764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.1e-57  Score=430.17  Aligned_cols=270  Identities=26%  Similarity=0.403  Sum_probs=215.7

Q ss_pred             HHHhhcCCCCCceecccCceEEEEeeeCCC-----CcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCC-CCeeceeeEEE
Q 015931           55 ILAATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKED-KESSKAFCRELMIASSLHH-PNIVPLVGFCI  127 (398)
Q Consensus        55 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~  127 (398)
                      .....++|...+.||+|+||+||+|.+...     ++.||||.+.... ....+.|.+|+.+|.+++| ||||+++|+|.
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            334457889999999999999999987543     3679999997653 3446779999999999965 99999999998


Q ss_pred             cCCCcEEEEEecCCCCCHHHHHhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCc
Q 015931          128 DPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  198 (398)
Q Consensus       128 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~N  198 (398)
                      +.++.+++|||||++|+|.++|.......         .....++|..++.++.|||+||+|||+++   ||||||||+|
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~N  215 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN  215 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccc
Confidence            77667899999999999999998643210         11246899999999999999999999988   9999999999


Q ss_pred             EEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCccccccc
Q 015931          199 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQG  277 (398)
Q Consensus       199 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~  277 (398)
                      |||++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.......
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999997765544444456789999999999999999999999999999999998 999997654321


Q ss_pred             chhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .  +    ...       +.+..  ++..+...+.   .+.+++.+||+.||.+|||+.||++.|+.+
T Consensus       296 ~--~----~~~-------i~~g~--~~~~p~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          296 E--F----CRR-------LKEGT--RMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             H--H----HHH-------HHHTC--CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H--H----HHH-------HHcCC--CCCCCccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            1  1    111       11111  1222233333   456677889999999999999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-56  Score=433.72  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=209.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      +.|...+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+|+.++|||||++++++.+. +.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEeC
Confidence            4688999999999999999999999999999999876555566789999999999999999999998775 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      |+||+|.+++..        ..+++..+..|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+.
T Consensus       230 ~~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          230 LEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             CTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            999999999965        35999999999999999999999998   9999999999999999999999999999775


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+....   .   .        .+...
T Consensus       299 ~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~---~--------~i~~~  362 (423)
T 4fie_A          299 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M---K--------MIRDN  362 (423)
T ss_dssp             SSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---H--------HHHHS
T ss_pred             CCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H---H--------HHHcC
Confidence            4432  23467899999999999999999999999999999999999999976543211   0   0        12222


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.+......+.   .+.+++.+||+.||.+|||+.|+++
T Consensus       363 ~~~~~~~~~~~s~---~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          363 LPPRLKNLHKVSP---SLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCCCCSCTTSSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCcccccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2333332222233   4566777899999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.2e-57  Score=421.95  Aligned_cols=273  Identities=22%  Similarity=0.260  Sum_probs=202.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC---cEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~lV  136 (398)
                      ++|...+.||+|+||+||+|.+.  |+.||||++..... ....+..|+..+.+++|||||+++|+|.+.+.   .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            34666789999999999999985  88999999965422 22233456666678899999999999987543   47999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCceeecccccCcEEeCCCCCeeEec
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----ERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ||||++|+|.++++.        ..++|+.+.+++.|+++||+|||+++     .++|+||||||+||||+.++.+||+|
T Consensus        80 ~Ey~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             ecCCCCCcHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            999999999999976        35899999999999999999999861     23599999999999999999999999


Q ss_pred             cccccccCCCCCce--eeeccccCCCcccchhhccC------CcCCccchhhHHHHHHHHHcCCCCCcccccccchhH--
Q 015931          212 FGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHG------KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL--  281 (398)
Q Consensus       212 fGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~--  281 (398)
                      ||+|+.........  ......||+.|||||++.+.      .++.++|||||||++|||+||+.||...........  
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            99998765543221  12346799999999999754      478899999999999999999988765432211000  


Q ss_pred             H--HHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          282 V--LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       282 ~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .  .+........  .....++|.+.......+....+.+++.+||+.||++||||.||++.|+.+
T Consensus       232 ~~~~~~~~~~~~~--~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          232 VPSDPSVEEMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SCSSCCHHHHHHH--HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccchHHHHHHH--HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            0  0000000000  112223343332222345667788999999999999999999999999764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-55  Score=406.25  Aligned_cols=246  Identities=24%  Similarity=0.335  Sum_probs=190.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||+||+|.+..+++.||||++.+..   ......+.+|++++++++|||||++++++.+ ++.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence            68999999999999999999999999999999997642   2345679999999999999999999998766 4568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||| +|+|.+++...       ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+
T Consensus        92 mEy~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             EECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             EeCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCe
Confidence            9999 78999999764       46999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ......   ...+.+||+.|+|||++.+..+ +.++||||+||++|||+||+.||...+...      ...         
T Consensus       161 ~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~---------  222 (275)
T 3hyh_A          161 IMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFK---------  222 (275)
T ss_dssp             -----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------
T ss_pred             ecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHH---------
Confidence            765433   2345789999999999988776 579999999999999999999997643221      111         


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        .+.......+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       223 --~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          223 --NISNGVYTLPKFLS---PGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --HHHHTCCCCCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --HHHcCCCCCCCCCC---HHHHHHHHHHccCChhHCcCHHHHHc
Confidence              11111111122222   34566778999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-55  Score=411.88  Aligned_cols=248  Identities=27%  Similarity=0.341  Sum_probs=194.8

Q ss_pred             cCCCCCceecccCceEEEEeee---CCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++|...+.||+|+||+||+|+.   +.+++.||||++.+..  ......+.+|++++++++|||||++++++.+. +.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-GKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-TEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEE
Confidence            5799999999999999999986   3467899999997542  22234688899999999999999999998774 5589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +|||||+||+|.+++...       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       103 ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EEEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccc
Confidence            999999999999999875       46999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      |+.......  ...+.+||+.|||||++.+..++.++|||||||++|||+||+.||...+..+.                
T Consensus       173 a~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----------------  234 (304)
T 3ubd_A          173 SKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET----------------  234 (304)
T ss_dssp             EEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             ceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH----------------
Confidence            986544322  23457899999999999999999999999999999999999999986543211                


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                       +..+....+..+...+.   .+.+++.+||+.||++|||     ++|+++
T Consensus       235 -~~~i~~~~~~~p~~~s~---~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          235 -MTMILKAKLGMPQFLSP---EAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -HHHHHHCCCCCCTTSCH---HHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -HHHHHcCCCCCCCcCCH---HHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             11111112222222333   4566778899999999998     456654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-54  Score=404.30  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=191.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-------
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-------  131 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  131 (398)
                      ++|+..+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35888899999999999999999999999999997543 3445679999999999999999999998875443       


Q ss_pred             ----cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCe
Q 015931          132 ----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  207 (398)
Q Consensus       132 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~  207 (398)
                          .+|+|||||++|+|.+++.....    ....++..++.|+.||++||+|||+++   |+||||||+||||+.++.+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT----IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS----GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC----CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcE
Confidence                36899999999999999986432    134567888999999999999999988   9999999999999999999


Q ss_pred             eEeccccccccCCCCCce----------eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc
Q 015931          208 KLCDFGLATWTSAPSVPF----------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  277 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~  277 (398)
                      ||+|||+|+.........          ..+..+||+.|||||++.+..++.++|||||||++|||++   ||...... 
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-  233 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-  233 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-
Confidence            999999998765432211          1234579999999999999999999999999999999996   77542210 


Q ss_pred             chhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                          ..           .+..+.+...  +.........+.+++.+||+.||.+|||+.|+++
T Consensus       234 ----~~-----------~~~~~~~~~~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 ----VR-----------TLTDVRNLKF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ----HH-----------HHHHHHTTCC--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HH-----------HHHHHhcCCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                00           0111111111  1111222334567888999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-51  Score=396.18  Aligned_cols=270  Identities=19%  Similarity=0.285  Sum_probs=202.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-----CCc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  132 (398)
                      ++|...+.||+|+||+||+|.+..+|+.||||++...  .....+.+.+|+++|+.++|||||++++++...     .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5788899999999999999999999999999999754  234456788999999999999999999986532     345


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|||||||+ |+|.+++...       ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~-------~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS-------QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEeCCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeec
Confidence            899999995 7899999764       56999999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCC--CceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          213 GLATWTSAPS--VPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       213 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      |+|+.+....  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....+.......
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998764321  11223457899999999998875 56999999999999999999999998765432221111000000


Q ss_pred             hh------chhhhhhhcCcccCCCCCCH-----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HR------GMAAVEELLDPRLKCTSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~------~~~~~~~~~d~~l~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..      ........+...-.......     .....+.+|+.+||..||.+|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00      00000000000000000000     01235678888999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.8e-50  Score=386.25  Aligned_cols=200  Identities=25%  Similarity=0.350  Sum_probs=169.1

Q ss_pred             hhcCCCCCceecccCceEEEEeeeC---CCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  133 (398)
                      ..+.|...+.||+|+||+||+|..+   .+++.||+|++....  ....+.+|+++|..+ +|||||++++++.+. +.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-DHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-TEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-CEE
Confidence            3578999999999999999999864   357889999986543  345678999999998 699999999987764 568


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeEecc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDF  212 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Df  212 (398)
                      |+|||||++|+|.+++.          .+++..+..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+||
T Consensus        96 ~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence            99999999999999983          3899999999999999999999998   9999999999999876 79999999


Q ss_pred             ccccccCCCCCc--------------------------eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHc
Q 015931          213 GLATWTSAPSVP--------------------------FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLT  265 (398)
Q Consensus       213 Gla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~ellt  265 (398)
                      |+|+........                          ......+||+.|+|||++.+. .++.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            999865432110                          112345799999999999875 58999999999999999999


Q ss_pred             CCCCCccc
Q 015931          266 GRKPIEAR  273 (398)
Q Consensus       266 G~~Pf~~~  273 (398)
                      |+.||...
T Consensus       243 G~~Pf~~~  250 (361)
T 4f9c_A          243 GRYPFYKA  250 (361)
T ss_dssp             TCSSSSCC
T ss_pred             CCCCCCCC
Confidence            99999643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.8e-50  Score=379.58  Aligned_cols=287  Identities=33%  Similarity=0.617  Sum_probs=237.0

Q ss_pred             cccCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEE
Q 015931           48 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI  127 (398)
Q Consensus        48 ~~~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  127 (398)
                      .++++.++...+++|...+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34566667778899999999999999999999975 58899999998776667788999999999999999999999976


Q ss_pred             cCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCe
Q 015931          128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  207 (398)
Q Consensus       128 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~  207 (398)
                      +.+ ..++||||+++|+|.+++.....   ....++|..++.++.|++.||.|||+.+   |+||||||+||+++.++.+
T Consensus       106 ~~~-~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~  178 (321)
T 2qkw_B          106 ERN-EMILIYKYMENGNLKRHLYGSDL---PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP  178 (321)
T ss_dssp             CTT-CCEEEEECCTTCBTGGGSSSSCC---CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCE
T ss_pred             CCC-eEEEEEEcCCCCcHHHHHhccCC---CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCE
Confidence            644 57999999999999999875431   1246999999999999999999999988   9999999999999999999


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      ||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....+........|...
T Consensus       179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  258 (321)
T 2qkw_B          179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE  258 (321)
T ss_dssp             EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred             EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence            99999999875543322233445689999999999988999999999999999999999999987766655555555544


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .....  .+...+++.+. ..........+.+++.+||+.||.+|||+.||++.|+..
T Consensus       259 ~~~~~--~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          259 SHNNG--QLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HHTTT--CCCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccc--cHHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            33222  34445555554 234567788899999999999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.2e-50  Score=406.44  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=208.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||+||+|.++.+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+ +..+|+||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEee
Confidence            578999999999999999999999999999999987776667789999999999999999999998776 4568999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC--CCeeEeccccccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLATW  217 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DfGla~~  217 (398)
                      |+||+|.+++....      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+.
T Consensus       236 ~~gg~L~~~i~~~~------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          236 MSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             CCCCBHHHHHTCTT------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             cCCCcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999999996542      46999999999999999999999998   9999999999999854  8999999999998


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      +....   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....                 +.
T Consensus       307 ~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-----------------~~  366 (573)
T 3uto_A          307 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----------------LR  366 (573)
T ss_dssp             CCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----------------HH
T ss_pred             ccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----------------HH
Confidence            76543   23456899999999999999999999999999999999999999986543211                 11


Q ss_pred             hhcCcccCCCC-CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+.......+. ........+.+++.+||+.||.+|||+.|+++
T Consensus       367 ~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          367 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111110000 00011234567788999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-49  Score=376.46  Aligned_cols=293  Identities=36%  Similarity=0.652  Sum_probs=236.7

Q ss_pred             cccccccCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeece
Q 015931           44 ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPL  122 (398)
Q Consensus        44 ~~~~~~~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  122 (398)
                      ......+++.++...+++|...+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            345678999999999999999999999999999999865 488999999976532 223368899999999999999999


Q ss_pred             eeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC
Q 015931          123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  202 (398)
Q Consensus       123 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~  202 (398)
                      ++++.+.+. .++||||+++|+|.+++.....   ....++|..++.++.|++.||.|||+....+|+||||||+|||++
T Consensus        93 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           93 RGFCMTPTE-RLLVYPYMANGSVASCLRERPE---SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD  168 (326)
T ss_dssp             CEEECCSSC-CEEEEECCTTCBHHHHHHCCST---TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred             EEEEecCCc-eEEEEEeccCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence            999876554 6899999999999999987532   235699999999999999999999998222399999999999999


Q ss_pred             CCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccc--cchh
Q 015931          203 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ--GEEN  280 (398)
Q Consensus       203 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~--~~~~  280 (398)
                      .++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......  ....
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM  247 (326)
T ss_dssp             TTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred             CCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence            9999999999999877544322 234556999999999999889999999999999999999999999743322  2223


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ...|........  .+..+.+..+. ..........+.+++.+||+.+|.+|||+.+|++.|++.
T Consensus       248 ~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          248 LLDWVKGLLKEK--KLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHHTTTTSSC--CSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHhhch--hhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            344443333322  34445555544 345677888999999999999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-49  Score=401.83  Aligned_cols=249  Identities=27%  Similarity=0.364  Sum_probs=200.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHH---HHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAF---CRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      ++|...++||+|+||+||+|....+|+.||||++.+..   ......+   ..++.+++.++|||||++++++.+. +.+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-CEE
Confidence            68999999999999999999999999999999996531   1112223   3446677788999999999987764 569


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      |+|||||+||+|..+|...       ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+|++||+|||
T Consensus       268 ylVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccc
Confidence            9999999999999999875       46999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +|+......    ..+.+||+.|||||++.. ..|+.++|||||||++|||++|+.||..........+.          
T Consensus       338 lA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----------  403 (689)
T 3v5w_A          338 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----------  403 (689)
T ss_dssp             TCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----------
T ss_pred             eeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----------
Confidence            998775433    245689999999999975 47899999999999999999999999875543321111          


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                          ..+.......+...+.   .+.+++.+||+.||.+|++     +.||++
T Consensus       404 ----~~i~~~~~~~p~~~S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          404 ----RMTLTMAVELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----HHHHHCCCCCCTTSCH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----HhhcCCCCCCCccCCH---HHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                1111112222222233   4566777899999999998     677775

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.1e-47  Score=356.22  Aligned_cols=285  Identities=31%  Similarity=0.564  Sum_probs=231.2

Q ss_pred             cccccCHHHHHHhhcCCCCC------ceecccCceEEEEeeeCCCCcEEEEEEecCC----ChhhHHHHHHHHHHHHhCC
Q 015931           46 SLIRLSYGEILAATHNFSKG------RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLH  115 (398)
Q Consensus        46 ~~~~~~~~e~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~  115 (398)
                      ....|++.++..++++|+..      +.||+|+||.||+|...  ++.||+|++...    .....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            34678999999999999888      89999999999999874  789999998653    2345678999999999999


Q ss_pred             CCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccc
Q 015931          116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  195 (398)
Q Consensus       116 h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlk  195 (398)
                      ||||+++++++.+.+ ..++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+.+   |+|||||
T Consensus        89 h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk  160 (307)
T 2nru_A           89 HENLVELLGFSSDGD-DLCLVYVYMPNGSLLDRLSCLDG----TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK  160 (307)
T ss_dssp             CTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHTGGG----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred             CCCeEEEEEEEecCC-ceEEEEEecCCCcHHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence            999999999987654 47999999999999999976432    256999999999999999999999988   9999999


Q ss_pred             cCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          196 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       196 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      |+||+++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999987655433333345679999999998864 589999999999999999999999986544


Q ss_pred             ccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ....  ..+.... ......+.+.+++.+.  .........+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       240 ~~~~--~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          240 PQLL--LDIKEEI-EDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             SSBT--THHHHHH-HTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             hHHH--HHHHHHh-hhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            3211  1111111 1111234555555553  345667778899999999999999999999999998653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5e-48  Score=362.02  Aligned_cols=251  Identities=22%  Similarity=0.364  Sum_probs=207.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||+||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-EEEEEEE
Confidence            368999999999999999999998889999999997665555677899999999999999999999987754 5899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++|+|.+++...        .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        98 ~~~~~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           98 YLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             CCTTCBHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            99999999999763        4899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........      ..        +..
T Consensus       167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~--------~~~  230 (297)
T 3fxz_A          167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YL--------IAT  230 (297)
T ss_dssp             CSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH--------HHH
T ss_pred             CCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH--------HHh
Confidence            54432  224567999999999999999999999999999999999999999764432110      00        011


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.+..+   ......+.+++.+||+.||.+|||+.|+++
T Consensus       231 ~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          231 NGTPELQNP---EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HCSCCCSCG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCc---cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111111111   112234667788999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.7e-48  Score=362.58  Aligned_cols=263  Identities=25%  Similarity=0.399  Sum_probs=213.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||+||+|.+..+++.||+|++........+.+.+|++++.+++||||+++++++.+. +..++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEE
Confidence            35788899999999999999999988999999999877777788999999999999999999999998875 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        88 ~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           88 YIKGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             CCTTCBHHHHHHHCC------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            999999999998743      46999999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCce------------eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh
Q 015931          219 SAPSVPF------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  286 (398)
Q Consensus       219 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  286 (398)
                      .......            ......||+.|+|||.+.+..++.++||||||+++|||++|..||.............. .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~  237 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-R  237 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-H
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-h
Confidence            5432211            01145799999999999999999999999999999999999999876443321110000 0


Q ss_pred             HHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCccc
Q 015931          287 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL  348 (398)
Q Consensus       287 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~  348 (398)
                      .       .......+..      +   ..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       238 ~-------~~~~~~~~~~------~---~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          238 G-------FLDRYCPPNC------P---PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             H-------HHHHTCCTTC------C---TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c-------cccccCCCCC------C---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0       0111111111      1   2366788899999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-47  Score=362.30  Aligned_cols=262  Identities=22%  Similarity=0.336  Sum_probs=213.3

Q ss_pred             cccCHHHHHHhhcC----------CCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCC
Q 015931           48 IRLSYGEILAATHN----------FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP  117 (398)
Q Consensus        48 ~~~~~~e~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  117 (398)
                      ..++++++..+++.          |+..+.||+|+||.||+|....+|+.||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45778888777754          56667999999999999999888999999999876666677899999999999999


Q ss_pred             CeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccC
Q 015931          118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  197 (398)
Q Consensus       118 niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~  197 (398)
                      ||+++++++...+ ..++||||+++++|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+
T Consensus       103 niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~  170 (321)
T 2c30_A          103 NVVEMYKSYLVGE-ELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD  170 (321)
T ss_dssp             TBCCEEEEEEETT-EEEEEECCCCSCBHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred             CcceEEEEEEECC-EEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence            9999999988754 58999999999999999864        35999999999999999999999988   999999999


Q ss_pred             cEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc
Q 015931          198 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  277 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~  277 (398)
                      ||+++.++.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus       171 NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~  248 (321)
T 2c30_A          171 SILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ  248 (321)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             HEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999987654322  1235679999999999999999999999999999999999999997643211


Q ss_pred             chhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ..   .        .+.....+.+......   ...+.+++.+||+.||.+|||+.++++
T Consensus       249 ---~~---~--------~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          249 ---AM---K--------RLRDSPPPKLKNSHKV---SPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ---HH---H--------HHHHSSCCCCTTGGGS---CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HH---H--------HHhcCCCCCcCccccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00   0        1112222222211111   234667778999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.4e-48  Score=367.30  Aligned_cols=276  Identities=24%  Similarity=0.285  Sum_probs=210.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC---cEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~  134 (398)
                      ..++|...+.||+|+||+||+|.+.  ++.||||++..... ....+..|+.++.+++||||+++++++.+...   .++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            3468899999999999999999876  78999999975433 34456678999999999999999999877543   368


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCceeecccccCcEEeCCC
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG----------TERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~----------~~~~ivHrDlkp~NIll~~~  204 (398)
                      +||||+++|+|.+++..        ..++|..++.++.|++.||.|||+.          +   |+||||||+|||++.+
T Consensus        99 lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             EEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTT
T ss_pred             EEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCC
Confidence            99999999999999976        3489999999999999999999987          6   9999999999999999


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc-----CCcCCccchhhHHHHHHHHHcCCCCCcccccccch
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  279 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~  279 (398)
                      +.+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++|||+||+.||.........
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999999999987655433322344679999999999986     35677899999999999999999999865443222


Q ss_pred             hHHHHhhH--HHhhchh-hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          280 NLVLWAKP--ILHRGMA-AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       280 ~~~~~~~~--~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                      ........  ....... .......+.+............+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11111000  0000000 01111112221111122445668899999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4e-47  Score=360.79  Aligned_cols=248  Identities=28%  Similarity=0.395  Sum_probs=205.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++... +..++|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-KTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEE
Confidence            46899999999999999999999888999999999754  345567788999999999999999999997664 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        93 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             ECCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             EECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            9999999999999775       45999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcC-CccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS-DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .......   .....||+.|+|||.+.+..++ .++|||||||++|||++|+.||...+....                 
T Consensus       163 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----------------  222 (328)
T 3fe3_A          163 EFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-----------------  222 (328)
T ss_dssp             GGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------
T ss_pred             ecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-----------------
Confidence            7654332   2456799999999999887764 799999999999999999999986543211                 


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.......+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       223 ~~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          223 RERVLRGKYRIPFYMS---TDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHHCCCCCCTTSC---HHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHHhCCCCCCCCCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0111111112122222   34567778899999999999999987

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-47  Score=367.75  Aligned_cols=275  Identities=26%  Similarity=0.400  Sum_probs=216.9

Q ss_pred             cCHHHHHHhhcCCCCCceecccCceEEEEee-----eCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeece
Q 015931           50 LSYGEILAATHNFSKGRVLGRGALSFVFKGK-----VGLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPL  122 (398)
Q Consensus        50 ~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l  122 (398)
                      +...+.....++|...+.||+|+||.||+|.     ...+++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3444555567899999999999999999998     45567899999997643 34456799999999999 79999999


Q ss_pred             eeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCC---------------------------------------------
Q 015931          123 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR---------------------------------------------  157 (398)
Q Consensus       123 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~---------------------------------------------  157 (398)
                      ++++.+.+...++||||+++|+|.+++........                                             
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998877768999999999999999986532000                                             


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC
Q 015931          158 --------------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  223 (398)
Q Consensus       158 --------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  223 (398)
                                    ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                          0123899999999999999999999988   99999999999999999999999999987655443


Q ss_pred             ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCc
Q 015931          224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  302 (398)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  302 (398)
                      ........||+.|+|||++.+..++.++||||||+++|||++ |+.||........  ..    .       .+......
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~-------~~~~~~~~  315 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----R-------RLKEGTRM  315 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH----H-------HHHHTCCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HH----H-------HHHcCCCC
Confidence            333445678999999999999999999999999999999998 9999976543211  00    0       01111111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          303 RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       303 ~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ..  +...+   ..+.+++..||+.+|.+|||+.||++.|+.+
T Consensus       316 ~~--~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          316 RA--PDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC--CCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11  11122   3466777899999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.6e-47  Score=356.94  Aligned_cols=261  Identities=31%  Similarity=0.482  Sum_probs=199.3

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ..++|...+.||+|+||+||+|...  ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+ ..++
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~l  111 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-NLSI  111 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-CCEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-ceEE
Confidence            3568888999999999999999874  7889999997653  345567999999999999999999999987654 4799


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|.+++.....    ...+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.+||+|||++
T Consensus       112 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGA----REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTH----HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEecCCCCcHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            9999999999999976421    124899999999999999999999764 34999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........   ...           
T Consensus       187 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~~~-----------  250 (309)
T 3p86_A          187 RLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---VAA-----------  250 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HHH-----------
T ss_pred             cccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-----------
Confidence            86543321  22456799999999999999999999999999999999999999976543211   000           


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      + .........+...+   ..+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       251 ~-~~~~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          251 V-GFKCKRLEIPRNLN---PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             H-HHSCCCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H-HhcCCCCCCCccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0 00111111122222   34667778999999999999999999998653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.3e-47  Score=358.27  Aligned_cols=258  Identities=24%  Similarity=0.388  Sum_probs=204.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCC---cEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+.||+|+||.||+|.+..++   ..||||++... .....+.+.+|+.+++.++||||+++++++.+.+ ..++
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l  127 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-LAMI  127 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-CCEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-ccEE
Confidence            46777899999999999999987544   45999999765 4445678999999999999999999999987644 4799


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       128 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EeeCCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcc
Confidence            999999999999997542      46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          216 TWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       216 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   ...          
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----------  265 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VIS----------  265 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHH----------
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----------
Confidence            877543221 12233456788999999998899999999999999999999 999997643321   100          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                       .+.....  ...+...   ...+.+++..||+.+|.+|||+.+|++.|+.+.
T Consensus       266 -~~~~~~~--~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          266 -SVEEGYR--LPAPMGC---PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             -HHHTTCC--CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHcCCC--CCCCCCc---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             0111111  1111112   245667788999999999999999999998753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.1e-47  Score=364.31  Aligned_cols=265  Identities=21%  Similarity=0.359  Sum_probs=208.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-------CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  129 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  129 (398)
                      .++|...+.||+|+||.||+|.+.       .++..||||++.... ......+.+|+.+++.+ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            357888899999999999999863       245679999997653 34567899999999999 899999999998765


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                       +.+|+||||+++|+|.+++......         ......+++..++.++.|++.||.|||+.+   |+||||||+|||
T Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          160 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             -CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence             4589999999999999999875310         001245899999999999999999999988   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccch
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  279 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  279 (398)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            99999999999999987654432222334567889999999999899999999999999999999 999997644321  


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                       +..           .+.....+..  +...   ...+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus       314 -~~~-----------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 -LFK-----------LLKEGHRMDK--PANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             -HHH-----------HHHTTCCCCC--CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHH-----------HHhcCCCCCC--CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             110           0111111111  1112   235667778999999999999999999998653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-47  Score=370.64  Aligned_cols=259  Identities=26%  Similarity=0.426  Sum_probs=207.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ..++|...+.||+|+||.||+|.+..+++.||||.+.... ......|.+|+.++++++||||++++++|.+. +..++|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv  190 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIV  190 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-SSCEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-CCcEEE
Confidence            3467888899999999999999998889999999987542 34456788999999999999999999998764 457999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       191 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             EECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999998653      35899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ...............++..|+|||.+..+.++.++|||||||++|||++ |..||........   .    ..       
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~----~~-------  327 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---R----EF-------  327 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---H----HH-------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HH-------
Confidence            6543221111112345778999999998899999999999999999998 9999976432210   0    00       


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      +...  .++..+...+   ..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       328 ~~~~--~~~~~~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          328 VEKG--GRLPCPELCP---DAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             HHTT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcC--CCCCCCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            1110  1111122223   3466777899999999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.8e-47  Score=360.13  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=201.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcE----EEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .++|...+.||+|+||+||+|.+..+++.    ||+|.+... .....+.+.+|+.++++++||||++++++|.+..  .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~   91 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--E
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--e
Confidence            35788899999999999999998766654    588877543 2345678999999999999999999999988743  6


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++|++|+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCc
Confidence            89999999999999998743      46999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++...............||..|+|||++.+..++.++|||||||++|||++ |+.||...........           
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----------  231 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----------  231 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----------
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-----------
Confidence            9987765543333344567889999999999999999999999999999999 9999976543321110           


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                         +....  ....+   ......+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       232 ---~~~~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          232 ---LEKGE--RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ---HHTTC--CCCCC---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHcCC--CCCCC---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence               11100  11111   122345777888999999999999999999998654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=366.73  Aligned_cols=266  Identities=26%  Similarity=0.376  Sum_probs=208.4

Q ss_pred             hcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .++|...+.||+|+||+||+|.+     ..++..||||++... .......+.+|+.++++++||||+++++++.+.. .
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-P  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-C
Confidence            36788899999999999999994     345778999999754 3455667899999999999999999999987654 4


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC---CeeE
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKL  209 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl  209 (398)
                      .++||||+++|+|.+++............+++..++.++.|++.||+|||+.+   |+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            79999999999999999876543333456999999999999999999999988   99999999999999554   5999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      +|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||.......   +..     
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~-----  297 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE-----  297 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH-----
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----
Confidence            99999975432222122234568999999999999999999999999999999998 999997654321   110     


Q ss_pred             HhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                            .+....  ....+...   ...+.+++.+||+.+|.+|||+.+|++.|+....
T Consensus       298 ------~i~~~~--~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          298 ------FVTSGG--RMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             ------HHHTTC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHcCC--CCCCCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                  011100  11111112   2346677889999999999999999999986543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.5e-47  Score=356.47  Aligned_cols=273  Identities=25%  Similarity=0.326  Sum_probs=206.6

Q ss_pred             hcCCCCCceecccCceEEEEee----eCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~  133 (398)
                      .++|...+.||+|+||+||+|.    ...+++.||||++........+.+.+|+.++.+++||||+++++++...+ ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            3678889999999999999998    45678999999998877777788999999999999999999999886432 347


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCc
Confidence            89999999999999998753      35899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH--HhhHHHh
Q 015931          214 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL--WAKPILH  290 (398)
Q Consensus       214 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~  290 (398)
                      +++........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+.............  .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            99876543221 11233457788999999999999999999999999999999999987543210000000  0000000


Q ss_pred             hchhhhhhhc-CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          291 RGMAAVEELL-DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       291 ~~~~~~~~~~-d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      .   ....+. ......+...   ...+.+++.+||+.+|.+|||+.||++.|+.+.
T Consensus       240 ~---~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          240 H---LIELLKNNGRLPRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             H---HHHHHHTTCCCCCCTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H---HHHHHhccCcCCCCcCc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            0   000111 1111112222   245667788999999999999999999998653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-46  Score=355.75  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=204.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++.+.   .......+.+|+.++..++||||+++++++.+. +.+++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-CEEEE
Confidence            35788899999999999999999989999999999753   223456788999999999999999999988764 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|..++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        83 v~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a  152 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             EEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccch
Confidence            99999999999999865       45899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +              
T Consensus       153 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~--------------  213 (337)
T 1o6l_A          153 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L--------------  213 (337)
T ss_dssp             BCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--------------
T ss_pred             hhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---H--------------
Confidence            86433221  2345679999999999999899999999999999999999999997643221   0              


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ...+....+..+...+   ..+.+++.+||+.+|.+||     ++.||++
T Consensus       214 ~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          214 FELILMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHHCCCCCCTTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHcCCCCCCCCCC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            0111111112122222   3456677789999999999     8999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-46  Score=363.74  Aligned_cols=259  Identities=28%  Similarity=0.435  Sum_probs=195.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeC---CCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|+||.||+|.+.   ..+..||||.+... .....+.|.+|+.++.+++||||+++++++.+. ...+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  122 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-KPVM  122 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CceE
Confidence            358999999999999999999876   45678999999765 344567899999999999999999999998765 4579


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       123 lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHD------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcc
Confidence            9999999999999997642      46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          215 ATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       215 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      ++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.......   ...         
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~---------  261 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIK---------  261 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHH---------
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---------
Confidence            9876543211 11122345788999999999999999999999999999998 999997543221   100         


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                        .+....  ....+   ......+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       262 --~i~~~~--~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          262 --AVDEGY--RLPPP---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             --HHHTTE--ECCCC---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHcCC--CCCCC---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence              011100  11111   122345677888999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-45  Score=345.36  Aligned_cols=260  Identities=27%  Similarity=0.395  Sum_probs=204.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|.+..++..||+|.+...   .....+.+.+|+.++.+++||||+++++++.+. +..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-DCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-SEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-CeEEE
Confidence            36789999999999999999999888999999998543   334567899999999999999999999997664 55899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        89 v~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             EEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             EEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            99999999999999875       45999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ...........
T Consensus       159 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~  231 (294)
T 4eqm_A          159 KALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDSVPN  231 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSCCCC
T ss_pred             ccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhccCCC
Confidence            876543221 22345799999999999998999999999999999999999999976543210      00111000000


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-CHHHHHHHHhcC
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-GIEEIIAILRGE  345 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~~  345 (398)
                      .....      ...   ....+.+++.+||+.+|.+|| ++.++.+.|+..
T Consensus       232 ~~~~~------~~~---~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          232 VTTDV------RKD---IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HHHHS------CTT---SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             cchhc------ccC---CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            00000      111   123567778899999999998 999999999764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.6e-46  Score=359.61  Aligned_cols=251  Identities=26%  Similarity=0.346  Sum_probs=204.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh------hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE------SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .+.|...+.||+|+||.||+|....+++.||+|++......      ..+.+.+|+.++..++||||+++++++.+. ..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~   89 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-TD   89 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-CE
Confidence            46788999999999999999999989999999999764321      356789999999999999999999998764 55


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC----Cee
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPK  208 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~k  208 (398)
                      .++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++    .+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC-------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEE
Confidence            89999999999999999753       46999999999999999999999988   99999999999998776    799


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      |+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....          
T Consensus       160 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~----------  226 (361)
T 2yab_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------  226 (361)
T ss_dssp             ECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------
T ss_pred             EEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----------
Confidence            999999987655322   2356799999999999988999999999999999999999999976543211          


Q ss_pred             HhhchhhhhhhcCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          289 LHRGMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             +..+.......+.. .......+.+++.+||..||.+|||+.|+++
T Consensus       227 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          227 -------LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -------HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------HHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   11111111110000 0001234667788999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=354.08  Aligned_cols=251  Identities=20%  Similarity=0.285  Sum_probs=205.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.++..++||||+++++++.+. +..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEE
Confidence            367888999999999999999999999999999997543 3456788999999999999999999998775 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC--CCCeeEecccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIPKLCDFGLAT  216 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DfGla~  216 (398)
                      |+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++
T Consensus        82 ~~~g~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           82 FISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             CCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             eCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            999999999997542      46999999999999999999999988   999999999999987  7899999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........                 +
T Consensus       153 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------------~  212 (321)
T 1tki_A          153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----------------I  212 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             ECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-----------------H
Confidence            775443   23456799999999999988899999999999999999999999976543211                 0


Q ss_pred             hhhcCcccCCCC-CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+......... ........+.+++.+||+.||.+|||+.|+++
T Consensus       213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111110000 00011235677888999999999999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9e-47  Score=357.70  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=202.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEEE
Confidence            3688999999999999999999998899999999975432 3345688999999999999999999998764 4579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        85 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  154 (323)
T 3tki_A           85 EYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV  154 (323)
T ss_dssp             ECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccce
Confidence            999999999998654       45999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ..............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+..     .    
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~-----~----  224 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-----K----  224 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT-----T----
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc-----c----
Confidence            654332222345679999999999987765 7799999999999999999999976543211 1111100     0    


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .....+       .......+.+++.+||+.||.+|||+.|+++.
T Consensus       225 ~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          225 KTYLNP-------WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             CTTSTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000000       01122345678889999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4e-46  Score=348.81  Aligned_cols=263  Identities=24%  Similarity=0.328  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHh--CCCCCeeceeeEEEcC---CCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDP---EQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---~~~~  133 (398)
                      .++|...+.||+|+||+||+|.+.  ++.||||++...   ....+..|.+++..  ++||||+++++++...   ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            468999999999999999999884  889999999653   34556667777766  7999999999987643   2347


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceeecccccCcEEeCCCC
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--------NGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      ++||||+++|+|.+++..        ..+++..++.++.|++.||+|||        +.+   |+||||||+|||++.++
T Consensus        82 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTS
T ss_pred             EEehhhccCCCHHHHHhh--------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCC
Confidence            899999999999999954        45999999999999999999999        666   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCcee--eeccccCCCcccchhhccC------CcCCccchhhHHHHHHHHHcC----------C
Q 015931          206 IPKLCDFGLATWTSAPSVPFL--CKTVKGTFGYLAPEYFQHG------KVSDKTDVYAFGVVLLELLTG----------R  267 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~Gvvl~elltG----------~  267 (398)
                      .+||+|||+++..........  .....||+.|+|||.+.+.      .++.++|||||||++|||++|          +
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            999999999986654332211  1234799999999999876      456799999999999999999          7


Q ss_pred             CCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          268 KPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       268 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .||........... .... .      .......+.+............+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       231 ~pf~~~~~~~~~~~-~~~~-~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          231 PPFYDVVPNDPSFE-DMRK-V------VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CTTTTTSCSSCCHH-HHHH-H------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccCCCCcchh-hhhH-H------HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            88865433221110 0000 0      000111111111111234566788899999999999999999999999753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=358.31  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=200.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++.+.   .......+..|..++..+ +||||+++++++.+. +.+|
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~  100 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-DRLF  100 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-CEEE
Confidence            47899999999999999999999989999999999754   223456678999999988 699999999987764 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|..++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       101 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~  170 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccc
Confidence            999999999999999875       35999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...                 
T Consensus       171 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------  231 (353)
T 3txo_A          171 CKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----------------  231 (353)
T ss_dssp             CBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------
T ss_pred             eeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----------------
Confidence            985433221  2345679999999999998889999999999999999999999998654321                 


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH------HHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI------EEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~------~evl~  340 (398)
                      ....+.......+...+   ..+.+++.+||+.+|.+||++      .++++
T Consensus       232 ~~~~i~~~~~~~p~~~~---~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          232 LFEAILNDEVVYPTWLH---EDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHHCCCCCCTTSC---HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHHcCCCCCCCCCC---HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            11112222222222222   345667788999999999998      77765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.5e-46  Score=353.11  Aligned_cols=267  Identities=24%  Similarity=0.356  Sum_probs=195.3

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCc---EEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      ...++|...+.||+|+||.||+|.+..++.   .||||++...  .....+.+.+|+.++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345789999999999999999999876554   7999999764  34456789999999999999999999999876543


Q ss_pred             c-----EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          132 G-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       132 ~-----~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      .     .++||||+++|+|.+++...... .....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhcc-ccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            2     38999999999999999765321 11236999999999999999999999988   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........      
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------  249 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY------  249 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH------
Confidence            99999999987654433222334567889999999999899999999999999999999 99999865432211      


Q ss_pred             hHHHhhchhhhhhhcCc-ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          286 KPILHRGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                                 ..+... ....+.   .....+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       250 -----------~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          250 -----------NYLIGGNRLKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             -----------HHHHTTCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------HHHhcCCCCCCCC---ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                       011110 111111   122456778889999999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-45  Score=344.71  Aligned_cols=275  Identities=23%  Similarity=0.299  Sum_probs=213.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-cEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~lV  136 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++..... ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367888999999999999999999889999999997543 2345678899999999999999999999876543 57999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe----CCCCCeeEecc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDF  212 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~Df  212 (398)
                      |||+++++|.+++.....    ...+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+||
T Consensus        88 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             EECCTTCBHHHHHHSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             EeCCCCCCHHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccC
Confidence            999999999999987542    234999999999999999999999988   9999999999999    78888999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhc--------cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ--------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      |+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.........  ...
T Consensus       161 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~  235 (319)
T 4euu_A          161 GAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEV  235 (319)
T ss_dssp             TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHH
T ss_pred             CCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHH
Confidence            99987755432   23456999999999986        467899999999999999999999999754322111  111


Q ss_pred             hhHHHhhchh-h---hhhhcC------cccCC-CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          285 AKPILHRGMA-A---VEELLD------PRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       285 ~~~~~~~~~~-~---~~~~~d------~~l~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .......... .   +.....      ..+.. ..........+.+++.+||+.||.+|||+.|+++.....
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1111111100 0   000000      01111 122355666788899999999999999999999987653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7e-46  Score=367.16  Aligned_cols=252  Identities=27%  Similarity=0.465  Sum_probs=206.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+.  ++.||||++....  ..+.|.+|+.++++++||||+++++++.+.+...++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            467888899999999999999986  6799999997653  456799999999999999999999998887767899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++|+|.+++.....     ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       268 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             CCTTCBHHHHHHHHCT-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            9999999999987532     45799999999999999999999988   999999999999999999999999999855


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ....     ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.........   .           .+.
T Consensus       340 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~-----------~i~  400 (450)
T 1k9a_A          340 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P-----------RVE  400 (450)
T ss_dssp             C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H-----------HHH
T ss_pred             cccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H-----------HHH
Confidence            4321     23357889999999999999999999999999999998 99999765433211   0           011


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ...  ++..+...+   ..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       401 ~~~--~~~~p~~~~---~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          401 KGY--KMDAPDGCP---PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             TTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCC--CCCCCCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111  111122223   34666778899999999999999999998653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-45  Score=339.81  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=207.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+.. +..||+|++..... ....+.+|++++.+++||||+++++++.+. ...++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   83 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-YPIYIVTE   83 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CceEEEEE
Confidence            4678889999999999999998874 67899999976543 346789999999999999999999987654 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        84 ~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           84 YISNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             CCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             ccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceec
Confidence            999999999998753      35899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||........   .   .        .+.
T Consensus       155 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~---~--------~~~  219 (268)
T 3sxs_A          155 LDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---V---L--------KVS  219 (268)
T ss_dssp             CTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H---H--------HHH
T ss_pred             chhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---H---H--------HHH
Confidence            55432 12234456778999999998899999999999999999999 9999975433211   0   0        001


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                      ...  ....+...+   ..+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus       220 ~~~--~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          220 QGH--RLYRPHLAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             TTC--CCCCCTTSC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             cCC--CCCCCCcCh---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            100  111111122   346677889999999999999999999987653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.9e-46  Score=368.76  Aligned_cols=264  Identities=26%  Similarity=0.329  Sum_probs=207.7

Q ss_pred             CHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeEEE
Q 015931           51 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCI  127 (398)
Q Consensus        51 ~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~  127 (398)
                      .+.++....++|...++||+|+||+||+|.+..+++.||+|++.+...   .....+.+|+.++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            445566677899999999999999999999998899999999975321   12234889999999999999999999887


Q ss_pred             cCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCe
Q 015931          128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  207 (398)
Q Consensus       128 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~  207 (398)
                      +. +.+|+||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||||+.++.+
T Consensus       145 ~~-~~~~lV~Ey~~gg~L~~~l~~~~------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~v  214 (437)
T 4aw2_A          145 DD-NNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHI  214 (437)
T ss_dssp             CS-SEEEEEECCCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred             eC-CEEEEEEecCCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCE
Confidence            75 45899999999999999997632      46999999999999999999999988   9999999999999999999


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                      ||+|||+++....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+...  
T Consensus       215 kL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~--  291 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--  291 (437)
T ss_dssp             EECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--
T ss_pred             EEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH--
Confidence            9999999987654332 2234467999999999987     4578999999999999999999999998654322111  


Q ss_pred             HHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCC--CCCHHHHHH
Q 015931          283 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIA  340 (398)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~  340 (398)
                          .+...    .....-+..  ....+   ..+.+++.+||..+|++  ||++.|+++
T Consensus       292 ----~i~~~----~~~~~~p~~--~~~~s---~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          292 ----KIMNH----KERFQFPTQ--VTDVS---ENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ----HHHTH----HHHCCCCSS--CCCSC---HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ----hhhhc----cccccCCcc--cccCC---HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                11100    000111111  01122   34566677888888888  999999987

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-46  Score=352.46  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=203.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      +.|...+.||+|+||.||+|....++..||+|++.....      ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~   89 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDV   89 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEE
Confidence            568889999999999999999998899999999976432      1357799999999999999999999998764 458


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC----CeeE
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  209 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl  209 (398)
                      ++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++    .+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEcCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEE
Confidence            9999999999999999753       46999999999999999999999988   99999999999999887    8999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      +|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........      .. 
T Consensus       160 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~~-  229 (326)
T 2y0a_A          160 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NV-  229 (326)
T ss_dssp             CCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HH-
T ss_pred             EECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HH-
Confidence            99999987754322   234679999999999998899999999999999999999999997643321100      00 


Q ss_pred             hhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             .. ........ ........+.+++.+||+.||.+|||+.|+++
T Consensus       230 -------~~-~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          230 -------SA-VNYEFEDE-YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -------HH-TCCCCCHH-HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------Hh-cCCCcCcc-ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   00 00000000 00011234667788999999999999999987

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=363.94  Aligned_cols=253  Identities=26%  Similarity=0.317  Sum_probs=203.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||+||+|....+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+. +..++|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-GHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-SEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-CEEEEE
Confidence            467889999999999999999999899999999997653  33456789999999999999999999998764 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC---CCCCeeEeccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFG  213 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DfG  213 (398)
                      |||+++|+|.+.+...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++   +++.+||+|||
T Consensus        89 ~E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             ECCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            9999999999999864       45999999999999999999999988   99999999999998   46789999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +.   ..+.    
T Consensus       159 ~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~---~~i~----  226 (444)
T 3soa_A          159 LAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LY---QQIK----  226 (444)
T ss_dssp             SCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHH----
T ss_pred             eeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HH---HHHH----
Confidence            9987654432  2235679999999999998899999999999999999999999997643221   10   0000    


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ....+.........   ...+.+++.+||+.||.+|||+.|+++
T Consensus       227 ---~~~~~~~~~~~~~~---s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          227 ---AGAYDFPSPEWDTV---TPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ---HTCCCCCTTTTTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---hCCCCCCccccccC---CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               11111111001112   234667778999999999999999987

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-45  Score=355.93  Aligned_cols=253  Identities=27%  Similarity=0.378  Sum_probs=203.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++.+. +..++|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence            46789999999999999999999988999999999754  334556789999999999999999999998764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC---CeeEeccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG  213 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DfG  213 (398)
                      |||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++   .+||+|||
T Consensus       107 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             ECCCCSCBHHHHHTTC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecC
Confidence            9999999999998754       45899999999999999999999988   99999999999998654   59999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...   +.   ..+.    
T Consensus       177 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~---~~i~----  243 (362)
T 2bdw_A          177 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LY---AQIK----  243 (362)
T ss_dssp             TCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH----
T ss_pred             cceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHH----
Confidence            9987654332   234679999999999998899999999999999999999999997643221   10   0000    


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                         ....+....   ........+.+++.+||+.||.+|||+.++++.
T Consensus       244 ---~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          244 ---AGAYDYPSP---EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---HTCCCCCTT---GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---hCCCCCCcc---cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               000110000   001112346677889999999999999999863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=348.86  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=196.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------------------------hhHHHHHHHHHHHH
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------------------------ESSKAFCRELMIAS  112 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  112 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3689999999999999999999988899999999975431                          12356889999999


Q ss_pred             hCCCCCeeceeeEEEcC-CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceee
Q 015931          113 SLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH  191 (398)
Q Consensus       113 ~l~h~niv~l~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH  191 (398)
                      +++||||+++++++.+. +...++||||+++++|.+++..        ..+++..++.++.|++.||.|||+.+   |+|
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH  160 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--------KPLSEDQARFYFQDLIKGIEYLHYQK---IIH  160 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence            99999999999998764 4568999999999999775432        46999999999999999999999988   999


Q ss_pred             cccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCC---cCCccchhhHHHHHHHHHcCCC
Q 015931          192 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGRK  268 (398)
Q Consensus       192 rDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvvl~elltG~~  268 (398)
                      |||||+|||++.++.+||+|||+++.......  ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999999999999999987654332  224567999999999997654   4788999999999999999999


Q ss_pred             CCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          269 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       269 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ||......      .......       ....  ........+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       239 pf~~~~~~------~~~~~~~-------~~~~--~~~~~~~~~---~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          239 PFMDERIM------CLHSKIK-------SQAL--EFPDQPDIA---EDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSCCSSHH------HHHHHHH-------HCCC--CCCSSSCCC---HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCccHH------HHHHHHh-------cccC--CCCCccccC---HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99754321      1111100       0000  111111122   34667788999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=348.64  Aligned_cols=245  Identities=28%  Similarity=0.415  Sum_probs=203.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|....+++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-CEEEEE
Confidence            57888999999999999999999889999999997532   23356688999999999999999999988764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        85 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             ECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcce
Confidence            9999999999999864       45899999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...                 ..
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------------~~  212 (318)
T 1fot_A          155 YVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----------------TY  212 (318)
T ss_dssp             ECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------HH
T ss_pred             ecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----------------HH
Confidence            76432     234679999999999999899999999999999999999999997643221                 01


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ..++...+..+...+   ..+.+++.+||+.+|.+||     ++.+|++
T Consensus       213 ~~i~~~~~~~p~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          213 EKILNAELRFPPFFN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHHCCCCCCTTSC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHhCCCCCCCCCC---HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            111112222222222   3456777889999999999     8888885

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=357.95  Aligned_cols=254  Identities=22%  Similarity=0.277  Sum_probs=206.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++..........+.+|+.++..++||||+++++++.+. ...++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-CEEEEEEE
Confidence            36799999999999999999999988999999999877666667899999999999999999999998764 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC--CCCeeEecccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIPKLCDFGLAT  216 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DfGla~  216 (398)
                      |+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++
T Consensus       129 ~~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          129 FLSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             CCCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccce
Confidence            999999999987542      46899999999999999999999988   999999999999974  4789999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...   .+....    
T Consensus       200 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~---~i~~~~----  266 (387)
T 1kob_A          200 KLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ---NVKRCD----  266 (387)
T ss_dssp             ECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---HHHHCC----
T ss_pred             ecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCC----
Confidence            7754432   234579999999999999899999999999999999999999997643211   100   000000    


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                       -..++..     .......+.+++.+||+.||.+|||+.|+++.
T Consensus       267 -~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          267 -WEFDEDA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -CCCCSST-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -CCCCccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             0001100     11122356778889999999999999999873

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.3e-46  Score=343.42  Aligned_cols=256  Identities=23%  Similarity=0.425  Sum_probs=206.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   85 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFE   85 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CceEEEEE
Confidence            3578888999999999999999874 77899999976533 346789999999999999999999998764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             CCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             eCCCCcHHHHHHhcC------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccc
Confidence            999999999997643      46899999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ..   .        .+.
T Consensus       157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~---~--------~~~  221 (269)
T 4hcu_A          157 LDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---E--------DIS  221 (269)
T ss_dssp             CCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---H--------HHH
T ss_pred             ccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HH---H--------HHh
Confidence            44221 11223456788999999998899999999999999999999 999997643321   00   0        011


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      .....  ..+...   ...+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       222 ~~~~~--~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          222 TGFRL--YKPRLA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             TTCCC--CCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCccC--CCCCcC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            11111  111112   234667778999999999999999999998653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-46  Score=354.05  Aligned_cols=267  Identities=25%  Similarity=0.395  Sum_probs=210.1

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  130 (398)
                      ...++|...+.||+|+||.||+|.+.     .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+. 
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-  122 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-  122 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-
Confidence            34678999999999999999999986     345889999997653 34567899999999999999999999998764 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecc
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGV-----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRD  193 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrD  193 (398)
                      +..++||||+++|+|.+++.......                 .....+++..++.++.|++.||.|||+.+   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            45799999999999999998742100                 01256999999999999999999999988   99999


Q ss_pred             cccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcc
Q 015931          194 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA  272 (398)
Q Consensus       194 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~  272 (398)
                      |||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999986643322222334568899999999998899999999999999999999 9999976


Q ss_pred             cccccchhHHHHhhHHHhhchhhhhhhcCccc-CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          273 RRLQGEENLVLWAKPILHRGMAAVEELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                      .....   ..              ..+.+... ..+...+   ..+.+++.+||+.+|.+|||+.+|++.|+.+.+
T Consensus       280 ~~~~~---~~--------------~~~~~~~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          280 MAHEE---VI--------------YYVRDGNILACPENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             SCHHH---HH--------------HHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CChHH---HH--------------HHHhCCCcCCCCCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            43221   10              11111111 1111222   356677789999999999999999999987643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.9e-46  Score=358.90  Aligned_cols=267  Identities=23%  Similarity=0.351  Sum_probs=211.0

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCC-------CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEc
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCID  128 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  128 (398)
                      ..++|...+.||+|+||+||+|.+..       .+..||||++... .......+.+|+++++.+ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            34688889999999999999998642       3357999999765 344557899999999999 99999999999876


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcE
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  199 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NI  199 (398)
                      .+ ..++||||+++|+|.+++......         ......+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus       147 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  222 (382)
T 3tt0_A          147 DG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  222 (382)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             CC-ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence            54 479999999999999999875310         011246999999999999999999999988   99999999999


Q ss_pred             EeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccc
Q 015931          200 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE  278 (398)
Q Consensus       200 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~  278 (398)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||....... 
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-  301 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-  301 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999987665433223344567889999999999999999999999999999999 999997643221 


Q ss_pred             hhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          279 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                        +..           .+........  +...   ...+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       302 --~~~-----------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          302 --LFK-----------LLKEGHRMDK--PSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             --HHH-----------HHHTTCCCCC--CSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHH-----------HHHcCCCCCC--CccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              110           0111111111  1112   2346677889999999999999999999987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-45  Score=350.26  Aligned_cols=253  Identities=24%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-------
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-------  131 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  131 (398)
                      ++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+...       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            57888899999999999999999889999999997543 3456789999999999999999999998865432       


Q ss_pred             -------------------------------------------------cEEEEEecCCCCCHHHHHhhhccCCCCCCCC
Q 015931          132 -------------------------------------------------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTL  162 (398)
Q Consensus       132 -------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l  162 (398)
                                                                       ..++||||+++|+|.+++.....    ....
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~  161 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS----LEDR  161 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS----GGGS
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC----ccch
Confidence                                                             27899999999999999987532    2446


Q ss_pred             CHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCc----------eeeecccc
Q 015931          163 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP----------FLCKTVKG  232 (398)
Q Consensus       163 ~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~g  232 (398)
                      ++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........          .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            78889999999999999999988   999999999999999999999999999877654211          11234569


Q ss_pred             CCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHH
Q 015931          233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSA  312 (398)
Q Consensus       233 t~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  312 (398)
                      |+.|+|||.+.+..++.++||||||+++|||++|..|+.....                   ..........  +.....
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-------------------~~~~~~~~~~--~~~~~~  297 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-------------------IITDVRNLKF--PLLFTQ  297 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-------------------HHHHHHTTCC--CHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-------------------HHHHhhccCC--Cccccc
Confidence            9999999999998999999999999999999999877532110                   0011111111  111122


Q ss_pred             HHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          313 QIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       313 ~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....+.+++.+||+.||.+|||+.|+++
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            3345678889999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.4e-46  Score=348.40  Aligned_cols=264  Identities=24%  Similarity=0.329  Sum_probs=209.1

Q ss_pred             hcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .++|...+.||+|+||.||+|.+     ..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+ .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-P  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC-c
Confidence            46788899999999999999987     334588999999754 3455678999999999999999999999987644 5


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGV-----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  195 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlk  195 (398)
                      .++||||+++|+|.+++.......                 .....+++..++.++.|++.||.|||+.+   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            799999999999999998743200                 01134899999999999999999999988   9999999


Q ss_pred             cCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccc
Q 015931          196 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARR  274 (398)
Q Consensus       196 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~  274 (398)
                      |+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987755433222334567889999999998889999999999999999999 999997654


Q ss_pred             cccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          275 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .....   .           .+.....+..  +...   ...+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       258 ~~~~~---~-----------~~~~~~~~~~--~~~~---~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          258 PERLF---N-----------LLKTGHRMER--PDNC---SEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GGGHH---H-----------HHHTTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHH---H-----------HhhcCCcCCC--CccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            32211   0           0111111111  1112   24567778899999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.3e-46  Score=372.19  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=209.7

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ...+|...+.||+|+||.||+|.+..++..||||.+..... ..+.|.+|+.++++++||||++++++|.+.+ ..++||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~  295 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIIT  295 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCC-cEEEEE
Confidence            34567788999999999999999988889999999976543 4578999999999999999999999987654 479999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++|+|.+++.....     ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       296 E~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             ECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             EccCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccccee
Confidence            99999999999986432     46899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ...... .......++..|+|||++....++.++|||||||++|||++ |+.||........   ..           .+
T Consensus       368 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~-----------~~  432 (495)
T 1opk_A          368 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE-----------LL  432 (495)
T ss_dssp             CTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH-----------HH
T ss_pred             ccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HH-----------HH
Confidence            654321 11223456788999999998899999999999999999999 9999976543211   10           01


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ....  +...+...+   ..+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       433 ~~~~--~~~~~~~~~---~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          433 EKDY--RMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             HTTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HcCC--CCCCCCCCC---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            1111  111122222   3466777899999999999999999999865

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-46  Score=355.44  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=203.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcE----EEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++|...+.||+|+||+||+|.+..++..    ||+|.+.... ......+.+|+.++..++||||+++++++.+  ...+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   90 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSLQ   90 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CccE
Confidence            5788889999999999999998776665    7778775432 2333557789999999999999999998753  4479


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        91 ~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEEEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCc
Confidence            9999999999999997642      45899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++...............||..|+|||.+.+..++.++||||||+++|||++ |+.||...........            
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------------  229 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL------------  229 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH------------
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH------------
Confidence            998765544333455678889999999998999999999999999999999 9999986543221111            


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                        +....  ....+..   ....+.+++.+||+.+|.+|||+.++++.|+....
T Consensus       230 --~~~~~--~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          230 --LEKGE--RLAQPQI---CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             --HHTTC--BCCCCTT---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             --HHcCC--CCCCCCc---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence              01000  0111111   11235677889999999999999999999987543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.2e-45  Score=340.61  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=193.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|+||.||+|.+.  +..||||++.....    ...+.+.+|+++++.++||||+++++++.+.+ ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP-NLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-ceE
Confidence            357888999999999999999975  78999999875432    23467889999999999999999999987654 479


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC--------CCC
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--------KKI  206 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~--------~~~  206 (398)
                      +||||+++++|.+++..        ..+++..++.++.|++.||.|||+.+..+|+||||||+||+++.        ++.
T Consensus        83 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             EEEECCTTEEHHHHHTS--------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             EEEEcCCCCCHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999999999999854        45899999999999999999999987556899999999999986        678


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  286 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  286 (398)
                      +||+|||+++.......    ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........    .  .
T Consensus       155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~--~  224 (271)
T 3dtc_A          155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----A--Y  224 (271)
T ss_dssp             EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----H--H
T ss_pred             eEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H--H
Confidence            99999999986654322    245699999999999988999999999999999999999999976432110    0  0


Q ss_pred             HHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          287 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       287 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ..       .....  ....+...   ...+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       225 ~~-------~~~~~--~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          225 GV-------AMNKL--ALPIPSTC---PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HH-------HTSCC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hh-------hcCCC--CCCCCccc---CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            00       00001  11111112   2456777889999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-45  Score=348.01  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=210.4

Q ss_pred             hcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||.||+|.+     ..++..||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+ 
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG-  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence            46888899999999999999984     4467889999997653 34557799999999999 9999999999987654 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKG-----------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                      ..++||||+++|+|.+++......           ......+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            479999999999999999875321           011235899999999999999999999988   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccch
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  279 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  279 (398)
                      ++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            99999999999999987765543333345567889999999998899999999999999999999 9999976543211 


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       ..    .       .+........  +...   ...+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       257 -~~----~-------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 -FY----K-------MIKEGFRMLS--PEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             -HH----H-------HHHHTCCCCC--CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HH----H-------HhccCCCCCC--cccC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             10    0       1111111111  1112   24567778899999999999999999999763

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-45  Score=342.65  Aligned_cols=255  Identities=31%  Similarity=0.529  Sum_probs=201.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhh-------HHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES-------SKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||+||+|.+..+++.||+|++.......       .+.+.+|+.++++++||||+++++++.+.  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            468889999999999999999998889999999986543211       16789999999999999999999987543  


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC-----
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----  206 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~-----  206 (398)
                       .++||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.     
T Consensus        96 -~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           96 -PRMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             -TEEEEECCTTCBHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             -CeEEEEecCCCCHHHHHhccc------CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCcee
Confidence             279999999999999887643      46999999999999999999999764 34999999999999988776     


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhc--cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ--HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      +||+|||+++.....     .....||+.|+|||.+.  ...++.++||||||+++|||++|+.||........    ..
T Consensus       168 ~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~  238 (287)
T 4f0f_A          168 AKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KF  238 (287)
T ss_dssp             EEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HH
T ss_pred             EEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HH
Confidence            999999999754332     24567999999999984  45678999999999999999999999976443211    00


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ....       ......+.+  +...   ...+.+++.+||+.||.+|||+.++++.|+.
T Consensus       239 ~~~~-------~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          239 INMI-------REEGLRPTI--PEDC---PPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHH-------HHSCCCCCC--CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHH-------hccCCCCCC--Cccc---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            0000       011111111  1112   2456777788999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.2e-45  Score=353.84  Aligned_cols=269  Identities=18%  Similarity=0.245  Sum_probs=205.9

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCC-----CcEEEEEEecCCChhhH-----------HHHHHHHHHHHhCCCCCeec
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESS-----------KAFCRELMIASSLHHPNIVP  121 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  121 (398)
                      ..++|...+.||+|+||.||+|.+..+     ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            356899999999999999999988653     57899999876543211           12345566777889999999


Q ss_pred             eeeEEEcCC---CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCc
Q 015931          122 LVGFCIDPE---QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  198 (398)
Q Consensus       122 l~~~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~N  198 (398)
                      +++++....   ...++||||+ +++|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~N  182 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA------KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASN  182 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHH
Confidence            999987642   3478999999 999999998742      46999999999999999999999988   9999999999


Q ss_pred             EEeC--CCCCeeEeccccccccCCCCCce-----eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCc
Q 015931          199 ILLS--SKKIPKLCDFGLATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE  271 (398)
Q Consensus       199 Ill~--~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~  271 (398)
                      ||++  .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999  88999999999998764322111     1133459999999999999899999999999999999999999998


Q ss_pred             ccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          272 ARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ......  ............   .+.+++++.+... ..+.   .+.+++..||+.+|.+||++.+|++.|+..
T Consensus       263 ~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~---~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          263 DNLKDP--KYVRDSKIRYRE---NIASLMDKCFPAA-NAPG---EIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             GGTTCH--HHHHHHHHHHHH---CHHHHHHHHSCTT-CCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccccCH--HHHHHHHHHhhh---hHHHHHHHhcccc-cCHH---HHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            643321  122222211111   2344444444311 2233   456667789999999999999999999764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=356.37  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=203.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||++....+++.||+|++....   ......+.+|+.++..++||||+++++++.+. ..+++|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEE
Confidence            67889999999999999999999999999999996532   23456788999999999999999999988765 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|..++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        94 ~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN-------VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             ECCCTTEEHHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceee
Confidence            9999999999999764       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhcc---CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ......   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+..          
T Consensus       164 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----------  230 (384)
T 4fr4_A          164 MLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH----------  230 (384)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH----------
T ss_pred             eccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH----------
Confidence            765433   2345679999999999974   358999999999999999999999997654332211111          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-HHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~  340 (398)
                          .+.......+...   ...+.+++.+||+.+|.+||+ +.+|++
T Consensus       231 ----~~~~~~~~~p~~~---s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          231 ----TFETTVVTYPSAW---SQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----HHHHCCCCCCTTS---CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----HHhhcccCCCCcC---CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                1111111112222   235667778999999999998 777765

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=350.51  Aligned_cols=245  Identities=23%  Similarity=0.281  Sum_probs=192.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|+..+.||+|+||+||+|.+..+++.||||++....  ......+..|+..+..+ +||||++++++|.+. +..++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-CEEEEE
Confidence            57888999999999999999999889999999986542  33344556666666555 899999999998764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+ +++|.+++....      ..++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       136 ~e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             Eecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeee
Confidence            9999 789999987753      46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|||++|..|+......     .     ...      
T Consensus       206 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~-----~~~------  265 (311)
T 3p1a_A          206 ELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----Q-----QLR------  265 (311)
T ss_dssp             ECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----H-----HHT------
T ss_pred             ecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----H-----HHh------
Confidence            7654322   234569999999998875 7999999999999999999997776543210     0     000      


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....+.+.  ..   ....+.+++.+||+.+|.+|||+.|+++
T Consensus       266 ~~~~~~~~~--~~---~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          266 QGYLPPEFT--AG---LSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TTCCCHHHH--TT---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCcccc--cC---CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            000111110  01   1245677888999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-45  Score=355.93  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...++||+|+||+||+|....+++.||+|++.+..   ......+..|..++.++ +||||+++++++.+. ..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-CEEE
Confidence            468899999999999999999999999999999997542   22334578899999876 899999999987764 5589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|..++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       130 lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecce
Confidence            999999999999999875       45999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccch--hHHHHhhHHHhhc
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE--NLVLWAKPILHRG  292 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~  292 (398)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ......       
T Consensus       200 a~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~-------  270 (396)
T 4dc2_A          200 CKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-------  270 (396)
T ss_dssp             CBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH-------
T ss_pred             eeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH-------
Confidence            986433221  234578999999999999999999999999999999999999999753322110  001110       


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH------HHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI------EEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~------~evl~  340 (398)
                         ...+....+..+...+   ..+.+++.+||+.||.+||++      .||++
T Consensus       271 ---~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          271 ---FQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ---HHHHHHCCCCCCTTSC---HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ---HHHHhccccCCCCcCC---HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence               1111222222222222   345677788999999999995      56655

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-46  Score=351.72  Aligned_cols=259  Identities=26%  Similarity=0.398  Sum_probs=200.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcE----EEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .++|...+.||+|+||.||+|.+..+++.    ||+|.+... .......+.+|+.++..++||||+++++++....  .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--c
Confidence            46899999999999999999998776665    477776543 3345678999999999999999999999987643  7


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++|++|+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             eEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCc
Confidence            89999999999999998753      46999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........           
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-----------  231 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----------  231 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----------
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----------
Confidence            9987755433333344567889999999999999999999999999999999 9999976543321110           


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                         +....  ....+..   ....+.+++.+||+.+|.+|||+.|+++.|+....
T Consensus       232 ---~~~~~--~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          232 ---LEKGE--RLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---HHTTC--CCCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ---HHcCC--CCCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence               11100  1111111   22346777889999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=353.03  Aligned_cols=266  Identities=24%  Similarity=0.424  Sum_probs=207.3

Q ss_pred             hhcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  130 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  130 (398)
                      ..++|...+.||+|+||.||+|.+     ..++..||+|++.... ......+.+|+.++.++ +||||+++++++... 
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence            457888999999999999999986     2356789999997542 33456789999999999 899999999998765 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccc
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGV----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  194 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDl  194 (398)
                      +..++||||+++|+|.+++.......                .....+++..++.++.|++.||.|||+.+   |+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            45799999999999999998653210                00134899999999999999999999988   999999


Q ss_pred             ccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCccc
Q 015931          195 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR  273 (398)
Q Consensus       195 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~  273 (398)
                      ||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987655443333445668889999999998899999999999999999998 99999765


Q ss_pred             ccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .....  ..    .       .+.....+..  +...   ...+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       279 ~~~~~--~~----~-------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          279 PVDAN--FY----K-------LIQNGFKMDQ--PFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             CCSHH--HH----H-------HHHTTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcHHH--HH----H-------HHhcCCCCCC--CCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            43211  10    0       0111111111  1112   24566777899999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=8.7e-46  Score=354.95  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=202.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      +.|...+.||+|+||+||+|.+..+++.||||++....     ....+.+.+|+.+++.++||||+++++++.+. +.++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-GMLY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEE
Confidence            56888999999999999999999899999999986421     12357789999999999999999999998774 5589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC---eeEec
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCD  211 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~D  211 (398)
                      +||||+++++|.+.+.....   ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus       103 lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRAD---AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             EEEeCCCCCCHHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEec
Confidence            99999999999988876432   1245899999999999999999999988   999999999999986654   99999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......    +.   .     
T Consensus       177 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~---~-----  242 (351)
T 3c0i_A          177 FGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LF---E-----  242 (351)
T ss_dssp             CTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HH---H-----
T ss_pred             CcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HH---H-----
Confidence            999987755332  224567999999999999889999999999999999999999999764211    10   0     


Q ss_pred             chhhhhhhcCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                            .+.......... .......+.+++.+||+.||.+|||+.++++
T Consensus       243 ------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          243 ------GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ------HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  000000000000 0011235677888999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-46  Score=356.58  Aligned_cols=268  Identities=25%  Similarity=0.385  Sum_probs=210.6

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCC-----cEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEc
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCID  128 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  128 (398)
                      ....++|...+.||+|+||.||+|.+..++     ..||+|.+.... ......+.+|+.++..+ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            344578999999999999999999986554     379999997653 34567799999999999 89999999999876


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKGV-------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~-------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                      .+ ..++||||+++|+|.+++.......       .....+++..++.++.|++.||.|||+.+   |+||||||+||++
T Consensus       122 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          122 GG-PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SS-SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             CC-ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            54 5799999999999999997642100       01246899999999999999999999988   9999999999999


Q ss_pred             CCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchh
Q 015931          202 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  280 (398)
Q Consensus       202 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  280 (398)
                      +.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |..||........  
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--  275 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--  275 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence            9999999999999986654433333344567889999999998899999999999999999999 9999976443211  


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ..    ..       +........  +...   ...+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       276 ~~----~~-------~~~~~~~~~--~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          276 FY----KL-------VKDGYQMAQ--PAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HH----HH-------HHHTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----HH-------HhcCCCCCC--CCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            00    01       111111111  1112   23567778899999999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.7e-46  Score=353.80  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=202.5

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      ...++|...+.||+|+||.||+|.+..+++.||+|++.+..   ......+..|..++..+ +||||+++++++.+. +.
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-~~   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-EN   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-CE
Confidence            44578999999999999999999999899999999997532   23345678899999876 899999999988764 45


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|+||||+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEC
Confidence            89999999999999999875       35899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      |+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +.          
T Consensus       163 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~----------  227 (345)
T 1xjd_A          163 GMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LF----------  227 (345)
T ss_dssp             TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----------
T ss_pred             hhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HH----------
Confidence            99986533221  2345679999999999999899999999999999999999999997654321   10          


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHH-HHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl~  340 (398)
                          ..+.......+...+   ..+.+++.+||+.+|.+||++. +|++
T Consensus       228 ----~~i~~~~~~~p~~~s---~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          228 ----HSIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ----HHHHHCCCCCCTTSC---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----HHHHhCCCCCCcccC---HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                111111111111222   3466777899999999999997 6653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-45  Score=352.12  Aligned_cols=246  Identities=24%  Similarity=0.339  Sum_probs=201.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++... ...++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence            68899999999999999999998889999999996432   12235688999999999999999999998775 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+ +|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus        88 ~E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             EECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccce
Confidence            9999 78999998765       45999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .......   .....||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||........                 
T Consensus       157 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------  216 (336)
T 3h4j_B          157 IMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------  216 (336)
T ss_dssp             TTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------
T ss_pred             eccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------
Confidence            7654332   235679999999999987776 7899999999999999999999976543221                 


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.......+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       217 ~~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          217 FKKVNSCVYVMPDFLS---PGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             BCCCCSSCCCCCTTSC---HHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcCCCCCcccCC---HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1111111111122222   34567788999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.8e-46  Score=349.25  Aligned_cols=274  Identities=26%  Similarity=0.403  Sum_probs=215.2

Q ss_pred             CHHHHHHhhcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeecee
Q 015931           51 SYGEILAATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLV  123 (398)
Q Consensus        51 ~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~  123 (398)
                      ...+.....++|...+.||+|+||+||+|.+     ..+++.||||++.... ......+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344445568899999999999999999984     3457899999997653 34456789999999999 799999999


Q ss_pred             eEEEcCCCcEEEEEecCCCCCHHHHHhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccc
Q 015931          124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  194 (398)
Q Consensus       124 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDl  194 (398)
                      +++...+...++||||+++|+|.+++.......         .....+++..++.++.|++.||.|||+.+   |+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            998876666899999999999999998643200         00123899999999999999999999988   999999


Q ss_pred             ccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCccc
Q 015931          195 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR  273 (398)
Q Consensus       195 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~  273 (398)
                      ||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987655443333445668899999999998899999999999999999998 99999764


Q ss_pred             ccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .....  ..    .       .+........  +...+   ..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       255 ~~~~~--~~----~-------~~~~~~~~~~--~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          255 KIDEE--FC----R-------RLKEGTRMRA--PDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCSHH--HH----H-------HHHHTCCCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhHH--HH----H-------HhccCccCCC--CCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            43211  10    0       0111111111  11122   3466777899999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.3e-45  Score=351.72  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=203.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++..++||||+++++++.+. ..+|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEE
Confidence            67889999999999999999999889999999996532   23456788999999999999999999987764 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       120 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccce
Confidence            9999999999999875       35999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...      .           .
T Consensus       190 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~-----------~  247 (350)
T 1rdq_E          190 RVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------I-----------Y  247 (350)
T ss_dssp             ECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-----------H
T ss_pred             eccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------H-----------H
Confidence            765432     34579999999999999899999999999999999999999997653221      0           1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                      ..+....+..+...+   ..+.+++.+||+.||.+||+     +.+|++
T Consensus       248 ~~i~~~~~~~p~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          248 EKIVSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHCCCCCCTTCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHcCCCCCCCCCC---HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            111111222222222   34667778899999999998     888876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-45  Score=350.04  Aligned_cols=274  Identities=24%  Similarity=0.297  Sum_probs=212.1

Q ss_pred             cCCCCCceecccCceEEEEee----eCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc-CCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID-PEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~~  134 (398)
                      ++|...+.||+|+||.||+|.    ...+++.||||++........+.+.+|++++++++||||+++++++.. .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            678889999999999999998    456789999999988777777889999999999999999999998874 344578


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++++|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             EEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence            9999999999999998753      35899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +.......... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.........   .+.........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~  250 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR---MMGCERDVPAL  250 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HCC----CCHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh---hcccccccccH
Confidence            98775443221 123356888899999999888999999999999999999999998754321100   00000000000


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ..+.+.+..... ..........+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       251 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          251 SRLLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHHHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            011111111111 0111122345677778899999999999999999998753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=362.82  Aligned_cols=263  Identities=26%  Similarity=0.291  Sum_probs=206.4

Q ss_pred             CHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEE
Q 015931           51 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCI  127 (398)
Q Consensus        51 ~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  127 (398)
                      .+.++....++|...+.||+|+||.||++....+++.||+|++.+..   ......+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            44555666789999999999999999999999899999999997532   122345789999999999999999999887


Q ss_pred             cCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCe
Q 015931          128 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  207 (398)
Q Consensus       128 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~  207 (398)
                      +. +.+|+||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus       132 ~~-~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~v  201 (412)
T 2vd5_A          132 DE-NYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHI  201 (412)
T ss_dssp             CS-SEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred             eC-CEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCE
Confidence            64 55899999999999999998653      35999999999999999999999988   9999999999999999999


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhc-------cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchh
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  280 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~  280 (398)
                      ||+|||+++....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||...+......
T Consensus       202 kL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  280 (412)
T 2vd5_A          202 RLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG  280 (412)
T ss_dssp             EECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999987654332 2223467999999999987       3568999999999999999999999998654322110


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCC---CCHHHHHH
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR---PGIEEIIA  340 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Pt~~evl~  340 (398)
                            .+....    ....-+.+  ....   ...+.+++.+||. +|.+|   |++.||++
T Consensus       281 ------~i~~~~----~~~~~p~~--~~~~---s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          281 ------KIVHYK----EHLSLPLV--DEGV---PEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ------HHHTHH----HHCCCC------CC---CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ------HHHhcc----cCcCCCcc--ccCC---CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                  111000    00001111  0112   2346677788999 99998   68999886

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-45  Score=355.16  Aligned_cols=214  Identities=25%  Similarity=0.301  Sum_probs=186.3

Q ss_pred             cccccCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-----CCCee
Q 015931           46 SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----HPNIV  120 (398)
Q Consensus        46 ~~~~~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv  120 (398)
                      ....+++.+.....++|...+.||+|+||+||+|.+..+++.||||++... ......+..|+.++..++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            345666666667788999999999999999999999888999999999743 344567788999999986     99999


Q ss_pred             ceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       121 ~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                      ++++++... +..++||||+ +++|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||
T Consensus       100 ~~~~~~~~~-~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  169 (360)
T 3llt_A          100 KYHGKFMYY-DHMCLIFEPL-GPSLYEIITRNNY-----NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENIL  169 (360)
T ss_dssp             CEEEEEEET-TEEEEEECCC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             cccceeeEC-CeeEEEEcCC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEE
Confidence            999998775 4589999999 9999999987532     45999999999999999999999988   999999999999


Q ss_pred             eCC-------------------------CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhh
Q 015931          201 LSS-------------------------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYA  255 (398)
Q Consensus       201 l~~-------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S  255 (398)
                      ++.                         ++.+||+|||+++......     ....||+.|+|||++.+..++.++||||
T Consensus       170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHH
Confidence            975                         7899999999998654432     3457899999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCccccc
Q 015931          256 FGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       256 ~Gvvl~elltG~~Pf~~~~~  275 (398)
                      |||++|||++|+.||.....
T Consensus       245 lG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCSSH
T ss_pred             HHHHHHHHHHCCCCCCCCcH
Confidence            99999999999999986543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.1e-45  Score=346.48  Aligned_cols=261  Identities=18%  Similarity=0.186  Sum_probs=207.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||.||+|....+++.||||++.....  ...+.+|+.+++.+ +||||+++++++.+. ...++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-KYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-TEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-CccEEEE
Confidence            4688999999999999999999988899999999875432  24588999999999 999999999988774 4579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC-----eeEecc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----PKLCDF  212 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~Df  212 (398)
                      ||+ +++|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.     +||+||
T Consensus        85 e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             EeC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            999 999999998642      46999999999999999999999988   999999999999998887     999999


Q ss_pred             ccccccCCCCCce-----eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          213 GLATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       213 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9998765433211     12356799999999999999999999999999999999999999987543322211111100


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ....        ...... ....+    .+.+++..||+.+|.+||++.+|++.|+..
T Consensus       235 ~~~~--------~~~~~~-~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          235 TKRA--------TPIEVL-CENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHHH--------SCHHHH-TTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hhcc--------CCHHHH-hccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            0000        000000 01122    577778889999999999999999999753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.9e-46  Score=363.81  Aligned_cols=259  Identities=26%  Similarity=0.369  Sum_probs=205.3

Q ss_pred             HHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC
Q 015931           53 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDP  129 (398)
Q Consensus        53 ~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  129 (398)
                      .++....++|...+.||+|+||+||+|.+..+++.||+|++.+..   ......+.+|+.++..++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344456789999999999999999999999999999999996521   11223478899999999999999999988764


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                       ..+|+||||+++|+|.+++..        ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus       142 -~~~~lV~E~~~gg~L~~~l~~--------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL  209 (410)
T 3v8s_A          142 -RYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL  209 (410)
T ss_dssp             -SEEEEEECCCTTEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             -CEEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEE
Confidence             558999999999999999975        34899999999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCC----cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK----VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +|||+++....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.....      
T Consensus       210 ~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------  282 (410)
T 3v8s_A          210 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------  282 (410)
T ss_dssp             CCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------
T ss_pred             eccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH------
Confidence            99999987654332 2234578999999999997654    889999999999999999999999865432111      


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCC--CCCHHHHHH
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIA  340 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~  340 (398)
                      ..+...       ............+   ..+.+++.+||..+|.+  ||++.||++
T Consensus       283 ~~i~~~-------~~~~~~p~~~~~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          283 SKIMNH-------KNSLTFPDDNDIS---KEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHTH-------HHHCCCCTTCCCC---HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHhc-------cccccCCCccccc---HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            111100       0000111111122   34566677899999988  999999997

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=354.61  Aligned_cols=247  Identities=24%  Similarity=0.283  Sum_probs=196.6

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      .+.||+|+||.||+|....+++.||+|++........+.+.+|+.++.+++||||+++++++.+. +..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCCCCc
Confidence            56799999999999999888999999999887666778899999999999999999999998775 45899999999999


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe--CCCCCeeEeccccccccCCCC
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL--SSKKIPKLCDFGLATWTSAPS  222 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll--~~~~~~kl~DfGla~~~~~~~  222 (398)
                      |.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++......
T Consensus       173 L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          173 LFDRIIDES------YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            999987643      35899999999999999999999988   9999999999999  567899999999998775443


Q ss_pred             CceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCc
Q 015931          223 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  302 (398)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  302 (398)
                      .   .....||+.|+|||++....++.++|||||||++|||++|+.||........      ...+...       ..+.
T Consensus       244 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~-------~~~~  307 (373)
T 2x4f_A          244 K---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILAC-------RWDL  307 (373)
T ss_dssp             B---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHT-------CCCS
T ss_pred             c---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-------cCCC
Confidence            2   2345699999999999988899999999999999999999999976543211      0011100       0000


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          303 RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       303 ~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........   ...+.+++.+||+.+|.+|||+.|+++
T Consensus       308 ~~~~~~~~---~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          308 EDEEFQDI---SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSGGGTTS---CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhhccC---CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000111   235677788999999999999999997

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-44  Score=338.08  Aligned_cols=262  Identities=19%  Similarity=0.218  Sum_probs=207.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++....  ....+.+|+.++..+ +|+|++++++++.+. ...++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-ceeEEEE
Confidence            467999999999999999999998889999999986543  234578899999999 799999999987664 4579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC-----eeEecc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----PKLCDF  212 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~Df  212 (398)
                      ||+ +++|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.     +||+||
T Consensus        86 e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             Eec-CCCHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999 999999998643      45999999999999999999999888   999999999999987776     999999


Q ss_pred             ccccccCCCCCc-----eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          213 GLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       213 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |+++........     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            999876554321     112356799999999999998999999999999999999999999987543322221111111


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .....  ..... .+      ..   ...+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       236 ~~~~~--~~~~~-~~------~~---~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          236 KKQST--PLREL-CA------GF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHS--CHHHH-TT------TS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hccCc--cHHHH-Hh------hC---cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            00000  00000 00      11   23567777889999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-44  Score=359.16  Aligned_cols=266  Identities=20%  Similarity=0.328  Sum_probs=198.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----C
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  131 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+     .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47899999999999999999999989999999999754  3455677889999999999999999999986543     3


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+|+||||+++ +|.+.+..         .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeCCCC-CHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEE
Confidence            47999999965 56666642         3899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh-----h
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----K  286 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~-----~  286 (398)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...     .
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          208 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             CCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99998765432   234567999999999999999999999999999999999999999875432211111000     0


Q ss_pred             HHHhhchhhhhhhcCcccCC--------------CCCC---HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 PILHRGMAAVEELLDPRLKC--------------TSRN---SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 ~~~~~~~~~~~~~~d~~l~~--------------~~~~---~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+..........+...-..              +...   ......+.+++.+||+.||.+|||+.|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000111111110000              0000   111456788999999999999999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-44  Score=345.91  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=202.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+.||+|+||.||+|.+..+++.||+|++.+.   .......+.+|..++.++ +||||+++++++.+. ..+|+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-CEEEE
Confidence            5788899999999999999999989999999999754   334456788999999987 899999999987764 56899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        88 v~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             EEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999999865       35999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccch--hHHHHhhHHHhhch
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE--NLVLWAKPILHRGM  293 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~  293 (398)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ......        
T Consensus       158 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------  227 (345)
T 3a8x_A          158 KEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------  227 (345)
T ss_dssp             BCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH--------
T ss_pred             ccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH--------
Confidence            86433221  234567999999999999989999999999999999999999999753221100  000000        


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH------HHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI------EEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~------~evl~  340 (398)
                        ...+.......+...+   ..+.+++.+||+.||.+||++      .++++
T Consensus       228 --~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          228 --FQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             --HHHHHHCCCCCCTTSC---HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             --HHHHHcCCCCCCCCCC---HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence              1111111222222222   345667788999999999995      56654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.4e-45  Score=351.39  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=193.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||+||++....+++.||+|++..... ....+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEEE
Confidence            4689999999999999999999998999999999976533 235688999999999999999999998765 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC--eeEecccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDFGLAT  216 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DfGla~  216 (398)
                      |+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+++
T Consensus        97 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           97 YASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             eCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            99999999999765       35999999999999999999999988   999999999999987765  9999999997


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCc-cchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ......   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........  .           .
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~-----------~  230 (361)
T 3uc3_A          167 SSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--K-----------T  230 (361)
T ss_dssp             -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--H-----------H
T ss_pred             cccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--H-----------H
Confidence            543222   1234579999999999988877655 899999999999999999998654332111  1           1


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +..+.......+. .......+.+++.+||+.+|.+|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          231 IQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            1122222221111 0011234667788999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.6e-46  Score=344.22  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=211.8

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ...++|...+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   87 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYII   87 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCEEEE
Confidence            34578888999999999999999999889999999997643 3467899999999999999999999997664 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        88 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             EECCTTEEHHHHHHHCCT-----TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             EEcCCCCcHHHHHHhccc-----CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence            999999999999987432     56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.........   .           .
T Consensus       160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~---~-----------~  224 (288)
T 3kfa_A          160 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---E-----------L  224 (288)
T ss_dssp             TSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H-----------H
T ss_pred             eccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H-----------H
Confidence            7654432 22334567889999999998899999999999999999999 99999765432211   0           0


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      +......  ..+...+   ..+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       225 ~~~~~~~--~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          225 LEKDYRM--ERPEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             HHTTCCC--CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccCCC--CCCCCCC---HHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            1111111  1111222   4567778899999999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.9e-46  Score=366.55  Aligned_cols=261  Identities=25%  Similarity=0.387  Sum_probs=208.4

Q ss_pred             HHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           54 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        54 e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      +.....++|...+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+++.++||||+++++++.  ....
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~  257 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPI  257 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSC
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCcc
Confidence            334455778888999999999999999874 7789999997654 34678999999999999999999999875  3457


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++|+|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             EEEEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCC
Confidence            999999999999999986432     35899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++....... .......+|..|+|||++....++.++|||||||++|||+| |+.||......+   ...         
T Consensus       330 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~---------  396 (454)
T 1qcf_A          330 LARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR---------  396 (454)
T ss_dssp             GGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH---------
T ss_pred             CceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH---------
Confidence            9987643211 11123446788999999998899999999999999999999 999997643221   110         


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                        .+....  ++..+...   ...+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       397 --~i~~~~--~~~~~~~~---~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          397 --ALERGY--RMPRPENC---PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             --HHHHTC--CCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             --HHHcCC--CCCCCCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence              011111  11111222   235667788999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.7e-45  Score=340.33  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=194.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCC---CcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|+||.||+|.+..+   +..||+|.+... .....+.+.+|+.++++++||||+++++++.+  +..+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   91 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW   91 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--CccE
Confidence            46788899999999999999988543   457999998764 33456679999999999999999999998743  4478


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccc
Confidence            9999999999999997643      46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++........ ......+|+.|+|||.+....++.++||||||+++|||++ |..||........   ..          
T Consensus       163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~----------  228 (281)
T 1mp8_A          163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG----------  228 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----------
T ss_pred             ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH----------
Confidence            9876543221 1233457789999999998899999999999999999997 9999976543221   10          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       .+.....  ...+...   ...+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       229 -~i~~~~~--~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          229 -RIENGER--LPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -HHHTTCC--CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHcCCC--CCCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             0111000  1111122   23466777899999999999999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=350.75  Aligned_cols=251  Identities=28%  Similarity=0.372  Sum_probs=188.3

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ..++|...+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|+.++.+++||||+++++++.+. ...++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-TEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC-CeEEEEE
Confidence            4567999999999999999999999889999999997643  345688999999999999999999998765 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeEecccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGL  214 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DfGl  214 (398)
                      ||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       128 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          128 ELVTGGELFDRIVEK-------GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             CCCCSCBHHHHHTTC-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             EeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            999999999999764       45899999999999999999999988   999999999999975   88999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .+             
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~-------------  259 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM-------------  259 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH-------------
T ss_pred             ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH-------------
Confidence            98665432   1235679999999999998899999999999999999999999997543221  00             


Q ss_pred             hhhhhcCcccCC-CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ...+....... ..........+.+++.+||+.||.+|||+.|+++
T Consensus       260 -~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          260 -FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             01111111110 0001112245677888999999999999999987

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.8e-45  Score=353.91  Aligned_cols=208  Identities=22%  Similarity=0.302  Sum_probs=179.0

Q ss_pred             hcCCCCCceeccc--CceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRG--ALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|  +||+||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-CEEE
Confidence            4689999999999  9999999999989999999999754  344557788999999999999999999998875 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM-----DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEEccCCCCHHHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccc
Confidence            99999999999999987532     45999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC-----ceeeeccccCCCcccchhhcc--CCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          215 ATWTSAPSV-----PFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       215 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      +........     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  242 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA  242 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            865432111     011123478999999999987  5789999999999999999999999976443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-45  Score=342.86  Aligned_cols=256  Identities=23%  Similarity=0.382  Sum_probs=203.1

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ..++|...+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++..++||||+++++++.+. +..++||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   98 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIIT   98 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC-CCeEEEE
Confidence            4568888999999999999999887 477899999976543 346789999999999999999999998664 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        99 e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           99 EYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             CCCTTCBHHHHHHCGG------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             eccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccc
Confidence            9999999999997643      45999999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.........      .        .+
T Consensus       170 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~--------~~  234 (283)
T 3gen_A          170 VLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------E--------HI  234 (283)
T ss_dssp             BCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------H--------HH
T ss_pred             cccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------H--------HH
Confidence            644221 11123456788999999998899999999999999999998 99999764432110      0        11


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ........  +...+   ..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       235 ~~~~~~~~--~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          235 AQGLRLYR--PHLAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             HTTCCCCC--CTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcccCCCC--CCcCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            11111111  11122   3566778899999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-45  Score=342.44  Aligned_cols=260  Identities=29%  Similarity=0.466  Sum_probs=193.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||+||+|.+..   .||+|++...  .....+.+.+|+.++++++||||+++++++..  ...++|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--CccEEE
Confidence            4689999999999999999998753   5999999754  34456789999999999999999999997543  347899


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        98 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             EECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             EEecCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence            99999999999996543      56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ...............||+.|+|||.+.   ...++.++||||||+++|||++|+.||.......  .+..    ...   
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~---  239 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MVG---  239 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HHH---
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----Hhc---
Confidence            665433222334567999999999986   5678889999999999999999999997643221  1111    010   


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                         .....+.+.  .........+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       240 ---~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          240 ---RGSLSPDLS--KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ---HTSCCCCTT--SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---ccccCcchh--hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence               111111111  011122245777888999999999999999999998653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.1e-45  Score=350.17  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=202.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++.+..   ......+..|..++..+ +||||+++++++.+. +.+|
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~   97 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLY   97 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-SEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-CEEE
Confidence            468999999999999999999999889999999997542   23456688899999887 799999999987664 5689


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        98 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            999999999999999875       35999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +             
T Consensus       168 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~-------------  229 (353)
T 2i0e_A          168 CKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L-------------  229 (353)
T ss_dssp             CBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H-------------
T ss_pred             ccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---H-------------
Confidence            986433221  2345679999999999999999999999999999999999999997654321   1             


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                       ...+....+..+...+   ..+.+++.+||+.+|.+||+     +.+|++
T Consensus       230 -~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          230 -FQSIMEHNVAYPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -HHHHHHCCCCCCTTSC---HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -HHHHHhCCCCCCCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             1111112222222222   34667778899999999995     566665

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-44  Score=340.04  Aligned_cols=265  Identities=23%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||+||+|.+.. ++.||+|++....  ......+.+|++++++++||||+++++++.+. ...++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-RCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-SCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-CEEEEE
Confidence            4789999999999999999999864 8999999997542  23346788999999999999999999987664 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||++ ++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        98 ~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           98 FEFME-KDLKKVLDENK------TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             EECCS-EEHHHHHHTCT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EcCCC-CCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCce
Confidence            99996 58888887643      45999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc-h-
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG-M-  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~-  293 (398)
                      .......  ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.............   ...... . 
T Consensus       168 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~~~~~~  242 (311)
T 3niz_A          168 AFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF---SILGTPNPR  242 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH---HHHCCCCTT
T ss_pred             ecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHHCCCChH
Confidence            7654322  1234578999999999876 468999999999999999999999998655433211110   000000 0 


Q ss_pred             -----hhhhhhcCcccCC-CCCCH-----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 -----AAVEELLDPRLKC-TSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 -----~~~~~~~d~~l~~-~~~~~-----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           ..+....+..... .....     .....+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 0000000000000 00000     11235678888999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-44  Score=337.39  Aligned_cols=264  Identities=19%  Similarity=0.226  Sum_probs=206.4

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ..++|...+.||+|+||.||+|.+..+++.||||++.....  ...+.+|+.++..++|++++..++++.......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            35789999999999999999999988899999998765432  2357889999999999998888888877677789999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe---CCCCCeeEecccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGL  214 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DfGl  214 (398)
                      ||+ +++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+
T Consensus        85 e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             ECC-CCBHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             Ecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            999 999999998543      45999999999999999999999988   9999999999999   7889999999999


Q ss_pred             ccccCCCCCce-----eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          215 ATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       215 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      ++.........     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...................
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            98765543211     1234679999999999999899999999999999999999999998754433222221111100


Q ss_pred             hhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ...   .......      ..+   ..+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       235 ~~~---~~~~~~~------~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          235 MST---PIEVLCK------GYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHS---CHHHHTT------TSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ccc---hhhhhhc------cCC---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            000   0000000      111   3567778899999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-44  Score=335.93  Aligned_cols=252  Identities=27%  Similarity=0.358  Sum_probs=203.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-CEEEEE
Confidence            46899999999999999999999988999999999654  344557788999999999999999999998764 457999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC---eeEeccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFG  213 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DfG  213 (398)
                      |||+++++|.+.+...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        84 ~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999999998775       45899999999999999999999988   999999999999986655   9999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........   .   ....    
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~---~~~~----  220 (284)
T 3kk8_A          154 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---Y---AQIK----  220 (284)
T ss_dssp             TCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHH----
T ss_pred             eeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---H---HHHH----
Confidence            9987654332   2346799999999999999999999999999999999999999976432211   0   0000    


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ..............   ...+.+++.+||+.+|.+|||+.|+++
T Consensus       221 ---~~~~~~~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          221 ---AGAYDYPSPEWDTV---TPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---HTCCCCCTTTTTTS---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hccccCCchhhccc---CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               01111111101111   234667778999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.9e-45  Score=342.45  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCC-------cEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||+||+|.+..++       ..||+|.+........+.+.+|+.++++++||||+++++++.+.+ 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD-   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence            357888899999999999999987655       469999998766667788999999999999999999999987754 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC-----
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----  206 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~-----  206 (398)
                      ..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.     
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTB
T ss_pred             CCEEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccc
Confidence            4789999999999999998753      34899999999999999999999988   999999999999998887     


Q ss_pred             ---eeEeccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          207 ---PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       207 ---~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                         +||+|||++......      ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.......  ...
T Consensus       157 ~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~  228 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKL  228 (289)
T ss_dssp             CCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH
T ss_pred             cceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHH
Confidence               999999998755322      23568999999999987 678999999999999999999655543322110  000


Q ss_pred             HHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          283 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                      .    .       ...  ...+  +...   ...+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       229 ~----~-------~~~--~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          229 Q----F-------YED--RHQL--PAPK---AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             H----H-------HHT--TCCC--CCCS---SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             H----H-------hhc--cCCC--CCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0    0       000  0111  1111   1236677889999999999999999999987644

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.5e-44  Score=339.90  Aligned_cols=271  Identities=21%  Similarity=0.351  Sum_probs=190.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++..... .....+.+|+.+++.++||||+++++++.+ ++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence            4689999999999999999999988899999999975432 234678899999999999999999998766 45689999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||++ |+|.+++...... .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        83 e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            9997 6999999765321 11245899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc----
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----  292 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----  292 (398)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............   .......    
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~  232 (317)
T 2pmi_A          158 FGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI---FDIMGTPNESL  232 (317)
T ss_dssp             TTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCTTT
T ss_pred             cCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCChhH
Confidence            654322  12345789999999999764 6899999999999999999999999865432211111   0000000    


Q ss_pred             hhhhhhh--cCcccCC--CCCCH---------HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEEL--LDPRLKC--TSRNS---------AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~--~d~~l~~--~~~~~---------~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+...  ..+.+..  .....         .....+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0000000  0000000  00000         11235778888999999999999999886

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.8e-44  Score=334.59  Aligned_cols=263  Identities=19%  Similarity=0.226  Sum_probs=208.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|++.....  ...+.+|+.++..++|++++..+.++...+...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            4689999999999999999999988899999999875433  24588999999999999988888887776777899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe---CCCCCeeEeccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  215 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DfGla  215 (398)
                      |+ +++|.+++....      ..+++..++.++.|++.||+|||+++   |+||||||+|||+   ++++.+||+|||++
T Consensus        86 ~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             ec-CCCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            99 999999997543      46999999999999999999999988   9999999999999   48889999999999


Q ss_pred             cccCCCCCce-----eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          216 TWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       216 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      +.........     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            8765543211     12346799999999999998999999999999999999999999986543322222211111000


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ..   ....+.+      ..+   ..+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       236 ~~---~~~~~~~------~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          236 ST---PIEVLCK------GYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HS---CHHHHTT------TSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             CC---chHHHHh------hCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            00   0000001      111   3467778899999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.5e-45  Score=336.84  Aligned_cols=250  Identities=24%  Similarity=0.313  Sum_probs=203.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-TDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeEEEEEe
Confidence            35788899999999999999999988999999999876555677899999999999999999999998764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe---CCCCCeeEeccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  215 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DfGla  215 (398)
                      |+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++
T Consensus        87 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           87 LCTGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             CCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             ccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            99999999999775       45899999999999999999999988   9999999999999   78899999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........   .             
T Consensus       157 ~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~-------------  216 (277)
T 3f3z_A          157 ARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV---M-------------  216 (277)
T ss_dssp             EECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------
T ss_pred             eeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH---H-------------
Confidence            87654332   234579999999999865 489999999999999999999999976443210   0             


Q ss_pred             hhhhcCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ..+.......+.. .......+.+++.+||+.+|.+|||+.++++
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          217 -LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -HHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000000000000 0011245677888999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.5e-45  Score=342.74  Aligned_cols=271  Identities=25%  Similarity=0.323  Sum_probs=204.6

Q ss_pred             cCCCCCceecccCceEEEEee----eCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~  133 (398)
                      +.|...+.||+|+||.||+|.    ...+++.||+|++.... ......+.+|+.++..++||||+++++++.+.+ ..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            457888999999999999998    45678999999997543 334577899999999999999999999987653 457


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccc
Confidence            89999999999999997653      45999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH-hhHHHhh
Q 015931          214 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW-AKPILHR  291 (398)
Q Consensus       214 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~  291 (398)
                      ++......... .......||..|+|||.+.+..++.++||||||+++|+|++|..|+.............+ .......
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence            99877654322 122345688889999999998999999999999999999999998754321100000000 0000000


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ....+....  ....+..   ....+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       252 ~~~~~~~~~--~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          252 LVNTLKEGK--RLPCPPN---CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHHHTTC--CCCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHhccC--CCCCCCC---CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            000011111  1111112   22456777889999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-44  Score=337.50  Aligned_cols=266  Identities=21%  Similarity=0.292  Sum_probs=199.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.++++++||||+++++++.+. +..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEE
Confidence            46888899999999999999999889999999997543  33457788999999999999999999998774 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++ +|.+.+....      ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        81 e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             ECCSE-EHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            99965 6666665532      46999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCC-cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc----
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----  292 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----  292 (398)
                      ......  ......||+.|+|||.+.+.. ++.++|||||||++|||++|..||.......  .............    
T Consensus       151 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~  226 (292)
T 3o0g_A          151 FGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTT
T ss_pred             cCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhh
Confidence            654322  123457899999999998765 7999999999999999999988864332211  1111110000000    


Q ss_pred             hhhhhhhcCc--------ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDP--------RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~--------~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........+.        ........+.....+.+++.+||+.||.+|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000000000        00000001122345667888999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.8e-45  Score=336.12  Aligned_cols=247  Identities=28%  Similarity=0.458  Sum_probs=200.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|.+..++..||+|++....   ......+.+|+.+++.++||||+++++++.+. ...++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEEE
Confidence            467889999999999999999999889999999986532   22346788999999999999999999998765 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        87 v~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~  156 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS  156 (279)
T ss_dssp             EECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred             EEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccc
Confidence            99999999999999875       35899999999999999999999888   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........                
T Consensus       157 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------  216 (279)
T 3fdn_A          157 VHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----------------  216 (279)
T ss_dssp             SCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------
T ss_pred             ccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH----------------
Confidence            6554332    23457899999999999889999999999999999999999999764432110                


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ..+.......+...+   ..+.+++.+||+.+|.+|||+.|+++
T Consensus       217 -~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          217 -KRISRVEFTFPDFVT---EGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -HHHHHTCCCCCTTSC---HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -HHHHhCCCCCCCcCC---HHHHHHHHHHhccChhhCCCHHHHhh
Confidence             001111111112222   34567778899999999999999997

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1e-44  Score=339.12  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCC---CcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .+|...+.||+|+||+||+|.+..+   ...||+|.+... .....+.+.+|+.++++++||||++++++|.+.++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4678889999999999999986532   346899998764 344567899999999999999999999998877777899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       105 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             EEeCCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccc
Confidence            999999999999997642      46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCc--eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          216 TWTSAPSVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       216 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +........  .......||+.|+|||.+.+..++.++||||||+++|+|++ |..||........   ...        
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~--------  244 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY--------  244 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHH--------
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH--------
Confidence            866543211  11234567889999999998899999999999999999999 5556654332211   100        


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                         +...  .....+...+   ..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       245 ---~~~~--~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          245 ---LLQG--RRLLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             ---HHTT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HhcC--CCCCCCccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0000  0111111122   3467778899999999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.4e-45  Score=342.97  Aligned_cols=267  Identities=21%  Similarity=0.339  Sum_probs=198.9

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCC---CCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  130 (398)
                      ....++|...+.||+|+||.||+|....   ++..||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3445788889999999999999998754   4558999998754  3445577999999999999999999999987654


Q ss_pred             C----cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          131 Q----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       131 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      .    ..++||||+++|+|.+++..... ......+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRL-ETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTB-TTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhh-hcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence            3    35899999999999999965321 112356999999999999999999999988   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||........   ... 
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~-  261 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY-  261 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH-
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH-
Confidence            99999999987654432222334567889999999999899999999999999999999 8899976543221   100 


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                                +.....+..  +...   ...+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       262 ----------~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          262 ----------LLHGHRLKQ--PEDC---LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             ----------HHTTCCCCC--BTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------HHcCCCCCC--Cccc---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                      001001111  1112   23567778899999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=338.71  Aligned_cols=259  Identities=24%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             CCCCCceecccCceEEEEeeeCCCC---cEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .|...+.||+|+||+||+|.+..++   ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+...++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556689999999999999865433   379999997643 345678999999999999999999999988766656899


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+.+|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       102 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ------RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             EecccCCCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence            99999999999997642      46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCC--ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          217 WTSAPSV--PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       217 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      .......  ........+|..|+|||.+.+..++.++||||||+++|+|++|..|+.......  .....          
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~----------  240 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHF----------  240 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHH----------
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHH----------
Confidence            6543221  111234568899999999999999999999999999999999666544322111  11110          


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                       +.....  ...+...+   ..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       241 -~~~~~~--~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          241 -LAQGRR--LPQPEYCP---DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             -HHTTCC--CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -hhcCCC--CCCCccch---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             111111  11111122   34667788999999999999999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-45  Score=348.35  Aligned_cols=256  Identities=25%  Similarity=0.363  Sum_probs=195.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC---c
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---G  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~  132 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++...   .......+.+|+.++.+++||||+++++++.....   .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36899999999999999999999888999999999764   23445678999999999999999999998765433   2


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .++||||+++++|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCC
T ss_pred             cEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeec
Confidence            48999999999999999865       45999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          213 GLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       213 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      |+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      .......
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~  234 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVRE  234 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHC
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcC
Confidence            999876543221 122345699999999999998999999999999999999999999976543211      0011100


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .      ...+... ....   ...+.+++.+||+.||.+||+..++++
T Consensus       235 ~------~~~~~~~-~~~~---~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          235 D------PIPPSAR-HEGL---SADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             C------CCCHHHH-STTC---CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             C------CCCcccc-cCCC---CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            0      0000000 0011   234667788999999999997777664

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.6e-45  Score=335.06  Aligned_cols=254  Identities=21%  Similarity=0.320  Sum_probs=202.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+.  +..||||++...  .....+.+.+|+.++++++||||+++++++.+.+ ...++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            57888999999999999999986  788999999764  3445677999999999999999999999987652 457999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++.++|+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN-----FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS-----CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             ecccCCCcHHHHHhhccc-----CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEecccee
Confidence            999999999999986432     46999999999999999999999754 349999999999999999999999998875


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCC---ccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD---KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ....       ....||+.|+|||.+.+...+.   ++||||||+++|||++|+.||........      ....     
T Consensus       162 ~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~-----  223 (271)
T 3kmu_A          162 SFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKV-----  223 (271)
T ss_dssp             TTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHH-----
T ss_pred             eecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHH-----
Confidence            4322       2346899999999998765544   79999999999999999999975432211      0000     


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                        ......+.+  +...+   ..+.+++..||+.+|.+|||+.++++.|+.+.
T Consensus       224 --~~~~~~~~~--~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          224 --ALEGLRPTI--PPGIS---PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             --HHSCCCCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             --HhcCCCCCC--CCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence              111111111  11222   34667778899999999999999999998653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.4e-45  Score=346.37  Aligned_cols=266  Identities=21%  Similarity=0.359  Sum_probs=207.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-------CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  129 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  129 (398)
                      .++|...+.||+|+||.||+|.+.       .++..||+|++.... ......+.+|+.++..+ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468889999999999999999874       346789999997653 34567789999999999 899999999998765


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                      + ..++||||+++|+|.+++.......         .....+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus       114 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          114 G-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             S-CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             C-ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            4 5799999999999999998653100         01235899999999999999999999988   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccch
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  279 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  279 (398)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.......  
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  267 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  267 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence            99999999999999987665433222334567889999999988889999999999999999999 999997643221  


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                       +..           .+........  +...   ...+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       268 -~~~-----------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          268 -LFK-----------LLKEGHRMDK--PANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             -HHH-----------HHHHTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHH-----------HHhcCCCCCC--CccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             110           0111111111  1112   2346677789999999999999999999987543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-44  Score=343.13  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=192.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeC---CCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||.||++...   .+++.||+|++....    ......+.+|+.+++.++||||+++++++.+. +
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-G   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-S
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-C
Confidence            367889999999999999999874   578999999997642    23345678999999999999999999998765 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~D  164 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTD  164 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEe
Confidence            589999999999999999865       35899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ||+++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   .          
T Consensus       165 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~----------  229 (327)
T 3a62_A          165 FGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---T----------  229 (327)
T ss_dssp             CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H----------
T ss_pred             CCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---H----------
Confidence            999975433221  2245679999999999998899999999999999999999999997643221   0          


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                          +..+.......+...+   ..+.+++.+||+.+|.+||     ++.++++
T Consensus       230 ----~~~i~~~~~~~p~~~~---~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          230 ----IDKILKCKLNLPPYLT---QEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----HHHHHHTCCCCCTTSC---HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----HHHHHhCCCCCCCCCC---HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                1111111112122222   3466777889999999999     7788876

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.2e-45  Score=362.14  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=194.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|....+++.||||++...   .......+.+|+.++..++||||+++++++.+. +.+++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEEE
Confidence            46788999999999999999999999999999999753   233446678899999999999999999998775 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      ||||+++|+|.+++...       ..+++..+..++.|++.||+|||+ .+   |+||||||+||||+.++.+||+|||+
T Consensus       226 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             EECCCSSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             EEeeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCC
Confidence            99999999999999775       459999999999999999999998 77   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........                
T Consensus       296 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------  357 (446)
T 4ejn_A          296 CKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------  357 (446)
T ss_dssp             CCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             ceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----------------
Confidence            986433222  23456799999999999999999999999999999999999999976433211                


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                       ...+.......+...+   ..+.+++.+||+.||.+||     ++.|+++
T Consensus       358 -~~~i~~~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          358 -FELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -HHHHHHCCCCCCTTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -HHHHHhCCCCCCccCC---HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence             0111111111122222   3466777899999999999     9999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-44  Score=359.43  Aligned_cols=247  Identities=28%  Similarity=0.424  Sum_probs=204.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+..+|+.||||++....   ......+.+|+.+++.++||||+++++++... ...++|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEE
Confidence            67889999999999999999999889999999997532   12346788999999999999999999998765 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        95 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           95 MEYVSGGELFDYICKN-------GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             EECCSSEEHHHHTTSS-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchh
Confidence            9999999999999753       45999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .......   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......   +              
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~--------------  224 (476)
T 2y94_A          165 MMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---L--------------  224 (476)
T ss_dssp             ECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---H--------------
T ss_pred             hcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---H--------------
Confidence            7654332   245679999999999988765 689999999999999999999998644321   1              


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.+.....+...+   ..+.+++.+||+.||.+|||+.++++
T Consensus       225 ~~~i~~~~~~~p~~~s---~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          225 FKKICDGIFYTPQYLN---PSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHTTCCCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhcCCcCCCccCC---HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            1112222222222222   34667778999999999999999997

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.3e-45  Score=341.71  Aligned_cols=265  Identities=23%  Similarity=0.417  Sum_probs=198.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++...   .......+.+|+.+++.++||||+++++++.+. +..++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CcEEE
Confidence            35789999999999999999999888999999999753   345567789999999999999999999998875 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus       110 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKK---QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             EEecCCCCCHHHHHHHhcc---cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            9999999999999976321   1256899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......    ......        
T Consensus       184 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~--------  249 (310)
T 2wqm_A          184 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK--------  249 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHH--------
T ss_pred             eeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHH--------
Confidence            86654321  1234568999999999998899999999999999999999999997543221    111111        


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCccc
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL  348 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~  348 (398)
                      +.....+.+. ....+   ..+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       250 ~~~~~~~~~~-~~~~~---~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          250 IEQCDYPPLP-SDHYS---EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             HHTTCSCCCC-TTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhcccCCCCc-ccccC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            1111111111 11122   3466777889999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=341.97  Aligned_cols=268  Identities=21%  Similarity=0.271  Sum_probs=199.5

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHHhC---CCCCeeceeeEEEcC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSL---HHPNIVPLVGFCIDP  129 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  129 (398)
                      .+++|...+.||+|+||+||+|.+..+++.||+|++....     ......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3578999999999999999999998889999999986432     11224566777776665   499999999998775


Q ss_pred             CC----cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          130 EQ----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       130 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      ..    ..++||||+. ++|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGG  157 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCC
Confidence            43    4789999995 699999987532     45999999999999999999999988   99999999999999999


Q ss_pred             CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh
Q 015931          206 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  285 (398)
                      .+||+|||+++.......   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||............   
T Consensus       158 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---  231 (308)
T 3g33_A          158 TVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI---  231 (308)
T ss_dssp             CEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH---
T ss_pred             CEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence            999999999987654332   24567999999999999999999999999999999999999999765432211110   


Q ss_pred             hHHHhhch-hhhhhh---cCcccC-CCCCC-----HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          286 KPILHRGM-AAVEEL---LDPRLK-CTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       286 ~~~~~~~~-~~~~~~---~d~~l~-~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........ ......   ....+. .....     +.....+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00000000 000000   000000 00000     011245677888999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-45  Score=339.28  Aligned_cols=252  Identities=27%  Similarity=0.466  Sum_probs=197.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|...  ++.||+|.+....  ..+.+.+|+.++.+++||||+++++++.+.++..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            467888999999999999999875  7899999997543  456789999999999999999999998776666899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        96 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CCTTEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             cCCCCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            9999999999986532     34899999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ....     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ...           .+.
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~-----------~~~  228 (278)
T 1byg_A          168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP-----------RVE  228 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH-----------HHT
T ss_pred             cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------HHh
Confidence            4322     23457889999999998899999999999999999998 999997643321   100           011


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ....+..  +...+   ..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       229 ~~~~~~~--~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          229 KGYKMDA--PDGCP---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             TTCCCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCCC--cccCC---HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            1111111  11222   34667778899999999999999999998754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8e-45  Score=344.61  Aligned_cols=250  Identities=21%  Similarity=0.314  Sum_probs=178.8

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEEecCCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      .+.||+|+||+||+|.+..+++.||||++...   ....+.+|+.++..+. ||||+++++++.+. ...++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-LHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-CEEEEEEEccCCC
Confidence            47899999999999999988999999999653   3456788999999997 99999999998764 4589999999999


Q ss_pred             CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC---CeeEeccccccccCC
Q 015931          144 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA  220 (398)
Q Consensus       144 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DfGla~~~~~  220 (398)
                      +|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||+++....
T Consensus        92 ~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           92 ELFERIKKK-------KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             BHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             cHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            999999874       46999999999999999999999988   99999999999997665   899999999986654


Q ss_pred             CCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhc
Q 015931          221 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  300 (398)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (398)
                      ...  ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..............          .+..+.
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----------~~~~i~  229 (325)
T 3kn6_A          162 DNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE----------IMKKIK  229 (325)
T ss_dssp             ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH----------HHHHHT
T ss_pred             CCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH----------HHHHHH
Confidence            332  22456789999999999988999999999999999999999999986543211110000          111122


Q ss_pred             CcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          301 DPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       301 d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ......... .......+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          230 KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            222111100 0112345777888999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.6e-45  Score=360.90  Aligned_cols=258  Identities=28%  Similarity=0.394  Sum_probs=201.9

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ...++|...+.||+|+||.||+|.+.. +..||||++..... ..+.|.+|+.++++++||||+++++++.+  +..++|
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv  256 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIV  256 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEE
Confidence            345678888999999999999999975 56799999976542 35679999999999999999999998765  447999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++.....     ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus       257 ~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             ehhhcCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccce
Confidence            999999999999976432     45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ....... .......++..|+|||.+....++.++||||||+++|||++ |+.||......+   ...           .
T Consensus       329 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~-----------~  393 (452)
T 1fmk_A          329 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD-----------Q  393 (452)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH-----------H
T ss_pred             ecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------H
Confidence            7654321 11223457889999999998999999999999999999999 999997643221   000           0


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      +....  +...+...   ...+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       394 i~~~~--~~~~~~~~---~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          394 VERGY--RMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             HHTTC--CCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHcCC--CCCCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            11111  11112222   235667778999999999999999999998753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.7e-45  Score=345.13  Aligned_cols=265  Identities=26%  Similarity=0.368  Sum_probs=203.9

Q ss_pred             hcCCCCCceecccCceEEEEeee-----CCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .++|...+.||+|+||.||+|.+     ..++..||||.+... .......+.+|+.++++++||||+++++++.+.+ .
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-P  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-C
Confidence            47899999999999999999984     456788999999754 3455668999999999999999999999987654 4


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeE
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKL  209 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl  209 (398)
                      .++||||+++++|.+++............+++..++.++.|++.||.|||+.+   |+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            79999999999999999876432223356999999999999999999999988   999999999999984   456999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      +|||++................||+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ...     
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~-----  256 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE-----  256 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH-----
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHH-----
Confidence            99999986544332222344568999999999998899999999999999999998 999997643221   110     


Q ss_pred             HhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                            .+.....+  ..+...   ...+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       257 ------~~~~~~~~--~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          257 ------FVTSGGRM--DPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             ------HHHTTCCC--CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHhcCCCC--CCCCCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                  01110011  111112   235667788999999999999999999998653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=339.60  Aligned_cols=268  Identities=23%  Similarity=0.351  Sum_probs=198.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||+||+|.+..+++.||+|++....  ....+.+.+|+.++.+++||||+++++++.+. +..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEEE
Confidence            57888999999999999999999889999999986543  23456788999999999999999999998774 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|..++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        82 e~~~~~~l~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ-------RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             ECCSEEHHHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeCCCchHHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            999999999988654       45899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-HHHhhchhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-PILHRGMAA  295 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~  295 (398)
                      ......  ......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||................ .........
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            654332  1234578999999999876 568999999999999999999999997654332211111000 000000000


Q ss_pred             h--hh-hcCcccCCCC--CC-----HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 V--EE-LLDPRLKCTS--RN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~--~~-~~d~~l~~~~--~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .  .. .....+....  ..     +.....+.+++.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0  00 0000000000  00     112234678888999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-45  Score=356.67  Aligned_cols=248  Identities=16%  Similarity=0.184  Sum_probs=192.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHH---HHHHhCCCCCeecee-------eE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCREL---MIASSLHHPNIVPLV-------GF  125 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  125 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+   ..++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788889999999999999999888999999999743   344567889999   555666899999998       66


Q ss_pred             EEcCCC----------------cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCce
Q 015931          126 CIDPEQ----------------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV  189 (398)
Q Consensus       126 ~~~~~~----------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i  189 (398)
                      +.+.+.                ..|+||||+ +|+|.+++............+++..++.|+.|++.||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            554322                378999999 78999999875331111234557899999999999999999988   9


Q ss_pred             eecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccC-----------CcCCccchhhHHH
Q 015931          190 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----------KVSDKTDVYAFGV  258 (398)
Q Consensus       190 vHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~S~Gv  258 (398)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2245567 999999999877           8999999999999


Q ss_pred             HHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHH
Q 015931          259 VLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI  338 (398)
Q Consensus       259 vl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  338 (398)
                      ++|||++|+.||.........                 ..+...    ....+   ..+.+++.+||+.||.+|||+.++
T Consensus       302 il~elltg~~Pf~~~~~~~~~-----------------~~~~~~----~~~~~---~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGS-----------------EWIFRS----CKNIP---QPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHSSCCC------CCS-----------------GGGGSS----CCCCC---HHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHHCCCCCcccccccch-----------------hhhhhh----ccCCC---HHHHHHHHHHcCCCchhCCCHHHH
Confidence            999999999999765432211                 111110    01122   346677789999999999999999


Q ss_pred             HH
Q 015931          339 IA  340 (398)
Q Consensus       339 l~  340 (398)
                      ++
T Consensus       358 l~  359 (377)
T 3byv_A          358 ME  359 (377)
T ss_dssp             HT
T ss_pred             hh
Confidence            86

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-45  Score=352.56  Aligned_cols=205  Identities=27%  Similarity=0.412  Sum_probs=167.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCC-CcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE-QGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~~  134 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++..+. ||||+++++++...+ ..+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            46899999999999999999999989999999998643  3455677889999999997 999999999987544 3589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||++ ++|..++..        ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        88 lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             EEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            9999996 699999876        35899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCC-------------------CceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          215 ATWTSAPS-------------------VPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       215 a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ++......                   .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            98654311                   0111234579999999999976 578999999999999999999999998654


Q ss_pred             c
Q 015931          275 L  275 (398)
Q Consensus       275 ~  275 (398)
                      .
T Consensus       236 ~  236 (388)
T 3oz6_A          236 T  236 (388)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-44  Score=342.78  Aligned_cols=251  Identities=26%  Similarity=0.329  Sum_probs=203.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .++|...+.||+|+||.||+|....+++.||+|.+.....      ...+.+.+|+.++..++||||+++++++.+. ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   89 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-TD   89 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CE
Confidence            3578889999999999999999998899999999976432      1357799999999999999999999998764 45


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC----Cee
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPK  208 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~k  208 (398)
                      .++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++    .+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEE
Confidence            89999999999999999763       45899999999999999999999988   99999999999999887    799


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      |+|||++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........   .      
T Consensus       160 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~------  227 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---L------  227 (321)
T ss_dssp             ECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H------
T ss_pred             EccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---H------
Confidence            999999987654332   2345699999999999988999999999999999999999999976432211   0      


Q ss_pred             HhhchhhhhhhcCcccCCCC-CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          289 LHRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                              ..+......... ........+.+++.+||+.||.+|||+.|+++
T Consensus       228 --------~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          228 --------ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --------HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --------HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    011110000000 00001134677888999999999999999987

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=347.35  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=194.5

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCC--CCeeceeeEEEcCCCcE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~  133 (398)
                      ..++|...+.||+|+||.||++... +++.||||++...  .......+.+|+.++..++|  |||+++++++.+. ...
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-CEE
Confidence            3467899999999999999999885 4889999999754  34455788999999999986  9999999998764 458


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++|||+ .+++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||
T Consensus        85 ~lv~e~-~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             EEEEeC-CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecc
Confidence            999995 588999999874       45899999999999999999999988   99999999999997 5789999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhcc-----------CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                      +++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     .
T Consensus       153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~  227 (343)
T 3dbq_A          153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I  227 (343)
T ss_dssp             SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred             cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----H
Confidence            9987765433323345679999999999864           67889999999999999999999999753211     0


Q ss_pred             HHhhHHHhhchhhhhhhcCcccC--CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          283 LWAKPILHRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .           .+..++++...  .+...+   ..+.+++.+||+.||.+|||+.|+++.
T Consensus       228 ~-----------~~~~~~~~~~~~~~~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 S-----------KLHAIIDPNHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             H-----------HHHHHHCTTSCCCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H-----------HHHHHhcCCcccCCcccCC---HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            0           12222222221  122222   346677788999999999999999873

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-44  Score=341.67  Aligned_cols=268  Identities=22%  Similarity=0.313  Sum_probs=197.6

Q ss_pred             cCCCC-CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSK-GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      +.|.. .+.||+|+||.||+|....+++.||||++..........+.+|++++.++ +||||+++++++.+. +..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEEE
Confidence            46666 47899999999999999888999999999876655677899999999985 799999999998775 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC---eeEecccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFGL  214 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DfGl  214 (398)
                      ||+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        91 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             ECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            999999999999875       35899999999999999999999988   999999999999998776   99999999


Q ss_pred             ccccCCCCC-----ceeeeccccCCCcccchhhcc-----CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          215 ATWTSAPSV-----PFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       215 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      +........     ........||+.|+|||.+..     ..++.++|||||||++|||++|+.||......+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            876542211     011123569999999999875     4688999999999999999999999986543321100000


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+....  .....+.......+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQN--MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHH--HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHH--HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0000000  0011111111110000 0001235678888999999999999999987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.7e-45  Score=342.92  Aligned_cols=267  Identities=24%  Similarity=0.365  Sum_probs=208.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc---CCCcEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID---PEQGLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~~~  134 (398)
                      ..++|...+.||+|+||.||++....+++.||+|++........+.+.+|+.+++.++||||+++++++..   .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            45789999999999999999999988899999999987767777889999999999999999999999863   233578


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++.....   ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus       107 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKD---KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEEeCCCCcHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCc
Confidence            99999999999999987422   1356999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCce-------eeeccccCCCcccchhhccCC---cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          215 ATWTSAPSVPF-------LCKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       215 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      +..........       ......||+.|+|||.+....   ++.++||||||+++|||++|+.||......... ... 
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~-  258 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VAL-  258 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHH-
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhH-
Confidence            87553211000       012345799999999987543   689999999999999999999999753222111 000 


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                                .+...  .........   ...+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       259 ----------~~~~~--~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          259 ----------AVQNQ--LSIPQSPRH---SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ----------HHHCC----CCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ----------Hhhcc--CCCCccccC---CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                      00110  011111112   2356777889999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-45  Score=352.20  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=194.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCC---CcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .|...+.||+|+||+||+|.+...   +..||+|.+... .....+.|.+|+.++++++||||++++++|.+.++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            355668999999999999987432   246899998654 3455678999999999999999999999988766678999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       170 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             EECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EECCCCCCHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccc
Confidence            99999999999997643      45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCc--eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ........  .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........   ...         
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~---------  308 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY---------  308 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH---------
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH---------
Confidence            66433211  11233457889999999999999999999999999999999 6777765443221   110         


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                        +...  .....+...+   ..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       309 --~~~~--~~~~~p~~~~---~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          309 --LLQG--RRLLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             --HHTT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHcC--CCCCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0000  0111112222   3466777899999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-45  Score=347.06  Aligned_cols=273  Identities=22%  Similarity=0.312  Sum_probs=212.8

Q ss_pred             cCHHHHHHhhcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeecee
Q 015931           50 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLV  123 (398)
Q Consensus        50 ~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  123 (398)
                      +...++....++|...+.||+|+||.||+|.+.     .+++.||+|.+.... ......+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344455566788999999999999999999875     346789999997543 34556789999999999999999999


Q ss_pred             eEEEcCCCcEEEEEecCCCCCHHHHHhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          124 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG---VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       124 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~---~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                      +++.+.+ ..++||||+++|+|.+++......   ......+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus        95 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl  170 (322)
T 1p4o_A           95 GVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM  170 (322)
T ss_dssp             EEECSSS-SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred             EEEccCC-ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence            9986654 579999999999999999764210   001145799999999999999999999988   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccch
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  279 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  279 (398)
                      ++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||.......  
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  248 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--  248 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence            99999999999999986644332222233457889999999998899999999999999999999 899997643221  


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCccc-CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                       ..              ..+..... ..+...   ...+.+++.+||+.+|.+|||+.++++.|+...
T Consensus       249 -~~--------------~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          249 -VL--------------RFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             -HH--------------HHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -HH--------------HHHHcCCcCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence             10              11111111 111112   234667778899999999999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.8e-45  Score=338.13  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=196.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||+|+||.||++....++..||+|++.... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-HNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-CeEEEEEE
Confidence            57888999999999999999998889999999997643 33467889999999999999999999998764 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe---CCCCCeeEeccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  215 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DfGla  215 (398)
                      |+++|+|.+++.....   ....+++..++.++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++
T Consensus       101 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A          101 TCEGGELLERIVSAQA---RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             CCSCCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             eCCCCcHHHHHHhhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999875421   1256999999999999999999999988   9999999999999   45678999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........   .....||+.|+|||.+. +.++.++||||||+++|||++|+.||..........      .        
T Consensus       175 ~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~--------  236 (285)
T 3is5_A          175 ELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------K--------  236 (285)
T ss_dssp             CC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H--------
T ss_pred             eecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------h--------
Confidence            86654321   23567999999999885 568999999999999999999999997644221100      0        


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .....+.....  .......+.+++.+||+.||.+|||+.||++
T Consensus       237 -~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          237 -ATYKEPNYAVE--CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -HHHCCCCCCC----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -hccCCcccccc--cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00011111100  0001234667788999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-45  Score=348.34  Aligned_cols=266  Identities=24%  Similarity=0.298  Sum_probs=201.4

Q ss_pred             HHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc
Q 015931           54 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCID  128 (398)
Q Consensus        54 e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  128 (398)
                      ++....++|...+.||+|+||.||+|....++..||+|++...     .....+.+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3455668899999999999999999999989999999998643     23456789999999999999999999999876


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccCC---------------------------------CCCCCCCHHHHHHHHHHHH
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKGV---------------------------------RGNSTLPWSVRYKVALGIA  175 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~---------------------------------~~~~~l~~~~~~~i~~qia  175 (398)
                      . +..++||||+++|+|.+++.......                                 .....+++..++.++.|++
T Consensus       100 ~-~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A          100 E-QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             S-SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             C-CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            4 55899999999999999986311100                                 0012246778889999999


Q ss_pred             HHHHHHHcCCCCceeecccccCcEEeCCCC--CeeEeccccccccCCCCC--ceeeeccccCCCcccchhhcc--CCcCC
Q 015931          176 ESVAYLHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAPSV--PFLCKTVKGTFGYLAPEYFQH--GKVSD  249 (398)
Q Consensus       176 ~aL~yLH~~~~~~ivHrDlkp~NIll~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~  249 (398)
                      .||+|||+.+   |+||||||+||+++.++  .+||+|||+++.......  ........||+.|+|||.+.+  ..++.
T Consensus       179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999988   99999999999998776  899999999986543221  112245679999999999975  67899


Q ss_pred             ccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCC-CCCHHHHHHHHHHHHhccccc
Q 015931          250 KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSE  328 (398)
Q Consensus       250 ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~~  328 (398)
                      ++||||||+++|||++|+.||........                 +..+........ .........+.+++.+||+.+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  318 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDADT-----------------ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN  318 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHHH-----------------HHHHHhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence            99999999999999999999976443211                 011111111000 000011235677788999999


Q ss_pred             CCCCCCHHHHHH
Q 015931          329 ESRRPGIEEIIA  340 (398)
Q Consensus       329 p~~RPt~~evl~  340 (398)
                      |.+|||+.++++
T Consensus       319 p~~Rps~~~~l~  330 (345)
T 3hko_A          319 VDERFDAMRALQ  330 (345)
T ss_dssp             TTTSCCHHHHHH
T ss_pred             hhHCCCHHHHhc
Confidence            999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=346.60  Aligned_cols=272  Identities=21%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHH--HHhCCCCCeeceeeEEEc----CCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI--ASSLHHPNIVPLVGFCID----PEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~----~~~~  132 (398)
                      .++|...+.||+|+||.||+|...  ++.||||++....   ...+..|.++  +..++||||+++++.+..    ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            468889999999999999999874  7899999997543   2344445444  445899999999975432    2234


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCceeecccccCcEEeCC
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG---------TERCVVHRDIKPSNILLSS  203 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~---------~~~~ivHrDlkp~NIll~~  203 (398)
                      .++||||+++|+|.+++...        ..++..++.++.|++.||.|||+.         +   |+||||||+|||++.
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~  155 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKN  155 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECT
T ss_pred             EEEEEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcC
Confidence            68999999999999999763        368999999999999999999988         6   999999999999999


Q ss_pred             CCCeeEeccccccccCCCCC------ceeeeccccCCCcccchhhcc-------CCcCCccchhhHHHHHHHHHcCCCCC
Q 015931          204 KKIPKLCDFGLATWTSAPSV------PFLCKTVKGTFGYLAPEYFQH-------GKVSDKTDVYAFGVVLLELLTGRKPI  270 (398)
Q Consensus       204 ~~~~kl~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~Gvvl~elltG~~Pf  270 (398)
                      ++.+||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||
T Consensus       156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            99999999999987653221      111234569999999999976       45678999999999999999998876


Q ss_pred             cccccccchhHHHHhhHHHhhchhhhhh-----hcCcccCC-CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          271 EARRLQGEENLVLWAKPILHRGMAAVEE-----LLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~d~~l~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .........................+..     ...+.+.. ..........+.+++.+||+.||.+|||+.||++.|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            5433221111000000000000000111     11111111 11123455678889999999999999999999999987


Q ss_pred             Cc
Q 015931          345 EE  346 (398)
Q Consensus       345 ~~  346 (398)
                      +.
T Consensus       316 ll  317 (336)
T 3g2f_A          316 LM  317 (336)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.8e-45  Score=347.20  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      +.|...+.||+|+||+||+|....+++.||||++....   ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEEE
Confidence            45888899999999999999998889999999997542   23446789999999999999999999998775 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+. |+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       133 ~e~~~-g~l~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS  202 (348)
T ss_dssp             EECCS-EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             EecCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCce
Confidence            99996 68888886543      46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      .....      ....||+.|+|||++.   ...++.++|||||||++|||++|+.||.......      ....      
T Consensus       203 ~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~------  264 (348)
T 1u5q_A          203 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH------  264 (348)
T ss_dssp             SSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH------
T ss_pred             ecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHH------
Confidence            66432      2356999999999984   5678999999999999999999999997543211      0001      


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                        +.....+.+. ....+   ..+.+++.+||+.+|.+|||+.++++.
T Consensus       265 --~~~~~~~~~~-~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          265 --IAQNESPALQ-SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             --HHHSCCCCCC-CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --HHhcCCCCCC-CCCCC---HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              1111111111 11122   345677788999999999999999863

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=334.75  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=183.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++.....   ...+.+.+|+.++..++||||+++++++.+. +..++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-NYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-SEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-CeEEE
Confidence            3578889999999999999999988899999999964321   2246788999999999999999999998764 55899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        89 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~  159 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRV------KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA  159 (278)
T ss_dssp             EEECCTTEEHHHHHHTCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecce
Confidence            999999999999997642      46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      .........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........                 
T Consensus       160 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------  220 (278)
T 3cok_A          160 TQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------------  220 (278)
T ss_dssp             EECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------
T ss_pred             eeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------------
Confidence            876543221  2345689999999999988899999999999999999999999976543211                 


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +..+.......+...+   ..+.+++.+||+.||.+|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          221 LNKVVLADYEMPSFLS---IEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---CCSSCCCCCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHhhcccCCccccC---HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1111111111122222   34667788999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.8e-45  Score=351.12  Aligned_cols=249  Identities=26%  Similarity=0.373  Sum_probs=193.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHH-HHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMI-ASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++.+..   ......+..|..+ ++.++||||+++++++.+. +.+|
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-SEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-CEEE
Confidence            468999999999999999999999999999999997642   2334456677776 4678999999999988764 5689


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++...       ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       116 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcc
Confidence            999999999999999875       35899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...                 
T Consensus       186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------  246 (373)
T 2r5t_A          186 CKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----------------  246 (373)
T ss_dssp             CGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----------------
T ss_pred             ccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----------------
Confidence            986433221  2345679999999999999899999999999999999999999997654321                 


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....++...+..+...+   ..+.+++.+||+.||.+||++.+.++
T Consensus       247 ~~~~i~~~~~~~~~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          247 MYDNILNKPLQLKPNIT---NSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             HHHHHHHSCCCCCSSSC---HHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             HHHHHHhcccCCCCCCC---HHHHHHHHHHcccCHHhCCCCCCCHH
Confidence            01111222222222222   34566778899999999999864433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-44  Score=341.06  Aligned_cols=269  Identities=22%  Similarity=0.294  Sum_probs=199.8

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC--CCCCeeceeeEEEcCC---C
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL--HHPNIVPLVGFCIDPE---Q  131 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~---~  131 (398)
                      ...++|...+.||+|+||.||+|.+.  ++.||||++...   ....+..|.+++...  +||||+++++++.+..   .
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            34578999999999999999999986  889999999643   233455566666554  8999999999987753   4


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCceeecccccCcEEeCCCCC
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----ERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~ivHrDlkp~NIll~~~~~  206 (398)
                      ..++||||+++|+|.+++..        ..+++..++.++.|++.||.|||+.+     ..+|+||||||+|||++.++.
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             ceEEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence            58999999999999999965        35899999999999999999999871     113999999999999999999


Q ss_pred             eeEeccccccccCCCCCce--eeeccccCCCcccchhhccCCcCCc------cchhhHHHHHHHHHcC----------CC
Q 015931          207 PKLCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHGKVSDK------TDVYAFGVVLLELLTG----------RK  268 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------sDv~S~Gvvl~elltG----------~~  268 (398)
                      +||+|||+++.........  ......||+.|+|||.+.+...+.+      +|||||||++|||++|          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            9999999997665432211  1124579999999999987766655      9999999999999999          55


Q ss_pred             CCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          269 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       269 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ||.......... ... ...      .......+.+............+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       261 p~~~~~~~~~~~-~~~-~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          261 PYHDLVPSDPSY-EDM-REI------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTTTTSCSSCCH-HHH-HHH------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cHhhhcCCCCch-hhh-HHH------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            655433221110 000 000      0001111111111112255677889999999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1e-44  Score=352.41  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=195.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCC--CCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH--HPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~  134 (398)
                      ..+|...+.||+|+||.||+|.... ++.||||++...  .......+.+|+.++..++  ||||+++++++... ..++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-CEEE
Confidence            3568999999999999999999875 889999999754  3445678999999999996  59999999988775 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||| +.+++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+
T Consensus       133 lv~E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~  200 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGI  200 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred             EEEe-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCc
Confidence            9999 5689999999864       35899999999999999999999988   99999999999995 57899999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhcc-----------CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  283 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  283 (398)
                      ++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     ..
T Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~  275 (390)
T 2zmd_A          201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS  275 (390)
T ss_dssp             SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HH
T ss_pred             cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HH
Confidence            987754433223345679999999999865           36889999999999999999999999753211     00


Q ss_pred             HhhHHHhhchhhhhhhcCcccC--CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          284 WAKPILHRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       284 ~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                                 .+..++++...  .+...   ...+.+++.+||+.||.+|||+.||++
T Consensus       276 -----------~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          276 -----------KLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             -----------HHHHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----------HHHHHhCccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                       12223332221  11222   234667778999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-44  Score=336.20  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCC---CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .++|...+.||+|+||.||+|.+..   ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCE
Confidence            4678889999999999999998643   3346999999765 345567899999999999999999999987543  368


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        89 ~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             EEEecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCC
Confidence            9999999999999997653      45899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........   ..          
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~----------  225 (281)
T 3cc6_A          160 SRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IG----------  225 (281)
T ss_dssp             GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HH----------
T ss_pred             Ccccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HH----------
Confidence            987654322 11234557889999999998899999999999999999998 9999975433221   10          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       .+.....  ...+...+   ..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       226 -~~~~~~~--~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          226 -VLEKGDR--LPKPDLCP---PVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             -HHHHTCC--CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHhcCCC--CCCCCCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence             0111001  11111122   3466777899999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-44  Score=334.68  Aligned_cols=251  Identities=26%  Similarity=0.393  Sum_probs=199.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC---CCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~  134 (398)
                      +.|...+.||+|+||+||+|.+..++..||+|.+...  .....+.+.+|+.+++.++||||+++++++...   ...++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3467778999999999999999988999999998754  345567899999999999999999999987642   34579


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CCCCeeEeccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFG  213 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DfG  213 (398)
                      +||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+ .+|+||||||+||+++ +++.+||+|||
T Consensus       106 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            999999999999999875       35899999999999999999999764 3499999999999998 78999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++.......    .....||+.|+|||.+. +.++.++||||||+++|+|++|+.||.......     .....      
T Consensus       178 ~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~------  241 (290)
T 1t4h_A          178 LATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRR------  241 (290)
T ss_dssp             GGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHH------
T ss_pred             Ccccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHH------
Confidence            997654432    23457999999999886 568999999999999999999999997533211     10000      


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        +.....+... ....   ...+.+++.+||+.+|.+|||+.++++
T Consensus       242 --~~~~~~~~~~-~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          242 --VTSGVKPASF-DKVA---IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --HTTTCCCGGG-GGCC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --HhccCCcccc-CCCC---CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              1111111100 0111   134677888999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.4e-45  Score=338.00  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=196.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||+||+|.. .+++.||+|++.....  .....+.+|+.+++.++||||+++++++.+. +..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEE
Confidence            4688889999999999999998 4689999999975432  2246788999999999999999999998765 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++ +|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        80 e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             ECCSE-EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EecCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            99965 9999987642      46899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc----
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----  292 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----  292 (398)
                      ......  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........   ..........    
T Consensus       150 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~  224 (288)
T 1ob3_A          150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKN  224 (288)
T ss_dssp             HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTT
T ss_pred             cCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhh
Confidence            653321  12345689999999999764 5899999999999999999999999764432111   1000000000    


Q ss_pred             hhhhhh--hcCcccCCC------CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEE--LLDPRLKCT------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~--~~d~~l~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.+  ..++.+...      .........+.+++.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000  011111100      000112245677888999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=345.87  Aligned_cols=268  Identities=18%  Similarity=0.233  Sum_probs=198.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCC---CCcEEEEEEecCCChhh-----------HHHHHHHHHHHHhCCCCCeeceee
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKES-----------SKAFCRELMIASSLHHPNIVPLVG  124 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  124 (398)
                      .++|...+.||+|+||.||+|.+..   ++..||+|++.......           ...+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3679999999999999999999976   67889999997653221           123667888999999999999999


Q ss_pred             EEEcC---CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          125 FCIDP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       125 ~~~~~---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                      ++...   ....++||||+ +++|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  184 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence            98762   45589999999 99999999764       25999999999999999999999988   9999999999999


Q ss_pred             CCCC--CeeEeccccccccCCCCCc-----eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          202 SSKK--IPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       202 ~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9877  9999999999876432111     11134579999999999998899999999999999999999999997532


Q ss_pred             cccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          275 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      .... ................+.....     ....+   ..+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       265 ~~~~-~~~~~~~~~~~~~~~~~~~~~~-----~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          265 KDPV-AVQTAKTNLLDELPQSVLKWAP-----SGSSC---CEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TCHH-HHHHHHHHHHHTTTHHHHHHSC-----TTSCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cccH-HHHHHHHhhcccccHHHHhhcc-----ccccH---HHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            2211 1111111111111001111110     00122   34667778899999999999999999998643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-44  Score=357.62  Aligned_cols=197  Identities=24%  Similarity=0.387  Sum_probs=157.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----Cc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  132 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+|+.++||||+++++++....    ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36899999999999999999999988999999999653  3445678999999999999999999999875432    45


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|+||||+ +++|.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-------VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecc-ccchhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccc
Confidence            89999998 67999998753       46999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCc-------------------------eeeeccccCCCcccchhh-ccCCcCCccchhhHHHHHHHHHcC
Q 015931          213 GLATWTSAPSVP-------------------------FLCKTVKGTFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLTG  266 (398)
Q Consensus       213 Gla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~Gvvl~elltG  266 (398)
                      |+++........                         ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            999876532211                         112345789999999986 456799999999999999999993

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=342.65  Aligned_cols=258  Identities=28%  Similarity=0.427  Sum_probs=197.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCC----cEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ++|...+.||+|+||.||+|.+..++    ..||+|.+... .......+.+|+.++..++||||+++++++.+. +..+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~  122 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMM  122 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-CCcE
Confidence            45666789999999999999876433    45999999764 334556789999999999999999999997664 4589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus       123 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCc
Confidence            9999999999999997642      46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          215 ATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       215 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      ++........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......   +..         
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~---------  261 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMK---------  261 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---------
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHH---------
Confidence            9876543211 11223446788999999998899999999999999999999 999997543211   100         


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                        .+....  ....+...   ...+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       262 --~~~~~~--~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          262 --AINDGF--RLPTPMDC---PSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             --HHHTTC--CCCCCTTC---BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --HHHCCC--cCCCcccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              011111  11111112   245677788999999999999999999998643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.7e-45  Score=339.00  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=201.6

Q ss_pred             hcCCCCCc-eecccCceEEEEeee--CCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           59 THNFSKGR-VLGRGALSFVFKGKV--GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        59 ~~~f~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      .++|...+ .||+|+||.||+|.+  ..+++.||||++....  ....+.+.+|+.+++.++||||+++++++.  .+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCc
Confidence            45677777 999999999999954  5567889999997543  234577999999999999999999999983  3447


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        93 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCC
Confidence            9999999999999999864       45899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCcee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhh
Q 015931          214 LATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       214 la~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ++........... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ...        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~--------  231 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA--------  231 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH--------
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--------
Confidence            9987755432211 123446788999999988889999999999999999999 999997644321   100        


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                         .+.....+..  +...   ...+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       232 ---~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          232 ---MLEKGERMGC--PAGC---PREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             ---HHHTTCCCCC--CTTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---HHHcCCCCCC--CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0111111111  1122   23566777899999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9e-45  Score=343.10  Aligned_cols=271  Identities=28%  Similarity=0.367  Sum_probs=205.9

Q ss_pred             CCCCceecccCceEEEEeee----CCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcEEE
Q 015931           62 FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFL  135 (398)
Q Consensus        62 f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~l  135 (398)
                      |...+.||+|+||+||++.+    ..+++.||||++.... ......+.+|++++++++||||+++++++.+.+ ..+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48889999999999987754    4468899999998653 345677999999999999999999999988753 55789


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|.+++...        .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       113 v~e~~~~~~L~~~l~~~--------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH--------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             EECCCTTCBHHHHGGGS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EEecccCCcHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence            99999999999999753        4899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      .......... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||........ ....+.......  .
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~--~  258 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTV--L  258 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHH--H
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhH--H
Confidence            8776543221 12345688889999999988999999999999999999999999975432100 000000000000  0


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                      .+.+.+..... ..........+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus       259 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          259 RLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11111111111 01111223457777889999999999999999999987544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7e-44  Score=339.75  Aligned_cols=267  Identities=23%  Similarity=0.322  Sum_probs=207.5

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHh--CCCCCeeceeeEEEcCCC--
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPEQ--  131 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~--  131 (398)
                      ....++|...+.||+|+||.||+|.+.  ++.||||++...   ....+.+|++++..  ++||||+++++++.....  
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            344578999999999999999999984  889999999643   34567889988887  789999999999887652  


Q ss_pred             -cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceeecccccCcEEeC
Q 015931          132 -GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--------NGTERCVVHRDIKPSNILLS  202 (398)
Q Consensus       132 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~ivHrDlkp~NIll~  202 (398)
                       ..++||||+++|+|.+++..        ..+++..++.++.|++.||.|||        +.+   |+||||||+||+++
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK  181 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred             ceeEEEEeecCCCcHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence             58999999999999999975        34899999999999999999999        666   99999999999999


Q ss_pred             CCCCeeEeccccccccCCCCCce--eeeccccCCCcccchhhccC------CcCCccchhhHHHHHHHHHcC--------
Q 015931          203 SKKIPKLCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHG------KVSDKTDVYAFGVVLLELLTG--------  266 (398)
Q Consensus       203 ~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~Gvvl~elltG--------  266 (398)
                      .++.+||+|||++..........  ......||+.|+|||.+.+.      .++.++||||||+++|||++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998765443211  12345799999999999765      344789999999999999999        


Q ss_pred             --CCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          267 --RKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       267 --~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                        ..||......... ...+....       ......+.+............+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus       262 ~~~~p~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPS-VEEMRKVV-------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCCTTTTTSCSSCC-HHHHHHHH-------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccCccccCcCccc-HHHHHHHH-------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence              6787654332211 11111100       1111222222111123566778899999999999999999999999986


Q ss_pred             Cc
Q 015931          345 EE  346 (398)
Q Consensus       345 ~~  346 (398)
                      +.
T Consensus       334 i~  335 (342)
T 1b6c_B          334 LS  335 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.6e-44  Score=349.56  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=190.7

Q ss_pred             cCCCCC-ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHH-hCCCCCeeceeeEEEc---CCCcEE
Q 015931           60 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS-SLHHPNIVPLVGFCID---PEQGLF  134 (398)
Q Consensus        60 ~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~---~~~~~~  134 (398)
                      ++|... ++||+|+||+||+|.+..+++.||||++...     ..+.+|++++. ..+||||+++++++..   ....+|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            455554 6899999999999999989999999999642     34667888774 4589999999998754   244589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeEec
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  211 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~D  211 (398)
                      +||||+++|+|.+++....     ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus       136 lv~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEe
Confidence            9999999999999998642     246999999999999999999999988   999999999999997   78999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchh-HHHHhhHHHh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWAKPILH  290 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~  290 (398)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...   . ..
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~-i~  280 (400)
T 1nxk_A          208 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---R-IR  280 (400)
T ss_dssp             CTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH---H-HH
T ss_pred             cccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH---H-HH
Confidence            99998665432   1245678999999999998999999999999999999999999998654332110 100   0 00


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .      ...+  +... ........+.+++.+||+.||.+|||+.|+++.
T Consensus       281 ~------~~~~--~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          281 M------GQYE--FPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             H------TCCC--CCTT-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c------Cccc--CCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0      0000  0000 001122446778889999999999999999973

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=340.34  Aligned_cols=255  Identities=33%  Similarity=0.545  Sum_probs=195.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||.||+|.+.  ++.||+|.+...  ...+.+.+|+.++++++||||+++++++.+   ..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEc
Confidence            56788899999999999999986  788999999654  345779999999999999999999998653   36899999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC-eeEecccccccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-PKLCDFGLATWT  218 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~-~kl~DfGla~~~  218 (398)
                      +++|+|.+++.....    ...+++..++.++.|+++||.|||+.+..+|+||||||+||+++.++. +||+|||++...
T Consensus        81 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             CTTCBHHHHHHCSSS----EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             CCCCCHHHHHhccCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999986432    135789999999999999999999943344999999999999998886 799999999765


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ....     ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ....+  .        +..
T Consensus       157 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~--~--------~~~  219 (307)
T 2eva_A          157 QTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMW--A--------VHN  219 (307)
T ss_dssp             -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHH--H--------HHT
T ss_pred             cccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHH--H--------Hhc
Confidence            4321     23469999999999999899999999999999999999999997533211  00111  0        011


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                      ...+.+.  ...+   ..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       220 ~~~~~~~--~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          220 GTRPPLI--KNLP---KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             TCCCCCB--TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             CCCCCcc--cccC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            1111111  1122   346677889999999999999999999987544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.8e-45  Score=333.82  Aligned_cols=256  Identities=23%  Similarity=0.416  Sum_probs=205.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+++++.++||||+++++++.+.+ ..++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e   83 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVTE   83 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SCEEEEC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CeEEEEe
Confidence            357888899999999999999987 478899999976543 3467899999999999999999999987654 4799999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             CCTTCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCCCCcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccc
Confidence            999999999997643      46899999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ..... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ..   .        .+.
T Consensus       155 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~--------~i~  219 (267)
T 3t9t_A          155 LDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---E--------DIS  219 (267)
T ss_dssp             CCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---H--------HHH
T ss_pred             ccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HH---H--------HHh
Confidence            43211 11123457788999999998889999999999999999999 899997643221   00   0        011


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      .....  ..+...   ...+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       220 ~~~~~--~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          220 TGFRL--YKPRLA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             TTCCC--CCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCcC--CCCccC---cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11111  111112   234667788999999999999999999998653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-45  Score=345.12  Aligned_cols=273  Identities=25%  Similarity=0.346  Sum_probs=209.4

Q ss_pred             hcCCCCCceecccCceEEEEeee----CCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-CcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~  133 (398)
                      .++|...+.||+|+||.||+|.+    ..+++.||+|++........+.+.+|+.++++++||||+++++++...+ ...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688889999999999999983    5578999999998777677788999999999999999999999876543 357


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCc
Confidence            89999999999999998743      45899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCcee-eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh--HHHh
Q 015931          214 LATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK--PILH  290 (398)
Q Consensus       214 la~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~  290 (398)
                      ++........... .....++..|+|||.+.+..++.++||||||+++|||++|..||......-. .......  ....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~-~~~~~~~~~~~~~  269 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-RMIGNDKQGQMIV  269 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH-HHHCTTCCTHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH-HhhccccchhhhH
Confidence            9987755432111 2234577789999999988899999999999999999999999864321100 0000000  0000


Q ss_pred             hchhhhhhhcCc--ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          291 RGMAAVEELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       291 ~~~~~~~~~~d~--~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                         ..+.+.+..  ....+...   ...+.+++.+||+.+|.+|||+.+|++.|+.+.+
T Consensus       270 ---~~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          270 ---FHLIELLKNNGRLPRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             ---HHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhhcCCCCCCCCcc---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               001111111  11111222   2456677889999999999999999999987543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-44  Score=335.74  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=204.9

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ..++|...+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|+++++.++||||+++++++.+  +..++||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~   86 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIIT   86 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEE
Confidence            34678889999999999999999864 6789999997543 245678999999999999999999998754  3478999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++..
T Consensus        87 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             ECCTTCBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            99999999999976431     35899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ...           .+
T Consensus       159 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~-----------~~  223 (279)
T 1qpc_A          159 IEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ-----------NL  223 (279)
T ss_dssp             CSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH-----------HH
T ss_pred             ccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHH-----------HH
Confidence            654321 11233457889999999998889999999999999999999 999997643221   110           01


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ........  +...+   ..+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       224 ~~~~~~~~--~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          224 ERGYRMVR--PDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             HTTCCCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcccCCCC--ccccc---HHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            11111111  11122   3566777889999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-44  Score=334.52  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=202.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-CEEEEEE
Confidence            35788899999999999999999888999999999754 234457789999999999999999999998764 4579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        85 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           85 EYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             ECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            999999999988653       45899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ..............||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+.     ..    
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----~~----  224 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-----EK----  224 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH-----TT----
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh-----hc----
Confidence            643322222345678999999999987665 7799999999999999999999976543211 111110     00    


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         . ....   ........+.+++.+||+.+|.+|||+.|+++
T Consensus       225 ---~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          225 ---K-TYLN---PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---C-TTST---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---c-cccC---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               0 0000   00111234667888999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.1e-44  Score=333.28  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=205.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+. +..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-CEEEE
Confidence            36788899999999999999999988999999998654   334567789999999999999999999998764 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        93 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  162 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA  162 (294)
T ss_dssp             EEECCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCc
Confidence            99999999999998765       45899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........                 
T Consensus       163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----------------  223 (294)
T 2rku_A          163 TKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----------------  223 (294)
T ss_dssp             EECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------
T ss_pred             eecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------------
Confidence            87653322  12346799999999999988899999999999999999999999976442210                 


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.......+...+   ..+.+++.+||+.+|.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          224 YLRIKKNEYSIPKHIN---PVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HHHHHTTCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHhhccCCCccccC---HHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0111111111111222   34667778999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.4e-44  Score=331.99  Aligned_cols=246  Identities=25%  Similarity=0.425  Sum_probs=203.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|....++..||+|++....   ......+.+|+++++.++||||+++++++.+. +..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-KRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-CEEEEE
Confidence            67888999999999999999999889999999996532   12346788999999999999999999998764 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        93 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccc
Confidence            9999999999999875       35899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......    .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........                 .
T Consensus       163 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------------~  221 (284)
T 2vgo_A          163 HAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-----------------H  221 (284)
T ss_dssp             ECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             cCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-----------------H
Confidence            654332    2345689999999999998999999999999999999999999976432210                 1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.......+...+   ..+.+++.+||+.+|.+|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          222 RRIVNVDLKFPPFLS---DGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHTTCCCCCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhccccCCCCcCC---HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            111111222222222   34567778899999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-44  Score=337.48  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=200.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||.||++....+++.||+|++..........+.+|+.++..++||||+++++++.+. ...++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   87 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-THYYLVMQL   87 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-CEEEEEEEc
Confidence            5788899999999999999999888999999999876555556788999999999999999999998764 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe---CCCCCeeEecccccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLAT  216 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DfGla~  216 (398)
                      +++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++.
T Consensus        88 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           88 VSGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             CCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             CCCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999999999765       35899999999999999999999988   9999999999999   788999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   +.   ..+ ..+    
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~i-~~~----  222 (304)
T 2jam_A          158 MEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LF---EKI-KEG----  222 (304)
T ss_dssp             CCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHH-HHC----
T ss_pred             ecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHH-HcC----
Confidence            654322    234569999999999998899999999999999999999999997643221   10   000 000    


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        ........   .......+.+++.+||+.||.+|||+.++++
T Consensus       223 --~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          223 --YYEFESPF---WDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             --CCCCCTTT---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             --CCCCCccc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              00000000   1112245677788999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=344.24  Aligned_cols=243  Identities=22%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  130 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....        .....+.+|+.++++++||||+++++++.+. 
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-  101 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-  101 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-
Confidence            4689999999999999999999988899999999976531        1234577899999999999999999998764 


Q ss_pred             CcEEEEEecCCCC-CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          131 QGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       131 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                      +..++||||+.+| +|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEE
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEE
Confidence            4589999999777 999999764       45999999999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      +|||+++.......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....             
T Consensus       172 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------  235 (335)
T 3dls_A          172 IDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------  235 (335)
T ss_dssp             CCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------
T ss_pred             eecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------
Confidence            99999987755432   234679999999999988776 7899999999999999999999965221             


Q ss_pred             HhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                                ........+...+   ..+.+++.+||+.+|.+|||+.++++.
T Consensus       236 ----------~~~~~~~~~~~~~---~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ----------TVEAAIHPPYLVS---KELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------GTTTCCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------HHhhccCCCcccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      1111111111122   346677788999999999999999984

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.7e-45  Score=336.19  Aligned_cols=263  Identities=25%  Similarity=0.347  Sum_probs=205.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc-CCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCID-PEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|....+++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+ .+...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46788899999999999999999988999999999754  34456779999999999999999999998764 3456899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceeecccccCcEEeCCCCCeeEeccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ||||+++++|.+++.....   ....+++..++.++.|++.||+|||+.+  ..+|+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999986532   1245999999999999999999999865  2349999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +++.......  ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.......   +.   .       
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~-------  226 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA---G-------  226 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---H-------
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HH---H-------
Confidence            9987654321  1234568999999999998889999999999999999999999997653211   11   0       


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       .+.....+.+  +...+   ..+.+++.+||+.+|.+|||+.||++.+...
T Consensus       227 -~i~~~~~~~~--~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          227 -KIREGKFRRI--PYRYS---DELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             -HHHHTCCCCC--CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             -HHhhcccccC--CcccC---HHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence             0111111111  11122   3466777899999999999999999876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-44  Score=337.67  Aligned_cols=258  Identities=23%  Similarity=0.338  Sum_probs=197.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.++..++||||+++++++.+. +..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-GQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-CeEEE
Confidence            478999999999999999999998889999999997542   33457789999999999999999999998774 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       112 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EEECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             EEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccC
Confidence            99999999999999865       35899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   +    ...       
T Consensus       182 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~----~~~-------  246 (309)
T 2h34_A          182 SATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---M----GAH-------  246 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---H----HHH-------
T ss_pred             ccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---H----HHH-------
Confidence            866543211 1234568999999999998899999999999999999999999997643220   0    000       


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-CHHHHHHHHhcC
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-GIEEIIAILRGE  345 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~~  345 (398)
                      +..............+   ..+.+++.+||+.+|.+|| ++.++++.|+..
T Consensus       247 ~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          247 INQAIPRPSTVRPGIP---VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             HHSCCCCGGGTSTTCC---THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             hccCCCCccccCCCCC---HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence            1111100000111112   2466777899999999999 999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=333.70  Aligned_cols=256  Identities=26%  Similarity=0.422  Sum_probs=203.4

Q ss_pred             cCCCCCc-eecccCceEEEEeeeC--CCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGR-VLGRGALSFVFKGKVG--LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+ .||+|+||.||+|.+.  .++..||+|++... .....+.+.+|++++..++||||+++++++..  +..++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~l   86 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML   86 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--CCcEE
Confidence            4555555 8999999999999863  35778999999865 34556789999999999999999999999843  34899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             EEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEeCCCCCHHHHHHhCC------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccce
Confidence            999999999999997532      46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          216 TWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       216 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      .......... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.......   ...          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----------  224 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----------  224 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH----------
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----------
Confidence            8775433211 1123456889999999988889999999999999999998 999997644321   111          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                       .+.....+  ..+...   ...+.+++..||+.+|.+||++.++++.|+..
T Consensus       225 -~i~~~~~~--~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          225 -FIEQGKRM--ECPPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             -HHHTTCCC--CCCTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHhcCCcC--CCCCCc---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             01111111  111122   23566777899999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=342.29  Aligned_cols=257  Identities=13%  Similarity=0.140  Sum_probs=202.4

Q ss_pred             HHHhhcCCCCCceecccCceEEEEee-----eCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCCeeceeeEE
Q 015931           55 ILAATHNFSKGRVLGRGALSFVFKGK-----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFC  126 (398)
Q Consensus        55 ~~~~~~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~  126 (398)
                      +....++|...+.||+|+||+||+|.     ...+++.||+|++....   ...+..|++++..++   |+||+++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            34456789999999999999999994     55678899999997654   345777888888776   99999999998


Q ss_pred             EcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---
Q 015931          127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---  203 (398)
Q Consensus       127 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---  203 (398)
                      ...+. .++||||+++|+|.+++......  ....+++..++.|+.|++.||+|||+.+   |+||||||+|||++.   
T Consensus       137 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          137 LFQNG-SVLVGELYSYGTLLNAINLYKNT--PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             ECSSC-EEEEECCCCSCBHHHHHHHHHTS--TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred             ecCCC-cEEEEeccCCCcHHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence            77554 79999999999999999864321  1256999999999999999999999988   999999999999998   


Q ss_pred             --------CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          204 --------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       204 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                              ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    899999999999765433333344567899999999999999999999999999999999999999975433


Q ss_pred             ccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCC-CCHHHHHHHHhc
Q 015931          276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR-PGIEEIIAILRG  344 (398)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Pt~~evl~~L~~  344 (398)
                      ...                    .+...+. .....+.+.   +++..|++.+|.+| |++.++.+.|+.
T Consensus       291 ~~~--------------------~~~~~~~-~~~~~~~~~---~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          291 GEC--------------------KPEGLFR-RLPHLDMWN---EFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             TEE--------------------EECSCCT-TCSSHHHHH---HHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             Cce--------------------eechhcc-ccCcHHHHH---HHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence            210                    0111111 112344444   45557999999998 678888887765

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-44  Score=339.21  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=198.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|++..........+.+|+.++..++||||+++++++.+.+ ..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-KLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-eEEEEEE
Confidence            468889999999999999999999889999999998766666788999999999999999999999987754 5899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        97 ~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           97 FCPGGAVDAIMLELD------RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             CCTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             eCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            999999999987643      45999999999999999999999988   999999999999999999999999997543


Q ss_pred             CCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ....  .......||+.|+|||.+.     ...++.++||||||+++|+|++|..||.......   .   ...      
T Consensus       168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~------  233 (302)
T 2j7t_A          168 LKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---V---LLK------  233 (302)
T ss_dssp             HHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHH------
T ss_pred             cccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---HHH------
Confidence            2111  0112356899999999983     5678999999999999999999999997643221   0   000      


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        +.....+....+   ......+.+++.+||+.+|.+|||+.++++
T Consensus       234 --~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          234 --IAKSDPPTLLTP---SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --HHHSCCCCCSSG---GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --HhccCCcccCCc---cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              011111111111   111234677788999999999999999876

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=349.54  Aligned_cols=275  Identities=23%  Similarity=0.302  Sum_probs=212.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-cEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~lV  136 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+. ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357888999999999999999999889999999997543 2345678899999999999999999999876543 57999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe----CCCCCeeEecc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDF  212 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~Df  212 (398)
                      |||+++|+|.+++.....    ...+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+||
T Consensus        88 ~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             EecCCCCCHHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecC
Confidence            999999999999987532    234999999999999999999999988   9999999999999    77888999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhcc--------CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      |+++.......   .....||+.|+|||++..        ..++.++|||||||++|||++|+.||..........  ..
T Consensus       161 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~  235 (396)
T 4eut_A          161 GAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EV  235 (396)
T ss_dssp             GGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HH
T ss_pred             CCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HH
Confidence            99987654321   234569999999999865        567889999999999999999999997543322111  11


Q ss_pred             hhHHHhhchh-h---hhhhcC------cccCC-CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          285 AKPILHRGMA-A---VEELLD------PRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       285 ~~~~~~~~~~-~---~~~~~d------~~l~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .......... .   +....+      ..+.. ..........+.+++..||+.||.+||++.++++.+..+
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            1111111000 0   000000      01111 122355667788899999999999999999999988764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=331.06  Aligned_cols=253  Identities=21%  Similarity=0.327  Sum_probs=201.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~  133 (398)
                      .++|...+.||+|+||.||++.+..++..||+|++....    ......+.+|+.+++.++||||+++++++... ....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999998889999999997532    23457799999999999999999999987643 3458


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||++++ |.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE-----KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEehhccCC-HHHHHHhCcc-----cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccc
Confidence            9999999776 7777766432     56999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCC--cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ++................||..|+|||.+.+..  .+.++||||||+++|||++|+.||.......      ..      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~------  222 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------LF------  222 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HH------
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------HH------
Confidence            998765433333344567999999999997643  4789999999999999999999997643211      00      


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           ..+.......+...+   ..+.+++.+||+.||.+|||+.++++
T Consensus       223 -----~~i~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          223 -----ENIGKGSYAIPGDCG---PPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             -----HHHHHCCCCCCSSSC---HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----HHHhcCCCCCCCccC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 001111111111222   34567778999999999999999997

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.1e-44  Score=331.73  Aligned_cols=250  Identities=27%  Similarity=0.355  Sum_probs=199.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      ++|...+.||+|+||.||+|....+++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   83 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-TDV   83 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-CeE
Confidence            468888999999999999999998899999999875421      1357799999999999999999999998764 458


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC----CeeE
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  209 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl  209 (398)
                      ++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++    .+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK-------ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEE
Confidence            9999999999999999764       45899999999999999999999988   99999999999998877    8999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      +|||++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........   .       
T Consensus       154 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------  220 (283)
T 3bhy_A          154 IDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---L-------  220 (283)
T ss_dssp             CCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H-------
T ss_pred             EecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH---H-------
Confidence            99999987654321   2345689999999999988999999999999999999999999976432210   0       


Q ss_pred             hhchhhhhhhcCcccCCCC-CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             ..+......... ........+.+++.+||+.+|.+|||+.++++
T Consensus       221 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          221 -------TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -------HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------HHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                   000000000000 00011234677888999999999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.7e-44  Score=331.65  Aligned_cols=254  Identities=24%  Similarity=0.385  Sum_probs=199.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|....+||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+. +..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEe
Confidence            3455667999999999999999888999999999877666677899999999999999999999998764 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeEecccccccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWT  218 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DfGla~~~  218 (398)
                      +++++|.+++.....    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++. ++.+||+|||++...
T Consensus       101 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A          101 VPGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             CSEEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             CCCCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999999986532    245789999999999999999999988   999999999999987 899999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCC--cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .....  ......||+.|+|||.+.+..  ++.++||||||+++|+|++|+.||........   ..+..         .
T Consensus       174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~---------~  239 (295)
T 2clq_A          174 AGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKV---------G  239 (295)
T ss_dssp             CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHH---------H
T ss_pred             CCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhh---------c
Confidence            54321  123457899999999997653  78999999999999999999999975332110   00000         0


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....+.+  +...+   ..+.+++.+||+.+|.+|||+.++++
T Consensus       240 ~~~~~~~~--~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          240 MFKVHPEI--PESMS---AEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHCCCCCC--CTTSC---HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccccc--cccCC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00111111  11122   34667778999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=341.67  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=192.0

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEE-------c
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCI-------D  128 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------~  128 (398)
                      ....+|...+.||+|+||.||+|.+..+++.||+|++..........+.+|+.++.++. ||||+++++++.       .
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            34468899999999999999999998889999999997777777788999999999996 999999999885       2


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCee
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  208 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  208 (398)
                      .....++||||+ +|+|.+++.....    ...+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+|
T Consensus       105 ~~~~~~lv~e~~-~g~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          105 GQAEFLLLTELC-KGQLVEFLKKMES----RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             SSEEEEEEEECC-SEEHHHHHHHHHT----TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEE
T ss_pred             CCceEEEEEEec-CCCHHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEE
Confidence            333478999999 5799999876432    256999999999999999999999754 3499999999999999999999


Q ss_pred             EeccccccccCCCCCce----------eeeccccCCCcccchhh---ccCCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          209 LCDFGLATWTSAPSVPF----------LCKTVKGTFGYLAPEYF---QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      |+|||+++.........          ......||+.|+|||.+   .+..++.++||||||+++|||++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998765432110          01134589999999998   566789999999999999999999999975332


Q ss_pred             ccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                      ..                 .+........  ....+   ..+.+++.+||+.+|.+|||+.|+++.|+....
T Consensus       259 ~~-----------------~~~~~~~~~~--~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          259 LR-----------------IVNGKYSIPP--HDTQY---TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ------------------------CCCCT--TCCSS---GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH-----------------hhcCcccCCc--ccccc---hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11                 0000010000  11111   235677889999999999999999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.1e-44  Score=339.44  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=205.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+. +..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEE
Confidence            46788899999999999999999988999999998754   334567789999999999999999999998764 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       119 v~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  188 (335)
T 2owb_A          119 VLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA  188 (335)
T ss_dssp             EECCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCc
Confidence            99999999999998765       45899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ........  ......||..|+|||.+.+..++.++||||||+++|+|++|+.||........      ...        
T Consensus       189 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~--------  252 (335)
T 2owb_A          189 TKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR--------  252 (335)
T ss_dssp             EECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH--------
T ss_pred             eecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHH--------
Confidence            87653322  12346799999999999988899999999999999999999999976432210      000        


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         +.......+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       253 ---~~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          253 ---IKKNEYSIPKHIN---PVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ---HHHTCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---HhcCCCCCCccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0001111111122   34566778999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-43  Score=348.91  Aligned_cols=202  Identities=23%  Similarity=0.366  Sum_probs=170.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----Cc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  132 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++....    ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999999999999999753  3445678899999999999999999999876653    45


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|+||||+. |+|.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-------IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecCC-cCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccC
Confidence            899999995 6999999753       45999999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCc--------------------eeeeccccCCCcccchhh-ccCCcCCccchhhHHHHHHHHHcCCCCCc
Q 015931          213 GLATWTSAPSVP--------------------FLCKTVKGTFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLTGRKPIE  271 (398)
Q Consensus       213 Gla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~Gvvl~elltG~~Pf~  271 (398)
                      |+++........                    .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            999876543211                    112456799999999986 45679999999999999999998665554

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=347.47  Aligned_cols=265  Identities=15%  Similarity=0.203  Sum_probs=204.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCC--------CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeec---------
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGL--------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP---------  121 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  121 (398)
                      .++|...+.||+|+||.||+|.+..        .++.||+|.+...     ..+.+|++++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999876        3789999999754     35778999999999999988         


Q ss_pred             ------eeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccc
Q 015931          122 ------LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  195 (398)
Q Consensus       122 ------l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlk  195 (398)
                            +++++...+...++||||+ +++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+|||||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik  186 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-----HVLSERSVLQVACRLLDALEFLHENE---YVHGNVT  186 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCC
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCC
Confidence                  6777776567789999999 9999999987522     46999999999999999999999988   9999999


Q ss_pred             cCcEEeCCCC--CeeEeccccccccCCCCCc-----eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCC
Q 015931          196 PSNILLSSKK--IPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK  268 (398)
Q Consensus       196 p~NIll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~  268 (398)
                      |+|||++.++  .+||+|||+++........     .......||+.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  9999999999866532211     01133579999999999999899999999999999999999999


Q ss_pred             CCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          269 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       269 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ||........ .+...... ...   ....+.+.... ....+   ..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       267 pf~~~~~~~~-~~~~~~~~-~~~---~~~~~~~~~~~-~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          267 PWTNCLPNTE-DIMKQKQK-FVD---KPGPFVGPCGH-WIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TTGGGTTCHH-HHHHHHHH-HHH---SCCCEECTTSC-EECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CcccCCcCHH-HHHHHHHh-ccC---Chhhhhhhccc-cCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            9987542211 11111110 000   01111111110 00112   44667778899999999999999999998643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.2e-44  Score=330.98  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=203.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc----------
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID----------  128 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  128 (398)
                      ..+|...+.||+|+||.||+|.+..+++.||+|.+.....    .+.+|++++..++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            3578889999999999999999988899999999976542    46789999999999999999998753          


Q ss_pred             -----CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC
Q 015931          129 -----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  203 (398)
Q Consensus       129 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~  203 (398)
                           .....++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||++++
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-----EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVD  157 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcC
Confidence                 12347899999999999999986532     46999999999999999999999988   999999999999999


Q ss_pred             CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH
Q 015931          204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  283 (398)
Q Consensus       204 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  283 (398)
                      ++.+||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.....        
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--------  226 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--------  226 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--------
T ss_pred             CCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--------
Confidence            99999999999987655332   2345699999999999988999999999999999999999998753210        


Q ss_pred             HhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       284 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      .           ...+.+..+.  ...+   ..+.+++.+||+.+|.+|||+.|+++.|....
T Consensus       227 ~-----------~~~~~~~~~~--~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          227 F-----------FTDLRDGIIS--DIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             H-----------HHHHHTTCCC--TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             H-----------HHHhhccccc--ccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            0           0111111111  1112   23567778999999999999999999997654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.5e-44  Score=359.61  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=205.8

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ..++|...++||+|+||.||+|....+++.||+|++.+..   ......+.+|+.++..++||||+++++++.+. +.+|
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~  260 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALC  260 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-CEEE
Confidence            3467889999999999999999999899999999996532   22345688999999999999999999987764 5689


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||++||+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       261 lVmEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQ-----AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccc
Confidence            99999999999999976432     45999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.............  . .      
T Consensus       333 a~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~--~-~------  400 (576)
T 2acx_A          333 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--R-L------  400 (576)
T ss_dssp             CEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH--H-H------
T ss_pred             ceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH--H-H------
Confidence            987754332   244679999999999998899999999999999999999999998654322111110  0 0      


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                       +..   .....+...+   ..+.+++.+||+.||.+||     ++.||++
T Consensus       401 -i~~---~~~~~p~~~s---~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          401 -VKE---VPEEYSERFS---PQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -HHH---CCCCCCTTSC---HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -hhc---ccccCCccCC---HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             000   0111111122   3466777889999999999     7888876

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=341.15  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=201.0

Q ss_pred             ccCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEE
Q 015931           49 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCI  127 (398)
Q Consensus        49 ~~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  127 (398)
                      .+.+.++....++|...+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.++.++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            34455555667899999999999999999999988899999999975432 346788999999998 7999999999987


Q ss_pred             cC-----CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC
Q 015931          128 DP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  202 (398)
Q Consensus       128 ~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~  202 (398)
                      ..     ....++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT  163 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEc
Confidence            64     3568999999999999999987432     46899999999999999999999988   99999999999999


Q ss_pred             CCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCccccccc
Q 015931          203 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  277 (398)
Q Consensus       203 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~  277 (398)
                      .++.+||+|||++........  ......||+.|+|||.+.     +..++.++||||||+++|+|++|+.||.......
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  241 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  241 (326)
T ss_dssp             TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             CCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence            999999999999986643321  123456899999999987     5578999999999999999999999997543211


Q ss_pred             chhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .   .   .        .+.....+.+.. ...+   ..+.+++.+||+.+|.+|||+.++++
T Consensus       242 ~---~---~--------~~~~~~~~~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          242 A---L---F--------LIPRNPAPRLKS-KKWS---KKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             H---H---H--------HHHHSCCCCCSC-SCSC---HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H---H---H--------HhhcCccccCCc-cccC---HHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0   0   0        011111112211 1122   34667778999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-44  Score=344.18  Aligned_cols=263  Identities=20%  Similarity=0.298  Sum_probs=196.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----C
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  131 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46889999999999999999999989999999999653  3344567899999999999999999999886543     2


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+|+||||+ +++|.+++..        ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEe
Confidence            369999999 8899999976        34899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh----
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  286 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~----  286 (398)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+............    
T Consensus       172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999876532     234578999999999887 678999999999999999999999998654322111110000    


Q ss_pred             -HHHhhc-----hhhhhhh---cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 -PILHRG-----MAAVEEL---LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 -~~~~~~-----~~~~~~~---~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ..+...     ...+..+   ....+.  .........+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence             000000     0000000   000110  001112245677888999999999999999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-43  Score=340.32  Aligned_cols=266  Identities=20%  Similarity=0.329  Sum_probs=194.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----C
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  131 (398)
                      .++|...+.||+|+||.||+|....+++.||||++...  .......+.+|+.+++.++||||+++++++...+     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36899999999999999999999888999999999753  3445567889999999999999999999987544     2


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||++ ++|.+.+..         .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ceEEEEEcCC-CCHHHHHhh---------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEE
Confidence            5799999996 578888752         3899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh-----h
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----K  286 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~-----~  286 (398)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...........     .
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998664332   123467999999999999989999999999999999999999999865432111000000     0


Q ss_pred             HHHhhchhhhhhhc--Ccc------------cCCCCCC---HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 PILHRGMAAVEELL--DPR------------LKCTSRN---SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 ~~~~~~~~~~~~~~--d~~------------l~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+......+....  .+.            ...+...   ......+.+++.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            00000000000000  000            0001111   122456888999999999999999999997

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6e-44  Score=340.85  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=197.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|++......    ..+|++++.++ +||||+++++++.+. ...|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDG-KYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcC-CEEEEEE
Confidence            46788899999999999999999989999999999765432    34688888887 799999999988764 5589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC----CCeeEeccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFG  213 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~DfG  213 (398)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||+.++    +.+||+|||
T Consensus        96 E~~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             CCCCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            999999999999764       45999999999999999999999988   9999999999998543    359999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+..   .+. .+ 
T Consensus       166 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~-~~-  238 (342)
T 2qr7_A          166 FAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIG-SG-  238 (342)
T ss_dssp             TCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HHH-HC-
T ss_pred             CcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HHc-cC-
Confidence            9987654332  2245679999999999988889999999999999999999999997543221111111   110 00 


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           .....-....   .....+.+++.+||+.||.+|||+.++++
T Consensus       239 -----~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          239 -----KFSLSGGYWN---SVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -----CCCCCSTTTT---TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CcccCccccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0110000011   12234667778999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.6e-44  Score=345.59  Aligned_cols=201  Identities=29%  Similarity=0.464  Sum_probs=176.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++..++||||+++++++.+. +..++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEE
Confidence            35788899999999999999999988999999999765 344567899999999999999999999998775 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++.
T Consensus       111 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             CCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             ECCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            999999999999875       3589999999999999999999985 7   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       181 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          181 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             HHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             cccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            553221    234579999999999999999999999999999999999999997644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=340.10  Aligned_cols=265  Identities=24%  Similarity=0.356  Sum_probs=193.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhh-HHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES-SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|...+.||+|+||+||+|....+++.||+|++....... ...+.+|+.+++.++||||+++++++.+. +..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEEec
Confidence            46888899999999999999999889999999997543221 12456799999999999999999998765 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |++ |+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCG------NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             CCS-EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             ccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            996 69999987653      46899999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch-h--
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM-A--  294 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~--  294 (398)
                      .....  ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............   ........ .  
T Consensus       151 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~  225 (324)
T 3mtl_A          151 SIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI---FRILGTPTEETW  225 (324)
T ss_dssp             --------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTS
T ss_pred             cCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChHhc
Confidence            54322  1234568999999999876 56899999999999999999999999875433211111   11100000 0  


Q ss_pred             -------hhhhhcCcccCCCC---CCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 -------AVEELLDPRLKCTS---RNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 -------~~~~~~d~~l~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             .......+......   ........+.+++.+||+.||.+|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                   00000000000000   00011234677888999999999999999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=366.26  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=196.2

Q ss_pred             eecccCceEEEEeeeC--CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCCCC
Q 015931           67 VLGRGALSFVFKGKVG--LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        67 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      .||+|+||.||+|.+.  ..+..||||++.... ....+.|.+|++++++++|||||+++++|..  +.+++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCC
Confidence            7999999999999875  345679999997643 3456789999999999999999999999875  3489999999999


Q ss_pred             CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCC
Q 015931          144 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  223 (398)
Q Consensus       144 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  223 (398)
                      +|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       421 ~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          421 PLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             BHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             cHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            9999997542      46999999999999999999999988   99999999999999999999999999987654322


Q ss_pred             ce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhhcC
Q 015931          224 PF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  301 (398)
Q Consensus       224 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  301 (398)
                      .. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   ...           .+...  
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~-----------~i~~~--  555 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA-----------FIEQG--  555 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHH-----------HHHTT--
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH-----------HHHcC--
Confidence            11 1122346789999999998999999999999999999998 999998654321   111           01111  


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          302 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       302 ~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .++..+...+   ..+.+++..||+.+|.+||++.+|++.|+..
T Consensus       556 ~~~~~p~~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          556 KRMECPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CCCCCCTTCC---HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1112222222   4566777899999999999999999999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.2e-44  Score=333.87  Aligned_cols=249  Identities=27%  Similarity=0.428  Sum_probs=204.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +.|...+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+.++..++||||+++++++.+. ...++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e  100 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIME  100 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEE
Confidence            56888999999999999999998889999999997543 34567899999999999999999999998774 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++++|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A          101 YLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             CCTTEEHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceec
Confidence            9999999999864        35899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      .....  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ...           .+..
T Consensus       170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~-----------~~~~  233 (303)
T 3a7i_A          170 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLF-----------LIPK  233 (303)
T ss_dssp             BTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH-----------HHHH
T ss_pred             Ccccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHH-----------Hhhc
Confidence            54322  1234578999999999999899999999999999999999999997543211   000           0111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ...+.+.  ...+   ..+.+++.+||+.+|.+|||+.++++.
T Consensus       234 ~~~~~~~--~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          234 NNPPTLE--GNYS---KPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SCCCCCC--SSCC---HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCc--cccC---HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1111111  1122   346677788999999999999999873

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-43  Score=341.58  Aligned_cols=255  Identities=26%  Similarity=0.365  Sum_probs=202.4

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhC-CCCCeeceeeEE
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSL-HHPNIVPLVGFC  126 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~  126 (398)
                      ....++|...+.||+|+||.||+|.+..+|+.||||++.....        ...+.+.+|+.++.++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            3345679999999999999999999988899999999875431        1245678999999998 799999999988


Q ss_pred             EcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          127 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       127 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      ... ...++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.
T Consensus       170 ~~~-~~~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          170 ESS-SFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EBS-SEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             eeC-CEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            764 5589999999999999999864       45999999999999999999999988   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhcc------CCcCCccchhhHHHHHHHHHcCCCCCcccccccchh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  280 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~  280 (398)
                      +||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.......   
T Consensus       239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---  312 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---  312 (365)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred             EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---
Confidence            99999999987764332   245679999999999863      358899999999999999999999997643211   


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...   .+..       .............   ...+.+++.+||+.||.+|||+.++++
T Consensus       313 ~~~---~i~~-------~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 MLR---MIME-------GQYQFSSPEWDDR---SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHH---HHHH-------TCCCCCHHHHSSS---CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHH---HHHh-------CCCCCCCcccccC---CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000   0000       0000000000001   234677888999999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-43  Score=356.00  Aligned_cols=257  Identities=25%  Similarity=0.342  Sum_probs=205.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...++||+|+||.||+|.+..+++.||+|++.+..   ......+.+|+.++..++||||+++++++.+. ..+|+
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~l  262 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-TDLCL  262 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-CEEEE
Confidence            367888899999999999999999889999999996542   22346788999999999999999999987664 55899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||++||+|..++.....   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       263 VmE~~~gg~L~~~l~~~~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDE---DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EECCCTTCBHHHHHHTSST---TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeccCCCHHHHHHHhhc---ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence            9999999999999976431   1256999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ....          
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~----------  402 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELK----------  402 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHH----------
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHH----------
Confidence            87654432  123457999999999999989999999999999999999999999865432111  1111          


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH-----HHHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI-----EEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evl~  340 (398)
                       ..+.......+...+   ..+.+++.+||+.+|.+||++     .+|++
T Consensus       403 -~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          403 -QRVLEQAVTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -HHHHHCCCCCCTTSC---HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -HHHhhcccCCCcccC---HHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             111111122222222   345667778999999999975     56654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4e-44  Score=345.02  Aligned_cols=269  Identities=22%  Similarity=0.333  Sum_probs=203.8

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----C
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----Q  131 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  131 (398)
                      ...++|...+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++.+++||||+++++++....    .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            34568999999999999999999998889999999997543 344577899999999999999999999886543    3


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||+. |+|.+++..        ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEcccC-cCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence            5899999996 699999875        35999999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCc-eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          212 FGLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       212 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      ||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............   ...
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~  248 (364)
T 3qyz_A          172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GIL  248 (364)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHH
T ss_pred             CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHh
Confidence            9999876533211 112345799999999987654 58999999999999999999999998755433211111   000


Q ss_pred             hhc-hhhhhhhcC-------cccC-CCCCC-----HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRG-MAAVEELLD-------PRLK-CTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~-~~~~~~~~d-------~~l~-~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ... ...+....+       ..+. .....     +.....+.+++.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000 000000000       0000 00000     011245678888999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.8e-44  Score=366.38  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=195.8

Q ss_pred             ceecccCceEEEEeee--CCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKV--GLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||.||+|.+  ..+++.||||++...  .....+.+.+|++++.+++|||||+++++|.+  +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence            4799999999999955  455688999999754  23446789999999999999999999999864  34789999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|.+++...       ..+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus       453 ~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          453 LGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             TEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            99999999764       45999999999999999999999988   999999999999999999999999999877543


Q ss_pred             CCc-eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          222 SVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       222 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........   .           .+...
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~-----------~i~~~  588 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---A-----------MLEKG  588 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H-----------HHHTT
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H-----------HHHcC
Confidence            321 11233457889999999999999999999999999999998 99999765432110   0           11111


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ..  ...+...+   ..+.+++..||+.+|.+|||+.+|++.|+.
T Consensus       589 ~~--~~~p~~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          589 ER--MGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CC--CCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CC--CCCCCCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11  11122222   456677788999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.7e-44  Score=351.65  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=191.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLHHPNIVPLVGFCIDP  129 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  129 (398)
                      ..++|...+.||+|+||+||+|.+..+++.||||++....        ......+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4578999999999999999999999999999999997532        1122357899999999999999999998754 


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC---C
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---I  206 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~---~  206 (398)
                       +..++||||+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++   .
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence             3479999999999999888653       46999999999999999999999988   99999999999997544   5


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhcc---CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  283 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  283 (398)
                      +||+|||+++......   ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........  +..
T Consensus       281 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~  355 (419)
T 3i6u_A          281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD  355 (419)
T ss_dssp             EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH
T ss_pred             EEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH
Confidence            9999999998765432   2345679999999999863   5678899999999999999999999976433221  110


Q ss_pred             HhhHHHhhchhhhhhhcCcccCCCCCCH----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          284 WAKPILHRGMAAVEELLDPRLKCTSRNS----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       284 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .              +......   ..+    .....+.+++.+||+.+|.+|||+.|+++
T Consensus       356 ~--------------i~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          356 Q--------------ITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             H--------------HHTTCCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H--------------HhcCCCC---CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0              0000000   001    11245677888999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=333.98  Aligned_cols=252  Identities=22%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ..++|...+.||+|+||.||+|.+..+++.||+|.+....  ....+.+|+.++..++||||+++++++.+. +..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-TDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEe
Confidence            3468999999999999999999999889999999997643  346788999999999999999999998774 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus       104 e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN------KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             ECCTTEEHHHHHHHHT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            9999999999997542      56999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........   . +          .+.
T Consensus       175 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-~----------~~~  238 (314)
T 3com_A          175 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---I-F----------MIP  238 (314)
T ss_dssp             CBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H-H----------HHH
T ss_pred             hhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---H-H----------HHh
Confidence            654322  12345689999999999998999999999999999999999999975432110   0 0          011


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....+.+..+..   ....+.+++.+||+.+|.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          239 TNPPPTFRKPEL---WSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HSCCCCCSSGGG---SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCCcccCCccc---CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            111111111111   1235677888999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-44  Score=341.59  Aligned_cols=268  Identities=23%  Similarity=0.279  Sum_probs=196.1

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh-----hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      ..++|...+.||+|+||.||+|.+..+++.||||++......     ....+.+|+.++..++||||+++++++.+. ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-Cc
Confidence            357899999999999999999999888999999999753221     124678999999999999999999998664 45


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .++||||+++ +|..++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEcCCC-CHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEec
Confidence            7999999975 8988887542      46899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      |+++.......  ......||+.|+|||.+.+. .++.++|||||||++|||++|..||.........  ... ......
T Consensus       157 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~--~~i-~~~~~~  231 (346)
T 1ua2_A          157 GLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TRI-FETLGT  231 (346)
T ss_dssp             GGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHH-HHHHCC
T ss_pred             ccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHH-HHHcCC
Confidence            99987654332  22346789999999999764 5789999999999999999999999765432111  000 000000


Q ss_pred             c-hh---hhhhhcCcc-cC-CCCCC-----HHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          292 G-MA---AVEELLDPR-LK-CTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       292 ~-~~---~~~~~~d~~-l~-~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      . ..   ......+.. .. .+...     ......+.+++.+||+.||.+|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0 00   000000000 00 00000     1112457788889999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.2e-44  Score=356.50  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=196.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      +.|...+.||+|+||+||+|.+..++..||+|++....  ......+.+|+.+++.++||||+++++++.+. ...++||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-RNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEE
Confidence            46888999999999999999999889999999997643  23356788999999999999999999998764 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC---CCeeEecccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGL  214 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DfGl  214 (398)
                      ||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++..   +.+||+|||+
T Consensus       116 e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          116 ECYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            999999999998765       45899999999999999999999988   9999999999999764   4599999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      +........   .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.........      ..+. .+  
T Consensus       186 a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~-~~--  252 (494)
T 3lij_A          186 SAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL------RKVE-KG--  252 (494)
T ss_dssp             CEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-HT--
T ss_pred             CeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hC--
Confidence            987654332   24567999999999986 57999999999999999999999999865432110      0000 00  


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ......+.+   ...   ...+.+++.+||+.+|.+|||+.++++
T Consensus       253 -~~~~~~~~~---~~~---s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          253 -KYTFDSPEW---KNV---SEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -CCCCCSGGG---TTS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCCCCchhc---ccC---CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             000001111   111   234667788999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=363.75  Aligned_cols=257  Identities=28%  Similarity=0.404  Sum_probs=205.8

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ...++|...+.||+|+||.||+|.+.. +..||||++..... ..+.|.+|+.++++++||||+++++++.+  +..++|
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv  339 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIV  339 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEe
Confidence            345678888999999999999999975 56799999976542 35679999999999999999999998765  447999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++|+|.+++.....     ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus       340 ~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             eehhcCCcHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            999999999999976432     45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      ....... .......++..|+|||.+....++.++|||||||++|||++ |+.||......+   ...           .
T Consensus       412 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~-----------~  476 (535)
T 2h8h_A          412 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD-----------Q  476 (535)
T ss_dssp             TCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHH-----------H
T ss_pred             ecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------H
Confidence            6643211 11123456788999999998999999999999999999999 999997643221   100           0


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      +....  ++..+...+   ..+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       477 i~~~~--~~~~~~~~~---~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          477 VERGY--RMPCPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             HHTTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHcCC--CCCCCCCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11111  111122222   3466777899999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-43  Score=329.07  Aligned_cols=247  Identities=24%  Similarity=0.323  Sum_probs=197.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||+||+|.+..+++.||+|++...  .......+.+|+..+..+ +||||+++++++.+. +..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEE
Confidence            46788899999999999999999988999999999764  334566788999999999 999999999998775 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-----------
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-----------  204 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-----------  204 (398)
                      ||||+++++|.+++.....   ....+++..++.++.|++.||.|||+++   |+||||||+||+++.+           
T Consensus        89 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYR---IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------
T ss_pred             EEEecCCCcHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccc
Confidence            9999999999999986532   1246899999999999999999999988   9999999999999844           


Q ss_pred             --------CCeeEeccccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          205 --------KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       205 --------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                              ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|+|++|..|+.....
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred             cccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence                    479999999998765432      23589999999999865 567899999999999999999987643211


Q ss_pred             ccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           ..            .+.....+.+.  ...+   ..+.+++.+||+.||.+|||+.++++
T Consensus       237 -----~~------------~~~~~~~~~~~--~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -----WH------------EIRQGRLPRIP--QVLS---QEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -----HH------------HHHTTCCCCCS--SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HH------------HHHcCCCCCCC--cccC---HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                 00            01111111111  1122   34667778899999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.1e-44  Score=338.55  Aligned_cols=260  Identities=24%  Similarity=0.370  Sum_probs=201.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEE--EEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSV--AIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+.||+|+||.||+|.+..++..+  |+|.+... .....+.+.+|++++.++ +||||+++++++.+. +..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~l  103 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL  103 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceEE
Confidence            67888999999999999999988777755  99998753 234456789999999999 899999999998765 45899


Q ss_pred             EEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          136 IYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      ||||+++|+|.+++......         ......+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            99999999999999764200         011246999999999999999999999988   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   +..  
T Consensus       181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~--  252 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE--  252 (327)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH--
T ss_pred             EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HHH--
Confidence            9999999987443211   1223457889999999988889999999999999999998 999997654221   000  


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                               .+......  ..+..   ....+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       253 ---------~~~~~~~~--~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          253 ---------KLPQGYRL--EKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             ---------HGGGTCCC--CCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------HhhcCCCC--CCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     01111111  11111   124567778899999999999999999998764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.9e-44  Score=334.56  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=196.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCC-CC--cEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGL-LR--TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .++|...+.||+|+||+||+|.+.. ++  ..||+|++...   .....+.+.+|+.++.+++||||+++++++.+..  
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence            3678899999999999999998642 23  36999998754   2345678999999999999999999999887643  


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred             ceeeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccc
Confidence            689999999999999998753      35899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHh
Q 015931          213 GLATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       213 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      |++.......... ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ..   .....
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~~~  239 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKIDK  239 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHT
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HH---HHHHc
Confidence            9998775443221 1234567889999999998889999999999999999999 999997653221   10   00000


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                             .  ........   .....+.+++.+||+.+|.+|||+.++++.|+...
T Consensus       240 -------~--~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          240 -------E--GERLPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             -------S--CCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -------c--CCCCCCCc---CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                   0  01111111   12245677788999999999999999999998653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3e-44  Score=341.20  Aligned_cols=269  Identities=20%  Similarity=0.289  Sum_probs=193.0

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ..++|...+.||+|+||+||+|.+..+++.||||++.....  .....+.+|+.++++++||||+++++++.+. ...++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~l  110 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLHL  110 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEEE
Confidence            34689999999999999999999988899999999975432  2345678999999999999999999998775 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-----CCCCeeEe
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-----SKKIPKLC  210 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-----~~~~~kl~  210 (398)
                      ||||++ |+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++     +++.+||+
T Consensus       111 v~e~~~-~~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             EEECCS-EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             EEecCC-CCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence            999996 5999999764       45999999999999999999999988   99999999999994     45569999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      |||+++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...................
T Consensus       180 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          180 DFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            9999987654322  12345689999999999875 48999999999999999999999997654321111000000000


Q ss_pred             h-hchhhhhhhcC--cccC-CCCCCHH------HHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 H-RGMAAVEELLD--PRLK-CTSRNSA------QIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~-~~~~~~~~~~d--~~l~-~~~~~~~------~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      . ..........+  ..+. .......      ....+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0 00000000000  0000 0000000      1245678888999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.7e-44  Score=355.64  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .......+.+|++++++++||||+++++++.+. ...++|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-CEEEEE
Confidence            35788999999999999999999988999999998643  123456789999999999999999999998764 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC---CCCCeeEeccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFG  213 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DfG  213 (398)
                      |||+++|+|.+.+...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++   .++.+||+|||
T Consensus       100 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECC
Confidence            9999999999998775       35999999999999999999999988   99999999999995   45679999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +++.......   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........   .   ..+.    
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~---~~i~----  235 (486)
T 3mwu_A          170 LSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---L---KRVE----  235 (486)
T ss_dssp             CTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHH----
T ss_pred             cCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHH----
Confidence            9987654322   235679999999999875 689999999999999999999999976543211   0   0000    


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ..........   .......+.+++.+||+.+|.+|||+.++++
T Consensus       236 ---~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          236 ---TGKYAFDLPQ---WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ---HTCCCSCSGG---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---hCCCCCCCcc---cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               0001111100   0111234667888999999999999999997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.6e-44  Score=357.48  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=202.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|....+++.||||++....   ......+.+|+.++++++||||+++++++.+. +..++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~l  103 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-GYFYL  103 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEE
Confidence            357888999999999999999999899999999996542   34567899999999999999999999998764 55899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe---CCCCCeeEecc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDF  212 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~Df  212 (398)
                      ||||+.+|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+||
T Consensus       104 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             EECCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             EEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            99999999999999764       45999999999999999999999988   9999999999999   56789999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      |+++.......   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+....   ..   .+. . 
T Consensus       174 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~---~i~-~-  241 (484)
T 3nyv_A          174 GLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LK---KVE-K-  241 (484)
T ss_dssp             THHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHH-H-
T ss_pred             eeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHH-c-
Confidence            99987654432   235679999999999865 789999999999999999999999986543211   10   000 0 


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           .........   .......+.+++.+||+.+|.+|||+.|+++
T Consensus       242 -----~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 -----GKYTFELPQ---WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -----CCCCCCSGG---GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCCCCCcc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                 001111100   0112244667788999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.2e-43  Score=336.86  Aligned_cols=271  Identities=20%  Similarity=0.285  Sum_probs=201.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-------C
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------E  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~  130 (398)
                      ++|...+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++...       .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            67889999999999999999998889999999986543  22345678999999999999999999998764       3


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      +..++||||++ ++|.+.+....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        97 ~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           97 GSIYLVFDFCE-HDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             ceEEEEEeccC-CCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEc
Confidence            35799999996 48877776543      45999999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCC--ceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          211 DFGLATWTSAPSV--PFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       211 DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999987653221  112234678999999999876 4579999999999999999999999987543321111110000


Q ss_pred             -HHhhchhh-----hhhhcCcccCCCCCCHHH------HHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 -ILHRGMAA-----VEELLDPRLKCTSRNSAQ------IARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 -~~~~~~~~-----~~~~~d~~l~~~~~~~~~------~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ........     ..+.+.............      ...+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence             00000000     000000000000001111      134678889999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-43  Score=342.93  Aligned_cols=267  Identities=19%  Similarity=0.227  Sum_probs=204.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC--------CCCeeceeeEEEc--
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH--------HPNIVPLVGFCID--  128 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~--  128 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++        |+||+++++++..  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36899999999999999999999888999999999754 345567889999999885        7889999998762  


Q ss_pred             -CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeCCCC-
Q 015931          129 -PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKK-  205 (398)
Q Consensus       129 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~~~~-  205 (398)
                       .....++||||+ +++|.+.+.....     ..+++..++.++.|++.||.|||++ +   |+||||||+|||++.++ 
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~  185 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY-----QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccch
Confidence             234589999999 6777777765431     4699999999999999999999997 7   99999999999999775 


Q ss_pred             ------------------------------------------------CeeEeccccccccCCCCCceeeeccccCCCcc
Q 015931          206 ------------------------------------------------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL  237 (398)
Q Consensus       206 ------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  237 (398)
                                                                      .+||+|||+++......     ....||+.|+
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~  260 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYR  260 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGC
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCccc
Confidence                                                            89999999998765432     3456899999


Q ss_pred             cchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh---HHHhhchhh-------hhhhcCcc--c-
Q 015931          238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK---PILHRGMAA-------VEELLDPR--L-  304 (398)
Q Consensus       238 aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~-------~~~~~d~~--l-  304 (398)
                      |||++.+..++.++|||||||++|||++|+.||................   .........       ........  + 
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            9999999899999999999999999999999998654432211111110   100000000       00000000  0 


Q ss_pred             ---------------CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          305 ---------------KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       305 ---------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                                     ............+.+++.+||+.||.+|||+.|+++
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                           001124556677889999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-43  Score=328.87  Aligned_cols=252  Identities=28%  Similarity=0.374  Sum_probs=202.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---------hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---------KESSKAFCRELMIASSLH-HPNIVPLVGFCID  128 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  128 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++....         ....+.+.+|+.++.++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999999889999999997543         123456889999999995 9999999999866


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCee
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  208 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  208 (398)
                       +...++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+|
T Consensus        96 -~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           96 -NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             -CCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEE
Confidence             45589999999999999999865       45899999999999999999999988   99999999999999999999


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhc------cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                      |+|||++........   .....||+.|+|||.+.      ...++.++||||||+++|+|++|+.||.......   . 
T Consensus       165 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-  237 (298)
T 1phk_A          165 LTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---M-  237 (298)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H-
T ss_pred             EecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---H-
Confidence            999999987654332   23456899999999985      4568899999999999999999999997543211   0 


Q ss_pred             HHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          283 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        ...+.       .....  .. ..........+.+++.+||+.+|.+|||+.++++
T Consensus       238 --~~~~~-------~~~~~--~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          238 --LRMIM-------SGNYQ--FG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHH-------HTCCC--CC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHh-------cCCcc--cC-cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              00000       00000  00 0001122345777888999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-43  Score=336.30  Aligned_cols=267  Identities=25%  Similarity=0.399  Sum_probs=199.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEEE
Confidence            57888999999999999999999889999999986543  33456688999999999999999999998765 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+++++|..++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus       104 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-------NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             ECCSEEHHHHHHHST-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             ecCCcchHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            999999998887653       45999999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH--------hhHH
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW--------AKPI  288 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~--------~~~~  288 (398)
                      ......  ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||..............        ....
T Consensus       174 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          174 LAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            654322  22345689999999999875 789999999999999999999999976543221111000        0000


Q ss_pred             HhhchhhhhhhcCcccCCCCCC----HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          289 LHRGMAAVEELLDPRLKCTSRN----SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +.... .......+.+......    +.....+.+++.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          252 FNKNP-VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHCG-GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhcc-ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000 0011111111100000    012345778888999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.6e-43  Score=347.60  Aligned_cols=262  Identities=22%  Similarity=0.247  Sum_probs=205.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++......  ..+..|++++..++|++.+..+.++.......++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999999888999999998754332  3578899999999886555555555555566899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe---CCCCCeeEeccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  215 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DfGla  215 (398)
                      |+ +++|.+++....      ..+++..++.|+.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||++
T Consensus        84 ~~-g~sL~~ll~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             CC-CCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99 999999998643      46999999999999999999999988   9999999999999   68899999999999


Q ss_pred             cccCCCCCce-----eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH-HH
Q 015931          216 TWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP-IL  289 (398)
Q Consensus       216 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~-~~  289 (398)
                      +.........     ......||..|+|||.+.+..++.++|||||||++|||++|+.||................. ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            8766543211     12256799999999999999999999999999999999999999987544332222211111 00


Q ss_pred             hhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ..   .+..+..       ..+   ..+.+++..||+.+|.+||++.+|++.|+.+
T Consensus       234 ~~---~~~~l~~-------~~p---~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          234 AT---SIEALCR-------GYP---TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HS---CHHHHHT-------TSC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cc---cHHHHhc-------CCc---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            00   0111100       111   3567778889999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.9e-43  Score=351.11  Aligned_cols=251  Identities=27%  Similarity=0.373  Sum_probs=199.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-------------hhHHHHHHHHHHHHhCCCCCeeceeeE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------------ESSKAFCRELMIASSLHHPNIVPLVGF  125 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~  125 (398)
                      .++|...+.||+|+||+||+|....+++.||+|++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4789999999999999999999998899999999975421             234678899999999999999999999


Q ss_pred             EEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC
Q 015931          126 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  205 (398)
Q Consensus       126 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~  205 (398)
                      +.+. ...++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       115 ~~~~-~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          115 FEDK-KYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKN  183 (504)
T ss_dssp             EECS-SEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTT
T ss_pred             EEcC-CEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCC
Confidence            8764 5589999999999999999775       45999999999999999999999988   99999999999998775


Q ss_pred             ---CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          206 ---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       206 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                         .+||+|||+++.......   .....||+.|+|||++. +.++.++|||||||++|+|++|..||...+......  
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--  257 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK--  257 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred             CCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence               699999999987755432   24567999999999986 569999999999999999999999998654321110  


Q ss_pred             HHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          283 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                          .+. .+      ............   ...+.+++.+||+.+|.+|||+.|+++
T Consensus       258 ----~i~-~~------~~~~~~~~~~~~---s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 ----KVE-KG------KYYFDFNDWKNI---SDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ----HHH-HC------CCCCCHHHHTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHH-cC------CCCCCccccCCC---CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                000 00      000000000011   234677788999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.3e-44  Score=338.21  Aligned_cols=258  Identities=23%  Similarity=0.307  Sum_probs=200.4

Q ss_pred             HHHhhcCCCCC-ceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCC
Q 015931           55 ILAATHNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE  130 (398)
Q Consensus        55 ~~~~~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  130 (398)
                      ...-.+.|... +.||+|+||.||+|....+++.||+|++....  ......+.+|+.++..+. ||||+++++++.+. 
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-  101 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-  101 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-
Confidence            33445566666 88999999999999999889999999997542  334677899999999995 69999999998764 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIP  207 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~  207 (398)
                      ...++||||+++|+|.+++....     ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.   ++.+
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPEL-----AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred             CeEEEEEEecCCCcHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence            45899999999999999986532     256999999999999999999999988   999999999999997   7899


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      ||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........   .   .
T Consensus       174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~---~  244 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY---L---N  244 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H
T ss_pred             EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---H---H
Confidence            9999999987654322   23467999999999999999999999999999999999999999764432110   0   0


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +.       ....+....   ........+.+++.+||+.+|.+|||+.++++
T Consensus       245 i~-------~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          245 IS-------QVNVDYSEE---TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HH-------HTCCCCCTT---TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HH-------hcccccCch---hhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            00       000111111   01112244667788999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.6e-43  Score=365.90  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=204.6

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  133 (398)
                      ..++|...++||+|+||.||+|.+..+++.||||++.+.   .......+..|..++..+ +||||+++++++.+ .+.+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~  417 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL  417 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEE
Confidence            346889999999999999999999999999999999753   123345678899999887 79999999987655 5568


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      |+||||+++|+|..++...       ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       418 ~lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecc
Confidence            9999999999999999875       35999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...                
T Consensus       488 la~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----------------  549 (674)
T 3pfq_A          488 MCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------  549 (674)
T ss_dssp             TCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------
T ss_pred             eeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----------------
Confidence            9986433322  2345789999999999999999999999999999999999999998654321                


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCH-----HHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI-----EEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evl~  340 (398)
                       ....++...+..+...+   ..+.+++.+||+.||.+||++     .||++
T Consensus       550 -~~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          550 -LFQSIMEHNVAYPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -HHHHHHSSCCCCCTTSC---HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -HHHHHHhCCCCCCccCC---HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence             12223333333332233   346667788999999999997     66664

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.7e-43  Score=325.66  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=194.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++.+. +..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CeEEE
Confidence            368889999999999999999998889999999996532   22356788999999999999999999998764 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus        89 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             EEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             EEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccc
Confidence            99999999999999875       35899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ........   .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.......   ..   ..       
T Consensus       159 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~-------  222 (276)
T 2h6d_A          159 NMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LF---KK-------  222 (276)
T ss_dssp             GCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HH-------
T ss_pred             cccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HH---HH-------
Confidence            87654321   234568999999999987665 689999999999999999999997543211   00   00       


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       +..   .....+...+   ..+.+++.+||+.+|.+|||+.++++
T Consensus       223 -~~~---~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          223 -IRG---GVFYIPEYLN---RSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -HHH---CCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -hhc---CcccCchhcC---HHHHHHHHHHccCChhhCCCHHHHHh
Confidence             111   0111111122   34667788999999999999999997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.8e-43  Score=344.72  Aligned_cols=200  Identities=24%  Similarity=0.330  Sum_probs=173.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC------CCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL------HHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~  133 (398)
                      .+|...+.||+|+||+||+|.+..+++.||||++... ......+.+|+.++..+      +|+||+++++++... ..+
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-CeE
Confidence            5688889999999999999999988999999999754 34456677888888776      577999999988765 458


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC--eeEec
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCD  211 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~D  211 (398)
                      ++||||+. ++|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF-----QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECC
T ss_pred             EEEEeccC-CCHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEee
Confidence            99999995 799999987532     45999999999999999999999988   999999999999999887  99999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      ||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       246 FG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          246 FGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99997654332     345789999999999999999999999999999999999999986543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-43  Score=330.17  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=184.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhH-HHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESS-KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||+||+|.+..+++.||+|++.... .... ..+..+...++.++||||+++++++.+.+ ..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-SEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-CEEEE
Confidence            467889999999999999999998889999999997642 2222 33444555678889999999999988754 58999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |||++ |+|.+++.....   ....+++..++.++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++
T Consensus        85 ~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVID---KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EECCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             Eehhc-cchHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCc
Confidence            99996 588888765321   125799999999999999999999997 7   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhh----ccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYF----QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      +.......   .....||+.|+|||.+    .+..++.++||||||+++|+|++|+.||.......    ... ..    
T Consensus       158 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~-~~----  225 (290)
T 3fme_A          158 GYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF----QQL-KQ----  225 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH----HHH-HH----
T ss_pred             cccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH----HHH-HH----
Confidence            87654322   2345699999999996    45678999999999999999999999997532211    000 00    


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                          ......+.... .   .....+.+++.+||+.+|.+|||+.|+++
T Consensus       226 ----~~~~~~~~~~~-~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          226 ----VVEEPSPQLPA-D---KFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ----HHHSCCCCCCT-T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----HhccCCCCccc-c---cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                00111111111 1   11234677788999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4e-44  Score=335.38  Aligned_cols=269  Identities=25%  Similarity=0.404  Sum_probs=184.9

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ...++|...+.||+|+||.||+|....+++.||||.+.... ......+.+|+.++..++||||+++++++...+ ..++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l   90 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWL   90 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-CEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEE
Confidence            34578999999999999999999988789999999986543 334567889999999999999999999987755 4899


Q ss_pred             EEecCCCCCHHHHHhhhcc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          136 IYKYVSGGSLERHLHEKKK-GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~-~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      ||||+++++|.+++..... .......+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999975311 1111356999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC---ceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          215 ATWTSAPSV---PFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       215 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      +........   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.........   .   ....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~---~~~~  241 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---M---LTLQ  241 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---H---HHHT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---H---HHhc
Confidence            986653321   111234569999999999875 46899999999999999999999999765432211   0   0000


Q ss_pred             hchhhhhh-hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          291 RGMAAVEE-LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       291 ~~~~~~~~-~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........ ..++...  ...+   ..+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~--~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 NDPPSLETGVQDKEML--KKYG---KSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SSCCCTTC-----CCC--CCCC---HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCCccccccccchhh--hhhh---HHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000000 0011110  1112   34667788999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.6e-44  Score=344.36  Aligned_cols=255  Identities=12%  Similarity=0.059  Sum_probs=183.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHH---HHHhCCCCCeecee-------eE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELM---IASSLHHPNIVPLV-------GF  125 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  125 (398)
                      ..+|...+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+.   .|+. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            3568889999999999999999988899999999987542   34556777854   5555 699988755       34


Q ss_pred             EEcCC----------------CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHc
Q 015931          126 CIDPE----------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR------YKVALGIAESVAYLHN  183 (398)
Q Consensus       126 ~~~~~----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~------~~i~~qia~aL~yLH~  183 (398)
                      +...+                ..+++||||++ |+|.+++....      ..+++..+      +.++.|++.||+|||+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            33221                23799999998 89999998753      23566666      7888999999999999


Q ss_pred             CCCCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc--CCcCCccchhhHHHHHH
Q 015931          184 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLL  261 (398)
Q Consensus       184 ~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvvl~  261 (398)
                      ++   |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|
T Consensus       213 ~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          213 KG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             TT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred             CC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence            88   999999999999999999999999999866432     124567799999999987  67899999999999999


Q ss_pred             HHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          262 ELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       262 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ||++|+.||...........   ...       .........+..+. .......+.+++.+||+.||.+|||+.++++
T Consensus       285 elltg~~Pf~~~~~~~~~~~---~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKGSW---KRP-------SLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTTCC---CBC-------CTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHhCCCCCCCcCcccccch---hhh-------hhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999999987643321100   000       00000111111110 0112245667778999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.6e-43  Score=338.82  Aligned_cols=268  Identities=23%  Similarity=0.305  Sum_probs=197.1

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  130 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  130 (398)
                      ....++|...+.||+|+||+||+|.+..+++.||||++......    ..+|+++++.++||||+++++++....     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999999889999999999754322    236999999999999999999885432     


Q ss_pred             --------------------------------CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 015931          131 --------------------------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV  178 (398)
Q Consensus       131 --------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL  178 (398)
                                                      ...++||||++ |+|.+.+.....   ....+++..++.++.|++.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR---SGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Confidence                                            23789999997 588888765321   125699999999999999999


Q ss_pred             HHHHcCCCCceeecccccCcEEeC-CCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhH
Q 015931          179 AYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAF  256 (398)
Q Consensus       179 ~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~  256 (398)
                      +|||+.+   |+||||||+|||++ .++.+||+|||+++.......   .....||..|+|||.+.+. .++.++|||||
T Consensus       155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (383)
T 3eb0_A          155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSI  228 (383)
T ss_dssp             HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence            9999888   99999999999998 688999999999987654332   2345789999999998765 48999999999


Q ss_pred             HHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh-chhhhhh-------hcCcccCCCC----CCHHHHHHHHHHHHhc
Q 015931          257 GVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR-GMAAVEE-------LLDPRLKCTS----RNSAQIARVIQAAAAC  324 (398)
Q Consensus       257 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-------~~d~~l~~~~----~~~~~~~~l~~l~~~c  324 (398)
                      ||++|||++|+.||......+..  ..... .... ....+..       ..-+.+....    ........+.+++.+|
T Consensus       229 G~il~ell~g~~pf~~~~~~~~~--~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          229 GCVFGELILGKPLFSGETSIDQL--VRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHH--HHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCChHHHH--HHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            99999999999999865432211  11100 0000 0000000       0000100000    0001123467888899


Q ss_pred             ccccCCCCCCHHHHHH
Q 015931          325 ISSEESRRPGIEEIIA  340 (398)
Q Consensus       325 l~~~p~~RPt~~evl~  340 (398)
                      |+.+|.+|||+.|+++
T Consensus       306 L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CCSSGGGSCCHHHHHT
T ss_pred             ccCChhhCCCHHHHhc
Confidence            9999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.8e-42  Score=328.59  Aligned_cols=262  Identities=20%  Similarity=0.285  Sum_probs=199.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcC-CCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP-EQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~~~lV  136 (398)
                      .++|...+.||+|+||+||+|.+..+++.||+|++....   .+.+.+|+.++.+++ ||||+++++++.+. ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            367889999999999999999998889999999997543   466889999999997 99999999998764 3457999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DfGla  215 (398)
                      |||+++++|.+++..          +++..++.++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||++
T Consensus       112 ~e~~~~~~l~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             EECCCCCCHHHHGGG----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EeccCchhHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            999999999998843          889999999999999999999988   99999999999999776 8999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH------
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI------  288 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~------  288 (398)
                      +.......   .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+.......      
T Consensus       179 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~  254 (330)
T 3nsz_A          179 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLY  254 (330)
T ss_dssp             EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHH
T ss_pred             eEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhh
Confidence            87654332   234578999999999977 578999999999999999999999996432211 1111110000      


Q ss_pred             --Hhhc----hhhhhhhcCcc----c---CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          289 --LHRG----MAAVEELLDPR----L---KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       289 --~~~~----~~~~~~~~d~~----l---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        ....    .....+.....    +   ............+.+++.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              0000    00000000000    0   000001112345778888999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=330.09  Aligned_cols=270  Identities=20%  Similarity=0.286  Sum_probs=196.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC---------
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---------  129 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  129 (398)
                      .++|...+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++...         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            36788899999999999999999988999999999877777778899999999999999999999987432         


Q ss_pred             ----CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CC
Q 015931          130 ----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SK  204 (398)
Q Consensus       130 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~  204 (398)
                          ....++||||++ |+|.+++..        ..+++..++.++.|++.||+|||+.+   |+||||||+||+++ ++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ--------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTED  157 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc--------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCC
Confidence                345799999996 699999864        45899999999999999999999988   99999999999997 56


Q ss_pred             CCeeEeccccccccCCCCC-ceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          205 KIPKLCDFGLATWTSAPSV-PFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                      +.+||+|||+++....... ........+|..|+|||.+.. ..++.++||||||+++|||++|+.||............
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7999999999987643211 111234567999999998865 67899999999999999999999999865432211111


Q ss_pred             HHhhHHH-hhchhhhhh----hcCcccCCCCCC-----HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          283 LWAKPIL-HRGMAAVEE----LLDPRLKCTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       283 ~~~~~~~-~~~~~~~~~----~~d~~l~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....+.. ......+..    .+......+...     ......+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000000 000000000    000000000000     011245777888999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.2e-43  Score=337.56  Aligned_cols=265  Identities=21%  Similarity=0.300  Sum_probs=185.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-----CC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  131 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999999889999999999653  334567788999999999999999999987653     13


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++|+|++ +++|.+++..        ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             CCEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEeccc-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEee
Confidence            479999999 7899998864        35999999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh----
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  286 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~----  286 (398)
                      ||+++.....     .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+............    
T Consensus       176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  250 (367)
T ss_dssp             --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999865432     234679999999999887 678999999999999999999999998654322111110000    


Q ss_pred             -HHHhhch-hhhhhhcCcccCCCCCCHH-----HHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 -PILHRGM-AAVEELLDPRLKCTSRNSA-----QIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 -~~~~~~~-~~~~~~~d~~l~~~~~~~~-----~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ..+.... ......+...-..+.....     ....+.+++.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence             0000000 0000000000000000100     1234678888999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-42  Score=330.47  Aligned_cols=266  Identities=20%  Similarity=0.262  Sum_probs=202.9

Q ss_pred             hcCCCCCceecccCceEEEEeee-CCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCC------CeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP------NIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||.||+|.+ ..+++.||||++... ......+.+|+.++..++|+      +++++++++.+. +
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-G   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-T
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-C
Confidence            36899999999999999999987 556889999999754 34456788999999888765      499999988765 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC--------
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--------  203 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~--------  203 (398)
                      ..++||||+ +++|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.        
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGF-----LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence            589999999 9999999987532     46899999999999999999999988   999999999999987        


Q ss_pred             -----------CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          204 -----------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       204 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                                 ++.+||+|||+++......     ....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                       6789999999998654332     345789999999999988999999999999999999999999986


Q ss_pred             cccccchhHHHHhhH-----HHhhc-------------------hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhccccc
Q 015931          273 RRLQGEENLVLWAKP-----ILHRG-------------------MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSE  328 (398)
Q Consensus       273 ~~~~~~~~~~~~~~~-----~~~~~-------------------~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~  328 (398)
                      .+.............     .....                   ...+.....+..............+.+++.+||+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            543221111110000     00000                   000000001101111122344567889999999999


Q ss_pred             CCCCCCHHHHHH
Q 015931          329 ESRRPGIEEIIA  340 (398)
Q Consensus       329 p~~RPt~~evl~  340 (398)
                      |.+|||+.|+++
T Consensus       317 P~~Rpt~~ell~  328 (339)
T 1z57_A          317 PAKRITLREALK  328 (339)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             cccccCHHHHhc
Confidence            999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-42  Score=333.80  Aligned_cols=276  Identities=22%  Similarity=0.296  Sum_probs=199.5

Q ss_pred             CHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-----------hhhHHHHHHHHHHHHhCCCCCe
Q 015931           51 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----------KESSKAFCRELMIASSLHHPNI  119 (398)
Q Consensus        51 ~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~ni  119 (398)
                      ...++....++|...+.||+|+||.||+|.... +..||||++....           ....+.+.+|+.++++++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            456777888999999999999999999999875 8999999985432           1224779999999999999999


Q ss_pred             eceeeEEEcCC----CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccc
Q 015931          120 VPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  195 (398)
Q Consensus       120 v~l~~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlk  195 (398)
                      +++++++...+    ...++||||+. |+|.+++....      ..+++..++.++.|++.||.|||+.+   |+|||||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  161 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR------IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH  161 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence            99999886432    35799999996 68888887542      46999999999999999999999988   9999999


Q ss_pred             cCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          196 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       196 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      |+||+++.++.+||+|||+++.......   .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999975543321   234578999999999876 678999999999999999999999998654


Q ss_pred             cccchhHHH-HhhH-----HHhhchhhhhhhcCcccCC-CCCCH-----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          275 LQGEENLVL-WAKP-----ILHRGMAAVEELLDPRLKC-TSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       275 ~~~~~~~~~-~~~~-----~~~~~~~~~~~~~d~~l~~-~~~~~-----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ......... ....     ..........+.+...+.. +....     .....+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            322111100 0000     0000000011111111110 00000     11244778888999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-43  Score=333.30  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=196.2

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  130 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....        .....+.+|+++++.++||||+++++++... 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence            3578889999999999999999998899999999965421        2234588999999999999999999987653 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC---e
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---P  207 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~  207 (398)
                      . .++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCE
T ss_pred             c-eEEEEecCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeE
Confidence            3 79999999999999998753       46999999999999999999999988   999999999999987654   9


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      ||+|||+++......   ......||+.|+|||++.   ...++.++|||||||++|+|++|+.||........  +...
T Consensus       157 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~  231 (322)
T 2ycf_A          157 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ  231 (322)
T ss_dssp             EECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH
T ss_pred             EEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH
Confidence            999999998765432   123457999999999974   45789999999999999999999999976443221  1110


Q ss_pred             hhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       285 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                          ...+...    ..+...  .   .....+.+++.+||+.||.+|||+.++++
T Consensus       232 ----~~~~~~~----~~~~~~--~---~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          232 ----ITSGKYN----FIPEVW--A---EVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ----HHHTCCC----CCHHHH--T---TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----HHhCccc----cCchhh--h---hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                0000000    000000  0   11245677888999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-42  Score=335.09  Aligned_cols=267  Identities=18%  Similarity=0.251  Sum_probs=201.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-----------CCCeeceeeEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----------HPNIVPLVGFCI  127 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  127 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++... ......+.+|+.++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36899999999999999999999888999999999753 334567889999988876           899999999887


Q ss_pred             cCC---CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeC-
Q 015931          128 DPE---QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLS-  202 (398)
Q Consensus       128 ~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~-  202 (398)
                      ..+   ...++|||++ +++|.+++.....     ..+++..++.++.|++.||+|||+. +   |+||||||+|||++ 
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-----RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEI  167 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc-----cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEec
Confidence            533   2578999999 9999999987432     4599999999999999999999997 7   99999999999994 


Q ss_pred             -----CCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccccc
Q 015931          203 -----SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  277 (398)
Q Consensus       203 -----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~  277 (398)
                           ..+.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence                 44589999999998765432     34568999999999999899999999999999999999999998654321


Q ss_pred             chhHHHHhhHH---Hhhchh-------hhhhhcCcc-----c-------------CCCCCCHHHHHHHHHHHHhcccccC
Q 015931          278 EENLVLWAKPI---LHRGMA-------AVEELLDPR-----L-------------KCTSRNSAQIARVIQAAAACISSEE  329 (398)
Q Consensus       278 ~~~~~~~~~~~---~~~~~~-------~~~~~~d~~-----l-------------~~~~~~~~~~~~l~~l~~~cl~~~p  329 (398)
                      ..........+   ......       .....++..     +             ............+.+++.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence            11110000000   000000       000000000     0             0011235566778899999999999


Q ss_pred             CCCCCHHHHHH
Q 015931          330 SRRPGIEEIIA  340 (398)
Q Consensus       330 ~~RPt~~evl~  340 (398)
                      .+|||+.|+++
T Consensus       323 ~~Rpt~~ell~  333 (373)
T 1q8y_A          323 RKRADAGGLVN  333 (373)
T ss_dssp             TTCBCHHHHHT
T ss_pred             cccCCHHHHhh
Confidence            99999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-43  Score=337.76  Aligned_cols=256  Identities=26%  Similarity=0.314  Sum_probs=199.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeC---CCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  130 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  130 (398)
                      .++|...+.||+|+||.||+|...   .+++.||||++....    ......+.+|++++..+ +||||+++++++... 
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence            368999999999999999999883   468999999986432    12334577899999999 699999999987764 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ...++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~  201 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLT  201 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEES
T ss_pred             ceEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEe
Confidence            4589999999999999999875       35899999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccC--CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      |||+++....... .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........  .......
T Consensus       202 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~  278 (355)
T 1vzo_A          202 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRI  278 (355)
T ss_dssp             CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHH
T ss_pred             eCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHH
Confidence            9999986643222 122346799999999999853  4789999999999999999999999765432211  1111111


Q ss_pred             HhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHHHH
Q 015931          289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIAIL  342 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~L  342 (398)
                      .        . ..+.+  +..   ....+.+++.+||+.||.+||     ++.++++..
T Consensus       279 ~--------~-~~~~~--~~~---~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 L--------K-SEPPY--PQE---MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             H--------H-CCCCC--CTT---SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             h--------c-cCCCC--Ccc---cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            0        0 01111  111   223466778899999999999     999998743

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-43  Score=332.39  Aligned_cols=259  Identities=23%  Similarity=0.379  Sum_probs=196.6

Q ss_pred             ccCHHHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCC--CCCeeceee
Q 015931           49 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH--HPNIVPLVG  124 (398)
Q Consensus        49 ~~~~~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~  124 (398)
                      .+.+..+....++|...+.||+|+||.||++.... ++.||+|++...  .......+.+|+.++.+++  ||||+++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            34445555567889999999999999999999864 889999999754  3445678899999999997  599999999


Q ss_pred             EEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       125 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      ++.+. ...++||| +.+++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||++++ 
T Consensus        96 ~~~~~-~~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-  162 (313)
T 3cek_A           96 YEITD-QYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-  162 (313)
T ss_dssp             EEECS-SEEEEEEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-
T ss_pred             EeecC-CEEEEEEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-
Confidence            98774 45899999 5589999999864       45899999999999999999999988   999999999999965 


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc-----------CCcCCccchhhHHHHHHHHHcCCCCCccc
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----------GKVSDKTDVYAFGVVLLELLTGRKPIEAR  273 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~Gvvl~elltG~~Pf~~~  273 (398)
                      +.+||+|||+++...............||+.|+|||.+.+           ..++.++||||||+++|||++|+.||...
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            8999999999987654432222335579999999999875           46888999999999999999999999753


Q ss_pred             ccccchhHHHHhhHHHhhchhhhhhhcCcccC--CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....     .           .+...+++...  .+...+   ..+.+++.+||+.+|.+|||+.|+++
T Consensus       243 ~~~~-----~-----------~~~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          243 INQI-----S-----------KLHAIIDPNHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CSHH-----H-----------HHHHHHCTTSCCCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHH-----H-----------HHHHHHhcccccCCcccch---HHHHHHHHHHccCCcccCcCHHHHhc
Confidence            2210     0           11122222211  111222   34667778899999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1e-42  Score=325.42  Aligned_cols=254  Identities=23%  Similarity=0.398  Sum_probs=192.5

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC---------
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---------  129 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  129 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++... ......+.+|+.+++.++||||+++++++.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45788899999999999999999888999999999653 34557789999999999999999999987653         


Q ss_pred             ---CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          130 ---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       130 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                         ....++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCC
Confidence               345789999999999999998642      35789999999999999999999988   999999999999999999


Q ss_pred             eeEeccccccccCCCCC------------ceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCccc
Q 015931          207 PKLCDFGLATWTSAPSV------------PFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEAR  273 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~  273 (398)
                      +||+|||++........            ........||..|+|||.+.+. .++.++||||||+++|||++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            99999999986643210            1112345689999999999764 68999999999999999998   55432


Q ss_pred             ccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...     ......        +.. ....+. ..........+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~-----~~~~~~--------~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 MER-----VNILKK--------LRS-VSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHH-----HHHHHH--------HHS-TTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhH-----HHHHHh--------ccc-cccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            110     000000        000 001111 1111222344667788999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3e-42  Score=330.07  Aligned_cols=267  Identities=23%  Similarity=0.282  Sum_probs=199.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC----CCcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDP----EQGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~  133 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...    ....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999999889999999997543 34456788999999999999999999987653    2558


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+. ++|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        90 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecc
Confidence            99999996 699999876        35899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCce--------eeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHH
Q 015931          214 LATWTSAPSVPF--------LCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  284 (398)
Q Consensus       214 la~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  284 (398)
                      +++.........        ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............  
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--  235 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI--  235 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--
Confidence            998765322111        1123468999999998764 67899999999999999999999999865432111100  


Q ss_pred             hhHHHhhc----------hhhhhhhcCcccCCCCCC-----HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          285 AKPILHRG----------MAAVEELLDPRLKCTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       285 ~~~~~~~~----------~~~~~~~~d~~l~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .......          .....+.+..........     +.....+.+++.+||+.||.+|||+.|+++
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          236 -FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             -HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             0000000          000000000000000000     011245677888999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-42  Score=341.34  Aligned_cols=264  Identities=27%  Similarity=0.328  Sum_probs=195.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC-----CcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~  134 (398)
                      .+|...+.||+|+||.||+|.+..+++.||||++.....    .+.+|+++++.++||||+++++++....     ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468888999999999999999988899999999975432    2346999999999999999999875421     2367


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-CCeeEeccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFG  213 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DfG  213 (398)
                      +||||+++ +|.+.+.....   ....+++..++.++.|+++||+|||+.+   |+||||||+||||+.+ +.+||+|||
T Consensus       130 lv~e~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eehhcccc-cHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccch
Confidence            99999965 67666654211   1256999999999999999999999988   9999999999999965 568999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+  .+.......-...
T Consensus       203 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~  277 (420)
T 1j1b_A          203 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPT  277 (420)
T ss_dssp             TCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCC
T ss_pred             hhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence            9987654332   2345789999999998765 78999999999999999999999998654321  1111111000000


Q ss_pred             hhhhhhhcCcccC---CCC---C------CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDPRLK---CTS---R------NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~---~~~---~------~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+... ++...   .+.   .      .......+.+++.+||+.||.+|||+.|+++
T Consensus       278 ~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          278 REQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0011111 11110   000   0      0111245778888999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-42  Score=334.10  Aligned_cols=274  Identities=23%  Similarity=0.282  Sum_probs=192.3

Q ss_pred             HHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-
Q 015931           53 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-  131 (398)
Q Consensus        53 ~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  131 (398)
                      .+.....++|...+.||+|+||.||+|.+..+++.||||++..... ....+..++..+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3455667899999999999999999999998899999999865432 23456678888899999999999999865332 


Q ss_pred             -----cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCceeecccccCcEEeCC-
Q 015931          132 -----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--NGTERCVVHRDIKPSNILLSS-  203 (398)
Q Consensus       132 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~ivHrDlkp~NIll~~-  203 (398)
                           ..++||||+++ +|...+.....   ....+++..++.++.|++.||.|||  +.+   |+||||||+|||++. 
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR---RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCC
Confidence                 27899999965 66555543211   1356899999999999999999999  777   999999999999996 


Q ss_pred             CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHH
Q 015931          204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  282 (398)
Q Consensus       204 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  282 (398)
                      ++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........... 
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-  243 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE-  243 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred             CCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH-
Confidence            89999999999987654332   2345789999999998665 489999999999999999999999987543321111 


Q ss_pred             HHhhHHHhhchhhhhhhcCcccC---------------CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          283 LWAKPILHRGMAAVEELLDPRLK---------------CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~d~~l~---------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .. .............+++...               ...........+.+++.+||+.||.+|||+.|+++
T Consensus       244 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          244 -IV-RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             -HH-HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HH-HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence             10 0000000000001111000               00011113456778888999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-42  Score=333.46  Aligned_cols=264  Identities=19%  Similarity=0.289  Sum_probs=196.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc----
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG----  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  132 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46888999999999999999999989999999999764  334457788999999999999999999998765431    


Q ss_pred             -EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          133 -LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       133 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                       .++||||+. ++|.+++.         ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECS
T ss_pred             eEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEe
Confidence             389999996 68888773         34899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh----
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  286 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~----  286 (398)
                      ||+++.....     .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.........    
T Consensus       188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            9999865432     234578999999999987 678999999999999999999999998654322111100000    


Q ss_pred             -HHHhhc----hh-hhhhhcCcccCC-CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 -PILHRG----MA-AVEELLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 -~~~~~~----~~-~~~~~~d~~l~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ......    .. ....+....... ....+.....+.+++.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             000000    00 000000000000 0000011245778888999999999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-42  Score=323.02  Aligned_cols=251  Identities=25%  Similarity=0.384  Sum_probs=200.1

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||.||+|....+++.||+|++...  .......+.+|++++++++||||+++++++.+. ...++|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   99 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIV   99 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-CeEEEE
Confidence            36889999999999999999999888999999998653  233467789999999999999999999998764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC---CCeeEeccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFG  213 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DfG  213 (398)
                      |||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.+   +.+||+|||
T Consensus       100 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A          100 GELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             EEccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence            9999999999998765       35899999999999999999999988   9999999999999764   479999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++........   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......   ..   ..+ ..+ 
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~-~~~-  237 (287)
T 2wei_A          170 LSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---IL---KRV-ETG-  237 (287)
T ss_dssp             GGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-HHC-
T ss_pred             cceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HH---HHH-HcC-
Confidence            9987654322   234468999999998865 58999999999999999999999997643221   10   000 000 


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           ............   ...+.+++.+||+.+|.+|||+.++++
T Consensus       238 -----~~~~~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          238 -----KYAFDLPQWRTI---SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -----CCCCCSGGGTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCchhhhhc---CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                 001111100111   234667788999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.1e-43  Score=335.38  Aligned_cols=261  Identities=22%  Similarity=0.362  Sum_probs=199.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChh-----------------hHHHHHHHHHHHHhCCCCCeec
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-----------------SSKAFCRELMIASSLHHPNIVP  121 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~  121 (398)
                      .++|...+.||+|+||.||+|..  +++.||+|.+......                 ....+.+|+.++.+++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999998  6899999999643211                 1178999999999999999999


Q ss_pred             eeeEEEcCCCcEEEEEecCCCCCHHHH------HhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeeccc
Q 015931          122 LVGFCIDPEQGLFLIYKYVSGGSLERH------LHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDI  194 (398)
Q Consensus       122 l~~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDl  194 (398)
                      +++++.+. +..++||||+++|+|.++      +....     ...+++..++.++.|++.||.|||+ .+   |+||||
T Consensus       108 ~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl  178 (348)
T 2pml_X          108 CEGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNY-----TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV  178 (348)
T ss_dssp             CSEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSS-----CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred             EEEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence            99998775 458999999999999998      43321     3679999999999999999999998 77   999999


Q ss_pred             ccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccC-CcCC-ccchhhHHHHHHHHHcCCCCCcc
Q 015931          195 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSD-KTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       195 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                      ||+||+++.++.+||+|||++......    ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||..
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999876543    23456799999999999877 6666 99999999999999999999986


Q ss_pred             cccccchhHHHHhhHHHhhchhhhh----hhcCcccCC--CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          273 RRLQGEENLVLWAKPILHRGMAAVE----ELLDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~d~~l~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....  .....   +..... ...    ....+....  ..........+.+++.+||+.+|.+|||+.|+++
T Consensus       255 ~~~~~--~~~~~---i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          255 KISLV--ELFNN---IRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SSCSH--HHHHH---HTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCcHH--HHHHH---HhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            54311  11110   000000 000    000000000  0000112245677888999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7e-42  Score=331.51  Aligned_cols=206  Identities=21%  Similarity=0.271  Sum_probs=173.6

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CC-----CeeceeeEEEcC
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HP-----NIVPLVGFCIDP  129 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~  129 (398)
                      ....++|...+.||+|+||+||+|.+..+++.||||++... ......+..|+.++..++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            34467899999999999999999999988999999999753 334567788888888875 55     499999988775


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC--CCCCe
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIP  207 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~--~~~~~  207 (398)
                       +..++||||+. |+|.+++.....     ..+++..++.++.|++.||.|||++ ..+|+||||||+|||++  .++.+
T Consensus       129 -~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          129 -NHLCLVFEMLS-YNLYDLLRNTNF-----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             -TEEEEEEECCC-CBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             -CceEEEEecCC-CCHHHHHhhcCc-----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence             45899999995 699999987532     4589999999999999999999953 12399999999999995  47889


Q ss_pred             eEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCccccc
Q 015931          208 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  275 (398)
Q Consensus       208 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~  275 (398)
                      ||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       201 kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          201 KIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999998765432     345789999999999999999999999999999999999999986543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=334.71  Aligned_cols=263  Identities=24%  Similarity=0.386  Sum_probs=199.1

Q ss_pred             HHHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC
Q 015931           53 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  130 (398)
Q Consensus        53 ~e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  130 (398)
                      .+.....++|...+.||+|+||.||+|.+..   .||+|++....  ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            3334456789999999999999999998863   49999987542  223355778999999999999999999988755


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                       ..++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++ ++.+||+
T Consensus       103 -~~~iv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          103 -HLAIITSLCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             -CEEEECBCCCSEEHHHHTTSSC------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEEC
T ss_pred             -ceEEEeecccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEe
Confidence             4899999999999999997642      46899999999999999999999988   99999999999998 6799999


Q ss_pred             ccccccccCCCC---CceeeeccccCCCcccchhhcc---------CCcCCccchhhHHHHHHHHHcCCCCCcccccccc
Q 015931          211 DFGLATWTSAPS---VPFLCKTVKGTFGYLAPEYFQH---------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE  278 (398)
Q Consensus       211 DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~  278 (398)
                      |||++.......   .........||+.|+|||.+..         ..++.++||||||+++|||++|+.||....... 
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-  250 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-  250 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            999987653211   1111234568999999999874         357889999999999999999999997643221 


Q ss_pred             hhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          279 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                        ..   .        .+.....+..... ..+   ..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       251 --~~---~--------~~~~~~~~~~~~~-~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          251 --II---W--------QMGTGMKPNLSQI-GMG---KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             --HH---H--------HHHTTCCCCCCCS-SCC---TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             --HH---H--------HhccCCCCCCCcC-CCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence              00   0        1111112222111 111   236677889999999999999999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=331.17  Aligned_cols=264  Identities=20%  Similarity=0.309  Sum_probs=196.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-----
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  131 (398)
                      .++|...+.||+|+||.||+|.+..+|+.||||++...  .......+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36788899999999999999999988999999999754  33445678999999999999999999999876543     


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||+. ++|.+++.         ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECS
T ss_pred             eEEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEee
Confidence            2489999996 68877663         24899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh----
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  286 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~----  286 (398)
                      ||+++.....     .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+............    
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999865432     234568999999999887 678999999999999999999999998654321111000000    


Q ss_pred             -HHHhhch-----hhhhhhc-CcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 -PILHRGM-----AAVEELL-DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 -~~~~~~~-----~~~~~~~-d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       .......     ..+..+. .+..............+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0000000     0000000 0000001111122345677788999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.6e-42  Score=327.26  Aligned_cols=263  Identities=18%  Similarity=0.257  Sum_probs=200.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCC-cEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC------eeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHHPN------IVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||+||+|....++ ..||+|++... ......+.+|+.++..++|++      ++.+++++... +
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-G   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-T
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-C
Confidence            468999999999999999999987666 68999999753 344567888999999987665      88998887664 4


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe----------
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----------  201 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll----------  201 (398)
                      ..++||||+ +++|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||+          
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNF-----QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred             eEEEEEecc-CCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence            589999999 7778777766432     46999999999999999999999988   9999999999999          


Q ss_pred             ---------CCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          202 ---------SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       202 ---------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                               +.++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                     567899999999998654332     345799999999999998999999999999999999999999986


Q ss_pred             cccccchhHHHHhhHHHhhchhh---------------------------hhhhcCcccCCCCCCHHHHHHHHHHHHhcc
Q 015931          273 RRLQGEENLVLWAKPILHRGMAA---------------------------VEELLDPRLKCTSRNSAQIARVIQAAAACI  325 (398)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl  325 (398)
                      ..........   ..........                           +.+...+..............+.+++.+||
T Consensus       242 ~~~~~~~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  318 (355)
T 2eu9_A          242 HENREHLVMM---EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML  318 (355)
T ss_dssp             SSHHHHHHHH---HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHH---HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence            5432211111   1100000000                           000000000001122344557888999999


Q ss_pred             cccCCCCCCHHHHHH
Q 015931          326 SSEESRRPGIEEIIA  340 (398)
Q Consensus       326 ~~~p~~RPt~~evl~  340 (398)
                      +.||.+|||+.|+++
T Consensus       319 ~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          319 EFDPAQRITLAEALL  333 (355)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             cCChhhCcCHHHHhc
Confidence            999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.2e-42  Score=329.29  Aligned_cols=253  Identities=22%  Similarity=0.283  Sum_probs=172.2

Q ss_pred             hcCCCCC-ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC---CCcEE
Q 015931           59 THNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLF  134 (398)
Q Consensus        59 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~  134 (398)
                      .++|... ++||+|+||+||+|.+..+++.||||++.... ..   .......+..++||||+++++++...   +...+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4678884 57999999999999999889999999997532 11   12223345677999999999987652   33478


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeEec
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  211 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~D  211 (398)
                      +||||+++|+|.+++....     ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|
T Consensus       103 lv~e~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG-----DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC------CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEeccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEec
Confidence            9999999999999998653     246999999999999999999999988   999999999999986   45599999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ||+++......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............   .     
T Consensus       175 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~-----  242 (336)
T 3fhr_A          175 FGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---K-----  242 (336)
T ss_dssp             CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             cccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---H-----
Confidence            99998665332    23456899999999998888999999999999999999999999765432210000   0     


Q ss_pred             chhhhhhhcCcccCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           ..+.......+ .........+.+++.+||+.||.+|||+.|+++
T Consensus       243 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          243 -----RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 00000000000 000112234667778999999999999999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5e-42  Score=335.08  Aligned_cols=208  Identities=28%  Similarity=0.479  Sum_probs=156.6

Q ss_pred             CCCC-CceecccCceEEEEeeeC--CCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc-CCCcEEEE
Q 015931           61 NFSK-GRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID-PEQGLFLI  136 (398)
Q Consensus        61 ~f~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~~lV  136 (398)
                      .|.. +++||+|+||+||+|.+.  .+++.||+|++.....  ...+.+|+.+++.++||||+++++++.. .+..+++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3444 568999999999999965  4678999999975432  3467899999999999999999999864 34568999


Q ss_pred             EecCCCCCHHHHHhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe----CCCCCeeEe
Q 015931          137 YKYVSGGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLC  210 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~  210 (398)
                      |||+. |+|.+++......  ......+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99995 5888887643210  111235999999999999999999999988   9999999999999    678899999


Q ss_pred             ccccccccCCCCCc-eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          211 DFGLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       211 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      |||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999876543211 122456799999999999874 58999999999999999999999997544

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-42  Score=356.68  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=201.7

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCC---CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      ..++|...+.||+|+||.||+|.+..   .+..||+|.+... .....+.+.+|+.++++++||||+++++++.+  +..
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cce
Confidence            34567788899999999999998754   3467999998754 33445789999999999999999999998743  347


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTT------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence            99999999999999997642      46899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......   ...         
T Consensus       537 ~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~---------  603 (656)
T 2j0j_A          537 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---------  603 (656)
T ss_dssp             CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---------
T ss_pred             CCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---------
Confidence            9987654322 12233457889999999998899999999999999999997 999997643321   110         


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                        .+.....  ...+...   ...+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       604 --~i~~~~~--~~~~~~~---~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          604 --RIENGER--LPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             --HHHHTCC--CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHcCCC--CCCCccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              0111111  1111122   23566778899999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.5e-42  Score=336.06  Aligned_cols=264  Identities=25%  Similarity=0.326  Sum_probs=191.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-----cEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----GLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~~  134 (398)
                      .+|...+.||+|+||+||+|.+..++ .||+|++......    ..+|+++++.++||||+++++++.....     .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            57889999999999999999997655 4888888654321    2369999999999999999998865332     278


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CCCCeeEeccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFG  213 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DfG  213 (398)
                      +||||++++.+.........    ...+++..++.++.|++.||+|||+.+   |+||||||+|||++ .++.+||+|||
T Consensus       115 lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKL----KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEeeccCccHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            99999976544433322211    256999999999999999999999988   99999999999999 79999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +++.......   .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+....  +.......-...
T Consensus       188 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~  262 (394)
T 4e7w_A          188 SAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPS  262 (394)
T ss_dssp             TCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCC
T ss_pred             CcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence            9987654332   2345789999999998765 589999999999999999999999987543221  111111000000


Q ss_pred             hhhhh----hhcCcccCC-CCCC------HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVE----ELLDPRLKC-TSRN------SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~----~~~d~~l~~-~~~~------~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.    ......+.. ....      ......+.+++.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            00000    001111100 0000      012245778888999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-42  Score=327.49  Aligned_cols=266  Identities=23%  Similarity=0.319  Sum_probs=197.9

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeC-CCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhC---CCCCeeceeeEEEc--
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKED--KESSKAFCRELMIASSL---HHPNIVPLVGFCID--  128 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--  128 (398)
                      ...++|...+.||+|+||.||+|.+. .+++.||+|++....  ......+.+|+.+++.+   +||||+++++++..  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34578999999999999999999984 568899999986432  11223455677666655   89999999998862  


Q ss_pred             --CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          129 --PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       129 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                        .....++||||+. |+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~  158 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ  158 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCC
Confidence              3445799999996 699999987532     45899999999999999999999988   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  286 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  286 (398)
                      +||+|||+++......   ......||..|+|||.+.+..++.++||||||+++|+|++|+.||............   .
T Consensus       159 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i---~  232 (326)
T 1blx_A          159 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---L  232 (326)
T ss_dssp             EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H
T ss_pred             EEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H
Confidence            9999999998654322   123467899999999999989999999999999999999999999865432111100   0


Q ss_pred             HHHhh-chhhhh-------hhcC----ccc-CCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 PILHR-GMAAVE-------ELLD----PRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 ~~~~~-~~~~~~-------~~~d----~~l-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..... ......       ....    ..+ .....   ....+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCS---CCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCCCcccCccccccchhhhcccCcchhhhcccc---CCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000 000000       0000    000 00111   1234667788999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.5e-42  Score=326.32  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=178.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHH-HHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||.||+|....+++.||||++.... ......+..|+. +++.++||||+++++++.+. +..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv   99 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWIC   99 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEE
Confidence            478899999999999999999998889999999997653 334455666666 67778999999999998775 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |||+++ +|.+++......  ....+++..++.++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++
T Consensus       100 ~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSV--LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHT--TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             EeecCC-ChHHHHHHHHhh--hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            999965 888887642210  125699999999999999999999997 7   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhh----ccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYF----QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      +.......   .....||+.|+|||.+    .+..++.++||||||+++|+|++|+.||........             
T Consensus       174 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------------  237 (327)
T 3aln_A          174 GQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------------  237 (327)
T ss_dssp             CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred             eecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------------
Confidence            86654321   2334699999999998    456789999999999999999999999975332100             


Q ss_pred             chhhhhhhcC---cccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLD---PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d---~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         .+..+..   +.+... ........+.+++.+||+.||.+|||+.+|++
T Consensus       238 ---~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          238 ---QLTQVVKGDPPQLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -----CCCCCSCCCCCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---HHHHHhcCCCCCCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence               0111111   111100 00112235677788999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-42  Score=322.91  Aligned_cols=243  Identities=26%  Similarity=0.403  Sum_probs=191.9

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh------hhHHHHHHHHHHHHhC----CCCCeeceeeEE
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSL----HHPNIVPLVGFC  126 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~~~  126 (398)
                      ...++|...+.||+|+||.||+|.+..+++.||+|++.....      .....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            345789999999999999999999988899999999975432      1223456799999888    899999999987


Q ss_pred             EcCCCcEEEEEec-CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CC
Q 015931          127 IDPEQGLFLIYKY-VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SK  204 (398)
Q Consensus       127 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~  204 (398)
                      .+.+ ..++|+|+ +.+++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++ .+
T Consensus       108 ~~~~-~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          108 ETQE-GFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR  176 (312)
T ss_dssp             ------CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred             ecCC-eEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence            6654 47899999 7899999999875       35999999999999999999999988   99999999999999 88


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcC-CccchhhHHHHHHHHHcCCCCCcccccccchhHHH
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS-DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  283 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  283 (398)
                      +.+||+|||++.......    .....||..|+|||++.+..+. .++||||||+++|||++|+.||.....        
T Consensus       177 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------  244 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------  244 (312)
T ss_dssp             TEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred             CeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------
Confidence            999999999998765432    2345699999999999877664 589999999999999999999965321        


Q ss_pred             HhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       284 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                                     +.......+...+   ..+.+++.+||+.+|.+|||+.|+++
T Consensus       245 ---------------~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ---------------ILEAELHFPAHVS---PDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---------------HHHTCCCCCTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------HhhhccCCcccCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence                           0001111111122   34667778999999999999999997

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.4e-42  Score=322.78  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=178.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhH-HHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESS-KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||.||+|.+..+++.||||++..... ... +.+..+..++..++||||+++++++.+. ...++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEE
Confidence            4678888999999999999999988899999999976532 222 3344455567888999999999998775 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |||+ ++.+..+.....      ..+++..++.++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++
T Consensus       103 ~e~~-~~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ------GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             Eecc-CCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence            9999 666666655432      4689999999999999999999984 7   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      ........   .....||+.|+|||.+.     ...++.++||||||+++|||++|+.||.......     ......  
T Consensus       173 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~--  242 (318)
T 2dyl_A          173 GRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKV--  242 (318)
T ss_dssp             -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHH--
T ss_pred             hhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHH--
Confidence            76644321   23456999999999994     4568899999999999999999999997532210     000111  


Q ss_pred             hchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       291 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                            .....+.+......+   ..+.+++.+||+.||.+|||+.++++
T Consensus       243 ------~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          243 ------LQEEPPLLPGHMGFS---GDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ------HHSCCCCCCSSSCCC---HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------hccCCCCCCccCCCC---HHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  111111111111122   34667778899999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.3e-42  Score=325.03  Aligned_cols=243  Identities=23%  Similarity=0.367  Sum_probs=197.7

Q ss_pred             HhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh------hhHHHHHHHHHHHHhCC--CCCeeceeeEEEc
Q 015931           57 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLH--HPNIVPLVGFCID  128 (398)
Q Consensus        57 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  128 (398)
                      ...++|...+.||+|+||.||+|....+++.||||++.....      .....+.+|+.++.+++  ||||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            345789999999999999999999988899999999975421      12245678999999996  5999999999876


Q ss_pred             CCCcEEEEEecCCC-CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CCCC
Q 015931          129 PEQGLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKI  206 (398)
Q Consensus       129 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~~~  206 (398)
                      . +..++|||++.+ ++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++ +++.
T Consensus       120 ~-~~~~lv~e~~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          120 P-DSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             S-SEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTE
T ss_pred             C-CcEEEEEEcCCCCccHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCC
Confidence            5 458999999976 8999999875       45899999999999999999999988   99999999999999 7899


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......         
T Consensus       189 ~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------  255 (320)
T 3a99_A          189 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------  255 (320)
T ss_dssp             EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------
T ss_pred             EEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---------
Confidence            9999999998765432    234569999999999987665 67899999999999999999999653210         


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                                ...    ........+   ..+.+++.+||+.+|.+|||+.+|++
T Consensus       256 ----------~~~----~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 ----------IRG----QVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----------HHC----CCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------hcc----cccccccCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      000    011111122   34667778999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.6e-41  Score=334.34  Aligned_cols=257  Identities=21%  Similarity=0.305  Sum_probs=183.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +.|...++||+|+||+||.+.. .+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+ ++..++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEe
Confidence            3445568899999999986544 35899999998653   335678899999876 89999999998766 455899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC-------------C
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-------------K  205 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~-------------~  205 (398)
                      |+. |+|.+++.............++..++.++.|++.||+|||+.+   |+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence            995 6999999865321110111234456789999999999999988   9999999999999654             4


Q ss_pred             CeeEeccccccccCCCCCce--eeeccccCCCcccchhhcc-------CCcCCccchhhHHHHHHHHHc-CCCCCccccc
Q 015931          206 IPKLCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQH-------GKVSDKTDVYAFGVVLLELLT-GRKPIEARRL  275 (398)
Q Consensus       206 ~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~  275 (398)
                      .+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            89999999998776543211  1234579999999999975       568999999999999999999 9999975432


Q ss_pred             ccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .. ..              .+....+...............+.+++.+||+.||.+|||+.+|++
T Consensus       246 ~~-~~--------------i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          246 RE-SN--------------IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HH-HH--------------HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hH-HH--------------HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11 00              0111111110011123445567888999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=330.06  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=183.1

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ...+|...++||+|+||+|+.... .+++.||||++......   .+.+|+.+++.+ +||||+++++++.+. ...|+|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv   96 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR-QFQYIA   96 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC-CEEEEE
Confidence            345788889999999998654333 34889999999754322   356799999999 799999999987764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-----CCCeeEec
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-----KKIPKLCD  211 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~D  211 (398)
                      |||+. |+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.     ...+||+|
T Consensus        97 ~E~~~-g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKD------FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EECCS-EEHHHHHHSSS------CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             EECCC-CCHHHHHHhcC------CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            99995 69999998653      23555567789999999999999988   999999999999953     23578999


Q ss_pred             cccccccCCCCCc-eeeeccccCCCcccchhhc---cCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhh
Q 015931          212 FGLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAK  286 (398)
Q Consensus       212 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~  286 (398)
                      ||+++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||........    .   
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~---  239 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----N---  239 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----H---
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----H---
Confidence            9999876543211 1224467999999999997   4567889999999999999999 9999964322110    0   


Q ss_pred             HHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                              .+..  ................+.+++.+||+.||.+|||+.+|++
T Consensus       240 --------~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 --------ILLG--ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             --------HHTT--CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------HHhc--cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                    0000  0011111112233345678888999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-41  Score=327.66  Aligned_cols=248  Identities=15%  Similarity=0.162  Sum_probs=183.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHHhCCC-CCeece---------e--
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHH-PNIVPL---------V--  123 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l---------~--  123 (398)
                      +.+|...++||+|+||+||+|.+..+++.||||++.....   ...+.+.+|+.++..++| +|....         .  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3457778899999999999999998899999999874322   235678999999999987 321111         1  


Q ss_pred             ----------eEEEcC----CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCce
Q 015931          124 ----------GFCIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV  189 (398)
Q Consensus       124 ----------~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i  189 (398)
                                .++...    ....+++|+++ +++|.+++............+++..++.++.|+++||+|||+.+   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                      111111    12256777766 78999998632111112346889999999999999999999988   9


Q ss_pred             eecccccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhh----------ccCCcCCccchhhHHHH
Q 015931          190 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF----------QHGKVSDKTDVYAFGVV  259 (398)
Q Consensus       190 vHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDv~S~Gvv  259 (398)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998865432     344567 999999999          55568899999999999


Q ss_pred             HHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHH
Q 015931          260 LLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII  339 (398)
Q Consensus       260 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl  339 (398)
                      +|||++|+.||.........                 ..++..    ....+   ..+.+++.+||+.+|.+|||+.+++
T Consensus       307 l~elltg~~Pf~~~~~~~~~-----------------~~~~~~----~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGS-----------------EWIFRS----CKNIP---QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCS-----------------GGGGSS----CCCCC---HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhhH-----------------HHHHhh----cccCC---HHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999765432211                 111111    11122   3467777899999999999988876


Q ss_pred             H
Q 015931          340 A  340 (398)
Q Consensus       340 ~  340 (398)
                      +
T Consensus       363 ~  363 (413)
T 3dzo_A          363 E  363 (413)
T ss_dssp             T
T ss_pred             h
Confidence            5

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.1e-41  Score=342.09  Aligned_cols=264  Identities=24%  Similarity=0.371  Sum_probs=199.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEc-----CCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCID-----PEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~  133 (398)
                      ++|...+.||+|+||+||+|.+..+++.||||++... .......+.+|+.++.+++||||+++++++..     .++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999999888999999998764 44556779999999999999999999998644     14457


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC---eeEe
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLC  210 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~  210 (398)
                      ++||||+++|+|.+++.....    ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.   +||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~----~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC----TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence            899999999999999986432    246899999999999999999999988   999999999999997765   8999


Q ss_pred             ccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHh
Q 015931          211 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  290 (398)
Q Consensus       211 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  290 (398)
                      |||++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ...|......
T Consensus       167 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~  238 (676)
T 3qa8_A          167 DLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVRE  238 (676)
T ss_dssp             SCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-
T ss_pred             ccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhc
Confidence            9999987654432   2446799999999999999999999999999999999999999975321     1111111111


Q ss_pred             hchhh--hhhhcCc------ccCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHH
Q 015931          291 RGMAA--VEELLDP------RLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEI  338 (398)
Q Consensus       291 ~~~~~--~~~~~d~------~l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  338 (398)
                      .....  ..+....      .+..+ .........+.+++..||..||.+|||+.++
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            00000  0000111      11101 1223345667888889999999999999774

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-40  Score=343.21  Aligned_cols=240  Identities=25%  Similarity=0.347  Sum_probs=192.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCC-CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc----
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG----  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  132 (398)
                      .++|...+.||+|+||+||+|.+.. +++.||||++... .......+.+|+.++.+++||||+++++++...+..    
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3789999999999999999999865 6899999998654 345566789999999999999999999998765442    


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .|+||||+++++|.+++..         .++|..++.++.|++.||.|||+.+   |+||||||+|||++.+ .+||+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             EEEEEECCCCEECC----C---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred             eEEEEEeCCCCcHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence            6999999999999887643         4899999999999999999999988   9999999999999986 8999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      |+++.....      ....||+.|+|||++.++. +.++|||||||++|+|++|..||.........             
T Consensus       226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------------  285 (681)
T 2pzi_A          226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------------  285 (681)
T ss_dssp             TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-------------
T ss_pred             ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-------------
Confidence            999876543      3456999999999987654 88999999999999999999988753322100             


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-HHHHHHHHhc
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIAILRG  344 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~~L~~  344 (398)
                                   ...........+.+++.+||+.||.+||+ +.++...|.+
T Consensus       286 -------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          286 -------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                         00000112245778888999999999995 5566666654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-39  Score=301.51  Aligned_cols=231  Identities=23%  Similarity=0.327  Sum_probs=176.8

Q ss_pred             cCCCCC-ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHH-HhCCCCCeeceeeEEEc---CCCcEE
Q 015931           60 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA-SSLHHPNIVPLVGFCID---PEQGLF  134 (398)
Q Consensus        60 ~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~---~~~~~~  134 (398)
                      ++|... ++||+|+||.||+|.+..+++.||+|++...     ..+.+|+.++ +..+||||+++++++..   .+...+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            466665 7899999999999999888999999999642     3466788887 66699999999998764   244579


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeEec
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  211 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~D  211 (398)
                      +||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEec
Confidence            99999999999999987532     46999999999999999999999988   999999999999998   78999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ||++....                        +..++.++|||||||++|||++|+.||...........          
T Consensus       164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----------  209 (299)
T 3m2w_A          164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------  209 (299)
T ss_dssp             CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----------
T ss_pred             cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----------
Confidence            99986432                        13467799999999999999999999976433210000          


Q ss_pred             chhhhhhhcCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ....+.......+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus       210 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          210 ---MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ---SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               000000000100000 0011245677888999999999999999997

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.7e-40  Score=304.76  Aligned_cols=231  Identities=13%  Similarity=0.132  Sum_probs=180.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+..+.+++||||+++++++.+. +..|+|
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv  109 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVV  109 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEE
Confidence            67999999999999999999999889999999997653   34457899999999999999999999998775 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+++++|.+++..        . .....+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+++|   
T Consensus       110 ~e~~~g~~L~~~l~~--------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT--------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             EECCCEEEHHHHHTT--------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             EEecCCCCHHHHHhc--------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---
Confidence            999999999999853        1 345568889999999999999988   9999999999999999999998543   


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                                         |++       .++.++|||||||++|||+||+.||............   ..       .+
T Consensus       175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~-------~~  218 (286)
T 3uqc_A          175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ER-------DT  218 (286)
T ss_dssp             -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CB-------CT
T ss_pred             -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HH-------Hh
Confidence                               333       3688999999999999999999999875543211000   00       00


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      .....+........   ...+.+++.+||+.||.+| |+.|+++.|+...
T Consensus       219 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          219 AGQPIEPADIDRDI---PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             TSCBCCHHHHCTTS---CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             ccCCCChhhcccCC---CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            00000000000111   2346677889999999999 9999999998743

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.9e-38  Score=300.65  Aligned_cols=243  Identities=15%  Similarity=0.199  Sum_probs=182.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--------hhhHHHHHHHHHHHHhCC---------CCCeec
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLH---------HPNIVP  121 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~  121 (398)
                      .++|...+.||+|+||+||+|.+  +++.||||++....        ....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            36788899999999999999998  47999999997642        223467889999988885         778877


Q ss_pred             eeeEEE-----------------c------------CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHH
Q 015931          122 LVGFCI-----------------D------------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL  172 (398)
Q Consensus       122 l~~~~~-----------------~------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~  172 (398)
                      +.+.+.                 +            ....+++||||+++|++.+.+..        ..+++..++.++.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~  168 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILH  168 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHH
Confidence            777543                 1            14568999999999977666643        3589999999999


Q ss_pred             HHHHHHHHHH-cCCCCceeecccccCcEEeCCCC--------------------CeeEeccccccccCCCCCceeeeccc
Q 015931          173 GIAESVAYLH-NGTERCVVHRDIKPSNILLSSKK--------------------IPKLCDFGLATWTSAPSVPFLCKTVK  231 (398)
Q Consensus       173 qia~aL~yLH-~~~~~~ivHrDlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~  231 (398)
                      |++.||.||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....       ...
T Consensus       169 qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~  238 (336)
T 2vuw_A          169 QLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV  238 (336)
T ss_dssp             HHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred             HHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence            9999999999 888   99999999999999887                    8999999999876532       346


Q ss_pred             cCCCcccchhhccCCcCCccchhhHHHH-HHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCC
Q 015931          232 GTFGYLAPEYFQHGKVSDKTDVYAFGVV-LLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN  310 (398)
Q Consensus       232 gt~~y~aPE~~~~~~~s~ksDv~S~Gvv-l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  310 (398)
                      ||+.|+|||++.+.. +.++||||+|++ .+++++|..||...         .|.......   .+..............
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~---~~~~~~~~~~~~~~~~  305 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDK---MLKQMTFKTKCNTPAM  305 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHH---HHHTCCCSSCCCSHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHh---hhhhhccCcccchhhh
Confidence            999999999998665 889999998777 77889999998542         111111100   0001001100001112


Q ss_pred             HHHHHHHHHHHHhcccccCCCCCCHHHHH
Q 015931          311 SAQIARVIQAAAACISSEESRRPGIEEII  339 (398)
Q Consensus       311 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl  339 (398)
                      ......+.+++.+||+.+     |+.|++
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            234567888999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.7e-33  Score=282.06  Aligned_cols=186  Identities=15%  Similarity=0.112  Sum_probs=131.3

Q ss_pred             ecccCceEEEEeeeCCCCcEEEEEEecCCC----------hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEEE
Q 015931           68 LGRGALSFVFKGKVGLLRTSVAIKRLDKED----------KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        68 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .+.|++|.+..+.....|+.||+|.+.+..          ....++|.+|+++|+++ .|+||+++++++.+ ++..|||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yLV  320 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWLV  320 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEEE
Confidence            456667766666655568899999997541          22346799999999999 69999999998766 4568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||++|++|.++|...       .+++..   +|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+
T Consensus       321 MEyv~G~~L~d~i~~~-------~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG-------EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             EECCCSEEHHHHHHTT-------CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             EecCCCCcHHHHHHhC-------CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCe
Confidence            9999999999999864       456654   48899999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCC
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI  270 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf  270 (398)
                      .......  ...+.+||++|+|||++.+ .+..++|+||+|++++++.+|..|+
T Consensus       388 ~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          388 TTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             SCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             eCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            7654332  2345789999999999864 5678899999999998887766554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=5.3e-29  Score=250.93  Aligned_cols=185  Identities=19%  Similarity=0.214  Sum_probs=144.0

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ...++||+|+||.||+|...  +..+++|+......        ...+.+.+|++++++++||||+++..++...+. .+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN-KR  415 (540)
T ss_dssp             ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT-TE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc-cE
Confidence            44678999999999999554  67899998754321        123458999999999999999966655555444 69


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+++++|.+++..               +..++.|+++||.|||+++   |+||||||+|||+++  .+||+|||+
T Consensus       416 lVmE~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED---------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             EEEECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred             EEEECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence            99999999999999864               4479999999999999988   999999999999999  999999999


Q ss_pred             ccccCCCCCce-----eeeccccCCCcccchhhcc--CCcCCccchhhHHHHHHHHHcCCCCC
Q 015931          215 ATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPI  270 (398)
Q Consensus       215 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~Gvvl~elltG~~Pf  270 (398)
                      ++.........     ......||+.|+|||++..  ..|+..+|+||..+-.++-+.++.+|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99876532211     1235679999999999986  56888899999999999888877765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3.4e-25  Score=205.22  Aligned_cols=150  Identities=17%  Similarity=0.117  Sum_probs=119.3

Q ss_pred             HHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh------------------hhHHHHHHHHHHHHhCCCC
Q 015931           56 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------------------ESSKAFCRELMIASSLHHP  117 (398)
Q Consensus        56 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~  117 (398)
                      ......|...+.||+|+||.||+|.+ .+++.||+|.+.....                  .....+.+|+.++++++  
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            34455666779999999999999999 6799999999965321                  13467899999999999  


Q ss_pred             CeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccC
Q 015931          118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  197 (398)
Q Consensus       118 niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~  197 (398)
                      | +++.+++..  +..++||||+++++|.+ +..             .....++.|++.||.|||+.+   |+||||||+
T Consensus       163 ~-~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~~-------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~  222 (282)
T 1zar_A          163 G-LAVPKVYAW--EGNAVLMELIDAKELYR-VRV-------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQY  222 (282)
T ss_dssp             T-SSSCCEEEE--ETTEEEEECCCCEEGGG-CCC-------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred             C-CCcCeEEec--cceEEEEEecCCCcHHH-cch-------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence            5 666665433  33589999999999987 421             124469999999999999988   999999999


Q ss_pred             cEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhcc
Q 015931          198 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH  244 (398)
Q Consensus       198 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  244 (398)
                      |||++ ++.+||+|||+++.               +..+.|||++..
T Consensus       223 NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          223 NVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             SEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             HEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            99999 99999999999863               334788998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.9e-21  Score=177.66  Aligned_cols=139  Identities=18%  Similarity=0.119  Sum_probs=106.9

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcE--EEEEEecCCChh------------------------hHHHHHHHHHHHHhC
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKE------------------------SSKAFCRELMIASSL  114 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  114 (398)
                      -|...+.||+|+||.||+|.+..+|+.  ||||++......                        ....+.+|+..+..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356778999999999999998556888  999987543111                        123678999999999


Q ss_pred             CCCCe--eceeeEEEcCCCcEEEEEecCCC-C----CHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCC
Q 015931          115 HHPNI--VPLVGFCIDPEQGLFLIYKYVSG-G----SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-NGTE  186 (398)
Q Consensus       115 ~h~ni--v~l~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~  186 (398)
                      +|+++  ..++++    + ..++||||+.+ |    +|.+....          .++..+..++.|++.||.||| +.+ 
T Consensus       128 ~~~~i~~p~~~~~----~-~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~~~g-  191 (258)
T 1zth_A          128 KEAGVSVPQPYTY----M-KNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKRLYQEAE-  191 (258)
T ss_dssp             HHTTCCCCCEEEE----E-TTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred             HhCCCCCCeEEEc----C-CCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence            88764  333332    1 25899999942 4    67766432          234457789999999999999 888 


Q ss_pred             CceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          187 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       187 ~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                        |+||||||+|||+++  .++|+|||+|....
T Consensus       192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          192 --LVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             --EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             --EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence              999999999999998  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=3.8e-18  Score=162.74  Aligned_cols=141  Identities=14%  Similarity=0.113  Sum_probs=99.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--------------hhHH--------HHHHHHHHHHhCCCC
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------------ESSK--------AFCRELMIASSLHHP  117 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~  117 (398)
                      .-|.+.+.||+|+||.||+|... +|+.||||+++....              ....        ....|...|.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34888999999999999999986 489999998753210              0011        123456666666544


Q ss_pred             CeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccC
Q 015931          118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  197 (398)
Q Consensus       118 niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~  197 (398)
                      ++....-+...  . .+|||||++|++|.++..           .  +....++.|++.+|.|||+.+   ||||||||.
T Consensus       174 gv~vp~p~~~~--~-~~LVME~i~G~~L~~l~~-----------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~  234 (397)
T 4gyi_A          174 GFPVPEPIAQS--R-HTIVMSLVDALPMRQVSS-----------V--PDPASLYADLIALILRLAKHG---LIHGDFNEF  234 (397)
T ss_dssp             TCSCCCEEEEE--T-TEEEEECCSCEEGGGCCC-----------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred             CCCCCeeeecc--C-ceEEEEecCCccHhhhcc-----------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence            43222111111  2 279999999988754321           1  123568899999999999988   999999999


Q ss_pred             cEEeCCCC----------CeeEeccccccccCC
Q 015931          198 NILLSSKK----------IPKLCDFGLATWTSA  220 (398)
Q Consensus       198 NIll~~~~----------~~kl~DfGla~~~~~  220 (398)
                      |||+++++          .+.|+||+-+.....
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence            99998776          389999998765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=1.9e-12  Score=117.89  Aligned_cols=144  Identities=17%  Similarity=0.103  Sum_probs=107.9

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ...+|.....+|.|+.+.||++...  +..+++|............+.+|+.++..+. +..+.++++++.+. +..|+|
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv   88 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSNLL   88 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-CceEEE
Confidence            3456777777888889999999754  6789999986522122235788999998884 66777888877654 457999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG--------------------------------  184 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~--------------------------------  184 (398)
                      |||++|.+|.+.+..            ......++.+++++|..||+.                                
T Consensus        89 ~e~i~G~~l~~~~~~------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EECCSSEEHHHHCCT------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             EEecCCeehhhccCC------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            999999999776321            112346888999999999981                                


Q ss_pred             ------------------------CCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          185 ------------------------TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       185 ------------------------~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                                              ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                    11459999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=1.8e-11  Score=110.82  Aligned_cols=136  Identities=16%  Similarity=0.129  Sum_probs=94.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe--eceeeEEEcCCCcEEEEEe
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI--VPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~lV~e  138 (398)
                      ++....+.+.|..+.||++... +|..+++|.....   ....+..|+.++..+.+.++  .+++++.... +..++|||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~e   95 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLG   95 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEE
T ss_pred             CCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEEEE
Confidence            3443322235556999999764 4678999997654   22456788888888865454  4577766554 44799999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT---------------------------------  185 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------  185 (398)
                      |++|.+|.  ...          .+   ...++.++++.|..||+..                                 
T Consensus        96 ~i~G~~l~--~~~----------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           96 EVPGQDLL--SSH----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             CCSSEETT--TSC----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             ecCCcccC--cCc----------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            99998884  211          11   1246677777777777643                                 


Q ss_pred             ----------------------CCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          186 ----------------------ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       186 ----------------------~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                                            ...++|+|++|.||+++++..+.|+|||.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                  1239999999999999877667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=1.4e-10  Score=110.50  Aligned_cols=142  Identities=19%  Similarity=0.235  Sum_probs=104.2

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEec--CCC-hhhHHHHHHHHHHHHhCC--CCCeeceeeEEEcCC--CcEEEEE
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KED-KESSKAFCRELMIASSLH--HPNIVPLVGFCIDPE--QGLFLIY  137 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~--~~~~lV~  137 (398)
                      .+.|+.|.++.||+....  +..+++|+..  ... ......+.+|+.++..+.  +..+.+++.++.+.+  +..++||
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            467899999999998875  4578888775  322 122346788999999887  455778888775542  3368999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--------------------------------  185 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------  185 (398)
                      ||++|..+.+..         ...++...+..++.++++.|..||+..                                
T Consensus       121 e~v~G~~l~~~~---------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          121 EFVSGRVLWDQS---------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             ECCCCBCCCCTT---------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EecCCeecCCCc---------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            999987774311         134778888899999999999999731                                


Q ss_pred             -----------------------CCceeecccccCcEEeCCCCC--eeEeccccccc
Q 015931          186 -----------------------ERCVVHRDIKPSNILLSSKKI--PKLCDFGLATW  217 (398)
Q Consensus       186 -----------------------~~~ivHrDlkp~NIll~~~~~--~kl~DfGla~~  217 (398)
                                             ...++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                   256999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=4.6e-10  Score=104.39  Aligned_cols=185  Identities=19%  Similarity=0.231  Sum_probs=121.3

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCC--eeceeeEEEcCC--CcEEEEEec
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPN--IVPLVGFCIDPE--QGLFLIYKY  139 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~--~~~~lV~e~  139 (398)
                      .+.++.|....||+..     ..+++|+...  ......+.+|+.++..+. +..  +.+++......+  ...|+||++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999873     4588898643  234567889999998873 332  233333322222  124789999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT----------------------------------  185 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----------------------------------  185 (398)
                      ++|.+|......         .++.+.+..++.+++..|..||+..                                  
T Consensus        98 i~G~~l~~~~~~---------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (304)
T 3sg8_A           98 IKGVPLTPLLLN---------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP  168 (304)
T ss_dssp             CCCEECCHHHHH---------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred             cCCeECCccccc---------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence            999888654322         2677777888888888888888621                                  


Q ss_pred             ---------------------CCceeecccccCcEEeCC--CCCeeEeccccccccCCCCCceeeeccccCCCc---ccc
Q 015931          186 ---------------------ERCVVHRDIKPSNILLSS--KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY---LAP  239 (398)
Q Consensus       186 ---------------------~~~ivHrDlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y---~aP  239 (398)
                                           ...++|+|++|.||++++  ...+.|+||+.+........      ......+   ..|
T Consensus       169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~  242 (304)
T 3sg8_A          169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGM  242 (304)
T ss_dssp             HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCH
T ss_pred             cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCH
Confidence                                 245899999999999998  45678999998865432110      0001111   222


Q ss_pred             hhhcc-----C---------CcCCccchhhHHHHHHHHHcCCCCCc
Q 015931          240 EYFQH-----G---------KVSDKTDVYAFGVVLLELLTGRKPIE  271 (398)
Q Consensus       240 E~~~~-----~---------~~s~ksDv~S~Gvvl~elltG~~Pf~  271 (398)
                      +....     +         ......+.|++|.++|.+.+|..+|.
T Consensus       243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            21110     0         01123589999999999999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.72  E-value=2.4e-07  Score=86.13  Aligned_cols=137  Identities=20%  Similarity=0.236  Sum_probs=93.1

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCC---CeeceeeEEEcCCCcEEEEEecCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP---NIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      .+.++.|....||+.     +..+++|+..  .......+..|+.+|..+.+.   .+.+.+.++....+..++||++++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456888888999987     4568888853  234456788999999998652   245556665444555789999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-------------------------------------  184 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-------------------------------------  184 (398)
                      |.+|....-         ..++...+..++.++++.|..||+.                                     
T Consensus        97 G~~l~~~~~---------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           97 GQILGEDGM---------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             SEECHHHHH---------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             CeECchhhh---------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            988866321         1133444444444455554444432                                     


Q ss_pred             --------------------CCCceeecccccCcEEeCC---CCCe-eEeccccccc
Q 015931          185 --------------------TERCVVHRDIKPSNILLSS---KKIP-KLCDFGLATW  217 (398)
Q Consensus       185 --------------------~~~~ivHrDlkp~NIll~~---~~~~-kl~DfGla~~  217 (398)
                                          ....++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                2335799999999999987   4554 7999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.52  E-value=1.1e-06  Score=79.83  Aligned_cols=135  Identities=15%  Similarity=0.144  Sum_probs=93.8

Q ss_pred             eecccCce-EEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCcEEEEEecCCCCC
Q 015931           67 VLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGS  144 (398)
Q Consensus        67 ~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~~gs  144 (398)
                      .+..|..| .||+......+..+.+|+-..   .....+..|...|+.+. +--+-++++++.+. +..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCcc
Confidence            45556555 699987766677899998653   23456788998888774 22355677777665 45789999999988


Q ss_pred             HHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 015931          145 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG----------------------------------------  184 (398)
Q Consensus       145 L~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~----------------------------------------  184 (398)
                      +.+......           .....++.+++..|.-||..                                        
T Consensus       107 ~~~~~~~~~-----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          107 AFQVLEEYP-----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             HHHHHHHCG-----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             ccccccCCH-----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            877654311           12234556666666666641                                        


Q ss_pred             ---------------CCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          185 ---------------TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       185 ---------------~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                                     ....++|+|+.+.||++++++.+-|.||+.+.
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           12238999999999999987777799998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.21  E-value=1.6e-06  Score=82.17  Aligned_cols=81  Identities=7%  Similarity=0.015  Sum_probs=51.5

Q ss_pred             cee-cccCceEEEEeeeC---C---CCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCC---CCeeceeeEEEcCC--
Q 015931           66 RVL-GRGALSFVFKGKVG---L---LRTSVAIKRLDKED---KESSKAFCRELMIASSLHH---PNIVPLVGFCIDPE--  130 (398)
Q Consensus        66 ~~l-G~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~--  130 (398)
                      +.| +.|....+|+....   .   .+..+++|......   ......+..|+.++..+..   -.+.+++.++.+.+  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            467 78889999988653   0   15678888765322   0012346678887777642   24566777665432  


Q ss_pred             CcEEEEEecCCCCCHH
Q 015931          131 QGLFLIYKYVSGGSLE  146 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~  146 (398)
                      +..++|||+++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            2358999999886653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.21  E-value=9.4e-06  Score=78.00  Aligned_cols=76  Identities=18%  Similarity=0.097  Sum_probs=47.7

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCCh-------hhHHHHHHHHHHHHhCCC--CCee-ceeeEEEcCCCcEE
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------ESSKAFCRELMIASSLHH--PNIV-PLVGFCIDPEQGLF  134 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~~  134 (398)
                      .+.||.|.++.||++.....+..++||.......       .....+..|.+++..+..  +..+ +++.+  +.+. .+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-~~  111 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AV  111 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc-cE
Confidence            4578999999999997655567899998653211       122346678888877642  3444 44433  3333 47


Q ss_pred             EEEecCCCC
Q 015931          135 LIYKYVSGG  143 (398)
Q Consensus       135 lV~e~~~~g  143 (398)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.13  E-value=2.7e-05  Score=72.85  Aligned_cols=145  Identities=19%  Similarity=0.313  Sum_probs=77.8

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhC-----CCCCeecee-e-EEEcCCCcEEEEEe
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-----HHPNIVPLV-G-FCIDPEQGLFLIYK  138 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~-~-~~~~~~~~~~lV~e  138 (398)
                      +.|+.|..+.||+....  +..+++|+.... .   ..+..|..++..+     ..|.++... | .+....+..++||+
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34666778999998875  345899998752 2   2233444444433     234444311 1 11111344689999


Q ss_pred             cCCCCCHH--------------HHHhhhccCCC-C------CCCCCHHHHH-----------------------------
Q 015931          139 YVSGGSLE--------------RHLHEKKKGVR-G------NSTLPWSVRY-----------------------------  168 (398)
Q Consensus       139 ~~~~gsL~--------------~~l~~~~~~~~-~------~~~l~~~~~~-----------------------------  168 (398)
                      |++|..+.              ..++....... .      ...-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              11222111110 0      0112343211                             


Q ss_pred             --HHHHHHHHHHHHHHc----------CCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          169 --KVALGIAESVAYLHN----------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       169 --~i~~qia~aL~yLH~----------~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                        .+...+..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111123345666653          123559999999999999888899999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.73  E-value=0.00033  Score=63.98  Aligned_cols=79  Identities=14%  Similarity=0.161  Sum_probs=55.1

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCC---CeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP---NIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~lV~  137 (398)
                      .......+|.|..+.||+....+ |+.|.+|+...........|..|+..|+.+.-.   -+.+++++  + .  -++||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~-~--~~lv~   89 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D-D--RTLAM   89 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E-T--TEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c-C--ceEEE
Confidence            44456779999999999999864 789999987654433344578899888877422   23344443  2 2  27999


Q ss_pred             ecCCCCCH
Q 015931          138 KYVSGGSL  145 (398)
Q Consensus       138 e~~~~gsL  145 (398)
                      ||++++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.71  E-value=0.00026  Score=68.42  Aligned_cols=78  Identities=8%  Similarity=0.123  Sum_probs=46.6

Q ss_pred             CCceeecccccCcEEeCCCCCeeEeccccccccCCCCCceeeecc-ccCCCcccchhhccC---CcCCccchhhHHHHHH
Q 015931          186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHG---KVSDKTDVYAFGVVLL  261 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~ksDv~S~Gvvl~  261 (398)
                      ...++|+|++|.|||++.++ ++|.||+.+..-.....  ..... .-...|.+|+.....   ......++.+....+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            45599999999999998776 99999998864432110  00000 001235666554311   1122345557777777


Q ss_pred             HHHcC
Q 015931          262 ELLTG  266 (398)
Q Consensus       262 elltG  266 (398)
                      +..++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77664

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.55  E-value=0.00096  Score=61.74  Aligned_cols=142  Identities=15%  Similarity=0.209  Sum_probs=89.1

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      .+.|+.|....+|+....  +..+++|+....   ....+..|...|+.+.   ...+.+++.++... +..++||||++
T Consensus        41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEEecc
Confidence            457899999999998763  567889987643   3456888988888773   35577777776553 45799999999


Q ss_pred             CCCHH--------H---HHhhhcc----CCC-----------CCCCCCHHHHH---HHHH----------------HHHH
Q 015931          142 GGSLE--------R---HLHEKKK----GVR-----------GNSTLPWSVRY---KVAL----------------GIAE  176 (398)
Q Consensus       142 ~gsL~--------~---~l~~~~~----~~~-----------~~~~l~~~~~~---~i~~----------------qia~  176 (398)
                      +..+.        .   .|+....    +..           ....-+|...+   ++..                .++.
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87642        1   2222111    000           00112565432   1111                1111


Q ss_pred             HH-HHHHc-CCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          177 SV-AYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       177 aL-~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      .+ ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            12 23432 2356799999999999999887 8899974

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.52  E-value=0.00043  Score=63.62  Aligned_cols=143  Identities=12%  Similarity=0.122  Sum_probs=74.2

Q ss_pred             CCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeEEEcCCCcEEEEEecC-C
Q 015931           64 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYKYV-S  141 (398)
Q Consensus        64 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV~e~~-~  141 (398)
                      ..+.|+.|....+|+.      ..+.+|+....... ......|+..+..+...++ .+++++  +.+. -++|+||+ +
T Consensus        22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~-~~~v~e~i~~   91 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPAT-GVMVTRYIAG   91 (301)
T ss_dssp             SCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTT-CCEEEECCTT
T ss_pred             ceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCC-CEEEEeecCC
Confidence            3678988999999998      35888887643211 1122457766666543233 344443  3322 26899999 6


Q ss_pred             CCCHHH---------------HHhhhcc-CCCCCCCCC-HHHHHHHHHH--------------HHHHH----HHHHc-CC
Q 015931          142 GGSLER---------------HLHEKKK-GVRGNSTLP-WSVRYKVALG--------------IAESV----AYLHN-GT  185 (398)
Q Consensus       142 ~gsL~~---------------~l~~~~~-~~~~~~~l~-~~~~~~i~~q--------------ia~aL----~yLH~-~~  185 (398)
                      +.+|..               .+..-.. ........+ +.....+...              +...+    ..+.. ..
T Consensus        92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~  171 (301)
T 3dxq_A           92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL  171 (301)
T ss_dssp             CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence            644421               1111000 000000011 1111111110              11111    12211 23


Q ss_pred             CCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ...++|+|+.+.||+ ..++.+.++||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            456999999999999 5667789999987753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.44  E-value=0.0015  Score=56.57  Aligned_cols=100  Identities=14%  Similarity=0.093  Sum_probs=66.7

Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      ..+|.+.|....      .+++++++|.++.|.+.+|.-+-....  -..+=+-|..|+|..+|.+.+.+ +.+.     
T Consensus        32 ~vSL~eIL~~~~------~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----   97 (229)
T 2yle_A           32 ALSLEEILRLYN------QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD-----   97 (229)
T ss_dssp             EEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred             cccHHHHHHHcC------CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----
Confidence            458999998875      689999999999999999877622111  11233457899999999987764 1110     


Q ss_pred             CCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc
Q 015931          222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT  265 (398)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt  265 (398)
                               .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                     1122366888763 345678899999999999885

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.31  E-value=0.00092  Score=61.83  Aligned_cols=163  Identities=15%  Similarity=0.173  Sum_probs=83.2

Q ss_pred             cCHHHHHHhhcCCCCC-----ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eece
Q 015931           50 LSYGEILAATHNFSKG-----RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPL  122 (398)
Q Consensus        50 ~~~~e~~~~~~~f~~~-----~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  122 (398)
                      ++.+++......|...     +.|+.|....+|+....+ + .+++|......  ....+..|+.++..+...+  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3444554444445442     346678889999987753 3 68899886521  1123445666665553212  2222


Q ss_pred             eeE-----EEcCCCcEEEEEecCCCCCHHH--------------HHhhhccCCCCC-----CCCCHHHHHHH--------
Q 015931          123 VGF-----CIDPEQGLFLIYKYVSGGSLER--------------HLHEKKKGVRGN-----STLPWSVRYKV--------  170 (398)
Q Consensus       123 ~~~-----~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~~~~~~~-----~~l~~~~~~~i--------  170 (398)
                      +..     +....+..+++++|++|..+..              .++.........     ....|...+.-        
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            211     0011234689999998865311              122211100000     00123321110        


Q ss_pred             ----HHHHHHHHHHHHcC----CCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          171 ----ALGIAESVAYLHNG----TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       171 ----~~qia~aL~yLH~~----~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                          ...+...+..+...    ....++|+|+++.||+++++..+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                01134445555532    24569999999999999887656899998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.25  E-value=0.0072  Score=55.88  Aligned_cols=147  Identities=18%  Similarity=0.169  Sum_probs=78.4

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eeceeeE----EEcCCCcEEEEEec
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGF----CIDPEQGLFLIYKY  139 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~----~~~~~~~~~lV~e~  139 (398)
                      ..|+ |....||+....+ |+.+++|....... ....+..|..++..+....  +.+++..    ....++..++||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDED-RRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTT-CCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCC-CCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4577 8888999987643 66799999864321 2345666777776663212  3334332    00112345789999


Q ss_pred             CCCCCHH-----H------H---HhhhccCC--CCCCCCCHHHH----------------------HHHHHHHHHHHHHH
Q 015931          140 VSGGSLE-----R------H---LHEKKKGV--RGNSTLPWSVR----------------------YKVALGIAESVAYL  181 (398)
Q Consensus       140 ~~~gsL~-----~------~---l~~~~~~~--~~~~~l~~~~~----------------------~~i~~qia~aL~yL  181 (398)
                      ++|..+.     .      .   ++......  ......++...                      ...+..++..+.-+
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875431     1      1   11111100  00112222211                      01111122222211


Q ss_pred             Hc-CCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          182 HN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       182 H~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      -. .....++|+|+++.||+++ + .+.|.||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            11 1245689999999999999 4 899999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.21  E-value=0.0041  Score=57.78  Aligned_cols=33  Identities=27%  Similarity=0.343  Sum_probs=27.9

Q ss_pred             CCceeecccccCcEEeCCC----CCeeEecccccccc
Q 015931          186 ERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWT  218 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~----~~~kl~DfGla~~~  218 (398)
                      ...++|+|+.+.||+++.+    ..+.|.||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4569999999999999874    67899999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.16  E-value=0.0012  Score=63.92  Aligned_cols=74  Identities=14%  Similarity=0.166  Sum_probs=48.0

Q ss_pred             CceecccCceEEEEeeeCC-------CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeEEEcCCCcEEEE
Q 015931           65 GRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV  136 (398)
                      .+.|+.|....||+.....       .+..+.+|+......  ...+..|..++..+...++ .++++.+ .  +  .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-~--~--g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIF-S--G--GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-T--T--EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-C--C--CEE
Confidence            3567888889999998753       246789998843211  1345578888887753344 4556543 2  2  389


Q ss_pred             EecCCCCCH
Q 015931          137 YKYVSGGSL  145 (398)
Q Consensus       137 ~e~~~~gsL  145 (398)
                      +||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999987443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.14  E-value=0.0015  Score=62.18  Aligned_cols=145  Identities=16%  Similarity=0.185  Sum_probs=80.9

Q ss_pred             ceecccCceEEEEeeeCC-------CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeEEEcCCCcEEEEE
Q 015931           66 RVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV~  137 (398)
                      +.|..|-...+|+.....       .+..+.+|+.... ........+|..+++.+.-.++ .++++++ + +   .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-~-~---g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-P-E---GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-T-T---EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-C-C---ccEE
Confidence            467668888999987642       3468899986332 2234556688888877642222 4555543 2 2   2899


Q ss_pred             ecCCCCCHH--------------HHHhhhccC-CCCCCCC--CHHHHHHHHHHHHH-------------------HHHH-
Q 015931          138 KYVSGGSLE--------------RHLHEKKKG-VRGNSTL--PWSVRYKVALGIAE-------------------SVAY-  180 (398)
Q Consensus       138 e~~~~gsL~--------------~~l~~~~~~-~~~~~~l--~~~~~~~i~~qia~-------------------aL~y-  180 (398)
                      ||++|.+|.              +.|..-... .......  -|.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999986542              111111110 0001112  25555555544322                   1222 


Q ss_pred             ---HHcC-CCCceeecccccCcEEeCCC----CCeeEecccccc
Q 015931          181 ---LHNG-TERCVVHRDIKPSNILLSSK----KIPKLCDFGLAT  216 (398)
Q Consensus       181 ---LH~~-~~~~ivHrDlkp~NIll~~~----~~~kl~DfGla~  216 (398)
                         |... ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               3222 24569999999999999876    689999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.10  E-value=0.0021  Score=62.82  Aligned_cols=75  Identities=20%  Similarity=0.151  Sum_probs=46.6

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeEEEcCCCcEEEEEecCCCC
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      .+.|+.|-...+|+......+..+.+|+........ -.-..|..++..+...++ .++++.+ .  +  .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-T--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-T--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-C--C--eEEEEeeCCc
Confidence            356788888999999876434788899875432111 112478888888765555 3556554 2  2  2599999875


Q ss_pred             CH
Q 015931          144 SL  145 (398)
Q Consensus       144 sL  145 (398)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.63  E-value=0.0038  Score=58.95  Aligned_cols=73  Identities=15%  Similarity=0.141  Sum_probs=41.5

Q ss_pred             ceecccCceEEEEeeeCC--------CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeEEEcCCCcEEEE
Q 015931           66 RVLGRGALSFVFKGKVGL--------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV  136 (398)
                      ..|+.|....+|+.....        .+..+.+|+...... .......|..++..+...++ .++++..   .+  ++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF---NG--GRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec---CC--cEE
Confidence            456778888999987653        125788887754322 11123567777776643333 3555432   22  689


Q ss_pred             EecCCCCC
Q 015931          137 YKYVSGGS  144 (398)
Q Consensus       137 ~e~~~~gs  144 (398)
                      |+|++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.46  E-value=0.013  Score=54.71  Aligned_cols=32  Identities=19%  Similarity=0.347  Sum_probs=27.8

Q ss_pred             CCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ...++|+|+.+.||++++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35699999999999999888899999987653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.96  E-value=0.11  Score=49.93  Aligned_cols=144  Identities=15%  Similarity=0.161  Sum_probs=81.6

Q ss_pred             ceecccCceEEEEeeeCCC-------CcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeEEEcCCCcEEEEE
Q 015931           66 RVLGRGALSFVFKGKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV~  137 (398)
                      +.|..|-...+|+......       +..+.+++....... .-...+|..+++.+.-.++ .++++.+   .+  ++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~---~~--~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF---PE--GRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc---CC--CEEE
Confidence            4666788889999887521       467888886543221 1123467777766643233 3444432   22  6899


Q ss_pred             ecCCCCCHHH--------------H---Hhhhcc---CCC---CCCCCCHHHHHHHHHHH-------------------H
Q 015931          138 KYVSGGSLER--------------H---LHEKKK---GVR---GNSTLPWSVRYKVALGI-------------------A  175 (398)
Q Consensus       138 e~~~~gsL~~--------------~---l~~~~~---~~~---~~~~l~~~~~~~i~~qi-------------------a  175 (398)
                      +|++|..|..              .   ++....   ...   ...+.-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999865311              1   111110   000   11222355554444332                   1


Q ss_pred             HHHHHHHc---------------------CCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          176 ESVAYLHN---------------------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       176 ~aL~yLH~---------------------~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ..+.+|..                     .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            22233321                     12356999999999999 788899999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.52  E-value=0.35  Score=45.96  Aligned_cols=29  Identities=38%  Similarity=0.517  Sum_probs=24.4

Q ss_pred             ceeecccccCcEEe------CCCCCeeEecccccc
Q 015931          188 CVVHRDIKPSNILL------SSKKIPKLCDFGLAT  216 (398)
Q Consensus       188 ~ivHrDlkp~NIll------~~~~~~kl~DfGla~  216 (398)
                      .++|+|+.+.||++      +++..+.++||..|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46799999999999      456779999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.16  E-value=0.68  Score=39.78  Aligned_cols=118  Identities=11%  Similarity=0.174  Sum_probs=77.8

Q ss_pred             CCCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecc
Q 015931          114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRD  193 (398)
Q Consensus       114 l~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrD  193 (398)
                      ..||+++.. .+-.+ ++.+.+.|+.-+++.=...+.          .++...+++++.+|+....+++.     -+|--
T Consensus        42 ~~~~~Fl~~-~I~e~-eD~v~~~y~~~~~~~~f~~ik----------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~  104 (215)
T 4ann_A           42 QHSPYFIDA-ELTEL-RDSFQIHYDINDNHTPFDNIK----------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFV  104 (215)
T ss_dssp             SCCTTBCCE-EEEEC-SSEEEEEECCCTTSEEGGGGG----------GSCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred             ccCCcccce-EEEEc-ccEEEEEEEcCcccCCHHHHH----------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence            368999876 33333 444556666554322222232          37888999999999988866653     57888


Q ss_pred             cccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcc
Q 015931          194 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       194 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~  272 (398)
                      |.|+|++++.++.+++.=.|+-..+                   +|.     ..++..=.-.+=+++..+++++..|..
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999999999877763322                   221     011111223577889999999998864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.62  E-value=0.058  Score=52.57  Aligned_cols=61  Identities=8%  Similarity=0.091  Sum_probs=17.5

Q ss_pred             CCceecccCceEEEEeeeCCCCcEEEE------EEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEE
Q 015931           64 KGRVLGRGALSFVFKGKVGLLRTSVAI------KRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCI  127 (398)
Q Consensus        64 ~~~~lG~G~~g~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  127 (398)
                      ..+.||   ||.||+|.+.....+||+      |.....  ..+....|.+|..+....+|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345666   999999998765567888      665432  2233456888888888899999999988654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.20  E-value=1.9  Score=37.03  Aligned_cols=115  Identities=15%  Similarity=0.146  Sum_probs=75.3

Q ss_pred             CCCCeeceeeEEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCceeecc
Q 015931          115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA-YLHNGTERCVVHRD  193 (398)
Q Consensus       115 ~h~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~-yLH~~~~~~ivHrD  193 (398)
                      .||++ .. .+ ...++.+.+.|+.-+++.=...+.          .++...+++++.+++.... +++.     -+|--
T Consensus        48 ~~~~f-~~-~I-~~~eD~~~i~y~~~~~~~~f~~i~----------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~  109 (219)
T 4ano_A           48 VDPCI-VR-DI-DVSEDEVKVVIKPPSSFLTFAAIR----------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFI  109 (219)
T ss_dssp             SCSSS-EE-EE-EECSSEEEEEEECCTTCEEHHHHH----------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECC
T ss_pred             cCCCC-Ce-EE-EEeCCEEEEEEEcCcccCcHHHHH----------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEE
Confidence            68888 32 22 233454666677654543344443          2788899999988887766 5543     67888


Q ss_pred             cccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccch-hhHHHHHHHHHcCCCCCcc
Q 015931          194 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDV-YAFGVVLLELLTGRKPIEA  272 (398)
Q Consensus       194 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv-~S~Gvvl~elltG~~Pf~~  272 (398)
                      |.|+||++|.++.+++.-.|+-..                   ++|.-+     + ..|. -.+=+++..++.++..|..
T Consensus       110 l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          110 VCPENLMFNRALEPFFLHVGVKES-------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             CCGGGEEECTTCCEEESCCEETTT-------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EeCceEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999999999998776332                   222211     1 1222 2567788888888887753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	398
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-44
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 4e-67
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 33/288 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
             + G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           I+  +G+   P+  L ++ ++  G SL  HLH  +                +A   A+ +
Sbjct: 66  ILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHIIET------KFEMIKLIDIARQTAQGM 117

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YLH    + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++A
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 239 PEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 295
           PE  +       S ++DVYAFG+VL EL+TG+ P          N       ++ RG   
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGY-- 226

Query: 296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
              L     K  S     + R++     C+  +   RP   +I+A + 
Sbjct: 227 ---LSPDLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 3e-61
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 15/214 (7%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 119
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V   G      + + +  +++ GGSL++ L +  +       +P  +  KV++ + + + 
Sbjct: 67  VGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLT 118

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YL    +  ++HRD+KPSNIL++S+   KLCDFG++          +  +  GT  Y++P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 273
           E  Q    S ++D+++ G+ L+E+  GR PI   
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 1e-57
 Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 35/283 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
                + +G+G    V  G        VA+K +  +   +++AF  E  + + L H N+V
Sbjct: 8   ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 63

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G  ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ Y
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           L        VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPE 170

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
             +  K S K+DV++FG++L E+ +  +               + +  L   +  VE+  
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVP-------------YPRIPLKDVVPRVEK-- 215

Query: 301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
             ++         +  V++    C   + + RP   ++   L 
Sbjct: 216 GYKMDAPDGCPPAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-57
 Identities = 65/284 (22%), Positives = 113/284 (39%), Gaps = 29/284 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
           ++     +G G+     K +       +  K LD     +   +    E+ +   L HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 119 IVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           IV      ID     L+++ +Y  GG L   +    KG +    L      +V   +  +
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT---KGTKERQYLDEEFVLRVMTQLTLA 121

Query: 178 VAYLH--NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
           +   H  +     V+HRD+KP+N+ L  K+  KL DFGLA   +  +     K   GT  
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPY 179

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 295
           Y++PE       ++K+D+++ G +L EL     P  A       +    A  I       
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA------FSQKELAGKIRE----- 228

Query: 296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
                    +   R S ++  +I      ++ ++  RP +EEI+
Sbjct: 229 -----GKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEIL 264

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 6e-57
 Identities = 67/283 (23%), Positives = 113/283 (39%), Gaps = 31/283 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
                   LG G    V+ G        VA+K L +    S  AF  E  +   L H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRL 70

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L          +++I +Y+  GSL   L            L  +    +A  IAE +A
Sbjct: 71  VRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGI-----KLTINKLLDMAAQIAEGMA 123

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           ++    ER  +HRD++ +NIL+S     K+ DFGLA      +     +  K    + AP
Sbjct: 124 FIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 299
           E   +G  + K+DV++FG++L E++T  +        G  N  +     L RG       
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQN--LERG------- 226

Query: 300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
              R+        ++ ++++    C       RP  + + ++L
Sbjct: 227 --YRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 34/285 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
            +     LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+         L+++ ++ +GG+++  + E ++       L  S    V     +++ Y
Sbjct: 73  KLLDAFYYENN-LWILIEFCAGGAVDAVMLELER------PLTESQIQVVCKQTLDALNY 125

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH   +  ++HRD+K  NIL +     KL DFG++   +         +  GT  ++APE
Sbjct: 126 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPE 180

Query: 241 YFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 295
                         K DV++ G+ L+E+     P            +  ++P        
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------- 232

Query: 296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
                 P L   SR S+     ++    C+      R    +++ 
Sbjct: 233 ------PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 73/282 (25%), Positives = 117/282 (41%), Gaps = 38/282 (13%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHP 117
           +F  GR LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
           NI+ L G+  D  + ++LI +Y   G++ R L +  K                   +A +
Sbjct: 67  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSK-------FDEQRTATYITELANA 118

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           ++Y H    + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT  YL
Sbjct: 119 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYL 171

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
            PE  +     +K D+++ GV+  E L G+ P EA   Q     +   +      +    
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 227

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
                        +     +I      +    S+RP + E++
Sbjct: 228 -------------TEGARDLIS---RLLKHNPSQRPMLREVL 253

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 7e-56
 Identities = 61/297 (20%), Positives = 104/297 (35%), Gaps = 29/297 (9%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 124
              +G+G    V++GK       VA+K     ++ S      E+     L H NI+  + 
Sbjct: 8   QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64

Query: 125 FCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
                      L+L+  Y   GSL  +L+           +      K+AL  A  +A+L
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHL 116

Query: 182 HN-----GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGTF 234
           H        +  + HRD+K  NIL+       + D GLA    +   ++        GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 235 GYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE--ENLVLWAK 286
            Y+APE         H +   + D+YA G+V  E+                  +LV    
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 287 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
            +        E+ L P +    ++   +  + +    C  +  + R     I   L 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 8e-56
 Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 30/280 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNI 119
           ++   + LG GA   V      +   +VA+K +D +   +  +   +E+ I   L+H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V   G   +     +L  +Y SGG L   +            +P     +    +   V 
Sbjct: 66  VKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGVV 117

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+AP
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 240 EYFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           E  +  +      DV++ G+VL  +L G  P +      +E      K            
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------- 223

Query: 299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 338
                L    +  +    ++      +    S R  I +I
Sbjct: 224 ---TYLNPWKKIDSAPLALLH---KILVENPSARITIPDI 257

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-54
 Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 36/281 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 122
              +GRG+   V+KG        VA   L      K   + F  E  +   L HPNIV  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 123 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
                   +G   + L+ + ++ G+L+ +L   K        +   V       I + + 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGLQ 126

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           +LH  T   ++HRD+K  NI ++      K+ D GLAT   A       K V GT  ++A
Sbjct: 127 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMA 181

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE ++  K  +  DVYAFG+ +LE+ T   P         +N     + +          
Sbjct: 182 PEMYE-EKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSG------- 228

Query: 299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
                         ++  +I+    CI   +  R  I++++
Sbjct: 229 --VKPASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDLL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 6e-54
 Identities = 57/279 (20%), Positives = 113/279 (40%), Gaps = 31/279 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
            +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
             +   +  ++ L+++ +Y++GGSL   + E                  V     +++ +
Sbjct: 81  NYLDSYLVGDE-LWVVMEYLAGGSLTDVVTETCM--------DEGQIAAVCRECLQALEF 131

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH      V+HRDIK  NILL      KL DFG     +         T+ GT  ++APE
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPE 186

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
                    K D+++ G++ +E++ G  P                     R +  +    
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------------RALYLIATNG 232

Query: 301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
            P L+   + SA     +     C+  +  +R   +E++
Sbjct: 233 TPELQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELL 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (454), Expect = 7e-54
 Identities = 59/258 (22%), Positives = 98/258 (37%), Gaps = 23/258 (8%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           FS  R +G G+   V+  +       VAIK++        E  +   +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
            +   G  +      +L+ +Y  G + +     KK        L       V  G  + +
Sbjct: 77  TIQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKP-------LQEVEIAAVTHGALQGL 128

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           AYLH      ++HRD+K  NILLS   + KL DFG A+  +         +  GT  ++A
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMA 179

Query: 239 PEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 295
           PE       G+   K DV++ G+  +EL   + P+           +   +    +    
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239

Query: 296 VEELLDPRLKCTSRNSAQ 313
            E   +    C  +    
Sbjct: 240 SEYFRNFVDSCLQKIPQD 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-53
 Identities = 71/308 (23%), Positives = 131/308 (42%), Gaps = 44/308 (14%)

Query: 61  NFSKGRVLGRGALSFVFKGK-VGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSL 114
           N   G+VLG GA   V      G+ +T     VA+K L ++ D    +A   EL + + L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 115 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK----------------GVR 157
             H NIV L+G C      ++LI++Y   G L  +L  K++                   
Sbjct: 98  GSHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 217
             + L +      A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 277
             + S   +    +    ++APE    G  + K+DV+++G++L E+ +           G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----YPG 269

Query: 278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEE 337
                 + K ++  G          ++      + +I  ++Q   +C + +  +RP    
Sbjct: 270 IPVDANFYK-LIQNG---------FKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPN 316

Query: 338 IIAILRGE 345
           + + L  +
Sbjct: 317 LTSFLGCQ 324

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 2e-53
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 39/304 (12%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESS-KAFCRELMIASS 113
           +  S G+ LG GA   V +     L  S     VA+K L      +  +A   EL + S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 114 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST----------- 161
           L +H NIV L+G C        +I +Y   G L   L  K+     + T           
Sbjct: 83  LGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 162 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
           L        +  +A+ +A+L     +  +HRD+   NILL+  +I K+CDFGLA      
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
           S   +    +    ++APE   +   + ++DV+++G+ L EL +               +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-----PV 253

Query: 282 VLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI 341
                 ++  G          R+       A++  +++    C  ++  +RP  ++I+ +
Sbjct: 254 DSKFYKMIKEG---------FRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQL 301

Query: 342 LRGE 345
           +  +
Sbjct: 302 IEKQ 305

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-53
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 34/295 (11%)

Query: 54  EILAATHNFSKGRV-LGRGALSFVFKGKVGLLRTS--VAIKRLDKE-DKESSKAFCRELM 109
           ++     N     + LG G    V +G   + +    VAIK L +  +K  ++   RE  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 110 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 169
           I   L +P IV L+G C    + L L+ +   GG L + L  K++       +P S   +
Sbjct: 62  IMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAE 113

Query: 170 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP-SVPFLCK 228
           +   ++  + YL     +  VHRD+   N+LL ++   K+ DFGL+    A  S      
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170

Query: 229 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 288
             K    + APE     K S ++DV+++GV + E L+  +       +  +   + A   
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAF-- 224

Query: 289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
           + +G          R++C      ++  ++     C   +   RP    +   +R
Sbjct: 225 IEQG---------KRMECPPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMR 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-53
 Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 31/283 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
             +  + +G G    V  G   L +  VAIK + +    S + F  E  +   L HP +V
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L G C++    + L+++++  G L  +L  +                 + L + E +AY
Sbjct: 64  QLYGVCLEQAP-ICLVFEFMEHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAY 116

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           L    E CV+HRD+   N L+   ++ K+ DFG+  +             K    + +PE
Sbjct: 117 LE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPE 172

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
            F   + S K+DV++FGV++ E+ +  K     R   E          +   ++    L 
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGFRLY 222

Query: 301 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
            PRL      S  + +++     C       RP    ++  L 
Sbjct: 223 KPRLA-----STHVYQIMN---HCWKERPEDRPAFSRLLRQLA 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (443), Expect = 2e-52
 Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 46/310 (14%)

Query: 51  SYGEILAATHNFSK---------GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKE-D 97
           ++ +   A   F+K          +V+G G    V  G +   G     VAIK L     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 98  KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 157
           ++  + F  E  I     HPN++ L G        + +I +++  GSL+  L +      
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-VMIITEFMENGSLDSFLRQNDG--- 123

Query: 158 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 217
                       +  GIA  + YL +      VHRD+   NIL++S  + K+ DFGL+ +
Sbjct: 124 ---QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 218 -TSAPSVPFLCKTV--KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 273
                S P     +  K    + APE  Q+ K +  +DV+++G+V+ E+++ G +P    
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237

Query: 274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP 333
             Q   N +                  D RL       + + +++     C   + + RP
Sbjct: 238 TNQDVINAIEQ----------------DYRLPPPMDCPSALHQLML---DCWQKDRNHRP 278

Query: 334 GIEEIIAILR 343
              +I+  L 
Sbjct: 279 KFGQIVNTLD 288

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 34/281 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           +F  G++LG G+ S V   +        AIK L+K     +       RE  + S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
             V L     D E+ L+    Y   G L +++ +             +        I  +
Sbjct: 69  FFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGS-------FDETCTRFYTAEIVSA 120

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  Y+
Sbjct: 121 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           +PE          +D++A G ++ +L+ G  P  A                        +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------------YLIFQ 220

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 338
           +++        +   +   +++     +  + ++R G EE+
Sbjct: 221 KIIKLEYDFPEKFFPKARDLVE---KLLVLDATKRLGCEEM 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 68/283 (24%), Positives = 111/283 (39%), Gaps = 31/283 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
            +      LG+G    V+ G        VAIK L      S +AF +E  +   L H  +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKL 74

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L     +    ++++ +Y+S GSL   L  +                 +A  IA  +A
Sbjct: 75  VQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYL-----RLPQLVDMAAQIASGMA 127

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           Y+        VHRD++ +NIL+    + K+ DFGLA      +     +  K    + AP
Sbjct: 128 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAP 183

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 299
           E   +G+ + K+DV++FG++L EL T  +      +  E              +  VE  
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------------LDQVER- 229

Query: 300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
              R+ C       +  ++     C   E   RP  E + A L
Sbjct: 230 -GYRMPCPPECPESLHDLMC---QCWRKEPEERPTFEYLQAFL 268

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (446), Expect = 2e-52
 Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 34/295 (11%)

Query: 48  IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 107
           + + +  +L    ++     LG GA   V +        + A K +    +   +   +E
Sbjct: 17  VEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE 73

Query: 108 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
           +   S L HP +V L     D  + + +IY+++SGG L   + ++         +     
Sbjct: 74  IQTMSVLRHPTLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNK------MSEDEA 126

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAPSVPF 225
            +    + + + ++H   E   VH D+KP NI+ ++K+    KL DFGL           
Sbjct: 127 VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 181

Query: 226 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA 285
             K   GT  + APE  +   V   TD+++ GV+   LL+G  P                
Sbjct: 182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------- 231

Query: 286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
              L    +    + D      S +     R        + ++ + R  I + + 
Sbjct: 232 -ETLRNVKSCDWNMDDSAFSGISEDGKDFIR------KLLLADPNTRMTIHQALE 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-52
 Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 33/284 (11%)

Query: 65  GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV 120
             V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+G C+  E    ++  Y+  G L   +  +      N T+   + + + +        
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKG----- 142

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT--VKGTFGYLA 238
           +     +  VHRD+   N +L  K   K+ DFGLA          +      K    ++A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
            E  Q  K + K+DV++FGV+L EL+T   P        + N       +L         
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQ-------- 249

Query: 299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
               RL         +  V+     C   +   RP   E+++ +
Sbjct: 250 --GRRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-52
 Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 37/286 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRELMIASSLHHPN 118
           + +  + LG G    V  GK    R    VAIK + +    S   F  E  +  +L H  
Sbjct: 5   DLTFLKELGTGQFGVVKYGK---WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEK 60

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           +V L G C      +F+I +Y++ G L  +L E +               ++   + E++
Sbjct: 61  LVQLYGVCTKQRP-IFIITEYMANGCLLNYLREMRH------RFQTQQLLEMCKDVCEAM 113

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            YL +   +  +HRD+   N L++ + + K+ DFGL+ +             K    +  
Sbjct: 114 EYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSP 169

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           PE   + K S K+D++AFGV++ E+ + G+ P E          +               
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 218

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
                RL      S ++  ++    +C   +   RP  + +++ + 
Sbjct: 219 -----RLYRPHLASEKVYTIMY---SCWHEKADERPTFKILLSNIL 256

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-51
 Identities = 63/285 (22%), Positives = 111/285 (38%), Gaps = 39/285 (13%)

Query: 66  RVLGRGALSFVFKGKVGLLRTS--VAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVP 121
           + LG G    V KG   + +    VA+K L  E  D         E  +   L +P IV 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
           ++G C        L+ +    G L ++L + +        +      ++   ++  + YL
Sbjct: 73  MIGICEAES--WMLVMEMAELGPLNKYLQQNRH-------VKDKNIIELVHQVSMGMKYL 123

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 240
                   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 241 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 300
              + K S K+DV++FGV++ E  +  +                  P      + V  +L
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQK-----------------PYRGMKGSEVTAML 223

Query: 301 --DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
               R+ C +    ++  ++     C + +   RPG   +   LR
Sbjct: 224 EKGERMGCPAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLR 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (434), Expect = 3e-51
 Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 29/284 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 119
            + +    LG G    V++G       +VA+K L + D    + F +E  +   + HPN+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75

Query: 120 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 179
           V L+G C       ++I ++++ G+L  +L E  +       +   V   +A  I+ ++ 
Sbjct: 76  VQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAME 129

Query: 180 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 239
           YL    ++  +HRD+   N L+    + K+ DFGL+   +  +        K    + AP
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAP 185

Query: 240 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 299
           E   + K S K+DV+AFGV+L E+ T                     P     ++ V EL
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYEL 228

Query: 300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
           L+   +   R      +V +   AC     S RP   EI     
Sbjct: 229 LEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 3e-50
 Identities = 68/320 (21%), Positives = 123/320 (38%), Gaps = 43/320 (13%)

Query: 60  HNFSKGRVLGRGALSFVFKG--KVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-H 115
           ++     V+G G    V K   K   LR   AIKR+ +   K+  + F  EL +   L H
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK---------KKGVRGNSTLPWSV 166
           HPNI+ L+G C      L+L  +Y   G+L   L +                 STL    
Sbjct: 70  HPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 167 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 226
               A  +A  + YL    ++  +HRD+   NIL+    + K+ DFGL+           
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--- 182

Query: 227 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 286
               +    ++A E   +   +  +DV+++GV+L E+++                    +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYE 237

Query: 287 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA----IL 342
            +              RL+       ++  +++    C   +   RP   +I+     +L
Sbjct: 238 KLPQ----------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRML 284

Query: 343 RGEEELIYCT-WKKHNFSGI 361
              +  +  T ++K  ++GI
Sbjct: 285 EERKTYVNTTLYEKFTYAGI 304

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-50
 Identities = 71/291 (24%), Positives = 117/291 (40%), Gaps = 34/291 (11%)

Query: 60  HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSL 114
              ++ +V+G G    V+KG +    G     VAIK L     E  +  F  E  I    
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            H NI+ L G     +  + +I +Y+  G+L++ L EK                 +  GI
Sbjct: 67  SHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGI 119

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGT 233
           A  + YL N      VHRD+   NIL++S  + K+ DFGL+      P   +     K  
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM 293
             + APE   + K +  +DV++FG+V+ E++T  +                  P      
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-----------------PYWELSN 219

Query: 294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG 344
             V + ++   +         + + Q    C   E +RRP   +I++IL  
Sbjct: 220 HEVMKAINDGFR-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (426), Expect = 6e-50
 Identities = 69/308 (22%), Positives = 118/308 (38%), Gaps = 47/308 (15%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASS 113
           +N    R +G GA   VF+ +   L      T VA+K L +E   +    F RE  + + 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----------------GV 156
             +PNIV L+G C   +  + L+++Y++ G L   L                        
Sbjct: 73  FDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 157 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 216
            G   L  + +  +A  +A  +AYL    ER  VHRD+   N L+    + K+ DFGL+ 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188

Query: 217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 276
              +               ++ PE   + + + ++DV+A+GVVL E+ +           
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248

Query: 277 GEENLVLWAKPILHRGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGI 335
                              +  + D   L C      ++  +++    C S   + RP  
Sbjct: 249 ----------------EEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSF 289

Query: 336 EEIIAILR 343
             I  IL+
Sbjct: 290 CSIHRILQ 297

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  169 bits (430), Expect = 7e-50
 Identities = 63/282 (22%), Positives = 104/282 (36%), Gaps = 31/282 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
            +     LG GA   V +            K ++            E+ I + LHHP ++
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L     D  + + LI +++SGG L   +  +         +  +          E + +
Sbjct: 90  NLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYK------MSEAEVINYMRQACEGLKH 142

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           +H   E  +VH DIKP NI+  +KK    K+ DFGLAT  +      + K    T  + A
Sbjct: 143 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAA 196

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE      V   TD++A GV+   LL+G  P       GE++L                 
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETLQN--------VKRC 243

Query: 299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
             +      S  S +    I+     +  E  +R  + + + 
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 4e-49
 Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 38/288 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH 116
           F K +VLG GA   V+KG        ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P++  L+G C+     + LI + +  G L  ++ E K  +               + IA+
Sbjct: 71  PHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNI------GSQYLLNWCVQIAK 122

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 296
           +A E   H   + ++DV+++GV + EL+T                     P      + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK-----------------PYDGIPASEI 222

Query: 297 EELLD--PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 342
             +L+   RL      +  +  ++     C   +   RP   E+I   
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMV---KCWMIDADSRPKFRELIIEF 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 4e-48
 Identities = 65/290 (22%), Positives = 108/290 (37%), Gaps = 35/290 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSL 114
           +      LG G+   V +G+         SVA+K L  +     E+   F RE+    SL
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
            H N++ L G  + P   + ++ +    GSL   L + +               + A+ +
Sbjct: 69  DHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRYAVQV 120

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGT 233
           AE + YL     +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM 293
           F + APE  +    S  +D + FGV L E+ T  +           N       I   G 
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDKEG- 231

Query: 294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
                    RL         I  V+     C + +   RP    +   L 
Sbjct: 232 --------ERLPRPEDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (406), Expect = 3e-47
 Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 38/295 (12%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 118
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 119 IVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           IV +              +++ +YV G +L   +H +         +      +V     
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADAC 121

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF-LCKTVKGTF 234
           +++ + H   +  ++HRD+KP+NI++S+    K+ DFG+A   +           V GT 
Sbjct: 122 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 235 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 294
            YL+PE  +   V  ++DVY+ G VL E+LTG  P             +   PI      
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI------ 232

Query: 295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIAILRG 344
                  P        SA +  V+      ++     R         +++ +  G
Sbjct: 233 -------PPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVHNG 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-47
 Identities = 69/300 (23%), Positives = 117/300 (39%), Gaps = 36/300 (12%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESS-KAFCREL-MIAS 112
                G+ LGRGA   V +     +  +     VA+K L +    S  +A   EL ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 113 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLP 163
             HH N+V L+G C  P   L +I ++   G+L  +L  K+                 L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 164 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 223
                  +  +A+ + +L     R  +HRD+   NILLS K + K+CDFGLA        
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 224 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 283
                  +    ++APE       + ++DV++FGV+L E+ +               +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDE 244

Query: 284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
                L  G          R++     + ++ + +     C   E S+RP   E++  L 
Sbjct: 245 EFCRRLKEG---------TRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-47
 Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 19/257 (7%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHH 116
           +F   ++LG+G+   VF  +        AIK L K+    D +       + +++ +  H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 117 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 176
           P +  +       E  LF + +Y++GG L  H+    K          S     A  I  
Sbjct: 63  PFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHK-------FDLSRATFYAAEIIL 114

Query: 177 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 236
            + +LH    + +V+RD+K  NILL      K+ DFG+              T  GT  Y
Sbjct: 115 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDY 169

Query: 237 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 296
           +APE     K +   D ++FGV+L E+L G+ P   +  +   + +    P   R +   
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE-- 227

Query: 297 EELLDPRLKCTSRNSAQ 313
           +E  D  +K   R   +
Sbjct: 228 KEAKDLLVKLFVREPEK 244

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-46
 Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 36/289 (12%)

Query: 60  HNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLH 115
                GR +G G    V +G          +VAIK       +S +  F +E +      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HP+IV L+G   +    +++I +  + G L   L  +K       +L  +     A  ++
Sbjct: 67  HPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKY------SLDLASLILYAYQLS 118

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 235
            ++AYL     +  VHRDI   N+L+SS    KL DFGL+ +    S  +     K    
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIK 174

Query: 236 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA 294
           ++APE     + +  +DV+ FGV + E+L  G KP +  +       +   +        
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 226

Query: 295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
                   RL         +  ++     C + + SRRP   E+ A L 
Sbjct: 227 --------RLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-46
 Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 31/297 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASS 113
              +  R LG+G+   V++G    +      T VAIK +++      +  F  E  +   
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST---LPWSVRYKV 170
            +  ++V L+G     +    +I + ++ G L+ +L   +  +  N        S   ++
Sbjct: 80  FNCHHVVRLLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
           A  IA+ +AYL+       VHRD+   N +++     K+ DFG+                
Sbjct: 139 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 290
                +++PE  + G  +  +DV++FGVVL E+ T  +       QG  N  +    ++ 
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY----QGLSNEQVLRF-VME 250

Query: 291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE 347
                        L         +  +++    C       RP   EII+ ++ E E
Sbjct: 251 ----------GGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME 294

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  157 bits (399), Expect = 9e-46
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 21/256 (8%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           +F   R LG G+   V   +        A+K L KE     +  +    E ++ S + HP
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            I+ + G   D +Q +F+I  Y+ GG L   L + ++        P  V    A  +  +
Sbjct: 65  FIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRF-------PNPVAKFYAAEVCLA 116

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    + +++RD+KP NILL      K+ DFG A +     VP +  T+ GT  Y+
Sbjct: 117 LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGTPDYI 168

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           APE       +   D ++FG+++ E+L G  P            +L A+          E
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN--E 226

Query: 298 ELLDPRLKCTSRNSAQ 313
           ++ D   +  +R+ +Q
Sbjct: 227 DVKDLLSRLITRDLSQ 242

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (397), Expect = 1e-45
 Identities = 72/283 (25%), Positives = 109/283 (38%), Gaps = 34/283 (12%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 120
           +    VLG GA S V   +    +  VAIK + K+  E  +     E+ +   + HPNIV
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L          L+LI + VSGG L   + EK                ++   + ++V Y
Sbjct: 71  ALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGF-------YTERDASRLIFQVLDAVKY 122

Query: 181 LHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           LH   +  +VHRD+KP N+L  S        + DFGL+      SV     T  GT GY+
Sbjct: 123 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYV 176

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           APE       S   D ++ GV+   LL G  P                  +  + + A  
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----------KLFEQILKAEY 226

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
           E   P     S ++    R        +  +  +R   E+ + 
Sbjct: 227 EFDSPYWDDISDSAKDFIR------HLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (399), Expect = 3e-45
 Identities = 70/305 (22%), Positives = 118/305 (38%), Gaps = 49/305 (16%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSL 114
           +FS  R++GRG    V+  +        A+K LDK      + +  +      L + S+ 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
             P IV +      P++ L  I   ++GG L  HL +             +     A  I
Sbjct: 65  DCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAAEI 116

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
              + ++H    R VV+RD+KP+NILL      ++ D GLA   S            GT 
Sbjct: 117 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTH 169

Query: 235 GYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM 293
           GY+APE  Q G   D   D ++ G +L +LL G  P    + + +  +            
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-------- 221

Query: 294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTW 353
                 L   ++     S ++  +++     +  + +RR G     A     +E+     
Sbjct: 222 ------LTMAVELPDSFSPELRSLLE---GLLQRDVNRRLGCLGRGA-----QEV----- 262

Query: 354 KKHNF 358
           K+  F
Sbjct: 263 KESPF 267

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 3e-45
 Identities = 53/280 (18%), Positives = 100/280 (35%), Gaps = 32/280 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
            +     LGRG    V +      + +   K +  +  +      +E+ I +   H NI+
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNIL 64

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L       E+ L +I++++SG  +   ++           L           + E++ +
Sbjct: 65  HLHESFESMEE-LVMIFEFISGLDIFERINTSAF------ELNEREIVSYVHQVCEALQF 117

Query: 181 LHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           LH      + H DI+P NI+  +++    K+ +FG A            + +     Y A
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA 171

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 298
           PE  QH  VS  TD+++ G ++  LL+G  P  A   Q     ++ A+            
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY----------- 220

Query: 299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 338
                 +     S +    +      +  E   R    E 
Sbjct: 221 --TFDEEAFKEISIEAMDFVD---RLLVKERKSRMTASEA 255

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (391), Expect = 4e-45
 Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 46/296 (15%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---------EDKESSKAFCRELMIA 111
           N+    +LGRG  S V +          A+K +D          E +E  +A  +E+ I 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 112 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 170
             +  HPNI+ L           FL++  +  G L  +L EK         L      K+
Sbjct: 64  RKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVT-------LSEKETRKI 115

Query: 171 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 230
              + E +  LH   +  +VHRD+KP NILL      KL DFG +            + V
Sbjct: 116 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREV 169

Query: 231 KGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW 284
            GT  YLAPE  +      H     + D+++ GV++  LL G  P   R+      +++ 
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229

Query: 285 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
                        +   P     S     +          +  +  +R   EE +A
Sbjct: 230 GNY----------QFGSPEWDDYSDTVKDLVS------RFLVVQPQKRYTAEEALA 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 6e-44
 Identities = 63/303 (20%), Positives = 117/303 (38%), Gaps = 44/303 (14%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKE-DKESSKAFCRELMIA 111
                G+ LG GA   V   +   L        T VA+K L  +  ++       E+ + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 112 SSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNST 161
             +  H NI+ L+G C      L++I +Y S G+L  +L  ++                 
Sbjct: 73  KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 162 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 221
           L        A  +A  + YL     +  +HRD+   N+L++   + K+ DFGLA      
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 222 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 281
                    +    ++APE       + ++DV++FGV+L E+ T                
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------ 236

Query: 282 VLWAKPILHRGMAAVEELL--DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
                P     +  + +LL    R+   S  + ++  +++    C  +  S+RP  ++++
Sbjct: 237 -----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLV 288

Query: 340 AIL 342
             L
Sbjct: 289 EDL 291

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 66/282 (23%), Positives = 112/282 (39%), Gaps = 35/282 (12%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 123
            +VLG G    V +      +   A+K L    K       RE+ +   +   P+IV +V
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 124 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
               +   G   L ++ + + GG L   + +     RG+         ++   I E++ Y
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQY 126

Query: 181 LHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           LH      + HRD+KP N+L +S     I KL DFG A  T++ +      T   T  Y+
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYV 180

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           APE     K     D+++ GV++  LL G  P  +       + +  +  +  R      
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS------NHGLAISPGMKTRIRMGQY 234

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 339
           E  +P     S     + R        + +E ++R  I E +
Sbjct: 235 EFPNPEWSEVSEEVKMLIR------NLLKTEPTQRMTITEFM 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 7e-42
 Identities = 70/289 (24%), Positives = 111/289 (38%), Gaps = 40/289 (13%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS------KAFCRELMIASSLH 115
           +  G  LG G  + V K +        A K + K   +SS      +   RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 116 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
           HPN++ L     +    + LI + V+GG L   L EK+        L      +    I 
Sbjct: 72  HPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKES-------LTEEEATEFLKQIL 123

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 231
             V YLH      + H D+KP NI+L  + +P    K+ DFGLA      +     K + 
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIF 177

Query: 232 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR 291
           GT  ++APE   +  +  + D+++ GV+   LL+G  P      Q            L  
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------ETLAN 227

Query: 292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
             A   E  D     TS  +    R        +  +  +R  I++ + 
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIR------RLLVKDPKKRMTIQDSLQ 270

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 7e-42
 Identities = 62/303 (20%), Positives = 109/303 (35%), Gaps = 35/303 (11%)

Query: 58  ATHNFSKGRVLGRGALSFVFKGK-VGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL 114
           A   +     +G GA   VFK + +      VA+KR+  +  ++    +  RE+ +   L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 115 ---HHPNIVPLVGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 167
               HPN+V L   C          L L++++V            + G      +P    
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG------VPTETI 118

Query: 168 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 227
             +   +   + +LH      VVHRD+KP NIL++S    KL DFGLA   S        
Sbjct: 119 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---L 172

Query: 228 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR----------RLQG 277
            +V  T  Y APE       +   D+++ G +  E+   +                 + G
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232

Query: 278 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEE 337
                 W + +     A   +   P  K  +        ++     C++   ++R     
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYS 289

Query: 338 IIA 340
            ++
Sbjct: 290 ALS 292

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 7e-42
 Identities = 50/290 (17%), Positives = 92/290 (31%), Gaps = 32/290 (11%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +  GR +G G+   ++ G        VAIK    + K        E  I   +     +P
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 181
            + +C        ++ + +     +      +K               +A  +   + Y+
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-------FSLKTVLLLADQMISRIEYI 119

Query: 182 HNGTERCVVHRDIKPSNILLSSKKIPKLC---DFGLATW-----TSAPSVPFLCKTVKGT 233
           H    +  +HRD+KP N L+   K   L    DFGLA       T         K + GT
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM 293
             Y +       + S + D+ + G VL+    G  P +  +   +               
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----- 231

Query: 294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
               ++  P         ++ A  +     C S     +P    +  + R
Sbjct: 232 ----KMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 8e-42
 Identities = 72/296 (24%), Positives = 108/296 (36%), Gaps = 30/296 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           +++  +V+G G+   V++ K+      VAIK++ ++ +       REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76

Query: 121 PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 175
            L  F     +      L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQLF 132

Query: 176 ESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
            S+AY+H      + HRDIKP N+LL     + KLCDFG A             +   + 
Sbjct: 133 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSR 186

Query: 235 GYLAP-EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----KPI 288
            Y AP   F     +   DV++ G VL ELL G+          +   ++       +  
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISS----EESRRPGIEEIIA 340
           +        E   P++K          R    A A  S       + R    E  A
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 9e-42
 Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 17/223 (7%)

Query: 53  GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 111
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 1   GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60

Query: 112 SSLHHPNIVPLVGFCIDP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 168
               H NI+ +      P   +     +  ++ G  L + L  +         L      
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--------LSNDHIC 112

Query: 169 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLC 227
                I   + Y+H      V+HRD+KPSN+LL++    K+CDFGLA             
Sbjct: 113 YFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169

Query: 228 KTVKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 269
                T  Y APE   + K      D+++ G +L E+L+ R  
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-40
 Identities = 57/289 (19%), Positives = 107/289 (37%), Gaps = 50/289 (17%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLH 115
           +  G +LG G    V+ G        VAIK ++K+      +  +      E+++   + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 116 --HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
                ++ L+ +   P+    LI +             ++        L   +       
Sbjct: 66  SGFSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGA------LQEELARSFFWQ 118

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
           + E+V + H      V+HRDIK  NIL+  ++   KL DFG                  G
Sbjct: 119 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDG 171

Query: 233 TFGYLAPEYFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR 291
           T  Y  PE+ ++ +   +   V++ G++L +++ G  P E                    
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------------------ 213

Query: 292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
                EE++  ++    R S++   +I+    C++   S RP  EEI  
Sbjct: 214 -----EEIIRGQVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (358), Expect = 4e-40
 Identities = 48/293 (16%), Positives = 91/293 (31%), Gaps = 34/293 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 120
           ++  GR +G G+   +F+G   L    VAIK   +           E      L     +
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGI 63

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
           P V +         L+   +     +      +K                A  +   V  
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-------FSVKTVAMAAKQMLARVQS 116

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIP-----KLCDFGLATW-----TSAPSVPFLCKTV 230
           +H   E+ +V+RDIKP N L+            + DFG+  +     T         K +
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 231 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 290
            GT  Y++       + S + D+ A G V +  L G  P +  +           + I  
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK---AATNKQKYERIGE 230

Query: 291 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 343
           +  +       P  +  +    +  + +       +      P  + +  +  
Sbjct: 231 KKQS------TPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-39
 Identities = 61/292 (20%), Positives = 117/292 (40%), Gaps = 24/292 (8%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L+       + L+L+++++     +        G      +P  +       + + +
Sbjct: 63  IVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG------IPLPLIKSYLFQLLQGL 115

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           A+ H      V+HRD+KP N+L++++   KL DFGLA     P           T  Y A
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRA 170

Query: 239 PE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----PILHRGM 293
           PE        S   D+++ G +  E++T R          +   +         ++  G+
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230

Query: 294 AAVEELLDPRLKCTSRNSAQIARVIQAAA-----ACISSEESRRPGIEEIIA 340
            ++ +      K   ++ +++   +           +  + ++R   +  +A
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 59/292 (20%), Positives = 96/292 (32%), Gaps = 33/292 (11%)

Query: 66  RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-----AFCRELMIASSLHHPNIV 120
             LG G  + V+K +       VAIK++    +  +K        RE+ +   L HPNI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 121 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 180
            L+         + L++ ++                     L  S      L   + + Y
Sbjct: 64  GLLDAFGHKSN-ISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYMLMTLQGLEY 115

Query: 181 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 240
           LH   +  ++HRD+KP+N+LL    + KL DFGLA    +P           T  Y APE
Sbjct: 116 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPE 170

Query: 241 YFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEAR----------RLQGEENLVLWAKPIL 289
                ++     D++A G +L ELL     +                G      W     
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 290 HRGMAAVEELLDPRLKCTSRN-SAQIARVIQAAAACISSEESRRPGIEEIIA 340
                  +      L          +  +IQ            R    + + 
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (349), Expect = 3e-38
 Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 34/281 (12%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 117
            F + + LG G+   V   K        A+K LDK+     +  +    E  I  +++ P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +V L     D    L+++ +YV+GG +  HL    +                A  I  +
Sbjct: 102 FLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGR-------FSEPHARFYAAQIVLT 153

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
             YLH      +++RD+KP N+L+  +   ++ DFG A             T+ GT   L
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEAL 205

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           APE       +   D +A GV++ E+  G  P  A +       ++  K       +   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS--S 263

Query: 298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 338
           +L D        +  +  R             + + G+ +I
Sbjct: 264 DLKDLLRNLLQVDLTK--RF-----------GNLKNGVNDI 291

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-38
 Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 18/256 (7%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 117
           +F   ++LG+G    V   +        A+K L KE    K+       E  +  +  HP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 118 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 177
            +  L       ++ L  + +Y +GG L  HL  ++                    I  +
Sbjct: 66  FLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117

Query: 178 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
           + YLH    R VV+RDIK  N++L      K+ DFGL     +           GT  YL
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172

Query: 238 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 297
           APE  +        D +  GVV+ E++ GR P   +  +    L+L  +    R ++   
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS--P 230

Query: 298 ELLDPRLKCTSRNSAQ 313
           E          ++  Q
Sbjct: 231 EAKSLLAGLLKKDPKQ 246

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-38
 Identities = 56/304 (18%), Positives = 108/304 (35%), Gaps = 34/304 (11%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
            + K   +G+G    VFK +       VA+K++  E   +       RE+ I   L H N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 119 IVPLVGFCIDP-------EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 171
           +V L+  C          +  ++L++ +          +   K          S   +V 
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-------FTLSEIKRVM 123

Query: 172 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKT 229
             +      L+      ++HRD+K +N+L++   + KL DFGLA   S    S P     
Sbjct: 124 QMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 230 VKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEAR----------RLQGE 278
              T  Y  PE     +      D++  G ++ E+ T    ++            +L G 
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 279 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIA--RVIQAAAACISSEESRRPGIE 336
               +W     +     +E +   + K   R  A +     +      +  + ++R   +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 337 EIIA 340
           + + 
Sbjct: 301 DALN 304

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 56/294 (19%), Positives = 104/294 (35%), Gaps = 30/294 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 118
            +     +G G    V+K +     T  A+K  RL+KED+       RE+ I   L H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L       ++ L L+++++     +     +         L         L +   +
Sbjct: 62  IVKLYDVIHTKKR-LVLVFEHLDQDLKKLLDVCEGG-------LESVTAKSFLLQLLNGI 113

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
           AY H   +R V+HRD+KP N+L++ +   K+ DFGLA     P   +    +   +    
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAP 169

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR----------RLQGEENLVLWAKPI 288
                  K S   D+++ G +  E++ G                 R+ G  N   W    
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 289 LHRGMAAVEELLDPRL--KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 340
                     + +P                ++      +  + ++R   ++ + 
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 56/292 (19%), Positives = 100/292 (34%), Gaps = 24/292 (8%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
            + K   +G G    VFK K       VA+KR+  +  D+    +  RE+ +   L H N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 119 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           IV L       ++   +                KK     N  L   +       + + +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC--------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 238
            + H+   R V+HRD+KP N+L++     KL +FGLA     P   +    V   +    
Sbjct: 115 GFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPP 170

Query: 239 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR-----LQGEENLVLWAKPILHRGM 293
              F     S   D+++ G +  EL    +P+         L+    L+          M
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 294 AAVEELLDPRLKCTSRNSAQIARVIQAAA-----ACISSEESRRPGIEEIIA 340
             + +     +   + +   +   + A         +     +R   EE + 
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 3e-34
 Identities = 46/214 (21%), Positives = 87/214 (40%), Gaps = 23/214 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNI 119
           ++   R LGRG  S VF+         V +K L    K+      RE+ I  +L   PNI
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGPNI 92

Query: 120 VPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 178
           + L     DP  +   L++++V+    ++             TL           I +++
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKAL 142

Query: 179 AYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 237
            Y H      ++HRD+KP N+++  + +  +L D+GLA +               +  + 
Sbjct: 143 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFK 196

Query: 238 APEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPI 270
            PE    +       D+++ G +L  ++  ++P 
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 43/217 (19%), Positives = 87/217 (40%), Gaps = 23/217 (10%)

Query: 60  HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 117
             +   + +G GA   V     G     VAIK+L +    +  +K   REL +   + H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 118 NIVPLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 172
           N++ L+      E        +L+  ++  G+    L + +K       L       +  
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-------LGEDRIQFLVY 128

Query: 173 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 232
            + + + Y+H      ++HRD+KP N+ ++     K+ DFGLA    +     +   V  
Sbjct: 129 QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVT 181

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
            +           + +   D+++ G ++ E++TG+  
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-32
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 20/218 (9%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTS---VAIKRLDK----EDKESSKAFCRELMIASS 113
           NF   +VLG GA   VF  +      +    A+K L K    +  ++++    E  +   
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 114 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           +     +  + +    E  L LI  Y++GG L  HL ++++                   
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVGE 137

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           I  ++ +LH   +  +++RDIK  NILL S     L DFGL+    A           GT
Sbjct: 138 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGT 193

Query: 234 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 269
             Y+AP+  + G        D ++ GV++ ELLTG  P
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-32
 Identities = 50/216 (23%), Positives = 83/216 (38%), Gaps = 23/216 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
            +     +G GA   V           VA+K+L +       +K   REL +   + H N
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 119 IVPLVGFCIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
           ++ L+          E     +  ++ G  L   +  +K        L       +   I
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--------LTDDHVQFLIYQI 130

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 234
              + Y+H      ++HRD+KPSN+ ++     K+ DFGLA  T              T 
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATR 182

Query: 235 GYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 269
            Y APE   +    +   D+++ G ++ ELLTGR  
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 5e-32
 Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 23/216 (10%)

Query: 61  NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 118
            +   + +G GA   V      +L  +VAIK+L +   ++  +K   REL++   ++H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 119 IVPLVGFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 173
           I+ L+      +     Q ++L+ + +     +    E                  +   
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----------DHERMSYLLYQ 127

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 233
           +   + +LH      ++HRD+KPSNI++ S    K+ DFGLA         F+      T
Sbjct: 128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVT 181

Query: 234 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 269
             Y APE        +  D+++ G ++ E++  +  
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (290), Expect = 7e-30
 Identities = 42/238 (17%), Positives = 82/238 (34%), Gaps = 12/238 (5%)

Query: 62  FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 121
           +   R LG G  S V+  K  +  T VA+K +   DK  ++A   E+ +   ++  +   
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 122 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--------RGNSTLPWSVRYKVALG 173
                 +    L   + +     +   +  +  G           +  +P     +++  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 174 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLCKTVKG 232
           +   + Y+H      ++H DIKP N+L+     P  L    +A   +A            
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 233 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 290
           T  Y +PE           D+++   ++ EL+TG    E                I+ 
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.5 bits (177), Expect = 1e-15
 Identities = 26/168 (15%), Positives = 48/168 (28%), Gaps = 26/168 (15%)

Query: 65  GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA----------FCRELMIASSL 114
           G+++G G  S VF            +K          K           F    + ++  
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 115 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 174
               +  L G  +                     +  +    +    +      +V   I
Sbjct: 64  EFRALQKLQGLAVPKVYAWE-----------GNAVLMELIDAKELYRVRVENPDEVLDMI 112

Query: 175 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 222
            E VA  +    R +VH D+   N+L+S + I  + DF  +       
Sbjct: 113 LEEVAKFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	398
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.54
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.92
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.88
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.82
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-57  Score=413.99  Aligned_cols=259  Identities=29%  Similarity=0.457  Sum_probs=201.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      .++|...+.||+|+||+||+|+++   ..||||++...  .....+.|.+|+.++++++|||||++++++.+  +.+++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEE
Confidence            468999999999999999999865   35999998654  34566789999999999999999999998754  347999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||++|+|.+++....      ..++|..+..|+.|+++||+|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus        82 ~Ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             EECCCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             EecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence            99999999999997643      46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhcc---CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ...............||+.|+|||++.+   +.++.++|||||||++|||+||+.||........  +.    ....   
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~----~~~~---  223 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----FMVG---  223 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHH---
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HH----HHHh---
Confidence            7765443333456789999999999864   3578999999999999999999999976433211  10    0111   


Q ss_pred             hhhhhhcCcccC-CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          294 AAVEELLDPRLK-CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       294 ~~~~~~~d~~l~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                         .....+.+. .+...+   ..+.+++.+||+.+|.+|||+.||++.|+.+.
T Consensus       224 ---~~~~~p~~~~~~~~~~---~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         224 ---RGYLSPDLSKVRSNCP---KAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             ---HTSCCCCGGGSCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---cCCCCCcchhccccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               111222221 111122   34667778999999999999999999998643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=411.03  Aligned_cols=250  Identities=22%  Similarity=0.371  Sum_probs=206.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.++++++|||||++++++.+.+ .+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-EEEEEEEe
Confidence            47999999999999999999999899999999997665555678999999999999999999999987754 58999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      |++|+|.+++..        ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        99 ~~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          99 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             CTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            999999998765        35999999999999999999999988   9999999999999999999999999999775


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+....      ......        .
T Consensus       168 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~--------~  231 (293)
T d1yhwa1         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIAT--------N  231 (293)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH--------H
T ss_pred             cccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHh--------C
Confidence            4432  23456799999999999999999999999999999999999999976443211      001110        1


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      -.+.+..+...   ...+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~---s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         232 GTPELQNPEKL---SAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CSCCCSSGGGS---CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCcccC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11112111111   234667778999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-56  Score=416.10  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=193.7

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCc---EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      +|...++||+|+||+||+|.+..+++   .||||.+... .....+.|.+|+++|++++|||||+++|+|.+.+ .+++|
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~iv  105 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-PVMII  105 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SCEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EEEEE
Confidence            45556899999999999999875554   5899988654 4455678999999999999999999999987654 48999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||++|+|.+++....      ..++|..++.++.|+++||+|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       106 ~Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             EECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEecCCCcceeeecccc------CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence            99999999999987643      46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCcee---eeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhc
Q 015931          217 WTSAPSVPFL---CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       217 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      ..........   .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.......   +..         
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~---------  244 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VIN---------  244 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---------
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHH---------
Confidence            7654322111   123457899999999999999999999999999999998 899997654321   111         


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                        .+..  +.++..+...+   ..+.+++.+||+.+|.+|||+.||++.|+.+
T Consensus       245 --~i~~--~~~~~~~~~~~---~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         245 --AIEQ--DYRLPPPMDCP---SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             --HHHT--TCCCCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --HHHc--CCCCCCCccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              0111  11122122222   4466777899999999999999999999754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-57  Score=412.80  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=202.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      ++|+..+.||+|+||+||+|.+..+++.||||++..... +..+.+.+|++++++++|||||++++++.+. +.+|+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEEe
Confidence            578889999999999999999998999999999976532 3446789999999999999999999998775 45899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      ||++|+|.+++...       ..+++..++.++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus        84 y~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          84 YCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             CCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheee
Confidence            99999999998653       46999999999999999999999988   999999999999999999999999999977


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ............+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.......... ..              
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~--------------  218 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD--------------  218 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HH--------------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HH--------------
Confidence            55443333456789999999999988776 678999999999999999999997654322110 00              


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       ....... ..........+.+++.+||+.||++|||+.|+++
T Consensus       219 -~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         219 -WKEKKTY-LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -HHTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -HhcCCCC-CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0000000 0000111234567788999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-56  Score=404.86  Aligned_cols=246  Identities=28%  Similarity=0.467  Sum_probs=205.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||+||+|.++.+++.||+|++.+..   ......+.+|+.++++++|||||++++++.+. +.+|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-CEEEEE
Confidence            46888999999999999999999999999999986432   23456788999999999999999999998764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||++|+|.+++...       ..+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        85 mEy~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EeecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceee
Confidence            9999999999999875       45999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....                 +
T Consensus       155 ~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----------------~  213 (263)
T d2j4za1         155 HAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----------------Y  213 (263)
T ss_dssp             CCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             ecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-----------------H
Confidence            765432    2456799999999999998999999999999999999999999976543211                 1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.......+...++   .+.+++.+||+.||.+|||+.|+++
T Consensus       214 ~~i~~~~~~~p~~~s~---~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         214 KRISRVEFTFPDFVTE---GARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHHTTCCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCCCCccCCH---HHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1111222222222333   4566778999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-56  Score=414.80  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=210.4

Q ss_pred             hhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ..++|...+.||+|+||+||+|.+..+++.||||++..... ..++|.+|+.++++++|||||+++++|.+.+ ..++||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~iv~   92 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIIT   92 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCC-eeEEEe
Confidence            34678888999999999999999988899999999976543 4567999999999999999999999987754 479999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |||++|+|.+++.....     ..++|..++.|+.|+++||+|||+++   |+||||||+||||++++.+||+|||+|+.
T Consensus        93 E~~~~g~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          93 EFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             ECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             ecccCcchHHHhhhccc-----cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence            99999999999976532     57999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.......  .+.    .       .+.
T Consensus       165 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~----~-------~i~  230 (287)
T d1opja_         165 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----E-------LLE  230 (287)
T ss_dssp             CCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----H-------HHH
T ss_pred             cCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHH----H-------HHh
Confidence            655432 22344568999999999999999999999999999999999777765332211  110    0       111


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .-.  +...+...+   ..+.+++.+||+.||.+|||+.||++.|+.+
T Consensus       231 ~~~--~~~~~~~~~---~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         231 KDY--RMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             TTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             cCC--CCCCCccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111  111122223   3466778899999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=408.63  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=195.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-CCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV  136 (398)
                      ++|+..+.||+|+||+||+|.+..+|+.||+|.+...  .....+.+.+|++++++++|||||++++++.+. ++.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5788999999999999999999999999999999765  344556789999999999999999999998754 4458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceeecccccCcEEeCCCCCeeEecccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      ||||++|+|.+++.....   ....+++..++.++.|++.||+|||+.+  ..+|+||||||+||||+.++.+||+|||+
T Consensus        84 mEy~~~g~L~~~i~~~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          84 MEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EECCTTEEHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EecCCCCcHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999975421   1257999999999999999999999854  23499999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      |+.......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+   +.   ..       
T Consensus       161 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~---~~-------  225 (269)
T d2java1         161 ARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA---GK-------  225 (269)
T ss_dssp             HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HH-------
T ss_pred             eeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH---HH-------
Confidence            998764332  2345789999999999999999999999999999999999999997643321   11   00       


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       +.....+.+  +...++   .+.+++.+||+.||.+|||+.|+++
T Consensus       226 -i~~~~~~~~--~~~~s~---~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         226 -IREGKFRRI--PYRYSD---ELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -HHHTCCCCC--CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHcCCCCCC--CcccCH---HHHHHHHHHcCCChhHCcCHHHHHh
Confidence             111111111  112223   4666778999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-56  Score=406.04  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=195.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||+||+|.+.+ ++.||||++.... ...++|.+|++++++++|||||+++|+|.+.+ ..++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC-ceEEEEEe
Confidence            567888999999999999999874 6789999997643 34567999999999999999999999987755 47999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|.+++....      ..++|..++.++.|+|.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        82 ~~~g~L~~~l~~~~------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          82 MEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             CTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             cCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheecc
Confidence            99999999987643      56899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcC-CCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG-RKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||......   .+..           .+..
T Consensus       153 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~-----------~i~~  217 (263)
T d1sm2a_         153 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE-----------DIST  217 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHH-----------HHHH
T ss_pred             CCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHH-----------HHHh
Confidence            44322 22346799999999999999999999999999999999995 5555432211   1111           1111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ...+  ..+...+   ..+.+++.+||+.+|.+|||++||++.|+.+.
T Consensus       218 ~~~~--~~p~~~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         218 GFRL--YKPRLAS---THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             TCCC--CCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCC--CCccccC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            1111  1111222   35667788999999999999999999998654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-56  Score=410.75  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=205.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      +.|+..+.||+|+||+||+|.+..++..||||++........+.+.+|++++++++|||||++++++.+. +.+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEec
Confidence            4678889999999999999999999999999999877666677899999999999999999999998775 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      |++|+|.+++....      ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        91 ~~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          91 CAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             CTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence            99999999987653      46999999999999999999999988   9999999999999999999999999997654


Q ss_pred             CCCCceeeeccccCCCcccchhhc-----cCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ...  .......||+.|+|||++.     ...++.++|||||||++|||+||+.||...+.....      ..       
T Consensus       162 ~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~-------  226 (288)
T d2jfla1         162 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LK-------  226 (288)
T ss_dssp             HHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HH-------
T ss_pred             CCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HH-------
Confidence            321  1123467999999999984     446889999999999999999999999865433211      00       


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       +...-.+.+..+..   ....+.+++.+||+.||.+|||+.|+++
T Consensus       227 -i~~~~~~~~~~~~~---~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         227 -IAKSEPPTLAQPSR---WSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -HHHSCCCCCSSGGG---SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -HHcCCCCCCCcccc---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             11111111211111   2235667778999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=402.87  Aligned_cols=255  Identities=24%  Similarity=0.352  Sum_probs=204.0

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||+||+|.++ ++..||||++.... ...+.|.+|++++++++|||||+++|+|.+  +..++|||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~E   87 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITE   87 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEE
Confidence            357888899999999999999987 47889999997643 345679999999999999999999998754  34689999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++|+|.+++.....     ..++|..++.|+.||++||+|||+++   |+||||||+||||++++.+||+|||+|+..
T Consensus        88 y~~~g~L~~~~~~~~~-----~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          88 YMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             CCTTCBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCCCcHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence            9999999998866532     45999999999999999999999988   999999999999999999999999999987


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... .......||+.|+|||++.++.++.++|||||||++|||+||..|+.......  .+..           .+..
T Consensus       160 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~-----------~i~~  225 (272)
T d1qpca_         160 EDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ-----------NLER  225 (272)
T ss_dssp             SSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH-----------HHHT
T ss_pred             cCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHH-----------HHHh
Confidence            65432 22345678999999999999999999999999999999999666554322111  1110           1111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ...+.  .+...+   ..+.+++.+||+.+|++||||.+|++.|+.
T Consensus       226 ~~~~~--~p~~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         226 GYRMV--RPDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             TCCCC--CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCC--CcccCh---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            11111  122222   346677889999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=402.26  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=197.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCC----cEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      ..|+..++||+|+||.||+|.++.++    ..||||++... .......|.+|+.++++++|||||+++|+|.+.+ ..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~-~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-PMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC-ceE
Confidence            46778899999999999999986543    46999999754 3344567999999999999999999999987754 489


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +||||+.++++.+++....      ..++|..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        86 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          86 IITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEecccCcchhhhhccc------ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccch
Confidence            9999999999999887653      56999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC-ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSV-PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++....... ........||+.|+|||++.++.++.++|||||||++|||++|..|+.......  .+..          
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~----------  224 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMK----------  224 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----------
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHH----------
Confidence            987654322 122234568999999999999999999999999999999999766654332211  1110          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                       .+.+...+..  +..   ....+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus       225 -~i~~~~~~~~--~~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         225 -AINDGFRLPT--PMD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             -HHHTTCCCCC--CTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -HHhccCCCCC--chh---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence             1111111111  112   2245677888999999999999999999997643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=398.17  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=197.2

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC---CCcEEEEE
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLFLIY  137 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~lV~  137 (398)
                      ...+.||+|+||+||+|.+..++..||+|.+...  .....+.|.+|++++++++|||||++++++.+.   +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4456899999999999999989999999998654  344567799999999999999999999987642   34579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC-CCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DfGla~  216 (398)
                      ||+++|+|.+++...       ..+++..++.++.|+++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+
T Consensus        92 E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999875       45999999999999999999999864 4499999999999996 57899999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......    .....||+.|+|||++.+ +++.++|||||||++|||++|+.||.......  .+.   .        .+
T Consensus       164 ~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~---~--------~i  225 (270)
T d1t4ha_         164 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY---R--------RV  225 (270)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH---H--------HH
T ss_pred             eccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHH---H--------HH
Confidence            654332    245689999999998864 69999999999999999999999997533211  010   0        01


Q ss_pred             hhhcCc-ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~-~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .....+ .+.  ...++   .+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~--~~~~~---~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         226 TSGVKPASFD--KVAIP---EVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TTTCCCGGGG--GCCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HcCCCCcccC--ccCCH---HHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111111 111  11222   3567778999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=404.93  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=203.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||+||+|.+..+++.||||++.+..   ....+.+.+|++++++++||||+++++++.+. +.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEE
Confidence            57899999999999999999999899999999996532   23456789999999999999999999987764 558999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+
T Consensus        87 mEy~~gg~L~~~~~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEccCCCCHHHhhhcc-------CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccce
Confidence            9999999999998875       45999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ...............||+.|+|||++.+..++.++|||||||++|||++|+.||...+....                 .
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----------------~  219 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----------------F  219 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------H
T ss_pred             ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-----------------H
Confidence            87654433334556799999999999999999999999999999999999999986543210                 1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+....+..+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       220 ~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         220 QKIIKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHHTTCCCCCTTCC---HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHHcCCCCCCccCC---HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            111122222222222   34667788999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=400.75  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=203.9

Q ss_pred             cCCCCCce-ecccCceEEEEeeeCC--CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRV-LGRGALSFVFKGKVGL--LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~-lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+. ||+|+||+||+|.++.  ++..||||+++.. .....+.|.+|++++++++|||||+++|+|.+  +.+++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEE
Confidence            45555564 9999999999998753  3457999999765 34556789999999999999999999999865  34799


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      |||||++|+|.+++....      ..+++..++.++.|+++||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus        86 vmE~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             EEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEeCCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhh
Confidence            999999999999986542      46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          216 TWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       216 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      +......... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+   +..          
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~----------  223 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----------  223 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH----------
T ss_pred             hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHH----------
Confidence            9776543221 1234568999999999999999999999999999999998 999997644321   111          


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                       .+....  ++..+...+   ..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       224 -~i~~~~--~~~~p~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         224 -FIEQGK--RMECPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             -HHHTTC--CCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHcCC--CCCCCCcCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             111111  111222233   345677789999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-55  Score=410.90  Aligned_cols=262  Identities=25%  Similarity=0.449  Sum_probs=205.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCC-----cEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      ++|...++||+|+||+||+|.+...+     ..||+|.+... .......+.+|+.++.++ +|||||+++++|.+.+ .
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-P  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-e
Confidence            57888899999999999999876443     36999998654 333456789999999998 8999999999987754 4


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccccc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGV----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  196 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp  196 (398)
                      +++|||||++|+|.+++.......                .....++|..++.++.|+++||+|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            899999999999999997643210                11246899999999999999999999988   99999999


Q ss_pred             CcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCccccc
Q 015931          197 SNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRL  275 (398)
Q Consensus       197 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~  275 (398)
                      +|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987765544444456678999999999999999999999999999999998 8999976543


Q ss_pred             ccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHh
Q 015931          276 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  343 (398)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  343 (398)
                      ...  +.    ..       +.....  +..+...+   ..+.+++.+||+.+|++|||+.||++.|.
T Consensus       273 ~~~--~~----~~-------~~~~~~--~~~p~~~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DAN--FY----KL-------IQNGFK--MDQPFYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHH--HH----HH-------HHTTCC--CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH--HH----HH-------HhcCCC--CCCCCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            211  11    11       111111  11122233   34667778999999999999999999985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=391.80  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=208.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|+..+.||+|+||+||+|+++ ++..||||+++.... ..++|.+|+.++++++||||++++|+|.+. +.+++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEc
Confidence            68999999999999999999986 578899999987543 356899999999999999999999998765 458999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|..++....      ..+++..+++++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        81 ~~~g~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          81 MANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             CTTEEHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             cCCCcHHHhhhccc------cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheecc
Confidence            99999999987654      46899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..+   +..           .+..
T Consensus       152 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~-----------~i~~  216 (258)
T d1k2pa_         152 DDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAE-----------HIAQ  216 (258)
T ss_dssp             SSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHH-----------HHHT
T ss_pred             CCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHH-----------HHHh
Confidence            44322 2234668999999999999999999999999999999998 899998654321   110           1111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      ..  ++..+...+   ..+.+++.+||+.+|.+|||+.+|++.|..
T Consensus       217 ~~--~~~~p~~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 GL--RLYRPHLAS---EKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TC--CCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CC--CCCCccccc---HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            11  111122222   356677889999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=397.81  Aligned_cols=248  Identities=26%  Similarity=0.420  Sum_probs=197.8

Q ss_pred             ceecccCceEEEEeeeC--CCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecCC
Q 015931           66 RVLGRGALSFVFKGKVG--LLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  141 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~  141 (398)
                      +.||+|+||+||+|.+.  .+++.||||++...  +....+.|.+|++++++++|||||+++|+|.. + ..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C-CEEEEEEcCC
Confidence            57999999999999864  34578999999653  33445789999999999999999999999864 3 4789999999


Q ss_pred             CCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCCC
Q 015931          142 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  221 (398)
Q Consensus       142 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  221 (398)
                      +|+|.+++...       ..++|..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        91 ~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          91 LGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             TEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            99999999764       45999999999999999999999988   999999999999999999999999999877654


Q ss_pred             CCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhhh
Q 015931          222 SVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  299 (398)
Q Consensus       222 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (398)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+   +..           .+...
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~-----------~i~~~  226 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA-----------MLEKG  226 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH-----------HHHTT
T ss_pred             ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHH-----------HHHcC
Confidence            3322 2234578999999999999999999999999999999998 899998644321   110           01111


Q ss_pred             cCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          300 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       300 ~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                        .++..+...+   ..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       227 --~~~~~p~~~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 --ERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             --CCCCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCCCCcccC---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence              1122222233   345677789999999999999999998864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-55  Score=409.83  Aligned_cols=201  Identities=29%  Similarity=0.463  Sum_probs=178.8

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|...+.||+|+||+||+|.+..+|+.||+|++... .......+.+|+.+|++++|||||+++++|.+.+ .+|+||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence            57899999999999999999999989999999999765 3344578999999999999999999999988754 589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||+++|+|.+++.+.       ..+++..++.++.|++.||.|||+ ++   |+||||||+||||+.++.+||+|||+|+
T Consensus        84 Ey~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             ECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            999999999999875       359999999999999999999997 47   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  274 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~  274 (398)
                      ......    ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus       154 ~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         154 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            664322    235689999999999999999999999999999999999999997654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-53  Score=406.01  Aligned_cols=253  Identities=21%  Similarity=0.299  Sum_probs=208.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.++++++|||||++++++.+. +.+|+||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEc
Confidence            5899999999999999999999989999999999877766778899999999999999999999998774 558999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC--CCCCeeEeccccccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKLCDFGLATW  217 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DfGla~~  217 (398)
                      |++|+|.+++....      ..+++..++.|+.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+++.
T Consensus       105 ~~gg~L~~~l~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         105 MSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             CCSCBHHHHHTCTT------SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999999996532      46999999999999999999999998   99999999999996  467899999999998


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.      ...+....     
T Consensus       176 ~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~-----  241 (350)
T d1koaa2         176 LDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCD-----  241 (350)
T ss_dssp             CCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTC-----
T ss_pred             cccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-----
Confidence            765432   3457899999999999999999999999999999999999999976543211      01111000     


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                        ......   ........+.+++.+||+.||++|||+.|+++.
T Consensus       242 --~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         242 --WNMDDS---AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --CCSCCG---GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CCCCcc---cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000000   001112346677889999999999999999883

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-54  Score=401.38  Aligned_cols=250  Identities=27%  Similarity=0.370  Sum_probs=188.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      +.|...+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.++++++|||||++++++.+. +.+|+|||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lvmE   87 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG-GHLYLIMQ   87 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEe
Confidence            568889999999999999999998999999999976532 2345688999999999999999999998764 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC---CCCCeeEeccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLA  215 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DfGla  215 (398)
                      ||+||+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||+.   +++.+||+|||+|
T Consensus        88 ~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          88 LVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             CCCSCBHHHHHHTC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             ccCCCcHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecccee
Confidence            99999999999764       46999999999999999999999988   99999999999994   5789999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              
T Consensus       158 ~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~--------------  217 (307)
T d1a06a_         158 KMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---L--------------  217 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H--------------
T ss_pred             EEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---H--------------
Confidence            87654332   245679999999999999999999999999999999999999997643321   1              


Q ss_pred             hhhhcCcccCCC-CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...+.......+ .........+.+++.+||+.||.+|||+.|+++
T Consensus       218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            011111111100 001112234667788999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-54  Score=401.76  Aligned_cols=245  Identities=26%  Similarity=0.389  Sum_probs=200.0

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .|+..+.||+|+||+||+|.+..+++.||||++....   ....+.+.+|+.++++++|||||++++++.+. +.+|+||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEEE
Confidence            4888899999999999999999899999999997653   23456789999999999999999999998775 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |||++|+|..++...       ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.
T Consensus        95 E~~~~g~l~~~~~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             ECCSEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccc
Confidence            999999998776553       46999999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCceeeeccccCCCcccchhhcc---CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      ....      ....||+.|+|||++.+   +.++.++|||||||++|||++|+.||...+....      ...       
T Consensus       165 ~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~-------  225 (309)
T d1u5ra_         165 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-------  225 (309)
T ss_dssp             SSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-------
T ss_pred             cCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHH-------
Confidence            5432      34579999999999863   4689999999999999999999999976432210      000       


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                       +.....+.+. ....+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       226 -i~~~~~~~~~-~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         226 -IAQNESPALQ-SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -HHHSCCCCCS-CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HHhCCCCCCC-CCCCC---HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence             1111111121 11122   34667778899999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=392.31  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=197.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||.||+|.++  |..||||+++...  ..+.|.+|++++++++||||++++|+|.+.++.+++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            46777889999999999999985  7889999997543  4467999999999999999999999998766668999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +++|+|.+++.....     ..++|..+++|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          83 MAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CTTEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             cCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC
Confidence            999999999976532     35899999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ...     ....+|..|+|||++.++.++.++|||||||++|||+| |+.||.......   +...           +..
T Consensus       155 ~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~-----------i~~  215 (262)
T d1byga_         155 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-----------VEK  215 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH-----------HTT
T ss_pred             CCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH-----------HHc
Confidence            332     34568999999999999999999999999999999998 677776543322   1111           111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ...+..  +...+   ..+.+++.+||+.||.+|||+.+|+++|+.++
T Consensus       216 ~~~~~~--~~~~~---~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         216 GYKMDA--PDGCP---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TCCCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCC--CccCC---HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            112222  22222   34567778999999999999999999998654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=399.93  Aligned_cols=256  Identities=27%  Similarity=0.403  Sum_probs=202.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCc----EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  134 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  134 (398)
                      .+|+..++||+|+||+||+|.+..+|+    +||+|.+... .....+.|.+|+.++++++|||||+++|+|.++  ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cee
Confidence            468999999999999999999876665    5889988653 344567899999999999999999999999864  368


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccc
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  214 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGl  214 (398)
                      +++|++.+|+|.+++....      ..+++..++.++.|+|.||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        87 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGl  157 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  157 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred             EEEEeccCCcccccccccc------cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccc
Confidence            9999999999999887753      56999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      |+...............||+.|+|||++.++.++.++|||||||++|||+| |..||...+.......            
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~------------  225 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI------------  225 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH------------
T ss_pred             ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH------------
Confidence            998765544433445679999999999999999999999999999999998 7888876543321111            


Q ss_pred             hhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          294 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       294 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                        +....  ++..+...   ...+.+++.+||+.+|.+|||+.||++.|..+
T Consensus       226 --i~~~~--~~~~p~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         226 --LEKGE--RLPQPPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             --HHHTC--CCCCCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHcCC--CCCCCccc---CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence              11111  11112222   24566778899999999999999999988764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.2e-53  Score=403.06  Aligned_cols=252  Identities=22%  Similarity=0.283  Sum_probs=207.7

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|...+.||+|+||+||+|.+..+|+.||||++..........+.+|+.++++++|||||++++++.+ ++.+|+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEc
Confidence            579999999999999999999998999999999987766667788999999999999999999998876 4568999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC--CCCCeeEeccccccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKLCDFGLATW  217 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DfGla~~  217 (398)
                      |++|+|.+++....      ..+++..++.|+.||+.||+|||+++   |+||||||+||||+  .++.+||+|||+|+.
T Consensus       108 ~~gg~L~~~~~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         108 LSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             CCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CCCChHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccccee
Confidence            99999998876542      46999999999999999999999988   99999999999998  678999999999998


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  297 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (398)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+....   .   ..+.       .
T Consensus       179 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~---~~i~-------~  242 (352)
T d1koba_         179 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---L---QNVK-------R  242 (352)
T ss_dssp             CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H---HHHH-------H
T ss_pred             cCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHH-------h
Confidence            765432   3456799999999999999999999999999999999999999976543211   0   0000       0


Q ss_pred             hhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...........   .....+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         243 CDWEFDEDAFS---SVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CCCCCCSSTTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCccccc---CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00010000011   12234667788999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-53  Score=398.48  Aligned_cols=266  Identities=25%  Similarity=0.372  Sum_probs=208.7

Q ss_pred             hhcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC
Q 015931           58 ATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        58 ~~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  131 (398)
                      ..++|+..+.||+|+||+||+|++.     .+++.||||++.... ....+.|.+|++++++++||||++++++|.+.+ 
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-   89 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-   89 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC-
Confidence            3568999999999999999999874     245789999997653 344677999999999999999999999987754 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhcc-----------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeeccc
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKK-----------------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  194 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDl  194 (398)
                      ..++||||+++|+|.+++.....                 .......+++..++.|+.|++.||+|||+.+   |+||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEE
Confidence            47999999999999999975321                 0111245899999999999999999999988   999999


Q ss_pred             ccCcEEeCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCC-CCCccc
Q 015931          195 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR-KPIEAR  273 (398)
Q Consensus       195 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~-~Pf~~~  273 (398)
                      ||+|||||.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. .||...
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999998765544333345677899999999999999999999999999999999986 567654


Q ss_pred             ccccchhHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          274 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      ...+   +..           .+.+...+  ..+...+   .++.+++.+||+.+|++||||.||+++|+.+.
T Consensus       247 ~~~e---~~~-----------~v~~~~~~--~~p~~~~---~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         247 AHEE---VIY-----------YVRDGNIL--ACPENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CHHH---HHH-----------HHHTTCCC--CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CHHH---HHH-----------HHHcCCCC--CCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            3321   111           01111111  1111222   35677888999999999999999999998754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=392.56  Aligned_cols=250  Identities=25%  Similarity=0.337  Sum_probs=204.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC------hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      +.|...+.||+|+||+||+|.+..+|+.||||++.+..      ....+.+.+|+.++++++|||||++++++.+. +.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~   88 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDV   88 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEE
Confidence            57899999999999999999999899999999997542      12357899999999999999999999998765 558


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC----CeeE
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  209 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl  209 (398)
                      |+|||||++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEe
Confidence            9999999999999999875       45999999999999999999999988   99999999999998776    5999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      +|||+|+.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....          
T Consensus       159 ~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----------  225 (293)
T d1jksa_         159 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------  225 (293)
T ss_dssp             CCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------
T ss_pred             cchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH----------
Confidence            99999987755432   24567999999999999989999999999999999999999999865432210          


Q ss_pred             hhchhhhhhhcCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             ..+.......+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus       226 -------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         226 -------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -------HHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------HHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   1111111100000 0011234667888999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=391.31  Aligned_cols=256  Identities=26%  Similarity=0.350  Sum_probs=199.6

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|+..+.||+|+||.||+|.+++ +..||||++.... ...+.|.+|+.++++++|||||+++|+|.+  +..++|||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~E   91 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE   91 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEE
Confidence            3578899999999999999999976 4679999997543 345779999999999999999999999854  34789999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  218 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~  218 (398)
                      |+++|+|..++.....     ..++|..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++..
T Consensus        92 y~~~g~l~~~~~~~~~-----~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          92 YMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             CCTTCBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             ecCCCchhhhhhhccc-----ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhc
Confidence            9999999999876542     46999999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          219 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ..... .......||+.|+|||++..+.++.++|||||||++|||+||..|+.......  .....           +..
T Consensus       164 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~-----------i~~  229 (285)
T d1fmka3         164 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQ-----------VER  229 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH-----------HHT
T ss_pred             cCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHH-----------HHh
Confidence            54332 22334679999999999999999999999999999999999766655432211  11111           111


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      ...+..  +...+   ..+.+++.+||+.+|++|||+.+|+++|+..
T Consensus       230 ~~~~~~--~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         230 GYRMPC--PPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             TCCCCC--CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             cCCCCC--CcccC---HHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence            111111  22222   3567778899999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=393.14  Aligned_cols=248  Identities=26%  Similarity=0.357  Sum_probs=206.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.+..+++.||||++.+.   .......+.+|+.+|+.++||||+++++++.+. +.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-cccccc
Confidence            5789999999999999999999999999999999753   223456788999999999999999999998775 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||++|+|.+++...       ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        84 ~ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          84 MEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             eeccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccc
Confidence            9999999999999875       45899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +              .
T Consensus       154 ~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~--------------~  214 (337)
T d1o6la_         154 EGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L--------------F  214 (337)
T ss_dssp             CSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--------------H
T ss_pred             ccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---H--------------H
Confidence            7654332  2345789999999999999999999999999999999999999998755321   1              0


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                      ..+....+..+...+.   .+.+++.+||++||.+||+     +.|+++
T Consensus       215 ~~i~~~~~~~p~~~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         215 ELILMEEIRFPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHCCCCCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhcCCCCCCccCCH---HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1111111222222333   3566778899999999995     788876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-53  Score=392.68  Aligned_cols=265  Identities=26%  Similarity=0.399  Sum_probs=200.3

Q ss_pred             cCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  132 (398)
                      ++|...+.||+|+||.||+|.+..     +++.||||++... .....+.+..|...+.++ +|+||+.+++++.+.+..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            578889999999999999998643     3468999999754 334556788888888776 689999999998887777


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  203 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~  203 (398)
                      +++|||||++|+|.+++.......         .....++|..++.++.|+++||+|||+++   |+||||||+||||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence            899999999999999997643210         01245899999999999999999999988   999999999999999


Q ss_pred             CCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCC-CCCcccccccchhHH
Q 015931          204 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR-KPIEARRLQGEENLV  282 (398)
Q Consensus       204 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~-~Pf~~~~~~~~~~~~  282 (398)
                      ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||.......  .+.
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~~  247 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC  247 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence            9999999999998765544333344567999999999999999999999999999999999975 5676543221  110


Q ss_pred             HHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          283 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                          .       .+.+...+..  +...+   ..+.+++.+||+.||.+|||+.||++.|+.+
T Consensus       248 ----~-------~~~~~~~~~~--~~~~~---~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         248 ----R-------RLKEGTRMRA--PDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ----H-------HHHHTCCCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----H-------HHhcCCCCCC--CccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                1       1111111211  22222   3467778899999999999999999999754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-52  Score=390.64  Aligned_cols=245  Identities=28%  Similarity=0.421  Sum_probs=204.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||+||+|.++.+|+.||||++.+.   .....+.+.+|+.+++.++|||||++++++.+. +.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-CeeeeE
Confidence            4688899999999999999999989999999999653   223456789999999999999999999998764 568999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ||||+||+|..++...       ..+++..+..++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus        83 mE~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          83 MDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             ECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             eeecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccce
Confidence            9999999999999875       45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+....                 .
T Consensus       153 ~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----------------~  210 (316)
T d1fota_         153 YVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----------------Y  210 (316)
T ss_dssp             ECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             Eecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-----------------H
Confidence            765432     356799999999999998999999999999999999999999986543211                 1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ..+.......+...+   ..+.+++.+||..||.+||     |+.++++
T Consensus       211 ~~i~~~~~~~p~~~s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         211 EKILNAELRFPPFFN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHHHCCCCCCTTSC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHcCCCCCCCCCC---HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            111111122222222   3456777889999999996     8999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=385.98  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=195.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCC---CcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+.||+|+||.||+|.+..+   +..||||.+... .....+.|.+|++++++++|||||++++++.+  +.+++
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~i   84 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWI   84 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEEE
Confidence            5788889999999999999988543   356999998654 33445679999999999999999999999854  45799


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|.+++....      ..+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+|
T Consensus        85 v~E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred             EEEeccCCcHHhhhhccC------CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhh
Confidence            999999999999887643      56999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhhchh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  294 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (398)
                      +....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||...+....   ..           
T Consensus       156 ~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~-----------  220 (273)
T d1mp8a_         156 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG-----------  220 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH-----------
T ss_pred             eeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HH-----------
Confidence            87654332 22345678999999999999999999999999999999998 8999986554321   11           


Q ss_pred             hhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          295 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       295 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      .+....  ....+...+   ..+.+++.+||+.||.+|||+.||++.|+.+
T Consensus       221 ~i~~~~--~~~~~~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         221 RIENGE--RLPMPPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             HHHTTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCC--CCCCCCCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            011111  111122223   3466777899999999999999999998754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-52  Score=387.55  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=202.8

Q ss_pred             CceecccCceEEEEeeeCCCC---cEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEecC
Q 015931           65 GRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  140 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~  140 (398)
                      .++||+|+||+||+|.+..++   ..||||+++.. .....++|.+|++++++++||||++++|+|.+.++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            468999999999999986533   36999999753 55566889999999999999999999999987777789999999


Q ss_pred             CCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccCC
Q 015931          141 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  220 (398)
Q Consensus       141 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  220 (398)
                      ++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++....
T Consensus       112 ~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         112 KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             TTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             ecCchhhhhcccc------ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            9999999987653      46889999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCCc--eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhhhh
Q 015931          221 PSVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  298 (398)
Q Consensus       221 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (398)
                      ....  .......||+.|+|||.+.++.++.++||||||+++|||+||..||.......  ....   .+.        .
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~---~i~--------~  249 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV---YLL--------Q  249 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHH--------T
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH---HHH--------c
Confidence            3221  12234568999999999999999999999999999999999888876533211  1111   111        1


Q ss_pred             hcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          299 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       299 ~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                      .  .+...+...+   ..+.+++.+||+.||++||||.||++.|+.+.
T Consensus       250 g--~~~~~p~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         250 G--RRLLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             T--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C--CCCCCcccCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            0  1111122222   34667788999999999999999999998653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-53  Score=386.91  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=195.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCC---CcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      ++|+..+.||+|+||.||+|.+...   ...||||++...   ..+..+.|.+|+.++++++|||||+++|+|.++  ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--ch
Confidence            5688889999999999999986432   246899998754   334567899999999999999999999998653  46


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+++   |+||||||+||+|+.++.+||+|||
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             heeeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccch
Confidence            89999999999999887754      45999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCce-eeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchhHHHHhhHHHhh
Q 015931          214 LATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       214 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      +++......... ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...+..+   ...   .+.. 
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~---~i~~-  229 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILH---KIDK-  229 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHT-
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHH---HHHh-
Confidence            999876543322 2234568889999999999999999999999999999998 899997654322   111   1111 


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                            ...  +...+...+   ..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       230 ------~~~--~~~~~~~~~---~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         230 ------EGE--RLPRPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ------SCC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCC--CCCCccccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                  101  111112222   346677889999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.1e-52  Score=382.56  Aligned_cols=260  Identities=26%  Similarity=0.358  Sum_probs=201.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC---c
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---G  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~  132 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++...   +......|.+|+++++.++|||||++++++...+.   .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999999989999999999754   33445679999999999999999999998875432   3


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .|+||||++|++|.+++...       ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.++++||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCC
T ss_pred             EEEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehh
Confidence            78999999999999998775       45999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCC-ceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          213 GLATWTSAPSV-PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       213 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      |.+........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||...+...      ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~  229 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVRE  229 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHC
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhc
Confidence            99876543321 122345679999999999999899999999999999999999999997654321      11111111


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-CHHHHHHHHhc
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-GIEEIIAILRG  344 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~  344 (398)
                      .       ..+........+   ..+.+++.+||++||.+|| |+.++++.|..
T Consensus       230 ~-------~~~~~~~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         230 D-------PIPPSARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             C-------CCCGGGTSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             C-------CCCCchhccCCC---HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            0       011111111122   3466777899999999999 89999887764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-51  Score=379.54  Aligned_cols=251  Identities=27%  Similarity=0.342  Sum_probs=202.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh---------hhHHHHHHHHHHHHhCC-CCCeeceeeEEEcC
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---------ESSKAFCRELMIASSLH-HPNIVPLVGFCIDP  129 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  129 (398)
                      ++|...+.||+|+||+||+|++..+++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.+ 
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-   81 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence            578889999999999999999988899999999976431         12346889999999997 9999999999876 


Q ss_pred             CCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          130 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       130 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                      ++.+|+|||||++|+|.+++...       ..+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEE
Confidence            45689999999999999999765       46999999999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhcc------CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  283 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  283 (398)
                      +|||+++.......   .....||+.|+|||++.+      ..++.++||||+||++|||++|+.||...+.....    
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~----  224 (277)
T d1phka_         152 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----  224 (277)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----
T ss_pred             ccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH----
Confidence            99999998765432   245679999999999853      34688999999999999999999999875432211    


Q ss_pred             HhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          284 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       284 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                        ..+...       -......   ........+.+++.+||+++|.+|||+.||++
T Consensus       225 --~~i~~~-------~~~~~~~---~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 --RMIMSG-------NYQFGSP---EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --HHHHHT-------CCCCCTT---TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHhC-------CCCCCCc---ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              011111       0000000   01112245677788999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=387.61  Aligned_cols=276  Identities=22%  Similarity=0.267  Sum_probs=201.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC---cEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~lV  136 (398)
                      ++|...+.||+|+||.||+|++.  |+.||||++..... ....+..|+..+..++|||||+++++|.+.+.   .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            45666789999999999999974  78999999965422 22223345555567899999999999986543   47899


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCceeecccccCcEEeCCCCCeeEec
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----ERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ||||++|+|.++++.        ..++|..++.++.|+|.||.|||+..     ..+|+||||||+||||+.++.+||+|
T Consensus        80 ~Ey~~~g~L~~~l~~--------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EecccCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            999999999999976        35899999999999999999999741     24599999999999999999999999


Q ss_pred             cccccccCCCCCce--eeeccccCCCcccchhhccC------CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHH
Q 015931          212 FGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHG------KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  283 (398)
Q Consensus       212 fGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  283 (398)
                      ||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||..||.............
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            99998775543221  22356799999999998754      36779999999999999999998886543221110000


Q ss_pred             -HhhHHHhhc-hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCc
Q 015931          284 -WAKPILHRG-MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  346 (398)
Q Consensus       284 -~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  346 (398)
                       ......... ........+|.+............+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence             000000000 001122233333222223345667889999999999999999999999997643

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=385.76  Aligned_cols=263  Identities=24%  Similarity=0.370  Sum_probs=204.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCC-------cEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCC
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  130 (398)
                      ++|...+.||+|+||.||+|+...++       ..||||++.... ......+.+|+..+.++ +|||||+++++|.+. 
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-   91 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-   91 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-
Confidence            57888899999999999999875433       479999997654 34557888999999888 899999999998875 


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  201 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll  201 (398)
                      +.+++||||+++|+|.+++......         ......+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            4589999999999999999765310         112356899999999999999999999988   9999999999999


Q ss_pred             CCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccchh
Q 015931          202 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  280 (398)
Q Consensus       202 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  280 (398)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |..||.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999987765544334455679999999999999999999999999999999998 788887544321   


Q ss_pred             HHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          281 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                      +..           .+.....+..  +...+   ..+.+++.+||+.+|.+|||+.||++.|+.+
T Consensus       246 ~~~-----------~i~~~~~~~~--p~~~~---~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         246 LFK-----------LLKEGHRMDK--PSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHH-----------HHHTTCCCCC--CSSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH-----------HHHcCCCCCC--Cccch---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            111           1111111111  22222   3467788899999999999999999999764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-51  Score=389.78  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=204.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  136 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV  136 (398)
                      ++|...+.||+|+||.||+|.++.+|+.||||++.+..   ....+.+.+|+.+|+.++|||||++++++.+. ...++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-cccccc
Confidence            57999999999999999999999999999999996432   23356788999999999999999999987764 458999


Q ss_pred             EecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          137 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       137 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      |||+.+|+|..++...       ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       120 ~e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeee
Confidence            9999999999999875       45999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+...      .           +
T Consensus       190 ~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~-----------~  247 (350)
T d1rdqe_         190 RVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------I-----------Y  247 (350)
T ss_dssp             ECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-----------H
T ss_pred             eccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------H-----------H
Confidence            775432     34679999999999999999999999999999999999999997653221      1           1


Q ss_pred             hhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 015931          297 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  340 (398)
                      ..+.......+...+   ..+.+++.+||+.||.+|+     |+.++++
T Consensus       248 ~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         248 EKIVSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHCCCCCCTTCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhcCCCCCCccCC---HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            111111111122222   3466777889999999994     8999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=385.36  Aligned_cols=264  Identities=25%  Similarity=0.399  Sum_probs=208.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeC-----CCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCC
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  131 (398)
                      .++|...+.||+|+||.||+|++.     .+++.||||++.... ......|.+|+.+++++ +|||||+++++|.+.+ 
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~-  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG-  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence            357888899999999999999862     456789999997653 34556799999999998 6999999999987754 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEE
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKG-----------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  200 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIl  200 (398)
                      ..++|||||++|+|.+++......           ......+++..+..++.||++||+|||+++   ++||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence            479999999999999999864321           012246999999999999999999999988   999999999999


Q ss_pred             eCCCCCeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHc-CCCCCcccccccch
Q 015931          201 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  279 (398)
Q Consensus       201 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  279 (398)
                      ++.++.+|++|||+++...............||+.|+|||.+.++.++.++|||||||++|||+| |.+||...+..+. 
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999998776554444556789999999999999999999999999999999999 5555544332211 


Q ss_pred             hHHHHhhHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          280 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                       +.    ..       +..-..+..  +...   ...+.+++.+||+.||.+|||+.+|+++|++
T Consensus       257 -~~----~~-------i~~~~~~~~--~~~~---~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         257 -FY----KM-------IKEGFRMLS--PEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             -HH----HH-------HHHTCCCCC--CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HH----HH-------HhcCCCCCC--cccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence             00    11       111111111  1112   2456778889999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.3e-51  Score=387.94  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=199.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHH---HHHHHHHhCCCCCeeceeeEEEcCCCcE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFC---RELMIASSLHHPNIVPLVGFCIDPEQGL  133 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~  133 (398)
                      ++|...++||+|+||.||+|.+..+|+.||||++.+..   ......+.   .++.+++.++|||||++++++.+. +.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CEE
Confidence            67899999999999999999999999999999986432   11222333   446777788999999999988765 558


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      |+|||||++|+|.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeec
Confidence            9999999999999999875       45899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc
Q 015931          214 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  292 (398)
Q Consensus       214 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  292 (398)
                      +|+......    .....||+.|+|||++..+ .++.++|||||||++|||+||+.||..........+           
T Consensus       153 la~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-----------  217 (364)
T d1omwa3         153 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------  217 (364)
T ss_dssp             TCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-----------
T ss_pred             eeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------
Confidence            998775443    2356799999999999754 689999999999999999999999987544321111           


Q ss_pred             hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          293 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                         ...........+...+.   .+.+++.+||+.||.+|||     +.|+++
T Consensus       218 ---~~~~~~~~~~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         218 ---DRMTLTMAVELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---HHHSSSCCCCCCSSSCH---HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---HHhcccCCCCCCCCCCH---HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence               11112222222222233   4567778899999999999     688875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=384.89  Aligned_cols=251  Identities=20%  Similarity=0.293  Sum_probs=204.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEe
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  138 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e  138 (398)
                      .++|...+.||+|+||+||+|.+..+++.||||++..... ....+.+|+++|+.++|||||++++++.+. +.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEe
Confidence            3678899999999999999999999999999999976543 345688999999999999999999988764 55899999


Q ss_pred             cCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC--CCeeEecccccc
Q 015931          139 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLAT  216 (398)
Q Consensus       139 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DfGla~  216 (398)
                      ||+||+|.+++....      ..+++..++.|+.||+.||+|||+.+   |+||||||+|||++.+  ..+||+|||+++
T Consensus        82 ~~~gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          82 FISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             CCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhh
Confidence            999999999997642      46999999999999999999999988   9999999999999854  589999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhhh
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  296 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (398)
                      ......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+....                 +
T Consensus       153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-----------------~  212 (321)
T d1tkia_         153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----------------I  212 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             ccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-----------------H
Confidence            765433   23456799999999999999999999999999999999999999987543211                 1


Q ss_pred             hhhcCcccCCCCCC-HHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          297 EELLDPRLKCTSRN-SAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       297 ~~~~d~~l~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+.......+... ......+.+++.+||..||.+|||+.|+++
T Consensus       213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111100000 001234677888999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=385.07  Aligned_cols=265  Identities=22%  Similarity=0.320  Sum_probs=209.4

Q ss_pred             hcCCCCCceecccCceEEEEeeeCC-----CCcEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  132 (398)
                      .++|...+.||+|+||+||+|.+..     ++..||||+++.. .......|.+|++++++++|||||+++++|...+ .
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-P   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-S
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC-c
Confidence            3677888999999999999998742     3578999999754 3445567999999999999999999999987654 4


Q ss_pred             EEEEEecCCCCCHHHHHhhhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeE
Q 015931          133 LFLIYKYVSGGSLERHLHEKKK---GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  209 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  209 (398)
                      .++||||+++|+|.+++.....   .......+++..+..++.|+|+||.|||+.+   |+||||||+|||+++++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence            7999999999999999875321   1112245799999999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCC-CCCcccccccchhHHHHhhHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR-KPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      +|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||...+....          
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~----------  244 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----------  244 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----------
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH----------
Confidence            9999998775544333344457899999999999999999999999999999999985 66654332211          


Q ss_pred             HhhchhhhhhhcCcc-cCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcCcc
Q 015931          289 LHRGMAAVEELLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  347 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~-l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  347 (398)
                             +..+.+.. ...+...+   ..+.+++.+||+.+|.+|||+.+|++.|+...+
T Consensus       245 -------~~~i~~~~~~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         245 -------LRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -------HHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------HHHHHhCCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                   11111111 11112222   357777889999999999999999999987543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=384.52  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=201.4

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHH-hCCCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIAS-SLHHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|...+.||+|+||+||+|.+..+++.||||++.+..   ....+.+..|..++. .++|||||++++++.++ +.+|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-CceeE
Confidence            57888999999999999999999999999999997532   233456677777765 68999999999998775 45899


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  215 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla  215 (398)
                      ||||+++|+|.+++...       ..+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++
T Consensus        81 vmEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             EEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchh
Confidence            99999999999999875       45899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhchhh
Q 015931          216 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  295 (398)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (398)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.....      ..+. .    
T Consensus       151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i~-~----  217 (320)
T d1xjda_         151 KENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------HSIR-M----  217 (320)
T ss_dssp             BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-H----
T ss_pred             hhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH------HHHH-c----
Confidence            86654332  234567999999999999999999999999999999999999999865432110      0000 0    


Q ss_pred             hhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHH-HHHH
Q 015931          296 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EIIA  340 (398)
Q Consensus       296 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl~  340 (398)
                          -.+.+  +...+   ..+.+++.+||+.||.+|||+. ++++
T Consensus       218 ----~~~~~--p~~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         218 ----DNPFY--PRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCCCC--CTTSC---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCCC--CccCC---HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                01111  22222   3466777899999999999995 6754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=384.27  Aligned_cols=260  Identities=24%  Similarity=0.366  Sum_probs=201.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCc--EEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeEEEcCCCcEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~l  135 (398)
                      ++|+..++||+|+||+||+|.++.++.  .||||.+... .....+.|.+|+++|+++ +|||||+++|+|.+. +.+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEE
Confidence            578888999999999999999987665  4778887643 334556799999999998 799999999998875 45899


Q ss_pred             EEecCCCCCHHHHHhhhcc---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCC
Q 015931          136 IYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  206 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~---------~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~  206 (398)
                      ||||+++|+|.+++.....         .......++|..++.++.|+|.||.|||+.+   |+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            9999999999999975310         0112357999999999999999999999988   999999999999999999


Q ss_pred             eeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCC-CCcccccccchhHHHHh
Q 015931          207 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK-PIEARRLQGEENLVLWA  285 (398)
Q Consensus       207 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~-Pf~~~~~~~~~~~~~~~  285 (398)
                      +||+|||+++.......   .....||..|+|||.+.++.++.++|||||||++|||++|.. ||...+...   +..  
T Consensus       166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~--  237 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE--  237 (309)
T ss_dssp             EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH--
T ss_pred             eEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHH--
Confidence            99999999986543221   234568999999999999999999999999999999999765 665543221   111  


Q ss_pred             hHHHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhcC
Q 015931          286 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  345 (398)
Q Consensus       286 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  345 (398)
                               .+.+...+..  +...+   ..+.+++.+||+.||++||||.||++.|+.+
T Consensus       238 ---------~i~~~~~~~~--~~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         238 ---------KLPQGYRLEK--PLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             ---------HGGGTCCCCC--CTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------HHHhcCCCCC--CccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     1111111111  12222   3566777899999999999999999998765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=383.35  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             cCCCCC-ceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHh-CCCCCeeceeeEEEc---CCCcEE
Q 015931           60 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS-LHHPNIVPLVGFCID---PEQGLF  134 (398)
Q Consensus        60 ~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~---~~~~~~  134 (398)
                      ++|.+. ++||+|+||+||+|.+..+++.||||++...     ..+.+|++++.+ .+|||||++++++.+   .+..+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            578765 4699999999999999889999999999643     346789988655 589999999998754   245589


Q ss_pred             EEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC---CCCeeEec
Q 015931          135 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  211 (398)
Q Consensus       135 lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~D  211 (398)
                      +|||||+||+|.+++....     ...+++..++.|+.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCS-----CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEECCCCCcHHHHHHhcC-----CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccc
Confidence            9999999999999997642     256999999999999999999999988   999999999999985   56799999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ||+|+.......   .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+.......          
T Consensus       158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~----------  224 (335)
T d2ozaa1         158 FGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------  224 (335)
T ss_dssp             CTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred             cceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH----------
Confidence            999987655432   2456799999999999998999999999999999999999999987543321100          


Q ss_pred             chhhhhhhcCcccCCCCC-CHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          292 GMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                         ....+.......+.. .......+.+++.+||+.||++|||+.|+++
T Consensus       225 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         225 ---MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               001111111111111 1122345778889999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=374.97  Aligned_cols=260  Identities=22%  Similarity=0.243  Sum_probs=193.2

Q ss_pred             CceecccCceEEEEeeeCCCCcEEEEEEecCCChh-----hHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           65 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        65 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      .++||+|+||+||+|.+..+|+.||||++......     ..+.+.+|+.++++++|||||++++++.+.+ .+|+||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-~~~ivmE~   81 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NISLVFDF   81 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-CCEEEEEC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-ceeehhhh
Confidence            46899999999999999989999999999754322     1246889999999999999999999987654 58999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccccC
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  219 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  219 (398)
                      +.++++..+....       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~~~~~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          82 METDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             CSEEHHHHHTTCC-------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             hcchHHhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccC
Confidence            9887776665432       46899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch-hhhh
Q 015931          220 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM-AAVE  297 (398)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~  297 (398)
                      .....  .....||+.|+|||++... .++.++|||||||++|||+||..||...+..+....+   ........ ....
T Consensus       152 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~  226 (299)
T d1ua2a_         152 SPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWP  226 (299)
T ss_dssp             SCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSS
T ss_pred             CCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhcc
Confidence            54322  2346799999999998755 5799999999999999999999999765432211110   00000000 0000


Q ss_pred             hhc----CcccC-CCCCCH-----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          298 ELL----DPRLK-CTSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       298 ~~~----d~~l~-~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ...    ..... .+....     .....+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000    00000 000010     11245778889999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=373.66  Aligned_cols=269  Identities=22%  Similarity=0.348  Sum_probs=198.6

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||+||+|.+..+++.||||++.....  .....+.+|++++++++|||||++++++.+. +.+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-cceeEEE
Confidence            578889999999999999999998999999999965432  2356789999999999999999999998775 4589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      ||+.+ ++..++....     ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus        81 e~~~~-~~~~~~~~~~-----~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             ECCSE-EHHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             eecCC-chhhhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCccee
Confidence            99965 5555554432     256999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCC-cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-HHHhhchhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-PILHRGMAA  295 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~  295 (398)
                      ......  ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+............ .........
T Consensus       152 ~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         152 FGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG  229 (298)
T ss_dssp             HCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc
Confidence            654432  234567999999999887655 5889999999999999999999997654322111000000 000000000


Q ss_pred             hhhhcC--cccCC-CCCCH-----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEELLD--PRLKC-TSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~~d--~~l~~-~~~~~-----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      +....+  ..... .....     .....+.+++.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            000000  00000 00000     11245677888999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=369.49  Aligned_cols=240  Identities=24%  Similarity=0.375  Sum_probs=194.5

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh------hhHHHHHHHHHHHHhCC--CCCeeceeeEEEcCCC
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLH--HPNIVPLVGFCIDPEQ  131 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  131 (398)
                      ++|...++||+|+||+||+|.+..+++.||||++.....      .....+.+|+.++++++  |||||++++++.+. +
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-~   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-D   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-S
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-C
Confidence            578999999999999999999998999999999975321      11234678999999986  89999999998765 4


Q ss_pred             cEEEEEecCCC-CCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-CCCeeE
Q 015931          132 GLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKL  209 (398)
Q Consensus       132 ~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl  209 (398)
                      ..++||||+.+ +++.+++...       ..+++..++.++.|++.||+|||+++   |+||||||+|||++. ++.+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred             eEEEEEEeccCcchHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEE
Confidence            58999999976 6788888765       45999999999999999999999988   999999999999985 479999


Q ss_pred             eccccccccCCCCCceeeeccccCCCcccchhhccCCc-CCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH
Q 015931          210 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       210 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      +|||+|+......    .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....     .       
T Consensus       153 ~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------  216 (273)
T d1xwsa_         153 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------  216 (273)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------
T ss_pred             Cccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------
Confidence            9999998765432    245679999999999987765 5679999999999999999999975321     0       


Q ss_pred             HhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          289 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       289 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                             ...    ....+...++   .+.+++.+||+.||++|||+.|+++
T Consensus       217 -------~~~----~~~~~~~~s~---~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 -------IRG----QVFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -------HHC----CCCCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------hhc----ccCCCCCCCH---HHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   000    1111122223   4566778999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-49  Score=367.09  Aligned_cols=270  Identities=22%  Similarity=0.282  Sum_probs=194.9

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCC-CcEEEEEEecCCC--hhhHHHHHHHHHHHHhC---CCCCeeceeeEEEc----
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLL-RTSVAIKRLDKED--KESSKAFCRELMIASSL---HHPNIVPLVGFCID----  128 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  128 (398)
                      .++|...+.||+|+||+||+|.+..+ ++.||||++....  ......+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999998654 6679999986432  22223455677666554   89999999998753    


Q ss_pred             CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCee
Q 015931          129 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  208 (398)
Q Consensus       129 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  208 (398)
                      .+..++++|||+.++++.......      ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP------EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             cCceEEEEEEeccCCchhhhhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCee
Confidence            234578999999887765554433      256899999999999999999999988   99999999999999999999


Q ss_pred             EeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH
Q 015931          209 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  288 (398)
Q Consensus       209 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  288 (398)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..............
T Consensus       157 l~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         157 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            99999988654322   234577999999999999999999999999999999999999999865433211111100000


Q ss_pred             -----HhhchhhhhhhcCcccC--CCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          289 -----LHRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       289 -----~~~~~~~~~~~~d~~l~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                           +................  ...........+.+++.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 00000000000000000  00000111234567788999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-48  Score=362.14  Aligned_cols=267  Identities=21%  Similarity=0.289  Sum_probs=195.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|...+.||+|+||+||+|.++ +++.||||++.....  ...+.+.+|+.++++++|||||++++++.+.+ ..+++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEEE
Confidence            57888999999999999999986 589999999976532  23568999999999999999999999987755 489999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      |++.++.+..+....       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        80 e~~~~~~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (286)
T ss_dssp             ECCSEEHHHHHHTST-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EeehhhhHHHHHhhc-------CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence            999777666665443       56999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHH-Hhhchhh
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI-LHRGMAA  295 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~  295 (398)
                      ......  ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+........... .......
T Consensus       150 ~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (286)
T d1ob3a_         150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (286)
T ss_dssp             HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence            654432  22345689999999998754 5689999999999999999999999765432211110000000 0000000


Q ss_pred             hhhh--cCcccCC------CCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          296 VEEL--LDPRLKC------TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       296 ~~~~--~d~~l~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....  .+.....      ..........+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000  0000000      0000111235677888999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-47  Score=357.46  Aligned_cols=261  Identities=19%  Similarity=0.242  Sum_probs=200.1

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEEec
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  139 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~  139 (398)
                      ++|+..+.||+|+||+||+|.+..+++.||||++.....  ..++..|+++++.++|+|++..++.|...+...++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            579999999999999999999988899999999876432  245788999999999888777777776667778999999


Q ss_pred             CCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeC---CCCCeeEecccccc
Q 015931          140 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLAT  216 (398)
Q Consensus       140 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DfGla~  216 (398)
                      + +++|...+....      ..+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+
T Consensus        85 ~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          85 L-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             c-CCchhhhhhhcc------CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcce
Confidence            9 677777766543      46999999999999999999999988   99999999999986   45579999999999


Q ss_pred             ccCCCCCc-----eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          217 WTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       217 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      ........     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            77543321     1224567999999999999999999999999999999999999999865443322211111100000


Q ss_pred             chhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          292 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       292 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .  .... +      ....+   ..+.+++..||+.+|.+||++.++.+.|+.
T Consensus       235 ~--~~~~-~------~~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         235 T--PIEV-L------CKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             S--CHHH-H------TTTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             C--ChhH-h------ccCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            0  0000 0      01122   345667778999999999999999988875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=360.86  Aligned_cols=270  Identities=22%  Similarity=0.312  Sum_probs=197.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----CcE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGL  133 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  133 (398)
                      +.+|...+.||+|+||+||+|.+..+|+.||||++.+.. ....+.+.+|+++|++++||||+++++++....    ...
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            357888999999999999999998899999999997643 345667899999999999999999999886532    224


Q ss_pred             EEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccc
Q 015931          134 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  213 (398)
Q Consensus       134 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfG  213 (398)
                      ++ ++++.+|+|.+++..        ..+++..++.++.|++.||+|||+++   |+||||||+||||++++.+||+|||
T Consensus        87 ~l-~~~~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG  154 (345)
T d1pmea_          87 YL-VTHLMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG  154 (345)
T ss_dssp             EE-EEECCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EE-EEeecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccC
Confidence            44 455669999999975        35999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCc-eeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhh
Q 015931          214 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  291 (398)
Q Consensus       214 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  291 (398)
                      +++........ .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+..............
T Consensus       155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~  234 (345)
T d1pmea_         155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  234 (345)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence            99866443211 12245679999999999854 46788999999999999999999999765432211111100000000


Q ss_pred             c------hhhhhh-hc-CcccCCCCCCH----HHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          292 G------MAAVEE-LL-DPRLKCTSRNS----AQIARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       292 ~------~~~~~~-~~-d~~l~~~~~~~----~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      .      ...... .. .+... .....    .....+.+++.+||+.||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         235 EDLNCIINLKARNYLLSLPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCC-CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhcccccCCccC-CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0      000000 00 00000 00000    011357788899999999999999999973

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=364.77  Aligned_cols=268  Identities=20%  Similarity=0.303  Sum_probs=197.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCC-----
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  131 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  131 (398)
                      .++|...+.||+|+||+||+|.+..+|+.||||++...  .....+.+.+|+++|++++|||||+++++|...+.     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46888899999999999999999989999999999754  33446678999999999999999999999876442     


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      .+|+||||+ +.+|..+...        ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+|++|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecc-cccHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccc
Confidence            469999999 6788887754        45999999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh----
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  286 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~----  286 (398)
                      ||+|+......     +...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+............    
T Consensus       165 fg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         165 FGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             CTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            99998765432     356799999999998764 56899999999999999999999997654322111110000    


Q ss_pred             -HHHhhc--------hhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHH--HhcC
Q 015931          287 -PILHRG--------MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI--LRGE  345 (398)
Q Consensus       287 -~~~~~~--------~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~--L~~~  345 (398)
                       ..+...        ...+.+.....+.  .........+.+++.+||..||.+|||+.|+++.  ++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence             000000        0000000000000  0001112345678889999999999999999983  5543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-48  Score=366.22  Aligned_cols=264  Identities=26%  Similarity=0.299  Sum_probs=193.9

Q ss_pred             CCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-----CCcEEE
Q 015931           61 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQGLFL  135 (398)
Q Consensus        61 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~~l  135 (398)
                      +|+..++||+|+||+||+|++..+++.||||++......    +.+|+++|++++||||+++++++...     ...+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            577788999999999999999999999999999765322    34799999999999999999988643     234789


Q ss_pred             EEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEecccc
Q 015931          136 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGL  214 (398)
Q Consensus       136 V~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DfGl  214 (398)
                      |||||+++.+..+......    ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRA----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEeccCCccHHHHHhhhhc----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccc
Confidence            9999976644444332221    257999999999999999999999988   99999999999999765 899999999


Q ss_pred             ccccCCCCCceeeeccccCCCcccchhhcc-CCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhch
Q 015931          215 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  293 (398)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  293 (398)
                      ++.......   .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+......  ...-....
T Consensus       170 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~--~~~g~~~~  244 (350)
T d1q5ka_         170 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII--KVLGTPTR  244 (350)
T ss_dssp             CEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH--HHHCCCCH
T ss_pred             hhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH--HHhCCChH
Confidence            987754432   234679999999998865 468999999999999999999999997654322111110  00000000


Q ss_pred             hhhhh----hcCcccCC---C----CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          294 AAVEE----LLDPRLKC---T----SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       294 ~~~~~----~~d~~l~~---~----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..+..    ..+..+..   .    .........+.+++.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000    01111100   0    001112234677788999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=357.85  Aligned_cols=269  Identities=19%  Similarity=0.277  Sum_probs=196.8

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-------C
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------E  130 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~  130 (398)
                      ++|+..+.||+|+||+||+|.+..+|+.||||++...  ......++.+|+++|++++||||+++++++...       +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6888999999999999999999988999999998654  233456788999999999999999999987553       2


Q ss_pred             CcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEe
Q 015931          131 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  210 (398)
Q Consensus       131 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  210 (398)
                      ..+++||||+.++.+.......       ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~-------~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             ceEEEEEeccCCCccchhhhcc-------cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEee
Confidence            3479999999877666544332       46899999999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCc--eeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          211 DFGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       211 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |||+++........  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+.........   .
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~---~  236 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS---Q  236 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---H
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH---H
Confidence            99999866543211  112335799999999998765 68999999999999999999999997654322111111   1


Q ss_pred             HHhhchhhh-hhhcCc----c---cCCCCCCH-HH------HHHHHHHHHhcccccCCCCCCHHHHHHH
Q 015931          288 ILHRGMAAV-EELLDP----R---LKCTSRNS-AQ------IARVIQAAAACISSEESRRPGIEEIIAI  341 (398)
Q Consensus       288 ~~~~~~~~~-~~~~d~----~---l~~~~~~~-~~------~~~l~~l~~~cl~~~p~~RPt~~evl~~  341 (398)
                      ......... ......    .   ........ ..      ...+++++.+||+.||++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            100000000 000000    0   00000111 11      2345678899999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5e-46  Score=345.36  Aligned_cols=261  Identities=20%  Similarity=0.233  Sum_probs=202.3

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCC-CCeeceeeEEEcCCCcEEEEE
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~lV~  137 (398)
                      .++|.+.+.||+|+||+||+|++..+++.||||++.....  ...+.+|++.+..+.| +|++.+++++.+. ...++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-CccEEEE
Confidence            4689999999999999999999998899999999865432  2356788899999875 8999999887664 4579999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCC-----CCCeeEecc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-----KKIPKLCDF  212 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~Df  212 (398)
                      ||+ +++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+||
T Consensus        81 e~~-~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             Eec-CCCHHHHHHhhc------cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence            999 889999987653      46999999999999999999999988   999999999999974     568999999


Q ss_pred             ccccccCCCCCc-----eeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhH
Q 015931          213 GLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  287 (398)
Q Consensus       213 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  287 (398)
                      |+|+........     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.................
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence            999876543211     112346799999999999999999999999999999999999999986544332221111111


Q ss_pred             HHhhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHHHHhc
Q 015931          288 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  344 (398)
Q Consensus       288 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  344 (398)
                      .....  ...++ .      ...++   .+.+++..|+..+|.+||++..+.+.|+.
T Consensus       231 ~~~~~--~~~~l-~------~~~p~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         231 KKQST--PLREL-C------AGFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             HHHHS--CHHHH-T------TTSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ccCCC--ChHHh-c------CCCCH---HHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            00000  01111 0      11223   35566677999999999999999888765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=349.60  Aligned_cols=266  Identities=21%  Similarity=0.267  Sum_probs=202.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCCCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~  137 (398)
                      ++|+..+.||+|+||+||+|++..+++.||||+++...  .....++.+|+.+++.++||||+++++++.+.. ..++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-ceeEEe
Confidence            47888999999999999999999899999999996543  345678999999999999999999999987755 478999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEeccccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  217 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~~  217 (398)
                      +++.+++|..++...       ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++.
T Consensus        81 ~~~~~~~l~~~~~~~-------~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~  150 (292)
T d1unla_          81 EFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             ECCSEEHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eeccccccccccccc-------cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhc
Confidence            999999988887654       46899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCceeeeccccCCCcccchhhccCC-cCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHHhhc----
Q 015931          218 TSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----  292 (398)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----  292 (398)
                      .......  .....++..|+|||.+.... ++.++|||||||++|||++|+.||.......  .............    
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  226 (292)
T d1unla_         151 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTT
T ss_pred             ccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhh
Confidence            7654322  23456788899999987665 6899999999999999999999975432211  1111100000000    


Q ss_pred             hhhhhhhcCc--------ccCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MAAVEELLDP--------RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~~~~~~~d~--------~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ........+.        ..............+.+++.+||+.||.+|||+.||++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000        00000111122245677888999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=355.46  Aligned_cols=265  Identities=20%  Similarity=0.319  Sum_probs=192.0

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcC-----CCc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQG  132 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  132 (398)
                      ++|...++||+|+||+||+|.+..+|+.||||++...  .......+.+|+.++++++||||+++++++...     ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999999989999999999754  344556789999999999999999999988643     346


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      +|+||||+.++ +.+.+.         ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+|++||
T Consensus        97 ~~iv~Ey~~~~-l~~~~~---------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEeccchH-HHHhhh---------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeech
Confidence            89999999665 444443         34899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHh-----hH
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----KP  287 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~-----~~  287 (398)
                      |+++......   ......||+.|+|||++.+..+++++||||+||++|||++|+.||...+...........     ..
T Consensus       164 ~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            9988665433   234567999999999999999999999999999999999999999765422111110000     00


Q ss_pred             HHhhchhhhhhhcC---------------cccCCC--CCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          288 ILHRGMAAVEELLD---------------PRLKCT--SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       288 ~~~~~~~~~~~~~d---------------~~l~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      .+............               ......  .........+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000001111111               011000  011234556888999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-46  Score=353.79  Aligned_cols=262  Identities=19%  Similarity=0.260  Sum_probs=197.2

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcC-CCcEEEEE
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP-EQGLFLIY  137 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~~~lV~  137 (398)
                      ++|...++||+|+||+||+|++..+++.||||+++...   .+.+.+|+++|..++ ||||+++++++... ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999999899999999997543   456889999999995 99999999988754 34589999


Q ss_pred             ecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCC-CeeEecccccc
Q 015931          138 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  216 (398)
Q Consensus       138 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DfGla~  216 (398)
                      |||.+++|..+.          ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+
T Consensus       112 e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         112 EHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             ECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             eecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccce
Confidence            999999986653          34899999999999999999999998   99999999999998655 68999999998


Q ss_pred             ccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhH--HHHhh-HHHhhc
Q 015931          217 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL--VLWAK-PILHRG  292 (398)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~--~~~~~-~~~~~~  292 (398)
                      .......   .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........  ..... +.....
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            7655432   2456789999999998765 479999999999999999999999975433211000  00000 000000


Q ss_pred             hh--------hhhhhcCcc-------cCCCCCCHHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          293 MA--------AVEELLDPR-------LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       293 ~~--------~~~~~~d~~-------l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ..        .........       .............+.+++.+||+.||.+|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00        000000000       0000001112245678888999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=353.16  Aligned_cols=253  Identities=26%  Similarity=0.322  Sum_probs=199.1

Q ss_pred             cCCCCCceecccCceEEEEeee---CCCCcEEEEEEecCCC----hhhHHHHHHHHHHHHhCCC-CCeeceeeEEEcCCC
Q 015931           60 HNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQ  131 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  131 (398)
                      ++|+..+.||+|+||+||+|..   +.+|+.||||++....    ....+.+.+|++++++++| |||+++++++.+.. 
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~-  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence            6799999999999999999986   4468899999986432    2234568899999999976 89999999877654 


Q ss_pred             cEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEec
Q 015931          132 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  211 (398)
Q Consensus       132 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  211 (398)
                      ..++||||+.+|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             ceeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEee
Confidence            589999999999999999876       35788999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCceeeeccccCCCcccchhhccC--CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhhHHH
Q 015931          212 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  289 (398)
Q Consensus       212 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  289 (398)
                      ||+++........ ......|++.|+|||.+...  .++.++|||||||+||||++|+.||.............      
T Consensus       173 FG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~------  245 (322)
T d1vzoa_         173 FGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------  245 (322)
T ss_dssp             SSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH------
T ss_pred             ccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------
Confidence            9999876543322 23456799999999999754  46889999999999999999999998765443221111      


Q ss_pred             hhchhhhhhhcCcccCCCCCCHHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 015931          290 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  340 (398)
Q Consensus       290 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  340 (398)
                             ..........+...+   ..+.+++.+||++||.+|||     ++|+++
T Consensus       246 -------~~~~~~~~~~~~~~s---~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 -------RRILKSEPPYPQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -------HHHHHCCCCCCTTSC---HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------HhcccCCCCCcccCC---HHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                   111111111122222   45666778899999999994     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=350.54  Aligned_cols=266  Identities=20%  Similarity=0.274  Sum_probs=195.7

Q ss_pred             hcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeEEEcCC----Cc
Q 015931           59 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  132 (398)
Q Consensus        59 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  132 (398)
                      +++|...+.||+|+||+||+|.+..+|+.||||++...  .....+.+.+|+++|++++|||+|++++++....    ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999999999989999999999754  3345567889999999999999999999875321    22


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCCCCeeEecc
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  212 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df  212 (398)
                      .+++++++.+|+|.+++..        ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~--------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEeecCCchhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccccc
Confidence            4566777789999999854        35999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCceeeeccccCCCcccchhhccC-CcCCccchhhHHHHHHHHHcCCCCCcccccccchhHHHHhh-----
Q 015931          213 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----  286 (398)
Q Consensus       213 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-----  286 (398)
                      |++......     .....||..|+|||...+. .++.++|||||||++|+|++|+.||.+.+............     
T Consensus       166 g~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         166 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             ----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            999765432     2346789999999987765 46889999999999999999999997654322111111000     


Q ss_pred             HHHhhch-hhhhhhcCcccCCCCCCH-----HHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 015931          287 PILHRGM-AAVEELLDPRLKCTSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  340 (398)
Q Consensus       287 ~~~~~~~-~~~~~~~d~~l~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPt~~evl~  340 (398)
                      ....... ..................     .....+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            0000000 000000000000000000     11234677888999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-41  Score=320.55  Aligned_cols=267  Identities=18%  Similarity=0.243  Sum_probs=191.9

Q ss_pred             cCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-----------CCCeeceeeEEEc
Q 015931           60 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----------HPNIVPLVGFCID  128 (398)
Q Consensus        60 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  128 (398)
                      ++|...++||+|+||+||+|+...+|+.||||++.... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35889999999999999999999899999999997643 33467788998888775           5789999988754


Q ss_pred             -CCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceeecccccCcEEeCCCC-
Q 015931          129 -PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKK-  205 (398)
Q Consensus       129 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDlkp~NIll~~~~-  205 (398)
                       .....+++++++..+...........    ...+++..+..++.|++.||+|||+ .+   |+||||||+||||+.++ 
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             ccccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCc
Confidence             23445677776655544333333221    2578999999999999999999997 66   99999999999998655 


Q ss_pred             -----CeeEeccccccccCCCCCceeeeccccCCCcccchhhccCCcCCccchhhHHHHHHHHHcCCCCCcccccccchh
Q 015931          206 -----IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  280 (398)
Q Consensus       206 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~Gvvl~elltG~~Pf~~~~~~~~~~  280 (398)
                           .++++|||.+.......     ....||+.|+|||.+....++.++||||+||++++|++|+.||..........
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             ccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence                 38999999998654332     34679999999999999999999999999999999999999998654322111


Q ss_pred             HHHHhh---HHHh--------hchhhhhhhcCc-----cc-------------CCCCCCHHHHHHHHHHHHhcccccCCC
Q 015931          281 LVLWAK---PILH--------RGMAAVEELLDP-----RL-------------KCTSRNSAQIARVIQAAAACISSEESR  331 (398)
Q Consensus       281 ~~~~~~---~~~~--------~~~~~~~~~~d~-----~l-------------~~~~~~~~~~~~l~~l~~~cl~~~p~~  331 (398)
                      ......   ..+.        ... ......+.     .+             ............+.+++.+||+.||.+
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGK-YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCT-THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             hhHHHHHHHHHhCCCCHHHhhccc-ccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence            111000   0000        000 00011110     00             011234566778899999999999999


Q ss_pred             CCCHHHHHH
Q 015931          332 RPGIEEIIA  340 (398)
Q Consensus       332 RPt~~evl~  340 (398)
                      |||++|+++
T Consensus       319 Rpta~e~L~  327 (362)
T d1q8ya_         319 RADAGGLVN  327 (362)
T ss_dssp             CBCHHHHHT
T ss_pred             CcCHHHHhc
Confidence            999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.2e-25  Score=191.42  Aligned_cols=163  Identities=17%  Similarity=0.127  Sum_probs=120.7

Q ss_pred             CCCceecccCceEEEEeeeCCCCcEEEEEEecCCCh------------------hhHHHHHHHHHHHHhCCCCCeeceee
Q 015931           63 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------------------ESSKAFCRELMIASSLHHPNIVPLVG  124 (398)
Q Consensus        63 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~  124 (398)
                      ..+++||+|+||+||+|.+. +|+.||||++.....                  .....+..|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            34689999999999999986 589999998753210                  11233557888999999999999886


Q ss_pred             EEEcCCCcEEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceeecccccCcEEeCCC
Q 015931          125 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  204 (398)
Q Consensus       125 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDlkp~NIll~~~  204 (398)
                      +.    . .+++|||+++..+.              .+++.....++.|++++|+|||+++   |+||||||+|||++++
T Consensus        82 ~~----~-~~lvme~~~~~~~~--------------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~  139 (191)
T d1zara2          82 WE----G-NAVLMELIDAKELY--------------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             EE----T-TEEEEECCCCEEGG--------------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred             ec----C-CEEEEEeecccccc--------------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence            52    1 27999999875542              1444556789999999999999988   9999999999999865


Q ss_pred             CCeeEeccccccccCCCCCceeeeccccCCCccc------chhhccCCcCCccchhhHHHHH
Q 015931          205 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA------PEYFQHGKVSDKTDVYAFGVVL  260 (398)
Q Consensus       205 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~ksDv~S~Gvvl  260 (398)
                       .++|+|||+|+....+....          |+.      .+.+ ...|+.++|+||..--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~~----------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWRE----------ILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHH----------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHH----------HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence             48999999998765443211          111      1222 35678899999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.54  E-value=1.2e-07  Score=83.47  Aligned_cols=148  Identities=17%  Similarity=0.128  Sum_probs=92.4

Q ss_pred             HHHHhhcCCCCCceecccCceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeEEEcCCCc
Q 015931           54 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQG  132 (398)
Q Consensus        54 e~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  132 (398)
                      |+...-..|...+..+.++.+.||+....  +..+.+|+...........+.+|...+..+. +--+-+++.++.+ ++.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~   84 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGW   84 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCc
Confidence            44444556655544443445789988643  5678889886554333445677888777663 3224555665544 345


Q ss_pred             EEEEEecCCCCCHHHHHhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------
Q 015931          133 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG----------------------------  184 (398)
Q Consensus       133 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~----------------------------  184 (398)
                      .++||++++|.++.+.....         ..   ...++.++++.+..||+.                            
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~---------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE---------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC---------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             eEEEEEeccccccccccccc---------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            78999999998876543211         11   122344445555555531                            


Q ss_pred             ----------------------------CCCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          185 ----------------------------TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       185 ----------------------------~~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                                                  ....++|+|+.|.||++++++.+-|.||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                        12238999999999999987767799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.92  E-value=2.8e-05  Score=67.41  Aligned_cols=74  Identities=16%  Similarity=0.076  Sum_probs=47.4

Q ss_pred             eecccCc-eEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCC--CCeeceeeEEEcCCCcEEEEEecCCCC
Q 015931           67 VLGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPEQGLFLIYKYVSGG  143 (398)
Q Consensus        67 ~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~lV~e~~~~g  143 (398)
                      .+..|.. +.||+..... +..+.+|.......   ..+..|...++.+..  -.+.+++.++.++ +..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccc-cceEEEEEeeecc
Confidence            3444553 6789987653 66788898765433   235667777766543  2245566665554 4578999999886


Q ss_pred             CH
Q 015931          144 SL  145 (398)
Q Consensus       144 sL  145 (398)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            54

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.88  E-value=5.5e-05  Score=70.29  Aligned_cols=76  Identities=17%  Similarity=0.053  Sum_probs=45.6

Q ss_pred             ceecccCceEEEEeeeCCCCcEEEEEEecCC-------ChhhHHHHHHHHHHHHhCC-C-C-CeeceeeEEEcCCCcEEE
Q 015931           66 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-------DKESSKAFCRELMIASSLH-H-P-NIVPLVGFCIDPEQGLFL  135 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~~l  135 (398)
                      +.||.|....||+.....+++.|.||.-...       ......+...|.+.|..+. + | .+.+++.+  +++. .++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~-~~l  108 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AVT  108 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC-CEE
Confidence            4689999999999988776788999975421       1112233456777776552 2 2 34445543  3344 379


Q ss_pred             EEecCCCCC
Q 015931          136 IYKYVSGGS  144 (398)
Q Consensus       136 V~e~~~~gs  144 (398)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.82  E-value=0.0029  Score=56.56  Aligned_cols=140  Identities=16%  Similarity=0.168  Sum_probs=74.0

Q ss_pred             ceEEEEeeeCCCCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-----ecee-eEEEcCCCcEEEEEecCCCCCH-
Q 015931           73 LSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-----VPLV-GFCIDPEQGLFLIYKYVSGGSL-  145 (398)
Q Consensus        73 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~-~~~~~~~~~~~lV~e~~~~gsL-  145 (398)
                      --.||++...+ |..|++|+..... ....++..|...+..+...++     +..- +.....++..+.++++++|..+ 
T Consensus        35 EN~vy~v~~~d-g~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDED-RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTT-CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCC-CCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            35899998864 8889999987542 234567778877766642211     1111 1111223446789999876322 


Q ss_pred             ----HHH---------Hhhhcc--CCCCCCCCCHHH----------------------HHHHHHHHHHHHHHH-HcCCCC
Q 015931          146 ----ERH---------LHEKKK--GVRGNSTLPWSV----------------------RYKVALGIAESVAYL-HNGTER  187 (398)
Q Consensus       146 ----~~~---------l~~~~~--~~~~~~~l~~~~----------------------~~~i~~qia~aL~yL-H~~~~~  187 (398)
                          ..+         ++....  .......+++..                      ....+..+...+.-+ .+....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                111         111100  000112222221                      111222222222221 122345


Q ss_pred             ceeecccccCcEEeCCCCCeeEecccccc
Q 015931          188 CVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       188 ~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      +++|+|+.+.|||++++  ..+.||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcc
Confidence            69999999999999754  4589998775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.50  E-value=0.0046  Score=56.78  Aligned_cols=73  Identities=14%  Similarity=0.181  Sum_probs=46.4

Q ss_pred             ceecccCceEEEEeeeCC-------CCcEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCee-ceeeEEEcCCCcEEEEE
Q 015931           66 RVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIY  137 (398)
Q Consensus        66 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~lV~  137 (398)
                      +.|+.|-.-.+|+.....       ....|.+++.-. .. ......+|..+++.+.-.+++ ++++++ .  +  .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~-~--~--g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIF-S--G--GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEE-T--T--EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEc-C--C--ceEE
Confidence            467778888999987643       235577766643 22 233455788888777534454 556554 2  2  5899


Q ss_pred             ecCCCCCH
Q 015931          138 KYVSGGSL  145 (398)
Q Consensus       138 e~~~~gsL  145 (398)
                      ||++|.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.16  E-value=0.038  Score=48.43  Aligned_cols=31  Identities=26%  Similarity=0.440  Sum_probs=27.2

Q ss_pred             CCceeecccccCcEEeCCCCCeeEecccccc
Q 015931          186 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  216 (398)
Q Consensus       186 ~~~ivHrDlkp~NIll~~~~~~kl~DfGla~  216 (398)
                      ..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4569999999999999988777899999764